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Beta 1 Integrin Associates with Caspase-8 and Triggers Anoikis in Human Keratinocytes
Lotti R, Marconi A, Panza MC, Pincelli C
Dermatology, University of Modena and Reggio Emilia, Italy
Anoikis is a mode of cell death that occurs after detachment from the extracellular matrix
(ECM). The anchorage of cells to the ECM is mainly mediated by integrins. We have shown
previously that blockade of beta 1 integrin signal induces apoptosis through the caspase-8
triggered apoptotic pathway. Anti beta1 integrin activates caspase-8 at 1 hr in human
keratinocytes. As the extrinsic apoptotic pathway is triggered by death receptor signal and
anoikis has been shown to be dependent from Fas/Fas ligand system, we first evaluated the
expression of Fas and Fas ligand in keratinocytes after addition of anti- beta 1 integrin.
Blockade of beta 1 integrin failed to up-regulate either Fas or Fas ligand in keratinocytes, as
shown by flow cytometry up to 3 hrs. Moreover, human keratinocytes retrovirally infected with
human Fas-associated death domain (FADD) shRNA underwent anoikis upon treatment with
anti beta 1 integrin antibody. These results indicate that death receptors are not involved in
caspase-8 mediated anoikis. In order to evaluate a correlation between caspase-8 and beta 1
integrin, we have immunoprecipitated beta 1 integrin in suspended cells and immunopre-
cipitate was blotted against caspase-8. We demonstrated that pro-caspase-8 co-
immuneprecipitate with beta 1 integrin and is cleaved starting at 1hr. These results seem
to indicate that unligated beta 1 integrin directly activates caspase-8 triggered extrinsic
apoptotic pathway, without the involvement of death receptors.
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EBBP is a Novel Interleukin-1beta (IL-1beta) Binding Protein Involved in IL-1beta
Activation and Secretion
Beer H1, Munding C2, Niklaus G1, Keller M1, Werner S1
1ETH Zu¨rich, Switzerland; 2King’s College London, United Kingdom
Keratinocytes of the epidermis constitute the first line of defense against the external
environment. They are a part of the innate immune system, which relies on a set of germline-
encoded receptors, specific for the detection of pathogen-associated molecular patterns that
are relatively invariant within a class of microorganisms. Recently, we identified the gene
encoding estrogen-responsive B box protein (EBBP) as a target of the epithelial mitogen
keratinocyte growth factor and we demonstrated a novel role of EBBP in keratinocyte
differentiation. EBBP (TRIM16) belongs to the same family of structurally related proteins as
Pyrin (TRIM20). Whereas mutations in the pyrin gene cause an antoinflammatory disease,
little is known about the biological function of EBBP. We identified the proinflammatory
cytokine proIL-1 as an interacting protein of EBBP. In addition, procaspase-1 and NALP1, two
components of the recently identified inflammasome, a platform for the activation of
procaspase-1, also interact with EBBP. All proteins bind to the carboxy-terminal RFP domain
of EBBP, suggesting that this domain of so far unknown function could be an important
protein binding domain. In addition, EBBP binds to procaspase-1 with its B box coiled-coil
(BBCC) domain. Transfection experiments with COS-1 cells or primary keratinocytes revealed
that EBBP activates procaspase-1 via its BBCC domain together with proIL-1, resulting in
enhanced proIL-1 maturation and secretion. EBBP is itself secreted in a procaspase-1-
dependent manner and this secretion is enhanced by proIL-1. These results suggest that
EBBP is an important player in the innate immune system. In contrast to its homologue Pyrin,
EBBP is an activator of the inflammasome, which recruits proIL-1 to this complex and
regulates the secretion of IL-1 and caspase-1.
003 [Oral 074]
IKKalpha Downregulation in Psoriasis: New Insights in the Pathway Regulating
Keratinocyte Proliferation
Giustizieri ML1, Koster M2, Marinari B1, Chimenti S1, Karin M3, Roop DR2, Costanzo A1
1Department of Dermatology, University of Rome Tor Vergata, Italy; 2Departments of
Molecular and Cellular Biology and Dermatology, Baylor College of Medicine, Houston TX,
USA; 3Department of Pharmacology, UCSD, La Jolla CA, USA
The rate of epidermal cell replication in psoriasis is markedly increased as suggested by the
higher number of basal and suprabasal mitotic figures. The source of cycling cells in
suprabasal layers is not yet well defined. It could be expanded population of basal
keratinocytes or could be cells committed to terminal differentiation that already express
markers of the spinous layer but still undergo rounds of amplifying divisions above basal
layer. We have confirmed that suprabasal cycling cells in psoriasis express the keratin marker
of the spinous layer K1. This K1 positive proliferating layer is reminiscent of the embryonic
intermediate layer, which transiently appears between the basal layer and the periderm at
early stages of embryogenesis and contains K1 positive proliferating cells, presumably to
accommodate the rapidly growing embryo. Interestingly the epidermis of IKKalpha knock-out
mice is composed of a basal layer and suprabasal layers composed by proliferating K1
positive cells that fail to exit the cell cycle and to form a spinous layer. Aim of our study was to
evaluate the potential involvement of the epidermis development regulator IKKalpha in the
formation of the K1 positive proliferating layer in Psoriasis. Therefore, we have IKKalpha
expression by immunohistochemistry in 5 biopsies from normal skin and 15 biopsies from
psoriasis plaques. We have observed a strong down-regulation of IKKalpha expression in all
psoriasis biopsies examined. IKKalpha downregulation occured at the transcriptional level as
detected by RT-PCR assays being the total amount of IKKa mRNA approximately one third of
the amount detected in wild type skin. IKKa downregulation in psoriasis is correlated to an
altered TAp63/DNp63 ratio that may contribute to IKKa transcriptional repression acting on
the p63 binding sites present on the IKKa promoter. These data suggest that, in analogy to
IKKa knock out mice, the low amount of IKKa in psoriatic epidermis may delay the exit from
the cell cycle of K1 positive cells thus contributing to psoriasis hyperproliferation.
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Retinoid Homeostasis in Skin is Dependent on Expression of CYP26AI that is Restricted
to Basal Keratinocytes in Normal Human Skin, Inﬂammatory Skin Diseases and
Differentiated 3D-Skin Models
Heise R1, Mey J2, Neis M1, Joussen S1, Marquardt Y1, Ott H1, Merk HF1, Baron J1
1Dept of Dermatology RWTH Aachen, Germany; 2Institute for Biology II RWTH Aachen,
Germany
Retinoids are potent regulators of cell proliferation, celldifferentiation, and morphogenesis.
Cellular levels of all-trans retinoic acid (ATRA) are meticulously regulated through a balance of
uptake, biosynthesis, catabolism and efflux-transport. Metabolic transformation of ATRA to
4-hydoxylated RA, a less activeand more readily excretable polar species appears to be
primarily catalyzed by the highly specific cytochrome P450 (CYP) enzyme 26AI. In this study
we have examined the expression and inducibility of CYP26AI by ATRA in normal human
epidermal keratinocytes (NHEK) and dermal fibroblasts on RNA and on protein level. Analysis
of monolayer cultures of NHEK and fibroblasts by quantitative real-time PCR, RT-PCR,
immunofluorescence and westernblot analysis revealed very low basal levels of CYP26AI
mRNA expression which was enhanced by addition of 106 M all-trans RA. Using a newly
developed peptide antibody we further examined the localisation of CYP26AI expression in
normal skin, inflammatory skin diseases and 3D skin models cultured for 21 days. In contrast
to the cell culture monolayers we showed strong constitutive expression of CYP26AI
restricted to the keratinocytes in the epidermal basal layer. These studies indicate that human
skin has the capacity to metabolise RA but that substantial differences exist in CYP
expression between normal skin and 3D skin models compared to monolayer cultures.
Complex metabolic processes such as retinoid metabolism may therefore be better studied
in model systems more closely resembling the in vivo situation such as 3D skin systems. In
light of our prior studies showing substantial retinoid metabolism in human skin fibroblasts
our data further confirm the concept that epithelial-mesenchymal cross-talk is likely to be an
important determinant of retinoid homeostasis in skin.
005 [Oral 076]
Epidermal Acetylcholine Receptors are Crucial for Epidermal Homeostasis
Kurzen H1, Booken D1, Henrich C1, Engstner M1, Maas-Szabowski N2
1University of Heidelberg, Germany; 2German Cancer Research Center, Heidelberg,
Germany
Increasing evidence suggests an important role of the extraneuronal cholinergic system in
skin physiology. The aim of the present study was to analyse the influence of cholinergic
(nicotine, carbachol, muscarine) and anticholinergic drugs (mecamylamine, atropine,
strychnine) on epidermal physiology using organotypic cocultures (OTC) as an in vitro skin
equivalent system. Immunofluorescence analysis was performed using the TUNEL assay, a
panel of antibodies against apoptosis markers, Mib-1, various differentiation markers and
adhesion molecules. Nile red was applied for visualization of lipids. Blocking of all
acetylcholine receptors (ACh-R) by combined treatment with mecamylamine and atropine
or treatment with strychnine (which blocks a9 ACh-R) for 5-12 days prevented the formation
of an intact epithelium. Blockage of nicotinic (n)ACh-R with mecamylamine led to a less
pronounced delay in epidermal differentiation and proliferation than blockage of muscarinic
(m)ACh-R with atropine, evidenced by reduced epithelial thickness and expression of
terminal differentiation markers like CK2e, CK10, ZO1 or filaggrin. In OTCs treated with
atropine, mecamylamine or strychnine we could demonstrate intracellular lipid accumulation
already in the lower epidermal layers indicating metabolical stress and a severely disturbed
epidermal barrier. In addition, we observed prominent acantholysis in the basal and lower
suprabasal layers in both, mecamylamine and atropine treated cultures, accompanied by a
decreased expression of several desmosomal (e.g. desmoglein 3, desmoplakin) and
adherens junction proteins (e.g. E-cadherin, b-catenin). Apoptosis was prominent as
evidenced by TUNEL assay and activated caspase 3 in the absence of elevated LDH levels
in the culture supernatant, indicating predominance of apoptosis over necrosis. In contrast,
stimulation of nACh-R and mACh-R with cholinergic drugs, resulted in a significantly
thickened epithelium accompanied by an increase of intercellular lipid content in the corneal
layer. CK2e, filaggrin and ZO1 showed a slightly extended expression in the upper epidermal
layers, whereas proliferation was not significantly increased. In summary we showed that
inhibition of epidermal ACh-R severely disrupts epidermal homeostasis. In particular, terminal
differentiation, barrier formation, cell adhesion, apoptosis and proliferation are controlled by
both nicotinic and muscarinic ACh-R.
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The Three Peptidylarginine Deiminases Expressed in Human Epidermis Differ by their
Substrate Speciﬁcities and Functional Properties: Evidence for the Involvement of PAD1
and PAD3 in Corniﬁcation
Me´chin MC1, Enji M2, Nachat R1, Chavanas S1, Charveron M3, Ishida-Yamamoto A4, Serre
G1, Takahara H2, Simon M1
1CNRS-Toulouse III University, UMR5165, France; 2Department of Applied Biological
Resourc, Japan; 3Institut de Recherche Pierre Fabre, Toulouse, France; 4Department of
Dermatology, Asahikawa Medical College, Japan
Deimination, a post-translational modification catalyzed by peptidylarginine deiminases
(PADs), appears as a crucial Ca2þ -dependent event in the last steps of epidermal
differentiation. In normal epidermis, three PADs are expressed (PAD1, 2 and 3) and the
major deiminated proteins are keratins and filaggrin. However, the relative role of each PAD is
not yet known. Here, we produced and purified active recombinant human PAD1-3 and
analyzed their biochemical properties using nine synthetic arginine-derivatives and human
filaggrin, either native or recombinant. The three PADs clearly showed distinct substrate
specificities. All of them were able to modify filaggrin, but with various efficiencies. They also
displayed different physicochemical characteristics, in particular calcium and pH sensitivities.
Furthermore, immunoelectron microscopy demonstrated for the first time that, in normal
human epidermis, PAD1 and PAD3 are located in keratohyalin granules in the stratum
granulosum, and co-located with filaggrin within the intracellular filamentous matrix of the
deeper corneocytes, where deimination of the protein takes place. PAD1 is the only isoform
to persist up to the upper stratum corneum where keratin K1 is deiminated. These results
demonstrate that PAD1 is responsible for the deimination of keratin K1, supposed to be
related to ultrastructural changes of the corneocyte matrix. They strongly suggest that PAD1
and PAD3 are involved in the modification of filaggrin an essential step leading to free amino
acid production necessary for epidermal barrier function.
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The Function of the N-terminal Domain of TGF-bII: A Systematic Genome-wide Protein-
Protein Interaction Study in Human Keratinocytes
Niedermayr P1, Bauer JW1, Hintner H1, Kern T2, Strasser W2, Siegl D2, Oender K1
1Department of Dermatology and 2Department for Research and Technology, Paracelsus
Private Medical University, Salzburg, Austria
The transforming growth factor-b (TGF-b) superfamily consists of a large number of
structurally related protein growth factors. TGF-b is a central regulator of the immune
system, promotes proliferation and differentiation of mesenchymal cells but strongly inhibits
epithelial cell proliferation and modulates angiogenesis and apoptosis. TGF-b initiates it’s
diverse cellular responses by binding and activating specific cell surface receptors that have
intrinsic serine/threonine kinase activity. The ligands are synthesized as large precursor
molecules that undergo proteolytic cleavage, releasing the N-terminal pro-domain from the
active, receptor binding, carboxy-terminal regions of the molecule. We isolated a variant of
the TGF-b II molecule created by a frame-shift mutation leading to a premature stop-codon.
This shorter variant (TGF-bII-s) is missing the active, receptor binding, C-terminal region. To
study TGF-bII-s in greater detail we first performed a yeast two hybrid screen with the
wildtype TGF-bII molecule against a keratinocyte library. In the resulting clones we identified
a novel interacting 25 kDa protein. This specific yeast two-hybrid interaction was confirmed
by immune precipitation analysis in vitro and by our in silico protein-protein interaction
validation tool. Moreover, TGF-bII-s was cloned into the bait vector and tested for interaction
capability with the wild type TGF-bII interacting clones. 10 out of 11 clones tested interacted
also with the TGF-bII-s. This indicates a TGF-b II receptor independent functionality since the
TGF-bII-s is lacking the active part of the TGF-b molecule. Only 1 from the tested prey
plasmids is not interacting with TGF-bII-s leading to the known TGF-b receptor mediated
pathway. These results indicate, that the majority of the isolated protein interaction partners
of TGF-bII are involved biological functions other than the known active receptor related
functions. Therefore, applying our systematic, proteomic approach we identified the TGF-b II
N-terminal pro-domain as a novel biologically active protein, probably contributing in
extracellular transport of TGF-bII producing cells or in the maturation of the precursor protein.
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MTS24 Expression Delineates a Population of Murine Hair Follicle Keratinocytes with
Stem Cell Characteristics
Nijhof J1, Braun K2, Giangreco A2, Van Pelt C1, Kawamoto H3, Boyd R4, Willemze R1,
Mullenders L1, De Gruijl F1, Van Ewijk W1
1Leiden University Medical Centre, The Netherlands; 2Cancer Research UK, United
Kingdom; 3Laboratory for Lymphocyte Development, RIKEN Yokohama Institute, Japan;
4Monash University, Australia
Epidermal stem cells are rarely dividing and highly persistent cells, localized in the hair follicle
bulge and the interfollicular epidermis. The identification of epidermal stem cells is critical to
our understanding of their role in skin homeostasis, wound healing and diseases like skin
cancer. MTS24 is a glycoprotein with a peptide backbone of  80 kD expressed on a rare
subset of epithelial progenitor cells in the thymus. In this study we describe the expression of
MTS24 in the murine hair follicle bulge. We characterized the MTS24þmouse keratinocytes
by the use of fluorescent-activated-cell sorting (FACS) and in vitro studies. We found that
MTS24 is membrane bound and predominantly expressed in the growing hair follicle of
several mouse strains (C57Bl/6, Balb/c, SKH1 and nude). MTS24 expression co-localizes
with expression of alpha-6 integrin and keratin 14 but not with keratin 10, keratin 15 and
CD34. Interestingly, BrdU-label retaining cells were found within the MTS24þ cell population,
confirming that MTS24þ cells are rarely dividing and highly persistent. Subsequently, we
enriched keratinocyte fractions for alpha-6 integrin and MTS24 by FACS-sorting. Sorted cells
were seeded at a density of 1000 cells/well on a J2-3T3 feeder layer and the formation of
colonies was determined after culturing for two weeks. We found that the alpha 6þ /
MTS24þ cells produced larger colonies than the alpha 6þ /MTS24- cells. Additionally, the
colony forming efficiency of alpha 6þ /MTS24þcells was significantly higher (5.53  1.44%)
than of the alpha 6þ /MTS24- cells (1.27  0.25%), suggesting that MTS24þ cells have a
high in vitro proliferative capacity. Taken together, these data indicate that MTS24, originally
found as a marker for thymic epithelial precursor cells, is also expressed on a population of
hair follicle keratinocytes with stem cell characteristics.
009 [Oral 080]
Do we Still Need Animal Experiments? A Human In Vitro Model for Efﬁcient Gene Knock
Down in the Skin
Mildner M, Stichenwirth M, Karner S, Tschachler E
Medical University Vienna, Austria
In the past great efforts had been made to search for alternative methods to animal
experiments. Especially for the investigation of the involvement of specific genes in the
development of different organs, the generation of knock out or transgenic animals is still
indispensable. In this study we present a new method to analyze specific gene knock down in
a human artificial skin model. Since the recently published matriptase knock out mouse show
a very severe skin phenotype, we have chosen this serine protease to compare the results of
the knock out mouse to our skin model. We first transfected primary keratinocytes with
matriptase specific RNAi. 24 hours after transfection expression of matriptase was blocked
by more than 95%. We then prepared 3D skin equivalent cultures from these cells and
allowed them to grow for 7 days. Similar to the skin of the matriptase knock out mouse
transplanted unto a scid mouse, we found an impaired differentiation of the keratinocytes in
the skin equivalent cultures i.e. extensive hyper- and parakeratosis. Furthermore, we could
show that, as in the knock out mouse, filaggrin processing was impaired, resulting in an
intermediate filaggrin form and the loss of fully processed filaggrin monomers. In summary,
we have shown for the first time that a specific gene knock down in an artificial skin model
shows effects comparable to those observed in the corresponding knock out mouse. One
strong advantage of this model is, that as compared to the generation of knock out or
transgenic animals, the in vitro knock down is less expensive and much less time consuming.
In addition it is possible to investigate the direct involvement of target genes in skin
development/differentiation, without the influence of any other cell type. We believe that this
model could strongly reduce the necessity of animal experiments in dermatological research.
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STAT5 Phosphorylation in Malignant Melanoma is Mediated through SRC and JAK-1
Kinases and Exerts Anti-Apoptotic Effects
Mirmohammadsadegh A, Hassan M, Gustrau A, Selimovic D, Doroudi R, Schmittner N,
Nambiar S, Marini A, Ruzicka T, Hengge U
Heinrich-Heine-University, Du¨sseldorf, Germany
Altered signaling pathways are key regulators of cellular functions in tumor cells. Constitutive
activation of signal transducer and activator of transcription (STAT) proteins, particularly
STAT3 and STAT5, may be involved in tumor formation and progression. In the present study,
we have investigated the role of STAT5 in cutaneous metastases of human malignant
melanoma. In 13 of 21 (76%) human melanoma metastases STAT5 was activated in
comparison to normal human melanocytes (NHM). Stat5b transcripts were upregulated
approximately 4-fold in the examined samples. The STAT5 target genes BCL-xL, BCL-2 and
c-MYC were frequently upregulated in melanoma metastases. The investigation of the
underlying mechanisms in melanoma cell lines revealed specific STAT5 activation by
recombinant human epidermal growth factor (rEGF). rEGF-induced activation of STAT5
occurred in vitro particularly through the non-receptor tyrosine kinases SRC and JAK1.
Stimulation with rEGF led to increased STAT5 DNA-binding activity, suggesting an important
role of the EGF-receptor in STAT5 signaling and malignant progression of melanoma.
Transfection with dominant-negative Stat5b led to enhancement of cell death and G1 arrest in
A375 melanoma cells and correlated with reduced expression of anti-apoptotic BCL-xL. Our
study suggests that activated STAT5 acts as a survival factor in the development and growth
of human melanoma and may hold potential for molecular therapy.
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The Search of New Markers of Keratinocyte Differentiation
Lemaitre G1, Gonnet F2, Lamartine J1, Le Minter P1, Vaigot P1,2, Gidrol X1, Tortajada J2,
Martin MT1, Waksman G1
1Universite´ Evry, CEA, France; 2Universite´ Evry, CNRS, France
The knowledge of the mechanism of keratinocyte differentiation is still uncompleted. The aim
of present study was to identify new markers involved in this process. The emergence of new
technologies, such as DNA microarrays or proteomic analysis, allowed us to identify genes
and proteins expressed in keratinocyte differentiation. A transcriptome analysis of
proliferating versus differentiated human keratinocytes was performed and revealed 33
transcripts that had not been previously described as differentially expressed in proliferating
versus differentiated keratinocytes. Some of these transcripts were similarly regulated in
human primary keratinocytes and in healthy epidermis. In addition, microarrays data analysis
revealed a co-regulation of some genes suggesting a common transcriptional regulation
during differentiation. Besides transcriptome, we performed a proteomic study, focused on
plasma membrane microdomains called caveolae. We characterized fifty three proteins of
which 26% were transmembrane and 32% associated-membrane proteins. The identification
of these plasma membrane markers isolated from caveolin-1-enriched microdomains
revealed that CD98-positive keratinocytes represented transient amplifying human keratino-
cytes. CD98 was found to be co-localized with b1 integrin at the plasma membrane of the
basal keratinocytes of healthy human epidermis. Furthermore, keratinocytes expressing high
level of a6 integrin was highly positive to CD98 suggesting that this marker could be used for
sorting basal cells and subsequently adult epidermal stem cells.
In summary, these studies bring new knowledge on keratinocyte differentiation and open
new areas of investigation in the comprehension of this process.
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The 27kD Heat Shock Protein and MAPK Signalling are Required for Epidermal
Differentiation
Jonak C, Kokesch C, Klosner G, Mildner M, Fo¨dinger D, Trautinger F
Medical University of Vienna, Austria
In human epidermal keratinocytes the expression of hsp27 is closely related to differentiation
in vitro and in situ. This project was aimed to gain further insight into the role of hsp27 in
epidermal differentiation by gene mediated overexpression, specific inhibition by siRNA, and
inhibition of p38-MAPK, the key enzyme in hsp27 phosphorylation.
Normal human keratinocytes (NHEK), the cell line A431, and organotypic skin cultures were
used. Hsp27 was either overexpressed by transfer of the human gene to A431 or inhibited in
organotypic cultures by siRNA. SB203580, a specific inhibitor of p38-MAPK, was used to
inhibit hsp27 phosphorylation. Tissue cultures were investigated by electron microscopy,
immunofluorescence and western blot for changes in ultrastructure and expression of hsp27,
loricrin, filaggrin, transglutaminase1, actin, and keratins.
Hsp27 co-localized with differentiation antigens in A431, NHEK, and organotypic cultures.
Both, overexpression of hsp27 in A431 and inhibition of hsp27-phosphorylation by SB203580
in NHEK changed the expression pattern of differentiation associated proteins. In organotypic
cultures inhibition of p38-MAPK and downregulation of hsp27 through siRNA resulted in
irregular differentiation and in disturbance of epidermal layers.
These results provide evidence that expression of hsp27 and phosphorylation by p38-
MAPK are required for keratinocyte differentiation and for the formation of a regularly
stratified epidermis.
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Keratinocyte-Speciﬁc Knockout of the Respiratory Chain Shows that Functional
Mitochondria Are Essential for Epidermal Differentiation
Schauen M1, Wille A1, Wickenhauser C2, Niessen C3, Krieg T4, Wiesner R1
1Institute of Vegetative Physiology, University of Ko¨ln, Germany; 2Department of Pathology,
University of Ko¨ln, Germany; 3Center for Molecular Medicine, University of Ko¨ln, Germany;
4Department of Dermatology, University of Ko¨ln, Germany
To elucidate the role of the mitochondrial respiratory chain in epidermal proliferation in vivo,
we have bred mice with an epidermis-specific deletion of the Tfam protein. This protein
controls the cellular amount of mitochondrial DNA (mtDNA), which is essential for respiratory
chain function. We have crossed mice having exons 6 and 7 of the Tfam gene flanked by
loxP-sites with mice carrying the Cre-recombinase transgene under control of the
keratinocyte-specific human K14 promoter. At the day of birth, Tfam protein is still detectable
in the epidermis, but older knockout animals show a progressive loss. At postembryonic day
6, the mtDNA-encoded subunit II of cytochrome oxidase is not detectable any more. The
epidermis gradually gets thinner, the basal layer is disordered, hair follicles fail to develop
normally and there is still no pelage at day 6. The knockout mice stop gaining weight at day 3
and die between day 4 and day 7. The tongue epithelium is also disordered and papillae show
a progressive degradation. The animals develop an ulceration at the back of the tongue, the
resulting pain probably inhibiting food intake, leading to the observed weight loss and
ultimately death. Considering the proposal by some authors that the epidermis is a
physiologically anaerobic tissue, the drastic effect of ablating respiratory chain activity is
even more striking. A HeLa cell line without mtDNA used as a model system showed a
profound proliferation defect, an effect not simply due to energetic or biosynthetic problems,
since levels of ATP, UTP, heme containing proteins and FeS cluster enzymes were normal.
These results point to a hitherto unknown role of mitochondria in cellular proliferation and
differentiation. In vivo, an intact mitochondrial respiratory chain is essential for differentiation
of epidermis and tongue epithelium.
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Survivin is Overexpressed in Keratinocyte Stem Cells and is Down-Regulated by Pro-
Apoptotic Agents
Marconi A1, Panza MC1, Lotti R1, Vaschieri C1, Peris K2, Pincelli C1
1Dermatology, University of Modena and Reggio Emilia, Italy; 2Dermatology, University of
L’Aquila, Italy
Survivin belongs to the family of inhibitor of apoptosis proteins (IAP) and it is involved in
regulation of cell death as well as cell division. It has been reported that survivin is almost
exclusively expressed in cancer tissues and in fetal stem cells, but not in adult normal cell
populations. By contrast, we have shown previously that survivin is expressed in the basal
layer of adult normal human epidermis. The aim of the present study was first to evaluate the
expression of the three splice variants of survivin in adult keratinocyte stem cells (KSC). RT-
PCR showed that survivin, survivin-2B and survivin DEx3 are expressed at highest levels in
KSC, while they tend to decrease in transit amplifying (TA) cells and disappear in post mitotic
cells (PM). Western blot analysis further confirmed that survivin is overexpressed in KSC.
Blocking b1 integrin signal strikingly down-regulates survivin expression and induces
apoptosis in human keratinocytes, indicating that the antiapoptotic function of survivin is
involved in the survival signal mediated by integrins. As psoriasis is characterized by a
reduced rate of apoptosis, we wanted to evaluate survivin expression in this hyperprolifera-
tive skin condition. Indeed, survivin is expressed throughout the epidermal layers in psoriasis.
Finally, as imiquimod has been used as a proapoptotic agent in antitumoral therapy, we
treated both squamous cell carcinoma (SCC) and Bowen’s disease lesions with imiquimod for
three months and compared skin pathology before and after treatment. In SCC, survivin was
localized in scattered suprabasal keratinocytes, while in Bowen’s lesions it was expressed in
most suprabasal keratinocytes. In both neoplastic conditions, surviving staining was at the
nuclear level. Imiquimod treatment reverted the histologic phenoytpe to normal surviving
expression with cytoplasmic staining. This study indicates that survivin protects KSC from
apoptosis and can contribute to the development of hyperproliferative skin diseases and to
skin tumorigenesis.
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The EGF Receptor of Normal Primary Cultured Keratinocytes is Activated by a Depletion
of Membrane Cholesterol but is not Responsible for Alteration of the Cell Phenotype
Poumay Y1, Ameels H1, Jans R1, Mathay C1, Lambert S1, Gniadecki R2
1University of Namur, Belgium; 2University of Copenhagen, Denmark
In many cell types, a depletion of membrane cholesterol activates signaling proteins like
epidermal growth factor receptor (EGFR), the human epidermal growth factor receptor 2
(HER2 or c-erbB2), or extracellular signal-regulated kinases (ERK). In this study, we explored
the effects of a treatment with methyl-beta-cyclodextrin (MbCD) in order to extract
membrane cholesterol from human primary cultured keratinocytes. MbCD treatment induces
phosphorylation of EGFR, HER2, and ERK, but not HER3. Analysis of the expression of
differentiation marker genes in early differentiating confluent cultures reveals that cholesterol
depletion induces downregulation of keratin 10 (K10) and upregulation of involucrin. Inhibition
of EGFR with PD153035 impairs the MbCD-induced phosphorylation of EGFR, HER2, and
ERK, but does not impair the alteration of K10, and involucrin gene expression, indicating that
other signalling proteins, actually the p38 MAP kinases, regulate this phenomenon. Although
the activation of EGFR by EGF results in cellular internalisation of the receptor, the activation
of EGFR by cholesterol depletion does not induce the same phenomenon. Thus cholesterol
likely interacts with keratinocyte membrane receptors of the EGFR family in keratinocytes,
but their activation is not responsible for alterations of the cell phenotype induced by
depletion of cholesterol. Other signalling cascades involving p38 must be activated by
cholesterol depletion through other interactions with the plasma membrane. PKC was a
candidate for such an interaction, but pharmacological inhibition of PKC using GF109203X
strongly suggests that another signalling cascade is involved. This is currently under
investigation.
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Heat Shock Protein 27 is Upregulated with Epidermal Differentiation in Human
Keratinocytes but is only Partly Under the Control of MAPKinase p38
Poumay Y, Brumenil V, Messinne A, Dupont F, Mathay C, He´rin M
University of Namur, Belgium
The heat shock protein (HSP) 27 is a member of the family of small human HSPs. This protein
has been found expressed by epidermal keratinocytes and its level of expression has been
linked to their differentiation. In this study, we have used cell density (i.e. culture confluence)
in order to induce differentiation of human keratinocytes cultured in autocrine conditions.
These conditions mean that cells were grown autonomously in absence of any exogenous
peptide growth factor. When differentiation was induced in this model, there was a clear
upregulation of the level of transcripts encoding HSP27. Simultaneously, the protein level of
HSP27 also increased with confluence, but particularly its phosphorylation was increased.
This phosphorylation was even higher when the culture was studied 4 days or more after the
confluence was reached. The phosphorylation of HSP27 has been shown to depend on the
activity of the MAPKinase p38, through the MAPKAP kinase 2 as intermediate. Using two
pharmacological inhibitors of MAPKinase p38 (SB202190 and PD169316) we observed that
phosphorylation of HSP27 was only partly inhibited by these compounds, suggesting that, up
to a certain level, the phosphorylation of HSP27 in differentiating keratinocytes does not
depend solely on p38 activity. The treatment of keratinocytes with TPA or their depletion in
membrane cholesterol by methyl-beta-cyclodextrin result in an induction of one later marker
of epidermal differentiation, i.e. involucrin. These two treatments activate different isoforms of
p38 and were found to increase simultaneously the phosphorylation of HSP27, further
demonstrating a link with epidermal differentiation. Contrarily, induction of p38 activation by
inhibition of the Rho/ROCK cascade was not associated with an increased phosphorylation
of HSP27. Thus, HSP27 in keratinocytes is phosphorylated during epidermal differentiation,
but this is not totally controlled by p38 activation. The roles of different p38 isoforms and the
intermediate between p38 and HSP27 need to be clarified.
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Cholesterol Depletion from the Membranes Activates EGFR in HaCaT Keratinocytes
without Participation of the Ligand
Lambert S1, Gniadecki R2, Poumay Y3
1Bispebjerg Hospital, Denmark; 2Biespebjerg Hospital, Denmark; 3University of Namur,
Belgium
Lipid rafts are membrane microdomains, which are enriched in cholesterol and form distinct
liquid-ordered phases in a lipid bilayer. Rafts have been implicated in the regulation of signal
transduction and membrane trafficking. Some receptors, such as Fas in HaCaTcells or EGFR
in COS-1 cells have been shown to be localized in lipid rafts and activated by cholesterol
depletion.
Since EGFR plays an important role during embryonic development and controls a wide
variety of biological responses in the epidermis such as proliferation, differentiation, migration
and modulation of apoptosis, we investigated whether lipid raft integrity influences the
activation of EGFR and its downstream signalling pathways. Pharmacologic disruption of lipid
rafts has been achieved by cholesterol sequestration by MbCD or filipin III.
Our results show that EGFR is phosphorylated after MbCD treatment and clustering of the
receptor was observed. The activation of EGFR appears to be ligand-independent as the
receptor remains activated in the presence of a neutralizing antibody.
We also investigated the downstream pathways of EGFR after cholesterol depletion and
found, in addition to the expected activation of Erk 1/2, phosphorylation of stress-activated
protein kinase p38. These events were dependent of EGFR tyrosine kinase activity as
incubation with tyrphostin AG1478 inhibited partially the p38 activation and totally blocked
the Erk 1/2 activity. The level and time-course of Erk 1/2 activation by EGF or MbCD seem to
be comparable. Thus, the pharmacologic manipulations of membrane lipid affect the activity
of EGFR in keratinocytes.
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Analyzing Interferon-c Responses in Primary Human Keratinocytes using 18O Labelling
and Liquid Chromatography-Electrospray Ionisation Ion Trap Mass Spectrometry
Hensbergen P, Balog CI, Weerheim AM, Deelder AM, Tensen CP
Leiden University Medical Center, The Netherlands
Interferon-g (IFN-g) is considered a key cytokine in innate and adaptive immunity. It affects
many cell types, thereby inducing an array of biological responses. Through stimulation of
keratinocytes, IFN-g is e.g. known to induce the production of several chemokines. These
small secreted, heparin binding proteins play an essential role in the directed migration of
leucocytes through activation of seven transmembrane G-protein coupled receptors. In the
present study we aimed to determine the total spectrum of heparin binding proteins that are
induced following IFN-g stimulation of primary human keratinocytes using trypsin catalysed
18O labelling and liquid chromatography-electrospray ionisation ion trap mass spectrometry.
Primary human keratinocytes were stimulated with 2000 U of IFN-g or left untreated for 6 hr.
Following removal of IFN-g, cells were incubated O/N in collection medium. Heparin affinity
chromatography was subsequently performed on the collected media and fractions of
heparin binding proteins were digested using trypsin. These fractions were concentrated, and
trypsin catalysed 18O exchange was subsequently performed on the IFN-g treated sample
while the unstimulated sample was treated similarly using 16O water. Untreated and IFN-g
stimulated samples were subsequently mixed and analysed by reversed phase nano-LC-MS
using an Ultimate nano-liquid chromatography system (Dionex) coupled to an Esquire HCT
ion trap mass spectrometer (Bruker).
We have identified at least 40 heparin-binding proteins in culture media of (IFN-g
stimulated) primary human keratinocytes. Following stimulation with IFN-g, we could identify
all three ligands for the chemokine receptor CXCR3. These chemokines were not identified in
LC-MS runs of samples from unstimulated cells. We confimed the induction of these
chemokines using 18O-labeling and mixing of IFN-g and untreated samples, demonstrating
the validity of our approach. In addition, our analyses clearly demonstrated other quantitative
differences in several other heparin-binding proteins between IFN-g stimulated and
unstimulated keratinocytes. In conclusion, our approach appears to be well suited for the
proteomic analysis of keratinocyte derived secreted proteins.
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Propionibacterium acnes Modulates Keratinocytes Proliferation and Differentiation
Jarrousse V1, Castex-Rizzi N2, Khammari A1, Charveron M2, Dreno B1
1Laboratoire de Dermatoimmunologie, INSERM U601 Nantes, France; 2Laboratoires Pierre
Fabre, Toulouse, France
Propionibacterium acnes plays an important role in the pathogenesis of acne vulgaris and it is
established that P.acnes is involved in the induction and maintenance of the inflammatory
phase of acne. At present, few studies focused on P.acnes and keratinocytes interactions.
The aim of our work was to determine whether P.acnes is implicated in the abnormal
keratinocytes proliferation and differentiation, which constitute an important step in acne
genesis.
Proliferative, differentiation and integrins b1, a3, a6, aV/b6 markers were examined on
normal human keratinocytes monolayers and on deep-frozen sections of normal human skin
explants after incubation with three different bacterial extracts (membrane fraction (FM),
supernatant A (SA) and B (SB)). Ki67, Integrins, and Filaggrin expression were investigated by
immunohistochemitry and flow cytometry.
P acnes extracts (not supernatants) induced an increase of the proliferation of
keratinocytes confirmed both by MTT viability test and Ki67. Both supernatants and P acnes
extracts induced filaggrin expression by suprabasal layer (granular and spinous) and by basal
layer on explants skin models (the strongest effect was observed with supernatants). This
effect was not obtained with keratinocytes monolayers where keratinocytes were not
differentiated. In a similar manner, the expression of integrins was also modified on explants
skin models (not modified on keratinocytes monolayers).
In conclusion, our work shows that the components of the membrane wall of P.acnes are
able to directly stimulate keratinocytes proliferation and that soluble factors present in
supernatants stimulate more keratinocytes differentiation, thus suggesting that the bacteria is
implicated in acne as soon as in the formation of microcomedone. Moreover, our results show
that keratinocytes have to be engaged in a differentiating process for interacting with
P.acnes. It is the first time that direct interaction between P. acnes and keratinocytes are
shown confirming that P. acnes is a crucial target in the strategy of treatment of acne lesions.
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Desmosealin Differs from the Other Epidermal Proteoglycans by its Expression Closely
Dependent on the Terminal Differentiation of Keratinocytes
Le Bitoux Ma1, Bertino B2, Duhieu S1, Zabawski B1, Schmitt D1, Denis A3, Rosdy M2, Pernet
I3, Haftek M1
1Universite´ Claude Bernard Lyon 1, EA3732, France; 2SkinEthic, Nice, France; 3Laboratoire
Bioderma, Lyon, France
Intercellular spaces of human epidermis contain extracellular matrix elements, such as
proteoglycans (PG), which are susceptible of influencing the cell behaviour, e.g. regulate cell
proliferation, migration or differentiation. We have previously described a new epidermal PG,
desmosealin, present between keratinocytes and integrated into the extracellular parts of
desmosomes.
Differentiation–related expression of desmosealin in normal human epidermis could be
demonstrated with post-embedding immunogold labelling. We have also studied the
expression of desmosealin and the other epidermal PG in various immersed and air-exposed
keratinocyte cultures, in order to better understand their implication in the biology of
epidermal cells. The reconstructed tissues were studied with antibodies to desmosealin/
KM48, syndecans 1 & 4, CD44/epican, a novel chondroitin/dermatan sulphate PG (7C1), and
to ‘‘differentiation antigens’’ such as suprabasal keratins, involucrin, or filaggrin, using
immunoperoxidase detection with a DAKO kit.
Contrary to the rest of the epidermal PG, desmosealin was not observed in the poorly
differentiated immersed cultures, whereas 7C1 expression was rudimentary. In the stratified
air-lifted cultures, all the epidermal layers were present, but the PG expression varied
according to the culture conditions and the composition of the medium. Specifically,
desmosealin wasn’t found in the lifted cultures in the presence of foetal calf serum. Only
emerged cultures obtained with a defined medium [citation removed] and, in particular, the
SkinEthic model of reconstructed human epidermis allowed for expression of this PG.
Cultures of keratinocytes from various donors of different ages were compared and some of
them tested in the presence of retinoic acid. The distinctive pattern of desmosealin
expression indicates a more specific involvement of this PG, incorporated into desmosomes,
in the process of epidermal keratinisation.
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The Receptor for the Morphogen Ectodysplasin A is Selectively Expressed by Epidermal
Stem Cells Postnatally
Gaide O, Roques S, Preynat-Seauve O, French LE
Dept of Dermatology, Geneva University Hospital, Switzerland
Ectodysplasin A (EDA), a member of the tumor necrosis factor (TNF) superfamily of ligands, is
required for the organogenesis of skin-derived structures such as teeth, hair and sweat
glands. Mutations affecting EDA or its signaling pathway result in a disease called
Hypohidrotic Ectodermal Dysplasia (HED). We have shown that a recombinant form of EDA
could cure murine HED provided that the treatment was initiated before day 5 after birth. This
suggests that EDA Receptor (EDAR) expression or signaling may be lost shortly after birth.
EDAR expression in the developing fetus has been well characterized, yet little is known
about its postnatal expression.
Herein we have analyzed EDAR expression using both RT-PCR and FACS analysis on
freshly isolated keratinocytes from postnatal mouse epidermis and the outer root sheath of
adult human hair. We show that EDAR is expressed by basal keratinocytes expressing both
the alpha6 and CD34 cell surface markers. In the epidermis, alpha6 expression is limited to
cells of the basal layer, whereas CD34 is classically expressed on dendritic cells. However,
CD34 has recently been demonstrated to also be expressed by a subset of basal
keratinocytes with stem cell properties. The alpha6þCD34þdouble positive keratinocyte
population, which express EDAR, are therefore believed to be stem cells or transit amplifying
cells. This suggests that keratinocytes with potential to respond to EDA exist in long-lived
cells of the basal compartment of adult epidermis.
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Keratinocyte Growth Factor: A Cytoprotective Factor for Keratinocytes
Braun S, Krampert M, Born-Berclaz C, Werner S
Institute of Cell Biology, ETH Zu¨rich, Switzerland
Keratinocyte growth factor (KGF) is a potent mitogen for epithelial cells and it promotes
survival of these cells under stress conditions. In mouse models, a cytoprotective effect of
KGF has been demonstrated for several organs, including the gastrointestinal tract, the lung
and the bladder. For example, recombinant KGF was successfully used as a pre-treatment for
intestinal damage caused by radiation and/or chemotherapy, i.e. KGF treatment resulted in a
remarkable reduction of the mortality rate, reduced weight loss, and in a significant increase
in mucosal thickness and crypt survival in the small intestine. In clinical studies, KGF
decreased the duration and incidence of severe oral mucositis in patients undergoing bone
marrow transplantation treatment for hematologic malignancies, such as lymphoma, multiple
myeloma, and leukemia.
The mechanisms, which underlie this protective effect of KGF, have only partially been
elucidated. To further study this effect and to determine if KGF also exerts a protective
function in the skin, we established an in vitro system where we pre-treat keratinocytes with
KGF and subsequently stress the cells with cytotoxic agents. Using this assay we found that
KGF does not protect keratinocytes from cell death induced by reactive oxygen species and
apoptosis-inducing and glutathione-depleting agents, but from the toxicity of xenobiotics
with electrophilic and oxidative properties. Additionally, KGF can protect from cell death
induced by UV irradiation. Finally, we demonstrate that the promotion of cell survival does not
rely on a single signaling pathway, but rather requires protein de novo synthesis, indicating
that the effect is mediated by an induced expression of a set of cytoprotective genes.
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The Expression of Keratinocyte Growth Factor Receptor is Associated with the High
Proliferative Rate of Immortalized HaCat Keratinocytes and is Up-Regulated in Psoriatic
Epidermis
Nagy N1, Bata-cso¨rgo˜ Zs1, Kopasz N1, Szeg Cs1, Pivarcsi A1, Koreck A1, Dobozy A1,
Keme´ny L1, Sze´ll M2
1University of Szeged, Hungary; 2Dermatological Research Group of the Hungarian
Academy of Sciences, University of Szeged, Hungary
Keratinocyte growth factor receptor (KGFR) is a tyrosine kinase receptor expressed by
keratinocytes and mediating the effects of fibroblast growth factors (FGFs). There are
contradictory data in the literature according to the role of KGFR during the proliferation/
differentiation program of keratinocytes. In this work we aimed to study the expression of
KGFR in in vitro cultured HaCaT keratinocytes and in psoriasis. We performed Real-Time RT-
PCR and Western blot analyses. Both KGFR mRNA and protein expression correlated with
the proportion of cells in S/G2/M phase in synchronized HaCaT cells and thus with
proliferation activity. After treatment with the antipsoriatic drug, dithranol, KGFR was down-
regulated dose dependently both at the mRNA and protein levels. When cell attachment was
inhibited, and the differentiation of HaCaT keratinocytes was induced by culturing them in
suspension, KGFR mRNA and protein expressions were reduced. We also compared the
expression of KGFR mRNA in psoriatic lesional, non-lesional and normal epidermis and we
found that KGFR mRNA was up-regulated both in uninvolved and involved psoriatic
epidermis compared to normal epidermis. Based on the results of our experiments we
conclude that KGFR expression in keratinocytes corresponds with the proliferative activation
of the cells and is not related to the differentiation program.
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The Raftosome: Initial Characterization of a Distinct Subcellular Structure in Keratinocyte
Line HaCaT
Wojewodzka U1, Vind-Kezunovic D2, Gajkowska B1, Gniadecki R2
1Dept of Cell Ultrastructure, Polish Academy of Sciences, Warsaw, Poland; 2Bispebjerg
Hospital, University of Copenhagen, Denmark
Lipid rafts are very small membrane microdomains enriched in cholesterol, glycosphingo-
lipids and sphingomyelin. The important property of these microdomains is the liquid ordered
(lo) state of the constituent lipid molecules in contrast to the less dense, liquid disordered (ld)
portions of the membrane composed mainly of phospholipids. Rafts play crucial role in matrix
adhesion, establishment of cellular polarity, cell migration, vesicular transport, and finally in
cell signaling processes due to their ability to compartmentalize many types signaling
molecules (receptor tyrosine kinases, G-protein coupled receptors, non-receptor tyrosine
kinases). Basic lipid raft units have tendency to aggregate to form larger units. Our previous
research has shown that in cultured normal keratinocytes and intact epidermis the
aggregates of rafts may be visualized by staining of their GM1 ganglioside component by
fluorescently-tagged B1 subunit of the cholera toxin (CTx). These structures are stable and
fairly large (a micrometer range). Here we have documented by FRAP technique that lateral
molecular mobility within superrafts is significantly lower than in the surrounding parts of the
membrane, confirming their lo lipid structure. Double staining experiments for confocal
microscopy revealed spatial overlap between CTxbright raft aggregates, caveolin 2 and flotillin
2, and patches of cortical F-actin. Immunoelectron microscopy observations showed that
these structures are preferentially located in cellular microvilli in the vicinity of actin filament
meshwork. Raft disruption by cholesterol sequestration by methyl-b-cyclodextrin led to
balloon distension and blebbing of microvilli and caused rearrangement of actin microfila-
ments. Conversely, actin-disrupting agents perturbed the structure of raft aggregates. We
propose the term ‘‘raftosome’’ to describe these distinct structures composed of lipid raft
aggregates and cortical actin. Raftosomes are likely to play role in the control of membrane
geometry and cell shape, and possibly signal transduction.
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Sensitization to Fas-Induced Apoptosis by Pharmacological Disruption of Lipid Rafts
Gniadecki R1, Wojewodzka U2, Karvinen S1, Gajkowska B2
1Bispebjerg Hospital, University of Copenhagen, Denmark; 2Dept of Cell Ultrastructure,
Polish Academy of Sciences, Warsaw, Poland
Fas-mediated pathway leading to apoptosis is of central importance for keratinocyte biology
and is perturbed in a number of inflammatory and neoplastic disorders of the skin. Activation
of Fas can be accomplished by its specific ligand (FasL) or non-specifically (e.g. by ultraviolet
radiation or free radical stress) and leads to apoptosis through a caspase-mediated pathway.
In many cell types, including keratinocytes, Fas is localized in the cholesterol-enriched
membrane microdomains called lipid rafts. We have recently discovered a ligand-
independent Fas activation pathway in keratinocytes, initiated by the disruption of the
cholesterol enriched lipid rafts in the plasma membrane [citation removed]. In cells in which
cholesterol was specifically depleted from the membrane by methyl-b-cyclodextrin, Fas was
relocated to the non-raft compartment of the membrane, and underwent spontaneous
clustering with FADD and caspase-8. Here we detected that cholesterol-depleted cells are
hyperresponsive to FasL and Fas-activating antibody, CH-11. The total amount of membrane
Fas available for antibody and ligand binding was significantly increased after depletion of
cholesterol. Treatment with methyl-b-cyclodextrin triggered formation of large Fas aggre-
gates in the membrane. Dose-response curves revealed that EC50 for FasL-induced cell
death is 10-fold increased in metyl-b-cyclodextrin treated cells. Surmountable, sinistral
displacement of dose-response curves suggests allosteric modulation of Fas upon its release
from lipid rafts. The finding of increased FasL sensitivity in cholesterol-depleted cells may find
therapeutic application, e.g. in the treatment of cancer.
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Actin Cytoskeleton Stabilizes the Raftosome Structure in Keratinocyte Membrane:
Studies by Fluorescence Recovery after Photobleaching (FRAP) Technique
Vind-Kezunovic D, Gniadecki R
Bispebjerg Hospital, University of Copenhagen, Denmark
Lipid rafts are dynamic assemblies of cholesterol and sphingolipids that form in the
exoplasmic leaflet of cellular bilayer membranes. Rafts are thought to be required for cellular
processes such as signal transduction, apoptosis and cell adhesion. Our research has shown
that in cultured keratinocytes lipid rafts form micrometer-large clusters (called ‘‘raftosomes’’),
which are detectable by cholera toxin B-FITC (CTx-FITC) conjugate binding to the raft
component ganglioside GM1. Recent experiments suggest that lipid rafts’ integrity is
maintained by the actin cytoskeleton. Here, we wished to determine whether actin filaments
influence raftosome stability. HaCaT cells were treated with the actin monomer-sequestering
drug latrunculin A (5 mM). Since lipid rafts and raftosomes exhibit higher molecular order of
the lipid component, the technique of FRAP (fluorescence recovery after photobleaching) was
employed to examine raft integrity. The mobile fraction of the CTx-FITC and AlexaFluor 568-
labeled transferrin receptor (a non-raft marker) were measured in the intact- and latrunculin A
– perturbed cells. Latrunculin A treatment caused rearrangement of the raftosomes which
coalesced into single, large CTx-FITCbright structures. In control cells the molecular mobility
within the raftosomes was lower than in the non-raftosome component of the plasma
membrane. Latrunculin A treatment did not affect molecular mobility in the non-raftosome
compartment but significantly decreased CTx-FITC mobility within rearranged raftosomes.
We conclude that actin cytoskeleton controls the structure and integrity of raftosomes in
HaCaT cells.
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Disruption of Lipid Rafts in HaCaT Cells has a Biphasic Effect on the EGFR-Dependent
Cell Proliferation
Karvinen S, Gniadecki R
Bispebjerg Hospital, University of Copenhagen, Denmark
Lipid rafts are cholesterol-enriched membrane microdomains, which are known to have an
important role in receptor-mediated signaling events. Disruption of lipid rafts can be achieved
by depletion of plasma membrane cholesterol by specific sequestering compounds, e.g.
filipin III or methyl-b-cyclodextrin (MbCD). Many receptors, including death receptor Fas,
FceRII, or T-cell receptors can be activated or inhibited in response to raft disruption. Our own
data and results from other laboratories showed that the receptor for epidermal growth factor
(EGFR) is activated (tyrosine phosphorylated) without the participation of the ligand, solely
due to cholesterol depletion and lipid raft disruption. Since the physiologic relevance of raft-
dependent EGFR activation has been unclear, we aimed here to examine the effect of
cholesterol depletion on the EGFR-dependent proliferation of keratinocytes. Our results
show, that cholesterol depletion by MbCD has a dose dependent effect on proliferation.
Growth was increased at low MbCD concentrations (0.5%) but decreased at higher
concentrations. However, the ability of the cells to respond to mitogenic stimulus provided
by EGF was inhibited upon cholesterol depletion, even in cells treated with low
concentrations of MbCD. Inhibition of EGFR tyrosine phosphorylation, or the activation of
MEK1, a known downstream component of the EGFR signaling cascade, abrogates the
mitogenic activity of MbCD. In conclusion, moderate depletion of membrane cholesterol
increases cell proliferation via the activated EGFR-ERK1/2 pathway.
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Contact Dermatitis: Amine-contaIning Irritants Induce Ionic Channel Modulation and
Intracellular Calcium Store Depletion in Human Keratinocytes
Raoux M1, Colomban C2, Laurent JC3, Delmas P1, Crest M1
1LNPC – CNRS UMR 6150, France; 2Laboratoire ATS – Eurofins Scientific Group, France;
3Bio Expertise Technologies SAS, France
Many amines are skin irritants and can induce contact dermatitis. It is well known that, in
response to such irritants, epidermal cells release factors that initiate the inflammatory
reaction and neuronal sensitization. However, little information is available with respect to the
cellular changes that are induced in skin cells by these chemicals. According to Mizumoto
et al. (2003), amine-containing irritants produce an ATP release by keratinocytes without lipid
bilayer disruption and through a yet unknown mechanism. Our aim here was to investigate the
cellular effects of two amine-containing irritants, heptylamine and aminoethyl-piperazine, on
cultures of Normal Human Epidermal Keratinocytes (NHEKs). On the first hand, we wanted to
know if these substances could modulate ionic channels in NHEKs. We showed by patch-
clamp recordings that these chemicals produce a drastic change in the membrane potential
of NHEKs. In fact, they induce a reversible and dose-dependent blockade of calcium-
activated and DIDS-sensible chloride channels and calcium-activated and charybdotoxin-
sensible potassium channels. On the other hand, we investigated the effects of heptylamine
and aminoethyl-piperazine on calcium levels of NHEKs. We showed, using the fluo4-AM dye,
that these irritants provoke a relevant and dose-dependent increase in free cytosolic calcium
levels probably due to a depletion of intracellular stores as this response still occurs when
extracellular calcium is removed. In conclusion, we have shown that heptylamine and
aminoethyl-piperazine, two amine-containing cutaneous irritants responsible for contact
dermatitis, induce chloride and potassium channels blockade and intracellular calcium
mobilization in NHEKs that should be the first steps of the inflammatory response.
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Decreased Syndecan-1 Expression by Human Keratinocytes during Skin Aging
Wegrowski Y1, Danoux L2, Contet Audonneau JL2, Pauly G2, Maquart FX1
1Faculte de Medecine de Reims, France; 2Laboratoires Se´robiologiques, Cognis France,
France
Skin aging is characterized by alterations of its functional properties and aspect. Several
studies have been devoted to the alterations of fibroblast functions during aging but fewer
have been devoted to keratinocytes. In the present study, we investigated the expression of
glycosaminoglycans (GAG) and proteoglycans by keratinocytes from normal donors of 1 to
69 years old. Keratinocytes were cultured from skin fragments obtained during circumcision,
plastic or orthopedic surgery, with the informed consent of the patients or their parents. They
were grown in keratinocyte-SFM medium (Life Technologies) until sub-confluent. Glycosa-
minoglycan synthesis was measured by [3H]-glucosamine and [35S]-sulfate incorporation
and electrophoretic analysis. Proteoglycan expression was appreciated by Northern-Blot and
RT-PCR.
GAG measurements in the culture medium and cell layer of keratinocytes showed no
significant variation during aging. Both chondroitin-sulfate and heparan sulfate were secreted
in similar amounts in the culture medium whereas heparan-sulfate was the major GAG
associated with the cell layer. RT-PCR experiments showed that keratinocytes expressed
versican, glypicans 1, 3, 4, 5 and 6, syndecans 1, 2 and 4, and serglycine
whereas no expression of decorin, biglycan or lumican was found. Northern blot analysis
showed that syndecan-1 expression decreased with the donor’s age.
These results demonstrate that human skin keratinocytes produce several proteoglycan
species, especially those associated with the cell membrane. Decreased syndecan–1
expression could be one of the features of keratinocytes from aged skin. Such a decrease
could impair the effects of some growth factors such as FGF-2 which use syndecan–1 as a
co-receptor.
030 [Oral 003]
Multipotent Nestin-Positive, Keratin-Negative Hair-Follicle Bulge Stem Cells can Form
Neurons
Amoh Y1, LI L1, Hamada Y2, Katsuoka K2, Hoffman RM1
1AntiCancer Inc., San Diego CA, USA; 2Dept. of Dermatology, Kitasato University, Japan
We have recently shown that the expression of nestin, the neural stem cell marker protein, is
expressed in bulge-area stem cells of the hair follicle. We used transgenic mice with GFP
expression driven by the nestin regulatory element [nestin-driven GFP (NDGFP)]. The ND-
GFP stem cells give rise to the outer-root sheath of the hair follicle as well as an ND-GFP
interfollicular vascular network. In this study, we demonstrate that ND-GFP stem cells
isolated from the hair-follicle bulge area that are negative for the keratinocyte marker keratin
15 can differentiate into neurons, glia, keratinocytes, smooth muscle cells, and melanocytes
in vitro. These pluripotent ND-GFP stem cells are positive for the stem cell marker CD34, as
well as keratin 15-negative, suggesting their relatively undifferentiated state. The apparent
primitive state of the ND-GFP stem cells is compatible with their pluripotency. Furthermore,
we show that cells derived from ND-GFP stem cells can differentiate into neurons after
transplantation to the subcutis of nude mice as well join the severed sciatic nerve in
immunocompetent mice, thereby restoring function. These results suggest that hair-follicle
bulge-area ND-GFP stem cells may provide an accessible, autologous source of
undifferentiated multipotent stem cells for therapeutic application.
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Regulation of HDM2 activity by MK2
Weber HO1, Ludwig RL2, Morrison D3, Kotlyarov A4, Gaestel M4, Vousden KH2
1University of Tuebingen, Dermatology, Germany; 2The Beatson Institute for Cancer
Research, Glasgow, United Kingdom; 3National Cancer Institute, USA; 4Medical School
Hannover, Germany
p53 plays a very important role for the suppression of tumor cell growth by inducing cell cycle
arrest or apoptosis. Over 50% of tumor cells harbour p53 mutations. It is believed that in
tumors with wild type p53 (e.g. melanoma cells) p53 is inactivated by posttranslational
modifications. In primary unstressed cells, p53 is degraded by the oncogene HDM2, a RING
domain protein that acts as an E3 ligase to ubiquitinate p53. DNA stressors like UV light
prevent the interaction of HDM2 with p53 thereby stabilizing and activating p53. UV light also
activates the ‘‘stress activated protein kinase’’ MK2 (MAPKAP Kinase 2). We investigated the
role of MK2 for the activity of HMD2 and p53.
We started with in vitro and in vivo- phosphorylation studies using MK2 as kinase and
HDM2 as substrate. By Cotransfection and in vitro ubiquitination experiments the activity of
HDM2 phosphorylation mutants was analyzed. Cell studies with murine ‘‘knock out’’ cells,
immunoblotting and FACS (fluorescence activated cell sorting) served to analyze the
physiologic relevance of MK2 activity for UV induced stabilization and activation of p53.
We show that MK2 is able to phosphorylate HDM2 in vitro and in vivo on the novel
phosphorylation site S157 and the previously reported AKT site S166. HDM2 mutants that
mimic phosphorylation by MK2 are more efficient to degrade p53 in cotransfection
experiments. As expected, UV treatment of wild type primary mouse embryo fibroblasts
(MEFs) stabilizes p53. However, MK2 knockout MEFs show a stronger and prolonged p53
stabilization after UV treatment leading to apoptosis while wild type MEFs survive. Together,
our results suggest that MK2 may act to dampen the extent and duration of the p53 response.
032 [Oral 063]
Design of a Novel Proteolysis Resistant VEGF Variant
Roth D, Lauer G, Krieg T, Eming S
Department of Dermatology, University of Cologne, Germany
Vascular endothelial growth factor (VEGF) is a potent angiogenic mediator in tissue repair.
Recently we demonstrated that in non-healing human wounds a plasmin-catalyzed cleavage
significantly reduces the bioactivity of the VEGF-A isoform VEGF165, suggesting that
VEGF165 degradation and inactivation contribute to an impaired healing response. Plasmin
digestion results in loss of the carboxyl-terminal heparin-binding domain. To investigate the
biological relevance of the protease sensitivity of VEGF165 during cutaneous repair, we
assessed the activity of a VEGF165 mutant resistant to plasmin proteolysis (VEGF165-
MutPro111) in a genetic mouse model of impaired wound healing (db/db mouse). In this
mouse model the stability of the mutant VEGF165 was substantially increased in wound
tissue lysates in comparison to VEGF165 wild type thus indicating a prolonged activity of the
plasmin resistant VEGF165 mutant. The db/db delayed healing phenotype could be reversed
by topical application of VEGF165-MutPro111 and most interestingly the resistance of
VEGF165 to plasmin cleavage resulted in the increased stability of vascular structures during
the late phase of healing due to delayed and reduced endothelial cell apoptosis. Our data
provide the first indication that plasmin-catalyzed cleavage modulates VEGF165 mediated
angiogenesis in vivo. Our experiments propose that the ability to stabilize the heparin-binding
capability of VEGF165-A may help to preserve the biological function of VEGF165 under
conditions in which proteases are highly active such as wound repair and inflammation.
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Characterization of Sequences Important for the Interaction of Plectin (PL) and
Desmoplakin (DP) with Desmin: Towards Understanding of the Molecular Basis of
Inherited Skin Disorders Associated with Muscular Dystrophy (MD)
Gontier Y1, Fontao L1, Champliaud MF1, Paulin D2, Green K3, Borradori L1
1University Hospital Geneva, Switzerland; 2Paris University, France; 3Northwestern Uni-
versity, Chicago, USA
PL and DP are versatile cytolinkers of the plakin family connecting the intermediate filament
(IF) system to other cytoskeletal networks and/or plasma membrane sites. PL and DP gene
defects cause severe skin disorders (e.g. epidermolysis bullosa, palmo-plantar keratoderma)
associated with muscular dystrophy and/or cardiomyopathy, an observation attesting to the
importance of these proteins in maintenance of cytoarchitecture and giving cell resilience.
Previous studies have shown that a region located in the COOH-terminal tail of PL and DP
between the B and C plakin repeats are important for their binding to vimentin and probably
desmin, two type III IF proteins, as well as to the epidermal keratins K5/K14. Here, we have
studied sequences within the PL and DP tails important for their binding to desmin and
vimentin. Our results show that: 1) the COOH-terminal regions of PL and DP bind to desmin in
overlay assays, and codistribute with the desmin IF network in transfected cells; 2) in yeast
two-hybrid assays, a region encompassing the B subdomain and linker region of PL and DP
interacts with both desmin and vimentin; 3) PL binds to sequences located in the NH2-
terminal half of the rod domain of desmin and vimentin, while DP preferentially associates
with their COOH-terminal rod half; 4) in contrast to what observed with desmin, DP binds to
the NH2-terminal half of the rod of keratins K5/K14; 5) the interaction of PL with vimentin, but
not with desmin, appears to be significantly affected by phosphorylation of a Ser residue
within its COOH terminus. Together, our findings demonstrate that PL and DP directly interact
with desmin. The binding of PL and DP with the highly homologous vimentin and desmin
appears to involve a different set of sequences. Furthermore, DP interacts with different IF
types by means of different recognition sites on these IF proteins. These observations provide
novel insights into the association between plakins and IF proteins and increase our
understanding of plakin- and IF-related human diseases associated with both skin and
muscular defects.
034 [Oral 098]
Characterization and Expression Analysis of a New Gene Encoding a Protease Inhibitor
of the Alpha2 Macroglobulin Family, which is Expressed in the Human Epidermis
Galliano MF1, Toulza E1, Gallinaro H1, Jonca N1, Ishida-Yamamoto A2, Serre G1, Guerrin M1
1CNRS UMR 5165, France; 2Asahikawa Medical College, Japan
In the course of a large-scale transcriptome analysis of granular keratinocytes, we identified a
new member of the a2-macroglobulin inhibitor family that we named A2ML (Alpha 2
Macroglobulin-Like). A2ML is localized in the same locus than A2M and PZP and shows
similar predicted organization. A2ML encodes a secreted glycoprotein of 1454 amino acids,
a2ML, which fits the characteristics of the a2Ms: 1) strong conservation in amino acid
sequence; 2) a putative central bait domain and 3) the presence of a typical thiol ester
sequence. In contrast to the human a2M and PZP proteins, a2ML lacks the two cysteine
residues involved in a2Ms dimerization.
Production of an antiserum against a2ML revealed restricted expression of a2ML in the
granular layer of epidermis and increased protein levels in keratinocytes differentiated in vitro.
Immunoelectron microscopy on skin sections showed a2ML in keratinosomes, and in the
extracellular space between the uppermost granular layer and the cornified layer. We
compared the inhibitory activity of recombinant a2ML with that of a2M on trypsin,
chymotrypsin, subtilisin A, thermolysin, papain and elastase. For all the proteases tested,
a2ML was found to be a less efficient inhibitor than a2M, as expected since a2ML is a
monomer. Binding assays with chymotrypsin and kallikrein 7 (stratum corneum chymotryptic
enzyme) demonstrated that a2ML binds covalently to these proteases, a feature shared with
other members of the family.
A2ML is the first a2M gene found to be expressed in the epidermis. a2ML might function as
a molecular trap for extracellular proteases, preventing proteolysis and/or protecting them
from any other proteases or inhibitors. Investigating the physiological targets of a2ML in
epidermis will help unravelling its role in differentiation and desquamation.
035
Corticotropin-Releasing Hormone (CRH) as Modulator of Human Skin Mast Cell
Differentiation and Activation
Ito N1, Ito T1, Bodo E2, Langenbuch C2, Takigawa M1, Paus R2
1Hamamatsu University School of Medicine, Japan; 2University Hospital Hamburg-
Eppendorf, Germany
It has previously been reported that the key hypothalamic stress response-hormone,
corticotropin-releasing hormone (CRH), for which human skin and hair follicles (HF) are now
recognized as major extra-hypothalamic expression sites, can activate rodent skin mast cells
(MC).
After organ culture of microdissected human scalp HF for several days, we noticed
emigration of cells with morphological and/or histochemical MC characteristics from the HF
connective tissue sheath (CTS). Since the CTS of murine HF reportedly contains MC
precursors, we were interested in learning whether CRH may activate CTS MC, and perhaps
even stimulate the maturation of mast cells from resident, immature precursors.
Here, we show that CRH not only stimulates MC degranulation within the CTS in HF organ
culture, but also up-regulates the total number of histochemically detectable CTS MC (as
assessed by Giemsa or toluidine blue histochemistry). In addition, we found many more c-kit-
positive than Giemsa-positive cells in the CTS, whose number is further up-regulated by CRH
treatment. This suggests that the CTS of human HF serves as a pools immature MC in the
CTS. Since we found the major cutaneous CRH receptors (CRH-R1/2) to be abundantly
expressed in human HF epithelium, but not in the CTS c-kit-positive cells, we then checked
whether CRH up-regulates the expression of stem cell factor (SCF), a major MC
differentiation factor.
CRH incubation of human scalp HFs does indeed stimulate intraepithelial SCF
immunoreactivity, and hair follicle steady state-levels for SCF mRNA, while SCF treatment
increases the number of c-kit positive CTS cells. Therefore, CRH may affect CTS-MC and
their precursors indirectly, e.g. via stimulation of SCF release from the HF epithelium.
Our currently available data suggest that CRH, indirectly via stimulation of SCF release
from the HF epithelium, stimulates immature human CTS-MC precursors to differentiate into
mature skin MC in vitro. This points to previously unknown neuroendocrine controls of human
skin MC biology in situ, and a key role for CRH in these controls.
036
Functional Characterization of the Disintegrin Domain of ADAM-9
Zigrino P1, Steiger J1, Nischt R1, Fox JW2, Mauch C1
1University of Cologne, Germany; 2University of Virginia, USA
Tumor cell adhesion, motility, proteolytic activities and cell receptors have important roles in
cancer invasion and metastasis. Recently, the family of ADAM proteases (A Disintegrin And
Metalloproteinase) has acquired attention in these processes. These proteins are composed
of metalloproteinase and Disintegrin-Cysteine domains and therefore display simultaneously,
enzymatic and adhesive functions, suggesting a pivotal role for these proteases/adhesive
proteins in a variety of physiological and pathological processes. We have previously shown
that expression of ADAM-9 is strong at the tumor-stroma border where direct or indirect
interactions between tumor cells and fibroblasts occur. However, the role of ADAM-9 in the
peritumoral areas is still unclear.
In order to gain more insight into the adhesive function of ADAM-9 we have produced the
recombinant Disintegrin-Cysteine domain of this protein by stable expression in 293-EBNA
cells. Melanoma cells of various invasive abilities and human primary fibroblasts from
different donors adhered to immobilized recombinant protein. The cation dependent
adhesion, with Mnþ þ being a potent stimulator, suggested an integrin-dependent
mechanism. This was corroborated by inhibition studies with either inhibitory antibodies or
cyclic peptides showing that adhesion was mediated by a beta-1 containing integrin receptor
but independent of the RGD recognition motif. Interestingly, stimulation of high but not of low
invasive melanoma cells with soluble recombinant Disintegrin-Cysteine domain resulted in an
enhanced de novo synthesis of MMP-2 similar to that observed in human dermal fibroblasts.
Taken together, these results demonstrate that ADAM-9 plays an important role as
adhesion molecule and signalling mediator, thus pointing out that the functions are not limited
just to the proteolytic activity of these proteins.
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The Role of Peroxiredoxin VI in Wound Repair
Ku¨min A1, Paigen B2, Werner S1
1ETH Zurich, Switzerland; 2The Jackson Laboratory, USA
Cells in healing skin wounds are exposed to high levels of reactive oxygen species (ROS),
which are produced by inflammatory cells as a defense against invading bacteria. Therefore,
cells had to develop strategies to protect themselves against these harmful insults. This may
be achieved by enhanced expression of ROS-detoxifying enzymes. Recently, we demon-
strated a strongly increased expression of peroxiredoxin VI (PrxVI) in healing skin wounds.
This enzyme detoxifies phospholipid hydroperoxides as well as H2O2, thereby protecting cells
from oxidative damage. To determine the role of PrxVI in skin development and wound repair,
transgenic mice overexpressing PrxVI in the epidermis were generated. No histological
abnormalities were observed in normal or wounded skin of these mice, and the expression of
major genes involved in wound healing was unaltered. However, primary keratinocytes
isolated from transgenic mice are more resistant to oxidative stress compared to wild-type
cells. To further investigate PrxVI function during the wound healing process, we performed
wound healing studies in PrxVI knockout mice. Surprisingly, the lack of PrxVI did not affect
skin morphogenesis and wound reepithelialization. However, 5 days after wounding massive
hemorrhage was observed. Although the number of newly formed blood vessels was not
altered, ultrastructural analysis revealed severe damage of the wound vessels, and the
number of apoptotic endothelial cells was elevated. This effect is most likely a result of
enhanced oxidative stress in the wounds of peroxiredoxin VI knockout mice. In spite of these
abnormalities, late stage wounds appeared normal, suggesting the onset of compensatory
mechanisms. Taken together, our results demonstrate a novel and important function of
peroxiredoxin VI in the protection of new wound vessels from oxidative stress.
038
Inactivation of p16ink4a Immortalizes Primary Human Keratinocytes by Maintaining Cells
in the Stem Cell Compartment
Maurelli R, Bondanza S, Guerra L, Abbruzzese C, Gellini M, Zambruno G, Dellambra E
Istituto Dermopatico Immacolata, Rome, Italy
Replicative senescence of human keratinocytes is determined by a progressive decline of
clonogenic and dividing cells, and its timing is controlled by clonal evolution, i.e. the transition
from stem cells to transient amplifying and post-mitotic cells. We show that inactivation of
p16INK4a, by an antisense strategy, allows primary human keratinocytes to escape replicative
senescence. Specifically, p16INK4a inactivation alone blocks clonal evolution and maintains
keratinocytes in the stem cell compartment. Immortalization is accompanied by resumption
of Bmi-1 expression and telomerase activity. Of note, antisense excision is followed by
keratinocyte senescence, confirming that persistent p16INK4a inactivation is necessary for
maintenance of clonal evolution block. Finally, p16INK4a downregulation in transient
amplifying keratinocytes does not affect clonal evolution, and cells undergo senescence
like normal controls. Thus, p16INK4a inactivation appears to selectively prevent clonal
conversion in cells endowed with a high proliferative potential. These data indicate that
p16INK4a regulates keratinocyte clonal evolution and that inactivation of p16INK4a in epidermal
stem cells is necessary for maintaining stemness.
039
Somatostatin Receptor 1-Mediated Endocytosis and Recycling of its Cognate Peptide
Somatostatin-14
Roosterman D, Meyerhof W, Steinhoff M
Department of Dermatology, University of Mu¨nster, Germany
Somatostatin-receptor 1 (sst1) modulates the release of somatostatin. Here, the specific
mechanisms of internalization and trafficking of this autoreceptor and the fate of its ligand
was investigated. Sst1 was located at the cell surface and intracellular resident within Rab5a-
and Rab11a-postive compartments. Somatostatin-14 (SST-14) activated trafficking of
intracellular resident sst1 and induced internalization of surface located receptors. Receptor
and ligand were initially transported within superficial cell compartments. During the first 2–3
minutes of stimulation, 50% of surface-located receptors were internalized, transporting
 50% of surface-bound SST-14 into the cell. Prolonged stimulation induced accumulation
of SST-14 at a constant number of cell surface binding sites indicating a dynamic process of
endocytosis, recycling and re-endocytosis of sst1. Accumulated SST-14 was not routed into
the lysosomal degradation pathway. The agonist was released as intact and biologically
active SST-14. These data demonstrate that the sst1-specific mechanisms of internalization
and trafficking maintaines the sustained action of the peptide agonist on the target cells and
indicate an autoregulative function of sst1.
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Intracellular Hydrolysis of Substance P by Endothelin-Converting-Enzyme 1 Regulates
Trafﬁcking and Resensitization of Neurokinin-Receptor 1
Roosterman D and Steinhoff M
Department of Dermatology, University of Mu¨nster, Germany
The neurokinin receptor 1 along with other G protein-coupled receptors is characterized by
prolonged desensitization after challenge with its cognate peptide agonist. Here, we
demonstrate a novel mechanism with fast recovery of substance P sensitivity. Internalized
NK1R was found to be co-localized with the endopeptidase, endothelin-converting-enzyme-
1 (ECE-1) in acidic early endosomes. ECE-1 inactivates endocytosed substance P by cleavag
of the peptide amino-terminal from position Phe7 and Leu10. This intracellular located
degradation of substance P allowed the dissociation of beta-arrestin from the internalized
neurokinin receptor 1 and rapid resensitization of substance P sensitivity. These data indicate
a new biological function of ECE-1-isoforms distributed in the endocytotic pathway and
suggest a novel mechanism of peptide receptors regulation.
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A New Peptide that Induces a Lipolysing Effect in Adipocytes and Exhibits Slimming
Properties
Bressier G, Bauza E, Botto JM, Dal Farra C, Domloge N
Vincience Research Center, Sophia Antipolis, France
Finding new active ingredients that can modulate fat cell metabolism and reduce adipocyte
storage of lipid droplets is a central interest in skin and cosmetic research. In this focus, we
developed a new synthetic peptide and were interested in studying its effect on the
modulation of adipocyte content and fat synthesis.
We used established pre-adipocyte 3T3-L1 cells in these studies in order to evaluate the
effect of this new peptide on the formation of lipids in 3T3-L1 cells, when applied at different
stages of cell growth and differentiation.
Evaluation of cell content of lipids by oil red staining in repeated dose studies,
demonstrated that application of the peptide at 1% significantly reduced fat cell lipid droplet
content. Moreover, time course studies involved the application of the peptide at different
stages of fat cell differentiation, and for different durations, and showed that the peptide
exhibits a remarkable effect of significantly reducing lipid droplets in differentiated cells. This
effect was observed exclusively in differentiated cells and at all study time points.
Time course studies of glycerol release showed that peptide application to differentiated
3T3-L1 cells induced glycerol release that was seen within 3h of application, and for up to 6h.
Furthermore, parallel cAMP assessment studies confirmed the lipolytic mechanism of
action of the peptide, and showed that peptide application induced cellular cAMP increase
within 3h, and this effect continued at 5h. Interestingly, comparative studies with caffeine
showed that the peptide reduced lipid droplets in differentiated adipocytes more than
caffeine, and this effect was observed at different application times.
These results demonstrate that this new peptide possesses remarkable slimming
properties that can be of great use in the fields of medicine and cosmetics.
042
HaCaT Cells Express SIRT1, the Human Homologue of SIR2, and SIRT1 Level Increases in
Response to Caloric Restriction and UV Stress
Bauza E, Roux E, Botto JM, Dal Farra C, Domloge N
Vincience Research Center, Sophia Antipolis, France
SIRT1, the human homologue of Sir2, plays a key role in cellular response to stress, and in
aging. Recent studies have shown that SIRT1 deacetylates p53, preventing cellular
senescence and apoptosis induced by stress.
Therefore, we were interested in studying SIRT1 expression in HaCaT cells, as these cells
are commonly used in skin research. We evaluated SIRT1 and p53 expression in HaCaT cells
after caloric restriction and UVB stress, by immunostaining, immunoblotting, and mRNA
studies.
Immunoblotting studies of UVB-irradiated HaCaT cells, using different doses of UVB,
showed that SIRT1 increased in these cells in a dose-dependent manner, up to 40mJ/cm2,
and that maximum expression of SIRT1 was seen at 30mJ/cm2. Interestingly, p53 expression
did not vary significantly, which is consistent with the immortal nature of this cell line.
Immunostaining studies revealed the nuclear expression of SIRT1 and confirmed the above
results. Furthermore, mRNA studies showed an increase in SIRT1 mRNA after low UVB
doses, and this effect lasted up to 48h after irradiation.
Studies on caloric restriction showed that SIRT1 expression increased in a dose-
dependent manner with glucose deprivation, and this effect was seen after 48h of
deprivation. Interestingly, p53 expression did not show significant variation.
These studies demonstrate that SIRT1 is expressed in HaCaT cells and that its expression
is correlated with UVB and caloric stress, strongly suggesting that SIRT1 plays a key role in
defense and aging in HaCaT cells.
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SIRT1, the Human Homologue of Sir2, a Gene Involved in Regulating Life Span, is
Expressed in Human Skin and in Cultured Skin Cells
Domloge N, Bauza E, Roux E, Perrin A, Gondran C, Botto JM, Dal Farra C
Vincience Research Center, Sophia Antipolis, France
Recent studies have shown that in yeast, caloric restriction delays aging by activating Sir2,
and that SIRT1, the human homologue of Sir2, associates with the tumor suppressor protein
p53, preventing cellular senescence and apoptosis induced by stress. However, studies thus
far have not concerned human skin. Therefore, we were interested in investigating SIRT1
expression in human skin, under normal and stress conditions, and in relationship with p53.
We performed our studies on human ex vivo skin and on different cultured human skin cells
(human keratinocytes and fibroblasts), using immunofluorescence and immunoblotting
methods. Cells were submitted to dose and time course UVB stress and caloric restriction
(CR) studies. SIRT1 mRNA studies were also performed in parallel.
The studies revealed the nuclear expression of SIRT1 in these cultured human cells.
These results also showed that under low and moderate UVB doses, SIRT1 expression
increases in a dose related manner and inversely with p53 expression. Under stronger UVB
doses with cell damage, the balance between SIRT1 (cell survival) and p53 (cell apoptosis)
shifts and p53 expression takes over, which underlines the importance of the physiological
balance between these two mechanisms. CR studies showed similar results and confirmed
this interplay between SIRT1 and p53. Moreover, histological studies confirmed the
expression of SIRT1 in human ex vivo skin, and revealed a diversity of expression patterns
depending on skin condition. Our studies demonstrate the expression of SIRT1 in human skin
and in cultured cells, and in relationship to stress. These results are of great interest to skin
biology, as well as to approaches to skin aging and stress defense.
044
A New Slimming Peptide that Reduces Adipocyte Lipid Synthesis through an
Uncoupling-Like Mechanism
Botto JM, Bauza E, Bressier G, Roux E, Dal Farra C, Domloge N
Vincience Research Center, Sophia Antipolis, France
Uncoupling proteins (UCPs) are proteins of the inner mitochondrial membrane that uncouple
mitochondrial respiration from oxidative phosphorylation, thereby increasing thermogenesis
while reducing the efficiency of ATP synthesis. Recent studies have demonstrated that these
UCPs play a key role in fatty acid and glucose utilization, and that they are involved in
thermogenesis and obesity disorders. Therefore, we developed an uncoupling-like peptide
with an amino acid sequence similar to a conserved sequence present in many UCPs, and
investigated its effect on adipocyte lipid synthesis. For these studies, established pre-
adipocyte 3T3-L1 cells were used. Oil red staining experiments demonstrated that
application of 0.5% of the UCP-like peptide on the cells significantly reduced their lipid
droplet content. Interestingly, this effect was significant when the active was applied early in
the first hours of culture before the beginning of differentiation. Furthermore, in order to
confirm the UCP-like mechanism of action of the peptide, ATP assessment, cAMP
assessment, and glycerol release experiments were performed, in comparison with an agent
that has a lipolysing effect. These experiments showed that, in parallel with the reduction in
fat droplet content in the adipocytes, no significant increase in cellular ATP, cAMP, or glycerol
was observed. These results confirm that the new peptide presumably uncouples, or
enhances the uncoupling of the cellular mitochondrial respiration process from its terminal
ATP synthesis step, therefore suppressing, gradually, lipid droplet accumulation in the cells,
and enhancing energy release, by the ATP-independent pathway.
These studies demonstrate that this new UCP-like peptide can be of great use in the
slimming products of modern cosmetics.
045
Neuropilin-1 Acts as a Receptor for Semaphorin 3A on HaCaT Cells and Inhibits Cell
Migration
Kurschat P, Bielenberg D, Klagsbrun M
Childrens Hospital, Harvard Medical School, Boston, USA
Neuropilin-1 (NRP1) was discovered as a cell surface receptor for class 3 semaphorins on
neuronal cells, mediating chemorepulsive effects and therefore regulating axonal outgrowth
and migration of neurons. Later, NRP1 was found to be expressed by endothelial cells, where
it serves as an isoform-specific co-receptor for vascular endothelial growth factor VEGF,
enhancing angiogenesis. We could show by in situ hybridization and by immunohistochemical
staining that NRP1 is also expressed by primary human keratinocytes in vivo and in vitro.
Furthermore, expression is strongly induced upon treatment with members of the epidermal
growth factor family, like EGF or HB-EGF. Using HaCaT cells, we investigated NRP1 function
in keratinocytes. Since semaphorin-effects require plexins as co-receptors, whereas VEGF-
signaling is dependent on VEGF receptor tyrosin kinases like VEGFR-1 or VEGFR-2, we
analyzed the expression of these molecules. HaCaT cells expressed several plexins like
plexin A1, A2, A3 or B1, but no VEGFRs. Therefore, a function of NRP1 as a semaphorin-
receptor seemed likely. When cells were stimulated with Sema3A or VEGF165, both ligands
had no effect on cell proliferation. But migration in transwell chambers was significantly
inhibited by Sema3A, whereas VEGF165 had no influence. The inhibitory effect of Sema3A
was even stronger, when HaCaT cells which stably overexpress NRP1 where exposed to this
ligand. Furthermore, Sema3A is expressed in the epidermis in vivo as well as by primary
keratinocytes and HaCaT cells in vitro. Therefore we conclude that besides its function in
neuronal guidance and angiogenesis NRP1 is also implicated in the regulation of keratinocyte
behaviour. It serves as a receptor for class 3 semaphorins, and cell migration can be
regulated by the receptor/ligand pair of NRP1 and Sema3A.
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A New Model for Modulating ‘Hair Follicle Aging’ and Pigmentation?
Hadshiew I, Barre K, Bo´do´ E, Paus R
Department of Dermatology, University Hospital Hamburg Eppendorf, Germany
Current concepts support a stringent coupling of melanogenesis in the hair-follicle
pigmentary unit and hair matrix keratinocyte proliferation/hair shaft formation. However,
during aging, a gradual loss of pigment typically occurs in individual hair follicles while the
hair remains in anagen. This graying of the hair follicle is due to a decrease of melanogenic
activity of melanocytes in the hair bulb and loss of melanocytes stem cells, while
keratinocytes remain actively cycling. Here, we demonstrate a new model for modulation
of hair growth and hair pigmentation in human scalp hair follicle organ culture by small DNA
oligonucleotides, homologous to the 30 overhang of human telomeres, called T-oligos.
Pigmented human female hairs were incubated either with T-oligo or medium control. Hairs
were fixed at different time points and processed for Fontana Masson, TUNEL and Ki67
staining, followed by image analysis; also hair shaft length and hair morphology were
assessed. Results revealed a 4-fold increase in pigmentation for T-oligo treated human scalp
hair follicles, while hair matrix proliferation was reduced by 65%, with no apparent increase in
apoptosis. Also, hair follicles treated with the T-oligo showed an inhibition of hair shaft
elongation of 20% when compared to diluent treated controls, while all hair follicles remained
in anagen VI. These findings raise the possibility that T-oligos mimic key processes that
modulate anti-aging/graying mechanisms in human hair follicles. Potentially, T-oligos might
slow down this natural process, by inducing specific repair mechanisms in melanocytes
allowing for extended cycling, cell-cycle arrest, DNA repair and potentially a reduced
apoptotic rate of cells, thus stalling the reduction of the pool of melanogenic stem cells.
Potentially, also induction of telomerase or modulation of the T-oligo interference with the
telomere loop structure in melanocytes might play an important role that remains to be
investigated in future studies.
047
Microtubule-Destabilizing Drugs Target VEGF Receptor-2 Expression
Meissner M, Stein M, Pinter A, Hergovic I, Kaprolat N, Kaufmann R, Gille J
Department of Dermatology, University Hospital Frankfurt, Germany
Cytoskeletal polymers control a wide range of fundamental cellular functions, including
proliferation, migration, and gene expression. As complex changes in endothelial cell shape
and motility are required to form new vascular networks, we hypothesized that disassembly
of actin filaments or microtubules may impact endothelial VEGF receptor-2 (VEGFR2)
expression as a critical determinant of angiogenesis. We therefore investigated the effect of
actin filament- and microtubule-disrupting agents on VEGFR2 expression by human vein
endothelial cells. While depolymerization of actin filaments (by cytochalasin D or latrunculin A)
failed to induce discernable changes in VEGFR2 protein expression, microtubule (MT)-
disassembly (by nocodazole, vinblastine, or colchizine) greatly inhibited endothelial VEGFR2
expression in a time- and concentration-dependent fashion. The suppressive effects of MT-
targeted compounds on VEGFR2 expression were neither conveyed by an inhibition of
endocytotic VEGFR2 recycling nor by an increase in lysosomal degradation. In addition,
VEGFR2 inhibition was not mediated via augmented VEGFR2 shedding or shortened protein
half-life, suggesting that transcriptional rather than posttranslational mechanisms account for
the observed effects. In line with this conclusion, MT disruption significantly suppressed
endothelial VEGFR2 mRNA accumulation. While analyses of mRNA half-lives did not reveal a
decrease in VEGFR2 mRNA stability, treatment with MT-targeted drugs considerably
suppressed transcriptional activity of 50-deletional VEGFR2 promoter gene constructs.
Hence, modulation of the rate of gene transcription represents the preferable molecular
mechanism by which MT disruption inhibits VEGFR2 expression. Together, our data identify
endothelial VEGFR2 expression as a novel target of MT-depolymerizing compounds. As
antivascular effects of microtubule-targeted drugs are increasingly appreciated, enhanced
insights in their modes of action are critical to define more optimal combinations with
additional classes of therapeutic compounds.
048
The Soluble Variant of the Vascular Endothelial Growth Factor Receptor VEGFR-1: A
Mediator in Wound Repair
Eming S1, Lauer G1, Jurk S1, Hornig C2, Weich H2, Krieg T1
1Department of Dermatology, University of Cologne, Germany; 2Department of Gene
Regulation and Differentiation, National Research Center for Biotechnology (GBF),
Brunswick, Germany
The endothelial cell-specific mitogen vascular endothelial growth factor-A (VEGF-A) is a
potent regulator of angiogenesis during wound healing. The soluble form of the VEGF
receptor VEGFR-1 (sVEGFR-1) is a strong and specific inhibitor of VEGF-A signaling and has
been characterized as a potent inhibitor of angiogenesis. In the present study we investigated
the hypothesis whether sVEGFR-1 plays a role during tissue repair and we evaluated the
expression of sVEGFR-1 in healing and non-healing human wounds. RT-PCR analysis
indicates that the full length receptor VEGFR-1 and its splice variant sVEGFR-1 are expressed
in normal skin and non-healing wounds. ELISA and western blot analysis demonstrate that
sVEGFR-1 is released at low levels in wound fluid obtained from normal healing wounds
averaging 2.2þ / 2.0 ng/ml (n¼ 11), and at significant higher levels in chronic non-healing
wounds with a mean sVEGFR-1 concentration of 9.3þ / 3.2 ng/ml (n¼ 16) (po0.001). Only
in those chronic wounds, which eventually entered a phase of granulation tissue formation
and finally wound closure, wound healing progression correlated significantly with a decline in
sVEGFR-1 levels (r¼ 0.92; po0.0005). Northern analysis of cultured HUVE cells exposed to
wound fluid indicate, that wound fluid obtained from chronic non-healing wounds contains
mediators that are able to enhance the expression of sVEGFR-1 mRNA. This report suggests
that sVEGFR-1 represents a regulatory molecule during wound repair. Our findings contribute
to a better understanding of the pathophysiology underlying chronic non-healing wounds and
indicate a predictive value for sVEGFR-1 levels for differentiating healing and non-healing
wounds.
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Casein Kinase 1alpha is Repressed During Melanoma Progression and Regulates Beta-
Catenin Signalling in Melanoma Cell Lines
Sinnberg T, Garbe C, Schittek B
University Clinical Center of Tuebingen, Germany
The identification of differentially expressed genes which are critical in homeostasis and
disease is a central task in cancer biology. Using a PCR-based subtractive hybridisation
approach comparing mRNA from metastatic and primary melanoma cells we identified the
casein kinase 1alpha among others as being differentially expressed. The casein kinase
1alpha is a Ser/Thr kinase which participates in the degradation of cytoplasmic beta-catenin
by phosphorylation at specific residues thereby inhibiting the beta-catenin signalling
pathway. Expression analysis on RNA and protein level with melanoma cell lines representing
different progression stages indicated that during melanoma progression and invasion the
casein kinase 1alpha is downregulated. Consistent with the lower protein expression of
casein kinase 1alpha in several metastatic melanoma cell lines a higher level of beta-catenin
and nuclear translocation was found. Functional studies indicated that the casein kinase
1alpha plays a critical role in melanoma cell survival. Overexpression of casein kinase 1alpha
in metastatic melanoma cell lines with a low endogenous level of this Ser/Thr kinase caused a
diminished cellular growth in vitro indicating a role for casein kinase 1alpha in melanoma cell
proliferation.
Nuclear beta-catenin acts as a transcription factor in combination with DNA binding
proteins like Tcf/Lef-1 and activates the transcription of oncogenic genes like c-myc, cyclin
D1, survivin, matrix metalloproteinase 7 and many others. Our data suggest that casein
kinase 1alpha may function as an important negative regulator of the Wnt signalling pathway
in melanocytes and that through its downregulation during melanoma progression a high
cellular level of active beta-catenin is generated.
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Postsecretory Processing of DCD-1L by Cathepsin D in Human Eccrine Sweat
Baechle D1, Flad T2, Cansier A1, Steffen H3, Garbe C3, Schittek B3, Kalbacher H1
1Medical and Natural Sciences Research Center, Tu¨bingen, Germany; 2Section for
Transplantation-Immunology and Immunohematology, University Clinics, Tu¨bingen, Ger-
many; 3Department of Dermatology, Eberhard-Karls-University, Tu¨bingen, Germany
The presence of proteases in sweat and their function is barely understood. The protein
pattern of healthy human eccrine sweat was investigated and 10 major proteins were
identified from which Apolipoprotein D, lipophilin B and cathepsin D (CatD) were identified for
the first time in human eccrine sweat. Further investigations were focused on the
physiological function of the aspartate protease CatD in sweat. The antimicrobial peptides
LL-37 and DCD-1L were shown to be present in sweat and could be possible substrates for
CatD. Therefore, LL-37 and DCD-1L were digested in vitro with isolated CatD. The data
indicate that DCD-1L - in contrast to LL-37- is processed by CatD featuring two cleavage
sites. The DCD-1L derived peptides generated in vitro by CatD were also found in vivo in
human sweat as determined by surface-enhanced laser desorption/ionization (SELDI) mass
spectrometry. Furthermore, besides the CatD processed peptides we identified C-terminally
trimmed DCD-1L derived peptides which are generated upon cleavage with a 1,10-
phenanthroline sensitive carboxypeptidase. The in vitro and in vivo results suggested the
following processing scheme of DCD-1L in sweat: The initial processing step is the cleavage
of C-terminal amino acids by the 1,10-phenanthroline sensitive carboxypeptidase. The next
processing step is the removal of an N-terminal tripeptide by an endoprotease. After these
processing steps DCD-1L is cleaved by CatD whereas the resulting peptides are further C-
terminal trimmed by the carboxypeptidase. Taken together our data show, that CatD and a
carboxypeptidase are the dominant proteases responsible for the postsecretory processing
of DCD-1L in human eccrine sweat.
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An Alpha-MSH Biomimetic Peptide Exhibits Interesting Protection of Human Skin Cells
from UV-Induced DNA Damage
Jocelyne F1, Andre´ P1, Dal Farra C2, Domloge N2, Loing E3, Hocquaux M3
1LVMH Recherche, Saint Jean de Braye, France; 2Vincience Research center, Sophia
Antipolis, France; 3IEB, Ramonville St Agne, France
Alpha-Melanocyte Stimulating Hormone (a-MSH) has previously been identified as a potent
anti-inflammatory agent in various tissues including the skin. We have shown that a
hexapeptide, derived from the a-MSH plays an important role in modulating UV-induced
inflammation (inhibition of IL-1 a, IL-8 production by keratinocytes, inhibition of the ability of
dermal endothelial cells to recruit leukocytes, inhibition of PGE2 production by fibroblasts).
Very recently, it has been shown that a-MSH markedly reduces the formation of UVB-induced
DNA damage demonstrated by reduced amounts of cyclobutane pyrimidine dimers,
ultimately leading to reduced apoptosis. Hence, we were interested in investigating the
effect of this a-MSH biomimetic peptide on UV-induced DNA damage in human cells.
Comet assay was performed using cultured human melanocytes, irradiated with 60mJ/cm2
of UVB. This study showed that when cells are treated with (3 107 to 1.8 106 M) of a-MSH
biomimetic peptide, these cells exhibited a dose dependant decrease of Tail Moment that
reached 67%. Moreover, reduction of Tail Moment was also seen after irradiation with 0.8J/
cm2 of UVA, and reached 70%.
Furthermore, the protective effect of a-MSH biomimetic peptide, is not restricted to
melanocytes and comprises other cells such as human keratinocytes and human dermal
fibroblasts. These studies demonstrate that this a-MSH biomimetic peptide reduces
significantly UV-induced DNA damage, and confirm that this a-MSH biomimetic peptide
confers a very interesting protection to human cells by controlling local cutaneous
inflammatory responses and by reducing UV-induced DNA damage.
052
Co-Culture of Neurones and Merkel Cells
Chateau Y1, Boulais N1, Dorange G1, Cle´ment Jf2, Rougier N3, Chesne´ C3, Misery L1
1Unite´ de Physiologie Compare´e et Inte´grative, Brest, France; 2LATIM, Brest, France;
3Biopre´dic International, Rennes, France
Merkel cells (MC) are about 1% of epidermal cells. They still remain poorly known because it
is difficult to maintain them in culture and it is not possible to obtain cell proliferation in vitro.
MC are narrowly linked to nerve endings issued from sensory neurones and synapses
between these cells are usual. These neurones originate in dorsal root ganglia (DRG) close to
spinal cord (SC). Neurites from these neurones are directed to both epidermis and SC.
In order to get a model reproducing this physiological circumstance, we have performed
compartmented cell cultures. In the middle, we have introduced a suspension of epidermal
cells, with 1% of MC (50000 cells) obtained from human skin biopsies. Around this central
domain, we have incubated sensory neurones (1500 cells) from rat DRG. The third
compartment was occupied by SC neurones (5000 cells). All cells were obtained by
enzymatic and mechanical dissociation. After 15 days of culture, cells were fixed and
immunostainings were made to identify neurones (PGP 9.5), keratinocytes (keratin) and MC
(CK 20 and chromogranin A).
Confocal scanning laser microscopy revealed the presence of in vitro connexions between
MC and neurones. The number of MC was near 10% in the epidermal equivalent.
This co-culture allows the in vitro reconstitution of synapse-like structures between MC and
neurones and the possibility to study interactions between these cells. Neurones may permit
a true culture of MC or at least the obtention of a cell suspension enriched in MC.
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Expression of Clusterin is Upregulated in Vitamin D-Sensitive but not in Vitamin D-
Resistant Melanoma Cells Following 1,25(OH)2D3 Treatment
Shannan B1, Seifert M1, Leskov K2, Boothman D3, Tilgen W1, Reichrath J1
1Saarland University Hospital, Germany; 2Case Western Reserve University, USA;
3University of Texas Southwestern Medical Centre, USA
The secretory glycoprotein clusterin (CLU) was shown to be involved in various cell functions
including cell growth, and apoptosis. The nuclear (nCLU) and the secretory (sCLU) are two
isoforms of CLU that are obtained by alternate splicing. While the pro-apoptotic nCLU was
shown to be involved in the regulation of cell-cycle progression and apoptosis, the other
isoform sCLU has been shown to have cytoprotective properties. We have analyzed the
expression of CLU (mRNA and protein) in various melanoma cell lines that have previously
been characterized as sensitive (SK-MEL-28, and MeWo) or resistant (SK-MEL-5, SK-MEL-
25) to antiproliferative effects of vitamin D analogues. Vitamin D-resisant melanoma cell lines
were shown to reveal a functional defect in vitamin D receptor-mediated gene transcription.
CLU mRNA and protein were present in all melanoma cells analyzed, with sCLU being the
most dominant isoform in both vitamin D-sensitive and resistant cells. 1,25-dihydroxyvitamin
D3 (1,25(OH)2D3) treatment of vitamin D-sensitive, but not of resistant, cells resulted in a time-
dependent upregulation of CLU mRNA levels, as measured using conventional PCR.
Treatment with 1,25(OH)2D3 did neither in vitamin D-sensitive, nor in resistant cells alter the
CLU splice variant pattern. Our findings indicate that; CLU is expressed in melanoma cells.
sCLU represents the most dominant isoform both in vitamin D-sensitive and resistant
melanoma cells. CLU mRNA expression is increased after 1,25(OH)2D3 treatment in vitamin
D-sensitive, but not in resistant melanoma cells. In conclusion, CLU may be of importance for
the growth characteristics of melanoma cells. It can be speculated (at least in melanoma
cells) that the antiproliferative effects of 1,25(OH)2D3 may be at least in part mediated via CLU
expression.
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Implications for Contribution of the DNA-Mismatch Repair Enzyme hMSH2 to the Repair
of UV-Induced DNA Damage in Melanoma Cell Lines
Seifert M1, Scherer S2, Edelmann W2, Meineke V3, Tilgen W1, Reichrath J1
1Saarland University Hospital, Germany; 2Einstein College of Medicine, USA; 3Federal
Armed Forces Medical Academy, Germany
Human MSH2 is a well characterized component of the DNA repair system. It is the most
frequently impaired gene in hereditary nonpolyposis colorectal cancer (HNPCC). The MSH2
gene is part of the post-replicative mismatch repair system that prevents the accumulation of
spontaneous mutations and, thereby, ensures the integrity and stability of the genome. The
mechanism how hMSH2 is involved in the complex response mechanisms to UV damage is
not clear. It was shown that the human MutS mismatch repair protein, a heterodimer
composed of hMSH2 and hMSH6, binds specifically to mismatched bases opposite to UV
light photoproducts. It was suggested that the mismatch repair system is an initial step of the
damage signaling and repair cascade. Here we show increased levels of hMSH2 mRNA in
malignant melanoma, metastases of malignant melanoma and malignant melanoma cell lines
as compared to primary cultured benign melanocytes. Overexpression of hMSH2 protein has
been reported in various other malignancies and may be related to an increased proliferation
rate. Furthermore we found hMSH2 expression in melanoma cell lines is modulated by UV-B
treatment and transfection of hMSH2 siRNA into human melanoma cells (MeWo) resulted in
modulation of UV-B-induced cell cycle arrest and apoptosis. Reduction of apoptotic cells
was less pronounced in siRNA treated melanoma cells as compared to Msh2-deficient
mouse fibroblasts. This difference is most likely due to the incomplete suppression of hMSH2
expression in siRNA-treated melanoma cells. In addition a MSH2 point mutation (MEFGA)
that affects DNA mismatch repair does not affect UV-B-induced apoptosis. In conclusion, our
findings support the concept that MSH2 expression modulates UV-B-induced apoptosis. This
mechanism may be of importance for pathogenesis and progression of malignant melanoma.
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Long Term Proliferative Potential of Human SP Keratinocytes
Larderet G1, Vaigot P2, Gidrol Xsity1, Waksman G1, Martin MT1
1Evry University, CEA, France; 2CNRS, CEA, France
The aim of the present study was to characterize human SP keratinocytes isolated from
primary cell cultures. For that purpose, keratinocytes were isolated from normal adult breast
samples and the Hoechst exclusion assay described for haematopoietic cells was adapted
for keratinocytes. Three types of keratinocytes were studied: the side population (SP), the
main population (MP) and the unsorted initial population. SP cells represented an average of
0.16% of the total population. They were undifferentiated epidermal cells but did not over-
express b1 and a6 integrins. In short-term cultures, SP keratinocytes exhibited an increased
colony forming efficiency and produced more actively growing colonies than unsorted and
MP keratinocytes. Moreover, SP cells exhibited a larger expansion potential in long-term
cultures. They performed a mean of 44 population doublings over up to 12 successive
passages. Unsorted and MP keratinocytes promoted a reduced expansion: mean of 14
population doublings over 6 passages and 12 population doublings over 4 successive
passages, respectively. To further characterize SP cells, cDNA microarrays spotted with 9120
probes were used to identify their molecular signature. Transcriptome analysis showed that
41 genes were differentially expressed in SP versus MP cells, with 37 up-regulated genes and
only 4 down-regulated genes in SP cells. The majority of these genes were functionally
related to the regulation of transcription and cell signalling. In conclusion, SP keratinocytes
can be isolated from primary cultures of adult human epidermis. These cells exhibit both
short and long-term high proliferative potential and a specific expression profile.
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Selective Induction of Apoptosis by Hyperthermia Treatment: Potential in Skin Cancer
Therapy
Shellman YG1, Howe WR1, Ribble D1, Goldstein NB1, Mahajan R2, Finch D2, Larue S,
Pacheco T1, Norris DA1
1Department of Dermatology, University of Colorado, USA; 2Mechanical Engineering
Department, University of Colorado, USA; 3College of Veterinary Medicine and Biomedical
Sciences, Colorado, USA
Hyperthermia treatment of cancer and hypertrophic conditions is undergoing a renaissance,
and cutaneous malignancies are obvious attractive targets for such treatment. We have
developed in vitro techniques to analyze cell survival and mechanisms of cell death in cell
lines of melanoma, squamous cell carcinoma and basal cell carcinoma exposed to
hyperthermia in vitro. Caspase-dependent apoptosis was measured by several quantitative
and morphologic assays.
We found that hyperthermia regularly induced necrosis in these cutaneous cancer cells at
high hyperthermia doses. However, at lower doses there was a ‘‘window of opportunity’’ for
the induction of apoptosis. This was uniformly seen with basal cell carcinoma cells, and in
some (but not all) melanoma cell lines. Basal cell carcinoma cells were the most susceptible
to hyperthermia-induced apoptosis, and the mechanism of apoptosis in these cells is being
characterized.
Selection of conditions that induce apoptosis would likely lead to cell death without
extensive tissue damage, and our data suggest that such as approach is reasonable for basal
cell carcinoma and even some melanomas. Additional work is underway to determine how
some melanomas resist hyperthermia induced apoptosis, and also to identify agents that
might potentiate hyperthermia-induced apoptosis in BCC, SCC and melanomas.
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Estimation of Interaction Between Human Keratinocytes and Xenogenic Collagen In Vitro
Lesiak-Cyganowska E, Jankowska-Steifer E, Kowalewski C, Wozniak K, Komender J
Medical University of Warsaw, Poland
Various forms of products containing collagen are applied in reconstructive surgery. This
study was focused on the interaction observed between human keratinocytes and xenogenic
collagen extracted from pig tendons with modified surface in vitro by their hydrolyzation in
0.1M acetic acid, homogenization, precipitation in 0.1 M Na2HPO4, digestion in 0.5% pepsin
solution for 24 hrs, formation of 0.05 mm thick membranes and sterilization. Human,
epidermal keratinocytes were isolated from amputated fragments of skin in course of plastic
surgery according to the method of Rheinwald and Green 1975. Keratinocytes were
cultivated for 3 to 10 days. In 3–10 days, the culture became multi-layered and maturation of
cells in upper layer was visible. Using electron microscope, morphological elements of basal
membrane interacting with support was seen. By the immunofluorescence cytochemistry, the
presence of BP-180, b4 integrin, laminin 5 and collagens IV, VII-N, VII-C was found that on
modified support between 3 and 7 days of culture whereas on the controlled xenogenic non
modified chemically collagen between 7 and 10 days of culture. This results show the
possibility of epidermis growth on xenogenic collagen and possibility basal membrane
formation which is promising for the future clinical application of such specimen.
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Geranylgeranylacetone Treatment Accelerates Cutaneous Wound Healing after Ionising
Exposure
Isoir M1, Milliat F1, Guipaud O1, Tamarat R1, Mas-Chamberlin C2, Mondon P2, Lati E3,
Benderitter M1
1IRSN, France; 2SEDERMA, France; 3BIO-EC, France
Normal cutaneous wound healing is a coordinated physiological process in which
reepithelization is a crucial step involving migration and proliferation of keratinocytes to
cover denuded dermal surface. Skin exposure to ionising radiation leads to pathological
wound healing. The aim of the present study is both to evaluate the skin reepithelization after
irradiation and geranylgeranylacetone (GGA) efficiency to accelerate cutaneous wound
healing. GGA, an acyclic polyisoprenoid, is clinically used as an anti-ulcer drug protecting
gastric mucosa damage. GGA might inhibit small GTPase RhoA activation and modulate the
caspase cascade. Activation (K6 confocal analysis and RT-PCR real time), proliferation (Ki67
flow cytometry, confocal analysis and western-blot), migration (scratch injury model),
cytokines and growth factors secretion (TNF-a, -IL-1b, IL-6, IL-8 and VEGF) and
differentiation (K10 confocal analysis and RT-PCR real time) were quantified on primary
NHEK until four days after a 10Gy g-radiation exposure with or without GGA treatment (24
hours). Primary NHEK were shown to acquire an activated phenotype after g-radiation
(increase of ICAM-1 and K6 labelling compared to non-irradiated cells). Significant increase
of pro-inflammatory cytokines release (TNF-a, 8-fold and 7-fold significative increases of IL-
1b and IL-6 respectively), chemo-attractant secretion (3-fold significative increase of IL-8)
and pro-angiogenic factor secretion (3-fold significative increase of VEGF) was observed 4
days after a 10Gy-irradiation compared to non-irradiated cells. Functional consequences (cell
proliferation, cell migration and cell differentiation) were related to this radio-induced
keratinocytes activation. Curative treatment with GGA accelerated the NHEK repopulating
capacity by 6-fold after a 10Gy-radiation. Our results suggested that cell proliferation and
activation are modulated by GGA. Involvement of RhoA pathway was investigated. This
in vitro study demonstrated first that reepithelization is altered after ionising radiation and
second that skin reepithelization is stimulated after GGA treatment, probably by inducing
RhoA-dependent NHEK activation.
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Constitutive Expression of Multidrug Resistance-Associated Proteins in Various Human
Skin Cells in Culture
Boury-Jamot M1, Tailhardat M2, Le Varlet B2, Dumas M2, Verbavatz JM1, Garrigos M1
1SBFM/DBJC, CEA/Saclay, Gif-sur-Yvette, France; 2LVMH Recherche, St Jean de Braye,
France
The human multidrug resistance-associated proteins form the ATP Binding Cassette ‘‘C’’
subfamily which is composed of nine MRP1 homologs named MRP1 (ABCC1) through MRP9
(ABCC12). These transport proteins mediate the translocation of different structurally
unrelated molecules across various membranes: MRP transporters differ in their tissue
localization and have different substrate selectivity. The knowledge of the distribution of each
transporter may help to understand which MRP substrate can be transported. Thus, we
investigated by RT-PCR the mRNA expression of the nine human MRP gene transcripts in a
variety of normal human skin cell lines including keratinocytes, melanocytes, monocytes,
immature and mature monocyte-derived dendritic cells (MDDCs), human dermal fibroblasts
(HDF), differentiated pre-adipocytes, adipocytes and dermal microvascular (DM) endothelial
cells. Whereas MRP9 and MRP5 gene transcripts were not detected in any cell type, MRP7
gene transcripts were ubiquitously found in all cell types. The mRNA expression pattern of the
other MRP isoforms was cell type-dependent. In human cells from skin epidermis, MRP1 and
MRP3 mRNA were detected in keratinocytes, while MRP2 was seen in melanocytes. MRP6
mRNA was found in monocytes, whereas MRP2,3,8 and MRP1,2 were seen in immature
MDDCs and mature MDDCs respectively. In cell from the dermis, MRP3 mRNA was seen in
HDF, MRP1,2,3,4,8 in differenciated pre-adipocytes but only MRP 6,8 were found in
adipocytes. Finally, MRP1 mRNA was detected in DM endothelial cells. These results indicate
a complex pattern of MRP expression in human skin cells. It is likely that some of these
transporters are involved in the selective transport of various molecules (endobiotics or
xenobiotics) in human skin. Thus, we will investigate the expression and localization of MRP
proteins in cell types where mRNA was detected.
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Stimulation of the Skin’s Energy Metabolism Provides Multiple Beneﬁts
Sta¨b F, Blatt T, Lenz H, Schmidt M, Welge V, Wittern KP, Wenck H
Beiersdorf AG, Hamburg, Germany
Cutaneous ageing is characterized by a decline in cellular energy metabolism, which is mainly
caused by detrimental changes in mitochondrial function. Any lack of mitochondrial function
may impair cellular ATP synthesis and strongly alters mitochondrial physiology. These
changes finally contribute to the formation of reactive oxygen species (ROS), which in turn
further accelerate the ageing process.
According to our results, a stress-induced decline in mitochondrial energy supply in human
skin cells correlates with a decrease in the level of mitochondrial regulatory components, like
CoQ10. Application of CoQ10 to human skin cells was identified as a potential mechanism to
reinforce the endogenous mitochondrial energy capacity. As it is well-known that skin cells try
to compensate any loss in mitochondrial energy by utilization of extra-mitochondrial
pathways such as the creatine system, we investigated the effects of a combined CoQ10/
creatine supplementation. According to our results in human skin cells, CoQ10 on one hand
bolstered the mitochondrial energy capacity and facilitated the release of mitochondrial ATP,
creatine on the other hand was capable of storing and transporting high amounts of ATP in
form of phosphocreatine to places of high energy demand.
Our results demonstrate that human skin cells which are energetically balanced with
CoQ10 and recharged with a stabilized form of the physiological energy precursor, creatine,
are markedly protected against a variety of cellular stress conditions. Protection against
oxidative and UV damage was found both in vitro and in vivo. This obviously has beneficial
effects for treatment and long-lasting prophylaxis of processes relevant for both premature
skin ageing and skin damage.
062 [Oral 062]
E-cadherin Regulates In Vivo Tight Junction Barrier Function and aPKC Distribution
Helfrich I1, Tunggal Ja1, Schwarz H2, Gu¨nzel D3, Fromm M3, Kemler R4, Krieg T1, Niessen
CM1
1University of Cologne, Germany; 2Max Planck Institute for Developmental Biology,
Tu¨bingen, Germany; 3Charite University, Campus Benjamin Franklin, Berlin, Germany;
4Max Planck Institute for Immunobiology, Freiburg, Germany
Cadherin cell-cell adhesion molecules can affect a wide range of cellular functions that
include activation of cell signalling pathways, regulation of the cytoskeleton, and control of
cell polarity. To determine the role of E-cadherin in stratified epithelium of the epidermis, we
have conditionally inactivated its gene in mice. Loss of E-cadherin in the epidermis results in
perinatal death of mice due to extensive trans epidermal water loss. Detailed analysis of the
epidermal barrier showed no difference in the barrier function of the cornified layer. However,
it did show an increased permeability of the tight junctions present in the granular layer
correlating with a decrease in epidermal resistance as measured by impedance analysis of
the skin. Immunohistochemical analysis showed that key tight junctional markers, such as
claudins and ZO-1, are either not or improperly incorporated into the epidermal tight
junctions, explaining the aberrant tight junctional barrier function. Cell-cell adhesion is not
obviously altered, probably due to the presence of desmosomes. However, lack of E-
cadherin did alter the localization of signalling molecules such as atypical PKC and Rac.
Indeed, using atypical PKC inhibitors, we found that epithelial resistance of isolated
keratinocytes is substantially delayed, implicating aPKC in E-cadherin mediated regulation of
epidermal tight junction formation. Our results show that E-cadherin is essential for epidermal
barrier formation by regulating tight junctional architecture most likely via signalling molecules
such as aPKC.
063 [Oral 100]
Analysis of Tissues Distribution and Cellular Location of Human CGI-58 Protein Mutated
in Dorfman-Chanarin Syndrome
Ben Selma Z1, Caux F1, Guerrin M2, Fischer J3, Laroche L1
1Dermatology and UPRES EA3408, C.H.U. Paris XIII, France; 2UMR 5165, Toulouse, France;
3Genotyping National Center, Evry, France
Dorfman-Chanarin syndrome (DCS) is a recessive disease characterized by an ichthyosiform
erythroderma associated with a diffuse tissular accumulation of triacylglycerol. We have
previously identified mutations in a new gene, CGI-58, in DCS. However, no information on
the protein is still available.
RT-PCR was used to study mRNA expression of CGI-58 in different cellular types and
human tissues. Polyclonal antibodies to the N- and C-terminal domains of CGI-58 were
elicited in rabbits by injections of peptides conjugated to hemocyanin. Indirect immuno-
fluorescence (IIF) and immunoblotting (IB) were performed using rabbit sera before and after
immunization. Specificity of these antibodies was tested by IB using recombinant CGI-58
providing from COS cells transfected by a plasmid encoding Myc and 6-histidine in frame
with the CGI-58 sequence (pCEP4).
CGI-58 mRNA was highly expressed in fibroblasts, Hacat cells and fat tissue by RT-PCR. It
also was detected with lesser amounts in epidermis, muscle, heart, liver, lung, stomach,
colon, tonsil and neutrophils.
Using IIF, a diffuse cytoplasmic staining was observed on cultures of human skin
fibroblasts, keratinocytes, IHH, HepG2 and Hela cells with both sera. A cytoplasmic staining
of keratinocytes in all epidermal layers, although more intense in the cornified one was
demonstrated by IIF on normal human skin.
The molecular weight of recombinant CGI-58 protein was around 47 kDa. Given that the
predicted weight of CGI-58 was 39 kDa, post-translational modifications was searched using
enzymatic digestion (PNGase F) and competitive inhibitor (tunicamycin) but no N-
glycosylation was detected.
Analysis of CGI-58 mRNA shows an ubiquitous distribution and an overexpression in some
trigger tissues involved in DCS. The cytoplasmic location of CGI-58 protein is in accordance
with the site of accumulation of triacylglycerol in DCS.
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Predicting Skin Flux for Minimal Toxicological Exposure or Maximal Therapeutic Delivery
Magnusson BM1, Pugh JW2, Roberts MS3
1Department of Dermatology, Linko¨ping University Hospital, Sweden; 2Welsh School of
Pharmacy, Cardiff, United Kingdom; 3Therapeutic Research Unit, Princess Alexandra
Hospital, Australia
One of the most important determinants of dermatological and systemic penetration after
topical application is the delivery or flux of solutes into or through the skin. The maximum
dose of solute able to be delivered over a given period of time and area of application is
defined by its maximum flux (Jmax, mole per cm
2 per h) from a given vehicle. In this work we
aimed to find the simplest set of readily accessible physicochemical properties that defined
compounds with extreme Jmax values.
Literature in vitro Jmax values across human skin were collected in a training set for 87
penetrants. Penetrants were assigned as ‘‘good’’ (Jmax410
5.52 mole/cm2/h), ‘‘bad’’
(Jmaxo108.84 mole/cm2/h) or ‘‘intermediate’’, based on the cut-off range of more than one
standard deviation (1SD) above mean. The feasibility of using readily available physico-
chemical properties: molecular weight (MW), melting point (MP, K), octanol-water partition
coefficient (K), water solubility (S, molarity), number of atoms available for H-bonding (HB),
number of hydrogen-bond donors (HB-d), number of hydrogen-bond acceptors (HB-a), in
assigning solutes was examined.
The most useful predictor property was MW followed by (HB-a, log S) better than (HB, log
K, MP, HB-d). Two or three predictors in combination should be used to minimize the risk for
misclassification of group 0 as 2 compounds or vice versa. Discriminant analysis is a more
refined approach that assigns a group together with the probability of being correct. Optimal
discrimination for epidermal penetration was obtained using MW in combination with MP, HB,
log K or log S as predictors, which also gave a satisfactory success rate for the validation. No
group compounds were ever misclassified. In conclusion, the scheme for percutaneous
absorption can be used as a rapid screening of environmental exposure risks or potential
drug delivery candidates.
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In Vivo Measurement of Dynamics of Water Movement Across the Stratum Corneum after
Barrier Disruption
Hellemans L1, Van Der Pol A2, Van Overloop L1, Riggs WM2, Declercq L1, Maes D3
1Este´e Lauder BCC, Belgium; 2River Diagnostics BV, The Netherlands; 3Este´e Lauder
Companies, USA
The epidermal permeability barrier, which resides in the stratum corneum (SC), is considered
to be a biosensor that regulates epidermal responses to various exogenous insults. Barrier
disruption by tape stripping initiates a response that results in a rapid restoration of the barrier
function. Kinetics of the trans-epidermal water loss (TEWL) after barrier disruption is a well-
known process, however the evolution of the water content as a function of depth after barrier
disruption is unknown. Therefore we used in vivo confocal Raman microspectroscopy, a non-
invasive technique for obtaining detailed information about the molecular composition of the
skin as a function of depth.
On 5 subjects the jawline of the face and the ventral forearm were evaluated. Baseline
TEWL levels on the face were higher compared to the arm (respectively 6.3 and 1.2 g/m2/hr).
The water content as a function of depth was higher in the face compared to the arm, starting
at 36 mass% respectively 29 mass% at the skin surface and going with a sigmoid curve to a
plateau level of 65 mass% in the viable epidermis for both sites. After barrier disruption by
tape stripping until TEWL levels of 18 g/m2/hr were reached, the water content increased to
45 mass% in the upper layers of the SC on both sites. During the first 4.5 hrs of the recovery
phase TEWL decreased to 12 g/m2/hr, while the water content remained elevated (47 mass%
at surface). 23 hrs after tape stripping the TEWL had not further recovered, while the water
content had slightly decreased to 43 mass% at the skin surface of face and arm.
It can be concluded that there is a difference in the dynamics of the recovery response after
tape stripping between the external water flux and the internal water content.
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Sunﬂower Oleodistillate a New Natural PPAR Alpha Activator with Anti-Inﬂammatory
Properties
Dubuquoy L1, Piccardi N2, Msika P2, Auwerx J1, Chambon P1
1IGBMC, France; 2Laboratoires Expanscience, France
PPARs (Peroxisome Proliferator-Activated Receptors) are nuclear receptors involved in
cutaneous barrier homeostasis and in inflammatory process. As lipid sensors, PPARs are
activated by a wide range of fatty acids and synthetic ligands. Sunflower oleodistillate is
obtained by molecular distillation and contains 90% essential lipids (linoleic and oleic acids),
5% phytosterol and 1% vitamin E.
Because Sunflower oloedistillate is able to stimulate the synthesis of key epidermal lipids,
we have checked if it was able to activate PPAR receptors, and to modulate the inflammation
induced by TPA application in mice.
The activation of PPARs receptors was assessed in vitro using CV1 cells transfected with
expression vectors containing PPAR in combination with PPRE-luciferase. Luciferase activity
that is proportional to PPAR activity was than recorded using a luminometer.
Mouse experiments were carried out according to the protocol previously described by
Feingold et col (2003). Briefly, PPAR activator was topically applied on mouse ear 45 min and
4 h before TPA application, and the reaction will monitor after 18 h. Mouse ear thickness as
well as mRNA for pro-inflammatory cytokines were studied.
Using CV1 cells, we have demonstrated that Sunflower oleodistillate was able to activate
PPAR alpha receptor. Topical application of 2% of Sunflower oleodistillate on mouse ear is
able to partially prevent TPA effect (decresase of ear thickness). Pro-inflammatory cytokines
production is under investigation.
Sunflower oleodistillate is a new natural PPAR alpha activator with anti-inflammatory
properties in mice. This natural lipid may be useful for the management of inflammatory
cutaneous disorders.
ABSTRACTS A11125 : 3 SEPTEMBER 2005
067
Studies on a New Natural PPAR Alpha Agonist: Application to the Management of Atopic
Dermatitis
De Belilovsky C1, Piccardi N2, Choulot JC2, Chadoutaud B3, Msika P2
1Dermatologist Consultant, France; 2Laboratoires Expanscience, France; 3Scientific con-
sultant, France
Sunflower oleodistillate is a new natural PPAR alpha activator which is able to stimulate the
synthesis of key epidermal lipids ex vivo. Moreover, Sunflower oleodistillate is able to inhibit
the inflammatory reaction after TPA application in mice (in collaboration with the IGBMC,
Strasbourg, France). Atopic dermatitis (AD) is a chronic inflammatory skin disorder
associated with skin barrier disruption related to a deficit in key epidermal lipids.
In this work we sought to determine the effect of this new natural PPAR agonist in the
management of AD and its potential contribution in the sparing of dermo-corticoides (DC).
An emulsion, containing 2% of Sunflower oleodistillate, has been specifically developed for
AD patients. An open study (227 children, light to moderate AD) has been conducted.
Dryness, desquamation, erythema and pruritus were evaluated before and after 30D of 2X/
day application of this specific emulsion. 35 pediatricians have included 86 children (light to
moderate AD) in a multicentric, randomized, blinded study. Children (4 months- 4 years) have
been randomly assigned to 5 homogeneous groups (5 different doses of DC). Clinical
examinations, quality of life evaluations and questionnaires were performed at D0, 7 and 21.
The items for clinical examination were those necessary to calculate the SCORAD index.
The open study demonstrated a clinical improvement of dryness (88%), desquamation
(84%), erythema (81%) and pruritus (80%). The randomised study showed: a 75%
steroid sparing effect of the emollient with improvement of the SCORAD470%; a significant
impact on the quality of life of the children and their families (IDQOL, DFIQ): 75% with the
emollientþ steroids versus 57% with steroids alone.
Activation of PPAR pathway, by natural activators, and especially by Sunflower
oleodistillate, may represent an innovative and efficient strategy for the management of AD
patients.
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Improvement of Stratum Corneum Barrier Function by Acidiﬁcation
Hachem JP1, Schu¨rer NY2, Man MQ3, Crumrine D3, Rogiers V1, Feingold Kr3, Mauro D3,
Elias PM3
1University of Brussels, Belgium; 2University of Osnabru¨ck, Germany; 3University of
California San Francisco, USA
Several key epidermal barrier functions are regulated by the acid nature of the stratum
corneum (SC). While, the deleterious effects of SC neutralization are known, we
hypothesized, in opposition that hyperacidification of normal SC would improve epidermal
structure and function. Here, the functional consequences of SC acidification, on intact and
disrupted skin barrier, in both human and mouse models were investigated by applying either
HEPES buffer (5 mM, pH¼ 4.5 versus pH¼ 7) on forearm skin or 2 chemically-unrelated
polyhydroxyl acids, lactobionic acid (LBA) and gluconolactone (GL) in propylene glycol:etha-
nol (7:3) compared to vehicle (NaOH-neutralized LBA or GL). Improvement in barrier recovery
kinetics following acute disruption and SC integrity/cohesion/desquamation of intact skin
paralleled the decrease in SC pH. In situ zymography on biopsies from hairless mice flanks
showed a marked decrease of serine proteases (SP) basal activity. Further, increased
glucocerebrosidase and acid sphingomyelinase activities were assessed zymographically.
Compared to vehicle treatment accelerated lamellar bilayer formation 3hrs following tape
stripping and LBA application was demonstrated by electron microscopy. Further, SC
acidification was performed by LBA application at 12 hrs interval during 5 consecutive days
immediately after tape stripping and compared to nLBA treatment. Tape stripping-induced
epidermal hyperplasia, quantified by the measurement of epidermal thickness was reduced
by repeated application of LBA compared to the nLBA treated site.
069 [Oral 014]
Ex Vivo Analysis of T Cell Epitopes of Desmoglein 3 in a HLA Class II-Transgenic Mouse
Model of Pemphigus Vulgaris
Eming R1, Schmidt J1, Visconti KC2, Sonderstrup G2, Hertl M1
1Philipps University Marburg, Germany; 2Stanford University, CA, USA
Pemphigus vulgaris (PV) is a life-threatening autoimmune blistering disease of the skin and
mucous membranes characterized by IgG autoantibodies (auto-ab) binding to desmoglein 3
(dsg3), a desmosomal adhesion molecule expressed on epidermal keratinocytes. Dsg3-
reactive CD4þT cells are considered crucial for the initiation and perpetuation of this auto-
ab-driven autoimmune disease. The aim of our study was to identify CD4þT cell epitopes of
dsg3, using HLA class II-transgenic mice carrying the PV-associated DR0402-DQ8-
haplotype, the human CD4 receptor and deficient for murine MHC class II (I-Ab/).
Immunization of these mice with recombinant human dsg3 led to the induction of dsg3-
specific ab. Moreover, T cells isolated from the draining lymphnodes were fused to T cell
receptor (TCR)-deficient murine thymoma cells (BW5147) resulting in the generation of dsg3-
specific T cell hybridomas which secreted IL-2 upon TCR-mediated stimulation. Using
overlapping peptides spanning the entire extracellular domain of dsg3 we identified two Tcell
epitopes in the COOH terminus of dsg 3. Epitope-driven activation of the T cell hybridomas
was restricted by HLA-DR0402. Utilizing truncated and alanine-substituted dsg3 peptide
variants, we were able to define a nine amino acid core epitope. In a well-defined dsg3
epitope, we characterized positions p1, p4 and p6 which are essential for binding to HLA-
DR0402, as well as positions p-2 and p2 which are crucial for TCR-mediated T cell activation.
Thus, the present humanized mouse model of PV allows for the ex vivo analysis of T cell
epitopes of dsg3. Moreover, T cell hybridoma technology can be applied to define the binding
motifs of dsg3 peptides to HLA-DR0402 and the positions of the epitope recognized by the
TCR providing the basis for the generation of immunomodulatory peptides in PV.
070 [Oral 058]
Newly Remittent Pemphigus Patients Exhibit an Elevation in Antigen Speciﬁc
CD8þCD28-IFNcþCells with a Suppressor Phenotype
Lee E, Rizzo C, Chow S, Dionisio R, Nguyen D, Spizuoco A, Sinha A
Weill Medical College of Cornell University, USA
Pemphigus vulgaris (PV) is an autoimmune skin disease in which autoantibodies directed
against the cell adhesion molecule desmoglein 3 (Dsg3) result in blister formation on
numerous membranes and cutaneous surfaces. In part, Dsg3-specific Th2 CD4þ cells
appear to be required for the production of anti-Dsg3 antibodies in patients in active disease.
The cellular immune mechanisms responsible for promoting disease remission, however, are
not well understood. We report deviation towards a Th1 type response and an antigen
specific elevation in CD8þ IFNg-secreting cells in newly remittent disease (no lesions for 1–5
mo). We used cell surface matrix technology to enrich for rare activated cytokine-secreting
cells in combination with flow cytometric analysis from the peripheral blood of active
(presence of lesion), newly remittent, long-term remittent (no lesions45 mo) patients as well
as HLA matched and HLA unmatched controls. We observed a significant elevation in IFN-g
secretion by CD8þCD28- cells in newly remittent patients after Dsg3 stimulation.
Furthermore, we detected an elevation in FoxP3þ expression in CD8þ cells isolated from
newly remittent patients that was not seen in a long-term remittent patient or HLA-matched
control. Subsequently, FoxP3 expression was directly shown to be upregulated in the
CD8þCD28-IFNg-secreting population. We did not detect Dsg3-induced expression of
intracellular perforin in the CD8þpopulation occurred in any patient or control. These
findings support the existence of a CD8þ regulator in a suppressor (vs. cytotoxic) response
that may be operative in curbing autoaggression in PV.
071 [Oral 059]
Immunization of Mice with the Extracellular Domain of Desmoglein 1, the Pemphigus
Foliaceus Autoantigen, Can Induce a B-Cell Tolerance Breakdown to Various Desmo-
some Autoantigens
Mouquet H1, Drouot L1, Cerruti M2, Arnoult C1, Bonnet-Bayeux F1, Courville P1, Joly P1,
Tron F1, Gilbert D1
1INSERM U519, Rouen, France; 2INRA-CNRS UMR5087, Station de Recherche, France
Pemphigus is a group of autoimmune blistering skin diseases characterized by the
production of pathogenic autoantibodies directed against desmogleins (Dsg), which are
transmembrane glycoproteins of the desmosome. As in other organ-specific autoimmune
diseases, tolerance breakdown in pemphigus involves other antigens of the target organ
which may be the consequence of various molecular or cellular mechanisms. Herein we show
that mice immunized with the recombinant extracellular domain of human Dsg1 (rEC1/5-
Dsg1) produced antibodies to different polypeptides present in human epidermal extract. Two
mAbs, CK1 and 10A1, derived from rEC1/5-Dsg1-immunized mice, bound respectively to, a
190–210-kDa doublet and 190-kDa protein by immunoblotting on an epidermal extract, with a
pattern resembling of that the corresponding mouse sera. CK1 immunoscreening of a lgt11
human keratinocyte cDNA expression library selected a bacterial clone encoding a part of the
envoplakin linker subdomain. 10A1 did not select a clone from the lgt11 library but
recognized periplakin on a 2D-PAGE-separated human epidermis protein map. Thus,
immunization of normal mice with the rEC-Dsg1 can induce a B-cell tolerance breakdown,
not only to Dsg1 but also to other desmosomal autoantigens, thereby indicating that a single
autoantigen can initiate the diversification of the autoantibody response in organ specific
autoimmune diseases.
072 [Oral 060]
Cloning of a Novel Antigen of Paraneoplastic Pemphigus that Exhibits a Domain
Organization Similar to Membrane-Bound Serine Proteases
Mariotti F, Castiglia D, Zambruno G, Mastrogiacomo A
IDI – IRCCS, Rome, Italy
Cell surface proteolysis has emerged as an important mechanism for the generation of
biologically active proteins that mediate a diverse range of cellular functions. Type II
membrane-anchored serine proteases (TTSPs) are thought to trigger proteolytic cascades
involved in matrix-degrading processes leading to tissue remodeling, inflammation and
cancer. A cDNA encoding for a protein, which we have designated ‘‘Human Epidermal Serine
Protease’’ (HESP), was isolated from a human keratinocytes cDNA expression library
screened with human IgGs purified from the serum of patients affected with Paraneoplastic
Pemphigus (PNP). PNP is an autoimmune, acantholytic mucocutaneous disease associated
to a neoplasm and characterized by circulating antibodies directed to a panel of epithelial
antigens. The pathogenesis of this disease and its correlation to the antigenic pattern is not
yet completely understood. HESP is a novel target antigen of PNP and exhibits a distinctive
TTSPs domain organization. The longest open reading frame encompasses 1254 bp and
encodes for a protein of 417 aa that shows strong similarity to other known TTSPs. Northern
blot analysis of selected human tissues demonstrated a weak expression of HESP mRNA in
heart and skeletal muscle, in addition to keratinocytes. Western Blot analysis of human
keratinocytes showed a specific immunoreactivity for a protein with an apparent mass of 50
kDa localized predominantly in cell membranes. Indirect immunofluorescence displayed an
intercellular staining pattern of epidermal cells in human skin sections. Autoantibodies
against HESP were found in all PNP and in some pemphigus vulgaris patients’ sera analyzed,
but not in other autoimmune bullous skin diseases or control sera. The discovery of a new
antigen of PNP may eventually provide new clues for the diagnosis, initiation and evolution of
the disease.
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Inhibition of the Transcription Factor Foxp3 in Autoreactive Type 1 Regulatory T Cells
Induces a T Helper 2-like Phenotype
Veldman C1, Pahl A2, Beissert S3, Dieckmann D2, Schuler G2, Hertl M1
1Philipp’s University Marburg, Germany; 2University of Erlangen-Nu¨rnberg, Germany;
3University of Mu¨nster, Germany
An imbalance of type 1 regulatory (Tr1) T cells and T helper 2 (Th2) specific for desmoglein 3
(Dsg3) may be critical for the loss of tolerance against Dsg3 in pemphigus vulgaris (PV)
because there is a much lower Dsg3-specific Tr1/Th2 ratio in the PV patients than in healthy
individuals. The aim of this study was to downregulate Foxp3 mRNA in Dsg3-specific Tr1 cell
clones utilizing Foxp3 antisense oligonucleotides (ODN) since the transcription factor Foxp3
is presumably associated with regulatory T (TR) cell function. Interestingly, Foxp3 antisense
ODN-treated Dsg3-specific Tr1 cell clones lost expression of GITR, CTLA-4, started to
secrete IL-2, the Th2 cytokines IL-5 and IL-10 but no IFN-g or TNF-a. Importantly, Foxp3
antisense-treatment enabled the formerly anergic Tr1 cells to proliferate to Dsg3 and
mitogenic stimuli. Additionally, these cells were no longer able to suppress the proliferative
response of autoreactive Dsg3-specific Th2 cell clones. Thus, inhibition of Foxp3 expression
in the Tr1 cells induced a Th2-like phenotype. These data strongly support the concept that
Foxp3 expression is inherent to T regulatory cell function and that modulation of Foxp3
expression may be utilized to restore tolerance against self proteins, such as Dsg3 in PV.
074
Immunization Against Type VII Collagen Induces an Active Subepidermal Autoimmune
Blistering Disease in Mice
Sitaru C1, Chiriac MT1, Mihai S1, Ishiko A2, Zillikens D1
1University of Lu¨beck, Germany; 2Keio University, Japan
Epidermolysis bullosa acquisita (EBA) is a blistering disease associated with tissue-bound
and circulating autoantibodies to type VII collagen, a major constituent of the dermal-
epidermal junction (DEJ). Recently, we developed in vitro and in vivo models that are useful to
dissect the pathogenic mechanisms of blister formation induced by autoantibodies in EBA.
However, the induction of the autoimmune response to type VII collagen cannot be studied in
these models. Therefore, in the present study, we attempted to develop a model of EBA
reproducing the active disease by immunization of mice. Animals of 4 different strains,
including BALB/c (H2d), FcgammaR2b-deficient (H2b), SJL-1 (H2s), and SKH-1 (outbred),
were immunized with a recombinant form of the murine type VII collagen NC1 domain. All
mice (n¼ 60) developed circulating serum IgG autoantibodies to type VII collagen as
determined by immunofluorescence and immunoblot studies. These antibodies exclusively
bound to the lamina densa of mouse skin by immunoelectron microscopy. Levels of serum
autoantibodies, evaluated at different time points by ELISA using recombinant antigen, were
shown to be similar in all strains. Immunofluorescence analysis of murine skin revealed bright
deposition of IgG at the dermal-epidermal junction (DEJ). Importantly, subepidermal blisters
developed in 70% of SJL-1 (n¼ 18/25) and 40% of BALB/c mice (n¼ 10/25), but not in SKH-1
and FcgammaR2b-deficient mice. While strong complement C3 deposits were detected at
the DEJ of perilesional skin in susceptible strains, complement fixation was weak or absent in
non-responder strains. In conclusion, for the first time, we report an active disease in mice
reproducing the clinical, histo- and immunopathological as well as ultrastructural findings in
EBA. This model should be most helpful to study the autoimmune response to type VII
collagen and to develop immunomodulatory therapies for this and other autoimmune
blistering diseases.
075
Blister-Inducing Autoantibodies from Pemphigoid Gestationis Patients Bind to 2 Distinct
Epitopes on Human Type XVII Collagen
Herrero-Gonzalez JE1, Brauns O2, Egner R2, Roenspeck W2, Mascaro Jr JM3, Jonkman
MF4, Zillikens D1, Sitaru C1
1University of Luebeck, Germany; 2Affina-Fresenius, Germany; 3University of Barcelona,
Spain; 4University of Groningen, The Netherlands
Pemphigoid gestationis (PG) and bullous pemphigoid (BP) are subepidermal autoimmune
blistering diseases characterized by self-reactive T and B cells specific for the transmem-
brane hemidesmosomal protein type XVII collagen/BP180. Major T and B cell epitopes are
located within the immunodominant 16th non-collagenous domain A (NC16A) of this
molecule. The aim of this study was to map the epitopes targeted by blister-inducing human
autoantibodies to type XVII collagen. For this purpose, we used an in vitro model of
leukocyte-dependent autoantibody-induced dermal-epidermal separation on sections of
frozen human skin. In the majority of BP patients tested (7/10), preadsorption against a
recombinant form of the NC16A region failed to eliminate the blister-inducing potential of
patients’ serum, demonstrating that, in addition to the immunodominant region of type XVII
collagen, pathogenically relevant epitopes localize also outside this domain. In contrast,
preadsorption against NC16A completely abolished the blister-inducing ability of PG sera (5/
5). Immunoadsorption against a shorter BP180 NC16A peptide spanning aa 507–520
(NC16A2), previously considered to bear the main antigenic determinants in PG, did not
abolish the blister-inducing ability of PG sera. This finding indicates that blister-inducing PG
autoantibodies bind to multiple epitopes on type XVII collagen. Therefore, using newly
synthesized overlapping SPOT-peptides, we demonstrated that serum autoantibodies bind to
2 defined epitopes within the NC16A region (aa 501–514 and aa 512–523) in PG patients.
Importantly, preadsorption using an affinity matrix containing these 2 epitopes completely
abolished dermal-epidermal separation induced by PG autoantibodies. These findings
provide new insights into the pathogenesis of pemphigoid diseases and should prove helpful
for the development of an antigen-specific immunoadsorption therapy in PG.
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Study of the B- and T-lymphocyte Responses in Pemphigus Patients Treated by Anti-
CD20 Immunotherapy (Rituximab)
Musette P1, Mouquet H1, Jacquot S1, Gilbert D1, Huetz F2, Roujeau JC3, D’Incan M4, Tron
F4, Joly P5
1INSERM U519, France; 2Immunologie, Institut Pasteur, France; 3Dermatologie, CHU Cre´teil,
France; 4Dermatologie, CHU Clermont Ferrand, France; 5Dermatologie, CHU Rouen, France
Rituximab (Mabthera
s
) is a chimeric mAb directed against the human CD20 molecule that is
expressed by pre-B cells and B lymphocytes but not by plasma cells. Rituximab induces the
destruction of CD20þ lymphocyte populations and represents an effective treatment for non-
Hodgkin’s lymphoma and for several autoimmune diseases. Pemphigus is a specific
autoimmune disease mediated by pathogenic autoAbs directed against desmogleins (Dsg).
We have treated pemphigus patients (n¼ 10) by anti-CD20 immunotherapy (Rituximab) in a
prospective study and analyzed the immunological modifications.
Ten patients presenting pemphigus vulgaris (PV) (n¼ 6), foliaceus (PF) (n¼ 3), or
paraneoplastic pemphigus (PNP) (n¼ 1) were included in the study. At D90, 8 patients were
in complete remission (CR) and 2 in partial remission (RP). Two patients relapsed at 8 months.
During the monitoring, rate and phenotype of B lymphocytes, CD4þ and CD8þT
lymphocytes as well as anti-epidermis, anti-Dsg1 and anti-Dsg3 Ab titers were determined
at D0, D21, D90, D120, D180, D270, D360. Moreover, the B-cell repertoire was analysed at
D0 by a B-cell immunoscope method.
Treatment by Rituximab (375 mg/m2/week) induced the complete depletion of circulating B
lymphocytes from D21. We observed 3 types of autoAb responses: (i) decreases of anti-Dsg
Ab titers that were associated with CR started at D21 to reach the negative threshold at D90
for anti-Dsg1 Abs (7/9 patients) and at D120 for anti-Dsg3 Abs (4/6 patients), (ii) in 2 PF
patients that relapsed at 8 months, we observed a persistence of anti-Dsg1 Abs (iii) anti-Dsg3
Abs persisted in 2 PV patients with CR. Between the 6th and 9th month following the first
Rituximab perfusion, a highly diverse B-cell repertoire is reconstituted moreover, B cells
presented a naı¨ve phenotype (CD5þ , CD27-). Study of the B-cell repertoire diversity before
treatment showed B-cell oligoclonal expansions. Moreover, B-cell depletion did not induce
any changes of number or distribution of NK cells, CD4þ and CD8þT lymphocytes as well as
in theirs phenotypes (activation, IL2, INFg and TNFa secretions).
Treatment by Rituximab induced the complete depletion of circulating B lymphocytes that
led to elimination of anti-Dsg autoAbs in respondent patients. Nevertheless, in 2 PV patients,
loss of anti-Dsg3 Abs did not seem necessary to CR. Thus, in these patients, disease could
result of pathogenic effect of anti-Dsg1rather than anti-Dsg3 Abs. Absence of CR is
associated with persistence of anti-Dsg1 Abs in 2 cases of PF. In these patients, it can be
hypothesized that Rituximab-resistant plasma cells continue to secrete autoAbs, because of
a low turn-over.
Treatment by anti-CD20 immunotherapy Rituximab induced a complete depletion of
circulating B lymphocytes leading to elimination of anti-Dsg autoAbs that allow a CR in
respondent patients.
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Tissue Microarray Based Analysis of Matrilysin-1 and Collagenase-3 in Cutaneous
Squamous Cell Carcinoma in Recessive Dystrophic Epidermolysis Bullosa
Kivisaari A1, Kallajoki M1, Mcgrath J2, Bauer JW3, Csiko´s M4, Ko¨nigova´ R5, Shimizu H6,
Beckert W7, Hausser I8, Ka¨ha¨ri VM1
1University of Turku, Finland; 2St Thomas’s Hospital, London, United Kingdom; 3General
Hospital, Salzburg, Austria; 4Semmelweis University Budapest, Hungary; 5Charles University
Hospital Kra´lovske´ Vinohrady, Prague, Czech Republic; 6Hokkaido University Graduate
School of Medicine, Japan; 7Laboratory for Histology and Cytology, Nu¨rtingen, Germany;
8University of Heidelberg, Germany
Recessive dystrophic epidermolysis bullosa (RDEB) patients have an increased tendency for
fast-growing and early metastasizing cutaneous squamous cell carcinoma (SCC). We studied
the role of extracellular matrix degrading proteinases matrilysin-1 (matrix metalloproteinase-
7; MMP-7) and collagenase-3 (matrix metalloproteinase-13; MMP-13) in these carcinomas.
Formalin-fixed, paraffin embedded samples were obtained from 25 cutaneous SCCs from 18
RDEB patients. Tissue microarrays (TMA) were generated from the 12 of those carcinomas.
For comparison, TMAs we generated from 65 cutaneous SCCs and 30 Bowen’s diseases of
non-EB patients. Immunohistochemistry was performed using monoclonal antibodies against
MMP-7, MMP-13, syndecan-1, CD44 variant 3 (CD44v3) and heparin binding epidermal
growth factor (HB-EGF). In RDEB SCCs, abundant cytoplasmic staining for MMP-7 was
noted in the invasive edge of the tumors. MMP-7 was expressed also in most of the non-EB
SCCs, but not as strongly as in RDEB SCCs. Syndecan-1 staining was clearly diminished in
MMP-7 positive tumor areas in both SCC subgroups. The expression of CD44v3 was strong
in the cell surface of tumor cells while there was weak or absent staining in normal
keratinocytes. HB-EGF was detected in the same tumor cells as CD44v3. CD44v3 and HB-
EGF were detected similarly in both SCC subgroups. Interestingly, expression of MMP-13
was stronger in non-EB SCCs compared to RDEB SCCs. Cytoplasmic staining for MMP-13
was detected in differentiating tumor cells where as staining for MMP-7 was located mostly in
tumor cells bordering the tumor islets. Expression of these MMPs was minimal in Bowen’s
disease. These results suggest that MMP-7 and MMP-13 play different roles in growth and
invasion of RDEB SCCs. Both MMPs studied can be considered as potential therapeutic
targets in RDEB SCC as well as in non-EB SCC.
078
Involvement of Cytotoxic Proteins such as TIA-1 and Granzyme B in Autoimmune
Bullous Dermatoses
Vuille N1, Bro¨nnimann M1, Kappeler A2, Braathen LR1, Yawalkar N1
1Dermatological Clinic, Inselspital, Bern, Switzerland; 2Department of Pathology, University
of Bern, Bern, Switzerland
Besides pathogenic autoantibodies T-cells may play an integral part in the development of
autoimmune bullous diseases. The aim of the present study was to investigate granzyme B (GrB)
and T-cell-restricted intracellular antigen (TIA-1) expression in autoimmune bullous dermatoses
such as pemphigus vulgaris, bullous pemphigoid and dermatitis herpetiformis Duhring.
The expression of GrB and TIA-1 was analyzed using immunohistochemistry in skin biopsies
from patients with pemphigus vulgaris (n¼ 8), bullous pemphigoid (n¼ 9) and dermatitis
herpetiformis Duhring (n¼ 9). All cases showed numerous TIA-1þand GrBþ cells, with higher
numbers of TIA-1þT-cells. A significant enhancement of TIA-1 expression was found in
pemphigus vulgaris and dermatitis herpetiformis Duhring as compared with bullous pemphigoid.
TIA-1þ and GrBþ cells were mainly located perivascularly as well as focally at sites of blister
formation. Remarkably not only T-cells were TIA-1þbut also most neutrophilic granulocytes in
dermatitis herpetiformis Duhring.
TIA-1 is not specific for cytotoxic T-cells since it is also expressed in neutrophilic granulocytes.
The latter might be an important pathogenetic factor in dermatitis herpetiformis Duhring.
Furthermore, our data indicate that cytotoxic proteins may contribute to blister formation and
suggest that T-cell-mediated mechanisms involving TIA-1 and GrB are involved in the
pathogenesis of autoimmune bullous dermatoses.
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Imbalance of MMP-1, MMP-2, MMP-9, MMP-10 and their Tissue Inhibitors (TIMP 1, TIMP 2
and TIMP 3) may Provide to Skin Lesions in Dermatitis Herpetiformis
Zebrowska A1, Kobos J2, Narbutt J1, Sysa-Jedrzejowska A1, Waszczykowska E3
1Dept of Dermatology and Venerology of Medical University of Lodz, Poland; 2Laboratory of
Immunopathology of Medical University of Lodz, Poland; 3Laboratory of Immunodermatol-
ogy of Medical University of Lodz, Poland
Dermatitis herpetiformis (DH) is one of the subepidermal autoimmune diseases characterized
by skin and intestinal lesions. Eruptions in DH are histologically characterized by neutrophilic
infiltrate leading to destruction of basement membrane zone proteins Intestinal lesions,
consistent with coeliac disease, are characterized by atrophy of intestinal villi. There are also
some data that MMPs are involved in development of skin lesions in DH, however their
precise role in this process is not fully understood.
We aimed to investigate whether MMPs and their inhibitors, assessed by their tissue
expression, are involved in pathogenesis of DH. The localization and expression of
collagenase (MMP1), gelatinase (MMP2), 92 kD gelatinase (MMP9) and stromelysin 2
(MMP10) and TIMP1, 2, 3 were examined by immunohistochemistry in lesional skin biopses
as well as in normal human skin biopsy specimens (n¼10). Study included 13 patients, in a
mean age of 44.78 at an active stage of the disease. The MMPs and TIMPs serum levels were
measured by ELISA.
Expression for collagenase, stromielysin 2 and gelatinases was detected in basal
keratinocytes in all the samples, in part of them it was very intensive. Metalloproteinases
expression was detected in the whole epidermis. Neutrophils in microabscesses and in blister
fluid gave positive staining as well. Expression of TIMPs was assessed as moderate or weak
in all examined biopsies. In all biopsies obtained from healthy volunteers only single basal
keratinocytes gave positive, weak signal for all the proteins. The MMPs and TIMPs serum
levels in DH group as well as controls were normal.
Our results allow us to conclude that imbalance between these enzymes really occurs and
it takes important part in the pathogenesis of the disease.
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Anti-BP180 IgG Autoantibodies in Oral Lichen Planus
Buijsrogge JJ1, Duske U2, Hagel C2, Kromminga A2, Vissink A1, Jonkman MF1, Pas HH1
1University Medical Center Groningen, The Netherlands; 2Institute for Immunology, Clinical
Pathology and Molecular Medicine, Hamburg, Germany
Oral Lichen Planus (OLP) is a chronic inflammatory disease of the oral mucosa that affects
about 2% of the adult population. The histopathology of lichen planus is quite uniform,
despite the different clinical subtypes. The etiology of OLP is still unknown, although there are
suggestions for an initial antigen-mediated process in the pathogenesis. The band-like
lymphocytic infiltrate along the epidermal basal membrane zone, and the interaction between
T-lymphocytes, basal keratinocytes, macrophages and dendritic Langerhans cells seen in
ultrastructural analysis studies suggest the putative antigen to be located in the epidermal
basal membrane zone. In this study we investigated sera of OLP patients for the presence of
autoantibodies to keratinocyte proteins.
Sixty consecutive patients with OLP were included. The diagnosis OLP was made on
clinical presentation in combination with histopathology and direct immunofluorescence.
SDS-PAGE and immunoblotting were performed with patient sera on normal keratinocyte
extract and on BP180-deficient extract from keratinocytes of a patient with generalized
atrophic benign epidermolysis bullosa (GABEB). Furthermore immunoblotting was performed
with baculovirus produced recombinant full-length-BP180 and bacterial recombinant NC16A
constructs.
Immunoblotting on keratinocyte extracts showed in 8 out of 60 patients (13%) IgG
autoantibodies to BP180 as a clear but weak band. Immunoblotting with GABEB ‘‘knock-
out’’-extracts confirmed that this IgG was indeed directed to BP180 as all 8 sera were
negative here. In 5 out of these 8 patients autoreactivity to the recombinant full-length-BP180
was seen and 2 of these 5 were directed to the NC16A.
These experiments show the presence of B-cell reactivity to BP180 in at least part of
patients with OLP. Future research will be necessary to investigate if also T-cell reactivity to
BP180 is present in these and other patients with OLP.
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Dexamethasone Pulse Versus Placebo on Pemphigus Vulgaris: Results of the PEMPULS
Trial
Mentink LF1, Toth GG1, Pavlovic MD2, Cianchini G3, Mackenzie MW1, Jonkman MF1
1University Medical Centre Groningen, The Netherlands; 2Military Medical Academy, Serbia
and Montenegro; 3Instituto Dermopatico dell’Immacolata, Rome, Italy
Objective: To validate the effectiveness of adjuvant oral dexamethasone pulse therapy in the
treatment of pemphigus. This is the first randomized, double blinded, placebo-controlled trial
in pemphigus ever undertaken.
Material and Methods: Between 2000-2005 patients with pemphigus vulgaris (PV) were
randomized in multiple centers for either 300 mg oral dexamethasone (DP) or placebo pulses
(PP) 3 days per month. All patients received in addition prednisolone 80 mg/day according to
tapering schedule and azathioprine 3 mg/kg/day. Monthly pulses were continued until
prednisolone was tapered to zero, in minimal per protocol 19 weeks (complete remission).
The follow-up period was 1 year. Results: After randomisation, 11 patients were included in
the DP arm, whereas 9 patients in the PP arm. Eight patients treated with DP and nine with PP
reached complete remission during the study. Mean time to complete remission was 173
days with DP and 175 days with PP. The mean duration of complete remission within the first
year was 150 days for DP and 141 days for PP. Mean cumulative prednisolone usage was
5300 mg in DP and 4882 mg in PP after one year. 30 adverse events, were recorded in 10
patients on DP, versus 14 adverse events in 5 patients in the PP group. Weight gain (45%)
occurred 8 times to patients treated with DP, versus one patient on PP. No statistical
significant differences (po0.05) between the groups, nor a tendency of an adjuvant effect of
DP on remission of pemphigus vulgaris was found.
Discussion: We conclude that we were unable to show the benefit of oral dexamethasone
pulse therapy as adjuvant in pemphigus vulgaris. The addition of pulse therapy on
prednsiolone induced more weight gain.
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Rituximab is an Effective Treatment for Refractory Autoimmune Bullous Diseases but
may be Associated with Considerable Side-Effects
Schmidt E1, Zillikens D2, Broecker EB1, Goebeler M3
1University of Wuerzburg, Germany; 2University of Schleswig-Holstein, Campus Lu¨beck,
Germany; 3University of Heidelberg, University Medical Center Mannheim, Germany
The mainstay of autoimmune blistering diseases are systemic corticosteroids, frequently in
combination with other immunosuppressants or immunomodulators. Rituximab is a
humanized monoclonal antibody against the B cell-specific antigen CD20 that leads to
depletion of these cells for 9-12 months. We here present 8 patients with pemphigus vulgaris
(PV, n¼ 4), pemphigus foliaceus (PF), mucous membrane pemphigoid (MMP), juvenile bullous
pemphigoid (BP), and epidermolysis bullosa acquisita (EBA), in whom conventional therapies
did not control disease activity. The patients, therefore, received rituximab (MabTherat)
which was administered intravenously at a dose of 375 mg/m2 for 4 times in weekly intervals.
Previous treatments were continued and included methylprednisolone alone or in combina-
tion with azathioprine, mycophenolate mofetil, dapsone, or colchicine as well as
dexamethasone-cyclophosphamide pulses. Complete clinical remission was achieved in 5
patients 2 (PF), 4 (PV), 8 (PV), 9 (EBA), and 32 weeks (PV) after the last rituximab infusion. In 1
patient with PV and the BP patient, a reduction of lesions by 50% and 90% after 16 and 9
weeks, respectively, was observed. Whereas nasopharyngeal lesions of the MMP patients
improved, vision further impaired leading to blindness of both eyes. As possible rituximab-
related adverse affects bacterial pneumonia, parainfluenzal pneumonia, varicella sepsis,
pulmonary embolism, and deep venous thrombosis as well as hypogammoglobulemia in both
juvenile patients with PV and BP were seen. In conclusion, rituximab appears to be an
effective therapeutic option in patients with refractory autoimmune blistering diseases.
However, it may be associated with considerable side-effects when accompanied with
immunosuppressants.
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Incidence of IgA Autoantibodies in the Pemphigoids and Linear IgA Bullous Dermatosis
(LABD)
Horvath B1, Niedermeier A2, Podstawa E2, Mu¨ller R2, Veldman CH2, Ka´rpa´ti S1, Hertl M2
1Semmelweis University Budapest, Hungary; 2Philipps Universita¨t Marburg, Germany
Background Most patients with pemphigoids, i.e. bullous pemphigoid (BP), mucous
membrane pemphigoid (MMP), and pemphigoid gestationis (PG) have pathogenic IgG
autoantibodies (auto-ab) – and occasionally IgA – against BP180 and BP230, components of
the hemidesmosomal plaque. Moreover, patients with LABD have IgA auto-ab reactive with a
97/120 kDa protein which is highly homologous to the extracellular domain of BP180.
Objectives The aim of our study was (i) to determine the incidence of IgA auto-ab against
BP180/BP230 in the pemphigoids and LABD compared to healthy controls, and (ii) to
determine the epitopes targeted by IgA antibodies specific for BP180/BP230.
Methods Utilizing baculovirus expressed recombinant BP180 and BP230 proteins we
performed immunoblot analyses for IgA reactivity of sera from patients with BP (n¼30), MMP
(n¼ 10), LABD (n¼ 6), PG (n¼ 6) and control donors (n¼33).
Results We detected IgA auto-ab reactivity in 19/30 of the BP sera, 7/10 of the MMP, 3/6 of
the PG and 6/6 of the LABD sera, respectively. IgA auto-ab against BP180 and BP230 were
also found in 9/33 control sera. In all the subgroups, the most frequent antigenic site for IgA
was the NH2-terminus of BP180 (aa490-812), but only the minority of these sera showed IgA
reactivity to the NC16A domain. In addition, IgA reactivity against the central domain of
BP180 (aa809-116) was more frequently seen than IgA reactivity against the COOH-terminus
of BP180. IgA antibodies against the COOH- and NH2-terminus of BP230 were detected in 6/
30 of the BP, 1/10 of the MMP, 1/6 of the LABD and 2/33 of the control sera.
Conclusions The majority of pemphigoid patients with IgG auto-ab against BP180/BP230
have also IgA auto-ab reactive against distinct domains of these autoantigens but commonly
not against the NC16A region of BP180. The observed IgA reactivity against BP180/BP230 in
healthy individuals requires further characterization of role that pathogenic vs. non-
pathogenic IgA auto-ab play in the pemphigoids.
084
Identiﬁcation of Novel and Known Mutations in Keratin 5 and 14 Genes in Weber-
Cockayne Subtype Epidermolysis Bullosa Simplex
Bo´na A, Csiko´s M, Sajo´ R, Ka´rpa´ti S
Semmelweis University, Hungary
Epidermolysis bullosa simplex (EBS) is a group of hereditary bullosus disorders characterized
by intraepidermal blistering due to mechanical stress-induced degeneration of basal
keratinocytes. Most patients had defects in one of the two keratin genes KRT5 and
KRT14. Our purpose was to identify mutations and polymorphisms underlying the clinical
symptoms and to compare with skin histology in order to define a phenotype-genotype
correlation more precisely. We have investigated genomic sequences of KRT5 and KRT14 for
mutations in 5 pedigrees from the register of the DEBRA Hungary. In four EBS pedigrees the
disease inherited autosomal dominantly, however in one family only the proband but not other
family members were affected. All patients with features of milder form the Weber-Cockayne
variant of EBS, the blistering confined to the hands and feet. In three of five cases novel
mutations were identified in KRT5 (R331G) and KRT14 (L136Q; E411K). Two families had
presented with previously identified mutations in KRT5 (E170K) and KRT14 (R388C). These
mutations add some data to those described previously and provide further evidence of
phenotype-genotype correlation in EBS.
085
Immunodominant Regions of BP180 and BP230 are Preferentially Targeted by IgG1
Autoantibodies (auto-ab) Present in the Sera and Blister Fluids of Patients with Bullous
Pemphigoid (BP)
Niedermeier A1, Horvath B2, Podstawa E1, Schwietzke S1, Hertl M1
1Philipps-Universita¨t Marburg, Germany; 2Semmelweis University, Hungary
BP is an autoimmune bullous disease characterized by IgG auto-ab against two components
of the dermo-epidermal basement membrane zone, BP180 and BP230. The goal of this study
was to determine whether both sera and blister fluids (bf) are suitable for refined analysis of
auto-ab profiles in pemphigoid. Sera and bf of 7 patients with acute onset BP were
characterized by ELISA and immunoblot analysis with recombinant BP180 and BP230
proteins. The titers of IgG reactive with BP180 and BP230 were slightly but significantly lower
in the bf than in sera. Patients had BP180 IgG-specific auto-ab in the sera and bf reactive with
the NC16A domain (7/7), the major immunodominant region of BP180, the COOH-terminus
(3/7) and the central domain (2/7). BP180-reactive IgG1 was the major auto-ab subtype in
sera and bf while IgG4 reactivity against BP180 was not detectable in any of the 7 BP sera.
Additionally, 5/7 patients had IgA auto-ab against BP180 in sera and bf targeting the N-
terminal region (5/7), the COOH-terminus (1/7) and central domain (3/7). BP230-reactive IgG
auto-ab preferentially targeted the COOH-terminus (5/7) in sera and bf. Our results suggest
that i) both sera and bf are suitable for auto-ab analyses, ii) lower auto-ab titers in the bf are
suggestive for tissue binding of all epitope-specific auto-ab iii) the complement-fixing IgG1 is
the major auto-ab subtype and iiii) IgA auto-ab are also frequently present.
086
Expression of Pro-Apoptotic Molecules in Cutaneous Lesions of Dermatitis Herpetifor-
mis
Antiga E, Torchia D, Degl’innocenti D, Barletta E, Baroni G, Santucci M, Fabbri P, Caproni M
Department of Dermatological Sciences, University of Florence, Italy
Apoptosis is a form of cell death that is claimed to be involved in a number of chronic
inflammatory and malignant skin diseases. The aim of the study was to investigate whether
apoptosis may contribute to the pathogenesis of cutaneous changes in dermatitis
herpetiformis (DH) and whether apoptosis-related markers such as Fas antigen, Fas ligand
(FasL), Bcl-2 and Bax proteins take part in this process.
For the detection of apoptotic DNA fragmentation, terminal deoxynucleotidyl transferase-
mediated deoxyuridine triphosphate nick end labelling technique (TUNEL) was employed on
cryostat sections. Lesional skin from six and perilesional from four patients with DH were
stained with monoclonal antibodies against Fas antigen, FasL, Bcl-2 and Bax proteins. The
same evaluation was also performed in three patients affected by bullous pemphigoid (BP)
and in two healthy donors.
Using TUNEL technique, a remarkable increase in the apoptotic rate within the epidermal
compartment was observed in DH and BP patients in comparison with normal controls. In our
immunohistochemical analysis, Bax/Bcl2 ratio was almost the same in the epidermis of
perilesional/lesional DH, BP, and healthy skin specimens. Fas showed a prevalently epidermal
staining both in DH and BP lesions, while FasL was distributed in perivascular and
subjunctional dermis; some FasLþ cells infiltrated the dermo-epidermal junction and the
basal layer of epidermis. No Fas or FasL staining was detected within the skin specimens of
healthy donors.
In conclusion, this study allowed us to highlight conspicuous apoptotic phenomena in
basal and suprabasal keratinocytes within lesional and perilesional skin of DH. We conclude
that in DH, as well as in BP, the activation of apoptotic pathways may play a role in the
pathogenesis of cutaneous lesions in concert with other pathogenetic mechanisms.
087
Three cases of Coexistence of Psoriasis and Bullous Pemphigoid
Wozniak K1, Lazarczyk M1, Hashimoto T2, Kowalewski C1
1Department of Dermatology, Medical University of Warsaw, Poland; 2Department of
Dermatology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
It has previously been reported that pemphigoid coexists with psoriasis more frequently than
it could be predicted on the basis of random distribution in general population. Interestingly, it
has been found that besides bullous pemphigoid also pemphigoid with antibodies directed
against autoantigen with molecular weight about 200 kDa (anti-p200 pemphigoid) may
coexist with psoriasis. We present three psoriatic patients who developed tense blisters,
which most likely were not provoked by anti-psoriatic treatment. Diagnosis of bullous
pemphigoid in those cases was established by an overlay antigen mapping technique by
laser confocal microscopy. Analysis revealed the presence of in vivo bound IgG linear
deposits along dermal-epidermal junction, above the localization of laminin-5 and at the level
of b4-integrin, which corresponds to their ultrastructural localization in the upper part of the
lamina lucida similarly to the bullous pemphigoid (BP 180kD) patients. Interestingly, in control
case of anti-p200 pemphigoid, immunoglobulin deposits were found to be present below the
localization of b4-integrin and above collagen IV, at the level of laminin-5, which corresponds
to their ultrastructural localization at the lamina lucida–lamina densa border. Serum study in
two out of three patients revealed the presence of anti-basement membrane zone antibody
directed to the epidermal side of salt split skin and reactive with NC16a fragment of BP 180
kD antigen. The cases presented herein are Caucasian psoriatic patients suffering from
bullous pemphigoid but not anti-p200 pemphigoid which is mostly observed among the
Japanese population.
088
Localized Epidermolysis Bullosa Acquisita-LSCM Study on Two Patients
Wozniak K, Kowalewski C
Department of Dermatology, Medical University of Warsaw, Poland
Localized blisters in a course of autoimmune subepoidermal bullous diseases were
previously described mainly in cicatricial pemphigoid whereas only a few cases of
epidermolysis bullosa acquisita (EBA) were reported. We present laser scanning confocal
microscopic (LSCM) on two patients. First patient is an eight-year-old child with tense blisters
of 3 months duration healing with scars and milia formation simetrically localized on the face.
Second patient is forty-year-old male with circumscribed scar on the lateral surface of the
neck of 1 year duration. The border of the scar consisted of small vesicles and milia. In both
patients direct immunofluorescence study showed the presence of in vivo bound IgG linear
deposits along the basement membrane zone (BMZ). LSCM study on perilesional skin was
performed to compare the localization of in vivo bound IgG anti-BMZ to the localization of
various BMZ markers. Confocal microscopic examination disclosed the presence of in vivo
bound IgG below the localization of collagen IV in both patients, which corresponded to their
ultrastructural localization under lamina densa similarly to the EBA control. Whereas in
pemphigoid and cicatricial pemphigoid in vivo bound IgG were localized above collagen IV.
Serum study in one of two studied patients disclosed the presence of circulating IgG anti-
BMZ antibody reactive exclusively with the floor of the salt split skin and recognized as 290
kDa protein by immunoblot on dermal extract. In second patient serum study was negative.
LSCM technique allow rapid differentiation of EBA from other autoimmune subepidermal
bullous diseases and is of special value in diagnosing of those cases in which circulating
antibody are not detectable.
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Bullous Pemphigoid Associated with Hypereosinophilic Syndrome
Hofmann SC, Technau K, Mu¨ller AM, Lu¨bbert M, Bruckner-Tuderman L
Department of Dermatology, University of Freiburg, Germany
Hypereosinophilic syndrome (HES) is a myeloproliferative disease defined by unexplained
hypereosinophilia for more than 6 months with organ involvement. Eosinophilic skin infiltrates
occur frequently in HES and lead to variable, often pruritic skin lesions. Recently, molecular
abnormalities leading to overexpression of kinases were detected in a subset of HES
patients, and successful treatment with imatinib mesylate, a tyrosine kinase inhibitor, has
been reported. Eosinophils also play a major role in the immunopathogenesis of bullous
pemphigoid, the most frequent bullous autoimmune dermatosis: The eosinophil chemoat-
tractants IL-5 and eotaxin have been detected in blister fluid of BP patients and 92-kDa-
gelatinase has been shown to induce dermoepidermal separation.
We describe a 70 year old man with severe pruritus, localized serous blisters and
disseminated, erythematous skin lesions. Histology revealed subepidermal blistering, direct
immunofluorescence showed linear C3 deposition at the dermoepidermal junction and
circulating antibodies against BP180 were detected by indirect immunofluorescence,
Western Blot and ELISA. In addition to these findings, typical for bullous pemphigoid, he
displayed constant peripheral hypereosinophilia and marked eosinophilic infiltrates in bone
marrow and skin. Cytogenetic examination revealed a chromosomal deletion (20)(q11)
leading to the additional diagnosis of HES. Durable remission of hypereosinophilia and skin
lesions was achieved by treatment with imatinib mesylate and correlated with anti-BP180-
antibody levels as monitored by ELISA.
Atypical bullous pemphigoid with persistent hypereosinophilia may reveal coexistence of
HES. In these cases, imatinib mesylate may represent a highly efficient treatment option. It
will be intriguing to elucidate the apparently similar molecular and immunological signals in
bullous pemphigoid and HES, their pathogenetic role and potential as therapeutic targets.
090 [Oral 013]
Immunization against Type VII Collagen Induces an Active Subepidermal Autoimmune
Blistering Disease in Mice
Sitaru C1, Chiriac MT1, Mihai S1, Ishiko A2, Zillikens D1
1University of Lu¨beck, Germany; 2Keio University, Japan
Epidermolysis bullosa acquisita (EBA) is a blistering disease associated with tissue-bound
and circulating autoantibodies to type VII collagen, a major constituent of the dermal-
epidermal junction (DEJ). Recently, we developed in vitro and in vivo models that are useful to
dissect the pathogenic mechanisms of blister formation induced by autoantibodies in EBA.
However, the induction of the autoimmune response to type VII collagen cannot be studied in
these models. Therefore, in the present study, we attempted to develop a model of EBA
reproducing the active disease by immunization of mice. Animals of 4 different strains,
including BALB/c (H2d), FcgammaR2b-deficient (H2b), SJL-1 (H2s), and SKH-1 (outbred),
were immunized with a recombinant form of the murine type VII collagen NC1 domain. All
mice (n¼ 60) developed circulating serum IgG autoantibodies to type VII collagen as
determined by immunofluorescence and immunoblot studies. These antibodies exclusively
bound to the lamina densa of mouse skin by immunoelectron microscopy. Levels of serum
autoantibodies, evaluated at different time points by ELISA using recombinant antigen, were
shown to be similar in all strains. Immunofluorescence analysis of murine skin revealed bright
deposition of IgG at the dermal-epidermal junction (DEJ). Importantly, subepidermal blisters
developed in 70% of SJL-1 (n¼ 18/25) and 40% of BALB/c mice (n¼ 10/25), but not in SKH-1
and FcgammaR2b-deficient mice. While strong complement C3 deposits were detected at
the DEJ of perilesional skin in susceptible strains, complement fixation was weak or absent in
non-responder strains. In conclusion, for the first time, we report an active disease in mice
reproducing the clinical, histo- and immunopathological as well as ultrastructural findings in
EBA. This model should be most helpful to study the autoimmune response to type VII
collagen and to develop immunomodulatory therapies for this and other autoimmune
blistering diseases.
091 [Oral 015]
Collagen XVII Promotes Integrin-Mediated Squamous Cell Carcinoma Transmigration: A
Novel Role for aIIb Integrin and Tiroﬁban
Parikka M1, Nissinen L2, Kainulainen T1, Bruckner-Tuderman L3, Salo T1, Heino J2, Tasanen
K1
1University of Oulu, Finland; 2University of Turku, Finland; 3University of Freiburg, Germany
The expression of collagen XVII (BP180), a transmembrane hemidesmosomal component, is
upregulated in invasive areas of epithelial tumors. In both keratinocytes and malignant
epithelial cells its collagenous ectodomain is cleaved from the plasma membrane, and the
released ectodomain is predicted to regulate cell detachment, differentation, and motility.
Here, the putative role of collagen XVII in physiological and pathological keratinocyte
migration was explored by immunostainings. Collagen XVII was not synthesized by the
leading keratinocytes during wound healing, whereas it was upregulated in the invading cells
of squamous cell carcinomas indicating that collagen XVII is differentially regulated during
physiological and malignant cell migration. This was supported by transmigration assays in
which the cell adhesion domain of collagen XVII, Col15, induced the transmigration of
invasive tongue HSC-3 carcinoma cells but not of HaCaT keratinocytes. Flow cytometry
analysis revealed that in addition to known Col15 binding integrins, a5b1 and av, a platelet
specific fibrinogen-receptor, aIIb, is expressed on the surface of HSC-3 cells. Accordingly,
the presence of function-blocking antibodies against a5b1, av and aIIb integrins inhibited the
promigratory effect of Col15 on carcinoma cells. Interestingly, tirofiban, a FDA-proved drug
widely used for the therapy of acute coronary ischaemic syndrome and the prevention of
thrombotic complications inhibited the Col15-induced transmigration of HSC-3 carcinoma
cells. Together, these data demonstrate a novel interaction between collagen XVII and aIIb
integrin, and also suggests a possibility to use tirofiban to inhibit the invasion of squamous
cell carcinomas.
092 [Oral 055]
Connective Tissue Growth Factor: A Key Regulator of Collagen Production is Reduced in
Aged Human Skin In Vivo
Fisher G, Quan T, Kang S, Voorhees J
University of Michigan, USA
Collagen loss during aging increases fragility and impairs wound healing. Loss of skin
collagen results from increased matrix metalloproteinase degradation and reduced collagen
production. The mechanism responsible for these alterations involves reduction of
transforming growth factor-b1 (TGF-b1), which is the most potent regulator of collagen
production. Recently, connective tissue growth factor (CTGF) has been implicated as a key
mediator of TGF-b-induced collagen synthesis. We have investigated expression of CTGF in
young and aged human dermis, and the role of CTGF in regulation of collagen production in
primary human skin fibroblasts (HSF). CTGF mRNA was significantly reduced 42% (n¼5) in
aged (480 years of age) vs. young (20-30 years of age) dermis. These reductions mirror
previously reported reduction of TGF-b1 in aged human dermis in vivo. Addition of TGF-b to
HSF induced CTGF mRNA and protein 10-fold, within 16 hours (n¼3), and type I collagen
(COL) mRNA and protein 3-fold, within 24 hours (n¼ 3). siRNA-mediated knockdown of type I
TGF-b receptor, Smad3, or Smad4, which mediate TGF-b signaling, reduced TGF-b-induced
COL, and CTGF gene expression by 70% and 50%, respectively (n¼ 3). siRNA-mediated
knockdown of CTGF reduced TGF-b-induced COL mRNA and protein levels 55% and 65%,
respectively (n¼3). Transient over-expression of CTGF increased TGF-b-induced COL gene
expression. This increase of COL production was abolished by type I TGF-b receptor inhibitor
SB431542. These data demonstrate that TGF-b regulates CTGF expression, which in turn,
acting through a TGF-b receptor-dependent mechanism, is required for TGF-b-induced COL
expression. Thus, CTGF emerges as a novel key target for therapy and prevention of COL
loss in aged human skin.
093 [Oral 056]
Activation of Smad Signaling Enhances Collagenase-3 (MMP-13) Expression and
Invasion of Head and Neck Squamous Carcinoma Cells
Leivonen S1, Ala-Aho R1, Koli K2, Grenman R1, Peltonen J3, Ka¨ha¨ri V1
1University of Turku, Finland; 2University of Helsinki, Finland; 3University of Oulu, Finland
Squamous cell carcinoma (SCC) cells of the head and neck specifically express collagenase-
3 (MMP-13), the expression of which correlates with their invasion capacity. Transforming
growth factor-b (TGF-b) enhances MMP-13 expression and invasion of SCC cells via p38
mitogen-activated protein kinase. The purpose of this study was to examine the role of Smad
signaling in regulating MMP-13 expression and invasion of head and neck SCC cells using
adenoviral delivery of wild-type and dominant negative components of TGF-b/Smad signaling
pathway. Treatment with TGF-b resulted in activation of Smad2 and Smad3 in SCC cells, but
had no effect on their proliferation or viability. Basal activation of Smad3 and p38 was noted in
SCC cells without exogenous TGF-b stimulation, and adenoviral delivery of Smad7 and
dominant negative Smad3 inhibited p38 activation in these cells. Adenoviral overexpression
of Smad3 augmented the upregulatory effect of TGF-b on MMP-13 expression by SCC cells.
Disruption of Smad signaling by adenoviral expression of kinase-defective TGF-b type I
receptor (ALK5), Smad7, and dominant negative Smad3 potently suppressed the basal and
TGF-b-induced expression of MMP-13 in SCC cells, and inhibited their basal and TGF-b-
induced invasion through type I collagen and Matrigel. Adenoviral overexpression of Smad7
in cutaneous SCC cells significantly inhibited their implantation in skin of SCID mice and
resulted in delayed growth of xenografts in vivo, as compared to LacZ adenovirus transduced
control SCC cells. In summary, these results show, that Smad signaling plays an important
role in promoting the invasive phenotype of human head and neck SCC cells by upregulating
their MMP-13 expression, suggesting TGF-b/Smad signaling pathway as a novel therapeutic
target in head and neck SCCs.
094 [Oral 057]
Dipeptidylpeptidase IV Activity Inﬂuences the Aggressiveness of Melanoma Cells by
Differential Expression of an Invasive Gene Cluster Triggered by Down Regulation of
ERK Activation
Becker B, Roesch A, Hafner C, Landthaler M, Vogt T
University of Regensburg, Germany
The dipeptidylpeptidase IV (DPPIV) is a multifunctional membrane receptor with an intrinsic
enzymatic peptidase activity. DPPIV is expressed in a variety of cell types and covers
functions like interaction with the extracellular matrix, proteolytic cleavage of chemokines as
well as the modulation of signaling cascades of other surface receptors. Expression of DPPIV
is inversely related with the stage of progression of melanocytic tumours and inhibits the
invasive capacity of melanoma cells. The mechanisms of how DPPIV influences the
malignancy of tumour cells is not known.
We re-expressed DPPIV in melanoma cells which do not express DPPIV. DPPIV re-
expressing cells had a slower growth rate. This effect was reversible by the DPPIV inhibitor H-
LysZ. Gene expression profiling on the Affymetrix platform showed a down regulation of a
cluster of genes involved in the invasive behaviour of cancer cells (TIMP-1, MMP2/9, IL8, IL1b
and CXCL1). The gene regulation was confirmed by RT-PCR. In addition, we show that TIMP-
1 protein expression and secretion was reduced by DPPIV re-expression along with down
regulation of both av and b3 integrin subunits. Analyses of signalling events which might lead
to the observed gene expression changes showed a down regulation of the activity of the
MAP kinase ERK1/2.
Conclusion: This is the first report that links the DPPIV tumorsuppressive action with the
regulation of a proinvasive gene cluster, which seems to be mediated by ERK signalling.
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The C-Terminus of BP180/Collagen XVII is Important for its Adhesive Function
Franzke C1, Has C1, Schulte C2, Vaisanen L3, Tasanen K3, Aumailley M2, Bruckner-
Tuderman L1
1Dept of Dermatology, University of Freiburg, Germany; 2Dept of Biochemistry, University of
Cologne, Germany; 3Dept of Dermatology, University of Oulu, Finland
Collagen XVII/BP180 belongs to the novel group of collagenous transmembrane proteins. As
membrane integrated hemidesmosome component, it mediates the anchorage of the basal
keratinocytes to the underlying basement membrane. Genetic defects of collagen XVII are
associated with epidermal detachment in junctional epidermolysis bullosa (JEB). Here we
analyzed a spontaneous mutation in the COL17A gene, which resulted in the deletion of the
43 most C-terminal amino acids of the collagen XVII ectodomain. Immunohistology and
immunoblot analysis revealed that truncated collagen XVII forms existed in cultured JEB
keratinocytes and in the skin, albeit at a somewhat lower level as the controls.
Immunofluorescence labeling of JEB keratinocytes showed an abnormal scattered deposi-
tion of laminin 5 and collagen XVII far away from the cell bodies, suggesting that ligand
interactions were perturbed. Ligand binding assays demonstrated that the normal
ectodomain of collagen XVII binds laminin 5 and heparin, and that these interactions were
reduced by the C-terminal truncation. Following of the cell motility by time-lapse
videomicroscopy disclosed a higher motility of JEB cells than normal keratinocytes, but in
an undirected manner. Comparable motility characteristics have been observed before with
collagen XVII deficient keratinocytes. These findings demonstrate that the deletion of the
laminin 5-binding domain of collagen XVII alters physiologic ligand binding and cell motility.
These observations suggest that the distal C-terminus of collagen XVII mediates its
physiological interactions with laminin 5 and heparin, and, thus, the adhesion of basal
keratinocytes to the basement membrane. The findings underline the role of the distal
ectodomain of collagen XVII in epidermal adhesion and etiopathogenesis of JEB.
096
ADAM10 Mediates E-cadherin Shedding and Regulates Epithelial Cell-Cell Adhesion,
Migration and Beta-Catenin Translocation
Scholz F1, Maretzky TU2, Reiss K2, Ludwig A2, Buchholz J2, De Strooper B3, Hartmann D3,
Proksch E1, Saftig P2
1UK-SH Campus Kiel, Germany; 2Biochemical Institute, Christian-Albrechts-University Kiel,
Germany; 3Dept. for Human Genetics, K.U. Leuven and Flanders Interuniv, Belgium
E-cadherin (epithelial-cadherin, uvomorulin) is one of the most important molecules involved
in tissue morphogenesis, wound healing and the maintenance of tissue integrity. We show
here that E-cadherin is cleaved specifically by the disintegrin and metalloprotease ADAM10 in
its ectodomain. Analysis of ADAM10-deficient fibroblasts, inhibitor studies as well as RNAi
mediated downregulation of ADAM10 demonstrated that ADAM10 is not only responsible for
the constitutive but also for the regulated shedding of this adhesion molecule in fibroblasts
and in keratinocytes. ADAM10 mediated E-cadherin shedding affects epithelial cell-cell
adhesion as well as cell migration. Furthermore, the shedding of E-cadherin by ADAM10
modulates the beta-catenin subcellular localisation and downstream signalling. ADAM10
overexpression in epithelial cells increased the expression of the beta-catenin downstream
gene cyclin D1 dose-dependently and enhanced cell proliferation. In ADAM10-deficient
mouse embryos the carboxyterminal E-cadherin fragment is not generated and the full length
protein is accumulating highlighting the in vivo relevance for ADAM10 in E-cadherin shedding.
Our data strongly suggest that this protease constitutes a major regulatory element for the
multiple functions of E-cadherin under physiological as well as pathological conditions.
097
Hyaluronan and Ultraviolet-B Irradiation Team up in Inducing Melanoma Cell Motility
Gebhardt C, Averbeck M, Viertel A, Kauer F, Voelcker V, Anderegg U, Saalbach A, Maier-
Simon C, Simon JC
University of Leipzig, Germany
The migratory capacity of melanoma cells together with cell-cell and cell-matrix interactions
is vitally important for local tumour spreading and metastasis. Hyaluronan is the most
important extracellular matrix (ECM) molecule of the skin. A correlation between tumour stage
and the serum level of hyaluronan could be demonstrated, as well as an influence of
hyaluronan on migration and invasiveness. Other investigators showed that transfection of
melanoma cell lines (MC) with the hyaluronan synthesising enzymes 1 and 2 leads to
increased migration. Different cytoskeletal proteins, which play a crucial role in the process of
migration are influenced by hyaluronan. It is also known that ultraviolet (UV) irradiation directly
acts on the amount and the molecular mass of hyaluronan in the skin. Therefore we
investigated the influence of ultraviolet irradiation on the expression of hyaluronan
synthesising and degrading enzymes and the migratory capacity of MC on hyaluronan and
glass. Using quantitative RT-PCR we show that in MC 24h after UV-irradiation only the
hyaluronan synthesising enzymes are upregulated. MC motility was higher on HA and also
24h after UVB-irradiation. Incubation of MC with hyaluronan leads to loss of podosomes as
shown by phalloidin-staining of the actin cytoskeleton. UVB-irradiation induced dramatic loss
of actin bundling and lamellopodial formations. These morphological changes demonstrate a
differential cytoskeletal organisation after UVB-irradiation that may account for mobilisation
of the cells. The data show that the previously observed correlation of HA-levels and tumour
stage have a functional correlate in-vitro and that UVB-irradiation enhances tumour cell
motility. This novel role of UVB-irradiation, promoting MC motility might be a crucial part in
the development of malignant melanoma.
098
Mechanism of CD44 Shedding in Human Melanoma Cells: Relevance for Tumor
Progression
Eichenberg T, Kauer F, Gebhardt C, Haiduk C, Averbeck M, Anderegg U, Simon J
University of Leipzig, Germany
Previous studies have shown that human melanoma cells (MM) can bind the matrix
component hyaluronic acid (HA), via the CD44 receptor. Such interaction of HA with
membrane-bound CD44 (mCD44) leads to proliferation of MM cells and progressive tumor
growth in vivo. Certain MM are capable of shedding soluble CD44 (solCD44) from their
surface. Interaction of solCD44 with HA abolishes proliferation of MM in vitro and in vivo by
inducing apoptosis. Autocrine or drug induced secretion of solCD44 by MM may thus exert
potent anti-tumoral effects. To elucidate the mechanism of CD44 shedding, a panel of
characterized MM cell lines differing in their capacity to shed solCD44 was analyzed. RNA
analysis revealed that solCD44 is not the result of alternative splicing of CD44 mRNAs and the
shedding activities are not linked with CD44 mRNA turnover. The differing shedding activities
from the observed are accompanied by similar expression of mCD44 on the cell lines
suggesting an increased protein turnover. Moreover, CD44-shedding was reduced drama-
tically by serine protease or metalloprotease inhibitors. Further, mRNA levels of MMP-1,2,3,9
were quantitated by qPCR. We found the low shedding cell line P2 lacking MMP1 and MMP3
mRNA while the high shedding cell line Bro expressed these MMP. The addition of HA
strongly induced MMP1,2,3 expression in the low shedding cell P2 line indicating the
regulatory role of the CD44 ligand HA. Further we analyzed whether CD44 shedding
correlates with the expression of MMP14, an important sheddase in various tumor cells. The
expression of MMP14 mRNA as well as MMP-14 activities on the cell surface do not correlate
with CD44 shedding, suggesting that in MM another proteases might define the observed
shedding differences. Medium exchange experiments showed that supernatants from
actively shedding cell lines contain a unknown transferable activity that strongly induces
solCD44 shedding in low shedding cell lines. These results indicate that solCD44 shedding
can be regulated by soluble mediators. Further, differentially expressed and HA-induced
MMPs possibly contribute to solCD44-shedding and melanoma progression.
099
Role of the Basement Membrane Proteins Nidogen-1 and -2 for Skin Physiology and
Pathology
Baranowsky A1, Mokkapati S1, Wickenhauser C2, Miosge N3, Krieg T1, Nischt R1
1Department of Dermatology, University of Cologne, Germany; 2Institute of Pathology,
University of Cologne, Germany; 3Centre of Anatomy, Department of Histology, Georg-
August-Universitat Gottingen, Germany
Nidogen-1 and -2 are ubiquitous basement membrane proteins with a common three globular
domain structure. In vitro binding assays have assigned a major role of nidogen-1 in linking
the collagen IV and laminin networks thereby stabilizing the basement membrane.
Inactivation of the NID-1 or NID-2 gene in mice, however, did not result in basement
membrane defects. Mice lacking both nidogen isoforms die shortly after birth with a wide
range of developmental abnormalities and basement membrane defects suggesting
complementary functions of the two isoforms. To analyse in detail if the two nidogen
isoforms have identical functions challenging experiments for basement membrane functions
in skin (non-specific irritant dermatitis, wound healing) were performed in nidogen-1 deficient
mice. Non-specific irritant dermatitis was induced by croton oil. The response was measured
by ear swelling. Immunohistochemical analysis using markers for epidermal differentiation
and the inflammatory response did not reveal significant differences between nidogen-1
deficient and wildtype mice. For the wound healing experiment excisional wounds were
inflicted on the back of wildtype and nidogen-1 deficient mice. At different time points the
wounds were processed for histology, immunofluorescence and protein/RNA analysis.
Complete wound closure was seen in both genotypes at day 7. Expression of the major
basement membrane components was indistinguishable in nidogen-1 deficient mice
compared to control mice. However, histological analysis revealed increased thickness of
the newly formed epidermis along with a delay in epidermal differentiation and remodelling of
the granulation tissue in mutant mice at day 7 and day 10 after wounding. This suggests an
important role of nidogen-1 in the late stages of the wound healing process, which cannot be
fully compensated by nidogen-2.
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Oxidative Stress Results in Selective Oxidative Damage and Activation of Macrophages
with Enhanced Nitric Oxide and Elastase Release Contributing to the Hostile
Microenvironment of Chronic Leg Ulcers
Sindrilaru A, Gall N, Welt K, Hainzl A, Hinrichs R, Peters T, Weiss JM, Wlaschek M,
Sunderko¨tter C, Scharffetter-Kochanek K
University of Ulm, Germany
Reactive oxygen (ROS) and nitrogen species (RNS) produced by macrophages in the
presence of iron released by erythrocytes have been suggested to be responsible for
impaired healing in chronic venous leg ulcers. However, there is little in vivo evidence how
ROS and RNS induce cellular events resulting in an unfavorable milieu for healing. Here we
analyzed the extent and the functional implications of oxidative damage in inflammatory cells
infiltrating chronic ulcers. Immunohistochemical analysis of 4 skin biopsies from patients with
chronic leg ulcers showed a prevalence of macrophages (CD68þ ) and low numbers of
neutrophils (CD66þ ). In contrast, in sequential biopsies of 5 acutely induced wounds,
neutrophils were present in high numbers at day one and were significantly reduced with the
advent of macrophages at day 2, while both cell types had almost disappeared after 5 days.
In chronic, but not in acute wounds, we detected a strong immunoreactivity for 8-hydroxy-2-
deoxyguanosine and nitrotyrosine in macrophages, indicating oxidative stress-induced DNA
and protein damage. We subsequently established an in vitro human and murine model trying
to reflect the pro-oxidant in vivo situation. Cultured human peripheral blood mononuclear
phagocytes and murine bone marrow macrophages were exposed to H2O2 and iron, which
also lead to generation of 8-hydroxy-2-deoxyguanosine and nitrotyrosine. As a consequence
of these alterations we observed an increased, iron-dependent (po0.05) production of nitric
oxide (po0.003) and metalloelastase (po0.05) by cultured macrophages. Corresponding
higher expression of metalloelastase and inducible nitric oxide synthase was detected in skin
biopsies from chronic leg ulcers when compared with normal skin or acute wounds. We thus
describe a new activation system in which both murine and human macrophages employ very
similar mechanisms with regard to NO release. This could have a major impact not only for
disturbed wound healing but also for NO physiology in general.
Our results indicate that in chronic venous leg ulcer, the enhanced release of nitric oxide in
conjunction with ROS leads to nitrosative damage. This oxidative stress is associated with
enhanced release of metalloelastase by macrophages, most likely leading to degradation of
extracellular matrix proteins, thus further amplifying the hostile environment and impaired healing.
ABSTRACTS A17125 : 3 SEPTEMBER 2005
101
Transmembrane Collagen XVII is Expressed by Amnion Epithelial Cells and Cytotropho-
blast Cells of Human Placenta
Va¨isa¨nen L1, Hurskainen T1, Autio-Harmainen H1, Hofmann S2, Ra¨sa¨nen J1, Franzke CW2,
Bruckner-Tuderman L2, Tasanen K1
1University of Oulu, Finland; 2University of Freiburg, Germany
In addition to the skin, human placenta is an excellent model to investigate epithelial-
mesenchymal interactions. Here we used it to investigate collagen XVII (or BP180), which is
associated with both inherited and acquired blistering skin diseases. As a structural
component of hemidesmosomes collagen XVII connects the epithelial cells, such as the basal
keratinocytes in skin or mucosa to the underlying basement membrane. Its ectodomain is
constitutively shed from the cell surface by ADAM (a disintegrin and metalloproteinase)
proteases in vitro and in vivo. However, the biosynthesis and functions of collagen XVII during
mammalian development remain largely unknown. The aim of this study is to analyze the
cellular origin and functions of collagen XVII in human placenta and amniotic fluid.
Western blot analysis of human amniotic fluid samples taken from different stages of
pregnancy demonstrated that ample amounts of the ectodomain of collagen XVII were
present in amnion fluid throughout the pregnancy. Both forms of collagen XVII, the
transmembrane form and the shed ectodomain, were found in extracts of cultured amniotic
fluid cells taken for karyotype analysis. Immunohistochemical staining of early human
placenta showed that collagen XVII is expressed by amnion epithelial cells and
cytotrophoblast cells, which function as pluripotent placental cells to guarantee the
continuous proliferation of placental tissue. Non-radioactive in situ hybridization also
produced positive signals for collagen XVII mRNA in cytotrophoblast tissue in both early
and term placenta. Taken together, amnion epithelial cells synthesize collagen XVII as a
structural component of the amniotic membranes and generate the soluble form of collagen
XVII detected in amniotic fluid. The function of collagen XVII in cytotrophoblast cells is likely
to be related to trophoblast adhesion and invasion during placental development.
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Skin Extracellular Matrix Organisation in the SSC Disease: Implication of the TGF-beta
Signaling Pathway
Verrecchia F1, Laboureau J1, Verola O2, Roos N1, Porcher R3, Tiev K4, Mauviel A1, Farge D5
1INSERM U697, Hopital Saint-Louis, France; 2Service d’Anapathologie, Hopital Saint-Louis,
France; 3Departement de Biostatistique, Hopital Saint-Louis, France; 4Service de Medecine
Interne, Hopital Saint-Antoine, France; 5Service de Medecine Interne, Hopital Saint-Louis, France
In order to (A) analyse the skin extracellular matrix (ECM) organisation in SSc patients and in
normal controls, (B) measure the expression levels of the second messengers involved in the
profibrotic TGF-beta signaling pathway, the Smad proteins, and (C) determine whether the
TGF-beta signals was modified according to the extent of skin involvement as measured by
the Rodnan modifed skin score, 18 patients with diffuse SSc underwent skin biopsies either
before receiving any treatment (n¼3) or after treatment by standard immunosuppressive
drugs (n¼ 4) or by autologous hematopoietic stem cell transplantation (HSCT, n¼11). In 3
patients, repeated biopsy was performed before and after HSCT.
Double blind optic microscopy standard histological analysis of biopsies allowed to classify
the skin biopsies in 3 different subgroups: 4 biopsies in the ‘‘grade 1 subgroup’’ with weak
fibrosis defined by the presence of no fibrosis in the papillary dermis (PD) and light fibrosis in
the superficial reticular dermis (SRD) or in the median reticular dermis (MRD) or in the deep
reticular dermis (DRD); 13 biopsies in the ‘‘grade 2 subgroup’’ with moderate degree of
fibrosis defined by the presence of no, light or moderate fibrosis in the PD and/or the
presence of no, light or moderate fibrosis in the SRD, of moderate or severe fibrosis in the
MRD, and of moderate or severe fibrosis in the DRD; and 4 biopsies in the ‘‘grade 3
subgroup’’ with severe fibrosis defined by the presence of moderate or severe fibrosis in the
MRD, and of severe fibrosis in the DRD. Linear regression statistical analysis demonstrated a
correlation between the Rodnan modified skin score values and the grades of fibrosis
(po0,0001). A significant regression of the degree of fibrosis was observed both in the
papillary dermis and in the three layers of the reticular dermis after HSCT; (B)
Immunohistochemistry analysis of the Smad proteins demonstrated that Smad3 staining
was increased in the SSc keratinocytes compared to normal keratinocytes, and that Smad3
and Smad4 were localized in the nucleus. (C) On skin fibroblast cultures, established by
explanting skin punch biopsy, strong increase in Smad3 phosphorylation level directly
correlated with the severity of the SSc disease.
We therefore demonstrate for the first time to our knowledge that, (A) the organisation of
the skin ECM is correlated with the severity of the SSc disease as measured by the Rodnan
modifed skin score, (B) a regression in the extent of skin fibrosis can be obtained after HSCT,
and (C) TGF-beta/Smad3 signaling pathway is involved in the pathogenesis of the disease.
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Soy Extract Reduces the Signs of Skin Aging in Mature Skin
Gallinat S1, Lochner K1, Su¨del K1, Venzke K1, Mielke H1, Breitenbach U1, Jaspers S1, Moll
I2, Wenck H1, Sta¨b F1
1Beiersdorf AG, Hamburg, Germany; 2Department of Dermatology and Venerology,
University Hospital Hamburg-Eppendorf, Germany
Biochemical and structural changes of the dermal connective tissue substantially contribute
to the phenotype of aging skin. In order to study connective tissue metabolism with respect to
UV exposure we performed an in vitro (human dermal fibroblasts) and an in vivo cDNA array
study in combination with protein analysis in young and old volunteers. Several genes of the
collagen metabolism such as collagen I, III and VI as well as heat shock protein 47 and matrix
metalloproteinase-1 are differentially expressed indicating UV-mediated effects on collagen
expression, processing and degradation. In particular, collagen I is time- and age-
dependently reduced after a single UV exposure in human skin in vivo. Moreover, older
subjects display a lower baseline level and a shorter UV-mediated increase in hyaluronan
levels. In order to counteract these age-dependent changes cultured fibroblasts were treated
with a specific soy extract. This treatment resulted in increased collagen- and hyaluronan
synthesis. In a placebo-controlled in vivo study, topical application of an isoflavone-
containing emulsion significantly enhanced the number of dermal papillae per area after 2
weeks. Since the flattening of the dermal-epidermal junction is the most reproducible
structural change in aged skin this soy extract appears to rejuvenate the structure of mature
skin.
104
Suppression of Fibroblast Activity by Inhibitors of Dipeptidyl Peptidase IV (DP IV, CD26)
In Vitro: Possible Therapeutic Potential in the Treatment of Keloids
Thielitz A1, Vetter R1, Schultze B2, Neubert K3, Faust J3, Ansorge S4, Reinhold D2, Gollnick H1
1Department of Dermatology, Otto-von-Guericke University Magdeburg, Germany; 2Institute
of Immunology, Otto-von-Guericke University Magdeburg, Germany; 3Institute of Biochem-
istry, Martin-Luther-University Halle, Germany; 4IMTM Magdeburg, Germany
Dipeptidyl peptidase IV (DPIV, CD 26) is a widely distributed serine exoprotease with
pleiotropic functions. Besides its proteolytic activity cleaving proline at the penultimate
position, it is involved in T cell activation and functions as binding protein for fibronectin,
collagen and adenosindesaminase. Inhibitors of DP-IV like activity have potent antiprolifera-
tive and anti-inflammatory effects on lymphocytes and other cell types and show therapeutic
potential in inflammatory diseases. The aim of this study was to investigate the in vitro effects
of the DP IV inhibitors Lys[Z(NO2)]-pyrrolidide and Lys[Z(NO2)]-thiazolidide on proliferation,
TGF-b1 production and collagen/matrix deposition of skin fibroblasts derived from normal
skin (NF; n¼5) and keloids (KF; n¼ 3).
The expression of DP IV was analyzed by flow cytometry and Gly-Pro-pNA hydrolysis and
revealed lower expression of DP IV on KF (48  23 pkat/106 cells and 51  17% positive
cells) as compared to NF (83  33 pkat/106 cells, 77  17% ). By qualitative PCR the mRNA
expression of DP IV and other DP IV–activity/structure homologues (DASH) was detected on
KF/NF. The proliferation measured by 3H-thymidine-incorporation and protein determination
was dose-dependently suppressed by both inhibitors (IC 25: 11–32 mM) comparably in KF/NF.
TGF-b1 expression was sigificantly decreased after 72 h as detected by ELISA in
supernatants of both KF and NF, and RT-PCR performed in NF confirmed suppression of
TGF-b1 mRNA after 24 and 48 h. Collagen and matrix deposition was significantly decreased
after 72 h of inhibitor incubation, which might be a secondary effect of TGF-b1 suppression.
The presented data provide evidence that inhibitors of DP IV-like activity influence
proliferation, pro-fibrogenic cytokine production and collagen/matrix deposition of fibroblasts
and may provide a novel approach in the treatment of hypertrophic scar and keloid. Beside
DP IV other DASH proteins may be involved in mediating the observed effects.
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Chloroquine Modulates the Number of HLA-DRþ and CD1aþCells in the Skin of SLE
Patients
Lesiak A, Sysa-Jedrzejowska A, Narbutt J, Kobos J, Smigielski J, Wozniacka A
Medical University of Lodz, Poland
Antimalarials are widely used in treatment of systemic lupus erythematosus (SLE). However,
the mechanisms by which they provide benefit are not fully elucidated. Literature data
indicate that expression of HLA-DR antigens on cells surface and number of antigen
presenting cells (mainly dendritic cells) play a role in the immune response and development
of autoimmunity. The aim of study was to determine the influence of 3-month chloroquine
(CQ) treatment (250 mg/24h) on number of HLA-DRþ and CD1aþcells in unchanged skin of
SLE-patients before and after exposure to 3 MED of UVB.
In 21 SLE- patients uninvolved back skin was irradiated with 3 MED of UVB. 24 h after
exposure two skin biopsies were taken from irradiated and non-irradiated skin. The same
procedures were performed once again after a 3-month CQ administration. All skin sections
were immunohistochemically stained with anti-human monoclonal antibodies directed
against HLA-DR antigens and CD1a molecule. The total number of HLA-DRþand
CD1aþ cells was counted in each skin section.
We found statistically significant lower number of HLA-DRþcells in SLE-patients both in
UV-exposed and non-exposed skin after treatment (po0.001). Irradiation did not cause any
alterations in the number of CD1aþ cells before treatment, but after CQ administration their
count was significantly decreased (po0.001).
The obtained results proved the influence of chloroquine treatment on immunological
parameters in the skin and partially explain its mode of action in SLE.
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Efﬁcacy of Epiglue, Suture, Honey and Animal Oil in Accelerating Healing of Full
Thickness Wound of Skin in Mice
Ghaderi R
Birjand University of Medical Scienes, Islamic Republic of Iran
Background: Management of patients with full thickness wound of skin continues to
challenge physicians and surgeons. At the present time, there are some medications and
procedures (for example; suture) that can be used to accelerate the healing of full thickness
wound of skin.
Based on studies that have demonstrated improved upper eyelid wound healing with
epiglue (octyl-2- cyano acrylate tissue glue) treatment and suture, improved burn wound
healing with honey treatment and based on traditional medicine have demonstrated improved
umbilical wound healing with animal oil (sheep butter), we anticipated that epiglue, suture,
honey and animal oil will accelerated healing of full thickness wound of skin.
Objective: The aim of research proposal is to compare the efficacy of epiglue (octyl-2- cyano
acrylate tissue glue), suture, honey and animal oil in accelerating healing of full thickness
wound of skin in mice.
Methods: Animals: Male N.mRi mice
Sample size: 6 per study group
Surgery: two mm full thickness wound of skin in back of mice under general anaesthesia
Treatment groups: 1) Control group: simple dressing, 2) Epiglue group: daily topical
application epiglue (octyl-2- cyano acrylate tissue glue), 3)Suture group: incision was closed
with 6.0 suture (naylon–nonabsorbable), 4) Honey group: daily topical application honey,
5)animal oil group: daily topical application animal oil (sheep butter)
Study Period: mice were euthanized on days 4, 7 and 10 post-operation to reflect different
phases of wound healing
Assay: 1- gross pathology of the skin noting presence of infections, dehiscence and repair
2- histological evaluation of the wound site for degree of healing.
Results: Honey4suture¼ epiglue4animal oil increased: 1) formation of granulation tissue 2)
density and activation of fibroblasts 3) keratinization in surface of wound 4) thickness of
basement membrane and epidermis. Honey4suture¼ epiglue4animal oil decreased
infection, inflammation, edema and dehiscence of wound.
Finally honey4suture¼ epiglue4animal oil increased resilience, ultimate strength and
toughness of wound in mice.
Conclusion: We conclude that honey4suture¼ epiglue4animal oil accelerates healing of
full thickness wound of skin in mice.
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Loss of Desmoplakin Tail Causes Lethal Acantholytic Epidermolysis Bullosa
Jonkman MF1, Pasmooij AM1, Pasmans SG2, Van Den Berg MP1, Ter Horst HJ1, Timmer A1,
Pas HH1
1University Medical Center Groningen, The Netherlands; 2University Medical Center Utrecht,
The Netherlands
The cytoplasmic plaque protein desmoplakin (DP) that constitutes to desmosomes plays a
major role in epithelial and muscle cell adhesion by linking the transmembrane cadherins to
the cytoplasmic intermediate filament network. Mutations of DP may cause striate
palmoplantar keratoderma, arrhythmogenic right ventricular dysplasia, skin fragility – woolly
hair syndrome, Naxos-like disease and Carvajal syndrome. DP is indispensable, since DP/
mice are early abortive. Here, we report a patient with severe fragility of skin and mucous
membranes caused by genetic truncation of the DP tail. The new phenotype is lethal in the
neonatal period due to immense transcutaneous fluid losses. The phenotype also comprised
universal alopecia, neonatal teeth, and nail loss. Histology showed suprabasal clefting and
acantholysis throughout the spinous layer mimicking pemphigus. Electron microscopy
revealed disconnection of keratin intermediate filaments from desmosomes. Immunofluor-
escence staining of DP showed a distinct punctate intercellular pattern in the patient’s skin.
Protein analysis revealed expression of truncated DP polypeptides. Mutational analysis of the
patient demonstrated compound heterozygosity for two DP mutations, 6079C ! T (R1934X)
and 6370delTT, respectively. Aberrant mRNA transcripts that predict premature termination of
translation with loss of the three intermediate filament binding subdomains in the DP tail were
detected by RT-PCR. The new dramatic phenotype, that we named lethal acantholytic
epidermolysis bullosa, underscores the paramount role of DP in epidermal integrity.
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Gene Transfer of Functional FALDH Augments In Vitro FALDH Activity in Sjo¨gren-
Larsson Syndrome
Braun-Falco M, Haug S, Ro¨dl D
Technical University Munich, Germany
Sjo¨gren-Larsson Syndrome (SLS) is caused by an autosomal recessive defect in the gene
coding for fatty aldehyde dehydrogenase (FALDH), an enzyme necessary for the oxidation of
long-chain aliphatic aldehydes to fatty acid as one enzyme of the fatty alcohol:nicotinamide-
adenine dinucleotide (NADþ )-oxidoreductase complex (FAO). The impaired activity of
FALDH leads to the clinical triad of generalized ichthyosis, mental retardation, and spastic
diplegia or tetraplegia. Current treatment options are purely symptomatic. The genetic re-
introduction of the functional FALDH gene into defective cells has so far not been considered
as a therapeutic modality. In order to pursue such an approach for SLS, we constructed a
recombinant adeno-associated virus-type 2 vector (rAAV-2) containing the human cDNA of
functional FALDH and evaluated its capability to restore the enzyme-deficiency. Firstly, we
proofed the concept by transducing a FALDH-deficient cell line (based on Chinese hamster
ovary cells) resembling the gene defect of SLS. rAAV-2 transduction of FALDH-deficient cells,
usually exhibiting less than 10% of normal FALDH activity, resulted in an increase of FALDH
activity within the range of unaffected cells. Moreover, FALDH-transduced cells regained
resistance over exposure to long chain aldehydes, which are otherwise toxic to FALDH-
deficient cells. Secondly, we performed transduction experiments on primary human
keratinocytes obtained from a patient with SLS. Although transduction efficacy is lower in
human keratinocytes than in CHO cells, FALDH activity could be restored to a level above 50–
60% of normal. Since heterozygous carriers of FALDH mutations display a partial enzyme
deficiency with an activity between 50–60% of normal without the manifestation of an altered
phenotype, the level of augmentation after gene transfer should be theoretically beneficial for
SLS-patients. Although the optimal target tissue for gene transfer in this neuro-cutaneous
disease remains to be elucidated, the presented results give the first support of the concept
that gene therapy might be a future option for the treatment of SLS.
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A Role for the p63-IKKalpha Pathway in the Development of Ectodermal Dysplasias
Marinari B1, Koster M2, Giustizieri ML1, Ballaro` C3, Chimenti S1, Alema` S3, Karin M4, Roop
DR2, Costanzo A1
1University of Rome, Italy; 2Departments of Molecular and Cellular Biology and Dermatology,
Baylor College of Medicine, Houston TX, USA; 3Istituto di Biologia Cellulare CNR,
Montorotondo, Italy; 4Department of Pharmacology, UCSD, La Jolla CA, USA
The P63 gene belongs to the p53 gene family of tumor suppressor genes and encodes for
sequence specific transcription factors that act either as activators or as repressors of
transcription. Two major kind of proteins are encoded by this gene: the TA- and the DN-p63
isoforms, characterized by the presence or the absence of a N-terminal canonical transcriptional
activation domain, respectively. During embryonic development a shift in the balance of p63
isoform expression from TA- to DNp63 isoforms regulates the correct development of epidermis,
skin adnexa, craniofacial structures and limbs. We have found that the morphogenesis
modulator IKKalpha is tightly regulated at the transcriptional level by different isoforms of p63.
We have observed that IKKa mRNA expression increases at the onset of the stratification
program during mouse skin development and at the onset of in vitro keratinocyte differentiation.
The selective downregulation of DNp63 by siRNA in primary keratinocytes abolishes IKKa
activation and the onset of terminal differentiation. This is consistent with transcriptional assay
data performed with an IKKa-promoter reporter gene showing a strong activation of IKKa
transcription by DNp63 isoforms and a repressory activity of TAp63 isoforms. Mutations of p63
have been found in at least five different disorders belonging to the group of ectodermal
dysplasia and characterized by different degrees of skin, craniofacial and limb developmental
defects. Interestingly, the p63 mutants derived from ectodermal dysplasia syndromes display an
altered ability to activate or repress the IKKa promoter. The DNp63 mutants from AEC cannot
activate the IKKa promoter and have a strong dominant negative activity towards wt DNp63
while truncated TAp63 mutatnts from EEC syndrome have a strong repressory activity on IKKa
promoter. Our results indicate IKKa as an important p63 target potentially involved in the the
pathogenesis of ectodermal dysplasias.
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Ex Vivo Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa using Safe
Retroviral Vectors Expressing Type VII Collagen under the Control of its Promoter
Titeux M1, Zanta-Boussif A2, Rochat A3, De´cha A1, Tonasso L1, Barrandon Y3, Danos O2,
Hovnanian A1
1INSERM U563 – CPTP, France; 2Ge´ne´thon III, France; 3EPFL, Lausanne, Switzerland
Our goal is to develop the essential preclinical steps for ex vivo gene therapy for recessive
dystrophic epidermolysis bullosa (RDEB, OMIM #22600). RDEB is caused by loss of function
mutations in the collagen VII gene (COL7A1) encoding anchoring fibrils. It is one of the most
severe genodermatoses in children and adults. The patients suffer since birth from skin
blistering, and from severe local and systemic complications resulting in poor prognosis. We
lack a specific treatment for RDEB, but ex vivo gene transfer to epidermal stem cells shows a
therapeutic potential. The chosen approach consists of transferring the COL7A1 cDNA under
the control of its promoter, using safe (SIN, Self Inactivating) retroviral and lentiviral vectors
into epidermal stem cells and dermal fibroblasts. These vectors have no selection marker,
they are self inactivating (reducing the risk of oncogenic events), and they provide a
physiological regulation of COL7A1 expression. We have used these vectors to genetically
correct primary RDEB keratinocytes and fibroblasts ex vivo. The transduced keratinocytes
are able to form fully differentiated epithelia using a skin equivalent system made of a human
plasma derived fibrin gel including corrected RDEB fibroblasts permitting a fully autologous
graft onto patients. We have demonstrated long term in vivo expression of recombinant type
VII collagen and the formation of anchoring fibrils in these genetically corrected skin
equivalents after grafting onto nude mice. The safe vectors, the tissue specificity of type VII
collagen expression and the autologous skin equivalent system used constitute key assets
for a clinical application. Finally, we aim to graft skin equivalents made of genetically
corrected autologous keratinocytes and fibroblasts onto localized areas of patients.
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Identiﬁcation of Susceptibility Loci in a Murine Model of Psoriasis
Kess D1, Lindqvist A2, Wang H1, Peters T1, Holmdahl R2, Scharffetter Kochanek K1
1University of Ulm, Germany; 2University of Lund, Germany
Psoriasis is a complex disease with both heritable and environmental factors contributing to
disease onset and severity. A number of genetic loci, but no single gene could be identified by
genome wide linkage scans so far. A CD18 hypomorphic polygenic PL/J mouse model with
severe reduction of CD18 (b2 integrin) to 2–16% of the wild-type results in the development of
a skin disease resembling human psoriasis. However, no psoriasiform skin disease develops
in C57BL/6J mice carrying the same hypomorphic CD18 mutation.
To identify chromosomal regions harbouring genes that apart from the hypomorphic CD18
mutation are responsible for the manifestation of the psoriasiform dermatitis a backcross
between CD18 hypomorphic mice of the susceptible PL/J and the resistant C57BL/6J strain
was performed. 343 mice of the (PL/J  C57BL/6J)F1  PL/J generation were observed for
their psoriasiform phenotype using an adapted PASI score revealing that compared to
susceptibility several more genes, in addition to the CD18 hypomorphic mutation, contribute
to severity of the psoriasiform dermatitis. Compared to males, females are more susceptible
to the psoriasiform skin disease. Backcross mice were analysed in a genome-wide linkage
analysis using microsatellite markers. Gene loci on chromosomes 10 (LOD score 7) and 6
(LOD score 3) were significantly linked to the psoriasiform skin disease suggesting that these
chromosomal regions harbour genes that are responsible for the manifestation of the
psoriasiform dermatitis.
For the first time, we have succeeded to identify gene loci playing a role in psoriasis in a
murine model very much reflecting human disease. The identification of genes associated
with psoriasis in this mouse model might contribute to further elucidate genes and
mechanisms causally involved also in human psoriasis and may have general relevance for
polygenic human inflammatory diseases.
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Association of NOD1 Polymorphisms with Atopic Eczema and Related Phenotypes
Weidinger S1, Ru¨mmler L1, Wagenpfeil S1, Novak N2, Darsow U1, Jakob T1, Behrendt H1,
Wichmann HE3, Ring J1, Illig T3
1Technical University Munich, Germany; 2University of Bonn, Germany; 3GSF-National
Research Center for Environment and Health, Germany
Background: Interactions with microbial pathogens are crucial for the maturation of the
immune system. The nucleotide-binding oligomerization domain protein 1 (NOD1) is a
cytosolic receptor sensing a muropeptide found mostly in gram-negative bacterial
peptidoglycans. NOD1 is located on chromosome 7p14-p15, a region that has been linked
with atopy. Recently, polymorphisms of the closely related NOD2 have been associated with
atopy-related traits.
Objectives: Within a large population-based cohort of German adults (n¼ 1417), a case-
control population for atopic eczema (n¼454), and a large cohort of parent-offspring trios for
atopic eczema (189 trios), we evaluated 11 NOD1 polymorphisms for associations with atopic
phenotypes.
Methods: Subjects were phenotyped by standardized questionnaires and interviews, skin
examination, and serum IgE measurements. Genotyping was performed by using matrix-
assisted laser desorption ionization–time of flight mass spectrometry.
Results: Analyses revealed significant association of one NOD1 haplotype with atopic
eczema in the population-based cohort (p¼ 0.004) and the case-control population
(p¼ 0.003). Another NOD1 haplotype was associated with increased total IgE (p¼ 0.008).
In addition, significant associations with total serum IgE levels were observed for
polymorphisms rs2907748 (p¼0.006), rs2907749 (p¼ 0.012), and rs2075822 (p¼ 0.018).
These polymorphisms were significantly associated with atopic eczema and asthma in the
family-based association analyses (P¼ 0.001–0.043). Seven polymorphisms showed sig-
nificant transmission distortion for total IgE levels (p¼0.0001–0.029).
Conclusion: These data indicate that genetic variants within NOD1 are important
determinants of atopy susceptibility.
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Early-Onset Sarcoidosis is Closely Related with CARD15 Gene Mutations causing
Constitutive Nuclear Factor-jB Activation
Kanazawa N1, Okafuji I2, Kambe N1, Nishikomori R2, Heike T2, Nakahata T2, Miyachi Y1
1Department of Dermatology, Kyoto University Graduate Schoool, Japan; 2Department of
Pediatrics, Kyoto University Graduate Schoool, Japan
Early-onset sarcoidosis (EOS) is considered as a rare subgroup of sarcoidosis, which is
distinguished by juvenile onset, high incidence of arthritis rather than lung involvement, and
poor prognosis. EOS rather resembles inheritable Blau syndrome (BS), juvenile-onset
systemic granulomatosis that mainly affects skin, joints and eyes. However, direct evidence
has never been shown for the possible common origin of these two diseases. Recently,
CARD15 has been identified as a susceptibility gene for BS. CARD15 (Nod2) is an intracellular
pattern recognition receptor and recognizes a component of bacterial peptidoglycan via the
leucine-rich repeat (LRR), to induce immune responses through nuclear factor (NF)-kB
activation. In contrast with loss-of-function mutations in the LRR found to be associated with
Crohn’s disease, gain-of-function mutations in the nucleotide-binding oligomerization domain
(NOD) are reportedly associated with BS. Therefore, we have collected Japanese EOS cases
as well as a BS family to search for CARD15 gene mutations. Among 12 EOS cases and a BS
family, heterozygous missense mutations were found in 9 EOS cases and a BS family. 4 EOS
cases and a BS family showed a C1000T (R334W) that has already been reported in BS, 4
showed novel A1487T (H496L), T1538C (M513T), A1813C (T605P) and C2010A (N670K), and
one case showed double C1146G (D382E)/G1834A (A612T) mutations on different alleles. All
of these mutations were localized on the NOD and none of them were found in 100 healthy
controls nor in analyzed relatives, except A612T, which was found in one allele of a healthy
control. By the functional analysis using luciferase assay, these 6 variants of CARD15
genotype showed increased basal NF-kB activity. In conclusion, EOS is highly related with
CARD15 gene mutations causing constitutive NF-kB activation and shares the common
genetic etiology with BS.
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An In Vitro Skin Model of Genetically Engineered Keratinocytes or Fibroblasts to
Systemically Produce Erythropoietin
Pfu¨tzner W, Lo¨ser M, Nachtigall I, Scheidemann F
Ludwig-Maximilians-Universita¨t, Munich, Germany
Because of its ready accessibiliy, the skin is an interesting target tissue for gene therapy
applications. One possibility would be to utilize the genetically modified skin as a biofactory
secreting a systemically needed product, such as erythropoietin (EPO). To test this approach
and determine which skin cells might be best suited to fullfill these expectations, either
human primary keratinocytes (KC) or fibroblasts (FB) were transduced with a retroviral vector
encoding human EPO. Skin equivalents (SE) representing an in-vitro model of normal skin
were created out of FB (4  105/SE, embedded in a collagen gel) and KC (1  106/SE,
seeded on top of the gel). The amount of EPO secreted by the transduced cells was
determined by ELISA. When cultered as a monolayer both cell types produced almost the
same amount of EPO (80.2þ /11.3 mU/105 KC and 82.0þ /10.2 mU/105 FB). However, a
SE with transduced FB but normal KC produced significantly more EPO than a SE with
transduced KC and normal FB (25.3þ /1.6 mU/SE versus 2.7þ /1.2 mU/SE, respectively).
The incorporation of both transduced cell types further increased the amount of secreted
EPO (30.5þ /2.3 mU/SE). Possible reasons for the lower EPO-levels when using human SE
with transduced KC only are a restricted access of epidermal EPO to the subdermal media
compartment or a loss of EPO-production during KC differentiation. Thus, FB might be the
more promising cell type to achieve systemic EPO-production through genetically modified
cells in skin. However, a future approach to increase the epidermal EPO-production could be
to topically select for KC transduced with a bi-cistronic retroviral vector containing the EPO-
gene connected to a selectable gene like the Multi-Drug Resistance (MDR) gene.
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Revertant Mosaicism caused by Multiple Correcting COL17A1 Mutations in Patients with
Junctional Epidermolysis Bullosa
Pasmooij M, Pas H, Deviaene F, Nijenhuis M, Jonkman M
University Medical Center Groningen, The Netherlands
Revertant mosaicism by somatic reversion of inherited mutations has been described for a
number of genetic diseases. Several mechanisms can underlie this reversion process, like
gene conversion, crossing-over, true back mutation and second-site mutation. In this study
two unrelated probands were seen with revertant mosaicism of non-Herlitz junctional
epidermolysis bullosa, an autosomal recessive blistering disorder. To investigate the
reversion mechanisms underlying the functional restoration of the skin, immunofluorescence
microscopy and DNA- and RNA analysis after laser dissection microscopy were performed
on biopsies of affected and unaffected skin.
Patient 1 was compound heterozygous for a mutation in exon 51 (3781C4T; R1226X) and
exon 54 (4424-5insC) of the COL17A1 gene, encoding type XVII collagen. In the revertant
middle finger a second-site mutation (4463-1G4A) was found as correction mechanism,
whereas in the upper arm a back mutation (3781T4C) was responsible for the re-expression
of type XVII collagen. Patient 2 was compound heterozygous for mutations in exon 51
(3781C4T) and exon 18 (1706delA). A second compensating mutation (3782G4C) was
present in the revertant patch of the ankle, while the exon 18 mutation was corrected by gene
conversion in the skin of the arm and hand.
In the described patients both inherited mutations, paternal as well as maternal, reverted at
least once by different genetic reversion events. Moreover, the mutation 3781C4T reverted in
two different ways. The occurrence of multiple correcting mutations within the same patient
indicates that in vivo reversion is less unique than generally thought. Furthermore, in one
patient a cellular mosaicism of type XVII collagen positive keratinocytes was present in
clinically unaffected and affected skin. This latter observation makes it likely that reversion
may be overlooked and happen more often than expected.
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Matriptase Expression is Strongly Diminished in Skin Diseases with Impaired Stratum
Corneum Formation
Bauer R, Mildner M, Karner S, Lengauer B, Tschachler E
Medical University Vienna, Austria
Matriptase is a member of type II serine proteases, which is expressed by most cells of
epithelial origin. Recently, it was shown that matriptase knock out mice die 48 hours after
birth due to severe skin problems. They display defects in lipid matrix formation, cornified
envelope morphogenesis, stratum corneum desquamation and an impaired filaggrin
processing. More importantly skin from newborn knock out mice transplanted on scid mice
develop an ichthyosis like phenotype. We therefore investigated in the present study the
expression of matriptase in normal skin and in psoriasis and ichthyosis. By staining of the skin
and skin equivalents we found a very distinct staining pattern of matriptase in the granular
layers of the epidermis. Double staining revealed that matriptase expression is completely
co-localized with filaggrin expression. In contrast to normal skin we could hardly detect any
matriptase expression in psoriasis and ichthyosis. Since it was shown that in mammary
epithelial cell matriptase and matriptase inhibitor HAI-1 are co-expressed, we also checked if
matriptase is in deed active in the skin. With enzymatic activity assays we could show that in
both, in normal skin and in skin equivalents matriptase is present in an active form. In
summary we could show that in contrast to normal skin the expression of matriptase is
dramatically reduced in skin disorders with impaired stratum corneum formation i.e. psoriasis
and ichthyosis. We suggest that matriptase, which is an important enzyme for proper terminal
differentiation of keratinocytes, might play an important role in the pathogenesis of these skin
diseases.
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Mutation Detection and Expression Studies in Patients with the Kindler Syndrome
Baer C1, Locatelli A2, Tadini G2, Morand V1, Bruckner-Tuderman L1, Has C1
1University of Freiburg, Germany; 2Clinic of Dermatology, IRCCS Ospedale Maggiore, Milan,
Italy
Kindler syndrome (KS) is a rare autosomal recessive genodermatosis characterized by skin
blistering, poikiloderma, photosensitivity and, occasionally, carcinogenesis. It is caused by
mutations in the KIND1 gene which encodes kindlin-1, a focal contact protein. Very little is
known about the physiological role of kindlin-1 and the molecular pathomechanisms of KS.
Here we assessed normal kindlin expression using RT-PCR and immunofluorescence and
immunoblot analysis, and determined KIND1 gene mutations in KS patients. RT-PCR
demonstrated that moderate levels of kindlin-1 mRNA are expressed in human keratinocytes,
HaCaT cells and in squamous cell carcinoma cells, but not in fibroblasts or COS-7 cells. For
protein studies, antibodies were generated against recombinant GST-kindlin-1 fusion protein
and affinity purified. They recognized in lysates of normal human keratinocytes and HaCaT
cells a 70 kDa protein, corresponding to the predicted molecular mass of kindlin-1. No signal
was detected in fibroblast and COS-7 cell extracts. For mutation detection, the entire coding
region of KIND1 was amplified from genomic DNA by PCR and submitted to direct
sequencing. The analysis disclosed a novel homozygous frame shift deletion 93_94delG, a
recurrent mutation E304X and suggested a homozygous large deletion spanning exons 10
and 11 in one patient. Eight gene polymorphisms were identified and their frequency in
population assessed. Genotype-phenotype correlations were studied in kindlin-deficient
keratinocytes carrying the homozygous mutation E304X. Immunofluorescence staining of
actin, vinculin, talin and integrin b1 showed that the actin-based cytoskeleton was defective,
with reduced stress fibres and filopodia. These observations suggest that the skin fragility in
KS is a consequence of abnormalities of the actin cytoskeleton secondary to lack of kindlin-1
and its putative interactions with the actin cytoskeleton and focal contact proteins.
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Differential Gene Expression in Chemically Induced Epidermal Skin Tumors from
Proteinase-Activated Receptor-2-Deﬁcient and Wild-Type Mice
Rattenholl A1, Seeliger S1, Buddenkotte J1, Ehrchen J1, Scho¨n MP2, Scho¨n M2, Schulze-
Osthoff K3, Steinhoff M1
1University of Mu¨nster, Germany; 2University of Wu¨rzburg, Germany; 3Universtiy of
Du¨sseldorf, Germany
Recent findings indicate a role of proteinase-activated receptors (PARs) in the tumorigenesis
of various tissues. PAR2 is a G protein-coupled receptor with seven transmembrane domains.
It can be activated by specific proteolytic cleavage of the extracellular N-terminus. The newly
formed N-terminus is able to interact with the second extracellular loop of the receptor,
leading to subsequent conformational changes and receptor activation. PAR2 is expressed by
epidermal keratinocytes and is known to inhibit keratinocyte proliferation in vitro. Moreover,
PAR2 formation is downregulated in epidermal skin tumors (squamous and basal cell
carcinomas). We could show that in a chemically induced skin tumor model, PAR2-deficient
mice developed fivefold more tumors as compared to the wild-type. Histological analysis
showed that these tumors were mainly benign papilloma-type tumors. At later stages,
squamous cell carcinomas were also observed. No differences regarding keratinocyte
differentiation, proliferation and apoptosis could be observed in these papillomas. To further
analyze potential reasons for the facilitated tumor growth in PAR2-deficient animals,
differences in papilloma gene expression of both groups were studied. We found that the
genes of certain cytokines/chemokines, immunoglobulins and matrix proteins were down-
regulated in PAR2-deficient mouse papillomas whereas other genes coding for protease-
inhibitors and an IL-1a-like cytokine were upregulated. This leads to the conclusion that in
PAR2-k.o. mice, immune defense mechanisms of the skin, i.e. against papilloma viruses or
transformed cells might be impaired, thus facilitating epidermal tumor formation and
progression.
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Towards Enzyme Substitution Therapy of Transglutaminase 1 Deﬁcient Lamellar
Ichthyosis
Aufenvenne K1, Oji V1, Walker T1, Ho¨wel M1, Aeschlimann D2, Sto¨cker W3, Traupe H1
1University Hospital Mu¨nster, Germany; 2School of Dentistry Cardiff, United Kingdom;
3Institute of Zoology Mainz, Germany
Lamellar ichthyosis is a congenital recessive skin disorder characterized by generalized
scaling. In about 35% of all patients it is caused by mutations in the TGM1 gene that encodes
transglutaminase 1 (TGase 1) which is a crucial for the assembly of the cornified envelope
(CE) and for attachement of the lipid envelope to the CE. TGase 1 is expressed in the upper
differentiated layers of the epidermis, existing as both cytosolic and membrane-bound forms.
To date, more than 70 distinct TGM1 mutations habe been identified, which lead to reduced
or absent enzyme production or diminish enyme activity. The therapeutic situation of patients
with TGase 1 deficiency is fully dissatisfactory. Therefore we decided to develop an enzyme-
substitution therapy. Wildtype TGase 1 as well as a construct lacking the amino-terminal 10
kDa membrane anchorage fragment were cloned in the Gateway entry vector pENTR 3C and
then expressed using the BaculoDirect C-term linear DNA (Invitrogen) in High five insect cells.
A carboxy-terminal cloned hexahistidine tag allows rapid purification by immobilized-metal
affinity chromatography. After purification of the recombinant proteins TGase activity was
measured by fluorescence spectroscopy. Biotinylated cadaverine was incorporated into N,N-
dimethylcasein in the presence of calcium-ions and the increase of fluorescence was
measured. As a positive control we used active recombinant TGase 2 (N-Zyme BioTec).
These results show, that recombinant enzyme is functional. In order to assess the in vivo
situation we also tested the recombinant enzyme directly on skin cryosections of TGase 1
deficient skins and show that deficient TGase 1 activity can be restored. We conclude that
enzyme substitution therapy should be a feasible approach to correct TGase 1 deficiency in
the skin.
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Expression and Properties of the LY6/PLAUR Family Members, SLURP1, LYNX1, LY6D
and LYPDC2, Clustered on Chromosome 8q24.3
Plantard L1, Favre B1, Feldmeyer L2, Hohl D1
1University Hospital, Lausanne, Switzerland; 2ETH, Zurich, Switzerland
The LY6/PLAUR family regroups GPI-anchored and secreted proteins with a common specific
pattern of cysteine residues forming disulfide bonds, resulting in a characteristic three-finger
folding, also found in some snake toxins. The importance of SLURP1, a small secreted LY6/
PLAUR protein, in skin homeostasis was revealed by its direct involvement in Mal de Meleda
(MdM), an autosomal recessive dermatological disease. Here, we studied SLURP1 and three
LY6/PLAUR genes closely clustered with it on chromosome 8q24.3, including the complex
gene LYNX1, encoding three different proteins. RT-PCR analysis on RNA from several tissues
revealed that SLURP1, LYNX1-B, LY6D and LYPDC2 were almost selectively expressed in
the skin and fetal bladder. On the contrary LYNX1-A and LYNX1-C expression was much
broader than the others except for the skin. In cultured keratinocytes expression of LY6D and
LYPDC2 was not dependent on calcium-induced differentiation, in contrast to that of
SLURP1, while LYNX1-B expression was increased by the calcium shift. These results were
correlated by in situ hybridization studies on foreskin tissue sections. LYPDC2 and LY6D
were expressed allover the epidermis, while SLURP1 and LYNX1-B transcripts were detected
in the granular layer. In transfected HEK 293T cells LYNX1-A, LYNX1-B and SLURP1 were
secreted in the culture medium, in contrast to the GPI-anchored LYPDC2 and LYNX1-C.
Expression of SLURP1 mutants, found in some MdM patients, revealed that W15R-SLURP1,
mutated in the signal sequence, was undetectable even within the cells, whereas G86R-
SLURP1 was secreted, suggesting that the biological function of the latter is affected.
SLURP1 was undetectable in four palmoplantar tissue sections from MdM patients with
mutations affecting the integrity of SLURP1. In conclusion, LYNX1-B, LY6D and LYPDC2 may
play important roles in the epidermis, as SLURP1.
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Assessment of Optimal Transduction of Primary Keratinocytes by Viral Vectors
Gagnoux-Palacios L1, Hervouet C1, Spirito F1, Roques S1, Mezzina M2, Danos O2,
Meneguzzi G1
1INSERM U634, France; 2Genethon III-CNRS UMR 8115, France
The ease with which epidermal keratinocytes are expanded in culture, manipulated and
regrafted back to the donor is a major advantage for the development of cutaneous gene
therapy. Preclinical efforts are focused on the identification of viral vectors for optimal
transduction of epithelial cells. To address this question, we compared the transduction
efficiency of human and canine adenovirus (Ad and CAV-2), AAV subtypes 2 and 5, retroviral
vectors including commonly used oncoretrovirals vectors (pMND, pBullet and pMSCV)
serotyped by the envelope proteins ampho, GaLV or VSV-G and a lentiviral-based vector
(pPGK-SIN-HIV-1) on human primary and immortalised keratinocytes. The transduction
efficiency and expression of the transgene (GFP) were assessed by flow cytometry and
immunofluorescence analysis. Transduction efficiency was near 90% with human and canine
adenovirus vectors, both in primary and immortalized keratinocytes. The AAV-2 and 5 vectors
efficiently transduced immortalized keratinocytes, but failed to trigger transgene expression
in primary keratinocytes. Both adenoviral vectors and AAVs lead to a transient expression of
the GFP (o4 days). The highest infection capacity was achieved using pMSCV vector
pseudotyped with VSV-G. Both oncoretroviral and lentiviral vectors displayed up to 100%
infection efficiency, with sustained and permanent expression of the GFP. However, the
lentiviral vector transduced epidermal stem cell twice more efficiently than the oncoretroviral
counterpart as demonstrated using a clonal assay analysis. In conclusion, we determined
optimal conditions for efficient viral transduction of human keratinocytes and demonstrated
that i) primary keratinocytes are not permissive to infection by AAVs; ii) CAV-2 infect as
efficiently keratinocytes than human adenoviruses and may be used for gene therapy
protocols when short term expression of the transgene is required; iii) lentiviral vectors might
be preferred to oncoretroviral vectors because of their particular ability to transduce
keratinocytes stem cells in culture.
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Characterization of Epidermal Defects in Patients with Netherton Syndrome
Descargues P1, Prost C2, Fraitag S3, Deraison C1, Mazereeuw J1, Zambruno G4, Bodemer
C3, Hovnanian A1
1INSERM U563, France; 2UFR Paris 13, France; 3Hoˆpital Necker-Enfants Malade, France;
4IDI-IRCCS, Rome, Italy
Netherton syndrome (NS) is a severe genodermatosis caused by mutations in SPINK5. This
gene encodes the multi-domain serine protease inhibitor LEKTI, strongly expressed in the
granular layer of the epidermis. The absence of LEKTI expression in the skin is a constant
feature of NS. We have recently characterized a mouse model for NS and demonstrated that
unregulated epidermal protease activities result in the degradation of desmosomal proteins
and enhanced profilaggrin proteolytic processing. To address whether the degradation of
desmosomal cadherins by unregulated proteases occurred in the epidermis of individuals
with NS, we have analyzed the expression of desmosomal proteins and terminal
differentiation markers by immunohistochemistry on skin sections from 12 NS patients.
Desmoglein-1 was present in the upper spinous layers but was remarkably reduced in the
most differentiated nucleated layers of the epidermis in 7 patients. Desmocollin-1 and
desmoplakin staining was also diminished in 4 patients in these layers. Desmoglein-3 and
desmocollin-3 were expressed in an increased number of suprabasal cell layers.
Corneodesmosin expression was increased and extended to the upper spinous layer of 3
patients. Involucrin and loricrin expression was enhanced and redistributed in the most
superficial spinous layers in the majority of cases analyzed. No obvious differences were seen
in the expression of filaggrin between NS and normal epidermis. The anomalies of
desmosomal proteins expression were associated with altered desmosome ultrastructure
in the upper living layers of epidermis. Interestingly, in 3 NS patients, SCTE immunostaining
extended to the same cellular layers where expression of desmosomal components was
reduced. In situ zymography showed an increased in epidermal protease activities in NS
epidermis in comparison with control. These results suggest that the absence of LEKTI in NS
causes enhanced epidermal protease activities and alteration of desmosome structure
through degradation of desmosomal components in the upper living epidermis.
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Association Between Apoptosis-Deﬁcient Pro Allele Of P53 Gene And The Resistance Of
The UV-Treatment In Psoriasis Patients
Hairutdinov V1, Moshkalov A2, Samtsov A1, Buslov K2, Kuligina E2, Suspitsin E2, Ievleva A2,
Sokolenko A2, Ulibina Y2, Imyanitov E2
1Military Medical Academy, St Petersburg, Russian Federation; 2N.N. Petrov Institute of
Oncology, St Petersburg, Russian Federation
Background: Disregulation of the programmed cell death is implicated the pathogenesis of
the most common skin disease, psoriasis. Furthermore, apoptotic elimination of infiltrating T-
cells appears to play a key role in the therapy-induced clearance from psoriatic plaques.
Objective: We hypothesized, that common arginine/proline (Arg/Pro) polymorphism in p53
gene, which affects the apoptotic properties of the corresponding protein, may correlate with
the psoriasis predisposition and treatment response.
Methods: p53 genotypes were determined by PCR and analyzed against case-control status
as well as selected disease characteristics.
Results: Distribution of Arg/Pro p53 alleles was similar in 110 psoriatic patients and 299 non-
affected subjects. However, analysis of the therapeutic response to the UV-based treatment
of psoriasis has revealed striking correlations. There was a drastic overrepresentation of Arg/
Arg homozygotes in good responders as compared to the moderate responders and non-
responders (45/52 (87%) vs. 13/58 (22%); p¼ 1.75  1011; OR¼ 22.25 (95% CI: 7.39–
70.31)). At the same time, none of 52 patients who benefited significantly from the exposure
to ultraviolet was homozygous for the Pro allele, while the Pro/Pro genotype was detected in
4/35 (11%) moderate responders and in as much as 6/23 (26%) cases of the UV therapy
failure (good responders vs. others: p¼ 1.69  103; OR¼ 0.00 (95% CI: 0.00–0.52)).
Consequently, the Pro allele frequency was significantly increased in moderate and non-
responders as compared to the UV-curable group (55/116 (47%) vs. 7/104 (7%);
p¼2.14  1011).
Conclusion: Carriership of the apoptosis-deficient Pro allele of the p53 gene is associated
with the low efficiency of UV-based therapy in psoriatic patients.
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Single Cell PCR Ampliﬁcation of Microsatellites Flanking the COL7A1 Gene and
Suitability for Preimplantation Genetic Diagnosis of Recessive Dystrophic Epidermolysis
Bullosa
Fassihi H1, Black C2, Pickering SJ2, Renwick PJ2, Mellerio JE1, Braude PR2, Mcgrath JA1
1Genetic Skin Disease Group, St John’s Institute of Dermatology, The Guy’s King’s College
and St Thomas’ Hospital Medical School, United Kingdom; 2Centre for Preimplantation
Genetic Diagnosis, London, United Kingdom
Recessive dystrophic epidermolysis bullosa (RDEB) is an inherited blistering skin disorder
caused by mutations in the anchoring fibril type VII collagen gene, COL7A1. There is no
effective treatment for RDEB but DNA-based prenatal testing in families at risk of recurrence
is possible, mostly involving chorionic villus sampling at 10-11 weeks’ gestation. A further
option in avoiding recurrence of RDEB is preimplantation genetic diagnosis (PGD), which
involves DNA analysis of single blastomeres extracted from 8–12 cell embryos following
in vitro fertilisation. To develop a PGD assay for RDEB, we have designed a sensitive semi-
duplex single cell PCR assay for two highly polymorphic dinucleotide repeat microsatellite
markers, D3S1581 (telomeric) and D3S1289 (centromeric), close to the COL7A1 gene on
chromosome 3p21.31. Amplification efficiency and allele drop out rates were assessed in 50
single buccal cells and 13 research blastomeres from donated embryos. Amplification
efficiency for D3S1581 was 90% for the buccal cells and 100% for the blastomeres, and for
D3S1289 the results were 94% and 100%, respectively. Allele drop out rates for D3S1581
were 11% for the buccal cells and 14% for the blastomeres, and for D3S1289 the results were
12% for the buccal cells but not known for the blastomeres as the embryo was homozygous
for this marker. No contamination was detected in any PCR reaction. These results compare
favourably with PGD tests already licensed and in clinical use for other inherited disorders.
Our data show that use of these markers and this PCR protocol now provide the basis for a
reliable generic single cell prenatal test for clinical use in RDEB. Moreover, the development
of PGD for RDEB broadens the range of prenatal testing options and personal choice for
couples at reproductive risk of this severe genodermatosis.
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Spectrum of KIND1 Gene Mutations in Kindler Syndrome
Wessagowit V, Fassihi H, McGrath JA
St John’s Institute of Dermatology, London, United Kingdom
Kindler syndrome is a rare autosomal recessive genodermatosis in which early features of
trauma-induced skin blisters are gradually superseded by skin atrophy. For almost 50 years,
this poorly understood condition was thought to be a variant of dystrophic epidermolysis
bullosa or a congenital poikiloderma, or possibly the simultaneous occurrence of both
disorders. In 2003, however, Kindler syndrome was shown to result from ablation of a novel
protein, kindlin-1 (also known as kindlerin), encoded by the gene KIND1 on 20p12.3. We have
now sequenced DNA from over 30 patients with this genodermatosis and have identified 21
different mutations (nine nonsense, nine frameshift and three splice site). Most mutations are
specific to individual families, but recurrent hotspot and founder effect mutations have been
identified. Specifically, the mutation R271X has been demonstrated in Panamanian,
Caucasian American, and Omani subjects, whereas R288X has been found in UK Caucasian
and Turkish patients with Kindler syndrome. Both these mutations occur at hypermutable
CpG dinucleotides. In contrast, mutated ancestral KIND1 alleles include 676insC, IVS7-
1G4A, E304X and W616X that have been detected in several Pakistani, Italian, British
Caucasian and Omani patients, respectively. Knowledge of the molecular basis of Kindler
syndrome has also facilitated earlier and more accurate diagnosis of this unusual disorder,
including in a 5-day old neonate, shown to be homozygous for the donor splice site mutation,
IVS13þ 2T4C. Kindlin-1 is a 677-amino acid protein that is predominantly expressed in
basal keratinocytes, where it provides a link between the actin microfilaments and the
extracellular matrix, and forms part of focal contact junctions at the dermal-epidermal
junction. Kindler syndrome is the first genodermatosis to involve pathogenic mutations in a
protein involved in anchorage of the actin cytoskeleton. However, we did not find KIND1 gene
mutations in  25% of cases of Kindler syndrome which suggests that genetic
heterogeneity is also present in this disorder.
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Photoprotective Antioxydant Lentiviral Gene Therapy in Normal and Xeroderma
Pigmentosum Human Epidermis
Rezvani H1, Cario-Andre M1, Ged C1, Pain C1, Bouadjar B2, De Verneuil H1, Taieb A1
1Victor Segalen Bordeaux2, INSERM E0217, France; 2CHU Algiers, Algeria
The skin is especially vulnerable to damage by reactive oxygene species (ROS) generated by
ultraviolet (UV) irradiation. In normal cells, various defence systems including antioxidant
enzymes such as superoxide dismutases (SOD) or catalase prevent damages caused by
ROS. Catalase activity is decreased in xeroderma pigmentosum (XP) type C keratinocytes, a
rare autosomal recessive nucleotide excision repair disorder. In the present study, we
investigated the effects of UVB irradiation on epidermis reconstructed with normal and XP-C
keratinocytes overexpressing sustainably the lentiviral vector-mediated catalase enzyme.
CPD and p53 levels were visualized by immunohistochemistry while serine-15 phosphory-
lated p53 and caspase3 activation were investigated by western-blotting.
Reconstructed epidermis made from genetically modified keratinocytes had an architec-
ture similar to normal non-transduced control epidermis. The number of sunburn cells and the
level of caspase 3 activation were lower in non-transduced XP-C than in normal epidermis.
There was a clear decrease in sunburn cell formation and caspase-3 activation in normal and
XP-C epidermis overexpressing catalase as compared to controls. On the contrary, an
increased number of positive nuclei for CPD and an accumulation of total p53 and serine-15
phosphorylated p53 were noted following UVB in XP-C vs normal epidermis. Overexpression
of catalase decreased significantly the accumulation of total p53 in both types of epidermis.
In conclusion, this study demonstrates that (1) XP-C epidermal reconstructs are less prone
to apoptosis than their normal counterpart, a finding in line with an increased risk to
accumulate UV-induced mutations and carcinogenesis (2) Vector-mediated catalase over-
expression can be a promising photoprotective tool in monogenic/polygenic photosensitive
disorders characterized by an accumulation of reactive oxygen species.
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Severe Photosensitivity and Finger Shortening in a Chilean Boy: The First Case of
Recessive Variegate Porphyria in South America
Poblete-Gutie´rrez P1, Wolf C2, Farias R3, Frank J1
1Department of Dermatology, University Hospital Maastricht, The Netherlands; 2Universidad
de Chile, Chile; 3Hospital San Juan de Dios, Chile
A 7-year-old boy presented with severe photosensitivity, blistering, erosions, and scarring on
the sun-exposed areas of the body since the age of six months. Additionally, he showed a
short stature and shortening of the fingers. Interestingly, laboratory examination revealed
drastically elevated protoporphyrin levels in the erythrocytes. Such biochemical findings can
be observed in recessive variants of usually autosomal dominantly inherited acute porphyrias
as variegate porphyria and hereditary coproporphyria, which normally do not become
manifest before the second or third decade of life. Using PCR based techniques we identified
a missense mutation in exon 7 on the paternal allele and a frameshift mutation in exon 13 on
the maternal allele of the protoporphyrinogen oxidase gene that harbors the mutations
underlying variegate porphyria. This is the first recessive case of variegate porphyria in South
America. Since variegate porphyria represents the most frequent type of acute porphyria in
Chile more such cases could be expected in the future, particularly because a founder
mutation for this disease has already been described in the Chilean population.
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A Case-Control Study Investigating Candidate Genes in Adult Eczema
Moffatt MF1, Allen MH2, Reynolds NJ3, Meggitt ST3, Cookson WO1, Barker JN2
1Wellcome Trust Centre for Human Genetics, Oxford, United Kingdom; 2St Johns Institute of
Dermatology, London, United Kingdom; 3Dermatological Sciences, University of Newcastle,
United Kingdom
In order to investigate the genetic basis of eczema persistent into adulthood, we have carried
out a case control study of genes previously reported to be involved in the aetiology of
asthma, atopy and childhood atopic dermatitis. One hundred and seventy two adult eczema
patients were recruited through Dermatology clinics at London (n¼ 130) and Newcastle
(n¼ 42). Two hundred and eight age and sex matched controls were recruited from staff and
students of St Johns Institute of Dermatology. None of the control individuals had evidence of
skin disease, although 15 were relatives of psoriasis patients. Forty-nine single nucleotide
polymorphisms (SNPs) in twelve candidate genes (PHF11, DPP10, CD14, FCERIB, IL13,
IL4RA, SPINK5, TGFB, TLR2, TLR4, TLR9, TNFA) were genotyped using the MassEXTENDt
system by Sequenom. These SNPs included those previously reported to show association to
atopic disease together with database SNPs with a minor allele frequency20%. In order to
control for multiple comparisons, logistic regression analysis was carried out with all SNPs
examined simultaneously as predictors of case/control status. Associations were seen for a
polymorphism in the beta chain of the high affinity receptor for IgE FCERIB ebþ10062
(P¼ 0.02) and a SNP in Toll like receptor 9, TLR9-1486, (P¼ 0.008). Potential gene-gene
interactions were sought by examination of correlations between genotypes in cases,
however no significant results remained after correction for the multiple tests.
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Assessment of Association with Psoriasis in the Class II and Class III Intervals of the
MHC in Relation to PSORS1 Associated Alleles
Veal CD1, Harty H1, Allen MH2, Burden AD3, Tillman D3, Barker JN2, Trembath RC1
1Division of Medical Genetics, University of Leicester, United Kingdom; 2St John’s Institute
of Dermatology, Kings College London, United Kingdom; 3Dept of Dermatology, Western
Infirmary, Glasgow, United Kingdom
The PSORS1 locus within the class I region of the MHC is recognised as being the major and
most widespread locus for psoriasis susceptibility. However, psoriasis is a multifactorial
disorder and therefore it is likely that other regions in the genome harbour additional
susceptibility alleles. It also remains possible that additional genes within the MHC, but
outside of the PSORS1 region, contribute to susceptibility. A number of publications have
reported allelic association with psoriasis in the class II and III regions interpreted as
providing evidence of independence from the psoriasis associated HLA-Cw0602 allele within
PSORS1. However, recent PSORS1 SNP based psoriasis associated haplotypes provide
greater detail of the extent of diversity across the region compared to HLA-C genotyping and
thus represent a more appropriate basis for tests of independent association outside of
PSORS1. In a UK based cohort of 300 affected offspring trios we have genotyped 22 SNPs by
allele specific oligonucleotide hybridisation, including polymorphisms in TAP-1, TAP-2, TNFa
and LTA. This SNP genotyping was combined with PSORS1 SNP based haplotypes and
reported hotspots of recombination within the MHC. TDT analysis finds evidence for weak
association at the TAP genes (p¼ 0.046) and at LTA (p¼ 0.017), albeit at a much lower level of
significance than observed at PSORS1 (p¼ 0.000000002). Haplotype construction placed
associated alleles observed in the class II and III intervals on PSORS1 susceptibility
haplotypes. Association within the MHC, yet outside of PSORS1, follows a pattern of decline
expected from the position of hotspots of recombination and the linkage disequilibrium
across the class I interval.
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Mutation Detection in Large Genes: How to Overcome the Bottleneck of Data Analysis?
Kern JS, Mu¨ller M, Bruckner-Tuderman L, Has C
Dept of Dermatology, University of Freiburg, Germany
Currently, direct sequencing of the entire gene is the gold standard for molecular diagnostics
in a considerable amount of dermatological single gene disorders, like dystrophic
epidermolysis bullosa (COL7A1 gene), non-Herlitz junctional epidermolysis bullosa
(COL17A1 gene), Kindler syndrome (KIND1 gene), ichthyosis and others. The high sensitivity
and specificity of DNA sequencing provides reliable diagnostics in the context of complex
gene structures, large varieties of mutations, high rates of novel mutations and heterogeneity
of phenotypes. One of the major obstacles in an effective mutation detection strategy is the
management of the large amount of sequencing data. A computer assisted data analysis
seems crucial to overcome the bottleneck of manual sequence-to-sequence comparison.
This is essential for a rapid final diagnosis, e.g. in prenatal diagnostics. For this purpose we
evaluated three commercially available products and one open source software. Criteria
applied were sensitivity (i.e. percentage of mutations found of all mutations), specificity and
accuracy (type of mutation, splitting of heterozygous in/del mutations, etc.). Minor criteria
were the quality of the user interface, import/export functionalities and customizable reports.
The software ‘‘Mutation Surveyor’’ (Softgenetics, State College, PA) best met our
requirements. Subsequently the software package was implemented in our COL7A1,
COL17A1 and KIND1 mutation analysis workflow. This led to a dramatic acceleration of
the analysis process and allows an earlier final diagnosis: in a test cohort of 39 patients with
dystrophic epidermolysis bullosa, consisting of 22 compound heterozygous, 3 dominant and
14 homozygous patients, the mutation detection rate was over 90%. The time span for one
COL7A1 analysis was reduced to two weeks. We showed that a sufficient data management
can improve quality and speed of the mutation detection process. Further steps will include
the computer assisted analysis of the entire workflow and accordingly its amelioration as well
as the optimization of quality management.
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Gene Expression Proﬁling of Differentiating Keratinocytes Using Whole Human Genome
Oligo DNA Arrays
Peltonen S, Yla¨-Outinen H, Heikkila¨ E, Kuosmanen J, Peltonen J
University of Turku, Finland
A switch from low to high extracellular calcium is known to induce growth arrest and terminal
differentiation in cultured human keratinocytes. Regulation of extracellular and intracellular
calcium concentration is crucial for keratinocyte differentiation also in vivo. Examples of
altered calcium concentrations linked with aberrant differentiation include e.g. psoriasis and
Darier disease. Several studies probing the effect of elevated calcium concentration on single
proteins or signal pathways have been published while extended profiling of the changes in
gene expression induced by calcium is not available. Genome-wide gene expression profiling
provides the opportunity to find previously unrecognized factors that mediate the effects of
elevated calcium concentration in cultured keratinocytes. In this study, we have utilized
Agilent whole human genome oligo arrays in order to study the changes in gene expression
during keratinocyte differentiation. Four normal human keratinocyte lines were cultured in
elevated (1.8 mM) calcium concentration for 30 min, 4 h, 8 h, 24 h or 48 h. Total RNA was
isolated, and 20 mg of RNA was used as a template for fluorescent cDNA labeling with cy3
and cy5. cDNAs representing parallel cultures that were maintained in low or high calcium
concentration were competitively hybridized to Agilent arrays. The data was analyzed using
KDE program. The results showed a widespread down-regulation of vast majority of genes,
induced by the elevated extracellular calcium concentration. The number of down-regulated
genes further increased during differentiation. Up-regulated genes include certain structural
proteins such as keratins and keratin-associated proteins, desmosomal, tight junction and
adherens junction proteins, apoptosis-related proteins and a number of proteinase inhibitors.
The preliminary data analysis indicates that this experimental design can be used for gene
expression profiling of keratinocyte differentiation process.
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Differential Expression of Genes Involved in Skin Homing, Proliferation and Apoptosis in
CD4þT-cells of Patients with Atopic Dermatitis
Nijhuis E1, Hijnen D1, De Bruin-Weller M1, Holstege F1, Groot Koerkamp M1, Kok I2,
Bruijnzeel-Koomen C1, Knol E1
1UMC Utrecht, The Netherlands; 2Asthmacenter Heideheuvel, The Netherlands
Atopic dermatitis is a common, chronic, allergic inflammatory disease. Atopic dermatitis is
characterized by chronically persistent, as well as recurrent, pruritic, erythematous skin
lesions. CD4þT-cells play a critical role in allergic diseases, such as atopic dermatitis and
allergic asthma, both in the affected tissue as well as systemically. Our objective was to
investigate the in vivo activation state of peripheral blood CD4þT-cells of atopic dermatitis
patients, by analyzing gene expression profiles of unstimulated CD4þT-cells. mRNA samples
from blood CD4þT-cells, isolated from 5 atopic dermatitis patients, and 7 healthy controls
were analyzed using oligonucleotide arrays. Differentially regulated genes were validated by
quantitative-PCR in a larger group of patients with atopic dermatitis, in a group of patients
with allergic asthma and in a group of healthy controls. In addition, ‘‘typical’’ Th1 and Th2
related genes were analyzed by quantitative-PCR. Microarray analysis revealed differential
expression of 52 genes in atopic dermatitis patients. Q-PCR confirmed several differentially
regulated genes in atopic dermatitis, including CCR10, CRTH2, C-JUN, TNFAIP3 and NR4A2.
None of the genes found to be differentially regulated in atopic dermatitis patients were
differentially expressed in allergic asthma patients compared to healthy controls. Two groups
of genes, with highly correlating gene expression levels, involved in tissue homing and
proliferation or apoptosis were identified. No marked differences were found in gene
expression levels of typical Th1 or Th2 genes in atopic dermatitis nor in allergic asthma
patients. This study demonstrates that peripheral blood, unstimulated CD4þT-cells in atopic
dermatitis patients show differentially expressed genes involved in tissue homing, prolifera-
tion and apoptosis.
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Expression Analysis of the Human S100 Fused-Type Protein (SFTP) Gene Family
WU ZH, Schro¨der JM
Dept of Dermatology, University of Kiel, Germany
The S100 fused-type protein (SFTP) gene family encode an evolutionarily conserved family of
intermediate filament-associated proteins involved in keratinocyte terminal differentiation
necessary for the maintenance of epithelial barrier functions. To better understand their
biology and function, we comprehensively examined SFTP gene expression in human
foreskin-derived primary keratinocytes, human adult tissues, human skin tumors and other
diseases. Reverse transcription PCR results showed that in the tested 22 tissues trichohyalin
(THH) was only expressed in the skin, whereas the other SFTP genes, repetin (RPTN),
hornerin (HRNR), proﬁlaggrin (PFLG) and C1orf10 were transcribed in a wide range of tissue
types. Real time PCR results show that the SFTP genes have distinct patterns that correlated
with variation in diseased lesions. For primary keratinocytes stimulated with 1.7 mM Ca2þ for
4 days, the SFTP genes appeared to be transcribed in a constant ratio of HRNR: THH:
C1orf10: RPTN: PFLG¼1: 1.7: 4.9: 111: 880. In cultured primary keratinocytes, calcium-
induced expression of the SFTP genes was inhibited by either p38 inhibitors SB202190/
SB203580 or the MEK inhibitor PD98059. Moreover, the JNK inhibitor SP600125 also
stimulated SFTPs expression at a high level. Taken together, this analysis provides a
comprehensive catalogue of the SFTP family in health and disease.
134
Polymorphisms in Folate and Pyrimidine Metabolic Enzymes and Clinical Response to
Methotrexate in Psoriasis
Campalani E1, Arenas M2, Marinaki AM2, Barker J1, Smith CH1
1Skin Therapy Research Unit, St Johns Institute of Dermatology, London, United Kingdom;
2Purine Research Laboratory, Chemical Pathology, Guys Hospital, London, United Kingdom
Methotrexate inhibits enzymes involved in folate, pyrimidine and purine metabolism.
Methotrexate is considered the gold standard therapy for moderate to severe psoriasis but
there is marked interpersonal variation in its efficacy and toxicity. Up to 30% of patients
discontinue therapy with methotrexate because of side effects. Methylenetretrahydrofolate
reductase (MTHFR) and thymidylate synthase (TS) are enzymes involved in folate metabolism
and de novo pyrimidine synthesis respectively. In patients with rheumatoid arthritis specific
MTHFR single nucleotide polymorphisms (SNPs) were associated with methotrexate toxicity,
and a polymorphism in the TS promoter region (2/3 tandem repeats) correlated with
decreased methotrexate efficacy. We hypothesised that in psoriasis: 1) MTHFR C677T and
A1298C SNPs are predictive of methotrexate toxicity and 2) TS 2/3 polymorphism is
predictive of disease response to methotrexate. 203 psoriasis patients treated with
methotrexate were recruited retrospectively and classified according to clinical response to
methotrexate. MTHFR SNPs were genotyped by restriction endonuclease digestion and TS 2/
3 polymorphism by PCR and agarose gel electrophoresis. Statistical analysis was by Fisher’s
exact test. TS 3 carriers [p¼ 0.048, OR 2.96(0.96–9.06)95%] and TS 3 allele [p¼ 0.029, OR
1.79(1–3)] were associated with poor response to methotrexate. TS 3 allele was also
associated with hepatotoxicity [p¼ 0.038, OR 3.6(1.12–11.7)95%] irrespective of folate
status, increased incidence of symptomatic side effects [(p¼ 0.002, OR 5.62(1.9–16.3)95%]
and methotrexate discontinuation due to any adverse event [p¼ 0.03, OR 2.10(1.09–
4.02)95%] in patients not taking folate. MTHFR SNPs distribution did not vary significantly
although the 677T/T genotype tended to be more frequent in patients experiencing adverse
events.
Our results suggest that a specific TS polymorphism could potentially be useful as a
genetic marker for predicting clinical response to methotrexate in psoriasis.
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Cowden Disease with Proteus-like Manifestations: Secondary Event as Mosaic PTEN
Allelic Defect Involving Several Dermal Cellular Types
Caux F1, Gerard M2, Fain O3, Laroche L1, Longy M4
1Dermatology and UPRES EA3408, C.H.U. Paris XIII, France; 2Genetics, C.H.I.Creteil,
France; 3Internal Medicine, C.H.U. Paris XIII, France; 4Molecular Oncology, Bergonie
Institute, Bordeaux, France
Mosaicism could explain segmental manifestations of autosomal dominant diseases but is
rarely proved in humans. We have been able to demonstrate this phenomenon in one woman
belonging to a family of Cowden disease (CD) with PTEN mutation.
In this family a PTEN germline mutation (I135V) was found in the seven affected individuals.
Six presented typical CD. One had a complex phenotype associating manifestations of CD
and congenital dysmorphia with segmentary lipomatosis, hemolymphangiomas, overgrowth
of lower limbs and epidermal naevi following Blaschko’s lines.
To understand this peculiar phenotype, DNA was extracted from lesional and normal
tissues. No second mutation was found in PTEN. Microsatellite genotyping analysis using 3
markers flanking the PTEN region was performed. Loss of heterozygosity (LOH) was found in
lesional skin but was absent in blood DNA. This LOH was present in three physically distant
biopsies (back, left foot, right calf) and involved the wild type allele. On the other hand no LOH
was found in DNA of normal skin. To determine the origin of tissue abnormality, fibroblasts
were grown from lesional skin of left foot and flank. Moreover skin of fibroma on the left foot
was cleaved by dispase, lipofibroma of the right calf sequentially dissected and digested by
collagenase. LOH was found in the dermis of cleaved skin, in a vessel and the lower part of
lipofibroma and in the adipocytes after digestion by collagenase. It was absent in cultured
fibroblasts, in epidermis and the superficial part of the lipofibroma.
Clinical data with Proteus-like syndrome of our patient could be explained by a germline
mutation of PTEN associated with an interstitial deletion of several dermal cellular types in
the 10q23 region related to a postzygotic somatic mosaicism.
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Sporadic Multiple Melanomas: Relevance of Xeroderma Pigmentosum C Gene Poly-
morphisms and Alternatively Spliced mRNA Variants
Thoms KM, Vollert S, Laspe P, Neumann C, Emmert S
Dept of Dermatology, Georg-August-University Goettingen, Germany
In the rare disease xeroderma pigmentosum (XP) defects in nucleotid excision repair genes
lead to an41000-fold increased risk for developing skin cancer including melanoma.
Recently three XPC gene polymorphisms (intron 11 C-6A, exon 15 A2920C and intron 9 poly
AT) in linkage disequilibrium have been described. The intron 11 C-6A polymorphism within
the XPC intron 11 splice acceptor site leads to an increased exon 12 skipping in the XPC
mRNA resulting in diminished DNA repair. To investigate if this may contribute to the
development of melanoma we assessed these polymorphisms and the expression of the
alternatively spliced XPC mRNA variant in a high risk group of 27 patients with sporadic
multiple melanomas and 30 matched healthy individuals.
In all 57 individuals these three XPC polymorphisms were in linkage disequilibrium. Using
quantitative real-time PCR we could confirm that the XPC intron 11 C-6A polymorphism leads
to an increased expression of the exon 12 deleted XPC mRNA isoform in an allele dosage
dependent manner. Overall, the relative isoform expression was 1.9-fold higher in individuals
carrying the polymorphism in both alleles (homozygous A/A genotype) and 1.6-fold higher in
heterozygous C/A genotype carriers compared to individuals with the homozygous C/C
genotype.
Referring to a possible association with melanoma we detected the homozygous A/A
genotype in 9 of 27 (33.33%) melanoma patients but only in 4 of 30 (15.38%) controls.
Consistent with this the XPC mRNA isoform was expressed in a relative amount of 1.22% in
patients compared to only 1.16% in controls. These findings show an interesting tendency
which might lead to the hypothesis that the XPC intron 11 C-6A polymorphism resulting in an
increased expression of the exon 12 deleted XPC mRNA isoform may contribute to
melanoma pathogenesis.
137
Intrinsic Skin Aging Regulates the Cytoskeleton
Trost A1, Bauer J1, Richter K2, Hintner H1, Oender K1
1University Hospital of Dermatology, Salzburg, Austria; 2Paris Lodron University Salzburg,
Austria
Skin aging is influenced by several factors including genetics, environmental exposure (UV
(ultraviolet) irradiation, xenobiotics, mechanical stress), hormonal changes and metabolic
processes (ROS production, sugar, aldehydes). These factors altogether lead to cumulative
alterations of skin structure, function and appearance. For a draft outline of the genes
involved in aging we performed 40,000 genes expression profiling by microarray analysis with
RNA isolated from young and aged skin. Whole genome micro-array analysis was done twice,
one time with total skin RNA and a second time with T7-RNA polymerase amplified cRNA.
Confirmation of up- or down regulated candidate genes was first done by highly sensitive
quantitative Real Time PCR (Q-RTPCR) analysis. Only those genes that showed differences in
gene expression in Q-RTPCR experiments were further studied by northern blotting. As
observed differences on gene expression levels do not necessarily imply regulation on protein
expression, we analysed the protein content of crude foreskin total protein isolations by
antibodies specific for the regulated genes. Interestingly cytoskeleton proteins, normally used
as housekeeping genes for normalization of experiments turned out to be regulated in the
aging process. This was supported by normalization of the probes via ethidium bromide
staining of total RNA for transcript analysis methods such as QRTPCR and Northern blotting
and quantitation of total protein for western blotting. Among other housekeeping genes we
were able to confirm an upregulation in young RNA samples compared to old ones in four
cytoskeletal genes: tubulin alpha, actin beta, alpha plakoglobin and alpha actinin. This study
implies that the term housekeeping gene has to be used cautiously in studies focussed at
skin aging.
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Werner Syndrome: Identiﬁcation of the Homozygous g. nt 77177 a4g Mutation (Genbank
acc# AY442327) in the WRN Gene in Two Apparently Unrelated Italian Families from
Sardinia Suggests a Founder Effect
Masala M1, Olivieri C2, Pirodda C1, Cottoni F1, Danesino C2, Cerimele D1, Scappaticci S2
1University of Sassari, Italy; 2University of Pavia, Italy
Werner Syndrome (WS, MIM#277700) is an autosomal recessive disorder. Clinical symptoms
includes atrophy of subcutaneous adipose tissue, especially in the lower extremities, which is
often described as ‘‘scleroderma-like’’, cataract, subcutaneous calcification, premature
arteriosclerosis, diabetes mellitus, and a wizened and prematurely aged facies. The habitus is
characteristic, with short stature, slender limbs, and stocky trunk. The nose is beaked.
Werner syndrome has been found to be caused by mutations in the RECQL2 gene, also
called WRN (MIM#604611), which encodes a homolog of the E. coli RecQ DNA helicase. This
gene has been mapped in 8p12-p11.2 and it is composed of 35 exons coding for a protein of
1432 amino acids. We studied two families affected with WS whose geographical origin is
from the Italian island of Sardinia. One of them was previously published in 1982 by [citation
removed]; in 1996 [citation removed] found a cDNA 105 bp insertion between exons 18 and
19 of WRN gene. After the enrolment of new members of the family (16 subjects, 5 affected),
we were able to characterize this mutation at DNA level, identifying a homozygous g. nt 77177
a4g mutation (Genbank acc# AY442327). Extensive cytogenetic analysis was also
performed. Surprisingly the second family, from a different place of Sardinia, showed the
same homozygous mutation. The two families were unrelated up to 4 generations.
Microsatellite analysis in order to verify the hypothesis of a common ancestor between
these families is in progress.
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Addictive Effect of Homozygous Mutation E170K in Gene KTR5 in Polish Patient with
Epidermolysis Bullosa Simplex
Kowalewski C, Szczecinska W, Wozniak K, Janowska K, Ploski R
Department of Dermatology, Medical University of Warsaw, Poland
We present 4-year-old girl, from consanguineous parents, with generalized epidermolysis
bullosa simplex (EBS) type Koebner. Her both parents and several relatives presented blisters
restricted to the soles typically for localized form of EBS type Weber-Cockeyne. The
diagnosis of EBS was confirmed by immunofluorescence mapping performed on lesional
patients skin. The mutational analysis revealed that proband has a homozygous mutation
changing G to A at base 508 leading to exchange of a glutamic acid to lysine at residue 170
(E170K) in 1A domain in KRT5 gene. No other mutation was found in KRT5 and KRT14 genes.
Analysis of her parents revealed that both of them are having a heterozygous E170K
mutation. Her healthy sister was shown to posses healthy alleles. The mutation E170K in the
gene KTR5 found in heterozygotous parents of our child seems to be partially dominant since
the severity of the disease is increased in a homozygote. To confirm this hypothesis
ultrastructural organization of the keratin intermediate filaments of the proband was studied.
Electron microscopic study on perilesional skin revealed gross alteration in organization of
cytoskeleton of the basal keratinocytes including keratin aggregation and clumping and
reduction of the number of intermediate filaments. This observation suggests the addictive
effect of homozygotous mutation E170K in gene KTR5modulating the phenotypic expression
of EBS.
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A Novel P Gene Mutation and the Frequency of Type 2 Oculocutaneous Albinism Among
Japanese Albino Patients
Ito S, Suzuki T, Inagaki K, Suzuki N, Tomita Y
Nagoya University Graduate School of Medicine, Japan
Type 2 oculocutaneous albinism (OCA2) is an autosomal recessive disorder that results from
mutations in the P gene that codes one of the melanosomal proteins. We previously screened
75 patients with OCA for mutations in the P gene, and reported six novel mutations and the
frequency of OCA2 in the Japanese albino population (  8%). In this study, we newly
studied 30 Japanese individuals with OCA, and detected 4 patients with OCA2 including a
pair of identical twins. A novel mutation (c.2373delCGT; p.792delV) was found in the twins,
who had mild clinical phenotype of white skin, blond hair, and brown eyelid. They were
compound heterozygous for the novel deletion and p.A481T, which was associated with a
mild phenotype and has approximately 70% function in melanogenesis compared with that of
the wild-type. The c.2373delCGT (p.792delV) was considered pathologic from following three
reasons. 1) We screened 101 normally pigmented Japanese for the c.2373delCGT and failed
to detect this mutation. 2) Valine at codon 792 is conserved among all known species,
including mouse and Drosophila 3) Their unaffected parents had one of the two kinds of
mutations, respectively. These findings indicate that the c.2373delCGT mutation is very rare
in general Japanese population and could be defined statistically as a pathological mutation.
Together with previous 75 patients, here we report the frequency of OCA2, 9.5% (10/105),
among the Japanese albino population. This is the largest study of patients with OCA2 among
Japanese population.
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Investigation of the Chromosome 17q25 PSORS2 Locus in Atopic Dermatitis
Morar N1, Bowcock AM2, Harper J3, Cookson WO1, Moffatt MF1
1Wellcome Trust Centre for Human Genetics, Oxford, United Kingdom; 2Washington
University School of Medicine, USA; 3Great Ormond Street Hospital and the Institute of
Child Health, London, UK
Psoriasis and atopic dermatitis (AD) are strongly genetic and inherited as multifactorial traits.
While both conditions are clinically and pathologically distinct, there is co-localization of
psoriasis and AD susceptibility loci on chromosome 17q25 (PSORS2).Two peaks of
association at this locus contain the psoriasis candidate genes SLC9A3R, NAT9 and
RAPTOR. We genotyped 14 of the most significantly associated SNPs in these genes in the
ECZ1 eczema panel recruited through a child with AD. ECZ1 has 150 families with 350
siblings and 245 sib-pairs. Replication of positive findings was sought in the MRC- E eczema
panel comprising 278 families, 634 siblings and 470 sib-pairs. Genotyping was carried out by
Sequenom MassArray technology. In the ECZ1 panel, rs878906 in intron 3 of NAT9 was
associated with AD (P¼ 0.001) using family based tests of association (TDTand QTDT). In the
MRC-E panel rs895691 between the end of exon 6 of SLC9A3R1 and exon 7 of NAT9 was
associated with AD (P¼ 0.037).In both panels, however, these were not significant when
multiple comparisons were taken into account. Analysis of 11 marker haplotypes did not
show association in either population. These results suggest that the psoriasis associated
genes do not account for linkage of the 17q25 PSORS2 locus to AD.
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Three Novel Mutations in the Membrane-Associated Transporter Protein Gene with
Oculocutaneous Albinism Type 4
Inagaki K, Suzuki T, Ito S, Suzuki N, Tomita Y
Dept of Dermatology, Nagoya University, Japan
Oculocutaneous albinism (OCA) is a group of autosomal recessive hypopigmentary disorders
of the skin, hair and eyes. Mutations in four genes have been reported in different types of
human OCA. OCA4 is caused by mutations in the MATP (Membrane-Associated Transporter
Protein) gene. The MATP protein is a 530-amino-acid polypeptide that contains 12 putative
transmembrane domains, and is a transporter that mediates melanin synthesis. Clinical
phenotypes of OCA4 vary from complete absence to some pigmentation with brown hair and
irides. Some patients showed improvement during the first decade of life. Eighteen mutations
in the MATP gene have been reported so far (two nonsense, four frameshift, one splice site,
one deletion and ten missense mutations). In this study, we report three novel mutations,
Tyr49Cys, Thr440Ala, and Gly473Asp, detected in three Japanese patients with OCA4, by
direct sequencing. These missense substitutions were not found in 104 unrelated normally
pigmented Japanese controls. Furthermore, the three missense substitutions were found at
amino acid residues conserved among all of medaka fish, mouse and human. From
genotype-phenotype correlations, the Thr440Ala mutant allele might have some activity on
melanogenesis, on the other hand, low activity was found in the Tyr49Cys and the Gly473Asp
mutant alleles.
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Steroid Sulfatase Gene Mutation and its Enzymatic Activity in Patients with X-Linked
Ichthyosis
Oyama N, Satoh M, Yanagihori H, Nakamura K, Kaneko F
Dept of Dermatology, Fukushima Medical University, Japan
X-linked ichthyosis (XLI) is a genodermatosis caused by deficiency of steroid sulfatase (STS)
activity resulting from the coding gene mutations. The majority of XLI patients (  90%) have
complete or partial deletions of the STS gene. In this study, we characterised the STS gene
mutations in seven unrelated Japanese patients with XLI, to look for the unidentified
genotype-phenotype correlation in the disease. PCR-SSCP and direct sequencing analyses
revealed that out of seven, four have complete deletion and the remaining three have different
point mutations. Among the latter three, two patients had different single base pair
substitutions within exon 8 encoding the C-terminal half of the STS polypeptide. The other
patient had a doublet base pair substitution within exon 10, encoding the same amino acid.
The two exon 8 mutations resulted in the transversion of functional amino acids; a G4C
substitution at nucleotide 1344, causing a predicted change of a glycine to an arginine and a
C4Tsubstitution at nucleotide 1371, causing a change from a glutamine to a stop codon. We
did not find the direct link between the mutation variations and clinical phenotypes of
individual subjects. Moreover, in vitro STS cDNA expression using site-directed mutagenesis
demonstrated that the two exon 8 mutations are pathogenic and reflect the levels of
decreased STS enzyme activity in the patients’ peripheral blood cells.
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c-kit Mutations in Patients with Childhood-Onset Mastocytosis and Genotype-Phenotype
Correlation
Yanagihori H, Oyama N, Nakamura K, Kaneko F
Dept of Dermatology, Fukushima Medical University, Japan
Mastocytosis represents a clonal proliferation of mast cell hematopoietic progenitors caused
by gain-of-function mutations of the c-kit gene. The heterogeneity of c-kitmutations may have
contributed to difficulties in characterizing genotype-phenotype correlation of the disease.
Our goal was to analyze a set of reported pathogenic c-kit mutations in patients with
childhood-onset cutaneous mastocytosis, in comparison with those with adult-onset
disease, and to correlate with clinical presentation. We performed polymerase chain reaction
and direct sequencing using genomic DNA samples from 20 non-familial Japanese subjects
with indolent cutaneous mastocytosis (14 with childhood-onset disease and 6 with adult-
onset disease), to look for the most common c-kit mutations at codon 816, 560, 820 and
839. A substantial number of patients had missense codon-816 mutations (12/14 in the
childhood-onset group, 85.7% and 6/6 in the adult-onset group, 100%). The most common
mutation was Asp816Val (12/18, 66.7%), followed by Asp816Phe (6/18, 33.3%). Moreover,
children with the Asp816Phe mutation tend to develop cutaneous mastocytosis at an earlier
age as compared to those with the Asp816Val mutation (mean age of onset 1.3 month vs. 5.0
month, respectively; p¼0.114), although there is no significant difference statistically
between both groups. No other mutation variations were found in our cohort. We confirmed a
high incidence of the two distinct c-kit mutations, Asp816Val and Asp816Phe, in patients with
childhood-onset cutaneous mastocytosis. Our results provide new insights into common c-kit
mutations, which may contribute to different clinical courses of the disease.
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Gene Expression Changes in Monocyte Derived Dendritic Cells Following Exposure to
Contact Allergens
Cluzel-Tailhardat M1, Bonnet-Duquennoy M1, Lazou K1, Kurfurst R1, Courtellemont P1,
Nicolas JF2, Le Varlet B1
1LVMH Recherche, St Jean de Braye, France; 2IFR 128 Biosciences Lyon-Gerland INSERM
U503, France
Chemical-induced allergy is an important occupational health problem. Development of
in vitro models to identify sensitizing chemicals receives interest since animal testing should
be avoided in 2009 for the cosmetic industry. A critical step in the induction of contact
hypersensitivity is the activation, maturation and migration of dendritic cells from the
epidermis to the draining lymph nodes to sensitize naı¨ve T lymphocytes. To explore the
concept of chemical allergen-induced dendritic cell maturation and to identify genes that are
differentially regulated by exposure to allergens, we developed a low density cDNA-array
using colorimetric revelation (OLISA–Apibio corporation) and studied 75 genes on monocyte-
derived dendritic cells (MDDC). Monocytes are negatively isolated from human peripheral
blood using magnetic microbeads and cultured for 7 days in GM-CSF and IL-4 supplemented
medium. The effects of exposure to chemicals were performed on immature, LPS-induced
mature and chemical-stimulated MDDC. Our data show that immature MDDC significantly
express transcripts for 44 of the 75 genes tested (59%). Upon LPS stimulation of MDDC
derived from 5 different donors, 14 genes were found to be regulated (8 upregulated and 6
down-regulated), whereas expression profiles were unchanged for 30 genes. Most of these
genes are involved in cell adhesion, signalling and stress. The variation in gene expression
was confirmed by real-time quantitative RT-PCR assay. In order to develop an in vitro
alternative method for predicting the sensitizing potential of chemicals, we currently perform
expression profiles analysis on MDDCs exposed to chemical allergens like DNBS, eugenol,
isoeugenol and hydroxycitronellal. Preliminary results show that the discrimination between
strong, moderate and weak allergens on one hand and irritants on the other hand could be
possible and requires the use of a panel of several different gene markers.
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Detection of COL7A1 Mutations Causing Dystrophic Epidermolysis Bullosa by Denatur-
ing- HPLC
Castiglia D1, Posteraro P2, Pascucci M1, Fusari R2, Colombi M3, Barlati S3, Zambruno G1
1IDI – IRCCS, Rome, Italy; 2IDI – Ospedale S. Carlo, Italy; 3University of Brescia, Italy
Dystrophic epidermolysis bullosa (DEB) is a clinically heterogeneous genodermatosis
transmitted either in autosomal dominant (DDEB) or recessive (RDEB) mode. Mutations in
type VII collagen gene (COL7A1) have been associated with all variants of DEB. Identification
of COL7A1 mutations is relevant to diagnosis, management, genetic counselling, and
prenatal diagnosis of DEB patients. However, mutation detection in COL7A1 is a challenge
since the 32 kb gene contains 118 exons and the majority of mutations are family specific. In
this study, we describe for the first time the use of denaturing high-performance liquid
chromatography (DHPLC) for COL7A1 mutation detection. To validate the technique, we
developed optimal DHPLC conditions by simulation of the wild-type sequence corresponding
to 72 COL7A1 amplicons using the WAVEMAKER (Navigator 1.5.4) software. These
conditions were then refined by screening DNA samples containing 38 known mutations.
DHPLC analysis was able to detect all previously reported mutations. Subsequent DHPLC
screening of 16 DEB families of unknown genotype allowed for the identification of 20 distinct
mutations, 9 of which were novel and included 4 insertion/deletions and 5 missense
mutations. In this patient cohort, the DHPLC mutation detection rate was significantly higher
compared with our standard mutation scanning rate with conventional techniques, namely
heteroduplex analysis on CSGE/MDE gels of amplified COL7A1 cDNA or genomic DNA (96%
versus 86%). Data from new patients conform to previous experience of the genotype-
phenotype correlation in this disease, showing a prevalence of homozygous truncating
mutations in the severe Hallopeau-Siemens (HS) RDEB variant, a combination of truncating
and missense/splice site mutations in the non HS-RDEB and heterozygous glycine
substitutions in DDEB. Overall, these findings indicate that DHPLC is the method of choice
for COL7A1 molecular characterisation in DEB patients.
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MC1R and Patched Gene Polymorphisms in French Patients with BCC
Liboutet M1, Delestaing G2, Dubertret L3, Vilmer C3, Granchamps B4, Soufir N4, Basset-
Se´guin N1
1INSERM U716 Hoˆpital Saint-Louis, France; 2INSERM U532 Hoˆpital Saint-Louis, France;
3Dermatologie Hoˆpital Saint-Louis, France; 4Biochimie Hoˆpital Bichat, France
Loss-of-function variants of the MC1R gene, a key control of human skin pigmentation, have
been shown to increase the risk of Basal Cell Carcinomas (BCC) in the Netherlands,
Queensland, and Irish population. In addition, germline mutations of patched predispose to
Gorlin Syndrome, an hereditary condition highly associated with BCC. Recently, association
of patched polymorphisms with sporadic BCC has been proposed. The prevalence and role
of MC1R and patched variants in the genetic predisposition to BCC are not known in the
French population. MC1R variants were searched in 125 BCC cases and in 151 controls. In
addition, exon 23 patched polymorphism (Pro1315Leu) was genotyped. MC1R loss-of-
function variants were present in 66% of BCC patients versus 41% of control subjects
(po0.0001), confirming the role of MC1R in genetic predisposition to BCC in the French
population. Three frequent variants were significantly associated with BCC risk: Val60Leu,
Arg151Cys, and Val92Met (respective Odds Ratios of 2.94 [1.74–4.97], 3.65 [1.24–10.74], and
2.7 [1.4–7.21]. The BCC dependant-MC1R risk strongly persisted after stratification on
clinical risk factors (skin type, hair and eye color, solar lentigines). In multiple logistic
regression analysis, MC1R variants appeared as the second BCC risk factor (OR¼ 2.45 1.31–
4.58) after solar lentigines (OR¼ 3.30 1.76–6.18). In addition, the patched 1315Pro allele was
also associated with BCC risk (OR 1.85 [1.14–3]). Our data show that MC1R loss-of-function
variants are also a strong and independent risk factor for BCC in France, and suggest that
assessing MC1R status could be useful, in association with clinical risk factors assessment,
for identifying high-risk groups to be targeted for prevention. In addition, our data suggest
that patched polymorphisms could also influence BCC susceptibility.
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mRNA Expression Studies of Housekeeping Genes on HaCaT Keratinocytes after UVB
Irradiation
Balogh A, Miko´ E, Scholtz B, Emri G, Horkay I, Remenyik E´
University of Debrecen, Hungary
Gene expression measurements play an important role in discovering molecular regulatory
pathways. Analysis of mRNA levels with the most widely used real-time quantitative reverse
transcription polymerase chain reaction method requires the use of normalizers. These
should be gene products that do not show expressional change under the various treatment
conditions tested. This requirement fits most likely some of the genes involved in basic
cellular functions, the so-called housekeeping genes. The optimal genes for normalizing may
differ significantly when looking at different cell lines or different cellular stressors. An earlier
study proved that the differentiation level of keratinocytes does not alter the expression of the
cyclophilin mRNA and the 28S ribosomal RNA. However, as we are studying the effect of UVB
radiation, we decided to test whether cyclophilin is the optimal normalizer in this treatment
modality and compare the expression levels of several housekeeping genes in keratinocytes
before and after UVB irradiation. Cultures of immortalized human keratinocyte cell line
(HaCaT) were subjected to 60-120mJ/cm2 broad band UVB radiation and RNA was extracted
at different time points (0,2,4,6,12,24,72 hours) after irradiation. Following random hexamer
primer RT-PCR the changes in the levels of cyclophilin, acidic ribosomal phosphoprotein P0
(36B4), hypoxanthine phosphoribosyltransferase 1, succinate dehydrogenase complex A,
beta-2-microglobulin, glyceraldehyde-3-phosphate dehydrogenase (GAPDH), -glucuroni-
dase, phosphoglycerate kinase 1, beta actin mRNAs were measured by real-time quantitative
RT-PCR. Data was analysed by the SDS 2.0 software, followed by further analysis by the
‘‘NormFinder’’ algorithm. According to the computer analyzis the best gene turns up GAPDH
with 0.215 stability value. Using two genes as normalizing further improve the accuracy. The
best combination of two genes was GAPD and 36B4 with 0.172 stability value. In summary,
this study helps to identify the optimal normalizing genes for UV-irradiated keratinocytes, thus
establishing a reliable basis for further photobiology studies.
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Speciﬁc Gene Expression Proﬁle of Keratinocytes Triggered by Propionibacterium acnes
type IB Isolate
Nagy I1, Szabo K1, Hegedus Z2, Puskas L2, Kemeny L1
1University of Szeged, Hungary; 2Hungarian Academy of Sciences, Szeged, Hungary
Although inflammatory acne has been well characterized clinically, the mechanisms by which
the lesions arise are still poorly understood. Little is known about the regulation and
coordinated expression of genes involved in the innate host response of the skin following
abnormal Propionibacterium acnes (P. acnes) colonization. To gain more insight into the gene
expression program of primary keratinocytes triggered by P. acnes type IB isolate we
examined the kinetic profile of transcriptome changes in primary keratinocytes.
Primary keratinocytes from healthy donors were isolated, and treated with P. acnes type IB
for 0, 3, and 24 hours in parallel with time-matched mock-treated control cells. RNA samples
were extracted and amplified for microarray analysis, using a cDNA chip containing 18.000
expressed sequence tags. After 3 and 24 hours of co-culture, a total of 416 (206 genes up-,
and 210 genes down-regulated), and 336 genes (155 up-, and 181 down-regulated) showed
significant gene expression changes, respectively.
P. acnes type IB isolate induced changes occurred at the level of transcription of genes
encoding proteins with antimicrobial properties, transcriptional regulators, metabolism-
associated proteins, and genes involved in stress induced signaling pathways, or during the
regulation of cell growth and differentiation. Our results provide new insights into the harmful
and beneficial effects of P. acnes colonization, and define possible target mechanisms and
genes for acne therapies.
Profiling host gene expression changes represents one tool in elucidating host-pathogen
interaction. By analyzing this aspect of the complex mechanism of acne occurrence can,
however, help us to discover better treatment options, and solutions for this very common
skin disease.
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Novel and Recurrent Mutations in Keratin K5 and K14 Genes in Epidermolysis Bullosa
Simplex Dowling-Meara: Implications for Disease Phenotype and Keratin Filament
Assembly
Mu¨ller FB1, Bruckner-Tuderman L2, Ku¨ster W3, Korge BP1, Arin MJ1
1University of Cologne, Germany; 2University of Freiburg, Germany; 3TOMESA Fachklinik,
Bad Salzschlirf, Germany
Epidermolysis bullosa simplex (EBS) is a group of autosomal-dominant genetic skin disorders
caused by mutations of the keratin genes KRT5 and KRT14 and characterised by basal
keratinocyte lysis leading to the development of intraepidermal blisters on minor mechanical
trauma. Within the framework of the newly founded German network for epidermolysis
bullosa (Netzwerk EB) we investigated 27 EBS cases of mainly German origin by sequence
analysis of the entire coding sequences of KRT5 and KRT14. We identified 10 novel
(K5:Glu168Lys, K5:Arg169Pro, K5:Glu170Lys, K5:Arg331His, K5:Arg471Cys, K14:Asn123Lys,
K14:Val133Leu, K14:Met272Thr, K14:1218delG and K14:Arg417Pro) and five previously
reported (K5:Asp328His, K5:Glu477Lys, K14:Leu122Phe, K14:Arg125Cys, K14:Arg125His)
mutations within the K5 and K14 genes.
The single base pair deletion in position K14:1218G (amino acid position 406) results in
frame-shift and generation of a premature termination codon 35 codons downstream of the
mutation. This mutation leads to an unexpectedly mild disease phenotype despite of a
predicted severely altered protein sequence in the c-terminal 2B domain of keratin 14
including the crucial RLLEGEE motif.
The study discusses possible implications of the novel mutations on protein structure,
keratin intermediate filament (KIF) formation and the corresponding phenotype and
summarises the spectrum of mutations reported so far in EBS.
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Inheritance Based Haplotype Analysis of PSORS-1 in German Psoriasis Families
Jenisch S, Kabelitz D, Christophers E, Weichenthal M
Dept of Dermatology, University of Kiel, Germany
Usually, a maximum likelihood (ML) approach is used to reveal haplotypes and haplotype
frequencies from family-based genotypes. However, in the case of complex families or rare
haplotypes, the ML based approaches are limited and may cause errors which cannot be
identified. In our effort to characterize risk haplotypes at the PSORS-1 locus for psoriasis
vulgaris, we therefore used the segregation information for 6p21.3 supplied by HLA data.
If segregation information of the respective chromosome is available in such families, SNP
haplotypes can be constructed. As far as siblings and parents are not all heterozygous at a
given position, the haplotype sequence can unambigously be clarified.
We analysed 51 families (547 members) in which the segregation of 6p21 was
unambigously clarified by use of the HLA haplotype information. A total of 306 independent
chromosomes could be assigned in which more than 75% of the polymorphisms were
characterized. When pairwise relative delta values were calculated out of these haplotypes, a
very well conserved block could be identified in which LD was495%. Of the 306 hapolotyes,
98 were positive for this block.which encompasses about 30 kB and includes the genes HCR,
TCF19, and POU5F1, all of them previously reported to be associated with psoriasis.
Of the 52 chromosomes positive for HLA-Cw6, 48 were positive for this SNP block
suggesting that the putative PSORS-1 gene(s) may reside within this highly conserved block.
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Distinct VEGFR-2 Promotor/Enhancer Sequences Show Activity in Ischemia-Induced and
Inﬂammatory Angiogenesis
Heidenreich R1, Murayama T2, Silver M2, Brill C1, Asahara T2, Ro¨cken M1, Breier G3
1Eberhard Karls University, Tuebingen, Germany; 2Tufts University School of Medicine,
Boston, USA; 3Carl Gustav Carus University, Dresden, Germany
Vascular endothelial growth factor (VEGF) and its high-affinity tyrosine kinase receptor
VEGFR-2 play a pivotal role during embryonic vascular development and adult neovascular-
ization. The VEGF/VEGFR-2 signal transduction system mediates proliferation, migration and
survival of endothelial cells and regulates blood vessel permeability. Characterizing the gene
regulatory regions of the mouse VEGFR-2 gene, we established transgenic mouse lines that
express the LacZ reporter gene under the control of a 939-bp fragment of the 50-flanking
region of the Flk-1 gene, in combination with an enhancer element located in a 2.3-kb
fragment of the first intron. These mice showed an endothelium-specific expression of the
reporter gene throughout vascular development, which is down-regulated in most mature
blood vessels. In three different experimental tumor models we had found a strong reporter
gene expression specifically in the tumor endothelium. Here, we further characterized the
activity of the identified gene regulatory sequences of the VEGFR-2 gene in ischemia-induced
and inflammatory angiogenesis in vivo. Using the hind limb ischemia model, we observed a
strong endothelium-specific reporter gene expression in most blood vessels of the ischemic
muscle tissue. In contrast, there were nearly no LacZ expressing capillaries detectable in
normoxic control tissue. Wound healing involves the induction of inflammatory processes as
well as the formation of new blood vessels. Therefore, we generated punch wounds on the
back of transgenic mice and histologically examined wound biopsies at different times after
wounding. At day 7 after wounding, the majority of the newly formed blood vessels in the
wound tissues showed strong LacZ reporter gene expression, indicating, that the regulatory
sequences that mediate the up-regulation of VEGFR-2 during inflammation-associated
angiogenesis, are contained in the promotor/enhancer sequences used. Thus, these VEGFR-
2 regulatory elements should allow the analysis of the transcriptional control mechanisms
involved in the induction of VEGFR-2 expression during embryogenesis, tumor development
and tissue repair.
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Comparative Genomic Hybridization in Malignant Melanoma
Fischer J1, Schanz S1, Ulmer A1, Yildiz M2, Fierlbeck G1, Klein CA2
1Universita¨tsklinikum Tu¨bingen, Germany; 2Ludwig-Maximillians-Universita¨t Mu¨nchen, Ger-
many
Molecular cytogenetic techniques usually require large amounts of DNA. Unfortunately, the
genomic DNA that can be obtained from highly interesting clinical samples, such as small
melanocytic lesions, is very limited. To study chromosomal aberrations in malignant
melanoma we therefore used a recently introduced amplification method for genomic DNA
based on adapter-PCR, termed SCOMP. We applied the amplification protocol to the DNA of
single melanoma cells that were isolated from the peripheral blood or sentinel lymph nodes
and to formalin-fixed paraffin-embedded tissue samples of primary tumors (cutaneous and
uveal melanoma) and distant metastases after laser microdissection. As controls we used
single lymphocytes and microdissected stroma samples as well as DNA from cell line cells
with known genomic aberrations. CGH showed remarkable genetic differences between
cutaneous and uveal melanoma. Cluster analyses of aberrations in primary tumors of uveal
melanoma (n¼ 25) revealed chromosomal patterns with prognostic impact characterized by
deletion chromosome 3 and gain 6p. Studies for cutaneous melanoma are still ongoing. We
found that SCOMP is a robust and valuable tool to study not only samples with a high number
of cells but also samples comprising single to few cells.
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Signaling Networks in Cutaneous Melanoma Metastasis Identiﬁed by cDNA Microarrays
Nambiar S, Mirmohammadsadegh A, Doroudi R, Hassan M, Gustrau A, Marini A, Stege H,
Roeder G, Ruzicka T, Hengge U
Heinrich-Heine-University, Du¨sseldorf, Germany
Melanoma is a complex multigenic disease, susceptibility to which is determined by several
parallel and stepwise progressive pathways affecting growth control, differentiation, cell
adhesion and survival. High-throughput microarrays are being used in expression profiling
with the objectives of identifying regulated genes, patterns and pathways, leading to
functional characterization and tumor subclassification. Towards a molecular profile of
melanoma, we analyzed 10 melanoma metastases by DNA array technology and identified
several important regulated candidate genes, which were subsequently confirmed by Real-
time RT-PCR. We identified hepatocyte growth factor (HGF) receptor (c-Met), growth factor
receptor-bound protein (Grb)-10, B-RAF and several MAP kinase kinases (MAPKK) as being
significantly upregulated in melanoma metastases and several melanoma cell lines relative to
normal human melanocytes (p¼0.03). Among the upregulated genes, phosphorylated Grb10
is known to serve as a molecular switch turning on the MAPK pathway in response to HGF
receptor binding. Our data suggest that the transcriptional activation of c-Met is correlated
with phosphorylated Grb-10 in melanoma metastasis and subsequent activation of the Raf/
MEK/ERK pathway as evidenced from elevated phosphorylation of ERK1/2 proteins.
Although phosphorylated Grb-10 was associated with increased signaling through the
MEK/ERK pathway, it is known to inhibit IGF receptor signaling. Therefore the HGF/c-Met/
Grb10/Raf/MEK/ERK pathway seems important in eliciting cell cycle progression, prolifera-
tion and migration in cutaneous melanoma metastasis, with phosphorylation of Grb-10
serving as a critical regulatory event.
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Epigenetic Inactivation of Tumor Suppressor Genes in Circulating DNA of Melanoma
Patients
Marini A, Doroudi R, Nambiar S, Mirmohammadsadegh A, Gustrau A, Ruzicka T, Hengge UR
Dept. of Dermatology, Heinrich-Heine-University, Du¨sseldorf, Germany
DNA methylation is a well-known epigenetic phenomenon that occurs in higher order
eukaryotes. Epigenetic inactivation of tumor suppressor genes (TSG) plays a fundamental
role in the pathogenesis of malignant tumors. It has been associated with tumor progression
and impaired prognosis.
We investigated the hypermethylation status of six genes (TSG and cell cycle genes) in the
serum of cutaneous melanoma patients with or without metastases and in healthy controls.
Serum before therapeutic intervention from 25 patients was collected, cell-free DNA was
isolated and sodium bisulfite conversion of genomic DNA was performed. The methylation
status of CpG islands in the promotor region of SOCS1, SOCS2, RASSF1a, APC, CDKN2a
and MGMT were analyzed. Moreover, the expression of these genes was investigated in
nevus, normal skin, primary melanoma, metastases and four different melanoma cell lines
(BLM, A375, MV3, and M13) using real-time PCR.
Analysis of 25 sera from cutaneous melanoma patients demonstrated circulating
hypermethylated SOCS 1 in 68%, SOCS2 in 44%, RASSF1a in 68%, APC in 48%, CDKN2a
in 52%, while the MGMT did not show clear methylation pattern. Of the 25 patients, 96% had
at least one hypermethylated gene, while 88% and 52% had at least two or three
hypermethylated genes, respectively. Serum of healthy controls showed no methylation of
any of the analyzed genes. Analysis of methylation of the beta-actin gene was run in all
samples for verification of modified DNA.
The mRNA transcript of these genes showed a clear and significant downregulation, except
for MGMT, for which an up regulation (7.3 times) was detected being consistent with the lack
of promotor methylation.
The gene expression profile of a cancer specimen is considered a valuable source of
biological information with potential clinical utility. Our findings indicate that the incidence of
TSG hypermethylation in serum of cutaneous melanoma patients is high and that this
methylation may play a significant role in the progression of cutaneous melanoma.
156
Pattern of p63 Mutations in Human Ectodermal Dysplasia Syndromes
Rinne T, Lamme E, Duijf P, Beusekom E, Schalkwijk J, Brunner H, Bokhoven H
University Medical Center St Radboud, Nijmegen, The Netherlands
A group of human developmental disorders is characterized by different combinations of
ectodermal dysplasia, craniofacial abnormalities and limb malformations. Six different clinical
entities of this group have been linked to mutations in the p63 gene, of which four present skin
problems combined with other defects in ectodermally derived structures such as teeth, nail,
hair and lacrimal ducts: EEC, AEC, ADULT and Rapp-Hodgkin syndrome. We have found
causative mutations in these syndromes in well over 100 different families. This analysis has
established strong genotype-phenotype associations. The differential pattern of mutations is
most prominent for EEC syndrome and AEC syndrome, which are mostly caused by missense
mutations in the DNA-binding domain and SAM domain, respectively. But also most other
mutations are syndrome-specific, such as the R298Q/G mutations in ADULT syndrome. The
domain-specificity of p63 mutations indicates that there are different molecular mechanisms
behind the various p63-associated syndromes. However, our knowledge about these
mechanisms is only superficial.
The aim of this study is to get more insight into the role of p63 in normal and abnormal
epidermal development and the molecular mechanisms of the various pathogenic p63
mutations. To this end, we have established primary keratinocyte lines from skin biopsies of
patients with a known p63 mutation, such as EEC Y163C, R279H, R304W; AEC T537P, a
stop-mutation from a Rapp-Hodgkin syndrome patient in the very beginning of dNp63isoform
(Q11X). These cells are used for in vitro skin reconstitution to see whether the p63 mutated
cells are able to proliferate and begin the differentiation program normally. We are also
studing protein and RNA levels with different methods, such as Western Blot, qPCR,
immunohistochemistry and immunofluorescense.
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Keratinopathies: Prevention of Sweat-Induced Foot Blistering by Plantar Injections of
Botulinum Toxin
Swartling C, Vahlquist A
Dept of Medical Sciences, Uppsala University, Sweden
Hyperhidrosis and a high ambient temperature increase the tendency to plantar blistering in
patients with EB simplex (EBS) – due to KRT 5 or 14 mutations - and in pachyonychia
congenita (PC) – due to KRT 6, 16 or 17 mutations. Both conditions are additionally
associated with painful, focal hyperkeratoses on the soles. Local injections of botulinum toxin
(btx) produce longstanding anhidrosis in skin healthy individuals suffering from essential
hyperhidrosis. However, the anaesthesia required for foot injections limits the usefulness of
this therapy in plantar hyperhidrosis and no previous report of its use in patients with a
genetic skin disease, such as epidermolysis, seems to exist.
Here we report 5 patients with EBS and PC who had major problems in walking due to
painful foot blisters, especially during summer time. They were treated with intracutaneous
injections of btx type A (Dysport, 100 units/ml, Ipsen, Slough, UK) after prior intravenous
regional anaesthesia of the foot with a low tourniquet and 25 ml of prilocain (5 mg/ml). Within
one week all 3 PC patients experienced dryness and a remarkable relief of pain at plantar
pressure sites. The effect duration was between 6 weeks and 6 months. Repeated injections
over a 2-year-period confirmed the good results with no side-effects or tachyphylaxis noted.
Two patients with EBS were treated in the same way with unilateral btx injections. However,
despite obvious anhidrosis on the treated side, the intensity of blistering and pressure-
induced pain only marginally benefited from the therapy. It remains to be studied whether PC
and EBS are truly different in this respect or if subsets other patients with EBS may also show
an excellent response to btx therapy.
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A Novel Connexin 26 (GJB2) Mutation Causing Vohwinkel Syndrome (Keratodermia
Mutilans with Hearing-Loss)
Vahlquist A1, Bondesson M2, Gunnarsson U1, Nystro¨m AM1
1Dept Medical Sciences, Uppsala University, Sweden; 2Dept Genetics & Pathology, Uppsala
University, Sweden
Neuroectodermal syndromes involving the skin and inner ear are sometimes associated with
mutations in the connexin proteins which constitute gap junctions important for passing small
molecules from one cell to the other. Specifically, mutations in the GJB2 gene which encodes
for connexin 26 causes Vohwinkel syndrome (keratodermia mutilans with hearing-loss) and
keratitis-ichthyosis-deafness (KID) syndrome. A 75-year old Swedish man affected with the
former syndrome was followed for over two decades. He had congenital deaf-mutism and
verrucous palmoplantar keratoderma in addition to generalized ichthyosis. Despite long-term
treatment with oral retinoids he developed a squamous cell carcinoma on his right foot
necessitating amputation. On DNA analysis, a novel connexion 26 mutation (G59A) was
detected which corroborates similar mutations in other, milder forms of Vohwinkel syndrome.
The clinical features, particularly a proneness to skin cancer, is discussed in relation to the
novel genotype and adjacent gene mutations in GBJ2 causing KID syndrome.
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Polymorphisms of Interleukin-1 Receptor Antagonist, Toll-like Receptor 2 and 4 Genes in
Patients with Acne
Kis K1, Koreck A1, Szegedi K1, Dioszegi CS1, Paunescu V2, Cioaca R2, Olariu R2, Keme´ny
L1, Sze´ll M3
1University of Szeged, Hungary; 2Victor Babes University of Medicine and Pharmacy,
Romania; 3Dermatological Research Group of Hungarian Academy of Science, Szeged
Hungary
Acne is a chronic inflammatory disease of the pilosebaceous unit. The etiology of acne is
multifactorial: immunological mechanisms as well as hereditary factors are suggested to play
a role in the pathogenesis. The aim of this study was to identify acne susceptibility
polymorphisms of genes contributing to innate immune responses and to the regulation of
inflammatory processes. We investigated the allelic distribution of the variable number of
tandem repeat (VNTR) polymorphism of interleukin-1 receptor antagonist (IL–1RN), and single
nucleotide polymorphisms (SNP) of TLR2 gene resulting in the amino acid changes
Arg677Trp, and Arg753Gln as well as SNP’s of TLR4 gene resulting in the amino acid
changes Asp299Gly, and Thr399Ile in patients with acne (n¼ 47), acne inversa (n¼18) and in
a control population (n¼ 16). Genomic DNA of patients was used for PCR, and the alleles
were detected by gel electrophoresis for IL–1RN polymorphism and by sequence analysis of
PCR products for the SNP’s of TLR’s. None of the studied TLR2 polymorphisms were
detected either in patients or healthy individuals and no difference was found in the
prevalence of TLR4 alleles among the three groups. The 86bp tandem repeat sequence in the
intron 2 of IL-1RN gene may occur in various copy numbers. The frequency of the two-repeat
allele of IL-1RN (allele 2) was slightly increased among acne patients compared both to
controls and to acne inversa patients, moreover, among the studied groups, only acne
patients were homozygotes for allele 2, and 4 of these 6 homozygotes suffered from acne
conglobata. Our results suggest that allele 2 of IL–1RN gene might contribute to the
development of acne similarly to other inflammatory and autoimmune diseases, although the
verification of this suggestion needs further investigations in a larger population.
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The C478T Single Nucleotide Polymorphism of Melanocortin-1 Receptor Gene might have
a Protective Role in Vitiligo
Sze´ll M, Balta´s E, Bodai L, Nagy N, Dallos A, Bata-Cso¨rgo˜ ZS, Dobozy A, Keme´ny L
University of Szeged, Hungary
Melanocortin-1 receptor (MC1R) and agouti signaling protein (ASIP) play pivotal roles in the
regulation of human pigmentation. Here we aimed to study whether single nucleotide
polymorphisms (SNPs) of the MC1R and ASIP genes contribute to the pathogenesis of the
polygenic pigment skin disorder, vitiligo. The PCR amplified full-length MC1R gene was
studied by sequence analysis, and the 30 untranslated region (30 UTR) SNP of ASIP was
detected by RFLP in 164 vitiligo patients and in 66 healthy control individuals. The allele
frequency of the ASIP SNP did not show any difference between the vitiligo and control
groups. One of the SNPs (C478T) out of the studied 12 polymorphisms of MC1R showed a
significant difference (p¼ 0.0442) in allele frequency between the diseased and control
groups, this allele frequency was higher in the control group, suggesting protection against
vitiligo. Since skin color as well as hair and eye color were also registered about all Hungarian
Caucasian participants in the study, we could demonstrate that the prevalence of vitiligo was
significantly higher (p¼ 0.0001) among people with dark skin color (Fitzpatrick 3 and 4) than in
the group of people with light skin color (Fitzpatrick 1 and 2). These data suggest that the
C478T SNP of MC1R gene might contribute to vitiligo pathogenesis as a protective allele
against the disease.
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Gene Expression Proﬁling of Murine Skin Affected with Contact Hypersensitivity
Hartmann B1, Fahrngruber H1, Hartmann N2, Meingassner JG1
1Novartis Institute for Biomedical Research, Vienna, Austria; 2Novartis Institute for
Biomedical Research, Basle, Switzerland
The transcriptional changes in epidermal and dermal sheets of BALB/c mice were examined
30 min, 1, 3, 6 and 24 hrs after the elicitation of the contact hypersensitivity (CH) reaction
against oxazolone. Inflamed auricular tissue was collected from 6 animals per time point. The
RNA from the affected epidermal and dermal sheets, along with corresponding tissue
samples from naı¨ve animals (controls) was extracted and hybridized on GeneChip
microarrays (Affymetrix Mouse Genome 430 2.0 Array, 45101 gene probe sets). Genes
which differed significantly (po0.01) in expression between mice with CH and controls were
analyzed. From the 18327 genes retrieved, 1895 genes in epidermis and 2001 genes in
dermis exhibited a 3-fold change in expression in at least one time-point after challenge.
Among genes associated with immune functions, Tnfsf-10, IL-24, Tlr-3 and Tlr-1 were up-
regulated whereas IL1f-10 and Tnfsf-13 were down-regulated in the epidermis. In dermal
tissue CCL-6, CXCL-5, CXCL-14, and CTLA-4 were up-regulated; however CXCL-13 was
down-regulated. In both compartments CCL-5, CCL-9, CCL-11, CCL-20, CXCL-9, CXCL-10
and CXCL-11 were up-regulated whereas IL-1ra and IL-1L1 were down-regulated. The
expression levels in most cases were time-dependent. Overall, most changes were seen in
the epidermis at 8 hrs and at 24 hrs in the dermis. The validated transcriptional signatures of
the responses of involved tissues will give more insight into the diverse molecular cascades in
CH which underlay the cellular events resulting in clinically manifest allergic contact
dermatitis.
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High-Penetrance Melanocortin 1 Receptor Gene Variants Contribute to Sporadic
Cutaneous Melanoma Risk in the Italian Population
Fargnoli MC1, Spica T1, Pellacani G2, Chiappugi A3, Seidenari S2, Carli P3, Chimenti S4,
Peris K1
1University of L’Aquila, Italy; 2University of Modena and Reggio Emilia, Italy; 3University of
Florence, Italy; 4University of Rome Tor Vergata, Italy
Specific allelic variants of the melanocortin 1 receptor (MC1R) gene have been shown to be
melanoma susceptibility alleles in fair-skinned populations. We investigated the contribution
of the MC1R genotype to the risk of sporadic cutaneous melanoma in an Italian population.
One hundred patients with melanoma of any stage and 100 controls were consecutively
recruited at the Department of Dermatology, University of L’Aquila. Data on phenotypic risk
factors, UV exposure habits and melanocytic nevi were collected and sequencing of the
entire coding region of the MC1R gene was performed. A total of 26 MC1R variants, including
a novel 123_124insT allele, was identified with the most frequent allele being V60L. All high-
penetrance MC1R alleles, that define MC1R variants strongly associated with the red hair
color phenotype, were more common in melanoma patients (41%) as compared with control
subjects (19%), conferring a 3-fold increased risk for melanoma (OR: 2.96). Among individual
MC1R variants, the R151C allele was significantly associated with melanoma, with an
OR¼2.94. The increase in melanoma risk remained after stratification by constitutional and
UV exposure risk factors. Sixty-five additional melanoma patients and 65 matched controls
recruited at the Departments of Dermatology of L’Aquila, Florence and Modena were
characterized for phenotypic traits and genotyped for the most frequently detected MC1R
variants (V60L, V92M, R142H, R151C, R160W, D294H) using specific single nucleotide
polymorphism assays. Distribution of these variants confirmed our previous data. These
results support the contribution of high-penetrance MC1R variant alleles to genetic
predisposition to sporadic cutaneous melanoma in populations with different ethnic
background.
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Association of Endothelin Receptor B Mutations with Melanoma Risk
Soufir N1, Meziani R1, Lebbe C2, Bertrand G1, Fumeron F3, Ge´rard A1, Descamps V1,
Basset-Seguin N4, Saiag P5, Grandchamp B1
1Hopital Bichat Claude Bernard, France; 2Hopital Saint Louis, France; 3Faculte´ Xavier
Bichat, France; 4Hopital Saint Louis, France; 5Hopital Ambroise Pare´, France
The endothelin system plays a crucial role in melanocyte differentiation and migration. In this
study, we hypothesized that germline mutations of endothelin receptor B (EDNRB), a gene
involved in Hirschsprung disease (HSCR), could also predispose to melanoma (MM). The
coding region of EDNRB was entirely sequenced in 137 MM patients and 130 ethnically
matched Caucasian controls. Six non-synonymous EDNRB variants were found in 15
patients (11%), but only 2 in 4 controls (3%, p-value, two-sided¼ 0.012, OR: 3.87[1.25–12]).
Overall, 14/15 MM patients carried EDNRB mutations reported in HSCR disease, some of
which were previously shown to be loss-of function. In multiple logistic regression analysis
including classical risk factors, the effect of EDNRB mutations on MM risk remained
significant (p¼ 0.030). Our results strongly support that EDNRB can be involved in
predisposition for two different multigenic disorders, Hirschsprung disease and melanoma.
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Towards a Molecular Classiﬁcation of Skin Diseases: Revelation of the Human Skin
Transcriptome
Peters B1, Schaffrath B1, Huebel F1, Baron JM2, Mauch C3, Wenzel J4, Merk H2, Krieg T3,
Bieber T4, Bosio A1
1Memorec Biotec GmbH, Germany; 2Department of Dermatology, University of Aachen,
Germany; 3Department of Dermatology, University of Cologne, Germany; 4Department of
Dermatology, University of Bonn, Germany
With the objective to understand the molecular basis of skin diseases we have analyzed the
gene expression of more than 750 human biopsies of healthy skin, skin affected by
inflammatory skin diseases, or skin cancers, as well as of cutaneous melanoma metastasis,
and congenital nevi. For data collection and analysis the SkinSAYSt database was designed,
covering the complete genomics data as well as a total of 700 medical history parameters
organized in 20 different tables. Gene expression was analyzed using SAGEt, Agilent arrays,
PIQORt arrays, or qPCR. The study setup allows for a most comprehensive cross-reference
between all clinical and genomics data sets. Understanding which mechanisms are general
and which are specific can have important therapeutic implications. Due to the broad
approach we are now able to address general questions concerning gene expression
programs in different skin conditions. As part of the study, the gene expression of more than
270 individual biopsies of healthy skin, nevi, melanoma, and metastases thereof has been
analyzed. While hybridizations and data retrieval are still going on, a first analysis led to the
successful identification of disease specific marker genes. Selected gene groups revealed a
fine structure in melanoma expression profiles pointing at a molecular classification which
has to be further characterized. In addition, an extensive data analysis correlating clinical and
expression data has revealed a set of genes allowing an initial stage specific clustering.
Whether these genes are suitable for melanoma prognosis has to await the completion of
patients follow-up. The correlation of gene expression and follow up data will help to evaluate
the risk of metastases formation on basis of the primary tumour.
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Targeting of Dendritic Cells from Blood to Lymph Nodes by Transfer of RNA Coding for a
Functional Chimeric E/L-Selectin Molecule
Do¨rrie J1, Schaft N1, Mu¨ller I1, Beck V1, Ha¨nig J1, Oostingh G2, Scho¨n M2, Robert C3,
Ka¨mpgen E1, Schuler G1
1University Hospital Erlangen, Germany; 2Rudolf Virchow Center Wu¨rzburg, Germany;
3Institut Gustave Roussy Villejuif, France
To efficiently exert their immunogenic function, dendritic cells have to reach peripheral
lymphatic tissue, usually peripheral lymph nodes. In contrast to T-lymphocytes, unmodified
monocyte-derived dendritic cells are unable to extravasate from the bloodstream into the
lymph-nodes. By RNA-transfection we manipulated human DC to express E/L-selectin, a
chimeric protein consisting of the extracellular domain of E-selectin and the transmembrane-
and intracellular domain of L-selectin. The transfection-efficiency was490%, and surface-
expression could be detected for more than 48 h. E/L-selectin-transfection did not alter the
expression of the surface markers CD25, CD80, CD83, CD86, HLA class I and class II. E/L-
selectin transfected DC displayed the same CCR7-mediated migratory capacity and, when
co-electroporated with MelanA RNA, expanded MelanA-specific T cells like DC transfected
with MelanA RNA alone. Importantly, in contrast to mock-transfected DCs, the E/L-selectin
transfected cells attached to and rolled on glass slides coated with sialyl lewisX, L-selectin’s
natural ligand, in a parallel plate flow chamber assay.
The presented method is suitable for clinical application, since no genetic manipulation or
viral transformation is involved, and allows intravenous injection of the DC-vaccine for
targeting of all peripheral lymph-nodes. This novel approach should make DC-vaccination
easier and hopefully more efficient.
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Rapid Anergy of CD8þT Cells in Draining Lymph Nodes by Cross Presentation of
Melanoma Antigens: Reversal by Tumor Removal
Preynat-Seauve O1, Contassot E1, Schuler P1, Nonda A2, French L1, Huard B1
1Geneva University Hospital, Switzerland; 2Lausanne University, Switzerland
Despite increasing evidence for tumor cell antigenicity, interactions between melanoma and T
lymphocytes remain poorly understood. In the present work, we analyzed the in vivo
spontaneous presentation of a model neo-antigen, ovalbumin (OVA), expressed by sub-
cutaneously growing B16 melanoma. OVA cross-presentation to CD8þ T cells was
detectable in draining lymph nodes of mice bearing sub-cutaneous B16-OVA melanomas.
OVA cross-presentation triggered robust CD8þ T cell proliferation without any induction of
cytolytic effector function. CD8þ T cells accumulated in draining lymph nodes and were
rapidly anergized. Indeed, in vivo re-stimulation with OVA peptide in a strong adjuvant
revealed an incapacity of OVA-specific CD8þ T cells to re-proliferate and mediate effector
functions, including IFN-g secretion and migration to the tumor site. The abortive CD8þ Tcell
response was associated with a lack of OVA-specific helper CD4þT cells in tumor-bearing
animals. Strikingly, the anergic state was dependent on the tumor presence, since IFN-g
secretion could be recovered after tumor resection followed by vaccination. By contrast,
persistent CD8þ T cell anergy was observed in mice with relapsing tumors. Our data indicate
that, for a murine melanoma, CD8þ T cells are cross-anergized. Accumulation of anergic
T cells upon tumor development may explain the frequently reported and paradoxical co-
existence of tumor-specific CD8þ T cells and uncontrolled tumor growth in cancer patients.
This anergy induced in draining lymph nodes may protect lymph colonizing melanoma cells
from T cell cytotoxicity and hence favor metastasis, a frequent event associated with bad
prognosis in patients. Importantly, the anergic state depends on tumor presence,
strengthening the idea that T cell targeted tumor vaccination should be applied after tumor
removal.
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CD11cþ Dendritic Cells Cooperate with Regulatory T Cells for Prevention of Toxic
Epidermal Necrolysis
Azukizawa H, Sano S, Kosaka H, Itami S, Katayama I
Dept of Dermatology, Osaka University, Japan
To analyze immunoregulation of autoreactive T cells specific for epidermal skin antigens, we
crossed transgenic mice expressing ovalbumin (OVA) selectively in keratinocytes under the
keratin 5 promoter (K5-mOVA) with mice expressing a Kb-restricted OVA-specific T cell
receptor transgene (OT-I). We have already reported that OT-I cells developed extrathymically
in athymic double transgenic (dTg) mice, initiated severe epidermal damage mimicking toxic
epidermal necrolysis (TEN) at 8-12 weeks of age. In contrast, euthymic dTg mice showed
thymic deletion of OT-I cells, had few of these cells in the periphery, and never develop skin
changes mimicking TEN. Here, we tried in vivo depletion of CD4þ T cells in euthymic dTg
mice. Intraperitoneal administration of anti CD4 mAb (GK1.5) resulted in the skin disease
mimicking TEN at 10-13 days after injection. Furthermore, we confirmed that CD4þCD25þ T
cells, not CD4þCD25 T cells, were necessary for preventing the skin disease. We have
previously demonstrated that irradiated K5-mOVA mice developed skin disease mimicking
TEN by adoptive transfer of OT-I cells. We transferred CD4þCD25þ cells or CD4þCD25
cells purified from K5-mOVA mice to 8Gy-irradiated K5-mOVA mice at 10 days in advance of
transferring OT-I cells. Unexpectedly, each of them could not prevent the skin disease. Then,
we transferred CD4þCD25þ cells or CD4þCD25 cells with CD11cþ dendritic cells purified
from K5-mOVA mice into irradiated K5-mOVA mice at 10 days in advance of transferring OT-I
cells. Although pretreatment by CD11cþ cells alone or by coinjection of CD4þCD25 cells
with CD11cþ cells never affected the skin disease, coinjection of CD4þCD25þ cells with
CD11cþ cells prevented the disease. These results suggested that thymus-derived
regulatory T cells cooperate with CD11cþ dendritic cells to prevent life-threatening skin
damage such as TEN.
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IgE Is a Negative Regulator of Toll-like Receptor-2-Dependent, Immediate-Type
Hypersensitivity Reactions Mediated by Mast Cells
Mizukawa Y, Shiohara T
Dept of Dermatology, Kyorin University School of Medicine, Japan
Historically, mast cells have been regarded as key effector cells in the elicitation of IgE-
dependent immediate-type hypersensitivity reactions (ITR). Mast cells also can be important
as initiators and effectors of innate immunity. Because full activation of inflammatory
responses by Toll-like receptors (TLR) requires the assembly of receptor signaling complexes,
TLR-mediated mast cell activation might be sensitive to modulation by simultaneous ligation
of other membrane molecules, such as cross-linking of FceRI. In this study, we therefore
asked whether cross-linking of FceRI on mast cells could have a strong impact on TLR-
mediated inflammatory responses. We previously demonstrated that repeated elicitation of
contact hypersensitivity (CH) in the ear resulted in the development of IgE-dependent,
hapten-specific ITR mediated by mast cell degranulation. Surprisingly, however, when elicited
with hapten in the footpad, IgE-independent, TLR-2-dependent ITR mediated by mast cell
degranulation emerged, because the ITR uniquely elicited in the footpad was never observed
in mast cell deficient W/Wv mice and TLR2/ mice. A marked increase in the ITR occurred in
B cell deficient (mMT) mice, which lack IgE, but not in IL-4/ mice, indicating an inhibitory
role of IgE. In contrast, the ITR was dramatically reduced in the footpad of TNP-IgE
transgenic mice. Reconstitution of the footpad skin of W/Wv mice with bone marrow-derived
mast cells from wild-type mice, but not from TLR2/ mice, rendered these otherwise
unresponsive mice susceptible to the development of the ITR. When bone marrow-derived
mast cells were pretreated with TNP-specific IgE before adoptive transfer, the reconstituted
mice failed to develop hapten-specific ITR on the footpad. These results support our
hypothesis that IgE/FceRI pathway may have arisen late in phylogeny and evolved to limit the
potentially harmful effects of innate immune responses.
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Distinct FOXP3þCD4þCD25þRegulatory T Cell Subsets Suppress Activation of Human
Effector T Cells
Garaczi E, Ferenczi K, Yan C, Goodman W, Cooper KD, Mccormick TS
Case Western Reserve University, USA
Naturally occurring regulatory T cells (Treg) are critical for maintaining a fine balance between
beneficial and harmful autoreactive T cell responses. Although the high expression of CD25 and
FOXP3, a master control gene in regulatory T cell function, is characteristic of CD4þTreg cells,
regulation of effector cell response is not exclusive to the CD25highþ cell population. High-
speed flow-cytometry sorted normal human peripheral CD25highþT cells (  1% of CD4þT
cell population) expressed significantly higher levels of FOXP3 mRNAs as compared to
simultaneously sorted CD25midþ , CD25lowþ and CD25- cell populations. The
CD25highþpopulation was anergic and developed a strong suppressive response in a cytokine
independent manner in vitro, all characteristic features of Treg cells. Interestingly, FOXP3 mRNA
was also upregulated in the CD25midþT cell population (2–3% of CD4þT cells).
CD25midþcells potently suppressed the IL-2 production of CD25- effector T cells, but differed
from CD25highþTreg cells in their degree of anergy. We found a significantly lower expression of
CD45RO, HLA-DR and CD71 in CD25midþ versus CD25highþcells, also indicating a distinct
subset of Treg cells. IL-2 has been shown to play a key functional role in the induction of potent
suppressor Treg cells. IL-2 mediated activation of human CD25highþ and CD25midþTreg cell
subsets resulted in a significant increase of FOXP3 mRNA expression in both groups.
Furthermore, Western blot analysis of the combined CD25highþ and CD25midþTreg popula-
tions showed increased FOXP3 protein production upon TCR stimulation with IL-2; thus, FOXP3
is a highly sensitive marker of Treg activation. Our results suggest that CD25highþ and
CD25midþcells represent distinct subsets of regulatory T cells. Whether these populations
represent various maturation stages of the same cell lineage remains to be definitively shown.
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Cutaneous Antigen Administration Primes Speciﬁc CD4þT Lymphocytes for Speciﬁc
Migration to the SALT
Glocova I, Ro¨cken M, Ghoreschi K
Dept of Dermatology, Eberhard Karls University Tu¨bingen, Germany
Tissue-selective imprinting and homing of antigen specific T lymphocytes plays an important
role in the pathogenesis of contact hypersensitivity and possibly also atopic dermatitis. Yet the
mechanisms of site-specific imprinting remain enigmatic. Here, we analyzed migration and
homing of ovalbumin (OVA) Tcell receptor (TCR) transgenic T lymphocytes. T lymphocytes were
either naive, activated by subcutaneous application of OVA in Complete Freund’s adjuvant
(CFA) or T lymphocytes were activated in the context of protein contact hypersensitivity.
Adoptive transfer of naive OVA-TCR transgenic CD4þ T lymphocytes into naive BALB/c mice
lead to random distribution in all lymphoid organs of the recipient. Subcutaneous priming of
these T lymphocytes with OVA peptide in CFA resulted in specific enrichment of OVA-TCR
transgenic CD4þ T lymphocytes, selectively in the draining lymph node. Following activation,
antigen-specific T lymphocytes showed a lower expression of L-selectin and P-selectin ligand
(P-lig) on OVA-TCRþ T lymphocytes after homing. Distant lymph nodes did not show significant
accumulation of OVA-TCRþ T lymphocytes. In sharp contrast, transfer of T lymphocytes
primed by epicutaneous peptide application showed selective migration predominantly into all
skin draining lymph nodes and not into other lymphoid organs. These skin primed T
lymphocytes also expressed lower levels of L-selectin and P-lig after OVA-peptide challenge.
Importantly, these T lymphocytes did not only migrate to the skin draining lymph nodes. They
had also acquired and preserved the capacity to cause protein-contact dermatitis upon
epicutaneous challenge with OVA-peptide. Thus, epicutaneous antigen-application may
instruct T lymphocytes to home preferentially into the skin associated lymphoid tissue (SALT)
and to cause allergic contact hypersensitivity reaction.
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T Cells Repertoire, Phenotype and Functionality in Drug Hypersensitivity Syndrome
Picard D, Janela B, Jacquot S, Dutot I, Tron F, Joly P, Musette P
Dept of Dermatology, INSERM59, Rouen, France
The drug hypersensitivity syndrome (DHS) or DRESS (Drug Reaction with Eosinophilia and
Systemic Symptoms) is a severe hypersensitivity reaction associated with visceral
manifestations. The immunological mechanisms involved are still poorly understood. We
propose to characterize the repertoire, phenotype and the functionnality of T cells in DHS.
30 patients with DHS were included in our study. CD4þand CD8þT cells were separated
from PBMC using positive selection on MACS columns. A T lymphocyte repertoire analysis was
performed with the immunoscope technique using Vb and Cb specific primers. Lymphocyte
phenotype (activation markers: CD25, CD68, CD134, CD45RO, HLA DR; cutaneous homing
receptors: CLA, CCR4; apoptosis marker: FasL) and cytokine secretion (IL2, IL5, IFNg, TNFa,
IL4, IL8, IL13 and IL10) were analysed by FACS on blood samples collected at D0, D30, D90,
and D360. Immunoscope analysis permitted to detect repertoire bias (i.e. non Gaussian
distribution) corresponding to expanded lymphocyte population within a particular Vb family, a
flow cytometry analysis with an anti-Vb antibody was performed in a second time to
characterize the phenotype and the cytokine secretion profile of the expanded population. In
order to study the modifications of gene expression in DHS, we performed a DNA micro-array
analysis of 901 genes expressed in PBMC for 2 patients with DHS induced by carbamazepine
and 1 by minocycline. Gene expression profiles were compared with PBMC from 3 healthy
donors and 4 patients taking carbamazepine without hypersensitivity reaction. Immunoscope
analysis reveals repertoire bias in all the patients, preferentially among the CD8þ subset. A
common pattern of TCR is found in 3 patients with carbamazepine induced DHS.
T cells presented an activated phenotype (CD25, CD69,CD38, HLADR), more remarkable
within the CD8þ subset. Expression of these markers decreases between D0 and D90.
CD4þ and CD8þ cells overexpress cutaneous homing markers at the early stages of the
disease. The cytokine profiling of CD4þT cells is Th1 orientated, and the proportion of
CD4þ and CD8þT cells secreting IFNg and TNFa increases between D0 and D90, which may
be an explanation for relapses when corticotherapy is decreased in this period. The analysis of
CD8þ expanded populations with anti-Vb antibody showed that these cells express higher
levels of activation markers and secrete higher levels of IFNg, TNFa and IL2.
Gene expression analysis with micro-arrays confirms the results obtained by FACS analysis. A
same profile was obtained when two different medications are responsible of DHS. 54 gene
transcripts are upregulated at D0, playing function in cell activation, signal transduction,
apoptosis, cutaneous homing and inflammation. In addition TNFa Receptor is down regulated at
D90. Quantitative PCR analysis confirms these results.
In DHS, the CD8þT cells population is predominantly activated, and include oligoclonal
expansions. A high proportion of CD8þTcells secretes TNFa, IFNg and IL2. Moreover, cytokine
profiling of CD4þ cells is Th1 orientated.
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Toll-like Receptor 9 is Required for the Anti-Nucleosome Production in Lupus Prone Mice
Lartigue A, Courville P, Arnoult C, Tron F, Gilbert D, Musette P
Dept of Dermatology, INSERM59, Rouen, France
Lpr/Lpr mice are widely used as an animal model for human systemic lupus (SLE). SLE is
characterized by nephritis and vasculitis associated with the production of antibodies
directed against nucleosome and dsDNA which correlate with the disease activity.
Nevertheless the origin of these antibodies and their importance in the development of
glomerulonephritis and vasculitis still remains a matter of debate. Toll-like receptors 9 (TLR9)
which bind bacterial DNA via unmethylated CpG sequences are thought to play a role in the
response to DNA and in the pathogenesis of SLE. We sought to determine this role by
creating C57BL/6.lpr/lpr.TLR9/ mice and analyzing their phenotype in term of lymphade-
nopathy, autoantibody production and renal injury. C57BL/6.lpr/lpr were crossed with C57BL/
6TLR9/ mice in order to obtain ten C57BL/6.lpr/lpr.TLR9/ mice. Ten C57BL/6.lpr/lpr
were used as control population. A clinical score including hair loss, vasculitis, lymph node
enlargement was used for the clinical assessment of each group. In addition urinary protein
was collected. Anti nucleosome, anti-DNA, were measured each month by ELISA. The
phenotype of T cells were analyzed by FACS. Mice were sacrified at 6 months and renal
histology was performed. Our study show that B6.lpr.TLR9/ presented a massive
lymphadenopathy and splenomegaly, with mean spleen and lymph node weights significantly
heavier than in the TLR9 KO group, associated to the expansion of CD4- CD8- double
negative T cells. Concerning lupus-like autoimmunity, the B6.lpr.TLR9/ seroprofile was
very different compared with B6.lpr since ANAs, as well as anti-nucleosome antibodies
remained negative until 6-month-old, the age at which all mice were sacrified. In contrast,
anti-ss and dsDNA, anti-CL antibodies and rheumatoid factor did not differed between the
two mouse strains and despite a delayed proteinuria in TLR9-KO, the renal disease was
similar in term of histoligical lesions and immune complexe deposits in both group.
All these results clearly demonstrate that TLR9 receptors are absolutely required for the
anti-nucleosome response observed in lupus disease moreover anti-nucleosome are involved
in the onset of the renal injury.
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Activated Platelets are Critically Involved in the Pathogenesis of P-selectin Dependent
Cutaneous Inﬂammatory Responses
Ludwig R1, Gille J1, Schulze Johann P1, Podda M1, Kafmann R1, Zollner T2, Boehncke WH1
1Dept of Dermatology, Klinikum der J.W. Goethe Universita¨t, Frankfurt am Main, Germany;
2RBA Dermatology, Berlex Biosciences, Germany
Injury of the vessel wall leads to activation of coagulation, which triggers immune responses.
Since injury bears the risk of infection, this may be beneficial. However, a pro-coagulant state
may have an implication in disease. We had shown, that activated, not resting platelets form
platelet-leukocyte aggregates in the bloodstream, leading to an increased leukocyte rolling.
These interactions were predominantly P-selectin dependent. We thus hypothesised, that
platelets contribute to leukocyte extravasation in P-selectin-dependent cutaneous inflam-
matory responses. To challenge this, a contact hypersensitivity (CHS) reaction using DNFB or
oxazolone was elicited in wildtype or P-selectin deficient mice. In accordance with published
data, P-selectin deficiency had no influence on oxazolone induced CHS. In contrast P-
selectin deficiency lead to a reduction in ear swelling and infiltration in mice challenged with
DNFB. Therefore, these models of CHS are different. Further experiments to determine the
contribution of platelets to pathogenesis of cutaneous inflammation were performed with
DNFB: Induction of thrombocytopenia before challenge lead to a reduced CHS response in
wild type mice. To analyse the impact of platelet P-selectin on development of a CHS
response, we infused thrombocytopenic mice with resting or activated platelets. To exclude,
that platelet derived mediators (serotonin) have an impact on ear swelling, platelets were
depleted of serotonin and recipient mice were additionally treated with a serotonin-
antagonist. In comparison to controls, ear swelling in mice receiving resting platelets was
similar to thrombocytopenic mice. Ear swelling responses were restored in mice infused with
activated platelets. To clarify the role of platelet P-selectin in cutaneous inflammation, we
generated mice deficient for platelet P-selectin while still expressing endothelial P-selectin
using bone marrow transplantation. Eliciting a CHS response in these mice using DNFB,
showed a decrease in ear swelling compared. In summary, platelet P-selectin expression
must be considered important effector cells of the (skin) immune system.
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Mast Cells induce Aberrant Angiogenesis in a Model of Psoriasis Arthritis
Hu¨ltner L1, Kneilling M2, Pichler BJ2, Mailhammer R2, Haubner R2, Morawietz L3, Krenn V3,
Illges H4, Weber WA5, Ro¨cken M2
1GSF, Germany; 2Eberhard Karls University, Tu¨bingen, Germany; 3Humboldt University,
Charite`, Berlin, Germany; 4University of Konstanz, Germany; 5University of California, Los
Angeles, USA
Auto-antibodies against glucose-6-phosphate isomerase (GPI) induce arthritis in mice, that
closely resembles rheumatoid or psoriatic arthritis. As mast cells are important amplifiers of T
cell-dependent and T cell-independent inflammation, and can produce mediators involved in
angiogenesis, we studied whether mast cells influence neoangiogenesis, a hallmark of
psoriasis arthritis and rheumatoid arthritis. Comparing wild type mice, mast cell-deficient
kitW/W-v mice and mast cell-reconstituted kitW/W-v mice, we found that mast cells were
essential for pannus formation and neoangiogenesis, and integrin avb3-expression on newly
built vessels during GPI-arthritis. This was confirmed by in vivo-quantification of activated
avb3 integrin using radio-labelled RGD-peptide and positron emission tomography. Despite
the lack of major inflammation and tissue destruction molecular analysis showed surprisingly,
little or no reduction of proinflammatory cytokines in mast cell-deficient kitW/W-v mice
compared to wild type mice. As these data suggested that preformed mediators released by
mast cells may cause inflammation and tissue destruction we induced GPI arthritis in mice
treated with mast cell stabilizers. Inhibition of mast degranulation almost completely
prevented avb3-activation, angiogenesis, and tissue destruction. These data unravel a
critical role of mast cells and mast cell-derived mediators in a model of psoriasis arthritis.
Thus, inhibition of mast cell-degranulation may not only attenuate symptoms of allergic
diseases but also the damages leading to psoriasis arthritis including neovasularization and
scar formation.
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Cell Volume Regulation by the Taurine Transporter TAUT Determines T Cell Survival
Sobiesiak M1, Kneilling M2, Lang PA1, Lang K1, Wieder T1, Heller-Stilb B3, Warskulat U3,
Ha¨ussinger D3, Lang F1, Biedermann T2
1Department of Physiology; 2Dermatology; 3Internal Medicine, University of Tu¨bingen,
Germany
Cell volume regulation is an intermediate step in the process of apoptosis. Among these
regulators is the cellular accumulation of organic osmolytes including the -amino acid
taurine. Cellular taurine release immediately precedes DNA fragmentation and phosphati-
dylserine exposure and the carrier accomplishing concentrative cellular uptake of taurine is
the taurine transporter TAUT. Analysis of taut/ mice revealed no differences in blood,
lymph node, or spleen CD19þ B cells compared to wild type littermates (tautþ /þ ). However,
CD4þ and CD8þ T cells were markedly decreased in taut/ as compared to tautþ /þmice
in peripheral blood and spleen but not in lymph nodes from naı¨ve mice. Most interestingly,
activated CD69þ CD4þ and CD69þ CD8þ T cells were significantly decreased in spleen
cells from taut/ mice. Therefore, lymph node analysis was performed in mice sensitized
with trinitrochlorobenzene (TNCB) to elicit contact hypersensitivity. In contrast to naı¨ve taut/
 mice, TNCB sensitized taut/ mice showed reduced T cell numbers within skin draining
lymph nodes after challenge with TNCB indicating a specific role for TAUT in activation
induced cell death of T cells. Indeed, enhanced exposure of phosphatidylserine in CD8þ T
cells from taut/ as compared to tautþ /þmice pointed to enhanced apoptosis of those
cells. Moreover, in vitro activation of tautþ /þ and taut/ CD8þ T cells resulted in
significantly increased numbers of annexinþ taut/ CD8þ T cells and 24 hours after
activation only 20% of taut/ T cells were still viable. The present observations point to a
functional significance of concentrative taurine uptake for the survival of both CD4þ and
CD8þ T cells, especially after activation. Thus factors regulating cell volume of T cells like
TAUT may contribute to the selection of memory T cells in contrast to activated T cells
undergoing apoptosis.
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In Vivo Transduction of ‘‘Steady State’’ Dendritic Cells with a T Cell Inhibitory Peptide
Leads to Suppression of Regulatory T Cells and Enhanced Anti-Melanoma Immunity
Mahnke K1, Storn V1, Schallenberg S1, Brueck J2, Enk A1
1University of Heidelberg, Germany; 2University of Tu¨bingen, Germany
We have recently shown that anti-DEC-205 antibodies (aDEC) target to dendritic cells (DCs)
after s.c. injection into mice. To utilize this unique targeting for selective in vivo gene transfer,
we generated recombinant adenovirus encoding for a suppressive T-cell receptor mimic
peptide (AdTCRpep) and coupled this adenovirus to aDEC antibodies. Upon injection into
mice we could show that aDEC-AdTCRpep conjugates specifically transduced CD11cþ DCs
in the lymph node. Since DCs in the steady state preferentially interact with CD25þ regulatory
T cells (Treg), we reasoned that the majority of T-cells affected by AdTCRpep transduced DCs
in vivo are Tregs. Therefore we isolated CD25þ T-cells from aDEC-AdTCRpep injected mice
and analyzed their regulatory capacity. Here we could show that Treg from injected mice
failed to inhibit proliferation of allogeneic T cells, indicating suppression of their regulatory
function. Moreover, in a contact hypersensitivity (CHS) model, injection of the aDEC-
AdTCRpep conjugates augmented ear swelling reactions, presumably via the suppression of
CD25þ Tregs as indicated by down regulation of the FoxP3 mRNA in CD25þ cells. In order to
test the effect of aDEC-AdTCRpep induced Treg suppression on immunity in a B16
melanoma model, we treated mice with aDEC-AdTCRpep conjugates and challenged for
tumor growth thereafter. In these experiments tumor growth was substantially slowed in
conjugate treated mice as compared to untreated controls. Thus these data indicate that
suppression of regulatory T cells in vivo counteracts their immunosuppressive function and
turning off the ‘‘regulators’’ may be a future goal for the improvement of vaccination
strategies.
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IL-10-Modulated Tolerogenic Human Dendritic Cells as Inducers of Anergic Regulatory T
Cells Display a Distinct Expression Pattern of Molecules of the B7 Family
Adler HS, Graulich E Main, Knop J Main, Steinbrink K Main
Dept of Dermatology, University of Mainz, Germany
Human IL-10-treated dendritic cells (IL-10DC) induce antigen-specific anergic CD4þ T cells
with regulatory activity, partially mediated by CTLA-4. In this study, we screened for surface
expression of members of the B7 family (B7-1, B7-2, B7-H2, B7-H3, PD-L1, PD-L2) on human
immature, mature and IL-10-treated DC. DC were generated from peripheral progenitor cells
by treatment with IL-4 and GM-CSF for 6 days (immature DC). Maturation was induced by IL-
1-beta, IL-6, TNF-alpha and PGE2 together with IL-4 and GM-CSF for another 2 days (mature
DC), or additional IL-10 (IL-10DC). B7-2 (CD86), B7-H3 and PD-L1 were expressed on
immature dendritic cells (495%) whereas expression of B7-1/CD80 and PD-L2 (o40%) was
low. FACS analysis demonstrated upregulation of all B7 family members during maturation.
The presence of IL-10 during maturation strongly reduced the surface density of B7-2/CD86
and of B7-1(CD80), yet B7-H3, PD-L1 and PD-L2 only to a minor extent, while still being
present on495% of IL-10DC. In contrast to the other members of the B7 family, B7-H2/
ICOSL expression was barely detectable on DC after treatment with IL-10. In addition,
blocking experiments with mAb to B7-1 and B7-2 demonstrated that signaling events
mediated by B7-2 but not of B7-1 are involved in the induction of anergic regulatory T cells.
Thus molecules of the B7 family show a distinct expression pattern on immature, mature and
IL-10-modulated dendritic cells. IL10-DC are characterized by a reduced cell surface density
of all members of the B7 family as compared to mature DC. These data suggest that the
relative cell surface expression and the binding affinity of the members of the B7 family
contributes to the final effect on T cell differentiation and activation.
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Natural Killer Cells Accelerate Tissue Destruction in Autoimmune Disease
Weigert CM, Ghoreschi K, Yazdi A, Ro¨cken M
Dept of Dermatology, Eberhard Karls University Tu¨bingen, Germany
To study the role of autoreactive Tcells in the development of autoimmune tissue destruction,
we used a mouse model of autoimmune pancreatitis: 415-EL-I-E C57BL/6 transgenic mice
express a ‘non-self’ MHC II I-E exclusively on the exocrine pancreas. T cell reactivity to this
‘‘autoantigen’’ is associated with T cells expressing T cell receptor (TCR) vb5 chains. In 415-
EL-I-E mice 4% of the CD4þ T cells express TCR vb5 chain. While in some animal facilities
415-EL-I-ExC57BL/6 mice remain healthy in others they develop inflammation and
destruction specifically of the exocrine pancreas. Stable blood glucose levels demonstrate
that the endogenous pancreas remains healthy. Surprisingly, crossing 415-EL-I-E mice to T
cell deficient Rag2/ mice did not protect from autoimmune pancreatitis. For this reason we
investigated an implication of ‘Natural Killer’ (NK) cells in the pathogenesis of this
autoimmune pancreatitis. NK cells were depleted by once weekly injection of anti-asialo
GM1 antibody. After five to six weeks we analyzed the pancreas of NK cell-depleted and
sham treated mice. Sham treated littermates showed a significantly reduced pancreas weight
in contrast to NK cell-depleted mice, demonstrating the loss of pancreas tissue. Histology
showed mononuclear cells infiltrating the pancreas of treated and untreated mice. NK cell-
depleted mice revealed a more peri-pancreatic infiltrate while in sham treated mice the
infiltrate focused to peri-vascular regions and the acini. On histology, destruction of the
exocrine pancreas tissue resulted in high density of Langerhans’ islets due to loss of inter-
islet tissue; in NK cell-depleted mice Langerhans’ islets were at lower density, showing the
preservation of exocrine pacncreas. Thus, NK cells might not only be involved in clearance of
viruses and tumors but significantly contribute to tissue damage in T cell-mediated
autoimmune disease.
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Contact Hypersensitivity to FITC Induces IgE and a Th2 to Th1 Cytokine Shift Typical for
Atopic Dermatitis
Chen K, Kaesler S, Volz T, Werner M, Kneilling M, Ro¨cken M, Biedermann T
Department of Dermatology, University of Tu¨bingen, Germany
Haptens such as trinitrochlorobenzene (TNCB) or oxazolon (Oxa) induce contact hypersen-
sitivity (CHS) reactions mediated by interferon-g (IFN-g) producing CD4þ and CD8þ T cells.
To evaluate the CHS model with the hapten fluorescein isothiocyanate (FITC), we defined an
effective sensitization protocol, the resulting immunological phenotype, and the expression
dynamics of typical Th1 and Th2 cytokines. To this end, BALB/c mice were sensitized with
FITC over 1-3 weeks with one or two sensitizations/week. While TNCB or Oxa were effective
after one single application, FITC elicited significant ear swelling responses only in mice
sensitized 2x/week in the three-week protocol. Interestingly, FITC-CHS responses showed a
biphasic pattern of cutaneous inflammation: an immediate phase maximal at 45 minutes and
a delayed type reaction peaking at 24-48 hours. Intracytoplasmic FACS of skin draining
lymph nodes revealed both IL-4þ and IFN-gþ CD4þ T cells. Moreover, ELISA of FITC-
specific immunoglobulin levels detected high levels of FITC-specific IgE in sensitized mice
only, indicating a functional relevance of FITC-specific IL-4 production. To further
characterize a functional role of IL-4, dynamic cytokine expression was analyzed by real
time PCR from lesional skin after exposure to FITC. Interestingly, IL-4 mRNA expression
reached a peak at 12 hr, whereas IFN-g levels increased at later time points dominating that of
IL-4 at 48 hr. Taken together, FITC-CHS like atopic dermatitis is associated with Th2 cells,
antigen specific IgE, and an early phase of inflammation with IL-4 expression that is followed
by a second IFN-g dominated phase, a pattern found in atopy patch test lesions. Therefore,
FITC-CHS is a suitable model to study the regulation of cytokine expression pattern, the
functional role of IL-4 for cutaneous inflammation, and the Th2-Th1 regulation that is seen in
atopic dermatitis.
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Sensitization Via the Skin Leads to Th2 Dominated Antigen Speciﬁc Immunity and
Antigen Speciﬁc Dermatitis
Kaesler S, Volz T, Chen KM, Werner M, Ro¨cken M, Biedermann T
Dept of Dermatology, University of Tu¨bingen, Germany
Patients suffering from Atopic Dermatitis (AD) show Th2-responses against ubiquitous
environmental allergens and allergen spreading is characteristic for an atopic career. One
hypothesis claims that sensitization via the skin is a crucial underlying mechanism of allergen
spreading and AD. We therefore wanted to compare the outcomes of systemic sensitization
with sensitization via the skin. BALB/c mice were exposed to ovalbumin (OVA) either
epicutaneously (EC) by repetitive applications or systemically (IP) by consecutive i.p.
injections with OVA. Analysis revealed that only EC- but not IP-sensitized mice developed a
Th2-phenotype. Exclusively in EC-sensitized mice, OVA-specific cutaneous anaphylaxis and
urticarial ear swelling, and high titers of OVA-specific IgE but low levels of Th1-associated
OVA-specific IgG2a were detected. In contrast, IP-sensitized mice showed only mild or no
reaction in cutaneous anaphylaxis test, and had high OVA-specific IgG2a and no OVA-
specific IgE. We then examined OVA-specific dermatitis. To that end, DO11.10 mice carrying
an OVA-specific transgenic T-cell-receptor were EC treated. In sensitized mice OVA
application provoked severe skin inflammation with strong cellular infiltration. The
pathogenetic role of OVA-specific Th2 cells for skin inflammation was proven by adoptive
transfer experiments into ear skin of naive mice. Only application of Th2 cells together with
OVA (Th2/OVA) induced strong ear swelling responses, but not Th2 cells or OVA alone. In
summary we found that sensitization via the skin is sufficient to elicit Th2 responses to protein
antigens thus indicating a possible mechanism of allergen spreading in atopic dermatitis
patients. Moreover, antigen-specific Th2 cells can elicit antigen-specific immune reactions in
the skin facilitating allergen uptake, sensitization and entering the vicious circle of allergen
spreading and the atopic march.
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Structural Requirements and Mechanism of Antimicrobial Activity of Dermcidin-Derived
Peptides
Steffen H1, Rieg S1, Kalbacher H2, Wiedemann I3, Sahl Hg3, Theil A1, Peschel A4, Garbe C1,
Schittek B1
1University Clinical Center of Tu¨bingen, Germany; 2Medical and Natural Sciences Research
Center, University of Tu¨bingen, Germany; 3Institute for Pharmaceutical Microbiology, Bonn
Germany; 4Medical Microbiology and Hygiene Department, University of Tu¨bingen,
Germany
Dermcidin (DCD) is a recently described antimicrobial peptide, which is constitutively
expressed in eccrine sweat glands and transported via sweat to the epidermal surface. By
postsecretory proteolytic processing in sweat the dermcidin protein gives rise to several
truncated DCD-peptides with different biochemical properties and yet unknown functional
activities. In this study we analyzed a) the spectrum of activity and b) the mechanism of
antimicrobial activity of several naturally occurring DCD-peptides which differ in length and
charge. Using circular dichroismus measurements we show that irrespective of charge the
DCD-peptides adopt an a-helix in helix-inducing solvents. Interestingly, the different DCD-
peptides have a diverse and partially overlapping spectrum of activity. Furthermore, we
investigated the mechanism of antimicrobial activity of DCD-peptides using carboxyfluor-
escein-loaded liposomes, membrane permeability studies and electron microscopy
examinations. Using all three methods we could not detect damage or pore formation of
the bacterial membrane by different DCD-peptides. In contrast, immune-EM studies
suggested that DCD-peptides bind to the bacterial membrane. These studies indicate that
irrespective of their charge DCD- peptides do not act by membrane desorption or pore
formation, but probably by receptor interaction on the bacterial membrane.
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FAS Mediates Lymphocyte Induction of Psoriasis
Gilhar A1, Kam Y1, Aasi B1, Kalish R2
1Faculty of Medicine, Technion,Haifa, Israel; 2Stony Brook University, New York, USA
Fas/FasL signaling is best known for induction of apoptosis. However, there is an alternate
pathway of Fas signaling that induces inflammatory cytokines TNF-alpha and IL-8, both of
which are prominent in psoriasis. This pathway may predominate in cells that express high
levels of anti-apoptotic molecules (e.g. Bcl-xL). Psoriatic epidermis has a low apoptotic index
with elevated Bcl-xL. This resistance to apoptosis in psoriatic epidermis may result from
increased epidermal expression of STAT3 which is known to induce Bcl-xL and resistance to
Fas mediated apoptosis. It was hypothesized that Fas mediates induction of psoriasis by
activated FasL positive lymphocytes. Non-involved skin from psoriasis patients was grafted
to beige-SCID mice and psoriasis was induced in the grafts by injection of FasL positive
autologous NK cells activated by IL2. Psoriasis histology was induced in (9/9) positive control
grafts. Blocking anti-Fas mAb (ZB4) which does not induce apoptosis or anti-FasL mAb were
injected IV on days 3 and 10 after NK-cell injection in 2 additional groups of 8 mice. Injection
of blocking anti-Fas or anti-FasL mAb prevented induction of psoriasis histology in all (8/8)
grafts for both groups. Anti-Fas mAb significantly (po0.01) inhibited epidermal proliferation
(Ki-67), and thickness. Epidermal expression of TNF-alpha, IL-15, HLA-DR, and ICAM-1 were
also inhibited by blocking anti-Fas mAb. Fas/FasL signaling is an essential early event in the
induction of psoriasis by activated lymphocytes and may provide the link between epidermal
expression of STAT3 and psoriasis.
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Coordinate and Sequential Expression of Fucosyltransferases, FucT-4 and FucT-7,
Regulates Skin-homing CD4þT Cell Differentiation
Takahashi R, Mizukawa Y, Shiohara T
Dept of Dermatology, Kyorin University School of Medicine, Japan
Two fucsyltransferases (FucTs), FucT-4 and -7, represent the leading candidates for
controlling lymphocyte homing into the inflamed skin. Although it has been suggested that
FucT-4 serves as an optional backup to FucT-7 for generation of E selectin ligands (ESL), little
is known concerning the dynamic balance between FucT-4 and -7 expression during skin-
homing T cell differentiation. We previously proposed the following lineage differentiation
model: the early activated ESLþCLA ! pre-terminally differentiated ESLþ þCLAþ
! terminally differentiated ESLCLAþ . We demonstrated here using transfectants that the
ESL generated by FucT-4 corresponded to that on the early activated T cells while that
constructed by FucT-7 corresponded to that on the pre-terminally differentiated T cells. We
next analyzed the temporal sequence of FucT-4 and -7 expression at the protein level during
in vitro differentiation. Surprisingly, at the early activation stage, both enzymes were detected
at similar frequencies in the presence of either IL-12 or IL-4. The cytokine milieu subsequent
to activation, however, had a strong impact on the expression of both FucTs. Upon transfer to
resting cultures with IL-12, FucT-4 was down-regulated while retaining FucT-7 expression,
which allowed the cell to express the FucT-7-dependent ESL, the pre-terminally differentiated
ESLþ þCLAþ . In contrast, transfer to resting cultures with IL-4 induced down-regulation of
FucT-7, but not FucT-4, thereby preventing their further differentiation. These results indicate
that skin-homing CD4þ T cells, when rested under appropriate cytokine conditions,
differentiate from FucT-4þ FucT-7þ to FucT-4 FucT-7þ , which is reflected in the appearance
of the pre-terminally differentiated ESLþ þCLAþ phenotype. Thus, the down-regulation of
FucT-4 represents a critical step of skin-homing T cell differentiation.
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Early Events in Regulation of Tregs Following Speciﬁc Immunotherapy
Hofbauer GF1, Welz R2, Kalkowski J2, Roll A1, Schmid-Grendelmeier P1, Blaser K2,
Schmidt-Weber C2
1Universita¨tsspital Zu¨rich, Switzerland; 2Schweizerisches Institut fu¨r Allergie und Asthma
Forschung, Davos, Switzerland
Specific immunotherapy (SIT) is known to induce regulatory T-cells, restoring peripheral
tolerance against allergens. However the mechanisms, which underlie and precede the
induction of Tregs are unknown. We therefore investigated expression of transcription factors
and cytokines before, 18 hours, 7 and 28 days after ultra-RUSH induction of hymenoptera
specific immunotherapy. To avoid culture artefacts, PBMC were lysed immediately after
separation of blood cells and subject to RT-realtime PCR. Surprisingly, FOXP3 expression,
but not t-bet or GATA-3 was increased 7 days following SIT. Some patients showed increased
IL-10 levels, which correlated with increased FOXP3 expression on day 7. In contrast
TGFbeta and IL-2 did not show any significant differences, however a clear tendency of
decreased IL-2 levels was observed as early as 18 hours following initiation of SIT. These data
demonstrate that SIT induces increased FOXP3 expression while leaving Th1- and Th2-
decisive signals t-bet and GATA-3 untouched. The decrease of IL-2 in many patients
suggests that SIT is accompanied by a phase of general immune suppression or the
immediate activation of FOXP3-negative Tregs. Ongoing studies are now focusing on the role
of innate immune components which associate with successful Treg induction.
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Blockade of a2b1 integrin inhibits psoriasis in a T cell independent manner
Tonel G, Conrad C, Nestle F
University of Zu¨rich, Switzerland
Psoriasis is a common inflammatory skin disease characterized by keratinocyte hyperpro-
liferation and increased dermal vascularity.
As integrin signaling plays a critical role in many aspects of normal growth, differentiation,
and injury response we focused our attention on the functional expression of a major
collagen-binding receptor, the integrin a2b1 (VLA-2).
We show that keratinocytes and dermal microvascular endothelial cells (DMVEC) express
VLA-2 and that its expression is altered in psoriatic lesions. Blockade of VLA-2 inhibits
keratinocyte hyperproliferation and angiogenesis in vitro. In vivo, anti VLA-2 antibodies
markedly inhibited keratinocytes hyperproliferation as well significantly reduced development
of psoriasis in a xenotransplantation mouse model of psoriasis. No expression of VLA-2 on T
cells could be detected during psoriasis development indicating a T cell independent
mechanism.
Taken together, these findings suggest that the pharmaceutical modulation of VLA-2 may
alter the course of disease in patients with psoriasis in a T cell independent manner.
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Single Stranded RNA Promotes Functional Maturation of Human Monocyte-Derived-
Interferon Dendritic Cells
Farkas A, Tonel G, Burg G, Nestle FO
University of Zu¨rich, Switzerland
In recent years dendritic cell (DC) vaccination became a promising therapeutic tool for cancer
immunotherapy. The numerous parameters which should be taken into account in DC
vaccination studies include the optimal DC source, type, maturation status and antigen
loading. Most of the vaccination studies were performed with monocyte-derived DCs (mo-
DCs) cultured in the presence of granulocyte/macrophage colony-stimulating factor (GM-
CSF) and interleukin-4 (IL-4) and matured in the presence of a cytokine cocktail and
prostaglandin E2 (PGE2) (referred as IL-4-DCs). Recent studies indicated that during the
generation of mo-DCs IL-4 can be replaced with interferon-alpha (IFN-alpha) and after 5 days
of culture a novel DC subset can be generated called IFN-DCs. IFN-DCs express a variety of
innate pattern recognition receptors including members of the Toll-like receptor (TLR) family
such as TLR8. Recent studies showed that immunostimulatory potential of single-stranded
RNA (ssRNA) is mediated through human TLR8. Therefore in this study we developed a
method to obtain fully mature IFN-DCs using ssRNA as maturation stimulus. We found that
ssRNA stimulation of IFN-DCs significantly improves their co-stimulatotry molecule
expression, phenotype stability, naı¨ve T cell promoting capacity and enhances their TNF-
alpha and IL-10 production. Under our experimental conditions IFN-DCs were not capable of
producing bioactive IL-12 but on the mRNA level IFN-DCs produced IL-23 and IL-27 which
could be further enhanced with ssRNA stimulus. Our studies show that ssRNA could be
useful in improving the phenotypical and functional properties of IFN-DCs as an adjuvant for
DC-based cancer immunotherapy and also highlight the importance of IFN-alpha for the
rapid generation of mo-DCs to be utilized for vaccination strategies.
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Immunological Events Precede Changes in the Epidermal Compartment in Developing
Psoriasis Lesions
Conrad C, Tonel G, Nestle FO
University Hospital of Zu¨rich, Switzerland
Clinical appearance of psoriasis is mainly caused by epidermal changes, including
hyperproliferation and altered differentiation of keratinocytes. Thus, epidermal changes are
believed to be of prime importance for disease pathogenesis. Recent evidence suggests that
infiltration and activation of T cells plays an important role during psoriasis development. In
fact, psoriasis is now considered to be one of the most frequent T cell mediated inflammatory
diseases in humans.
To determine the chronology of pathogenic events in psoriasis we took advantage of a
recently described xenotransplantation model with spontaneous development of psoriasis.
Uninvolved human skin from patients with plaque-type psoriasis was engrafted onto AGR
mice, mice deficient in type I and type II interferon receptors in addition to being RAG/. 5
weeks after transplantation, skin grafts develop a fully-fledged psoriasis with all typical
histological features. Time course experiments revealed that early during psoriasis
development, as early as day 7, the dermal T cell pool largely expanded in the absence of
any increase of keratinocyte proliferation or acanthosis. Starting after 3 weeks, the
percentage of keratinocytes staining positive for Ki-67 paralleled the migration of dermal T
cells into the epidermis. Likewise, the onset of typical epidermal changes in psoriasis,
represented by the papillomatosis index, correlated with the expansion of intraepidermal T
cells. In one time course experiment dermal T cells did not markedly proliferate upon
transplantation. As a consequence, a psoriatic phenotype was not induced, and after 5
weeks, grafts were indistinguishable from uninvolved skin prior to transplantation. Also, the
percentage of keratinocytes staining positive for Ki-67 remained unchanged after 5 weeks.
Our findings indicate that in developing psoriasis lesions expansion of dermal T cells is
crucial and precedes subsequent epidermal changes. Hyperproliferation of keratinocytes is
linked to an influx of intraepidermal T cells representing potential key inducers of epidermal
changes in psoriasis.
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Contact Allergens Skew Monocyte-Derived Dendritic Cells Towards a Type 1 Proﬁle and
Respiratory Allergens Towards a Type 2 Proﬁle
Toebak M1, Moed H2, Von Blomberg M1, Gibbs S1, Bruynzeel D1, Scheper R1, Rustemeyer
T1
1VU Medical Centre, Amsterdam, The Netherlands; 2Erasmus Medical Centre, Rotterdam,
The Netherlands
Th1 cells are thought to be primary effector cells in contact allergy and Th2 cells in
aeroallergen-mediated diseases. Both types of allergy are controlled by allergen-presenting
dendritic cells (DC). To analyse the skewing potentials of putative sensitising agents, we
investigated whether contact and respiratory allergens skew DC into DC1 and DC2 by their
cytokine and chemokine secretion profiles.
Monocyte-derived DC were exposed to contact allergens dinitrochlorobenzene (DNCB),
nickel sulphate (NiSO4) and respiratory allergens trimellitic anhydride (TMA), Dermatopha-
goides pteronyssinus (Der p1). As positive controls for DC1 or DC2, DC were exposed to
interferon-gamma or prostaglandin respectively, in combination with lipopolysaccharide.
Cytokine and chemokine production was determined by ELISA (DC1: IL-12p70, TNF-a,
CXCL10; DC2: IL-10, CCL17 and CCL22).
DC1 polarisation resulted in an increased IL-12p70/IL-10 ratio, TNF-a and CXCL10
production, which was the opposite to DC2 polarisation. The contact allergen DNCB showed
DC1 polarisation by increasing the IL-12p70/IL-10 ratio. The respiratory allergens TMA and
Der p1 induced a lower IL-12p70/IL-10 ratio compared to control. The contact allergen NiSO4
induced DC1 (TNF-a production) and DC2 aspects (decreased IL-12p70/IL-10 ratio, CCL17
production).
The contact allergens DNCB skew DC towards a DC1 type and respiratory allergens Der p1
and TMA towards a DC2 type, thus contributing to the prominent roles of type 1 and 2 T cells
in contact allergy and aeroallergen-mediated diseases, respectively. The contact allergen
NiSO4 induce a combined DC1 and DC2 cytokine profile, which can explain the presence of
nickel specific-Th1 and Th2 cells in allergic individuals.
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Killer Cell Immunoglobulin-like Receptors are Potential Co-Stimulatory Molecules in
Malignant CD4þSe´zary Cells
Huet D1, Bensussan A1, Bagot M2
1INSERM U659 and 2Service de Dermatologie, Hoˆpital Henri Mondor, Cre´teil, France
Cutaneous T cell lymphomas (CTCL) are characterized by proliferation and accumulation of
abnormal epidermotropic T cells in the skin. Se´zary Syndrome (SS) is a leukemic variant of
CTCL. The members of the killer cell Ig-like receptor family (KIR) can be either inhibiting or
activating receptors. In healthy individuals, the majority of circulating T cell KIR expression is
limited to CD8þ cells. CD4þCD28null KIRþ cells have been implicated in the pathophysiol-
ogy of rheumatoid arthritis and acute coronary syndromes. In the present work, we studied in
one SS patient, the expression of an extended range of KIR on circulating malignant cells and
on a derived long term T cell line, illustrating the high complexity of CTCL. The phenotype of
Se´zary cells was CD3þVb8þCD4þCD8-CD7þCD26þCD45ROþ . CDR3 analysis and
Vb8/Jb2.5 transcript sequencing demonstrated the clonality and the identity of both the
circulating and the cultured cell line population. CD4þ tumor cells expressed not only the
Se´zary cell marker CD158k, but also a significant amount of p50 and p58 KIR molecules as
determined by biochemical analysis. Further, they were stained by anti- CD158a and anti-
CD158b mAbs and expressed KIR2DL1/2 and KIR2DS1/2 transcripts. The Tcell receptor was
functional, since the malignant cells proliferated to coated anti-CD3 mAb. Surprisingly,
triggering of KIRs by specific mAbs up-regulated anti-CD3 induced proliferation (EB6, 31
folds, po0.05; Gl183, 64 folds, po0.005). We demonstrate that SHP-1 was present but it was
not recruited, neither by CD158a nor CD158b inhibitory molecules. KIRS have already been
associated to T cells survival via inhibition of activation induced cell death. Here, we
demonstrate that KIRs may also be involved in malignancy invasion by potentiating the
proliferative capacity of Se´zary cells.
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CD158k/KIR3DL2 for the Diagnosis of Erythroderma in Skin Specimens
Ortonne N, Wechsler J, Bagot M, Martin-Garcia N, Bensussan A
INSERM U659, Department of Pathology, Hoˆpital Henri Mondor, Cre´teil, France
Erythroderma may result from different causes, including Se´zary syndrome (SS) and
inflammatory diseases, and diagnosis on skin specimens is difficult. KIR3DL2/CD158k,
normally expressed by minor subsets of CD8þ and natural killer lymphocytes, is a marker of
Se´zary cells both in the blood and skin, but whether CD158k can help for the diagnosis of
erythroderma in tissue samples is unknown.
35 skin specimens from 12 SS and 23 erythrodermic inflammatory diseases (EID) (drug
reactions, psoriasis, eczema) were analyzed. In 3 SS patients, the malignant T cell clone,
identified in the blood, was shown to be present in the skin by the immunoscope technique.
Immunohistochemistry for CD158k, CD3, CD4, CD8 was performed on frozen sections. In
addition, RT-PCR for CD158k was performed in 12 cases, from the same skin sample used for
immunohistochemistry.
As expected, CD158k was positive in all SS. However, CD158kþ cells were also observed
in 17 EID. Erythrodermic SS displayed lower CD8/CD3 ratios in both the epidermis (mean
CD8/CD3 ratio: 12% in CTCL versus 38% in EID) and dermis (83% of CTCL vs 38% of EID
had CD8/CD3o25%). Mean CD158k/CD3 ratios were similar in both groups in the epidermis.
However, EID had a lower CD158k expression in the dermis (33% of SS vs 74% EID with
CD158k/CD3o25%). RT-PCR, performed in 12 cases displaying similar levels of CD158k
immunostainings, showed a stronger expression of CD158k mRNA in SS.
In conclusion, CD158k immunostaining is a useful tool for the diagnosis of erythroderma in
tissue samples. CD158kþ cells in EID may correspond to CD8 cytotoxic T-cells, what is
supported by a higher proportion of CD8þ lymphocytes in EID. Whether the combination use
of CD158k RT-PCR and immunohistochemistry might be even more accurate for the
diagnosis of erythroderma in cutaneous specimens remains to be confirmed.
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Melanoma-Inﬁltrating Dendritic Cells are Potent Antigen Presenting Cells Able to Activate
and Mediate Tumor Rejection
Preynat-Seauve O, Schuler P, Contassot E, French LE, Huard B
Dept of Dermatology, Geneva University Hospital, Switzerland
We analyzed the phenotype and functions of dendritic cells infiltrating mouse melanomas.
Cells with a phenotype of dendritic cells (DCs) (CD11cþ /MHC IIþ ) were found in two
subcutaneous transplantable melanomas (B16 and K17-35). DCs were also found in a
spontaneous melanoma obtained in the tyrosinase/ras-mutated model. These Tumor
Infiltrating Dendritic Cells (TIDCs) corresponded in majority to myeloid DCs (CD11cþ /
CD11bþ /DEC205-/CD8-). It is noteworthy that small numbers of plasmacytoid DCs
(CD11cþ /B220þ ) were also observed, particularly in the spontaneous model. TIDCs in
melanomas rapidly up-regulated MHC II and co-stimulatory molecules for T cells activation
(CD40, CD80 and CD86) after ex vivo stimulation. This activation was associated with a
strong production of IL-12, a major Th1-driving cytokine, indicating that TIDCs could be
differentiated into fully mature antigen presenting cells. Thereafter, the capacity of TIDCs to
process antigens and present MHC–peptide complexes to T cells was investigated in vivo.
TIDCs were purified from the subcutaneously ongoing K17-35 melanoma and loaded with the
model antigen OVA before injection in tumor-free mice. Within 3 days, injected TIDCs had
migrated spontaneously to draining lymph nodes and activated both OVA-specific CD4þand
CD8þT cells. Finally, the capacity of TIDCs to locally process naturally-occuring tumor
antigens was investigated. TIDCs were purified from a mouse melanoma and injected directly
into tumor-free animals. Injected mice were protected against a tumor challenge, indicating
that TIDCs were naturally loaded with tumor-associated antigens. In conclusion, we
demonstrate that melanomas are infiltrated by fully functional DCs. These observations
suggest that manipulation in vivo of this potent antigen presenting cells could be a promising
approach for immunotherapy.
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Beta2 Integrins Deﬁne the Destination of Circulating Naı¨ve Lymphocytes in Secondary
Lymphoid and Non-Lymphoid Organs
Oreshkova T, Renkl A, Seier A, Kess D, Wang H, Weiss J, Scharffetter Kochanek K, Peters T
Dept of Dermatology, University of Ulm, Germany
The immune system relies on a sophisticated cellular organization based on a dynamic
homeostasis and maintained by constant migration and redistribution of immune cells. Each
cell type along with its lineage markers possesses additional surface molecules including
chemokine and integrin receptors that distinctly encode migratory behavior. b2 integrin
receptors are particularly prominent in mediating adhesive events that contribute to
lymphocyte migration.
The objective of the present study was to clarify the role of b2 integrins (CD11/CD18) in
determining the migratory pattern of naı¨ve lymphocytes. For this purpose, adoptive cell
transfers were performed. Naı¨ve cells were isolated from peripheral lymph nodes of wild-type
(WT) and CD18null (CD18/) mice, stained separately with cytoplasmic cell-tracker dyes,
and injected intravenously at a 1:1 ratio into WT recipients. Redistribution of the labeled cells
into lymphoid and non-lymphoid organs was analysed at 3 or 18 h after the transfer.
Additionally, lymphocyte markers were stained and flow-cytometrical analyses performed. In
contrast to WT lymphocytes, almost no CD18/ cells could be detected in peripheral lymph
nodes at either time points after transfer. In addition, a reduced accumulation of CD18/
cells was observed in the other secondary immune organs and bone marrow. Strikingly, a
considerable amount of CD18/ cells was detected in the recipients’ lungs and livers. The
accumulated cells represented a fraction of unconventional T cells lacking their CD4 and CD8
co-receptors. Those T cells share T cell receptors from both types alpha-beta and gamma-
delta and demonstrate strong proliferative dependence on IL-2 supplementation in in vitro
culture.
Collectively, our data show that b2 integrins are of central importance for maintaining the
balance of lymphocyte subpopulations and for defining the destination of naı¨ve lymphocytes
within immune and non-immune organs.
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Maintenance of the Psoriasiform Dermatitis Critically Depends on Activated Macro-
phages in a Murine Psoriasis Model
Wang H1, Peters T1, Kess D1, Oreshkova T1, Sindrilaru A1, Stratis A2, Funteh A2, Haase I2,
Scharffetter Kochanek K1
1Department of Dermatology and Allergic Diseases, University of Ulm, Germany; 2Depart-
ment of Dermatology and Venerology, University of Cologne, Germany
In the CD18 hypomorphic (CD18hypo) PL/J mouse model, a mutation in the CD18 gene
resulting in a reduced expression of the CD18 protein to 2–16% of wild-type levels leads to
the development of a dermatitis resembling human psoriasis. In skin of psoriasis patients, an
increased number of macrophages was found in the dermis along the basement membrane,
but their role in the pathogenesis of psoriasis remains unclear. In this study, we investigated
the role of macrophages in the psoriasiform skin disease of CD18hypo mice. Macrophages
which are the major source of TNF-a were significantly increased in lesional skin as well as in
inflamed skin draining lymph nodes (DLNs) of affected CD18hypo mice. In vivo depletion of
macrophages by Cl2MDP-liposomes resulted in a significant reduction of the psoriasiform
phenotype in parallel with decreased numbers of CD4þ T cells and TNF-a protein levels.
Compared to wild-type mice, both MCP-1 mRNA and protein levels were enhanced in
lesional skin of affected CD18hypo mice. To recruit or activate macrophages, we intradermally
injected recombinant JE/MCP-1 or LPS in the skin of healthy CD18hypo mice. Both
administrations caused a distinct accumulation of macrophages in the injected skin areas
and skin DLNs of healthy CD18hypo mice, but failed to trigger the psoriasiform skin disease,
which could be explained by the absence of persistent recruitment of CD4þ T cells and TNF-
a expression in injected skin areas. Taken together, our data suggest that maintenance, not
initiation of the psoriasiform skin disorder critically depends on activated macrophages,
whereas elicitation of the psoriasiform phenotype may need persistent recruitment and
activation of CD4þ T cells through antigen presentation in CD18hypo mice.
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Expression of Functional Toll-like Receptors and CD14 in Human Sebocytes
Oeff MK1, Seltmann H1, Bornstein SR2, Zouboulis CC1
1Charite´ University Medicine Berlin, Germany; 2Carl Gustav Carus University Hospital,
University of Dresden, Germany
Toll-like receptor (TLR) which are - together with CD14 - involved in the innate immunity and
are able to recognize microbial components from gram-positive and gram-negative bacteria.
A bacterial role in the increase of inflammatory acne has been widely accepted. We address
here a potential mechanism of gram-negative (LPS) and gram-positive bacterial component
(LTA) action on human sebocytes through a possible modulation of TLR2, TLR4 and CD14
expression. Changes in TLRs and CD14 expression by these agents were compared to the
action of retinoids and hydrocortisone. The regulation of TLR mRNA levels was investigated
by using QRT-PCR. To detect the possible pro- or anti-inflammatory effects of microbial
components and antiinflammatory agents we measured cytokine expression QRT-PCR and
its secretion by ELISA, respectively. We have shown that human SZ95 sebocytes
constitutively express TLR2, TLR4 and CD14, as detected by RT-PCR and immunocyto-
chemistry. The expression was augmented by exposure to LPS, LTA and retinoids. In
addition, LPS induced a marked increase of IL1a, IL1b, IL6 and IL8 expression. LTA slightly
stimulated IL6 and IL8 expression from SZ95 sebocytes. Retinoids did not affect cytokine
expression. Hydrocortisone induced TLR2 but markedly reduced TLR4, CD14 and cytokine
expression. To determine whether IL8 and IL6 synthesis in SZ95 sebocytes is TLR- and/or
CD14 regulated, the effect of anti-TLRs and anti-CD14 antibodies on LPS- and LTA-induced
IL8 and IL6 release was investigated. We could show that microbial components induce
human SZ95 sebocyte IL8 and IL6 release by a TLR- and CD14-dependent mechanism. This
is first evidence that microbial components may directly influence human sebocytes in a TLR-
and CD14-dependent manner. Human sebocytes may act as immune cells capable of
pathogen recognition and they might have an important role in initiating and perpetuating the
activation of both innate and adaptive immune responses.
196
IL-22 Regulates only a Limited Number of Genes Responsible for Antimicrobial Defense,
Cellular Differentiation, and Mobility in Keratinocytes
Wolk K1, Witte E1, Wallace E1, Do¨cke WD2, Kunz S1, Asadullah K2, Volk HD1, Sterry W1,
Sabat R1
1University Hospital Charite´, Berlin, Germany; 2Schering AG, Berlin, Germany
IL-22 is a recently discovered protein which belongs to the IFN – IL-10 cytokine family. Similar
to IFN-g, IL-22 is produced by activated Th1 and NK cells. Epithelial cells express the
functional IL-22 receptor complex and are the most important target of this cytokine. Here we
demonstrate that IL-22, in contrast to IFN-g, regulates the expression of only a few genes in
primary human keratinocytes. This may be due to the activation of different signal
transduction pathways. Although both cytokines activated ERK1/2 and JNK in these cells,
IL-22 additionally activated STAT3, while IFN-g primarily activated STAT1 but also STAT3 and
STAT5. The genes whose expression was regulated by IL-22 play a role in either antimicrobial
defense (S100A7, S100A8, S100A9), cellular differentiation (e.g. FLG, KRT1, KRT10,
CALML5), or cellular mobility and migration (e.g. MMP1, MMP3, DSC1). IFN-g influenced
the expression of a multitude of genes mainly encoding molecules from the MHC pathways,
adhesion molecules, cytokines, chemokines, and their receptors. The IL-22 effects were
transcriptional, and either independent of protein synthesis and secretion or mediated by a
secreted protein. The keratinocyte differentiation state did not change their sensitivity to IL-
22. Inflammatory conditions amplified the IL-22 effects. High levels of IL-22 were associated
with strongly upregulated S100A7 expression in skin from psoriasis patients. This shows that,
despite similarities, IFN-g primarily amplifies inflammation, while IL-22 strengthens the innate
immunity of epithelial cells, inhibits their differentiation, and increases their mobility. IL-22
therefore may play an important role in dermatoses, wound healing, and reorganization of
epithelia.
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Demonstration of Antipsoriatic Efﬁcacy of a New Topical Formulation of a Small Molecule
Selectin Antagonist Bimosiamose
Philipp S1, Friedrich M1, Vollhardt K2, Zahlten R2, Sterry W1, Wolff G1
1University Hospital Charite´ Berlin, Germany; 2Revotar Biopharmaceuticals AG, Germany
The attraction of leukocytes to tissues is essential for inflammation and the host response to
infection. Psoriasis vulgaris is a T-cell mediated inflammatory skin disease with a prevalence
of 2–3% in the general population. The selectin family of vascular cell adhesion molecules is
comprised of structurally related carbohydrate binding proteins, which mediate the initial
rolling or ‘‘tethering’’ of leukocytes on the vascular endothelium following inflammation. In T-
cell-mediated diseases this process is a crucial event in initiating and maintaining
inflammation. Therefore, selectins are an attractive target for the development of new anti-
inflammatory therapeutics. We investigated topical bimosiamose, a synthetic pan-selectin
antagonist in 12 subjects with stable psoriatic plaques in a randomised two-center vehicle
controlled study, double blind for the study preparations and observer-blind for the
comparators. Measurements (sonography, chromametry, photodocumentation and clinical
assessments) were made at baseline (day 1) and on days 8 and 12. Analyzed parameters of
the employed psoriatic plaque test were erythema intensity (mean redness) measured by
chromametry and infiltrate thickness of the plaque as measured by 20 MHz sonography.
Mean redness values remained nearly constant over time for bimosiamose microemulsion
and its corresponding vehicle. Thickness of the plaque infiltrate did not change after 10 days
of treatment in the vehicle group. In contrast, bimosiamose microemulsion treated plaques
demonstrated a significant decline in infiltrate thickness after 10 days of treatment as
compared to its corresponding vehicle (10.5%, p¼0.019) and as compared to its own
baseline (13%, p¼ 0.0007). In this phase IIa exploratory trial, a new topical formulation of
the small molecule selectin antagonist bimosiamose has been investigated. These data
suggest that topical selectin antagonists may be effective in the treatment of psoriasis.
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Anti-L-Selectin Therapy is not Effective in Psoriasis: A Randomized Trial
Friedrich M1, Philipp S1, Rincic M1, Mueller C2, Soo´s N3, Hoeflich C1, Sabat R1, Merk HF4,
Sterry W1, Mrowietz U3
1University Hospital Charite´ Berlin, Germany; 2SCIL Biomedicals GmbH, Germany;
3University Hospital Kiel, Germany; 4University Hospital of the RWTH Aachen, Germany
The majority of circulating T cells, B cells, NK cells, monocytes, polymorphonuclear
granulocytes and other immune cells express L-selectin on their surfaces. L-selectin is an
adhesion molecule involved in leukocyte interactions with vascular endothelial cells. This
process plays an important role in initiating and maintaining inflammation in various diseases.
The blockade of L-selectin and thus the inhibition of tissue infiltration of leukocytes, dendritic
cells and macrophages is an attractive option for targeted therapy of inflammatory diseases.
We performed a multi-center, randomized, placebo-controlled trial to investigate the
efficacy and safety of a recombinant humanized monoclonal antibody to L-selectin, BNP001
(Aselizumab), in the treatment of psoriasis.
21 patients with moderate/severe psoriasis were selected for this study. 14 patients
received 1 infusion/week of BNP001 (given as a loading dose of 2 mg/kg BW and thereafter
1mg/kg BW) for 4 weeks. To 7 subjects placebo infusions were given. The treatment was well
tolerated. After 4 weeks treatment and 7 weeks follow up observation there was no significant
reduction in PASI in the BNP001-treated group compared to placebo group. Immunohisto-
chemical analysis of biopsies taken from psoriatic skin lesions showed no significant
reduction in numbers of CD3þ , CD4þ and CD8þ lymphocytes in the dermis or epidermis.
However, a decrease of L-selectin (CD62L) staining in lesional skin was observed (29.3 cells/
mm2 before and 12.3 cells/mm2 after therapy). A marked decline of CD62L staining was also
detected on granulocytes in BNP001-treated patients by flow cytometry. There were no
significant changes in the peripheral blood NK cell and CD3þ , CD4þor CD8þ cell counts.
This data shows that anti-L-selectin treatment is well tolerated but not clinically effective in
the treatment of chronic plaque psoriasis.
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CD8þCytotoxic T Cells Mediate Amoxicillin Allergy Presenting as Maculo-Papular
Exanthema
Rozieres A1, Rodet K1, Bosset-Saint-Mezard S1, Cozon G2, Bienvenu J2, Berard F2, Nicolas
JF1
1INSERM U503, Lyon, France; 2CH Lyon Sud, France
Drug allergic reactions presenting as maculo-papular exanthema (MPE) are frequent skin
delayed type hypersensitivity (DTH) reactions mediated by the activation of drug-specific T
lymphocytes in the skin. To get insights into the nature of T cells involved in drug-induced
MPE, we analysed the phenotype and functions of specific T cells in the blood and in the skin
of 21 patients allergic to amoxicillin (amox) who have developed a MPE during amox
treatment and who developed positive patch tests to amox. Analysis of blood T cells showed
the presence of amox-specific CD8þT cells producing IFNg and granzyme B upon amox
restimulation in vitro in amox-allergic but not in amox-tolerant patients. The frequency of
amox-specific CD8 precursors ranged from 50 to 200/106 PBMCs. Analysis of skin T cells
showed that activated CD8þ cytotoxic T cells (IFNgþ , granzyme Bþ /perforinþ ) were
recruited in the amox skin patch test as early as 10 hours after amox application. Infiltration of
CD8þT cell in the skin was associated with apoptosis of keratinocytes demonstrated by
Tunel staining. Recruitment of CD4þT cells and other leucocytes occured later (24 hrs) and
paralleled the down-regulation of CD8þT cell activation assessed by a decrease in the IFNg
production. Collectively, these data show that amox-specific CD8þT cells, found in high
numbers in the blood of amox-allergic patients and able to infiltrate the skin upon re-
exposure to amox, are effector cells in amox-induced drug MPE.
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Mast Cells and NK Cells are Involved in Irritant Contact Dermatitis.
Bonneville M1, Saint-Mezard P1, Chavagnac C1, Benetiere J1, Vocanson M1, Di Santo J2,
Mecheri S2, Nicolas JF1
1INSERM U503, Lyon, France; 2Institut Pasteur Paris, France
Irritant contact dermatitis (ICD) is a frequent eczematous skin disease mediated by the
proinflammatory and toxic effects of xenobiotics able to activate the skin innate immunity.
ICD often evolves in allergic contact dermatitis (ACD). It has been postulated that
keratinocytes and dendritic cells are the main targets of the pro-inflammatory effects of
contact haptens. However, the role of resident bone-marrow-derived cells in the development
of ICD is still not known precisely. Here, we analysed the contribution of bone-marrow-
derived cells in the development of DNFB-induced ICD using several types of gene-deficient
mice, i.e. MHC class I1/1 (deficient in CD8þT cells), MHC class II1/1 (deficient in CD4þT
cells), rag1/1 (deficient in T and B cells), gc rag1/1 (deficient in T, B and NK cells), W/Wv mice
(deficient in mast cells), and wild type C57BL/6 mice. The magnitude of ICD was assessed as
the ear swelling observed in the hours (1, 3, 6 and 12) following DNFB ear painting. The ICD
reaction occurring in MHC class I1/1, MHC class II1/1 and rag1/1 mice was similar to that
observed in C57BL/6 demonstrating that T and B cells are not involved in the skin
inflammation. In contrast, mice deficient in NK cells (gc rag1/1) and in mast cells were unable
to mount an optimal ICD reaction to DNFB. Reconstitution of W/Wv mice with bone-marrow-
derived mast cells restored the ICD reaction to normal levels, confirming that mast cells are
necessary for optimal ICD. In conclusion, several cell types of the skin innate immunity,
among which mast cells and NK cells, contribute to the ICD skin inflammation. These results
open new avenues for the prevention and treatment of ICD.
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The Antigen Density Plays a Dominant Role for Effective In Vitro CD8 T Cell Priming by
Dendritic Cells
Schaft N, Do¨rrie J, Beck V, Mu¨ller I, Schuler G, Ka¨mpgen E
Dept of Dermatology, University Hospital Erlangen, Germany
Efficient stimulation of naive antigen (Ag) specific T cells in vitro is best obtained using
professional antigen presenting cells (APCs) such as dendritic cells. It is known from in vitro as
well from in vivo studies that naı¨ve T cell stimulation involves repeated T-APC interactions. We
have now analyzed to which extend the number of APCs and the level of presentation per cell
(i.e. Ag density) contribute to the expansion of specific Tcells and induction of effector functions.
We used monocyte-derived dendritic cells (DCs) as professional APCs and MelanA as a
model-Ag, for its well-characterized and highly immunogenic HLA-A2-presented peptide
EAAGIGILTV. DCs were transfected with RNA coding for MelanA using electroporation or a lipid-
based transfection reagent. These resulted in different percentages of transfected cells and
expression levels on a per cell base. In addition different percentages of the DCs were loaded
with a MelanA derived analogue peptide (ELAGIGILTV). The DC’s capacity to expand
autologous T cells was analyzed by in vitro stimulation and subsequent A2-MelanA tetramer-
staining in combination with phenotyping (CCR7/CD45RA) for T cell function. Our results clearly
showed that methods yielding higher levels of Ag density per cell are by far superior in
generating high numbers of effector CD8þTcells, even if the Ag was presented only by a small
percentage of the DCs, compared to methods that transfect almost 100% of the cells but
yielding lower Ag density. Surprisingly as little as 10% of peptide presenting DCs displayed the
same stimulatory capacity as 100% peptide loaded DCs to expand Melan-A specific CD8þT-
cells.
Our in vitro data indicate a dominant role of a high antigen density displayed by few DCs for
effective CD8þTcell activation and thus may have consequences when designing vaccination-
strategies with RNA transfected or peptide-loaded DCs.
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Effector and Regulatory T Cell Populations in Patients Treated with Extracorporeal
Photochemotherapy for Severe Erosive Lichen Planus
Viguier M1, Fazilleau N1, Oro S2, Farhi D2, Guyot A3, Rabian C4, France`s C7, Di Santo J1,
Bachelez H2
1INSERM U668, Pasteur Institute, Paris, France; 2INSERM U697, Saint Louis Hospital, Paris,
France; 3Dermatology, Pitie´ Salpe´trie`re Hospital, France; 4Immunology, Saint Louis Hospital,
Paris, France
Lichen planus (LP) is an auto-immune disease characterised by a CD4þ and CD8þ T-cell skin
infiltrate associated with alterations of keratinocyte viability. Dramatic remission of severe LP
has been recently reported following extracorporeal photochemotherapy (ECP) in patients
with severe erosive mucosal LP refractory to immunosuppressive drugs. In order to
investigate physiopathological mecanisms involved in LP and those underlying tolerance
induction by ECP, we sequentially analysed effector and regulatory T cells (Tregs) populations
and TCR repertoire in 9 patients treated with ECP for severe erosive LP.
Peripheral blood lymphocytes (PBLs) subsets were analysed at different end points: flare,
partial remission, complete remission. Absolute blood counts and proportions of CD3þ ,
CD4þ , CD8þ Tcells and CD19þ B cells populations, and also of regulatory CD4þ CD25 high
in parallel with CD4þ CD25þ activated T cells populations were studied by flow cytometry.
Expression of the transcription factor specific for Tregs FoxP3 was assessed in the CD4þ
CD25 high population by RT-PCR. TCR repertoire analysis was performed in purified CD4þ /
CD8þ blood cells by quantitative PCR, followed by CDR3 length characterization using
Immunoscope and sequencing of CDR3 peaks. In 2 patients, TCR repertoire was also
performed in lesional skin and/or mucosa.
A striking predominance of activated CD4þCD25þ Tcells was detected in peripheral blood
before ECP, while regulatory CD4þ CD25 high percentage was meanly 4.46% (range: 1.72–
12%). T-cell repertoire analysis in the peripheral blood CD4þ subset showed gaussian
patterns, while TCR repertoire of CD8þ PBLs was strikingly restricted with evidence for
clonal expansion in the TCVBV3 family, in 3 studied patients. These CD8þ clonotypes were
also detected in lesional mucosa and/or skin in 2 cases.
Under ECP treatment, a decrease in absolute blood counts of CD4þ and CD8þ T cells was
observed together with a dramatic decrease of the CD4þ CD25þ /CD4þCD25 high ratio (22.3
before treatment vs 8.05 at the time of complete remission). Sequential analysis of T-cell repertoire
revealed the long-term persistence of the CD8þ clonal expansions observed before treatment.
Severe erosive LP is characterized by the predominance of activated CD4þ T cells in the
peripheral blood and by clonal CD8þ expansions, both in PBLs and in tissular lesions. Clinical
response under ECP is associated with an increase of Tregs/activated T cells ratio, without
significant alteration of the CD8þ predominant clonotypes which are likely to contribute to
epithelial cytotoxic damage.
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Antimicrobial Activities of Histidine-rich glycoprotein and Histidine-Rich Peptides are
Potentiated by Zinc
Rydenga˚rd V, Andersson Nordahl E, Schmidtchen A
Dept. of Clinical Sciences, Lund University, Sweden
Antimicrobial peptides are effector molecules of the innate immune system. We recently
showed that peptides containing the Cardin and Weintraub sequences AKKARA and
ARKKAAKA, which occur in many heparin-binding proteins, exert antimicrobial activities
against bacteria and fungi. Here, we show that the replacement of lysine and arginine in these
motifs by histidine, abrogates the antimicrobial effects of these peptides. Presence of Zn2þ
or low pH restored the antimicrobial activity of these motifs. Fluorescence microscopy
experiments showed that Zn2þ enabled peptide binding to the Gram-positive bacterium
Enterococcus faecalis. Similar antimicrobial activities were demonstrated for a peptide
containing the motif GHHPH, derived from the heparin-binding and histidine-rich domain of
histidine-rich glycoprotein, and peptides derived from the D5 domain of HMW kininogen.
Thus, the results demonstrate a novel antimicrobial activity of domains of histidine-rich
glycoprotein and HMW kininogen, two significant proteins found in plasma and released from
human platelets during coagulation and wound repair. Furthermore, our data indicate an
important role for Zn2þ and pH in the regulation of antimicrobial activities of histidine-rich
peptides.
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Generation of Peptide Mimics of Melanoma Antigen GD2
Bra¨mswig KH1,2, Riemer AB1, Fo¨rster-Waldl E2, Dehof A3, Neumann D3, Lode HN4, Zielinski
C5, Scheiner O1, Pehamberger H6, Jensen-Jarolim E1
1Center of Physiology and Pathophysiology, Medical University of Vienna, Austria;
2Department of Pediatrics and Juvenile Medicine, Medical University of Vienna, Austria;
3Center of Bioinformatics, Saarland University, Germany; 4University Children’s Hospital,
Charite´ Berlin, Germany; 5Department of Internal Medicine I, Medical University of Vienna,
Austria; 6Department of Dermatology, Medical University of Vienna, Austria
Disialoganglioside GD2, a relevant tumor antigen, is overexpressed on numerous malig-
nancies as melanomas, leptomeningeal cancers, osteosarcomas and neuroblastomas. The
chimeric anti-GD2 antibody ch14.18 is presently applied in clinical trials for targeting GD2
overexpressing advanced melanoma and osteosarcoma, as well as neuroblastoma.
For developing an active immunotherapy, we defined peptide mimics of the 14.18 epitope
on GD2. By biopanning a random peptide phage display library with the antibody, thirteen
GD2 mimotope candidates could be identified. They were proven to be true epitope mimics
by mimicry tests in the ELISA format. Using three-dimensional computer modeling
(BALLView), we were able to demonstrate that two selected mimotopes fitted into the
antigen binding pouch of a GD2 specific antibody in the same manner as original antigen
GD2. We conclude that we succeeded in generating peptide mimics of the carbohydrate
antigen GD2. In contrast to GD2 which is a poor immunogen, these peptides might be utilized
to develop an active immunization against overexpressing GD2 tumors.
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The Lymphatic Glycoprotein Podoplanin Enhances Inﬂammation in a Podoplanin
Transgenic Mouse Model
Schacht V1, Meadows K2, Hirakawa S2, Bruckner-Tuderman L1, Detmar M3
1Universita¨t Freiburg, Germany; 2Massachusetts General Hospital, USA; 3Swiss Federal
Institute of Technology Zurich, Switzerland
The mucin-type glycoprotein podoplanin is specifically expressed by lymphatic, but not
blood vascular endothelial cells, in culture and in tumor-associated lymphangiogenesis. Our
previous studies showed that podoplanin deficiency results in congenital lymphedema and
impaired lymphatic vascular patterning, and that podoplanin enhances migration, adhesion
and tube formation of endothelial cells by reorganization of the cytoskeleton. However, its
biological role in postnatal skin and in skin diseases has remained unclear.
We generated a transgenic mouse model overexpressing rat podoplanin in the epidermis
under the control of the loricrin promoter B-879. Delayed-type hypersensitivity (DTH)
reactions were induced in the ear skin of 8 weeks old female wild-type mice or transgenic
mice by sensitization and challenge of the ear skin with oxazolone solution. Measurements of
the ear thickness in vivo or hematoxylin & eosin staining ex vivo showed a significant increase
of the ear thickness of podoplanin transgenic mice as compared to wild-type mice 24 hours
after challenge. The ears of podoplanin transgenic mice revealed an increase of edema
formation and CD4 or CD11b positive inflammatory infiltrates as compared to wild-type mice.
However, the molecular mechanisms which are responsible for this increased inflammatory
reaction in podoplanin overexpressing skin are not clear yet. The possibility of the cleavage of
podoplanin or induction of other mediators between podoplanin and inflammatory cells will
be addressed by our future experiments.
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Induction of Cutaneous Inﬂammation in Normal Balb/c Mice by Human T Cells
Pont M1, Gime´nez-Arnau AM1, Bellosillo B2, Pujol RM1, Santamaria-Babi LF1
1Department of Dermatology, Hospital del Mar, Barcelona, Spain; 2Department of Pathology,
Hospital del Mar, Barcelona, Spain
Current animal models to study the mechanisms of human T cell migration into cutaneous
sites involve immunodeficient mice grafted with human skin. We have developed a model
where non-sensitized normal Balb/c mice are injected i.v. with the human T cell line Hut-78 to
induce ear inflammation. DNFB is applied topically on the right ear, acetone is applied on the
left, and 3  105 Hut-78 T cells are injected i.v.. Net ear swelling in each mouse is calculated
by weight subtraction between right and left ear after 24 h of cells injection. Net ear swelling
depends on the number of cells injected and the percentage of DNFB applied. Under these
conditions we have compared the capacity to induce cutaneous inflammation by CLAþ Hut-
78 vs CLA Hut-78 T cell lines. DNFB-treated and Hut-78 CLAþ cells injected mice
presented a net ear weight of 18,4  4,7 mg, Hut-78 CLA cells injected mice of 7,9  4,4
mg and DNFB-treated mice without human T cells of 7,3  3,2 mg. T-cell tracking dye
experiment with Hut-78 CLAþ cells demonstrated the presence of fluorescence only in the
inflamed right ear (36.6 positive cells per 60.000 total cutaneous cells). Unequivocal signs of
inflammation were only detected histollogically in the right ears. Cutaneous inflammation
induced by CLAþ Hut-78 T cells could be inhibited by the previous in vitro incubation of cells
with PTX or neuraminidase. Furthermore injection of Hut-78 CLAþ transfected T cells with
human CCR10 induced cutaneous inflammation that directly correlated with their in vivo
chemotaxis capacity to mouse CTACK. Our data indicate that this novel animal model may be
useful to study the mechanisms of human CLAþ T cells migration to skin in vivo.
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Lesional Lichen Planus Skin is Characterized by the Presence of Human Herpesvirus-7
Protein and Abundant Inﬁltration of Plasmacytoid Dendritic Cells
Teunissen MB, Picavet DI, De Vries HJ
Academic Medical Center, Amsterdam, The Netherlands
Lichen planus (LP) is a self-limiting, common inflammatory skin disease that is characterized
by a saw-tooth pattern of epidermal hyperplasia, basal keratinocyte damage, and a dense
band-like lymphocytic infiltrate. Based on the observation of herpes virus virions by electron
microscopy and the selective presence of human herpesvirus-7 (HHV7) DNA in lesional LP
skin, as compared to non-lesional skin and normal human skin [citation removed], it was
suggested that LP may result from local reactivation of HHV7. To support this assumption we
performed this immunohistochemical study to detect HHV7 protein, using an antibody that
recognizes an 85-kDa phosphoprotein of the tegument of HHV7 virion particles. Because
HHV7 has a high seroprevalence it was not surprising to find some HHV7-positive cells in
non-lesional LP skin or normal skin. However, all (18/18) lesional LP skin samples consistently
contained more HHV7-positive cells, both in the dermis (significant) and epidermis, indicating
that indeed HHV7 may be involved in the pathogenesis of LP. The probable viral cause of LP
and the fact that LP resolves spontaneously prompted us to investigate whether
plasmacytoid dendritic cells (PDCs) are recruited in LP lesions. PDCs are regarded as
important effector cells against viral infections because of their high production of IFN-a/b,
which induce antiviral factors such as Mx proteins. Numerous cells that expressed CD123
and BDCA-2, two typical markers for PDCs, were observed in involved LP dermis, but not in
symptomless skin. These PDCs had a scattered distribution throughout the band-like
infiltrate. We also demonstrated the presence of MxA protein, which is considered as a
reporter protein for IFN-a/b activity. We postulate that PDCs may contribute in the healing
process of LP.
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Expression of Antimicrobial Peptides Studied in a Xenogeneic Transplantation Model
Sticherling M1, Bu¨rkle CP2, Wandel E1
1Department of Dermatology and 2Department of Anatomy, Universita¨tsklinikum Leipzig,
Germany
Human epidermis has recently been shown to express diverse antibiotically active proteins
and peptides and thus explain the surprisingly low rate of overt infections regarding the highly
exposed skin organ. The study of peptide expression in humans is restricted for obvious
ethical reasons and on the other side biased when examining in vitro tissue cultures or
artificial epidermis equivalents. Therefore, a xenogeneic transplantation model was adapted
by transferring healthy human skin to NOD-SCID mice and subsequently injecting cytokines
to experimentally modulate the expression of the human b-defensins (HBD) 2 and 3 as well as
psoriasin. Expression was studied by in situ hybridisation using in –house primers and by
immunohistochemical methods using commercial mono- and polyclonal antibodies. Tumor
necrosis factor a and interferon g were injected intradermally either alone or in combination at
different dosages in addition to phosphate buffered saline as negative control. Psoriasin was
constitutively expressed in 70 % of samples and further increased upon injection of either
cytokine at doses above 100 ng/ml similar to the expression of HBD 2 and 3. Thus, these
primary cytokines play an important role in inducing the expression of antibiotic proteins and
may mediate anti-bacterial response indirectly in addition to primary bacterial mediators and
components. Furthermore such effects explain the differential expression of diverse antibiotic
peptides in chronic inflammatory diseases like psoriasis and atopic eczema as well as the
specific incidence and spectrum of infections observed in these diseases.
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CD4 Antibodies have the Potential to Amplify Tumor-Speciﬁc CD8 Responses
Schneeberger A, Luehrs P, Kutil R, Stingl G
Dept of Dermatology, Medical University of Vienna, Austria
We are interested in the identification of strategies aimed at amplyfying specific immune
responses.
While evaluating the contribution of CD4 cells to the protective effect of certain vaccines,
we made the following surprising observation. We found the administration of antibodies
(Abs) to CD4 to enable experimental animals to reject inocula of RENCAlacZ tumor cells.
While none of 5 control mice was capable of preventing the growth of RENCAlacZ tumors,
only 1 of 5 animals injected with Abs to CD4 developed a tumor upon s.c. RENCAlacZ
inoculation. The protective effect was long-lived since rechallenge of protected animals 90
days after the first tumor cell implantation did not lead to tumor formation in any of the
animals tested. To unravel the effector mechanism involved, we performed CD8 depletion
experiments. Elimination of CD8 T cells was found to completely abolish the protective effect
of administering CD4 Abs. We thus evaluated the bgal-specific CD8 response in more detail
employing ELISPOT analysis. Injection of RENCAlacZ cells into syngeneic BALB/c mice was
found to induce low numbers of IFN-g-producing, specific CD8 cells. This response was
maximal only by day 21 after tumor cell inoculation. By contrast, RENCAlacZ-recipients
treated with Abs to CD4 were shown to exhibit a pronounced bgal-specific CD8 response (5–
10 fold difference) which peaked by day 14. We next asked whether CD4þCD25þ
regulatory T cells would mediate the phenomena observed. Preliminary results for both, the
immunological as well as clinical effects seen, are compatible with the contribution of
additional types of regulatory cells.
Taken together, we provide evidence to suggest that the s.c. inoculation of cancer cells
induces a CD8 response to antigens expressed by the tumor cells and that this can be
significantly enhanced by the administration of Abs to CD4. It remains to be seen whether
such a strategy is applicable in a more general sense and whether it can be employed without
causing immunosuppression.
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In Situ Analysis of Imiquimod-Induced Regression of Basal Cell Carcinomas: Involve-
ment of Plasmacytoid Dendritic Cells?
Stary G1, Bangert C1, Altrichter S1, Boeckmann D1, Strohal R2, Stingl G1, Kopp T1
1Medical University of Vienna, Austria; 2Federal Academic Hospital Feldkirch, Austria
Imiquimod is a synthetic agonist to toll-like receptor 7 (TLR7) and acts as an immune
response modifier with profound anti-viral and anti-tumour activity. The mechanisms leading
to tumour regression involve a local cellular anti-tumour immune response, which may well be
initiated/guided by the TLR7-expressing plasmacytoid dendritic cells (pDCs), the natural
interferon-producing cells of the peripheral blood.
To address this issue we assessed the cellular characteristics of imiquimod-mediated
regression of skin tumours by analyzing the peritumoural infiltrate of basal cell carcinomas
(BCC) (n¼ 7) before and after 2 weeks of imiquimod treatment by immunofluorescence
double- and triple-stainings.
Although virtually absent in untreated BCC, imiquimod induced an accumulation of
CD123þ /CD45RAþ pDCs after 2 weeks of therapy, which was associated with a strong
induction of type I interferon activity, as detected by MxA expression. Interestingly, these cells
were often located in close proximity to CD56þ /CD94þ natural killer cells, indicative of a
functional interaction between these cell types. Distinct to the effect of imiquimod on pDCs,
we observed a reduction of CD1cþ dermal dendritic cells and Langerinþ /CD1aþ Langerhans
cells, possibly as a result of their emigration to the lymph nodes. Imiquimod significantly
augmented the T-cell infiltrate compared to untreated BCC and reversed the initial
predominance of CD3þ /CD4þ over CD3þ /CD8þ T-cells. This great increase of CD8þ T-
cells may contribute to the imiquimod-mediated tumour regression.
The detailed knowledge of the cellular composition of the inflammatory infiltrate caused by
the application of imiquimod on skin cancers should form the basis for the investigation of the
immunologic and molecular events operative in their regression.
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Tacrolimus and Regulatory CD4þCD25þ T Cells Inhibit Th1 and Th2 Responses in
Individuals with Atopic Dermatitis
Birch K1, Vukmanovic-Stejic M2, Mcquaid A2, Reed J2, Macgregor C2, Akbar A2, Rustin M1
1Royal Free Hospital, London, United Kingdom; 2Windeyer Institute of Medical Sciences,
United Kingdom
The aim of this study was to assess the effects of regulatory T cells in combination with
tacrolimus on activated T cells from patients with atopic dermatitis (AD). AD is characterised
by a persistent T cell infiltrate in the dermis and an exaggerated Th2 response to allergens.
Regulatory T cells, a subset of CD4þCD25þ T lymphocytes, have a role in maintaining a
balance between immunity and pathology through their suppression of T cell responses. Loss
of regulatory T cell function, as in the IPEX syndrome, results in severe AD indicating a role for
regulatory Tcells in skin disease. Topical tacrolimus (FK506) is known to successfully treat AD
although its precise mechanism of action is unknown. CD4þCD25- T cells derived from the
peripheral blood of AD patients or non-atopic donors were stimulated to proliferate with
tuberculin purified protein derivative (PPD), a Th1 antigen, or house dust mite antigen (DerP),
a Th2 antigen. Tacrolimus and regulatory CD4þCD25þ T cells were either added separately
or in combination to the responder cells. Proliferation was measured by radioactive thymidine
incorporation. Regulatory T cells from AD patients and non-atopic donors were able to
suppress both Th1 and Th2 CD4þCD25- T cell responses in vitro. The combination of
Tacrolimus and CD4þCD25þ T cells had an additive effect on the inhibition of T cell
proliferation, suggesting that they mediate their suppression by inhibiting different stimulatory
pathways. It remains unclear whether regulatory T cells are functionally impaired in lesional
skin in atopic dermatitis, however this study demonstrates that they are present in the
peripheral blood and can suppress T cell activation in vitro. Enhancement of regulatory T cell
function in AD patients in combination with commonly used immunosuppressants may
enhance therapeutic efficacy.
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Pathogenetic Mechanisms of Vitiligo in a Patient with Sezary Syndrome
Knol A1, Guilloux Y1, Quereux G2, Marques-Briand S2, Pandolfino M3, Khammari A2, Dreno
B2
1INSERM U601, CHU Hoˆtel Dieu, Nantes, France; 2Clinique Dermatologique, CHU Hoˆtel
Dieu, Nantes, France; 3UTCG, CHU Hoˆtel Dieu, Nantes, France
Cases exhibiting association between vitiligo and cutaneous T-cell lymphoma (CTCL) remain
rare and for the moment it remains unanswered whether some T-cell sub-populations of the
CTCL are able to recognize in a specific manner some melanocytic epitopes, thus inducing
vitiligo.
The aim of our study was to determine whether some T-cells specific to melanocyte
differentiation antigens are detectable among tumour infiltrating lymphocytes (TIL) extracted
from hypopigmented skin lesions of a Sezary syndrome patient.
We clinically examined one patient with Sezary syndrome who developed a vitiligo during
her evolution, and performed immunohistochemical and immunological studies on skin
biopsies of both pigmented and hypopigmented skin. We realized an in vitro study by
transfecting COS7 cells with patient’s class I molecules and melanoma associated antigens.
Immunohistochemical studies showed a staining with HMB45 and Melan-A monoclonal
antibodies in the pigmented skin biopsy, whereas no staining was observed in the
hypopigmented skin biopsy. In the HLA-A2301 context, we observed a production of TNF
by CD8þ TIL against COS7 cells transfected with three melanocyte differentiation antigens:
Melan-A/MART1, tyrosinase and gp100. The strongest production of TNF was observed with
Melan-A/MART1 antigen.
Our study supports the concept that vitiligo developed during the course of a CTCL is
related to the presence of a T-lymphocytes sub-population reactive against melanocyte
differentiation antigens (mainly Melan-A/MART1) present in skin lesions.
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Topical Diphenylcyclopropenone as a Measure of Immune Competence in HIV
Seropositive Subjects
Levis W1, Kaplan L2
1Dept of Dermatology, NYU Medical School, USA; 2PharmaQuality Associates, USA
CD4 T cell counts are generally recognized as the standard method for monitoring HIV
seropositive patients and along with viral load are clinically important indications for initiating
HAART. Contact sensitizers such as diphenylcyclopropenone (DPC) have been used safely in
dermatology to treat warts and alopecia areata. Diagnostically, skin reaction scores following
topical application of DPC also can serve as a measure of immune competence.
We used low sensitizing doses of DPC applied in a unique non-volatile, non-irritating topical
delivery system manufactured under cGMP conditions to assess immune competence in
forty HIV seropositive subjects. Standardized patch test reading scores were used with 2þ
or greater scores (erythema and induration) indicative of a positive response. Considering
CD4 counts of 300 per cumm as a cut off criterion, the concentrations of 0.4% and 0.2% DPC
successfully resulted in 90% sensitivity skin reaction scores following a single 0.1 milliliter
application to the inner aspect of the forearm. Lower DPC concentrations of 0.1% and 0.05%
were too low for initial sensitization reactions. Three subjects with CD4 counts between 150
and 300 per cumm showed positive skin reactions indicative of other immune biological
factors to be further researched.
We conclude that a single topical application of DPC In our unique topical drug delivery
system at concentrations between 0.2% and 0.4% can serve as a measure of immune
competence in HIV seropositive patients. As DPC is a functional measure of immune
competence, it can serve as a useful diagnostic adjunct to CD4 blood level counts in the
clinical decision to initiate HAART. This consideration is particularly important in resource
poor settings where laboratory equipment to obtain CD4 blood level counts may not be
readily available.
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Effects of Ionizing Radiation Exposure on Human Mast Cells
Mu¨ller K1, Ko¨hn FM2, Mayerhofer A3, Ring J2, Meineke V1
1Bundeswehr Institute of Radiobiology, Munich, Germany; 2Clinic and Policlinic for
Dermatology and Allergology, Technical University of Munich, Germany; 3Institute of
Anatomy, University of Munich, Germany
Exposure of human skin to ionizing radiation results in a cutaneous radiation reaction which
includes various acute and long-term effects such as fibrosis and keratosis. In irradiated skin,
the number of mast cells is significantly increased. Several mast cell mediators have been
suggested to be involved in the pathogenesis of fibrosis. The purpose of our study was to
analyze mechanisms underlying the mast cell accumulation at sites of cutaneous
inflammation and to elucidate the functional role of mast cells in the development of late
radiation effects.
The site-directed recruitment of effector cells into inflamed tissues is mediated by
chemokines which act by binding to specific G protein-coupled receptors on target cells. As
mast cells express various chemokine receptors we investigated the effect of ionizing
radiation on chemokine receptor expression using human leukemic mast cells (HMC-1). By
flow cytometry, we demonstrate that irradiation with 5 Gy leads to elevated expression of
CCR5 and CXCR4 in mast cells. Our results suggest a possible relevance of these chemokine
receptors in radiation-induced mast cell recruitment into the skin. To evaluate whether
ionizing radiation activates mast cells, skin tissue explants were ex vivo irradiated with 5 Gy
and subjected to transmission electron microscopy. We found clear signs of acute mast cell
degranulation. Determination of histamine and tryptase in irradiated HMC-1 cells employing
ELISA and FACS analysis, respectively, revealed that histamine and tryptase are among the
radiation-induced acute mast cell secretory products. Moreover, ionizing radiation leads to an
up-regulation of intracellular protein expression of various interleukins as demonstrated by
FACS analysis. Taken together, our data suggest the radiation-induced activation of mast
cells to be a key event in the development of the cutaneous radiation reaction which might
offer promising targets for a selective treatment of radiation injuries.
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Role of Squalene Peroxidation in the Development of Inﬂammation in Acne Vulgaris
Ottaviani M1, Mastrofrancesco A1, Alestas T2, Flori E1, Zouboulis C2, Picardo M1
1San Gallicano Dermatological Institute (IRCCS), Rome, Italy; 2University Medical Center
Benjamin Franklin, Berlin, Germany
Inflammatory processes play an important role in the development of acne vulgaris.
Increased cytokines levels in the infundibulum, hyperkeratinization of the pilosebaceous duct
and augmented sebogenesis seem to be correlated. In order to study whether products
deriving from the oxidation of sebum can be responsible for the clinical manifestation of acne,
spontaneously immortalized human keratinocytes (HaCaT) were treated with peroxidated
squalene for 3 hours. Squalene was UVA-irradiated (365 nm, 1h) and the resulting reaction
mixture was applied to preconfluent HaCaT in serum free conditions. NF-kB activation,
secretion of IL-6 and its mRNA level, as well as PPAR- amRNA expression, were measured at
the end of the treatment and after 24 and 48 h of recovery. The concentrations of the applied
squalene peroxidation products (1.0–5.0 mg/ml) were those able to cause significant
hyperproliferation and induction of lipoxygenase activity. The results showed an early
activation of NF-kB followed by an increase of PPAR-a mRNA levels. Moreover, squalene
peroxides induced an initial up-regulation of IL-6 production and secretion that was
counteracted by PPAR-a activation, as suggested by the subsequent decrease of NF-kB
nuclear translocation and IL-6 mRNA levels. Taking account our previous findings indicating
an association of lipoxygenase stimulation with an increase of pro-inflammatory lipids
percentage, IL-6 release and reduction of PPAR-amRNA levels in human sebocytes and acne
patients, the present data further support the involvement of squalene peroxidation products
in the establishment of the inflammatory process in acne.
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Hapten Sensitization is Associated with Increased Recruitment of Caucig P CD8þ
T-Cells to Skin
Steinbrink K, Knop J, Von Stebut E
Dept of Dermatology, Johannes Gutenberg-University, Mainz, Germany
Contact hypersensitivity (CHS) is a T cell-mediated immune response of the skin. In contrast
to the challenge phase, little is known about the events during sensitization and we
hypothesized that local inflammation after sensitization is important for subsequent CHS
development. We therefore compared the inflammatory infiltrate of mouse ears after
treatment with contact allergen (450 mg TNCB), irritant (5% benzalkonium chloride (BAC))
or vehicle. Ear swelling was measured and inflammatory cells were characterized by FACS
after enzymatic/mechanical disruption every 24 hrs for 3 days. In C57BL/6 mice, maximal
increases of ear thickness were determined in TNCB- compared to BAC-treated ears after 24
hrs. In parallel, 2-3-fold more inflammatory cells were harvested from TNCB-treated
compared to BAC- or vehicle-treated ears (10.9  1.5, 3.3  0.5, and 4.9  0.4 x106/24
hrs, n¼ 6, p  0.05). Ear swelling after sensitization was associated with enhanced
immigration (  2-fold) of Gr-1þ neutrophils, PK136þ NK cells, and MHC IIþ cells (F4/
80þ MF and CD11cþ DCs), which was not observed after BAC or vehicle application. No
influx of B-cells was detected after any treatment. Interestingly, the total number of CD8þ
cells was 10-fold higher in TNCB- compared to BAC-painted skin (254  74 vs.
24  7  103/24 hrs, n¼ 9, p0.002). In contrast, both TNCB- and BAC-treatment similarly
induced transient CD4 immigration. Thus, no hapten-associated skin infiltration with CD4þ T-
cells was detected. Although C57BL/6 and BALB/c mice ed differences in their degree of
inflammation, no alterations in the composition of the cellular infiltrate were found. Increased
ear swelling of BALB/c ears was associated with higher cell numbers and increased
immigration of Gr-1þ and MHC IIþ cells, but no differences in T-cell recruitment. In summary,
hapten-sensitization through skin – unlike treatment with irritant – is associated with
increased recruitment of CD8þ T-cells to the site of inflammation. Future studies will
determine the effector function of these early inflammatory CD8þ T-cells for the development
of CHS.
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The Role of MAPKAP2 in Cutaneous Inﬂammation
Zu¨gel U1, Schottelius A1, Do¨cke WD1, Gaestel M2, Asadullah K1
1Corporate Research Business Area Dermatology, Schering AG, Berlin, Germany; 2Institute
of Biochemistry, University of Hannover, Germany
The p38 mitogen-activated protein kinase (MAPK) pathway is activated by stress and is
involved in phosphorylation of transcription factors. The MAPK-activated protein kinase 2
(MK2) is regulated through direct phosphorylation by p38 and involved in post-transcriptional
regulation of inflammatory and stress responses. It was shown that MK2 k.o. mice develop an
increased resistance to stress and an elevated survival rate in the LPS-induced endotoxic
shock model due to inpaired post-transcriptional stimulation of cytokine biosynthesis
especially in macrophages. For analysis of MK2 in cutaneous inflammation we applied the
MK2 k.o. mice to skin inflammation models. While initial studies confirmed the published role
of MK2 in the endotoxin shock model, MK2 deficiency had no significant impact on acute
cutaneous inflammation (unspecific phorbolester-induced or T cell-specific DNFB-induced
inflammation). Thus, other than in the acute endotoxin shock model, MK2 k.o. mice showed
no reduced acute cutaneous inflammatory response when compared to WT mice. Analysis in
subchronic T cell-dependent skin inflammation models gave a somewhat differential
outcome. Repeated DNFB challenge (once daily for 3 subsequent days) resulted in significant
reduced net increase of skin inflammation (measured by ear thickness) in MK2 k.o. vs WT
mice. In contrast, repeated DNCB challenge caused a slightly more pronounced net increase
of skin inflammation in MK2 k.o. vs. WT mice. In conclusion, our studies confirm the role of
MK2 in acute systemic inflammation whereas MK2 seems to play only a minor role in acute
skin inflammation. The role of MK2 in subchronic T cell-dependent skin inflammation is not
fully understood and awaits further analysis. Since expression analysis of MK2 in human
lesional skin from patients with chronic plaque-type psoriasis revealed an upregulation of
MK2 protein in inflamed psoriatic skin, the role of MK2 in T cell-mediated skin inflammation
(e.g. psoriasis) is still subject of further investigations.
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Modulation of Immune Markers by a Dissociated Vitamin D Analog
May E, Do¨cke WD, Asadullah K, Zu¨gel U
Corporate Research Business Area Dermatology, Schering AG, Berlin, Germany
The study assessed (i) the immunomodulatory potential of a novel 1,25-Dihydroxyvitamin D3
analog (ZK 203278) and (ii) the identification of biomarkers for ZK 203278-mediated effects
for subsequent clinical studies.
A broad selection of markers was evaluated in vitro using human PBMCs and ex vivo
accompanying a toxicity study in minipigs. In human PBMC, CD25, CD69, CD154, HLA-DR,
and CD28 were analyzed on CD4þ and CD8þ T cells. Monocytes were screened for CD4,
CD14, CD11b, CD54, HLA-DR, CD40, CD80, and CD86 expression. IFN-gamma, IL-1beta,
IL-2, IL-4, IL-5, IL-6, IL-8, IL10, and TNF-alpha were analyzed using a bead-based multiplex
system after in vitro stimulation with PHA or LPS. Biomarkers were evaluated ex vivo from
minipigs treated with ZK 203278 at 1, 5, 20 mg/kg/d for 4 weeks. CD4þ and CD8þ T cells
were analyzed regarding activation markers (SLA-DR, SLA-DQ, CD25), CD45RA, prolifera-
tion, and cytokine production (IL-2, IFN-gamma, IL-10). Monocytes were monitored on CD4,
SLA-DR, -DQ and CD14, and on secretion of TNF-alpha.
In human PBMCs, ZK 203278 inhibited monocytic CD4, HLA-DR, CD40, and CD54,
whereas CD14 was strongly increased. Limited effects have been observed on surface
markers of T cells. However, secretion of IFN-gamma, IL-2, and TNF-alphawas decreased. A
4-wk-treatment of minipigs resulted in marginal modulation of the selected markers. After
LPS-stimulation CD14 and SLA-DQ expression was enhanced on monocytes in the high dose
groups relative to the vehicle group, whereas expression of monocytic CD4 was reduced.
In conclusion, profound immunomodulatory effects, similar to those of calcitriol have been
observed with ZK 203278, most impressively on monocytes. In vitro data and animal
experiments showed that ZK 203278 is a calcitriol-derivative with considerable immunomo-
dulatory capacities at non-hypercalcemic dosages and might therefore suit for the systemic
treatment of immune diseases in man.
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Inverse Correlation of Perforinþ CD8dimþ Lymphocytes with Disease Activity of Alopecia
Areata and with the Serum Level of Total IgE
Schmidt I, Bonnekoh B, Gollnick H, Ambach A
Dept of Dermatology and Venerology, Otto-von-Guericke-University Magdeburg, Germany
Recently, in patients with alopecia areata (AA), a significant alteration of the perforin (Pf)
system in peripheral lymphocytes was reported. We now asked for a possible correlation
between different Pf-containing cell types and para-/clinical markers.
Peripheral mononuclear cells from 22 AA-patients (no systemic therapy; o30% scalp
involvement n¼ 15,  30% n¼ 7) and 12 healthy control individuals were triple stained with
fluorochrome-labeled antibodies against CD3, CD4, CD 8, CD28, CD56 and Pf and analyzed
in a flow cytometer employing the CellQuest software. Using the SPSS software, a Pearson
correlation of 40 parameters was calculated, correlation coefficient and significance is given.
The percentage of PfþCD8dimþ lymphocytes correlated negatively with disease activity
(0.54, p¼ 0.02) as did the number of Pfþ56þ cells (0.58, p¼ 0.01). PfþCD8dimþ cells
showed, in addition, a significant negative correlation with the serum titer of total IgE (0.48,
p¼0.01). This was restricted to the CD28 subtype (0,50, po0.01). The IgE level correlated
negatively with the percentage of all CD8dimþ lymphocytes (0.49, p¼ 0.01), but positively
with the number of CD28þCD8dimþ cells (0.42, p¼0.03) and the atopy score (0.46, p¼ 0.04).
There was a positive correlation of the area involved (extent) and serum level of ECP (0.43,
po0.05), but not to any Pfþ subtype. Duration of disease correlated with the number of
PfþCD28þCD8hiþ cells. PfþCD8dimþ lymphocytes correlated negatively with the number of
CD3þ , CD4þ and CD28þ lymphocytes, and positively with the percentage of other Pfþ
subtypes and of CD8dimþ and CD56þ cells.
PfþCD8dimþ lymphocytes are a mixture of CD8þCD56þ , T delta-gamma and CD4þCD8þ
lymphocytes. The involvement of these cells in both, disease activity and serum total IgE,
may contribute to the coincidence of atopy and AA observed in up to 50% of AA-patients.
221
Role of Proteinase-Activated Receptor-2 (PAR-2) in Human Neutrophil Functions In Vitro
and Experimentally-Induced Endotoxemia In Vivo
Shpacovitch V1, Seeliger S2, Buddenkotte J3, Varga G1, Balkow S1, Kerkhoff C4, Homey B5,
Luget T1, Steinhoff M1,2
1Dept of Dermatology, Univ Mu¨nster, Germany; 2Ludwig Boltzmann Inst Immunobiol Skin,
Univ Mu¨nster, Germany; 3Genomic Research Institute, Novartis Res Foundation, San Diego,
USA; 4Dept of Experimental Dermatology, Univ Mu¨nster, Germany; 5Dept of Dermatology,
Univ Du¨sseldorf, Germany
Proteinase-activated receptor-2 (PAR-2) belongs to a novel subfamily of G protein-coupled
receptors with seven trans-membrane domains. This receptor, reported to play a crucial role
in the development of different inflammatory disorders, can be activated by serine proteases
such as trypsin, mast cell tryptase, or bacterial proteases. Some inflammatory mediators
such as TNF-a, IL-1a and LPS are known to upregulate PAR-2 expression. However, the
simultaneous actions of inflammatory stimuli and PAR-2 agonists are still poorly investigated
in both in vivomodels and in cultured human cells. In the present study we demonstrated that
PAR-2 knockout animals are more resistant to harmful effects of LPS-induced endotoxaemia
as compared to wild-type mice. Further experiments with isolated human neutrophils also
demonstrated that simultaneous stimulation of these cells with PAR-2 agonists and LPS
results in enhanced damaging effects as compared to effects of LPS its own. Among these
effects are a) a delayed apoptosis of human neutrophils, which is known to be injuring for
surrounding tissues, and b) a strong down-regulation of CD88 (C5a anaphylatoxin receptor)
expression. Interestingly, a decreased expression of CD88 on neutrophils is thought to be
associated with an immunosuppressive stage of the immune response in humans during
sepsis and HIV. Moreover, a positive correlation between the level of CD88 expression on
neutrophils and animal survival during sepsis was recently demonstrated. Taken together, our
in vivo and in vitro data indicate that PAR2 stimulation enhances harmful LPS-induced effects,
in part by regulating key functions of immune cells. Thus, PAR2 may be considered as a
potential therapeutic target for the treatment of endotoxic shock and probably sepsis.
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Molecular Weight Determines the Frequency of Delayed Type Hyper-Sensitivity Reac-
tions to Heparin and Synthetic Oligosaccharides
Ludwig R1, Schindewolf M1, Alban S2, Kaufmann R1, Lindhoff-Last E1, Boehncke WH1
1Klinikum der J.W. Goethe Universita¨t, Frankfurt am MainGermany; 2Pharmaceutical
Institute, Christian-Albrechts University of Kiel, Germany
Eczematous lesions, resulting from type IV sensitizations are well-known and relatively
frequent cutaneous adverse effects of s.c. heparin therapy. If anticoagulation is further
required intravenous heparin, heparinoids or lepirudin may be used as a substitute. However,
these alternatives are not optimal in terms of practicability and/or safety-profiles. As
molecular weight of different heparin preparations has repetitively been implied to determine
the frequency of sensitization, we hypothesized, that due to its low molecular weight the
pentasaccharide fondaparinux may provide a practicable and save anticoagulant therapy in
patients with delayed type hypersensitivity reactions to heparin and other oligosaccharides.
To test this concept, patients referred for diagnosis of cutaneous reactions after s.c.
anticoagulant treatment underwent a series of in vivo skin allergy- and challenge-tests with
unfractionated heparin, a series of low molecular weight heparins (nadroparin, dalteparin,
tinzaparin, enoxaparin and certoparin), the heparinoid danaparoid and the synthetic
pentasaccharide fondaparinux. In total, data from twelve patients was evaluated. In
accordance with previously published data, we report a high crossreactivity among heparins
and heparinoids. In contrast – and in support of our initial hypothesis, sensitization towards
the synthetic pentasaccharide fondaparinux was rarely observed. Plotting the cumulative
incidence against the determined molecular weight of the individual anticoagulant
preparations, shows that molecular weight generally is a key determinant of sensitization
towards heparins and other oligosaccharides (r2¼ 0.842, p¼0.009). In summary, the
observations of a different antimetastatic activity and different sensitization potential of
anticoagulant preparations are two examples demonstrating that heparins have to be
considered as individual drugs. This allows to choose the optimal drug for each patient
requiring anticoagulant therapy. As shown here, for patients with cutaneous heparin
sensitization, fondaparinux may provide a safe and practicable alternative.
223
Establishment of Mouse Models of Atopic Dermatitis: Getting New Insights into the Role
of T Cells
Hennino A1, Benetie`re J1, Rodet K1, Berard F2, Vocanson M1, Schmitt AM3, Aries MF3,
Nicolas JF2
1INSERM U503, Lyon, France; 2Department of Clinical Immunology and Allergology, Lyon,
France; 3CERPER, Pierre Fabre Medicament, France
Skin lesions of atopic dermatitis (AD) are mediated by allergen-specific T cells. However, the
precise nature of T cells infiltrating the skin as well as the mechanisms by which they induce
the skin inflammation are not yet well characterized. Mite antigens, e.g. Dermatophagoides
farinae (DF), play important roles in the development of AD, and mite antigen-induced
dermatitis models appear beneficial for the basic study of AD. In the current study, we
established Dermatophagoides farinae – induced AD models in normal C57Bl6 mice. Mice
were sensitized by either skin painting with a DF antigen solution (repeated for several days)
or by sc injection of bone-marrow-derived DC pulsed with DF. Blood IgE levels increased in
DF-sensitized mice. Analysis of immune responses in draining lymph nodes showed the
presence of DF-specific CD4 and CD8 T cells. Development of AD lesions occurred upon ear
skin challenge with DF in sensitized animals only which resulted in ear swelling, thickening of
the epidermis and infiltration of the skin by CD4 and CD8 T cells and eosinophils.
Upregulation of mRNA expression for IL-4 and the chemokine TARC was observed in AD
lesional skin only. Therefore, the DF-induced skin inflammation obtained in our models
exhibits the main characteristics of human AD skin lesions, allowing us to study the
pathophysiology of the disease.
224
Gene Expression Proﬁle of Psoriatic Plaque-Derived Keratinocytes
Mascia F1, Rogge L2, Mariotti F1, Sinigaglia F3, Girolomoni G4, Pastore S1
1Istituto Dermopatico dell’Immacolata, Rome, Italy; 2Institut Pasteur, Paris, France; 3BioXell
SpA, Milan, Italy; 4University of Verona, Verona, Italy
Psoriasis is one of the most common inflammatory skin disorders in Western countries.
Presently its pathogenesis remains unclear, and it is controversial as to whether psoriasis results
from a primary abnormality in epidermal keratinocytes and/or from deregulation of the immune
system. In order to possibly define abnormal gene expression in epidermal keratinocytes, we
performed an oligonucleotide microarray analysis of the mRNA extracted from unstimulated
keratinocytes obtained from the plaques of psoriatic patients (n¼ 6) and from normal skin of
healthy controls (n¼ 6). This analysis led to the identification of 408 differentially expressed
transcripts, corresponding to 3.25% of the genes examined, which included transcription
factors, signal transducers, cytokines and chemokines, proteases and protease inhibitors,
numerous cell surface proteins, components of the extracellular matrix and cell cycle regulators.
In particular, when compared to healthy controls, keratinocytes from psoriatic patients displayed
a significant down regulation of IL-1ra but also of IL-18, whereas the angiogenic PDGF and the
anti-angiogenic thrombospondin-1 appeared both up regulated. Several metalloproteinases,
including MMP-1, MMP-9 and MMP-10, but also distinct inhibitors of serine and cysteine
proteases, including megsin and the plasminogen activator inhibitor 1, were potently
dysregulated. We also found exaggerated expression of TGF-b2, TGF-b1 binding protein, and
oncosuppressor p16INK4A. SYBR Green-based quantitative real-time RT-PCR confirmed the
differential expression levels of transcripts chosen from distinct gene clusters. In keeping with
gene expression data, unstimulated keratinocytes obtained from psoriatic plaques produced
lower levels of IL-1ra and IL-18 proteins when compared to healthy controls. They however
released exaggerated levels of MMP-1 and stained more intensely for p16INK4A. Our data
indicate that a constitutive defect in the expression of numerous genes characterizes
keratinocytes from psoriatic plaques, and suggest that a primary abnormality in the epidermis
may provide major pathogenic factors in psoriasis.
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Activation of the Complement System Generates Antibacterial Peptides
Andersson Nordahl E1, Rydenga˚rd V1, Nyberg P1, Nitsche P1, Mo¨rgelin M1, Malmsten M2,
Bjo¨rck L1, Schmidtchen A1
1Dept of Clinical Sciences and 2Dept of Pharmacy, Biomedical Center Lund, Sweden
The complement system represents an evolutionary old and significant part of the innate
immune system involved in protection against invading microorganisms. Here we show that
the anaphylatoxin C3a, and its inactivated derivative C3a-desArg are antibacterial,
demonstrating a previously unknown direct antimicrobial effect of complement activation.
The C3a peptide, as well as functional epitopes in the sequence, efficiently killed the Gram-
negative bacteria Eschericia coli, Pseudomonas aeruginosa, and the Gram-positive
Enterococcus faecalis. In mice, a C3a-derived peptide suppressed infection by Gram-
positive Streptococcus pyogenes bacteria. Fluorescence and electron microscopy demon-
strated that C3a binds to and induces breaks in bacterial membranes. C3a was also found to
induce membrane leakage of liposomes. These findings provide an interesting link between
the complement system and antimicrobial peptides, two important branches of innate
immunity.
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Does PPAR-Alpha Deﬁciency Modulate Epidermal Langerhans Cell Function?
Dubrac S1, Stoitzner P1, Schoonjans K2, Auwerx J2, Schmuth M1
1Dept of Dermatology, Medical School Innsbruck, Austria; 2Institut de Ge´ne´tique et Biologie
Cellulaire, Universite´ Louis Pasteur, Illkirch, France
Recently, it was demonstrated that PPAR-alpha is involved in the skin immune response.
Epidermal Langerhans cells (LC) are well characterized immature dendritic cells resident in
the epidermis. LC are antigen presenting cells and thus are essential modulators of the
cutaneous inflammatory response. The aim of this work was to investigate, if PPAR-alpha
deficiency alters LC maturation and function. GM-CSF-induced maturation of LC isolated
from PPAR-alpha deficient mice was similar to littermate controls since expression of
maturation markers (MHC class II molecule, CD40 and CD86) were not significantly changed.
However, LC isolated from PPAR-alpha deficient mice were less viable than littermate
controls. When PPARalpha-null mice or littermate controls were sensitized by a single
application of a contact allergen on both ears, migratory capacity of LC isolated from the
epidermis was impaired in PPAR-alpha deficient mice as compared to littermate controls; i.e.,
their departure was delayed and less LC emigrate within 24 hours after sensitization. Taken
together, these data indicate that PPAR-alpha deficiency modulates epidermal LC viability
and migratory capacity suggesting a role of PPAR-alpha in the adaptive immune response.
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Pimecrolimus Leads to an Apoptosis-Induced Depletion of T Cells but not Langerhans
Cells in Patients with Atopic Dermatitis
Hoetzenecker W1, Ecker R2, Kopp T3, Stuetz A4, Stingl G3, Elbe-Bu¨rger A3
1Department of Dermatology, Medical Univesitiy of Vienna, Austria; 2TissueGnostics,
Vienna, Austria; 3Department of Dermatology, Medical University of Vienna, Austria;
4Novartis Institutes for BioMedical Research, Vienna, Austria
Pimecrolimus, a calcineurin inhibitor, is highly effective in atopic dermatitis and appears to
have therapeutic potential also in other inflammatory skin diseases. In vitro it inhibits
selectively the production and release of cytokines and other pro-inflammatory mediators in T
cells and mast cells. The aim of this study was to investigate the target cells and mode of
action of pimecrolimus in vivo in healthy and diseased human skin and to compare these
effects with those of a corticosteroid (beta-methasone-17-valerate). While topical pimecro-
limus-treatment did not alter the morphology, phenotype and numbers of resident dendritic
cells (Langerhans cells) in healthy and atopic skin, inflammatory dendritic cells in atopic skin
lesions were markedly reduced. In contrast to these divergent effects, corticosteroid-
treatment depleted both dendritic cell types. Furthermore, clinical improvement of atopic
dermatitis with both corticosteroid- and pimecrolimus-treatment correlated well with a
decrease in lesional T cells, and the latter was shown to be mediated by apoptosis.
Collectively, our data demonstrate that pimecrolimus has a more selective mode of action
than corticosteroids.
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CD8þ T cells are Effector Cells of Contact Dermatitis to Common Skin Allergens
Vocanson M1, Saint-Mezard P1, Tailhardat-Cluzel M1, Benetiere J1, Ducluzeau MT1,
Chavagnac C1, Tedone R1, Berard F1, Kaiserlian D2, Nicolas JF1
1INSERM U503, Lyon, France; 2INSERM U404, Lyon, France
Allergic Contact Dermatitis (ACD) is the most frequent skin disorder and one of the
commonest occupational diseases. ACD to strong experimental contact allergens, referred to
as haptens, is mediated by hapten-specific CD8þ effector Tcells. Here, we show that similar
mechanisms occur for weak contact allergens, which comprise the vast majority of chemicals
responsible for human ACD. We used a model of ACD, i.e. the contact hypersensitivity
reaction, to test for the allergenicity of three weak haptens involved in fragrance allergy in
normal mice and in mice deficient in CD4þ T cells. ACD to weak haptens could not be
induced in normal mice. In contrast, mice acutely depleted in CD4þ T cells developed a
typical ACD reaction to the three weak fragrance allergens which peaked 24 hours after
challenge. Priming of CD8þ T cells was observed in draining lymph nodes 5 days after
sensitization and development of ACD was associated with the infiltration of activated CD8þ
T cells in the challenged skin. CD8þ T cells were effectors of the ACD reaction since in vivo
treatment with depleting anti-CD8 mAbs abrogated the ACD responses and since purified
CD8þ T cells could adoptively transfer ACD to naive recipients. In conclusion, our data
demonstrate an unanticipated dominant role of CD8þ Tcells as initiators of ACD to common
contact allergens, and suggest that CD8þ T cells may represent potential targets for
preventing or treating ACD.
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Dimethylfumarate for Psoriasis has Pronounced Effects on Lesional T-Cell Subsets,
Epidermal Proliferation and Differentiation, but not on NK-T Cells
Bovenschen HJ, Langewouters AM, Seyger MM, Van De Kerkhof PC
Dept of Dermatology, Radboud University Nijmegen, The Netherlands
T-cell infiltration, epidermal hyperproliferation and disturbed keratinization are pathological
hallmarks of plaque psoriasis. Oral fumaric acid esters (FAEs) are an effective therapy for
psoriasis and are believed to exert their effects mainly through their anti-inflammatory
properties.
Our aim was to investigate the differential effects of dimethylfumarate for psoriasis on
lesional T-cell subsets, NK-T cells, keratinocyte hyperproliferation and differentiation.
Biopsies were taken from lesional skin of 6 psoriatic patients, at baseline and after 16
weeks therapy of with dimethylfumarate, 720 mg daily. Clinical severity scores were obtained
(PASI and SUM). T-cell subsets (CD4þ , CD8þ , CD45ROþ , CD45RAþ , CD2þ , CD25þ ),
cells expressing natural killer receptors (CD94, CD161), an epidermal proliferation (Ki67) and
a keratinization marker (K10) were immunohistochemically stained and, together with
epidermal thickness, quantified using image analysis.
At week 16, the mean PASI and SUM-scores were reduced by 55% (po0.01) and 49%
(po0.01), respectively. In line with these results, epidermal hyperproliferation, keratinocyte
differentiation and epidermal thickness significantly improved. In the dermis and in the
epidermis, all relevant T-cell subsets significantly declined. However, in both the lesional
psoriatic dermis and epidermis, cells expressing NK-receptors (CD94 and CD161) persisted
after 16 weeks of treatment.
Dimethylfumarate is an effective therapy for moderate-to-severe plaque psoriasis, which
may result from a reduction of lesional T-cell subsets and a restore of epidermal
hyperproliferation and keratinization, but not from reduction of NK-T cells.
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Dimethylfumarate has a Suppressive Effect on Circulating T-cells, with the CD4þ
Population as a Main Target
Langewouters A, Bovenschen H, Van Erp P, De Jong E, Van De Kerkhof P
Dept of Dermatology, Radboud University Nijmegen, The Netherlands
Fumaric acid esters (FAE) have been proven to be effective in the systemic treatment of
psoriasis vulgaris. Its exact mechanism of action is still not fully understood. One of the
modes of action is thought to be an inhibition of T-cell activation, indicating an
immunosuppressive effect. Currently, one of the main components of the marketed FAE-
mixture, dimethylfumarate, is under investigation as a monotherapy.
The aim of the present study is to determine the effect of a 16-week treatment with
dimethylfumarate on circulating numbers of T-cells expressing CD4, CD8, CD45RO, CD45RA,
CD94, CD161, CD25, CLA or combinations of these cell markers, as compared to placebo.
Ten patients with moderate-to-severe psoriasis (PASI412) were included in this study and
randomized to receive either 3  2 capsules of 120 mg dimethylfumarate per day, or
placebo. Peripheral blood was obtained before and after 16 weeks of therapy. T-cell subsets
were analysed by means of flow cytometry.
Enumeration of cells showed a significant decrease in absolute circulating numbers of
CD4þ , CD45ROþ , CD4þCD45ROþ , CD4þCD25þ and CD4þCLAþ T-cells after a 16-
week treatment course with dimethylfumarate, whereas the cellcounts of the CD8þ and
CD45RAþ populations remained stable. In the control group, no changes in circulating
lymphocyte subsets were found.
Dimethylfumarate as a monotherapy has a suppressive effect on various lymphocyte
subpopulations. Its effect seems to be mainly directed against the CD4þ and CD45ROþ
populations of T-cells, without influencing the CD8þ and CD45RAþ populations. This
implies a selective inhibition of activated T-cells.
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Characterisation of the T cell Response to the Model Hapten 2,4-Dinitrochlorobenzene
and Identiﬁcation of Intracellular Target Proteins
Pickard C1, Smith A2, Friedmann PS1
1Southampton General Hospital, United Kingdom; 2Imperial Cancer Research Fund,
London, United Kingdom
Allergic contact hypersensitivity (CHS) to small molecular weight environmental xenobiotics
results in great morbidity with loss of time from work. In order for a small molecule or hapten
to be recognized by T cells, it must become protein-bound. Such chemicals are thought to
bind covalently to serum or cellular proteins which are then processed and presented to the T
cells in association with MHC molecules by antigen presenting cells (APC). In addition, it has
been shown that some chemicals (e.g. nickel) may directly associate with peptides
embedded in the MHC groove (or the MHC molecule itself) in a processing-independent
manner. In most instances the mechanism of self-protein haptenation by contact sensitizers
and the identities of the immunologically relevant peptides remain unknown. Indeed,
differences in the way xenobiotics are metabolised during detoxification, and the degree of
protein binding, could be a critical factor in determining whether an individual generates an
immunogenic form of a hapten or not.
2,4-Dinitrochlorobenzene (DNCB) is a useful tool for investigation of mechanisms in CHS as
it can sensitise all normal humans. Here we have shown the human immune response to
DNCB, as in mice, is mediated by both CD4þ and CD8þ Th1/Tc1 T cell subtypes (N¼ 7).
Using DNCB-specific T cell clones and autologous Epstein-Barr transformed B (EBV-B) cells
as APC, we observed that the hapten is presented via both metabolism dependent and
independent pathways. Thus for some clones responses were abrogated by glutaraldehyde
fixation of APC while others could respond to fixed APC pulsed with DNCB. Finally, we have
shown that DNCB binds to a large number of intracellular proteins none of which appears to
be immnodominant. However, there is preferential binding to the lymphocyte actin bundling
protein L plastin; we are investigating the role of this protein in presentation of DNCB.
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Characterization of the Dendritic Cells in Vitiligo
Bro¨nnimann M, Spanou Z, Hunger RE, Braathen LR, Yawalkar N
Dermatological Clinic, Inselspital, Bern, Switzerland
The role of the dendritic cells (DCs) in the pathogenesis of vitiligo is not yet completely
determined. Our previous data indicate that the number of Langerhans cells (LCs) is
diminished in vitiligo lesions. The aim of the present study was to further examine the
presence and distribution of different DC subpopulations in lesional and non-lesional skin of
vitiligo patients.
The expression of CD11c, CD1c, CD209 and CD68 was analyzed using immunohisto-
chemistry in 6 healthy controls and in lesional and non-lesional skin of 10 patients with vitiligo.
CD11c expression, a pan-myeloid DC marker, was significantly decreased in the epidermis
but not in the dermis of vitiligo lesions. A significantly reduced number of CD209þ DCs
(immature phenotype), which were only detected in the dermis, was found in lesional skin as
compared to normal skin. CD1c molecule is expressed on a subpopulation of CD1aþ DCs.
The number of these cells was reduced in the dermis but not in the epidermis of vitiligo skin.
Futhermore, we observed an increased number of macrophages (CD68þ ) in lesional skin.
Our data demonstrate a reduction of DCs in lesional skin of vitiligo patients. A possible
explanation could be the destruction of DCs by cytotoxic factors released during melanocyte
destruction with consequently enhanced numbers of CD68þ macrophages being involved in
the clearance of cellular debris. Another explanation is the migration of DCs to regional lymph
nodes in order to present (auto-antigens).
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Altered Serum Concentration and Altered Expression of the Components of the CD14/
TLR Complex on the Peripheral Leukocytes of Patients with Atopic Dermatitis
Szegedi A, Su¨megi A, Irinyi B, Hunyady J, Antal-Szalma´s P
University of Debrecen, MHSC, Hungary
Atopic dermatitis is frequently associated with Gram-positive (Staphylococci) bacterial
infections. As the cell-wall components of these bacteria are recognized by the molecules of
the CD14/TLR2 complex, we hypothised that alterations in the serum concentration and in
the expression and function of these receptors on leukocytes might be observed in atopic
patients.
Therefore we quantitated the CD14, TLR1, TLR2, TLR4, CD180 expression on whole blood
leukocytes of 24 healthy controls and 29 patients suffering from atopic dermatitis using flow
cytometry and standard beads (DAKO QIFIKIT). The CD14, Fc- and complement-receptor
mediated phagocytosis and endotoxin binding of the leukocytes was tested using bodipy-
E.coli, FITC-LPS and flow cytometry. The serum soluble CD14 (sCD14) concentration was
measured by a newly developed inhibitory flow cytometric assay.
The TLR1 and TLR2 expression on the patients’ monocytes and granulocytes was
increased compared to the controls (atopic monocytes - TLR1: 806  209, TLR2:
5167  1961; atopic granulocytes – TLR1: 491  276, TLR2: 866  386; control monocytes
– TLR1: 595  345, TLR2: 4005  1532; control granulocytes – TLR1: 371  234, TLR2:
633  236). The CD180 expression on the lymphocytes and monocytes was also elevated
(atopic monocytes: 1859  621, atopic lymphocytes: 3975  1055; control monocytes:
1404  555, control lymphocytes: 3080  953). In contrast there was no difference in the
CD14 and TLR4 expression of these cells furthermore the LPS-binding and phagocytosis was
also not altered in patients compared to controls. The serum sCD14 concentration was lower
in the atopic patients (1118þ366 ng/ml) compared to controls (1334þ 366 ng/ml).
The altered TLR1, TLR2 and CD180 expression on atopic leukocytes is probably a result of
the generalized systemic cellular activation induced by Gram-positive infections frequently
associated with the atopic dermatitis.
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The Selective Effect of Alefacept on Memory T cells
Lawrence P, Darif M, Sweetser M, Mathes B
Biogen Idec, Cambridge, USA
Alefacept is a fully human LFA-3/IgG1 fusion protein with a dual mechanism of action. The
LFA-3 domain reversibly binds to CD2 on the surface of T cells, thereby blocking a key co-
stimulatory pathway for T-cell activation. The IgG1 domain engages FcgRIII on cytotoxic cells
(eg, natural killer cells) to induce T-cell apoptosis. CD4þ and CD8þ memory T cells are
preferentially targeted by alefacept because these cells have much higher levels of CD2
expression on their surface compared to naı¨ve CD4þ and CD8þ T cells. No significant effect
of alefacept on CD19þ B cells or CD16þ /CD56þ natural killer cells has been observed. The
effects of alefacept on T cells are therefore selective in nature. This is in contrast with the
broader immunosuppressive effects of other T-cell therapies such as alemtuzumab, a
humanized CD52 monoclonal antibody and muromonab, a murine anti CD3 monoclonal
antibody. Moreover the immunological outcomes of alefacept’s effects also differ from other
biological, viral and chemical agents such as etanercept, human immunodeficiency virus and
methotrexate, respectively. The targeted pharmacodynamic effects of alefacept are key to its
encouraging safety profile. In the integrated safety database, 1869 patients have received up
to 9 courses of alefacept over a 5-year period. There have been no increases in infections
with multiple courses of alefacept and the incidence of serious infections has been low. No
association with absolute T-cell counts and infections have been seen. Of the 2132 patients
who have received alefacept in the clinical program, there have been no cases of
tuberculosis, disseminated viral infections, opportunistic infections or deaths related to
infection. Importantly, alefacept-treated patients maintain immune function as demonstrated
by intact antibody responses to recall (tetanus) and neoantigens (bacteriophage). These data
suggest that alefacept is safe for the long-term treatment of psoriasis based on its unique
targeted mechanism of action.
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Mast Cell-Derived TNF Regulates DTHR through TNFR1 Expressing Endothelial Cells
Kneilling M1, Mailhammer R2, Scho¨nberger T1, Eichner M1, Maier KA2, Hu¨ltner L2, Pfeffer K3,
Gawaz M1, Biedermann T1, Ro¨cken M1
1Eberhard Karls University Tu¨bingen, Germany; 2GSF-National Research Center for
Environment and Health, Mun, Germany; 3University of Du¨sseldorf, Germany
Signaling through tumor necrosis factor receptor 1 (TNFR1) plays a central role in the control
of intracellular pathogens and the induction of inflammatory Th1 cell-mediated autoimmune
diseases, such as non-obese diabetes or autoimmune encephalitis. Yet, the underlying
mechanisms remain enigmatic and various models have been proposed. Dissecting Th1 cell-
mediated delayed type hypersensitivity responses (DTHR) into single steps, here we show
that the central defect is localized to the missing TNFR1-expression by endothelial cells (EC).
TNFR1 was not needed for in vivo priming of effector-Th1 cells capable to induce strong
DTHR, as shown by adoptive transfer experiments. In addition, mast cell-knock-in
experiments, using TNF/ or TNFR1/ recipient mice showed that the signaling defect
was downstream between mast cells and endothelia. Downstream analysis showed that
TNFR1/ mice are highly defective in inducing mRNA-expression of P-selectin, ICAM-1 and
VCAM-1 during DTHR. In order to definitely ask whether TNFR1-signalling on endothelia is
required, we performed intra-vital fluorescence microscopy. In TNFR1/ mice lymphocyte
rolling was strongly suppressed at 2 h post challenge. More importantly firm adhesion was
reduced to 20% even at 3.5 h a time when lymphocytes infiltrate the ear tissue. Thus, TNFR1-
signalling from MC to TNFR1-expressing EC is critically needed for lymphocyte recruitment
during Th1 cell-induced DTHR. Appropriate expression of P-selectin, ICAM-1 and VCAM-1 by
EC is essential for recruitment of mononuclear and polymorphonuclear cells during Th1 cell-
mediated inflammation. Thus, signaling at mast cell derived TNF through TNFR1-expressing
EC is essential for control of intracellular pathogens or the induction of inflammatory
autoimmune diseases.
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Differential Regulation of T cell and Innate Immune Responses by interLeukin-10 Derived
from Different Cell Types
Roers A1, Siewe L1, Strittmatter E1, Deckert M1, Schlueter D2, Stenzel W1, Gruber A3, Krieg
T1, Rajewsky K4, Mueller W5
1University of Cologne, Germany; 2University of Magdeburg, Germany; 3School of Veterinary
Medicine, Hannover, Germany; 4Harvard Medical School, Boston, USA; 5German Research
Center for Biotechnology, Braunschweig, Germany
Interleukin-10 (IL-10) is a regulator of immune responses produced by a number of cell types
including macrophages, lymphocytes, epithelial and mast cells. Complete IL-10 deficiency
results in exaggerated Tcell as well as innate responses. In order to elucidate the contribution
of the various IL-10 secreting cell types to immune regulation we generated mice with an
inactivation of the IL-10 gene restricted to specific cell types. Immune responses of mice
deficient for IL-10 specifically in T cells were analysed and compared to responses of animals
with complete IL-10 deficiency. The T cell-specific IL-10 mutants reproduced the deregulated
T cell immunity of complete IL-10 deficiency but did not develop exaggerated innate
responses. We found that the TLR-9-mediated response to CpG oligodeoxynucleotides is
dramatically enhanced in complete IL-10 knock outs, but not in T cell- or macrophage-
specific IL-10 mutants. Thus, IL-10 from cell types other than macrophages or T cells is
responsible for the regulation of the TLR-9 response. The inflammatory response to TLR-4
ligation by LPS is enhanced in IL-10/ mice but not in T cell-specific knock outs of the
cytokine. However, the macrophage-specific mutants developed more vigorous inflammatory
reactions to LPS as compared to wt mice, demonstrating that macrophage-derived IL-10
regulates the LPS response. Our results show that secretion of IL-10 from different cell types
can serve distinct and non-redundant functions.
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CD4þCD25þ Regulatory T Cells Suppress Contact Hypersensitivity Reactions by
Blocking Inﬂux of Effector T Cells into Inﬂamed Tissue In Vivo
Ring S1, Mahnke K1, Schaefer S2, Lehr H2, Enk A1
1University of Heidelberg, Germany; 2University of Mainz, Germany
CD4þCD25þ regulatory T cells (Tregs) exert suppressive function(s) on effector T cells in vitro
and in vivo and to date it is not clear whether soluble mediators play a role in mediating these
effects. To elucidate Treg function during contact hypersensitivity (CHS) reactions, we
established a novel model using intravital fluorescence microscopy in awake C57BL/6 mice
implanted with a skinfold chamber. This experimental setup allows us to monitor the blood
flow during CHS reactions at the side of antigen challenge. In this model we adoptively
transferred syngeneic CD4þCD25þ T cells during elicitation of a CHS reaction and our
results showed that the inflammatory reaction was significantly reduced after injection of
Tregs. Moreover, this effect was associated with a reduction of the influx of leukocytes into
the inflamed tissue and a blockade of leukocyte-endothel interaction at the site of
inflammation. Interestingly, we were not able to detect any of the injected Tregs in the
vascular system in this area, and injection of tissue culture supernatant derived from
cultivated Tregs suppressed CHS reactions as well as leukocyte influx into respective tissues
similar to Tregs themselves. These effects could be blocked by administration of anti-IL-10
antibodies while neutralization of TGF-b was inefficient. Thus these data show that Tregs
suppress CHS reactions by blocking the influx of effector T cells into inflamed tissues. This
suppression was not dependent on cell-cell-contact, instead Treg derived IL-10 played an
important role in the suppression of CD8þ T cell-mediated immune response in the skin after
exposure to contact allergens.
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Wound-Healing Defect of CD18/ Mice Due to a Decrease in TGF-beta1 and
Myoﬁbroblast Differentiation
Peters T1, Sindrilaru A1, Hinz B2, Al-Azzeh E1, Menke A1, Hinrichs R1, Oreshkova T1, Kess
D1, Sunderko¨tter C1, Scharffetter Kochanek K1
1University of Ulm, Germany; 2Swiss Federal Institute of Technology, Switzerland
We studied the mechanisms of a severely impaired wound healing in leukocyte-adhesion
deficiency syndrome-1 using a murine disease model. In CD18/ mice, full-thickness
wounds were severely increased during the phase of granulation-tissue contraction normally
dominated by myofibroblasts. Interestingly, expression levels of the myofibroblast markers a-
smooth muscle actin and ED-A fibronectin were substantially reduced in CD18/ mice. We
identified decreased levels of TGF-b1 and TGF-b receptor type-II as a potential cause for
impaired myofibroblast differentiation, as injecting TGF-b1 into wound margins fully re-
established wound closure. Since in CD18/ mice, defective migration leads to a severe
reduction of neutrophils in wounds, we envisioned that infiltrating macrophages may not
phagocytose apoptotic CD18/ neutrophils, thus, lacking their main stimulus to secrete
TGF-b1. We demonstrated that in absence of neutrophils, or in co-cultures with CD18
/
neutrophils, TGF-b1 release by macrophages was dramatically reduced due to defective
phagocytic clearance of CD18/ neutrophils, whereas pro-inflammatory cytokines were
increased. Our data demonstrate that the paracrine secretion of growth factors induced by
wound-infiltrating neutrophils is essential for cellular differentiation in wound healing.
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p38-Mitogen Activated Protein Kinase is a Key Regulator of Interleukin-20 Gene-
Expression in Human Keratinocytes
Otkjær K1, Kragballe K1, Nrby PL2, Just H1, Clausen JT2, Iversen L1
1Aarhus University Hospital, Denmark; 2Novo Nordisk A/S, Denmark
Interleukin-20 (IL-20) is a member of the IL-10 cytokine family. IL-20 over expressing
transgenic mice have skin changes that resemble those seen in human psoriatic skin.
Furthermore, it has been demonstrated that keratinocytes in the basal layer of lesional
psoriatic skin express increased levels of IL-20 mRNA. Therefore IL-20 is believed to be a key
cytokine in the pathogenesis of psoriasis.
The aim of the present study was to identify important signalling pathways controlling IL-20
gene expression in human keratinocytes.
Cultured normal human keratinocytes were stimulated with IL-1b, UVB, IFNg or TNF-a. In
separate experiments cells were pre-incubated with inhibitors of PKC, p38 MAPK or ERK and
then stimulated for one hour with IL-1b (10 ng/ml) or vehicle. Furthermore, tissue cultures with
punch biopsies from normal or non-lesional psoriatic skin were stimulated with IL-1b or
vehicle. Total RNA was purified and analysed with quantitative-RT-PCR.
Incubation with IL-1b or UVB lead to a significant increase in IL-20 mRNA expression in
human keratinocytes, whereas IFNg and TNF-a did not induce IL-20 mRNA expression. The
induction of IL-20 mRNA by IL-1b was also demonstrated in punch biopsies from normal and
non-lesional psoriatic skin cultured ex vivo.
Pre-incubation with the p38 MAPK inhibitor, SB 202190 dramatically decreased IL-20
mRNA expression to a level below vehicle treated cells. Inhibition of ERK with PD 98059
resulted in a moderate although statistically significant decrease in IL-20 gene-expression
whereas inhibition of PKC did not affect IL-20 gene expression significantly.
These data demonstrate p38 MAPK as a key regulator of IL-20 gene expression in human
keratinocytes. Because IL-20 is believed to be an important cytokine in the pathogenesis of
psoriasis, p38 MAPK may also be a possible target in the treatment of this disease.
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TRANCE and its Receptors TRANCE-R and OPG are Expressed in Human Epidermis and
Regulate Langerhans Cell Viability and Numbers
Barbaroux JB1, Mee J1, Mu¨ller C2, Groves R1
1King’s College London, United Kingdom; 2INSERM U255, France
Recent data indicate that epidermal Langerhans cells (LC) have a marked capacity to survive
for long periods in the periphery. A newly described TNF superfamily signalling pathway
consisting of TRANCE, its functional receptor TRANCE-R and a decoy receptor osteopro-
tegerin (OPG), has been associated with numerous activities including regulation of dendritic
cell (DC) function. We and others have shown that TRANCE/TRANCE-R interactions support
DC survival and we hypothesised that this system might be of relevance to the survival ability
of LC. In this study we sought to define expression and function of TRANCE and its receptors
in epidermis.
Normal human skin (n¼ 3) and keratinocyte cultures (n¼ 3) were analysed by RT-PCR for
TRANCE, TRANCE-R and OPG. We observed mRNA for TRANCE and both receptors in vivo
and in in vitro keratinocyte cultures. In vivo, TRANCE-R was strongly expressed by dendritic
cells in the epidermis and double labelling studies demonstrated that all CD1aþ epidermal LC
expressed TRANCE-R. To explore the functional relevance of these observations, LC were
derived in vitro from CD34þ cord blood progenitors and, following TRANCE-R induction by
TNFa, LC viability increased from 42.5% to 61.9% after 8 days of culture in the presence of
50ng/ml of rHuTRANCE (n¼ 3). Additionally, in vivo studies demonstrated a 35% decrease in
epidermal LC counts in TRANCE KO mice when compared to wild type controls (n¼ 6).
These data indicate that TRANCE, TRANCE-R and OPG are all present within epidermis at
both mRNA and protein levels and appear to be involved in the regulation of epidermal LC
survival. The distribution of TRANCE (produced by KC) and TRANCE-R (expressed on LC)
suggests a cross-talk between these two cell types and implies a further key regulatory role
for keratinocytes in the cutaneous immune response.
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Increased Sensitivity to IFN-a in Psoriatic T Cells
Eriksen KW1, Lovato P1, Skov L2, Krejsgaard T1, Kaltoft K3, Geisler C4, Ødum N1
1Institute of Medical Microbiology and Immunology, University of Copenhagen, Denmark;
2Department of Dermatology, Gentofte Universtiy Hospital, Copenhagen, Denmark;
3Institute of Human Genetics, University of Aarhus, Denmark; 4Institute of Medical
Microbiology and Immunology, University University of Copenhagen, Denmark
Psoriasis is a chronic inflammatory skin disease characterized by abnormal epidermal
proliferation. Several studies have shown that skin-infiltrating activated T cells and cytokines
play a pivotal role during initiation and maintenance of the disease. Interferon (IFN)-a plays an
important role in host defence against infections, but recent data have also implicated IFN-a
in psoriasis. Thus, IFN-a induces or aggravates psoriasis in some patients, and mice lacking a
transcriptional attenuator of IFN-a/b signaling spontaneously develop a psoriasis-like
inflammatory skin disease characterized by CD8þ infiltrating T cells. In the present study
we therefore investigate IFN-a signaling in T cells isolated from involved skin of psoriatic
patients. By Western Blotting (WB) we show that psoriatic T cells have increased and
prolonged responses to IFN-a, on the level of signal transducers and activators of
transcription (STAT) activation, compared to infiltrating T cells from skin of non-psoriatic
donors. These findings are associated with an equal protein- and surface-expression of the
IFN-a-receptor in psoriatic and control T cells as measured by WB and flow cytometric
analysis, respectively. Functionally, the increased IFN-a signaling leads to an increased
binding of STAT4 to the IFN-g promotor (oligonucleotide affinity purification followed by
Western Blotting), IFN-g production (ELISA-measurement), and inhibition of T-cell growth
(proliferation assay with [3H]thymidine incorporation). In contrast to the abnormal IFN-a
response, STAT responses to other cytokines were not changed in psoriasis. In conclusion,
we provide the first evidence that T cells from involved skin of psoriatic patients have an
increased sensitivity to IFN-a. Thus, our data suggest that increased IFN-a signaling is
involved in the pathogenesis of psoriasis.
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CCL1-CCR8 Interactions: An Axis Mediating the Recruitment of T Cells and Langerhans-
Type Dendritic Cells to Sites of Atopic Skin Inﬂammation
Gombert M1, Dieu-Nosjean MC2, Winterberg F1, Bu¨nemann E1, Kubitza RC1, Da Cunha L2,
Haahtela A3, Lehtima¨ki S4, Mu¨ller A1, Rieker J1, Homey B1
1Departments of Dermatology and Radiation Oncology, Heinrich-Heine University, Du¨ssel-
dorf, Germany; 2Laboratoire d’Immunologie Cellulaire et Clinique, Centre de Recherches
Biome´dicales des Cordeliers, Paris, France; 3Skin and Allergy Hospital, Helsinki University
Central Hospital, Finland; 4Finnish Institute of Occupational Health, Helsinki, Finland
Atopic dermatitis represents a chronically relapsing skin disease with a steadily increasing
prevalence of 10–20% in children. Skin-infiltrating T cells, dendritic cells (DC), and mast cells
are thought to play a crucial role in its pathogenesis. We report that the expression of the CC
chemokine CCL1 (I-309) is significantly and selectively up-regulated in atopic dermatitis in
comparison to psoriasis, cutaneous lupus erythematosus, or normal skin. CCL1 serum levels
of atopic dermatitis patients are significantly higher than levels in healthy individuals. DC,
mast cells, and dermal endothelial cells are abundant sources of CCL1 during atopic skin
inflammation and allergen challenge, and Staphylococcus aureus-derived products induce its
production. In vitro, binding and cross-linking of IgE on mast cells resulted in a significant up-
regulation of this inflammatory chemokine. Its specific receptor, CCR8, is expressed on a
small subset of circulating T cells and is abundantly expressed on interstitial DC, Langerhans
cells generated in vitro, and their monocytic precursors. Although DC maintain their CCR8þ
status during maturation, brief activation of circulating T cells recruits CCR8 from
intracytoplamic stores to the cell surface. Moreover, the inflammatory and atopy-associated
chemokine CCL1 synergizes with the homeostatic chemokine CXCL12 (SDF-1a) resulting in
the recruitment of T cell and Langerhans cell-like DC. Taken together, these findings suggest
that the axis CCL1-CCR8 links adaptive and innate immune functions that play a role in the
initiation and amplification of atopic skin inflammation.
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IL-22 increases the Innate Immunity of the Skin
Wolk K, Kunz S, Witte E, Friedrich M, Asadullah K, Sabat R
University Hospital Charite´ Berlin, Germany
Interleukin(IL)-22 was discovered in 2000. It belongs to the IL-10 family of cytokines whose
members (additionally IL-10, IL-19, IL-20, IL-24, and IL-26) are structurally related molecules.
We have previously shown that IL-22 is mainly produced by activated T cells, particularly the
Th1 subset. Unlike IL-10, the data presented here surprisingly show that IL-22 does not act
on immune cells. This conclusion is based on a systematic study at all possible levels of
analysis: on receptor expression, signal transduction, effects in vitro, and effects in vivo. In
contrast, the quantitative analyses of a wide range of tissues and corresponding primary cells
and cell lines showed that many non-immune tissue cells are target of IL-22 as they express
both chains of the IL-22 receptor complex. Very high levels of IL-22 receptor chains were
found in skin and keratinocytes. In primary human keratinocytes these levels were further
upregulated by IFN-g suggesting an increased sensitivity of these cells towards the IL-22
action under T1 conditions. The receptor complex on these cells was functional as deduced
from IL-22-induced STAT3 tyrosine phosphorylation. For the first time, we identified effects of
IL-22 on keratinocytes, namely the upregulation of the antimicrobial agents b-defensin 2 and
3. This effect was transcriptionally regulated, and independent on protein de novo synthesis
and alternative protein secretion indicating a direct effect of IL-22. Additionally, this induction
was time- and dose-dependent, and enhanced upon cellular differentiation. The extent of
induction was comparable to that by other known inducers of b-defensins. In skin from
patients with T cell-mediated dermatoses, high levels of IL-22 were highly significantly
associated with strongly upregulated expression of b-defensin 2 and 3 suggesting a
protective effect of IL-22 in these disorders. Taken together, IL-22 does not serve the
communication between immune cells but is a T cell mediator that directly promotes the
innate, non-specific immunity of the skin. The observation that activated T1 cells directly
regulate the non-specific immune defense in tissues demonstrates a so far unknown but very
important side of the immune system.
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Two-Dimensional Western blotting and Mass Spectrometry of Tryptic Peptides Reveal
Novel IgG-Reactive Autoantigens in the Proteome of Psoriatic Epidermis
El-Rachkidy R, Hales J, Freestone P, Camp R
University of Leicester, United Kingdom
Psoriasis appears to be a T cell-mediated autoimmune disease, but convincing autoantigens
have not been identified. The use of T cells to screen for autoantigens amongst a large
population of lesional proteins is also technically very difficult. There is longstanding evidence
for the presence of abundant IgG in the upper epidermis and stratum corneum (SC) of
psoriatic lesions, and we have now confirmed this using aqueous extracts of lesional SC in an
ELISA with alkaline phosphatase (AP)-labelled anti-human IgG, and in Western blotting.
Lesional SC homogenates were also subjected to high-resolution denaturing 2-D electro-
phoresis on parallel gels, some of which were blotted onto nitrocellulose and probed with
pooled sera from donors with chronic plaque psoriasis or from healthy matched controls
(n¼ 7). Bound IgGs on these 2-D Western blots were detected with AP-labelled anti-human
IgG. Pooled psoriatic serum IgGs were reproducibly found to recognise at least 18 different
protein spots whereas pooled control serum IgGs recognised only 5 spots. Corresponding
Coomassie-stained protein spots on a parallel gel were excised and tryptic peptide mapping
done by matrix assisted laser desorption ionisation mass spectrometry (MALDI-MS). This
allowed identification of six proteins that have not previously been reported as autoantigenic
in skin disease: enolase 1, arginase 1, squamous cell carcinoma antigen (SCCA), SCCA 1,
SCCA 2 and SCCA 2b, most of which have biological properties relevant to inflammatory and
proliferative skin disease. Others proteins reactive with psoriatic serum IgG and identified by
MALDI-MS included keratin 10, alpha-tubulin, and 60 kDa and 70 kDa heat shock proteins.
Assays allowing more precise quantification of serum IgGs that react with these molecules
are being developed. The findings indicate new avenues of research into the pathogenesis of
psoriasis.
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Interleukin 20 Controls Psoriasis Induction and Maitenance
Rosada C1, Stenderup K1, Dagnaes-Hansen F2, Steiniche T3, Hasselager E4, Holmberg HL4,
Iversen L4, Kragballe K1, Clausen JT4, Dam TN5
1Dept of Dermatology, Aarhus Sygehus, Denmark; 2Dept of Medical Microbiology and
Immunology, University of, Denmark; 3Dept. of Pathology, Aarhus Sygehus, Denmark;
4Discovery, Novo Nordisk, Denmark; 5Dept of Dermatology, Roskilde Hospital, Denmark
The relevance of interleukin 20 (IL-20) as modulating agent in psoriasis and its potential as
target for therapy is investigated. The human xenograft model using keratomes (dermis and
epidermis) from lesional or non-lesional skin from psoriatic patients transplanted onto SCID
mice was employed. Psoriasis was induced in non-lesional skin upon intra-dermal injection of
staphylococcal enterotoxin B activated autologus peripheral blood mononuclear cells
(PBMC). Each experiment was repeated using keratomes from three or four patients and
included at least 12 mice per keratome biopsy (minimum 3 mice/treatment group).
Cyclosporine A (CsA) was administered as positive and vehicle as negative control to
xenografts from psoriatic plaques. The grafts were evaluated and given semi-quantitative
psoriasis scores (redness, scaliness, and thickness) in all experiment from the first day of
treatment. On the day of sacrifice biopsies were obtained. The psoriatic phenotype was
confirmed by histology and by immunohistochemistry. RhIL-20 co-administered with non-
activated PBMC to non-lesional skin significantly increased the epidermal thickness and the
psoriasis score as compared to PBMC alone, (p¼0.0001 and p¼ 0.048, respectively). Non-
activated PBMC or vehicle did not induce the psoriatic phenotype. Psoriasis induction in non-
lesional grafts was inhibited by polyclonal rabbit anti-IL-20 (pAb). These findings were
paralleled when pAb anf CsA were tested in plaque psoriasis. The psoriasis score was
significantly reduced after pAb (p¼ 0.036) or CsA (p¼0.036) treatment compared to vehicle.
Most importantly, the epidermal thickness was significantly reduced (pAb, p¼0.039; CsA,
p¼0.025). In contrast, rhIL-20 sustained or even aggravated psoriasis. In conclusion, this
xenograft study demonstrates that IL-20 plays an important role in the induction and
maintenance of psoriasis. IL-20 infusion leads to induction of psoriasis and IL-20 blocking
leads to remission.
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Induction of Targeted Cell Migration by Dermal Administration of a DNA Vector Encoding
a Biologically Active Chemokine
Jalili A1, Pashenkov M1, Wagner C2, Nakano H3, Stingl G1, Wagner SN1
1DIAID, Department of Dermatology and CeMM, Medical University of Vienna, Austria;
2DIAID, Department of Dermatology, Medical University of Vienna, Austria; 3Division of
Cardiology, Department of Medicine, Duke University, USA
CCL21 is a CC chemokine expressed in secondary lymphoid organs (SLO) and lymphatic vessels,
known to exert chemotactic activity mainly on CCR7þ and also CXCR3þ cell types including
naı¨ve and central memory T cells, mature DCs, and effector memory T cells, respectively.
Its expression is an important prerequisite for spatial and functional organization of SLO and
adequate mounting of adaptive immune responses.
Inflammation in peripheral tissues such as skin can induce local expression of CCL21, which is
subsequently drained to LNs where it influences the cellular composition of the LN.
To see whether we can influence the cellular composition of the LNs by dermal administration of
a pDNA encoding CCL21 we generated a pDNA based gene construct allowing high-level
expression of CCl21. Secretion and expression of biologically active CCL21 was confirmed in vitro
by IHC, WB analysis and ELISA and chemotactic transwell migration assays.
In vivo experiments showed cellular expression of transgenic CCL21 after particle-mediated
gene delivery into skin. CCL21 was secreted into the upper dermis and presumably transported
into the draining LNs as indicated by increased total cell number and frequencies of CD11cþ
DCs, CD4þ /CD62Lþ naı¨ve T cells, CD4þ /CD62L and CD8þ /CD62L effector memory T cells
(cell populations known to express CCR7 or CXCR3) in draining LNs of plt/plt mice which lack
endogenous production of CCL21. Interestingly, this strategy did not lead to retention of DCs at
the site of gene delivery.
Our studies show that biologically active CCL21 can be expressed by genetic means in vitro
and in vivo. Transgenic CCL21 is subsequently secreted into the pericellular compartment and
allows reconstitution of a genetic defect or the co-localization of different cell types at the site of
choice, an important prerequisite for targeted cell migration or cellular cargo delivery.
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Osteopontin Production by Dendritic Cells is Differentially Regulated and is Essential for
their Migratory Capacity
Renkl A, Schulz G, Seier A, Schlick J, Weiss J
Dept of Dermatology and Allergology, University of Ulm, Germany
The expression of the pleiotropic cytokine osteopontin (OPN) in lymphatic organs is crucially
involved in the migration of dendritic cells (DC) to skin draining lymph nodes and their
initiation of cutaneous contact hypersensitivity (CHS). When analyzing the source of OPN
during the sensitization phase of CHS, we found that DC in draining lymph nodes highly
express OPN mRNA.
We now investigated OPN secretion by DC during their differentiation and analyzed its
functional relevance for their migration. When DC were differentiated from murine bone
marrow (BM) by GM-CSF and IL-4, OPN highly accumulated in such cultures. Quantifying
OPN mRNA and secreted protein from DC enriched and depleted BM-cells we identified DC
as the major source of OPN throughout BM-culture. Immature DC enriched on day 6 were
matured by IL-4, IFN-g, TNF-a IL-1a or LPS in the presence of GM-CSF. In the absence of
cytokines DC secrete low amounts of OPN, which was strongly increased by a combination
of GM-CSF and IL-4. When replacing IL-4 by TNF-a or IL-1a, that both induce migratory DC,
an upregulated OPN secretion was observed. In contrast, DC that have become immobile
following terminal maturation by LPS did not secrete OPN. When functionally correlating the
role of DC OPN expression for their migratory potential, we found that in comparison to OPN
wild type DC, DC from OPN deficient mice revealed diminished chemotaxis in Boyden
chamber assays. Importantly, in vivo OPN deficient DC were insufficient in their migration to
lymph nodes upon cutaneous adoptive transfer into OPN wild type mice. In conclusion, OPN
production by DC is differentially regulated by inflammatory and migration promoting
cytokines and loss of OPN production leads to impaired DC migration.
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Topical Nuclear Factor kappa B Decoy: An Effective, Safe and Novel Treatment for Atopic
Dermatitis
Dajee M, Muchamuel T, Schryver B, Alleman-Sposeta J, Oo A, Komuves L, Mcevoy L,
Ehrhardt R
Corgentech Inc., South San Francisco CA, USA
Long-term use of topical corticosteroids and calcineurin inhibitors raises concerns about
undesirable side effects in atopic dermatitis (AD). The nuclear factor kappa B (NF-kB)
transcription factor plays a central role in AD. This study explores the possibility of using
topical NF-kB decoy (NFkBD) as a therapeutic alternative for AD. The efficacy and skin
penetration of a specific NFkBD was examined in several animal models. In a dustmite
antigen induced AD mouse model, topical NFkBD produced a dose-dependent reduction of
ear swelling (up to 80%), similar to betamethasone. Also, NFkBD shows efficacy in a TPA-
induced dermatitis murine model. In both models, NFkBD decreased expression of pro-
inflammatory cytokines such as IL-1b, IL-6, TNFa and IFNg by an average of 60-80%. Both
NFkBD and betamethasone therapy dramatically reduced mononuclear cells infiltration and
epidermal proliferative indices. Gene expression profiling between betamethasone and
NFkBD treatment on inflamed ears illustrate distinct regulation of target genes. Also, severe
rebound of inflammation was seen after cessation of betamethasone, however, NFkBD
therapeutic benefit was maintained for at least 15 days after discontinuation of drug
treatment. Unlike betamethasone that induces skin atrophy of 15%, prolonged NFkBD
application fails to show such side effect. We show that betamethasone, but not NFkBD,
down-regulates major components of extracellular matrix of the skin, like Collagen I and III
(50%), tenacin C (40%) elastin (30%). Furthermore, 23 weeks of NFkBD application, on
chemically induced skin cancer murine model does not increase skin papilloma formation.
Lastly, we show efficient transfection of 0.5% NFkBD in keratinocytes and dermal cells in pig
skin, suggestive of effective human skin delivery. The present study illustrates the potential of
topical NFkBD as a novel, effective and safer therapeutic agent for the treatment of
inflammatory skin diseases.
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Toxic Epidermal Necrolysis: Identiﬁcation of a Molecular Link between Drug-Speciﬁc T-
Cell Activation and Keratinocyte Apoptosis
Viard-Leveugle I1, Cooper H2, Friedmann P2, French LE1
1Geneva University Hospital, Switzerland; 2University of Southampton, United Kingdom
Toxic epidermal necrolysis (TEN) is a severe adverse drug reaction that results in epidermal
necrolysis due to FasL-mediated keratinocyte apoptosis. Evidence suggests that TEN is
initiated by an immune response to a drug or its metabolite(s), but the signaling pathway
linking this immune response to the up-regulation of keratinocyte FasL expression is
unknown.
Here we show that FasL and inducible nitric oxide synthase (iNOS), an enzyme that leads to
the production of the pro-inflammatory and cytotoxic molecule nitric oxide (NO), are co-
expressed by keratinocytes in skin lesions of TEN. In vitro, exposure of keratinocytes to NO
donors rapidly increases keratinocyte FasL expression and results in Fas-mediated
keratinocyte apoptosis. We also show that keratinocyte iNOS expression and NO production
can be triggered by both IFN-g and TNF-a, with a synergistic effect resulting from their
combination. Similarly, conditionned media from CD3-activated peripheral blood mono-
nuclear cells - that contain high levels of IFN-g and TNF-a induce keratinocyte NO production.
Finally, conditionned medium generated by phenytoin exposure of phenytoin-specific T cell
clones from a patient with phenytoin-induced TEN specifically induce keratinocyte iNOS
expression, NO production, and FasL-mediated cell death.
Taken together, our data identify T-lymphocyte IFN-g and TNF-a, followed by keratinocyte
NO, as minimal essential constituents of a novel molecular link between activated drug-
specific T cells and keratinocytes. This molecular link likely accounts for the induction of
keratinocyte FasL expression and apoptosis after drug-specific T cell activation in TEN.
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SCID Mice Transplanted with Human Gut as A Pre-Clinical Model for Studying the
Migration of Human Lymphocytes to the Small Intestine
Gu¨nther C1, Schwa¨rzler C2, Kund J2, Carballido J2, Hinteregger S2, Fassl S2, Biedermann
T3, Carballido J2
1Novartis Institutes for Biomedical Research Vienna, curr. a, Germany; 2Novartis institutes
for biomedical research Vienna, Austria; 3Department of Dermatology, University of
Tu¨bingen, Germany
Diseases of the skin frequently occur as complications of inflammatory bowel disease or
together with alimentary truct disorders. The recruitment of pathologic T cell populations into
the small intestine is mediated by CCL25. This chemokine exclusively interacts with CCR9,
which is expressed by essentially all CD4þ and CD8þ T lymphocytes displaying the
intestinal homing receptor alpha4beta7. Thus, CCR9 antagonists are potential therapeutics
for the treatment of inflammatory bowel diseases (IBD) and may also prevent associated skin
disorders.
Studying the in vivo function of human chemokines and their pharmacological inhibition
often requires species specific models. To develop a system for proving the efficacy of
compounds interfering with the CCL25-CCR9 mediated T cell recruitment in a relevant in vivo
environment we established a humanized severe combined immunodeficiency (SCID) mouse
model. SCID mice were transplanted with fragments of human fetal small intestine (SCID-hu
Gut) and reconstituted with a human T cell line. This line was derived from adult mesenteric
lymph nodes and expressed CCR9 and alpha4beta7 integrin. In response to CCL25 this
mesenteric lymph node derived T cell line specifically migrated in the chemotaxis chamber.
Homing of human T cells to the human intestine in vivo was induced by intragraft
administration of CCL25 and evaluated by flow cytometry and histological analysis using
HLA-specific mAbs. CCL25 administration induced a significant migration of CD4þ and
CD8þ T cells to the human intestinal graft. The in vivo T cell recruitment was specifically
inhibited using a neutralizing mAb against CCL25. This new mechanistic model will allow the
preclinical evaluation of human specific compounds interfering with the different steps that
regulate homing of T cells to the small intestine and thereby abolishing inflammatory
responses in intestinal and related skin diseases.
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Mimotope Immunizations against High Molecular Weight: Melanoma-Associated Antigen
Elicit Anti-Melanoma Immune Responses
Riemer AB1, Hantusch B1, Hafner C2, Zielinski CC3, Scheiner O1, Pehamberger H2, Jensen-
Jarolim E1
1Department of Pathophysiology, Medical University of Vienna, Austria; 2Department of
Dermatology, Medical University of Vienna, Austria; 3Department of Internal Medicine I,
Medical University of Vienna, Austria
Background. Size and posttranslational modifications are obstacles in the recombinant
expression of high molecular weight – melanoma-associated antigen (HMW-MAA). Creating
a tumor antigen mimic via the phage display technology may be a means to overcome this
problem for vaccine design.
Objective. In this study, we aimed to generate an immunogenic epitope mimic of HMW-MAA.
Methods. We screened a linear 9mer phage display peptide library, using the anti-HMW-MAA
monoclonal antibody (mAb) 225.28S. This antibody mediates antibody-dependent cellular
cytotoxicity (ADCC) and was already used for anti-idiotype therapy trials. One mimotope was
chosen to be fused to albumin binding protein (ABP) as an immunogenic carrier.
Subsequently, the fusion protein was tested for immunogenicity in BALB/c mice.
Results. Fifteen peptides were selected by mAb 225.28S in the biopanning procedure. They
share a consensus sequence, but show only partial homology to the amino acid sequence of
the HMW-MAA core protein, indicating mimicry with a conformational epitope. Immunoas-
says with 225.28S indicated that the mimotopes and the mimotope fusion protein were folded
correctly. The induced anti-mimotope antibodies recognized HMW-MAA of 518A2 human
melanoma cells, whereas sera of mice immunized with the carrier ABP alone showed no
reactivity. These anti-mimotope antibodies were capable of inducing specific lysis of 518A2
melanoma cells in ADCC assays with murine effector cells.
Conclusion. In conclusion, the presented data indicate that mimotopes fused to an
immunogenic carrier are suitable tools to elicit epitope-specific anti-melanoma immune
responses.
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Stratum Corneum of Normal and Psoriatic Skin Contains Angiogenin, an Antimicrobial
Protein
Abtin A, Eckhart L, Ghannadan M, Mildner M, Tschachler E
Medical University of Vienna, Austria
Angiogenin (ANG), a multifunctional member of the RNase A family, was recently shown to
function as endogenous antimicrobial agent in the gut. Here we investigated the expression
of ANG in the epidermis. Structural analysis of human RNase gene products revealed that
ANG and RNase-4, an RNase of unknown function, are transcribed from a common promoter
and formed by alternative pre-mRNA splicing. Expression of both ANG and RNase-4 was
detected by RT-PCR in keratinocytes (KC) growing in monolayer culture and in the epidermis.
ELISA demonstrated ANG in the culture supernatant of KC in vitro and in aqueous extracts of
stratum corneum (SC) that also contained an immuno-reactive protein of the expected size in
ANG-specific immunoblot analysis. The concentration of ANG varied considerably among SC
samples of healthy individuals and was significantly increased in lesional scales of psoriasis
patients. Addition of recombinant ANG to cultures of Candida albicans confirmed a potent
growth-inhibitory effect on this facultative skin pathogen. Our data suggest that ANG
contributes to cutaneous antimicrobial defense.
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Primary Keratinocytes Express Nucleotide-Binding Site and Leucine-Rich Repeat (NBS-
LRR) Proteins
Voss E, Schro¨der JM, Harder J
University of Schleswig-Holstein, Kiel, Germany
Human keratinocytes are able to initiate a defense response by the release of antimicrobial
proteins and proinflammatory cytokines by the detection of microorganisms and their
products (so-called ‘‘pathogen-associated molecules or patterns, PAMPs’’). Specific
receptors (so-called ‘‘Pattern Recognition Receptors, PRRs’’) mediate the recognition of
specific PAMPs. It has been shown that various Toll-like receptors, which are involved in the
detection of microbes in the extracellular compartment, are expressed in keratinocytes
suggesting that they function in keratinocytes to recognize PAMPs. A novel class of
intracellular receptors have recently been implicated in the recognition of specific PAMPs.
These NBS-LRR proteins (for nucleotide-binding site and leucine-rich repeat), are involved in
intracellular recognition of microbes and their products (e.g. peptidoglycan). We analysed the
gene expression of NBS-LRR proteins in keratinocytes using conventional RT-PCR as well as
real-time PCR to gain more insight into the role of these putative sensors of microbial
products in the innate immune response of human skin. To differentiate between cDNA and
contaminating genomic DNA Intron-spanning primer pairs were designed. Distinct gene
expression of 7 NBS-LRR proteins (out of 20 tested) were detected in primary foreskin-
derived keratinocytes. Among them were Nalp1, Nalp 2, Nalp10, NOD1, NOD2, NOD9 and to
a minor degree NOD27. Whereas most of the genes were not influenced by stimulation with a
mucoid Pseudomonas aeruginosa, NOD2 and Nalp 10 were slightly induced. We conclude
that keratinocytes express a distinct subset of NBS-LRR proteins. Further studies are now in
progress to elucidate whether these putative intracellular PRRs initiate a defense response in
keratinocytes upon sensing of microbial products.
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RNase 8: A Novel Human Antimicrobial Protein
Riudolph B, Podschun R, Harder J
Dept of Dermatology, University Hospital Schleswig-Holstein, Germany
The ribonuclease RNase 7 has been isolated from human skin as a potent broad-spectrum
antimicrobial protein. Recently, a novel ribonuclease, termed RNase 8, has been discovered
by screening the human genome sequence. Although RNase 7 and RNase 8 share an amino
acid sequence similarity of 78% and a genomic distance of only 15000 bp, no antimicrobial
activity has been associated with RNase 8.
Using real-time PCR we detected gene expression of RNase 8 in primary keratinocytes.
Gene expression was moderately induced by Phorbol-12-Myristate-13-Acetate (PMA). To
reevaluate a potential antimicrobial function of RNase 8 we established the recombinant
production of RNase 8 in E. coli and tested its antimicrobial activity in a microdilution assay
system. Surprisingly, recombinant RNase 8 exhibited a broad spectrum of antimicrobial
activity. Pathogenic bacteria like Staphylococcus aureus, Pseudomonas aeruginosa,
Streptococcus pyogenes, Klebsiella pneumoniae and the yeast Candida albicans were
effectively killed at concentrations below 1 mM. Also multi-resistant strains like MRSA were
highly susceptible to RNase 8. RNase 8 exhibited no significant ribonuclease activity
suggesting that the antimicrobial activity of RNase 8 requires no functional ribonuclease
activity.
In summary, we identified RNase 8 as a novel broad spectrum antimicrobial protein, which
could help to protect human skin and other epithelia against infection.
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Probing the Effects of ‘‘Stress’’ on the Human Hair Follicle: Substance P Upregulates
MHC Class I and NGF Immunoreactivity Ex Vivo and Stimulates Degranulation of
Connective Tissue Sheath Mast Cells
Peters EM1, Liotiri S2, Bodo´ E3, Ohnemus U2, Bı´ro´ T3, Arck PC1, Paus R2
1University-Medicine Charite´, Berlin, Germany; 2University Hospital Eppendorf, Germany;
3University of Debrecen, Hungary
The controversial debate whether or not psychoemotional stress can alter hair growth has
recently been revived by our finding that a defined stressor indeed exerts multiple hair growth-
inhibitory effects in the mouse, which critically depend on mast cell degranulation induced by the
stress-related neuromediators substance P (SP) and nerve growth factor (NGF). However, it is as
yet completely unclear whether human hair follicles will respond in a comparable manner. Here,
we report that normal human scalp hair follicles (HF) in the growth stage (anagen VI) express
prominent immunoreactivity (IR) for the SP receptor NK-1. This suggests that the growing human
hair follicle is sensitive to SP-stimulation. In order to probe this hypothesis and to transport our
understanding of stress-induced hair growth inhibition from the murine to the human system, we
have utilized an in vitro assay for the culture of anagen IV HF and exposed these to SP in analogy
to in vivo stress-exposure. In this assay, SP upregulated IR for NGF and its low-affinity receptor
p75, which is the key receptor in neurotrophin induced hair follicle regression. By contrast, IR for
the high affinity receptor TrkA, which is known to mediate the growth signal of NGF, was
decreased. Moreover, we found that SP (10-8 to -12M) stimulated mast cell degranulation in the
HF connective tissue sheath in all donors. Strikingly, SP treatment also up-regulated MHC class
Ia IR and induced its ectopic expression in the dermal papilla and hair matrix, thus endangering
the HF immune privilege and threatening it to collapse as observed e.g. in alopecia arreata. SP
also upregulates IR of the MHC class Ia-associated molecules b2-microglobulin and HLA-A/B/C
and of the MHC I-expression promoting transcription factor NFkB. Together these findings
suggest an anti-growth and pro-inflammatory and pro-regression effect of SP on the human HF.
In conclusion, we present a simplistic, but instructive organ culture assay for exploring the effects
of key mediators of psychoemotional stress in vitro. We demonstrate that the HF is highly
sensitive to the administration of such stress mediators and responds with down regulation of
growth promoting signalling systems and up-regulation of regression and inflammation
promoting signalling systems. SP may therefore exert profound effects on human scalp HF
growth and neuroimmunology in support of the concept that our previous observations in mice
are quite relevant to the effects of psychoemotional stress on human hair growth.
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Angiotensin II Suppresses TNFa-Induced IL-6 mRNA Expression Via the AT2-Receptor in
Human Dermal Fibroblasts
Steckelings UM, Reinemund J, Guhl S, Henz BM, Unger T, Artuc M
Charite´-Universita¨tsmedizin Berlin, Germany
Recently, we demonstrated the presence of a complete tissue renin-angiotensin-system in
human skin. However, the characterisation of cutaneous actions of angiotensin II (Ang II) is
only at the very beginning. Interleukin 6 (Il-6) is a pro-inflammatory cytokine known to be
synthesised by dermal fibroblasts. In order to test for the hypothesis that Ang II may be
involved in cutaneous inflammatory processes, we examined IL-6 expression in response to
Ang II with or without co-stimulation by TNFa and distinguished between AT1- and AT2-
receptor mediated responses.
Human primary dermal fibroblasts were isolated from female thoracic skin derived in the
course of cosmetic breast surgery. For these experiments, cells were used in passage 5.
Fibroblasts were stimulated with Ang II (107 M) for 24 hours. In order to distinguish between
AT1- and AT2-receptor mediated effects, cells were co-incubated with irbesartan (10-5 M) or
PD 123319 (10-5 M), respectively. The same experiment was performed on a second set of
cells, which were additionally treated with TNFa (10 ng/ml) in order to stimulate Il-6
expression and to examine the effect of Ang II on elevated Il-6 levels. Il-6 mRNA was detected
by semiquantitative RT-PCR normalized against b-actin.
Basic Il-6 expression in primary dermal fibroblasts was almost not detectable, and the
basic expression was not altered by Ang II. Stimulation of cells with TNFa led to a marked
increase in Il-6 expression, which could be prevented by Ang II. The Ang II induced prevention
of TNFa stimulated Il-6 overexpression could be completely blocked by the specific AT2-
receptor antagonist PD 123319, but not by the AT1-receptor antagonist irbesartan. Thus, in
human dermal fibroblasts, Il-6 expression is stimulated by TNFa, an effect which is
counteracted by Ang II via the AT2-receptor.
From these data we conclude, that Ang II may be involved in the regulation of cutaneous
inflammatory processes, and that it may exert anti-inflammatory actions by inhibition of
cytokine expression via the AT2-receptor.
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CC Chemokine Ligand 18, an Atopic Dermatitis-Associated and Dendritic Cell-Derived
Chemokine, is Regulated by Staphylococcal Products and Allergen Exposure
Pivarcsi A1, Gombert M1, Dieu-Nosjean MC2, Lauerma A3, Kubitza R1, Meller S1, Rieker J1,
Muller A1, Da Cunha L2, Haahtela A3
1Departments of Dermatology and Radiation Oncology, Heinrich-Heine University, Du¨ssel-
dorf, Germany; 2Laboratoire d’Immunologie Cellulaire et Clinique, Centre de Recherches
Biome´dicales des Cordeliers, Paris, France; 3Department of Dermatology, University of
Helsinki, Finland
Atopic dermatitis is a chronic inflammatory skin disease with a steadily increasing prevalence.
Exposure to allergens or bacterial superantigens triggers Tand dendritic cell (DC) recruitment
and induces atopic skin inflammation. In this study, we report that among all known
chemokines CCL18/DC-CK1/PARC represents the most highly expressed ligand in atopic
dermatitis. Moreover, CCL18 expression is associated with an atopic dermatitis phenotype
when compared with other chronic inflammatory skin diseases. DCs either dispersed within
the dermis or clustering at sites showing perivascular infiltrates are abundant sources of
CCL18. In vitro, microbial products including LPS, peptidoglycan, and mannan, as well as the
T cell-derived activation signal CD40L, induced CCL18 in monocytes. In contrast to
monocytes, monocyte-derived, interstitial-type, and Langerhans-type DCs showed a
constitutive and abundant expression of CCL18. In comparison to Langerhans cells,
interstitial-type DCs produced higher constitutive levels of CCL18. In vivo, topical exposure
to the relevant allergen or the superantigen staphylococcal enterotoxin B, resulted in a
significant induction of CCL18 in atopic dermatitis patients. Furthermore, in nonatopic NiSO4-
sensitized individuals, only relevant allergen but not irritant exposure resulted in the induction
of CCL18. Taken together, findings of the present study demonstrate that CCL18 is
associated with an atopy/allergy skin phenotype, and is expressed at the interface between
the environment and the host by cells constantly screening foreign Ags. Its regulation by
allergen exposure and microbial products suggests an important role for CCL18 in the
initiation and amplification of atopic skin inflammation.
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Generation of Multiple Stable Dermcidin-Derived Antimicrobial Peptides in Sweat of
Different Body Sites
Rieg S1, Seeber S2, Steffen H1, Humeny A2, Kalbacher H1, Stevanovic S1, Garbe C1,
Schittek B1
1Eberhard-Karls-University Tu¨bingen, Germany; 2Friedrich-Alexander-University Erlangen,
Germany
Antimicrobial peptides (AMPs) are effector molecules of innate immunity. Dermcidin (DCD), a
recently discovered AMP with broad spectrum activity, is produced constitutively by eccrine
sweat glands and secreted into sweat. In the present study we investigated the proteolytic
processing, site specific expression and stability of DCD-peptides in eccrine sweat. Using
surface-enhanced laser desorption ionization time of flight mass spectrometry (SELDI-TOF-
MS) and RP-HPLC-analysis we identified in eccrine sweat 14 proteolytically processed DCD-
peptides. Semi quantitative SELDI-TOF-MS analysis indicated that processing of DCD-1L is
individually different but generates a few dominant peptides. At body sites with a high
probability for contact with pathogenic microorganisms a high amount of antimicrobial active
DCD-peptides was detected in sweat. Furthermore, we show that the secretion rate of DCD is
constant during a period of prolonged sweating and that DCD-peptides are stable in sweat
over several hours. Other known antimicrobial peptides like the human cathelicidin LL-37 and
a- or b-defensins were not detected in significant quantity in eccrine sweat. Due to the
durable and abundant presence, DCD-derived peptides contribute to the first line of defense
by building a constant barrier that overlies the epithelial skin.
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Epithelial Toll-like Receptor 4 is Crucial for Host Defence in a Model of Oral Candidosis
Weindl G1, Korting HC2, Schaller M1
1Department of Dermatology, Eberhard-Karls-University Tu¨bingen, Germany; 2Department
of Dermatology, Ludwig-Maximilians University Munich, Germany
In humans, cells of the innate immune system can discriminate between pathogens and self
by using signals from the Toll-like receptor (TLR) family. TLRs recognise conserved motifs
called pathogen-associated molecular patterns (PAMPs), which represent broad groups of
microbial pathogens or components (bacteria, fungi, RNA, DNA). Despite extensive studies in
this new field, little is known regarding the role of TLRs in mucosal immunity against common
fungal pathogens like Candida albicans. In addition, the interaction of epithelial cells with
principal cells of the mucosal innate defence system, such as polymorphonuclear leukocytes
(PMNs), has not been studied in detail.
In this study, using an established model of oral candidosis based on reconstituted human
oral epithelium (RHE), we examined the role of TLRs in sensing C. albicans by oral epithelial
cells and the affect of PMNs on this interaction. Stimulation of oral epithelium by C. albicans
failed to induce TLR expression by quantitative RT-PCR, confocal laser and immunoelectron
microscopy. However, when the C. albicans-infected oral RHE model was supplemented with
PMNs we detected a strong increase (4100-fold) in epithelial TLR4 expression. Confocal
laser and immunoelectron microscopy confirmed stimulation of epithelial TLR4 expression on
the protein level and demonstrated TLR4 presence only by epithelial cells directly in contact
with C. albicans. Furthermore, upregulation of epithelial TLR4 in the presence of PMNs was
also associated with increased IL-8 production and an attenuated virulence phenotype of C.
albicans, which could be reversed by anti-TLR4 neutralising antibodies.
Our data implicates a pivotal role for ‘immunological cross-talk’ between C. albicans-
infected human epithelium and PMNs, resulting in the TLR-mediated sensing of C. albicans
by human epithelial cells.
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Non-Complement Fixing IgG4 Autoantibodies from Bullous Pemphigoid Patients
Activate Leukocytes and Induce Blisters in Cryosections of Human Skin
Mihai S1, Herrero-Gonzalez JE1, Goodall M2, Jefferis R2, Savage CO2, Zillikens D1, Sitaru C1
1University of Lu¨beck, Germany; 2University of Birmingham, United Kingdom
Bullous pemphigoid (BP) is a subepidermal autoimmune blistering disease associated with
autoantibodies to the dermal-epidermal junction. Complement and leukocyte activation are
major pathogenic events in blister formation of BP. We previously demonstrated that BP
patients’ autoantibodies generate dermal-epidermal separation when co-incubated with
cryosections of human skin and leukocytes from healthy volunteers. However, the subclass of
pathogenic IgG autoantibodies in BP sera has not yet been characterized. Therefore, in this
study, we isolated the two major subclasses of circulating autoantibodies, IgG1 and IgG4,
from BP patients’ serum, and analysed their blister-inducing potential in our cryosection
assay. Purification of IgG subclasses was performed using monoclonal antibodies against
IgG1 and IgG4 immobilized on affinity matrices. Purified IgG1 and IgG4 preparations were
adjusted to the same reactivity against the dermal epidermal junction as revealed by indirect
immunofluorescence microscopy when compared with the IgG subclass reactivity of the
crude BP sera. Subsequently, the preparations were tested in our cryosection assay. As
expected, complement-fixing IgG1 autoantibodies induced subepidermal splits in this
experimental model. Purified IgG4 did not fix complement, but, interestingly, like IgG1,
recruited and activated leukocytes to the basement membrane and induced dermal-
epidermal separation. Our results demonstrate that, in addition to IgG1, IgG4 autoantibodies
are able to activate leukocytes and point to a hitherto less recognized function of IgG4.
Moreover, for the first time, we clearly demonstrate that IgG4 autoantibodies from BP patients
have the capacity to induce dermal-epidermal separation. Our present observation,
demonstrating a pathogenic role of IgG4 autoantibodies, suggests that immunoapheresis
therapies in BP should remove not only IgG1 but also IgG4 serum autoantibodies.
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Decreased IFN-j production by keratinocytes and monocytes of patients with psoriasis
or atopic dermatitis
Scarponi C1, Nardelli B2, Lafleur DW2, Moore PA2, Madonna S1, De Pita` O1, Girolomoni G3,
Albanesi C1
1IDI-IRCCS, Rome, Italy; 2Human Genome Science, Inc., USA; 3University of Verona, Italy
IFN-k is a type I IFN expressed constitutively only by monocytes, dendritic cells and
keratinocytes. In human keratinocytes it is produced in response to double-strand RNA and
other IFNs, and can protect from viral infections. In monocytes and dendritic cells, IFN-k
induces TNF-a and IL-10, and inhibits LPS-induced IL-12 release by monocytes and dendritic
cells. Here we report that IFN-k is upregulated in human keratinocytes preferentially by IFN-g,
it accumulates in the cytoplasm and on the plasma membrane, and only limited amounts are
released extracellularly. Soluble IFN-k did not influence keratinocyte proliferation nor
chemokine and membrane molecule expression. Notably, membrane-associated IFN-k was
able to induce the activation of the IFN-stimulated response element signaling pathway.
Importantly, the constitutive and IFN-g-inducible production of IFN-k by keratinocytes and
monocytes from patients with psoriasis and atopic dermatitis (AD) was reduced compared to
those from healthy subjects. Consistently, keratinocytes in lesional AD and psoriasis skin
expressed lower levels of IFN-k compared to keratinocytes in skin affected by allergic
contact dermatitis or lichen planus. The lack of IFN-k in psoriasis and AD could be the result
of a genetic defect shared by the two diseases, and, together with other intrinsic alterations,
may contribute to the pathogenesis of psoriasis and to the high susceptibility of AD patients
to viral infections.
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Keratinocyte Derived IL-1a and TNF-a Trigger Chemokine Secretion by Fibroblasts:
Implications for Skin Inﬂammation
Spiekstra SW, Breetveld M, Draaijers L, Bruynzeel DP, Blomberg Von BM, Scheper RJ,
Rustemeyer T, Gibbs S
VU University Medical Center Amsterdam, The Netherlands
Cytokines and chemokines play a key role in skin inflammatory responses and skin disease.
In this study we investigated the mechanism whereby keratinocytes and fibroblasts interact
to produce a cytokine/chemokine cascade between the epidermal and dermal compartments
of the skin. Human Skin Equivalents (HSE) (reconstructed epidermis on fibroblast-populated-
dermis) which have increased expression of activation markers compared to normal skin
(e.g.: keratins 6, SKALP, involucrin) were used as a model to represent inflamed skin.
Cytokines/chemokines secreted by HSE were identified with the aid of a protein array. The
influence of keratinocyte - fibroblast interactions on the secretion of these cytokines/
chemokines was investigated with the aid of the HSE, Epidermal Equivalents (EE)
(reconstructed epidermis on acellular dermis) and Dermal Equivalents (DE) (fibroblast
populated dermis). Cytokines/chemokines secreted into culture supernatants were quantified
by ELISA.
HSE produced high amounts of CCL2, CXCL1, CXCL8 and IL-6. EE and DE produced
insignificant amounts of these cytokines/chemokines. However, addition of EE culture
supernatants to DE resulted in a synergistic increase in the secretion of CCL2, CXCL1,
CXCL8 and IL-6 from the DE reaching levels observed in HSE. In contrast addition of DE
culture supernatants to EE did not result in an increase in cytokines/chemokine secretion
from the EE. Neutralizing IL-1a and TNF-a in EE supernatants showed that these
keratinocyte-derived pro-inflammatory cytokines mediate the secretion of CCL2, CXCL1,
CXCL8 and IL-6 by fibroblasts in the DE.
These results show that epidermal derived IL-1a and TNF-a trigger the release of dermal
derived CCL2, CXCL1, CXCL8 and IL-6 thus creating a cytokine / chemokine cascade
between the epidermal and dermal compartments of the skin. Such keratinocyte – fibroblast
interactions enable alarm signals from the environment to be translated into inflammatory
signals, which penetrate deep into the skin.
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In Situ Real-Time Proﬁling and Quantiﬁcation of Cytokines Released During UVB-
Induced Inﬂammation by a New Method Combining Dermal Microdialysis and Protein
Microarrays
Averbeck M1, Beilharz S2, Bauer M3, Gebhardt C1, Kauer F1, Voith U2, Simon JC1, Termeer
C2
1Leipzig University, Germany; 2Freiburg University, Germany; 3Forschungszentrum Karls-
ruhe, Germany
In skin an evolving inflammatory response is triggered by early release of a cytokine cascade
into the extracellular space. Investigation of real time extracellular cytokine secretion in situ
has been limited by low-cut off filtering membranes and sample volume size and the inability
to monitor changes in cytokine protein levels in real-time in situ. Here, we combine for the first
time the methods of intradermal microdialysis and antibody protein arraying to profile the
early cascade of multiple cytokines in a complex inflammatory response exemplified by UVB-
induced inflammation. First, we observed significant differences between the cytokine and
growth factor responses after tissue injury by catheter placement and UVB-induced
inflammation. UVB-irradiation initiates a rapid proinflammatory response followed by a
mixed TH1/TH2 response in which ultimately TH2 cytokines IL-4 and IL10 predominated after
24h. This most likely indicates the termination and self limitation of the inflammatory
response. We conclude that the combination of dermal microdialysis and protein microarray
offers a powerful new tool to analyze in real-time the complex and rapidly changing interstitial
protein milieu during cutaneous inflammatory responses.
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In Vitro Irradiation of Keratinocytes with Narrow-Band Ultraviolet B Light Inhibits the Toll-
Like Receptor 3-Induced Production of Inﬂammatory Mediators
Racz E, Van Dijk G, Prens E, Van Der Fits L
Erasmus University Rotterdam, The Netherlands
Phototherapy with narrow-band ultraviolet B radiation (NB-UVB; 311 nm) is a relatively safe
and effective treatment for an increasing number of skin diseases, such as psoriasis, vitiligo
and atopic dermatitis. However, the exact mechanism of its mode of action is not completely
understood. We studied the effect of in vitro irradiation of keratinocytes with NB-UVB on their
production of inflammatory mediators.
HaCaT keratinocytes were exposed to a single dose of 250 or 500 mJ/cm2 NB-UVB light
using the Philips TL-01 fluorescent light source. Immediately after irradiation, keratinocytes
were activated by Toll-like receptor (TLR) ligands (i.e. the TLR3-ligand poly I:C) or with
inflammatory cytokines (i.e. interferon (IFN)-a or IFN-g). Cells and supernatants were
collected at different time-points. The expression of inflammatory cytokines and transcription
factors was studied by quantitative real-time PCR and ELISA.
Our data showed that NB-UVB light inhibited several poly I:C-induced responses (i.e.
expression of the transcription factor IRF-7, the proinflammatory cytokine IL-1b and the
chemoattractant RANTES). In contrast, no consistent effect of NB-UVB radiation on IFN-a- or
IFN-g-induced keratinocyte activation was observed.
Our findings demonstrate that NB-UVB light suppresses the TLR ligand-induced
production of inflammatory mediators in keratinocytes. This might represent an additional
mechanism contributing to the effectiveness of NB-UVB phototherapy in inflammatory skin
diseases.
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TNF-a Expression in Psoriatic Skin is Regulated at a Post-transcriptional Level by MK2
Johansen C1, Funding AT1, Kragballe K1, Otkjaer K1, Madsen M2, Nielsen TS1, Iversen L1
1University of Aarhus, Denmark; 2Leo Pharma A/S, Denmark
The pro-inflammatory cytokine TNF-a plays a key role in the pathogenesis of psoriasis. The
purpose of this study was to investigate the signaling pathways regulating TNF-a expression
in lesional psoriatic skin. Protein expression was determined by ELISA, Western blotting and
by a kinase assay. mRNA was determined by quantitative RT-PCR.
In vitro experiments with cultured human keratinocytes showed that the specific p38 MAPK
activator, anisomycin caused a significant 15–fold increase in TNF-a protein expression. This
increase in TNF-a protein expression was completely blocked by the p38 inhibitor SB202190.
Therefore, the p38 MAPK signaling pathway was further investigated in lesional psoriatic skin.
A 5-fold increase in TNF-a protein expression was found in lesional compared with non-
lesional psoriatic skin. Interestingly, no difference in TNF-a mRNA levels was seen in lesional
compared with non-lesional psoriatic skin (n¼ 7). This strongly indicates that TNF-a
expression in lesional psoriatic skin is regulated at a post-transcriptional level.
A significant and consistent increase in the activated (phosphorylated) form of both the p38
MAPK and its downstream target MK2 was seen in lesional compared with non-lesional
psoriatic skin. Furthermore, immunohistochemical staining demonstrated activated MK2 in
keratinocytes in the basal layers of the psoriatic epidermis, whereas no positive staining was
seen in the epidermis of non-lesional psoriatic skin.
MK2 is known to stabilize mRNA and to stimulate mRNA translation. Transfection of
cultured human keratinocytes with MK2 specific siRNA, resulted in a significant inhibition of
both anisomycin and IL-1b induced TNF-a protein expression demonstrating that MK2 is
important in the regulation of TNF-a protein expression. These results show that TNF-a
expression in lesional psoriatic skin is regulated at a post-transcriptional level by MK2,
making MK2 a potential target in the treatment of inflammatory diseases such as psoriasis.
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Interleukin-20 Protein and Related Receptors in Psoriatic Skin Plaques
Hasselager E1, Clausen JT1, Steiniche T2, Zahn S1, Kragballe K3
1Novo Nordisk, Denmark; 2Aarhus Kommunehospital, Aarhus, Denmark; 3Marselisborg
Hospital, Aarhus, Denmark
Interleukin-20 (IL-20) is implicated in psoriasis. We have reported a distinct and selective
expression of IL-20, IL-20R1, IL-20R2, and IL-22R1 mRNA in keratinocytes of the psoriatic
plaque.
Using specific antibody to IL-20, IL-20R’s and a series of CD-markers we examined the
localization of the IL-20 protein in epidermal and dermal psoriatic lesions using biopsy
material from psoriatic patients.
In epidermis the IL-20 was most pronounced in the basal layer of the keratinocytes, but the
strongest reaction was found in Langerhans’ cells (CD1a) which also had co-localization of IL-
20R’s as shown by double immune fluorescence staining.
In dermis many IL-20 positive cells were observed in the psoriatic papillae and in focal
infiltrates beneath the papillae and along vessels. Some CD4 positive lymphocytes and CD8
positive cells co-stained with IL-20. Other CD8 cells showed co-staining for cutaneous
lymphocyte antigen (CLA) but not IL-20. Neither B-cells (CD20), natural killer-cells (CD57) nor
granulocytes (CD15) were seen to harbour the IL-20 protein. Monocytes (CD68) and dendritic
cells (CD1a) were positive for IL-20 and for IL-20R’s.
CD-31 positive capillary buds were seen in the psoriatic papillae. Many venules in the
subpapillary areas had a cuboidal endothelium characteristic of high endothelial venules. The
vessels with thickened endothelium also showed reaction for IL-20 and IL-20R’s.
Only small amounts of IL-20 were found in basal epidermal keratinocytes of non-lesional
and normal skin. Short term treatment with oral Cyclosporin A or topical Calcipotriol reduced
the amount of IL-20 in psoriatic plaques.
These findings indicate that IL-20 may not only be an autocrine growth factor for
keratinocytes, but is also implicated in the inflammatory and angiogenic aspects of the
psoriatic lesion.
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Development of Allergic Contact Dermatitis Requires Activation of Skin Innate Immunity
Bonneville M, Chavagnac C, Vocanson M, Saint-Mezard P, Benetiere J, Ducluzaeu MT,
Nicolas JF
INSERM U503, Lyon, France
Irritant Contact Dermatitis (ICD) is a frequent inflammatory skin disease following the
repeated skin contact with chemicals called haptens which are endowed with toxic/pro-
inflammatory properties leading to the activation of skin innate immunity. Allergic contact
dermatitis (ACD) is a frequent complication of ICD and is secondary to the induction of
hapten-specific T cells. Although it is established that the frequency with which individuals
develop ACD directly correlates with the pro-inflammatory properties of haptens, the immune
parameters linking ICD and ACD are still not known precisely. Here, we analysed the cellular
and molecular mechanisms involved in the skin inflammatory reaction occurring in the hours
(ICD) and days (ACD) following skin painting with low (0.1%), intermediate (0.3%) and high
(0.5%) doses of DNFB on the ear of naı¨ve C57BL/6 and BALB/C mice, using the recently
described protocol of ‘‘primary allergic contact sensitivity’’. C57BL/6 mice were highly
sensitive to the irritant effect of DNFB (and therefore referred to as ‘‘sensitive skin’’) and
exhibited an ICD twice more intense than BALB/C mice (which were called ‘‘normal skin’’). In
both strains of mice, the ICD reactions were dose-dependant and started 1 hour after DNFB
painting. Whereas low dose of DNFB induced an ICD which resolved in a few hours,
intermediate dose- and high dose-induced ICD reactions increased during the days following
DNFB painting and evolved in an ACD reaction from day 5 with priming/expansion of DNFB-
specific CD8þ T cells in draining lymph nodes. The magnitude of the ACD response at day 5
directly correlated with the intensity of the ICD reaction at 3 hours. Kinetics analysis of
cytokine production in the ICD skin showed an upregulation of mRNA for TNFa, IL-1b and IL-6
starting at 1, 3 and 6 hours post-DNFB painting, respectively. In conclusion, this study
provides new insights in the pathophysiology of ICD and demonstrates that activation of skin
innate immunity is necessary for the development of ACD. Ongoing studies are directed to
the understanding of the differences between the ‘‘normal’’ and ‘‘sensitive’’ skin phenotype of
BALB/C and C57BL/6 mice, respectively.
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Major Latex Allergens Induce Proinﬂammatory Cytokines and Chemokines from
Peripheral Blood Mononuclear Cells in Latex Allergy
Lehto M1, Palosuo K2, Kotovuori A1, Lehtima¨ki S1, Kalkkinen N3, Alenius H1, Reunala T4
1Finnish Institute of Occupational Health, Finland; 2University Hospital for Skin and Allergic
Diseases, Finland; 3Institute of Biotechnology, Finland; 4Tampere University and University
Hospital, Finland
Background: Hev b6.01 and Hev b5 are major sensitizing allergens in latex gloves. In
addition to IgE-mediated immediate symptoms latex allergic patients present often with hand
eczema. This can disappear after avoidance of latex gloves suggesting that latex allergens
might also induce inflammatory mediators.
Methods: Hev b6.01 and Hev b5 were purified under non-denaturating conditions using
chromatographic methods. Proliferation of peripheral blood mononuclear cells (PBMC) was
examined in 10 latex allergic patients, all with IgE antibodies to Hev b6.01, and 10 controls.
Hev b6.01 and Hev b5 (10, 5, 1 and 0.1 mg/ml) induced cytokine and chemokine production
was measured by real-time PCR and ELISA. Chemokine receptors CCR4 and CXCR3 were
analysed by flow cytometry.
Results: Hev b6.01 enhanced significantly (po0.05) PBMC proliferation in latex allergic
patients compared to controls. Hev b6.01 and Hev b5 elicited significant induction of IL-13,
IL-10, TNF-a, IL-12p40, MIP-1a (CCL3), MIP-1b (CCL4) and MIP-3a (CCL20) expression
whereas no change was seen in IFN-g and IP-10 (CXCL10) expression. The patients showed
increased CCR4 expression on CD4þ T cells and decreased CXCR3 expression on CD8þ T
cells.
Conclusion: The observed allergen-specific induction of proinflammatory cytokines and
chemokines from mononuclear cells may play an important role in the pathogenesis of hand
eczema in latex allergy.
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IgG Antibodies Reactive with Proteins Secreted by Streptococcus pyogenes are more
Abundant in the Blood of Patients with Chronic Plaque Psoriasis than Matched Controls
Camp R1, Hales J1, Freestone P1, Young H2, Griffiths C2, El-Rachkidy R1
1University of Leicester, United Kingdom; 2University of Manchester, United Kingdom
Although provocation of guttate psoriasis by throat infection with Streptococcus pyogenes
(Sp) is well recognised, the pathogenic role of this infection in chronic plaque psoriasis is
unclear. We have now characterised the IgG-reactive components of the proteome of Sp.
Secreted proteins in culture supernatants were concentrated by ammonium sulphate
precipitation, and cellular proteins recovered by sonication of pelleted bacteria from the
same cultures. High-resolution 2-D electrophoresis of these fractions and probing of Western
blots with pooled sera from 6–8 patients with chronic plaque psoriasis, showed for the first
time that the majority of IgG-reactive Sp proteins are secreted. Probing of parallel 2-D
Western blots of secreted Sp proteins with pooled sera from age- and sex-matched healthy
controls indicated a lower abundance of reactive IgGs than in pooled chronic plaque
psoriasis sera (n¼ 3). Subsequent analysis of psoriatic serum or plasma samples (n¼57) by
ELISA using the total secreted protein fraction of Sp as substrate showed substantially higher
titres of Sp-reactive IgG than in samples from matched healthy controls (n¼42; p¼ 0.0008,
Mann-Whitney test). Assay for antistreptolysin O (ASO) titres did not distinguish the samples
from the two sources. In addition, ELISAs with total cellular and secreted proteins from
Staphylococcus aureus and cellular proteins from Staphylococcus epidermidis and E coli
indicated no difference in the abundance of IgGs reactive with these protein fractions in
pooled psoriatic versus control sera. We have established a novel assay that detects Sp-
reactive IgGs more sensitively than standard ASO titre measurement. Our findings also
indicate that immune responses to Sp infections are commoner in chronic plaque psoriasis
than previously recognised and are possibly pathogenically relevant.
271
Expression and Function of Serotonin 2C Receptors on Murine Langerhans Cell-Like
Cells and Murine Contact Allergy
El-Nour H1, Lundeberg L1, Boman A1, Abramowski D2, Holst M1, Nordlind K1
1Karolinska Institute, Stockholm, Sweden; 2Novartis Institute for BioMedical Research,
Switzerland
Serotonin (5-HT, 5-hydroxytryptamine) is a neurotransmitter of the central and peripheral
nervous system.
The aim of this study was to investigate the expression of serotonin 2C receptor (5-HT2CR)
in a murine model of allergic contact eczema.
Sixteen female BALB/c mice were sensitized, and after six days challenged on the ears
with oxazolone. Ear biopsies were fixed, sectioned and stained for 5-HT2CR using a
streptavidin-biotin technique.
5-HT2CR expression was seen on epidermal dendritic cells that were more numerous
(po0.01) in the inflamed skin compared to control skin. The inflamed cells appeared larger
and possessed longer dendrites than normal cells. Double staining showed colocalization of
5-HT2CR and I-A antigen on these epidermal cells. The effect of 5-HT2CR agonist RO60-
0175/007 on a murine Langerhans cell-like cell line (XS52) regarding its interleukin (IL)-1b
production, and cellular proliferation were then tested, using PCR, ELISA and a thymidine
incorporation assay, respectively. Whereas there was no difference in mRNA signal
by PCR, there was, by using ELISA, an increased IL-1b production with concentrations
5  105 and 105 mol/L (po0.006 and po0.02, respectively) of the agonist, and also a
strong tendency to an increase with 5  106 mol/L (po0.055). The lowest tested
concentration, 1010 mol/L, gave a tendency to a decrease in the production of IL-1b and
also a decreased (po0.04) proliferation.
Our findings demonstrate the expression of 5-HT2C receptor on epidermal dendritic cells in
murine contact allergy, and indicate that this receptor can be important for the maturation of
Langerhans cells, which might result in the modulation of allergic contact eczema.
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Expression of Murine Beta–Defensins 3 (mBD-3), but not mBD-1 and -14, is Stimulated by
Experimental Skin Barrier Disruption and by Proinﬂammatory Cytokines Tumor Necrosis
Factor and Interleukin-1beta
Schunck M, Linke N, Schroeder JM, Proksch E
Dept of Dermatology, University of Kiel, Germany
Protection of the skin against microbiological infection is provided by the physical
permeability barrier and by antimicrobial proteins of the innate immune system including b-
defensins. Previously, the importance of proinflammatory cytokines for the regulation of skin
barrier function has been shown. We asked whether the expression of murine b-defensins
(mBDs) is stimulated by disruption of the permeability barrier or by the proinflammatory
cytokines tumor necrosis factor-a (TNF-a) and interleukin-1b (IL-1b). The expression, the
distribution pattern, and the amount of the defensins in mouse epidermis were analyzed by
immuno-histochemistry and by Real Time PCR. Immuno-histochemistry showed that mBD-3
was localized in the epidermis with increasing staining intensity in the outer layers, suggesting
a function in the defense against germs reaching the skin from the outside. Sequence
analysis revealed that mBD-1, -3 and -14 are homologous to the well characterized human b-
defensins HBD1, –2 and –3, respectively. mBD-1 and -14mRNA were found to be expressed
constitutively in embryonic and five days old mice. mBD-3 was not expressed constitutively,
but found in adult skin after contact with natural skin flora. Disruption of the permeability
barrier by tape-stripping led to an upregulation of mBD-3 expression, but not mBD-1 and -14.
Also, TNF-a and IL-1b stimulated mBD-3 expression in primary keratinocytes, only. In
contrast, experimental skin infection by Staphylococcus aureus resulted in the upregulation of
all three defensins examined, suggesting a mechanism for activation independent of
inflammation. In summary, our results show that mouse epidermis contains constitutively
expressed and inducible defensins. In summary, we found constitutively expressed
defensins, mBD-1 and -14, and inducible defensin, mBD-3, in mouse skin. Barrier disruption,
which potentially may lead to increased penetration of environmental germs, selectively
upregulated mBD-3 expression. A selective upregulation of mBD-3 was also induced by
proinflammatory cytokines.
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Regulation of Proopiomelanocortin Peptide-Induced Melanocortin 1 Receptor Signalling
by Proteolytic Peptidases in Dermal Microvascular Endothelial Cells
Scholzen TE1, Fastrich M1, Bo¨hm M2, Ko¨nig S3, Brzoska T1, Luger TA2
1University of Mu¨nster, Ludwig-Boltzmann Institute, Germany; 2University of Mu¨nster, Dept.
of Dermatology, Germany; 3University of Mu¨nster, Integrated Functional Genomics,
Germany
Neuropeptides and endocrine hormones play an essential role in modulating innate and
adaptive immune responses. Dermal microvascular endothelial cells (EC) are target of
Substance P (SP), calcitonin gene-related peptide CGRP, and of the proopiomelanocortin
(POMC) peptides adrenocorticotropin (ACTH) and alpha-melanocyte stimulating hormone
(a-MSH). These mediators participate in controlling vascular permeability, vasodilatation,
and the expression of EC cytokines or adhesion molecules. The bioavailability of these
neuropeptides is controlled by neuropeptide-specific peptidases, such as neutral endopep-
tidase (NEP) or angiotensin-converting enzyme (ACE). Present evidence suggests that
recombinant NEP and ACE as well as NEP and ACE expressing EC are involved in the
proteolytic processing of ACTH and a-MSH in vitro. In this study we have tested the
hypothesis that activation of ACTH/a-MSH-specific melanocortin 1 receptor (MC1) may be
modulated by proteolytic peptidases. When NEP expressing microvascular EC (HMEC-1)
were stimulated with ACTH1-39, a-MSH, or a smaller a-MSH fragment that resulted from NEP
and/or ACE processing of a-MSH, a dose-dependent induction of intracellular cAMP could
be detected. This cAMP induction was significantly increased in HMEC-1 or HEK293 cells
transfected with a hemaglutinin-tagged MC1 (HA-MC1). When HA-MC1 transfected HMEC-1
were cotransfected with a CRE-luciferase reporter construct, we observed an ACTH or a-
MSH dependent induction of luciferase activity. Pharmacologic inhibition of NEP in HMEC-1
increased cAMP induction by ACTH and a-MSH, whereas induction of cAMP by the a-MSH-
fragment was less affected. This indicates that NEP processing of ACTH and a-MSH
modulates MC1 activation, but does not completely inactivate the peptide ligand. Thus, the
present data suggest that ACE and NEP by proteolytic cleavage of POMC peptide mediators
have a significant role in controlling accessibility of MC1 receptors, which may be of
importance for vascular function and cutaneous inflammatory responses.
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Dominance of Innate Immune Responses in Psoriatic Epidermis Suggested by
Transcriptome Analysis of Cytokine-stimulated Keratinocytes
Mee JB1, Morar N2, Groves RW1
1King’s College London, United Kingdom; 2University of Oxford, United Kingdom
Psoriasis has been considered an auto-immune, T-cell mediated disorder, in which adaptive
immune responses predominate over those of non-antigen specific innate immunity. We have
previously defined the psoriatic lesional transcriptome using Affymetrix microarrays. In the
present study, we have profiled the keratinocyte transcriptome in response to the prototypic
pro-inflammatory cytokine, interleukin-1a (IL-1a) and the key Th1 cytokine, interferon-g
(IFN-g).
Second passage human keratinocytes, derived from normal adult donors, were stimulated
with either IL-1a (100 ng/ml) or IFN-g (20 ng/ml) for 24 hours prior to isolation of total RNA,
cDNA synthesis and preparation of biotinylated cRNA (n¼ 5). Samples were hybridised to
Affymetrix U133A human microarrays, scanned and analysed using GeneSpring software to
identify transcripts showing a consistent difference of at least 2-fold between any 2 arrays in
at least 4 out of 5 donors. Stimulation with IFN-g resulted in consistent induction of 228 probe
sets, with particularly strong expression of the CXCR3-binding ligands, CXCL9, 10 and 11
and class II MHC genes, primarily those of the HLA DP and DR families. By contrast, the
transcriptome resulting from IL-1a stimulation elicited consistent up-regulation of 25 probe
sets, with strong induction of transcripts within the epidermal differentiation complex (S100
A7/psoriasin, SPRR2B and 2C) and antimicrobial peptides including SKALP/Elafin and b-
defensin 4. Mutual exclusivity between the two transcriptomes was exhibited with only 4/25
upregulated IL-1a transcripts also consistently enhanced in the IFN-g set, including IL-32.
Further comparisons between the two present data sets and our previous microarray data
from stable, lesional psoriatic epidermis identified an unexpectedly high correlation with the
IL-1a transcriptome (9/25 common probe sets, compared with 0/228 for IFN-g).
These findings suggest that the inflammatory milieu in the epidermal microenvironment in
psoriasis is more dependent on an innate, rather than the expected adaptive immune
response.
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Artemia Extract Helps to Restore the Decrease in Hsp70 Level Caused by Cell Treatment
with All-Trans Retinoic Acid, and Down-Regulates ATRA-Induced IL-1 after UV Exposure
Dal Farra C, Bauza E, Domloge N
Vincience, Sophi Antipolis, France
Hsp70 is critical for skin protection from different types of stress, and in particular from UV
stress. Previous data has shown that long-term treatment with retinoids induces a post-
transcriptional decrease of constitutive Hsp70 level, and that ATRA-treated skin is fragile
toward UV stress. Our prior studies have shown that Artemia extract (AE) induces Hsp70 in
human cells and enhances cell protection from UV stress. Hence, we were interested in
investigating the effect of AE on long-term ATRA-treated cells, with and without UV stress, by
immunoblotting and ELISA. These studies confirmed a general decrease in constitutive
Hsp70 that accompanies the aging of cells. Interestingly, cells treated with ATRA 107M for 3
to 7 weeks exhibited a lower level of Hsp70 than the control level, while AE administration
significantly restored Hsp70 to a level which approached the control constitutive level.
Moreover, IL-1 beta assessment of human fibroblasts treated with ATRA 107M for up to 2
months, and irradiated with 100 mJ/cm2 of UVB was performed at different time points and
the results were submitted to statistical analysis using the Mann-Whitney test.
These studies showed that cells treated with ATRA and irradiated with UVB exhibited a
higher level of IL-1 than control cells (þ 22.35% increase of AUC over control). Interestingly,
AE administration to ATRA-treated cells significantly decreased UV-induced IL-1 in the cells
(AUC 44%) to a level lower than that of UV control cells.
These results suggest that Artemia extract can be of great use in increasing skin comfort
especially toward UV stress, during long-term retinoid therapy.
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Using a New Full Skin Model to Evaluate Cell-Cell Interaction and the Anti-Inﬂammatory
Activity of Glucocorticoids
Zoeller N1, Mewes K2, Raus M2, Draeger K2, Bereiter-Hahn J3, Kaufmann R1, Bernd A1
1University Hospital Frankfurt/Main, Germany; 2Phenion GmbH & Co. KG, Frankfurt/Main,
Germany; 3Kinematic Cell Research Group, J. W. Goethe University, Frankfurt/Main,
Germany
The ability to permit cross-talk between dermal fibroblasts and epidermal keratinocytes is a
main advantage of three dimensional full skin models versus monolayer cultures. Both cell
species can influence each other, triggered responses correlate closely to in vivo monitored
responses.
For the evaluation of the anti-inflammatory activities of glucocorticoids and direct
monitoring of pro-inflammatory cytokines we used a new full skin model. Primary fibroblasts
and keratinocytes were isolated from foreskin of boys less than four years of age. They were
seeded on a collagen matrix (Phenion, Frankfurt, Germany) and cultivated according to
common protocol. A stratified epidermis containing stratum basale, -spinosum, -granulosum
and -corneum developed on a fibroblast rich dermis.
Release of pro-inflammatory cytokines was induced by irradiating the skin models using 50
mJ/cm2 to 300 mJ/cm2 UVB. The release of IL-6 and IL-8 was measured using commercial
ELISA (R&D, Wiesbaden, Germany). The IL-6 and IL-8 concentrations in the cell supernatants
increased dependent on the used UVB intensity. To monitor which cells are responsible for
the release of the pro-inflammatory cytokines, skin model sections were stained with anti-IL-6
and anti-IL-8 (abcam, Cambridge, UK). Both cytokines were predominantly located in the
region of vital keratinocytes.
Furthermore we could show that Betnesol
s
, topically applied, generated comparable
results to systemic treatment with 20 mM Betamethason-17-valerate. In both cases the UVB
induced release of IL-6 and IL-8 and their basal levels were suppressed.
These results suggest that full skin models offer the opportunity to investigate
glucocorticoid mediated anti-inflammatory effects in vitro including topical application. Apart
from analysing supernatants, they enable IHC studies on tissue that resembles human skin.
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Galanin-Like Peptide Inhibits Substance P and CGRP Induced Microvascular Perme-
ability
Schmidhuber S1, Bauer JW1, Kofler B1, Brain S2
1Paracelsus Private Medical University, Austria; 2King’s College, London, United Kingdom
Urticaria is a cutaneous pathophysiological pattern involving plasma extravasation. Since it
was postulated that the cutaneous neuropeptide galanin is involved in this process we
investigated peptides of the galanin family with regard to their ability to regulate
microvascular permeability in a murine model system. Galanin and galanin-like peptide
(GALP) are hypothalamic neuropeptides, which share 13 identical amino acids essential for
activation of galanin receptors. Within the mature human GALP (1-60) potential proteolytic
cleavage sites might lead to shorter C-terminally amidated peptides. GALP as well as these
smaller peptides (GALP 1-32, GALP 3-32) are able to activate the galanin receptor GALR2.
The presence of galanin receptors in close association to blood vessels suggests a role of
peptides of the galanin family in the regulation of cutaneous microvasculature.
The extravascular plasma accumulation was assessed by measurement of intravenously
injected 125I-albumin. Injection of galanin into dorsal murine skin revealed an inhibition of
substance P (SP) and calcitonin gene related peptide (CGRP) induced cutaneous plasma
extravasation in a dose dependent manner. The potential proteolytic fragments of GALP
(GALP 1-32 and GAPL 3-32) were also able to suppress SP/CGRP induced oedema
formation. Since GALP is a selective ligand for GALR2, we can exclude that the effect is
mediated by the galanin receptor GALR1.
Previous studies showing involvement of galanin in plasma extravasation have speculated
on a presynaptic blockade of the release of vasoactive peptides from sensory nerves by
galanin. However, the inhibition of SP/CGRP induced plasma extravasation by galanin
presented here, indicates that the effect of galanin receptor agonists on oedema formation is
mediated by a postsynaptic action.
To our knowledge is the first report on a physiological effect of GALP in vivo.
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IgA Autoantibodies in the Small Intestine from Patients with Dermatitis Herpetiformis and
Celiac Disease
Kornsee Z, Preisz K, Sardy M, Kosnai I, Zagoni T, Berczi L, Karpati S
Dept of Dermatology, Semmelweis University Budapest, Hungary
Dermatitis herpetiformis (DH) and celiac disease (CD) are gluten sensitive autoimmune
diseases (GSD), induced by gliadin, the glue-protein of large number of different corns. IgA
type anti-jejunal antibodies in sera of these patients, corresponding to tissue type
transglutaminase (TGc), are characteristic for gluten sensitive enteropathy (GSE).
Previous datas indicated that a disease specific IgA staining pattern, colocalised with TGc
in the mucous membrane of the small intestine of DH and CD patients, can be detected in the
jejunal tissue. The main purpose of our study was to elucidate how these findings in a large
group of GSD patients represented are.
181 biopsy samples taken at the duodenal/ small bowel border from 73 DH, 45 CD and 63
non-GSD patients were examined for the presence of disease-specific IgA fluorescence and
for small intestine histology. CD was verified by small bowel histology and positive EMA and
TGc serological tests, DH by skin immunofluorescence microscopy and rutine histology.
Disease specific IgA staining was found in 62/73 patients with DH, in 40/45 patients with
CD and in none of the non-GSD patients. 3/5 CD and 3/11 DH patients with negative small
bowel staining were under gluten free diet.
Out of the 102 patients with disease specific IgA staining in the small bowel, 22 were EMA
negative (16 under gluten free diet, 2 became later seropositive) and 23 had no histological
changes indicating GSD in the small bowel biopsy. These data suggest, that in patients with
gastrointestinal diseases the detection of IgA-TGc immunocomplex accumulation within the
jejunum is a useful diagnostic marker of gluten sensitive enteropathy wich can be earlier
detected than EMA/TGc seropositivity and/or villous atrophy.
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Behavioral Characteristics in 3-12 Months Old Infants with Atopic Dermatitis: A Case-
Control Study
Pourpak Z, Afrooz GA, Afrooz Az, Sedighipour L, Ghobrai B, Kazemnejad A, Bemanian MH
Immunology, Allergy and Asthma Research I, Islamic Republic of Iran
Background: Atopic dermatitis (AD) is a chronic disorder that is most common in early
childhood. There is general agreement that both, immunological and psychological factors
are important in AD pathogenesis and should therefore be taken into account. It has been
said that psychological component in atopic dermatitis may either initiate the process of skin
disease or be the consequences of chronic eruption. To test this hypothesis, we compared
behavioral characteristics of 30 infants (3-12 months old) with AD with 40 matched controls.
Methods: The diagnosis of atopic dermatitis was made according to the Hannifin & Rajka
criteria. For assessing behavioral characteristics we used Early Childhood Behavior
Questionnaire (ECBQ), version 2000, that was composed of total 97 questions for measuring
the following scales: Fear, Distress to limitation, Smiling&laughter, Duration of orienting, High
pleasure, Low pleasure, Soothability, Rate of recovery from distress, Perceptual Sensitivity,
Sadness & approach (11 scales). Questionnaires were filled out by the parents or the child
care givers.
Results: There was no statistically significant difference in mean age of the two groups.
There was no statistically significant difference between the two groups in Distress to
limitation, Fearfulness, Fearfulness, Duration of orienting, Rate of recovery from distress,
Sadness and Low pleasure; but the AD group showed significantly higher scores in
Perceptual Sensitivity (P¼.000), Soothability (P¼.000) and High Pleasure (P¼.000)
Conclusion: Infants with AD tend to have higher perceptual sensitivity to the environment
around them and show more pleasure and excitement when subjected to an intense, rapid,
novel or incogruit stimuli compared with non atopic infants. Higher scores in ‘‘high pleasure’’
and ‘‘approach’’ among infants with atopic dermatitis compared to the control group are
concordant with the pervious studies about adrenomedullary system over activity and higher
level of basal catecholamine in patients with AD.
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Anti-Inﬂammatory and Immunomodulatory Activity of Avena Rhealba Oatmeal -
Polyphenolic Extract: Interest in Skin Inﬂammatory Disorders as Atopic Dermatitis
Pathology
Aries MF, Vaissiere C, Charveron M
Pierre FABRE Research Institute, Toulouse, France
During cutaneous inflammatory diseases, the neuro-immuno-cutaneous system is impaired.
In atopic dermatitis pathology, a perturbation of neuromediators release such as substance P
(SP) could be in part involved in the neurogenic inflammatory state; identified in human skin,
SP is a potent inducer of vasodilatation, may induce pruritus and could mediate its effects via
nitric oxide (NO). NO is generated by Nitric Oxide Synthase (NOS) enzymes identified in
several cell types in the skin. NO, displaying vasodilatator properties, is constitutively
released and can also be synthetized in response to SP mediator. In atopic dermatitis,
immune mechanisms play also a crucial role through the activation of T lymphocytes. The
both role of T-helper 1 (Th1) and Th2 cells which differ in their secretory patterns of cytokines
is postulated in the disease process, albeit at different stages, and make the use of topical
potent immunosuppressive agents logical therapeutic considerations.
The aim of the present study was first to induce neurogenic inflammation on human
endothelial cells with SP (10-100pM) and to evaluate the activity of Avena Rhealba oatmeal -
polyphenolic extract- (0.001%–0.005%) on eNOS mRNA expression by RT-PCR. The second
objective was to evaluate the activity of Avena Rhealba oatmeal -polyphenolic extract-
(0.003%–0.01%) on immune cellular responses through the production by human peripheral
blood mononuclear cells (PBMC) of interleukine 2 (Th1 cytokine) and interleukine 4, 5, and 13
(Th2 cytokines) which are up-regulated in atopic dermatitis.
Avena Rhealba significantly inhibited endothelial cells SP-induced expression of eNOS.
Avena Rhealba was also able to significantly down-regulate Th1 and Th2 cytokines
production (20% to 80% for 6h exposure) by PBMC. Our results demonstrate that Avena
Rhealba extract is a potent regulator of neurogenic inflammation and immune response
showing, therefore, a real interest of Avena Rhealba topical preparations in atopic dermatitis
inflammatory pathology.
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Regulation of TNF-alpha mRNA Expression by Repeated and Acute Irradiation with UVB
Narbutt J1, Lesiak A1, Sysa-Jedrzejowska A1, Cierniewska-Cieslak A2
1Dept of Dermatology, Medical University of Lodz, Poland; 2Department of Biophysics,
Medical University of Lodz, Poland
Ultraviolet radiation (UVR) is the most important exogenous factor influencing human
epidermis and triggering cutaneous immunity. Under this stimulus keratinocytes and other
epidermal cells secrete various cytokines, e.g. IL-1, IL-6, IL-10 and TNF-alpha.
The aim of our study was to examine the effect of low and repeated irradiation with UVB on
expression of IL-1 beta, IL-6, IL-10, and TNF-alpha mRNAs in healthy human volunteers. We
also tried to find whether repeated exposure to UVB causes adaptation to acute UVB
irradiation.
Our study included 45 healthy volunteers who were exposed to UVB: 15 subjects (whole-
body, low doses of UVB for 10 days with subsequent irradiation with 3 MED UVB), 15 subjects
(locally, 3 MED UVB), 15 subjects (whole-body, low doses of UVB for 10 days UVB).
Additionally 10 individuals served as controls. Skin samples were taken twice or three times
before and 24 h after final exposure. IL-1 beta, IL-6, IL-10 and TNF-alpha mRNAs were
determined in each specimen by relative quantitative RT PCR. Concentrations of mRNAs for
tested cytokines were normalized in each sample in relation to b actin mRNA.
We found a statistically significant increase (po0.001) in the expression of IL-1beta, IL-6,
IL-10, and TNF-alpha mRNAs in all volunteers after irradiation with repeated, low doses of
UVB. In group exposed only to a single acute dose of UVB, the same significant tendency
was observed (po0.001). Additional irradiation of 3 MED UVB after repeated exposure to
UVB caused a statistically significant increase in mRNA expression of IL-1 beta, IL-6, IL-10,
however, a statistically decrease in TNF-alpha mRNA expression. Our results indicate that
UVB radiation (both repeated as well as a single dose) regulate mRNA expression of the
examined cytokines. A 10-day exposure of humans to suberythemal doses of UVB causes no
clinical symptoms, however it induces alterations in skin immunity at the molecular level.
Single exposure to erythematogenic dose of UVB, applied 24 h after repeated UVB
irradiation, down-regulates TNF-alpha mRNA, what is probably at least partially responsible
for lowering intensity of inflammatory response, as observed by clinical symptoms (erythema,
oedema).
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Induced Eotaxin mRNA-Expression in Atopic Dermatitis-Derived Cultured Dermal
Fibroblasts Indicates Enhanced Fibroblast Responsiveness to IL-4
Bartels J, Gahr N, Fo¨lster-Holst R, Christophers E, Schro¨der J
UK-SH Campus Kiel, Germany
The presence of eosinophils and/or eosinophil derived products in the dermis is characteristic
for involved skin areas of patients with atopic dermatitis (AD) and is believed to be
responsible for the observed tissue injury. Eotaxin is a potent chemoattractant and activator
of human eosinophils and IL-4 is a potent inducer of eotaxin-expression in dermal fibroblasts.
Since increased fibroblast eotaxin expression may explain eosinophilic infiltration of involved
skin areas in AD, we asked, whether dermal fibroblasts from atopic lesions differ in their
ability to express eotaxin from normal fibroblasts. To address this question we cultured
dermal fibroblasts derived from biopsies obtained from normal (4), chronic-lesional (5) and
acute-lesional (4) atopic skin and compared IL-4-induced eotaxin mRNA expression using
gel-based and real-time RT-PCR.
We found significant variability in IL-4 induced fibroblast eotaxin mRNA expression when
comparing fibroblasts derived from different biopsies of the same group. The EC50 of IL-4
induced eotaxin mRNA expression was found to be lowest in fibroblasts originating from
acute inflamed atopic lesions, when compared to fibroblasts obtained from chronic atopic
lesions or normal skin. The variability in eotaxin expression in fibroblasts cultured from
different AD patients may indicate heterogeneity of factors determining atopic phenotype in
AD. The lower EC50 of IL-4-induced eotaxin-expression in fibroblasts originating from acute-
inflamed atopic skin-lesions may indicate a special role for IL-4-induced dermal fibroblast
eotaxin-expression in these lesions.
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Induction of a Chemoattractive Proinﬂammatory Cytokine Response after Stimulation of
Keratinocytes with Propionibacterium Acnes and Coproporphyrin III
Borelli C1, Schaller M2, Loewenstein M2, Merk K1, Jacob K3, Vogeser M3, Plewig G1
1Department of Dermatology, University of Munich, Germany; 2Department of Dermatology,
University of Tu¨bingen, Germany; 3Institute of Clinical Chemistry, University of Munich,
Germany
The inflammation in acne vulgaris is widely thought to be induced by an immunological
reaction but the role of Propionibacterium acnes (P. acnes) is unclear.
In the present study we examined the local host response mechanism of a keratinocyte cell
line 3 h and 6 h after stimulation with viable and heat-killed P. acnes.
The quantitative expression of cytokines was measured at the mRNA level by real time RT-
PCR.
The co-incubation of a keratinocyte cell line with viable, but not heat-killed, P. acnes
modulated an adequate cytokine response for IL-1beta, GM-CSF, and IL-8. High-
performance liquid chromatography analysis of the in vivo porphyrin pattern secreted by P.
acnes revealed a predominance of coproporphyrin III in acne lesions. This same porphyrin
fraction also modestly induced IL-8 expression by keratinocytes.
This cytokine pattern may favor a chemotactic response and implicates P. acnes and
coproporphyrin III in the recruitment of inflammatory cells to the site of infection and in the
development of acne lesions.
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An Immunoistochemical Study Comparing Spontaneous and Autologous Serum-Induced
Wheals of Patients with Chronic Idiopathic Urticaria
Caproni M, Melani L, Giomi B, Antiga E, Volpi W, Cardinali C, Fabbri P
Dept of Dermatological Sciences, University of Florence, Italy
In the latest years, the demonstration of circulating functional autoantibodies against the high
affinity IgE receptor or against IgE themselves in about one third of patients with chronic
idiopathic urticaria has suggested that an autoimmune mechanism might be involved in the
pathogenesis of this entity, defining a specific disease subset called ‘‘chronic autoimmune
idiopathic urticaria’’. In this study we wish to compare immunoistochemical findings
concerning infiltrating cells and related molecules from serum-induced and spontaneous
wheals of chronic urticaria patients. Possible differences and/or similarities between the two
kinds of wheals will be highlighted, to finally discuss if ASST may be regarded as in vivo
experimental model, reproducing the physiological stimulus causing urticaria skin condition.
We compared the mean of stained cells between spontaneous and autologous wheal
sections, these last evaluated at 10’ and 30’. Statistical significance (po0,05) was assessed
by Student’s t test. To what concerns T lymphocytes and mast-cells no significant difference
could be highlighted between spontaneous and autologous lesions. EG1 and EG2 staining
showed a preponderant presence of these cells in spontaneous wheals, as well as
neutrophils, IL-5, IL-8 and adhaesion molecules (VCAM, ELAM and ICAM). Basophils and
IL-4 showed a major expression in serum-provoked lesion. While IFN-g was poorly
represented in both kind of lesions, CCR3 and CXCR3 expression was major in spontaneous
wheals. To conclude, spontaneous lesions of cronic urticaria patients seems to be
preponderantly substained by neutrophils, eosinophils and their related molecules IL-8 and
IL-5, respectively, with an important role for adhaesion molecules. On the other hand, in
serum-evoked wheal development, basophils and IL-4 seems to be main actors in flogosis
development. In both kind of lesions a mixed Th1-Th2 pattern is recognizable.
A48 ABSTRACTS THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
285
Effects on Pro-Inﬂammatory Cytokines in HaCat Cells Treated by Tetrabromoﬂuorescin
(EOSIN)
Feliciani C1, Zampetti A1, Amerio PL1, Picardo M2, Mastrofrancesco A2, Flori E2, Maresca V2
1Catholic University of the Sacred Hearth, Rome, Italy; 2IFO, Italy
HaCaT cells are considered the closest model in vitro to study physiopathologic process of
human basal Keratynocites cells (KC). The task of our study was to test the response of
HaCaT to tetrabromofluorescin (eosin) at various concentrations and for different time of
treatment to verify a potential modification in the production of cytokines mainly involved in
the pathogenesis of psoriasis. HaCaT cells were cultivated in presence of scalar
concentration of eosin: 4%, 2%, 1%, 0,5%, 0,2%, 0,1%, 0,05%, 0,02%, 0,01%. Viability
of cells was measured by WST-1 test and MTT test after 5 and 24 hours of treatment. The
non-toxic doses were used in two HaCaT populations: one stimulated by 200UI of INFg for 14
hours, the other no stimulated. After that time they were treated by non-toxic doses of eosin
for 6 and 24 hours. ELISA was used to measure the IL6, IL8 and TNFa concentrations after 24
and 48 hours of recovery time. PCR analysis was used to test mRNA IL6 expression after 24
hours of treatment and 12 hours of recovery time. The WST-1 and MTT test revealed that
0,05%, 0,02, 0,01% were concentrations tolerated by HaCaT. The IL-6 and IL- 8 production
was dramatically reduced in presence of eosin 0,05% and 0,025%. For IL6 this reduction was
more evident by PCR after 12 hours of recovery. No significant variation in the production of
TNFa was recorded. In HaCaT cells stimulated by INFg, eosin seems to down-regulate the
production of IL6 and IL8 in a narrow concentrations window.
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A Link between Cytokines and Acute Phase Proteins Alterations in Patients with Mycosis
Fungoides
Sobieska M, Pawlaczyk M, Samborski W, Wiktorowicz K
University of Medical Sciences, Poznan, Poland
We have previously reported alterations of concentrations and glycosylation profiles of
selected acute phase proteins (APP) in patients suffering from mycosis fungoides (MF). MF is
the most common form of cutaneous T-cell lymphomas and cytokine balance is considered to
be of major importance for its pathogenesis. The aim of the study was to evaluate relationship
between concentrations and glycosylation profiles of some APP and concentrations of
selected cytokines in various stages of MF.
Sera samples were obtained from 52 patients with MF, aged from 33 to 82 years. Patients
were classified acc. to staging into four groups: 13 patients with MF in patch stage (IAþ IB),
12 patients with plaque stage (IIA), 12 patients with tumour stage (IIB), 15 patients with
erythroderma (IVA). Results were analyzed using STATISTICA 6.0 Software.
Along with increased concentrations also glycosylation of the investigated glycoproteins
showed alterations: both factors indicate inflammatory conditions. The changes of glycosylation
profiles were seen in all except patients with IIA stage of MF, with the highest intensity for
IIIþ IVA MF patients. It suggests that in early stage of MF the inflammatory reaction seems to be
acute and changes during progression of the disease towards chronic image.
It is possible to consider that the alterations seen in glycosylation profiles are due to altered
cytokine proportions, mainly the reported increase of IL-4 concentration.
Statistically significant correlations of cytokines concentrations with stage of the disease: IL-4
r¼0,766, IL-5 r¼ 0,612, IL-10 r¼0,665, IL-15 r¼0,551, IFNg r¼-0,689, sIL-2R r¼ 0,888.
Correlations between cytokines and acute phase proteins:
IL-4 – with AGP and W0; ACTand A1: increases concentrations of variants weakly reactive to
Con A. IL-10 – correlated selectively with variant W1; sIL-2R – correlated with W0 i A1; IFN-g –
negatively with: AGP, W0, W1; ACT, A1, A2, A3. Similar correlations were thus observed for IL-4,
IL-10 and sIL2R, and opposite for IFNg.
It seems that IL-4, IL10 and sIL-2R may relate to the same feature: increase in concentrations
and decrease in reactivity with ConA, though they do not cause it on themselves, as correlation
coefficient are low. This change may be due to activation of T helper lymphocytes, previously
mentioned in MF.
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Anti-Inﬂammatory Properties of Licochalcone A isolated from Glycyrrhiza inﬂata on
Human Skin Cells
Kolbe L, Immeyer J, Wensorra U, Weber T, Wolber R, Sta¨b F
Beiersdorf AG, Hamburg, Germany
Licorice extract is frequently used as a basis for candies or as a sweetener in the food and
tobacco industry of western countries. In the Far East, however, licorice is well known as a
basic ingredient of several traditional medicines for a broad range of diseases. Pharmaco-
logical activities have been attributed to several phenolic ingredients and terpene saponins
found in different Glycyrrhiza species. In this study we focused on the anti-inflammatory
properties of licochalcone A, a retrochalcone from Glycyrrhiza inflata which has been shown
previously to possess anti-bacterial and anti-parasitic activity. The production of various pro-
inflammatory mediators by skin cells was determined in vitro, including LPS-induced PGE2
release by adult dermal fibroblasts, fMLP or zymosan induced oxidative burst of neutrophils,
UVB-induced PGE2 release by keratinocytes, fMLP-induced LTB4 release by granulocytes,
and LPS-induced IL-6 and TNF-alpha secretion by monocyte-derived dendritic cells. Our
data clearly demonstrate that Licochalcone A is a potent inhibitor of pro-inflammatory
mediator release of a variety of dermatologically relevant cell types. The anti-inflammatory
in vitro properties of Licochalcone A at submicromolar concentrations and the broad action
profile makes it a promising candidate for dermatological and cosmetic applications.
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CD137 Ligand Mediated Differentiation of Immature Human Dendritic Cells is Associated
with Enhanced (Antigen Speciﬁc) T Cell Activation
Lippert U1, Zachmann K1, Brunner E1, Lafti AH1, Ferrari DM2, Neumann C1, Soruri A1
1Georg-August-University, Go¨ttingen, Germany; 2Max-Planck-Institute for Biophysical
Chemistry, Germany
Dendritic cells are well established as effective antigen presenting cells that activate T cells
via their T cell receptor in concert with a variety of costimulatory molecules. CD137, also
known as ILA (‘‘induced by lymphocyte activation’’) represents such an additional
costimulatory signal for T lymphocytes. Activation of the CD137 receptor on T cells can
induce T cell proliferation and the release of cytokines like IFN-g and IL-2. In view of these
facts, we asked the question whether the corresponding CD137 ligand is expressed in human
monocyte-derived dendritic cells (MoDCs) and whether it can mediate cell-cell communica-
tion between T lymphocytes and DCs. Using flow cytometry analysis, we found a basal level
of expression of CD137 ligand in immature MoDCs. Activation of CD137 ligand leads to
accelerated differentiation, with up-regulation of the maturation markers CD83, CXCR4, and
CCR7, as well as of HLA-DR and the T cell costimulatory molecule CD86. In addition, an
associated secretion of TNF-a was observed using the Elisa technique. These effects are
specific since blocking of the CD137 receptor/ligand interaction by specific antibodies
prevented MoDc activation. Co-cultivation of allogeneic T cells with CD137 differentiated
MoDCs led to the release of IFN-g, whereas IL-10 secretion decreased simultaneously.
Importantly, CD137 ligand activated MoDCs provide strong costimulatory signals to T cells in
an autologous antigen-specific T cell-dendritic cell reaction. This leads to antigen specific T
cell proliferation and shifts the Tcell response towards a Th1 cytokine pattern. These findings
suggest a novel physiological means of T cell-dendritic cell interaction, with important
implications for the regulation of an immune response in acquired immunity.
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RANTES-Containing Granules in Lymphocytes do not Belong to SNAREþ Secretory
Vesicles and can be Released in Part in the Absence of Extracellular Calcium
Ambach A1, Besser C1, Hartig R2, Bonnekoh B1, Schraven B2, Gollnick H1
1Depts of Dermatology and Venereology and 2Immunology, Otto-von-Guericke-University,
Magdeburg, Germany
We recently described the discovery, isolation and release kinetics of a pan-lymphocytic
RANTES (R)-granule system which was not part of intracellular organelles known so far. Since
in eosinophilic granulocytes VAMP2þ secretory vesicles were reported to contain R, and the
release of secretory vesicles is known to be dependent on extracellular calcium (Caþ þ ), now,
R-granules of peripheral lymphocytes were investigated for coexpression of VAMP/
synaptobrevin and the SNARE markers SNAP-25 and syntaxin-1. In addition, the
dependence of R-granule release on extracellular Caþ þ was investigated.
Flow cytometry and laser scan microscopy of double labeled cells, as well as activation of
cells using ionomycin and phorbol ester (PMA) in the presence and absence of extracellular
Caþ þ were employed.
R-granules did not colocalize with VAMP2, syntaxin-1 or SNAP-25 in all lymphocytic
subtypes investigated. The kinetics of R-granule release was slower in PBS without Caþ þ as
compared to PBS with Caþ þ . Chelating extracellular Caþ þ using EGTA also reduced R-
release. However, R-release was blocked only in part by removal of extracellular Caþ þ .
Whereas the release of secretory organelles like lytic granules from cytotoxic lymphocytes
or like SNAREþ acetyl choline-containing secretory vesicles was reported to be strictly
Caþ þ dependent, lymphocytic R-granules seem to be in part independent of extracellular
Caþ þ levels. This, together with the absence of SNARE molecules and other known
organelle markers (as demonstrated before), strengthens the hypothesis that R-granules
represent a unique and so far not identified cellular organelle.
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TNF-Receptor-2 Signaling in CD8þ Effector T Cells of Contact Hypersensitivity is Critical
for Tolerance to Contact Allergens
Seidel-Guyenat W1, Maurer M2, Alt R1, Metz M3, Knop R1, Steinbrink K1
1University of Mainz, Germany; 2University of Berlin, Germany; 3University of Stanford, USA
Low zone tolerance to contact allergens is induced by epicutaneous application of
subimmunogenic doses of haptens resulting in the generation of suppressor CD8þ T cells
(Tc2) that inhibit the development of Tc1-mediated contact hypersensitivity (CHS). In this
study, TNFa/ and TNFa receptor-deficient mice were used to characterize the role of TNFa
during LZT. Tolerizing doses of the contact allergen TNCB (0.45 or 4.5 mg per site, 5 times per
mouse) were applied epicutaneously. Tolerance induction in vivo was assessed by measuring
the inhibition of ear swelling in CHS. Importantly, we found that LZT is TNFa-dependent as
TNFa/ and receptor-double-KO-mice failed to develop LZT. Interestingly, TNFR1/
(p55/) mice showed normal LZT responses, whereas no induction of LZTwas observed in
TNFR2/ (p75/) mice. In addition, prevention of hapten-specific clonal expansion of
lymph node cells and upregulation of Tc2 cytokines did not occur in TNFa/, receptor-
double-KO- and p75/ mice after tolerization. Adoptive transfer of T cells from tolerized
TNFa/, TNFR2/ or WT mice that were injected vice versa into WT or TNFa/,
TNFR2/ animals demonstrated that TNFa and TNFR2 signaling is not required for the
induction and function of CD8þ suppressor T cells of LZT. However, TNFa induced signaling
via TNFR2 (p75) is essential for the effector phase of LZT. Notably, reconstitution of TNFa/
and TNFR2/ mice with T cells obtained from WT mice between tolerization and
sensitization revealed that the expression of TNFR2 on CD8þ effector T cells of CHS is
mandatory for the induction of LZT. Thus, our data demonstrate that TNF-a effects on TNFR2
(p75) expressing Tcells are critical in the effector phase of LZT, in which TNFa/ inhibits the
generation of CHS-promoting Tc1 cells and consequently the development of CHS.
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Gastric Acid Suppression Supports Sensitization to Dietary Proteins and Lowers
Threshold Levels
Untersmayr E1, Bakos N2, Scho¨ll I1, Szalai K1, Scheiner O1, Stahl-Skov P3, Poulsen LK3,
Boltz-Nitulescu G1, Jensen-Jarolim E1
1Center of Physiology and Pathophysiology Medical University of Vienna, Austria; 2Hete´tenyi
Ge´za Hospital, Hungary; 3Allergy Clinic, National University Hospital, Copenhagen, Denmark
Background and Aims: We could show previously that treatment with antacids or anti-ulcer
drugs promotes the development of type I food allergy towards digestion-labile food proteins
in BALB/c mice. In the present study we aimed to analyse whether our murine observations
have clinical impact in patients.
Methods and Results: An observational cohort study including 152 gastroenterological
patients, who were treated with H2-receptor blockers or proton pump inhibitors due to
dyspeptic disorders for 3 months, was performed.
After therapy, 25% of all patients showed an increase of food specific IgE, 10% a boost of
pre-existing IgE and 15% de novo IgE formation. Interestingly, 11.8% of all patients formed
IgE towards numerous digestion labile dietary compounds, like potato, celery, carrot, apple
codfish, wheat and rye flour without concomitant inhalative sensitization. Five months after
discontinuation of therapy, food specific IgE could still be measured in 6% of all patients and
7% had positive skin tests.
In addition, we investigated the role of gastric digestion in the effector phase of food
allergy. We addressed this question by comparing the biological activity of digested and
undigested codfish proteins in SDS-PAGE, IgE immunoblot, RAST inhibition experiments and
histamine release assays using the sera of codfish allergic patients. These in vitro methods
revealed that physiologically degraded codfish proteins exhibit an up to 10.000-fold
decreased IgE-binding and triggering capacity.
Conclusion: Our data suggest that hindrance of gastric digestion promotes the sensitization
towards dietary compounds. Furthermore, threshold levels of food allergens for triggering
anaphylaxis may be lowered in these settings.
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Induction of Regulatory T Cells in Allergic Individuals by IL-10-Treated Dendritic Cells
Together with TGF-b
Bellinghausen I, Ko¨nig B, Bo¨ttcher I, Knop J, Saloga J
Dept of Dermatology, University of Mainz, Germany
In grass pollen allergic individuals T cell anergy can be induced by IL-10-pretreated dendritic
cells (DC) resulting in a decreased proliferation and Th1 as well as Th2 cytokine production.
This study was set out to analyze further whether such anergic Tcells are able to suppress the
function of other T cells and to analyze the role of TGF-b as potential inducer of regulatory T
cells in this system. Freshly isolated CD4þ T cells from grass pollen allergic donors were
stimulated with autologous mature monocyte-derived allergen-pulsed dendritic cells in the
presence or absence of CD4þ T cells of the same donor previously cultured with IL-10-
treated DC with or without addition of TGF-b. Anergic T cells induced by IL-10-treated DC
enhanced IL-10 production and strongly inhibited IFN-g production of peripheral CD4þ T
cells while proliferation and Th2 cytokine production were only slightly reduced. The addition
of TGF-b had an additional effect leading to a much stronger suppression of Th2 cytokine
production and proliferation. These data demonstrate that regulatory/suppressor T cells that
also suppress Th2 cytokine production are induced most efficiently by DC that have been
pretreated with IL-10 and TGF-b. This might be exploited for future strategies aiming at the
downregulation of allergic immune responses in atopic diseases.
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Modiﬁcation of IgE Production by Allergen-DNA Transfected Dendritic Cells
Ko¨nig B1, Bellinghausen I1, Bo¨ttcher I1, Petersen A2, Becker W1, Knop J1, Saloga J1
1Dept of Dermatology, University of Mainz, Germany; 2Research Center Borstel, Germany
Atopic/allergic diseases are characterized by Th2-dominated immune responses resulting in
IgE production. DNA-based immunotherapies have been shown to shift the immune response
towards Th1 in animal models. In further studies we showed that human dendritic cells (DC)
transfected with allergen-DNA are able to stimulate autologous CD4þ T cells from atopic
individuals to produce Th1 cytokines instead of Th2 cytokines and to activate IFN-g
producing CD8þ T cells. The aim of this study was to analyze whether DC transfected with
allergen-DNA are also able to influence IgE production by human B cells. For this purpose,
mature monocyte-derived DC from grasspollen allergic donors were transfected with an
adenovirus encoding the allergen Phl p 1 and cocultured with autologous B cells, CD4þ T
cells, and CD40L- transfected L-cells.Total IgE production of B cells receiving help from
CD4þ T cells stimulated with allergen-transfected dendritic cells decreased dose-
dependendly compared to stimulation with allergen protein-pulsed DC. Total IgG production
was not affected in summary. Allergen-DNA transfected dendritic cells are able to direct the
atopic/allergic immune response from Th2-dominance towards Th1 and Tc1 also resulting in
decreased IgE-Production.
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Proteomic Identiﬁcation of New Metal-Protein Interactions in Human Antigen Presenting
Cells (APC) Links Innate and Adaptive Immune Responses in Human Nickel Allergy
Thierse HJ1, Junkes C2, Guerreiro N3, Lottspeich F4, Wild D1, Weltzien HU2
1MPI Immunobiology Freiburg & University Heidelberg, Germany; 2MPI Immunobiology
Freiburg, Germany; 3Novartis Basel, Switzerland; 4MPI Biochemistry Martinsried, Germany
Objective: Nickel (Ni) represents the most common occupational as well as public contact
allergen, causing metal-specific allergic reactions in about 10–15% of the human population.
To elucidate molecular events potentially underlying this disease, we have previously
demonstrated that such Ni-protein-interactions involving skin-related human serum albumin
(HSA) lead to functional, Ni-specific human T cell clone activation. T cell receptor (TCR)-
transfected cell lines were also activated in a Ni-dependent and HLA-restricted manner by
such HSA-Ni metalloprotein-complexes [citation removed]. With the aim of identifying
unknown cellular Ni-protein interactions in human blood-derived professional antigen
presenting cells (APC), we used in vitro generated human dendritic cells (DC), as a model
system for a metal-specific subproteomic approach (metalloproteome). Results were
compared to Ni-interacting proteins in human B cells, which have just recently been
described by our laboratory (Heiss K et al., Proteomics, in press).
Methods: Ni-protein interactions were detected via Ni-NTA-enrichment, 2-D electrophoresis,
mass spectrometry and database analysis. If possible, data were con firmed by Western
blotting, graphite furnace atomic absorption spectrometry and/or Biacore analysis.
Summary and Conclusions: In DCs 32 out of 57 isolated Ni-interacting proteins were
identified. Comparative analysis of both cell types revealed differential Ni-interacting
molecules in B cells and in vitro generated human DCs. Among others, several
chaperones/heat shock proteins were detected, which may be involved in Ni-epitope
presentation and/or cellular stress responses towards heavy metal Ni. Functional under-
standing of these metal-protein interactions potentially helps to elucidate the development
and pathophysiology of T cell-mediated human nickel allergy and/or processes like Ni-
induced cell toxicity.
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The IgE-Bearing B-Cell Receptor Repertoire of Atopic Dermatitis Patients Shows
Unbiased VH-Usage but Patient-Speciﬁc Clonal Expansions
Mempel M1, Gauger A1, Schnopp C1, Ring J1, Ollert M1, Kourilsky P2, Lim A2
1Technical University Munich, Germany; 2Pasteur Institute, Paris, France
Previous studies have postulated a bias in the usage of IgE-associated VH-chains in atopic
individuals favouring a preferential usage of the VH6 segment. We have analyzed CD19-
sorted B-lymphocytes from several adult atopic eczema patients displaying very high serum
IgE levels (41000 IU/ml). These purified B-cells were screened in a quantitative Real-Time
RT-PCR technique for their transcription of all eight VH-genes together with CH-primers of the
e-, g1-4, and m-type, representative for the repertoire of IgE-, IgG-, and IgM-families. The VH-
CHe amplifications were analyzed for their complementary determining region 3 (CDR3)
spectra by a modified Immunoscope technique. In some patients, clonal expansions were
further sequenced and compared to corresponding expansions of the IgM and IgG
transcripts in order to screen for somatic mutations of the expanded clones and/or
commonly selected clones. Serum IgE levels and antigen-specific IgE were determined using
the IMMULITE system.
Our approach revealed a preferential usage of VH3b-, VH4-, and VH1-chains in IgE-
producing B-cells regardless of the individual sensitization pattern. These chains were also
preferentially found in IgG and IgM transcripts. Each patient however, harbored specific
clonal expansions which were identified by the CDR3-spectratyping and which were not
shared between patients even in cases of highly similar specific IgE production. Extensive
sequence analysis revealed unique CDR3-sequences showing somatic mutations. However,
sporadic clonal sequences were shared between IgE- and IgG transcripts suggesting a
common origin.
Atopic individuals with high IgE levels show a highly individual pattern of IgE-bearing B-cell
expansions with no preferential VH-usage but particular CDR3-composition.
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In Vivo T Helper Cell Polarizing Capacity of Pollen-associated Lipid Mediators (PALMs)
during Primary Sensitization in DO11.10/BALB/c Chimeric Mice
Gutermuth J1, Traidl-Hoffmann C1, Ring J2, Behrendt H1, Jakob T1
1ZAUM Center for Allergy and Environment, Technical University of Munich, Germany; 2Dept
of Dermatology and Allergy Biederstein, Technical University of Munich, Germany
Pollen grains not only function as allergen carriers, but also release bioactive lipid mediators
(PALMs) upon contact with the aqueous phase. PALMs modulate human dendritic cells
function in a fashion that results in a Th2 polarization of human naı¨ve T cells in vitro (JEM
201:627-36, 2005). To address, whether PALMs show similar effects in vivo, we analyzed
events of early T cell polarization during primary sensitization in mice. To overcome the low
frequency of naı¨ve antigen-specific T cells in wild type mice, we established a DO11.10/
BALB/c chimera using adoptive transfer, thus ensuring a defined number of OVA323-339-
specific CD4 cells in regional lymph nodes. 48 hours after intranasal instillation of OVA323-339
alone or OVA323-339 plus aqueous birch pollen extract (APE) to DO11.10/BALB/c chimeras,
cells were obtained from draining lymph nodes, restimulated with peptide in vitro and on day
6 intracellular IL-4 and IFN-g were analyzed by flow cytometry. Transfer of 5  106 T cells led
to 1–2% of OVA323-339 TCR transgenic T Cells in regional lymph nodes. 48 hours after
intranasal instillation of OVA323-339, proliferation of antigen specific T cells was detected in
draining, but not in non-draining lymph nodes. In comparison to exposure with OVA323-339
alone, intranasal instillation of OVA323-339 plus APE lead to an increase in IL-4 - and a
decrease of IFN-g producing antigen specific T cells, as determined after peptide
restimulation. In conclusion, PALMs appear to exert immunomodulatory activities on the
early phase of primary sensitization in vivo, that result in a bias towards Th2 polarization.
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Generation of Peptide-Mimotopes for the Treatment Of Fish Allergy
Szalai K1, Untersmayr U1, Riemer A1, Hemmer W2, Swoboda I1, Scheiner O1, Jarisch R1,
Boltz-Nitulescu G1, Jensen-Jarolim E1
1Medical University of Vienna, Austria; 2Floridsdorf Allergy Center, Austria
Background: Fish is among the most common food allergens, and can trigger life-
threatening reactions. Parvalbumin, the major fish allergen, is recognized by over 90% of all
fish allergic patients. In the present study we have focus on the generation of mimotopes i.e.
epitope mimics for localizing IgE epitopes on parvalbumin.
Materials and Methods: Specific IgE was purified from fish allergic patient’ sera using
recombinant parvalbumin (Cyp c 1) and was used to select parvalbumin specific mimotopes
from a circular random decapeptide phage library. After 4 successive rounds of biopanning,
75 phage clones were screened for binding capacity with parvalbumin-specific IgE and the
most reactive clones were further analyzed by DNA sequencing.
Results: DNA sequencing revealed homology among the selected clones. Interestingly, 3
regions on the surface of the natural allergen were defined by computational matching of the
selected mimotopes. The importance of these regions as epitopes could be verified by
comparing with previously defined epitopic sections of cod parvalbumin, which were found in
close proximity, or overlapping with our mimotope matching areas.
Conclusion: Based on our data, we suggest that these identified peptide mimotopes
represent IgE-binding epitopes of the major fish allergen parvalbumin and, thus, represent
valid tools for the development of vaccination strategies for treatment of fish allergy.
Supported by grant 10326 of Austrian National bank ‘‘Jubila¨umsfond’’ and by grant SFB-
F1808-B04 of the Austrian National Science Foundation (FWF).
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Grass Pollen Allergic Patients Harbor Anti-Idiotypic Antibodies Mimicking Natural Phl p 5
Epitopes
Wallmann J1, Hantusch B1, Knittelfelder R1, Szalai K1, Untersmayr E1, Riemer AB1, Vogel
M2, Stadler BM2, Boltz-Nitulescu G1, Jensen-Jarolim E1
1Center of Physiology and Pathophysiology, Medical University of Vienna, Austria; 2Institute
of Immunology, Inselspital Bern, Switzerland
Since the presentation of the network hypothesis by Jerne in 1974, numerous studies have
shown that indeed anti-idiotypic antibodies occur in humans and harbor regulatory functions.
Moreover, they were already exploited as immunogens, because they represent an ‘‘internal
image’’ of an antigen. In type I allergy, naturally occuring anti-Ids have been reported, too.
This study aims to precisely define the molecular characteristics of anti-Ids to allergen-
specific IgE, taking grass pollen major allergen Phl p 5 as an example. Our hypothesis was that
in case of true molecular mimicry, they could be applied as epitope-specific vaccines.
By using Phl p 5-specific IgE we screened the combinatorial Fab library and among six
candidates we selected two anti-idiotypic Fabs, designated C29 and E39. Both Fabs were
recognized by Phl p 5-IgE with high specificity. The hypervariable regions of these two anti-
idiotypic antibodies revealed partial sequence homology with solvent accessible sites of Phl p
5a. The generated Fabs, therefore, mimic the molecular surface regions relevant for IgE binding
with the advantage to represent a larger part of the epitopic areas than do peptide mimotope
approaches.
Phagemid DNAs derived from the phage clones C29 and E39 were used to produce soluble
recombinant anti-idiotypic Fabs in E.coli and afterwards were purified by affinity chromatography.
For proof of concept, studies were applied in mouse immunization, where they indeed were
able to induce anti-Phl p 5 specific antibodies. Consequently we suggest them to represent
internal images of Phl p 5a.
As the Fabs were derived from a human repertoire, we believe that they might harbor
physiological regulatory functions, and possibly support IgE production to Phl p 5 outside the
grass pollen season.
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Differentially Stimulated Keratinocytes Play a Regulatory Role for the Course of Chronic
Inﬂammatory Skin Diseases
Purwar R, Werfel T, Wittmann M
Dept of Dermatology and Allergology, Hannover Medical School, Germany
Atopic dermatitis (AD) is an allergic skin inflammatory disease. Cytokine expression in lesional
skin is characterized by a more Th2-like cytokine pattern in the acute and a more Th1-like
pattern in the chronic phase of the disease. Recent studies suggest that keratinocytes may
play a decisive role in pathogenesis of AD through the regulated expression of chemokines
dependent on the ambient cytokine milieu. In this study we investigated the role of
differentially stimulated human keratinocytes for the course of AD. HPKs stimulated with IL-
13 – a Th2 cytokine - synthesize and release CCL22/MDC (ligand of CCR4). This was of
functional significance as verified in migration assays with CD4þ T-cells either from AD
patients or healthy subjects. We observed preferential migration of Th2-cells (CCR4þCD4þ ;
CRTH2þ CD4þ ) towards IL-13 stimulated HPKs. Interestingly, Th2-cells from AD showed a
higher chemotactic response than those from healthy individuals. On the contrary, IL-18 -
initially termed IFN-g inducing factor - induced CXCL10/IP-10 production by HPKs which
consequently attract Th1-cells (CXCR3þCD4þ ). Furthermore, we demonstrate that
keratinocytes freshly isolated from skin biopsies of lesional AD have a significantly higher
expression of the IL-18Ra as compared to normal donors. Taken together our data suggest
that HPKs participate in a positive feedback loop by preferentially enriching Th1 or Th2-cells
in skin lesions depending on the micromilieu thus regulating the course of chronic
inflammatory skin diseases such as AD.
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Investigation of the Requirement for Antigen Processing and Presentation in T-Cell
Hypersensitivity to Phenytoin
Cooper HL, Pickard C, Healy E, Friedmann PS
University of Southampton, United Kingdom
Adverse drug reactions (ADRs) are unpredictable and potentially serious. Studies have shown
a pivotal role for drug-specific T-cells in ADRs but questions remain regarding the actual
antigen and how it is presented to immune effector cells. Classical theory predicts the need
for the metabolism of an unreactive parent drug into a ‘‘hapten’’ that covalently binds to
peptides and is presented to T cells in the context of class I & II classical major
histocompatibility molecules (MHC). Other studies have suggested that drugs may interact
at the surface of antigen presenting cells (APC), binding non-covalently between MHC and T-
cell receptors (TCR) without internalisation and processing (Pi hypothesis). To investigate this
further, we have studied ADRs to the anti-convulsant phenytoin. Skin patch tests (1 & 5%
phenytoin) applied for 48hrs showed dose-related reactions in 5/6 allergic patients and no
response in 12 controls (6 drug naı¨ve, 6 drug exposed). Lymphocyte proliferation assays with
peripheral blood mononuclear cells incubated with phenytoin in vitro demonstrated
proliferative responses with stimulation indices of 12 to120 only in the 6 allergic patients.
To examine the mechanisms by which phenytoin is ‘‘presented’’ to T cells, 34 phenytoin-
specific T cell clones (TCC) were raised from a phenytoin allergic patient. These proliferated
when cultured with phenytoin in the presence of g-irradiated autologous Epstein Barr virus
transformed B-cells (EBLCLs) as APC. FACS analysis showed all clones to be CD4þ . Drug
specific cytokine release identified high levels of IL-5, IL-4, TNF-a and IFN-g, consistent with
a T-helper 0 profile. The requirement for parent drug to be taken up and processed by APC for
presentation to T cells was examined using viable or glutaraldehyde fixed EBLCLs as APCs.
These were incubated (a) with phenytoin for 24 hrs before 3 washes and the addition of drug-
specific TCC, and (b) with TCC in the continuous presence of drug for 6 days and responses
compared (n¼ 10 clones). Four clones responded to phenytoin-pulsed viable APCs whereas
six required the continued presence of the drug; however, fixation significantly reduced
responses in all cases. Staphylococcal super antigen F was used as positive control as it
induces proliferation in a fixation independent manner. Our data indicate that, most phenytoin
specific T-cell clones require processing and presentation by viable APCs. However, some
clones also appear to respond to a small degree via a processing independent mechanism as
suggested by the Pi hypothesis. In conclusion metabolism-dependent processing appears to
be critical for inducing T-cell hypersensitivity to phenytoin.
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Rapid and Lasting Antigen Speciﬁc Immune Response and non Responsiveness to
Aerosol Challenge Induced by Intranasal Instillation of Antigen Loaded DC
Gutermuth J1, O’Keefe M2, Alessandrini F1, Traidl-Hoffmann C1, Ring J3, Behrendt H1,
Hochrein H2, Jakob T1
1ZAUM Center for Allergy and Environment, TUM, Germany; 2Bavaria Nordic GmbH,
Munich, Germany; 3Dept of Dermatology and Allergy Biederstein, TUM, Germany
We evaluate the impact of a single intranasal sensitization with antigen loaded DC subsets on
humoral and cellular immune responses and allergen induced bronchoalveolar lavage (BAL)
cellular infiltrate. BALB/c bone marrow derived DC were generated under the agis of Flt-3
ligand (FL-DC) or GM-CSF (GM-DC) containing plasmacytoid DC and myeloid DC,
respectively. DC were loaded with OVA (1 mg/ml) for the final 12 hrs in the presence or
absence of CpG-ODN (1 mM). OVA loaded DCs (106/25 ml) were administered by a single
intranasal installation and OVA specific humoral and cellular immune response was
determined. BAL analysis was performed 24 hrs after 2 OVA aerosol challenge (d 166
and 167). Mice sensitized with OVA loaded DC developed a rapid, long lasting (4130d) Ab
response. CpG activated FL-DC induced a solid IgG2a response, but failed to induce IgE or
IgG1. In contrast, GM-DC induced a mixed profile (IgG2a, IgG1 and IgE). CpG activation led
to a shift with increased IgG2a and decreased IgG1 and IgE. Splenic CD4 T cells obtained
from DC-sensitized mice demonstrated high level of spontaneous cytokine production,
suggesting a long lasting memory effect and upon restimulation in vitro substantial amounts
of IL-4 and IL-5 (GM-DC4FL-DC). Interestingly, mice sensitized by OVA loaded DC when
challenged with OVA aerosol did not develop an allergic inflammation of the lung (while OVA/
alum i.p. sensitized mice did). In conclusion, a single intranasal administration of antigen
loaded DC induces a rapid and long lasting humoral and cellular immune response. Despite
high levels of antigen specific IgE and IgG1, animals were non responsive to aerosolized
antigen challenge, suggesting that intranasal administration of antigen loaded DC may
convey protection against inflammatory responses to harmless airborne allergens.
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Adjuvant Effects of Ultraﬁne Particles on Allergic Airway Inﬂammation
Alessandrini F1, Schulz H2, Takenaka S2, Lentner B2, Karg E2, Behrendt H1, Jakob T1
1ZAUM Center for Allergy and Environment, KKG-UDA GSF/TUM, Germany; 2Institute of
Inhalation Biology, GSF Munich, Germany
Epidemiological studies show that exposure to particulate air pollution is associated with
asthma exacerbation. Ultrafine particles (UFP, diameter o100nm) may contribute to these
adverse effects. The objective of our study was to investigate the effects of elemental carbon
(EC)-UFP inhalation on allergic airway inflammation. For this ovalbumin (OVA) sensitized and
non sensitized mice were exposed to EC-UFP (526 mg/m3, 24h) 24, 96, or 168 h prior, or 24 or
72h after ovalbumin aerosol challenge. Allergic inflammation was analyzed at different time
points after allergen challenge by means of bronchoalveolar lavage fluid (BALF) cell count and
cytokine/total protein assays, lung histology and airway hyperresponsiveness. In sensitized
mice inhalation of ultrafine particles 24h prior to allergen challenge caused a significant
increase of BALF inflammatory infiltrate, protein, interleukin (IL)-4, IL-5, and IL-13 compared
to all relevant controls. These adjuvant effects were dose and time dependent and still
present when particle exposure was performed 4 days prior to allergen challenge. The
adjuvant effect of ultrafine particles was also documented by increased mucus production,
peribronchiolar and perivascular inflammation and enhanced airway hyperresponsiveness. In
contrast, particle exposure after allergen challenge caused only moderate effects, such as a
delay of inflammatory infiltrate and a reduction of cytokines in bronchoalveolar lavage fluid. In
conclusion, exposure to ultrafine particles before allergen challenge exerts strong adjuvant
effects on the manifestation of allergic airway inflammation. Allergen sensitized individuals
may thus be more susceptible to detrimental health effects of ultrafine particles.
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Pollen Associated Lipid Mediators (PALMs) Modulate Cytokine and Chemokine Proﬁle of
Human Dendritic Cells Leading to Induction and Attraction of Th2-Cells
Mariani V, Jakob T, Ring J, Behrendt H, Traidl-Hoffmann C
Center for Allergy and Environment GSF/TUM, Germany
We could recently show that pollen grains not only function as allergen carriers but are also a
rich source of bioactive lipid mediators. The primary site of exposure to pollen grains is the
epithelium of the upper respiratory tract, which is densely populated by immature dendritic
cells (DCs). The trafficking of DCs through tissues is regulated by the pattern of chemokine
receptors expressed on DCs and the local availability of chemokines. These chemokines,
along with adhesion molecules, are crucial during inflammatory response for a timely
recruitment of specific leukocyte subpopulations to sites of tissue damage. DCs are an
important source of chemokines influencing the recruitment of distinct T-lymphocytes
subsets. We already demonstrated that pollen associated lipid mediators inhibited LPS-
induced IL12 release, thereby reducing a Th1 polarization in an allogeneic reaction. The aim
of this study was to investigate whether pollen-derived factors can have immunomodulatory
effects on the immune response through influencing DCs function and consecutively driving
the T cells’ chemokine production toward a particular direction.
DCs were prepared from purified peripheral blood monocytes of healthy individuals.
Differently stimulated DCs were analyzed for chemokine receptors CCR1, CCR5, CCR7 and
CXCR4 and chemokines such as CXCL10, CCL5, CCL17 and CCL22 on protein and mRNA
level. Functionality of the released chemokines was analysed by migration of polarized Th1
and Th2 T-cell clones towards differently stimulated DC-supernatants. Furthermore,
expressed chemokine receptors on DCs were proofed for functionality by migration towards
CCL3, CCL16, CCL21, CCL19 and CXCL12.
LPS-purified aqueous pollen extracts (APE) induced in DCs a significant downregulation of
CCR1 and CCR5 while CXCR4 was upreagulated. In migration studies, APE or APE plus LPS
stimulated DCs showed a reduced response to CCL3, CCL16 while the response towards
CCL19, CCL21 and CXCL12 were dramatically increased. Interestingly, APE induced a
significant downregulation of LPS/CD40L induced CXCL10 and CCL5 while LPS/CD40L
induced CCL22 and CCL17 were significantly increased. DC supernatants from APE or LPS
plus APE stimulated DCs lead to a primarily attraction of Th2 cells.
These results suggest that pollen derived lipid mediators (PALMs) play an important role in
the modulation of dendritic cells function and, consequently in the nature of the
corresponding T cell response leading to an enhanced induction and attraction of Th2 cells.
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Detection of Functional Melanocortin Receptors in Human Basophils: Implications for an
Immunoregulatory Role of alpha-MSH in Allergic Diseases
Bo¨hm M, Wolff I, Scholzen TE, Luger TA
Dept of Dermatology, University of Mu¨nster, Germany
Melanocortins such as alpha-melanocyte-stimulating hormone (alpha-MSH) elicit their
biological effects by binding to melanocortin receptors (MC-Rs). The biological activities of
alpha-MSH include immunomodulatory effects linking the endocrine system, i. e. the
classical as well as the cutaneous hypothalamic-pituitary-adrenal axis, with the immune
system. Since mononuclear cells and mast cells have been shown to express MC-Rs, we
wondered if human basophils would represent another target for alpha-MSH. Using RT-PCR
analysis and specific primers against all known MC-R subtypes we detected the expression
of MC-1R at RNA level in the human basophil cell line KU812. MC-1R expression on the cell
surface of these cells was also detectable by FACS analysis using an antibody directed
against the amino acids 2-18 of the extracellular N-terminal domain of human MC-1R. Double
staining with an antibody against IgE or the basophil-activation marker CD203c in
combination with the anti-MC-1R confirmed the presence of MC-1R immunoreactivity also
in basophils of total peripheral blood samples derived from healthy human volunteers. In
contrast to the majority of human skin cell types, KU812 cells lacked expression of the alpha-
MSH precursor pro-opiomelanocortin therefore excluding an autocrine regulatory loop of
melanocortins in this in vitro cell culture system. The MC-1Rs as detected in KU812 basophils
were functional as alpha-MSH treatment resulted in a significant and dose-dependent
increase in intracellular cAMP. Most interestingly, alpha-MSH suppressed the inductive effect
by calcium ionophore A23187 on mRNA expression of IL-4, a classical proallergic and
profibrotic cytokine. These data for the first time demonstrate that human basophils express
functional receptors for the neuropeptide alpha-MSH which regulates expression of a
cytokine crucially involved in the pathogenesis of allergic diseases.
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Bullous Cimicosis is Due to Allergic Hypersensitivity to Nitrophorin from cimex
lectularius Saliva
Leverkus M1, Jochim R2, Scha¨d S3, Bro¨cker EB3, Andersen J2, Valenzuela J2, Trautmann A3
1Otto-von-Guericke-Universita¨t Magdeburg, Germany; 2Medical Entomology Section,
Laboratory o, USA; 3Department of Dermatology, University of, Germany
In Central Europe bites from the common bed bug (Cimex lectularius) are nowadays rather
uncommon. However, infestations are sometimes observed in old framehouses and by
immigration due to international travel and migration. The clinical picture of bug bites
substantially vary between individuals, depending upon previous exposure and the degree of
an immune response. However, the potential antigens present in the saliva of Cimex
lectularius or specific antibodies have not been characterized thus far. Here we describe a
patient with bullous bite reactions after sequential contact with Cimex lectularius over the
period of one year. In skin tests we observed immediate reactions to salivary gland
preparations of Cimex lectularius which were followed by a pronounced partially blistering
late-phase response in the patient, whereas several healthy control patients did not show any
reactivity. Immunoblot analysis as well as immunoblot inhibition studies of the patient’s serum
with salivary gland extracts as well as recombinant Cimex lectularius saliva proteins revealed
specific IgE-antibodies against the 32 kDa Cimex lectularius nitrophorin, but not to Cimex
lectularius apyrase. Our data demonstrate that bullous cimicosis may be the late phase
response of an allergic IgE-mediated hypersensitivity reaction to Cimex lectularius
nitrophorin.
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In Vitro Diagnosis of Contact Allergy to Nickel: The Value of the ELISpot Assay
Spiewak R1, Moed H2, Von Blomberg BM2, Bruynzeel DP2, Scheper RJ2, Gibbs S2,
Rustemeyer T2
1Jagiellonian University Medical College, Poland; 2VU University Medical Centre, Amster-
dam, The Netherlands
Background: Diagnosis of contact allergy is based on clinical data and patch tests. Among
in vitro tests, lymphocyte proliferation test (LPT) is most frequently used. A disadvantage of LPT
is that it is based on radiochemicals, which restricts its use only to laboratories with radionuclide
facilities.
Objective: To find a cytokine secretion assay giving results that correlate best with clinical
diagnosis and with LPT.
Methods: PBMC from 14 patients with ACD to nickel and 14 non-allergic controls were tested for
their reactivity to nickel. In all subjects, patch tests and LPT with nickel sulphate were done. A
range of non-radioactive secretion assays was performed, including ELISpot assays for IL-2, IL-
5, IL-13 and IFN-g, and ELISA for IL-5 and IFN-g. Beside standard culture conditions, cytokine
secretion was also measured in cultures favouring the development of Tc1/Th1 or Tc2/Th2
lymphocytes (‘‘skewing’’ through addition of IL-7 with respectively IL-12 or IL-4).
Results: The best correlation with clinical diagnosis (patch tests and history) was observed for IL-
13 ELISpot with Tc2/Th2 skewing (r¼0.654, Po0.001), followed by LPT (r¼0.612, Po0.001),
and IL-5 ELISpot with Tc2/Th2 skewing (r¼0.551, P¼ 0.002). The non-radioactive method that
correlated best with LPT was IL-2 ELISpot (r¼ 0.809, Po0.001), followed by IL-13 ELISpot
(r¼0.778, Po0.001), and IL-5 ELISA (r¼ 0.669, Po0.001). Interestingly, IFN-g ELISpot and IFN-g
ELISA correlated very poorly with both clinical diagnosis and LPT results (ro0.010 in each case).
Conclusions: Results of IL-13 ELISpot with Tc2/Th2 skewing correlate best with clinical diagnosis
of contact allergy to nickel, whereas IL-2 ELISpot seems a good non-radioactive alternative for
lymphocyte proliferation test.
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A Novel Microarray-Based Assay for Murine Allergen-Speciﬁc IgE Quantiﬁcation
Busch M1, Schroeder C2, Baron JM2, Mahler V1
1Friedrich-Alexander University, Erlangen, Germany; 2University of Aachen, Germany
Aim of this study was to investigate and quantify the allergenicity and immunogenicity of
different allergen sources (latex, soy and casein) in a mouse model, since proteins from
foreign protein sources (e.g. casein) have recently found to be contained in finished latex
products.
Protein extracts from different sources were obtained by standard aqueous extraction and
characterized by Lowry protein assay, antigen specific IgE and IgG1-ELISA, SDS-PAGE, IgE-
and IgG1-immunoblot.
BALB/c mice were repetitively immunized subcutaneously in groups of ten animals with
equal amounts of either one of three natural rubber glove extracts, soy extract or casein each
adsorbed to Al(OH)3 as an adjuvant. Repetitive immunizations and bleedings of the animals
were done in parallel over 196 days.
Allergen-specific IgE and IgG1-antibody responses in the course of immunization were
analyzed by ELISA and statistically evaluated by analysis of variance. Antibody binding was
investigated by IgE-immunoblot. For quantification of allergen-specific murine IgE-induction
a novel microarray-based technique was established.
The different allergen sources (latex, soy and casein) induced specific IgE and IgG1-
responses. Allergen-specific human and murine antibodies are directed against allergens of
similar molecular weight. By microarray technology clear IgE responses against kappa casein
could be detected in mice immunized with an extract derived from a natural rubber latex
glove presenting a hidden casein source.
In this study, we were able to establish a new immunological method based on micro-array
technology to determine allergen-specific murine IgE antibodies. Foreign proteins were
detected in latex products. Based on the results of IgE-induction caused by these foreign
proteins in our mouse model, a shift and a new increase in sensitization profiles elicited by the
finished products can be anticipated.
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Development of Melanocyte Patch for Vitiligo Treatment
Lin S1, Hsiao W2, Jee S1, Yu H1, Young T2
1National Taiwan University Hospital, Taiwan; 2Institute of Biomedical Engineering, Taiwan
Autologous melanocyte transplantation has been used in treatment of difficult cases of
vitiligo. Conventionally, transplantation by use of cell suspension has drawbacks including
possible cell damage in cell preparation and transportation, difficult manipulation of cell
suspension and low engraftment rate in acral lesions. We have proposed melanocyte cellular
patch as a potential solution. Chitosan, a deacetylated product from natural chitin, can be an
ideal membranous part of the patch due to its biocompatibility, good adherence to skin,
antimicrobial activity, and appropriate tensile strength. We have shown that chitosan
membrane supports the growth and phenotype expression of melanocytes. In addition,
melanocytes spontaneously grew into three dimensional spheroids on chitosan-coated
surface. The biological function of spheroidal melanocytes was previously unknown. In this
work, we demonstrate that, compared with monolayered melanocytes, melanocyte spheroids
show a better survival in growth factor deprived condition which normally induced apoptosis
in melanocytes. Our results also show that melanocytes are morphologically transformable
depending on the substratum used and spheroidal melanocytes have a superior survival to
that of monolayered dendritic melanocytes in stringent conditions. Preculturing melanocytes
into spheroids can provide melanocytes a survival advantage during transplantation.
Chitosan-based melanocyte patch can be a promising method to enhance the engraftment
rate and facilitate the cell preparation and transplantation procedures in melanocyte
transplantation for vitiligo treatment.
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Silencing of C-Kit in Mast Cells Using a New Approach to Increase shRNA-Transfection
Efﬁciency
Artuc M, Guhl S, Mangoldt D, Zuberbier T, Truss M
Charite´ Universita¨tsmedizin Berlin, Germany
RNA interference (RNAi) has developed into a new gateway for elucidating gene function.
RNAi is a sequence-specific, posttranscriptional gene silencing mechanism that is effected
through double stranded RNA molecules homologous to the sequence of the target gene.
The delivery of the siRNA to mammalian cells largely depends on transfection efficiency,
and for many hematopoetic cell lines as well as primary cells, efficient transfection cannot be
achieved. Selection of the positive transfected cells is difficult and not efficient. One possible
approach to overcome these problems is the application of vector systems combining both,
an expression unit for a cell surface marker as well as short hairpin RNAs.
In the present study, we introduced c-kit DNA oligos (for endogenous short hairpin RNA
(shRNA) synthesis) into the mast cell line HMC-1, which grows independent of SCF due to a
mutation of the KIT receptor.
For transient silencing of c-kit, we cloned DNA oligos corresponding to three different gene
positions of c-kit into a pMACS-Kk2-H1 vector via BglII and HindIII restriction sites. This
vector expresses a mouse MHC class I H-2Kk protein as a selection marker with a truncated
cytoplasmic domain. After 24 hours of electroporation, the transfected cells were labelled
with MACSelect Kk Micro beads and labelled cells were separated using AutoMACS.
Transfection efficiency was 100% in selected, but only 30% to 50% in non-selected HMC-1
cells. Expression of KIT was analysed by FACS using a MAB against CD117 (KIT). In
successfully transfected cells, expression of KIT was downregulated by 85%.
In summary, we were able to efficiently silence KIT in HMC-1 cells by a novel approach
using a vector which combines a cell surface expression marker for selection of successfully
transfected cells together with the respective oligo for silencing of the targeted RNA (c-kit).
Using this approach, we achieved a transfection rate of 100%.
We conclude that selection of cells is a useful tool to increase transfection efficiency, which
was proved in this study by successful KIT silencing in HMC-1 cells.
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Differential Gap Junctional Intercellular Communication Between Melanoma Cells and
Cells in their Microenvironment
Haass N1, Brandner J2, Brafford P1, Wladykowski E2, Kazianis S1, Moll I2, Herlyn M1
1The Wistar Institute, Philadelphia PA, USA; 2University Hospital Hamburg-Eppendorf,
Germany
Keratinocytes control melanocytes through growth factors and adhesion molecules.
Disrupting this balance can alter cell-cell communication and provoke melanoma develop-
ment. Gap Junctional Intercellular Communication (GJIC) is required for maintaining tissue
homeostasis and the life and death balance of cells. Changes in connexin (Cx) expression
may result in a loss of GJIC, which contributes to tumor progression.
Using microarrays and RT-PCR, we show that Cx43 is not or only weakly expressed in
melanoma cells, but highly in melanocytes, keratinocytes, fibroblasts and endothelial cells.
Cx32 is expressed in melanoma cells and, at a lower level, in melanocytes, but not in
keratinocytes, fibroblasts and endothelial cells. Cx26 and Cx30 are only weakly expressed in
some melanoma lines. Using immunofluorescence on human tissue sections, we did not
detect Cx43, Cx26 and Cx30 in melanoma. We show an induction of Cx26 and Cx30 in the
epidermis adjacent to melanoma, while both are not detectable in the epidermis adjacent to
nevi. Using specific markers, we show that the induction of Cx26/Cx30 is not a reflection of
reactive hyperproliferative or traumatized epidermis. Dye transfer experiments show that – in
contrast to the highly communicating keratinocytes – there is GJIC only between
subpopulations of melanocytes and also melanoma cells. In some cases there appears to
be unidirectional communication between melanoma cells and fibroblasts. RNAi for
connexins in lentiviral vectors will determine the putative roles of GJIC in tumor progression.
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Regulation Melanogenesis and Activation of Amelanotic Melanocytes In Hair Outer Root
Sheath by 8-Methoxypsoralen In Vitro
Ma HJ, Zhu WY, Wang DG, Yue XZ, Li CR
The First Affiliated Hospital of Nanjing, China
Psoralen-ultraviolet A is an effective way to treatment with vitiligo, but little is known about the
mechanism. Recent studies have shown that psoralens can directly stimulate melanogenesis
by increasing the activity and synthesis of tyrosinase in the absence of ultraviolet light. Up to
data, however, whether psoralens such as 8-Methoxypsoralen (8-MOP) can directly stimulate
amelanotic melancytes (AMMC), an inactive unpigmented melanocyte from hair outer root
shealth (ORS) is still not known. On the basis of successful culture of AMMC before, we study
the effects of 8-MOP on melanogenesis, tyrosinase activity and expression of melanogenic
key enzymes of AMMC in hair ORS. Four different concentrations(10, 50, 100, 500mmol/L) of
8-MOP were incubated with AMMC for 24h, 72h and 120h and melanin content, tyrosinase
activity were respectively measured. Meanwhile, the changes of intracellular expression of
tyrosinase (TYR), tyrosinase related protein (TRP) 1, TRP2 were observed by laser scanning
confocal microscopy. It showed that 8-MOP can increase the cellular melanin content and
activity of the tyrosinase in a non-dose dependence manner. Treatment of 100mmol/L 8-MOP
for 120h increased melanin content and activity of the tyrosinase on AMMC most. In
untreated controls, the expressions of TYR, TRP-1, TRP-2 all in a very low level that
confirmed the AMMC in an inactive condition. After treatment of 50 mmol/L and 100 mmol/L 8-
MOP for 72 h, the expression of the TYR was increased significantly compare with controls
(Po0.01). The levels of TRP1 and TRP2 also increased after further incubation for 120 h
(Po0.05). From above data we verified that 8-MOP directly stimulate melanogenesis of
AMMC in vitro, which is associated with activation of melanogenic key enzymes: TYR, TRP-1
and TRP-2.
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Endothelin-1 Promote the Adhesion and Chemotaxis of Amelanotic Melanocytes in Hair
Outer Root Sheath on Extracellular Matrix Proteins by Modulating Reorganizations of
Actin Cytoskeleton In Vitro
Ma HJ, Zhu WY, Yue XZ, Wang DG, Li CR
The First Affiliated Hospital of Nanjing, China
Narrow band ultraviolet B (NB-UVB) radiation is an effective way to treatment for vitiligo.
During repigmentation of vitiligo lesions, inactive amelanotic melanocytes (AMMC) located in
hair follicle outer root shealth (ORS) become activated, proliferate, and migrate into the
depigmented skin. However, the mechanisms are not thoroughly clarified. Previous
researches showed UVB radiations might induce keratinocytes to secrete endothelin-1(ET-
1), which is an important cytokine in melanogenesis and migration of epidermal melanocytes.
On the basis of successful culture of human AMMC in human hair ORS before, we study the
effects of ET-1 to the adhesion and chemotaxis of human AMMC on extracellular matrix
proteins (ECMP) and observe its effects on actin and tubulin cytoskeleton. Human AMMC
was treated with different concentrations of ET-1 (0.1-100 nM) to observe adhesion on culture
dishes which were respectively coated with fibronectin (FN), laminin (LN), collagen type w (Cw)
and without any ECMP. And then, chemotaxis on FN, LN and Cw coated micropore filters,
culture medium containing various concentrations of ET-1 (0.1-100 nM) as attractants, was
investigated by Boyden chemotaxis chamber. Cellular microfilaments and microtubules were
immunostained with Rhodamine labeled actin and FITC labeled b-tubulin. The effects of
cytoskeleton before and after expose to ET-1 were observed with laser scanning confocal
microscopy. This study has demonstrated that ET-1 increase the human AMMC adhesion on
FN in a non-dose dependent manner, but minor increase is found on coated surfaces with LN
and Cw. ET-1 also induces chemotaxis of AMMC on FN, LN and Cw in a dose-dependent
manner. The great effect was seen with Cw and LN, while FN only has a moderate role on
migration. No chemotactic effects were observed on micropore filters without any ECMP
coated.  10 nM ET-1 induced actin to form stress fiber fasciculus underneath cell
membrane. However, the network of tubulin was still well-distributed in whole cytoplasm. ET-
1 and ECMP are two synergistic efforts determining the optimal level of AMMC attachment
and migration. ET-1 has different effects on the adhesion and chemotaxis of AMMC on
different ECMP, which mainly due to modulate the reorganizations of actin cytoskeleton.
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Exogenous Cholesterol Overload Dysregulates Fc Epsilon Receptor 1-Mediated Signal-
ing in Human Monocyte Derived Dendritic Cells
Murota H, Izumi M, Nakagawa Y, Nakamura T, Katayama I
Dept of Dermatology, Osaka University, Japan
Stratum corneum contains various lipids such as ceramides, cholesterol, and free fatty acids,
and acts as biological barrier against pathogens and various sensitizers. Altered epidermal
barrier function might result in induction of a various kind of dermatoses, including atopic
dermatitis (AD). Recent studies showed that reduced amount of total ceramides are
responsible for functional abnormalities of the skin of AD. On the one hand, amount of
cholesterol composition is controversial among individual studies. Moreover, it has been
reported that utilization of physiological lipid mixture improves barrier repair effectively. These
results indicated that cholesterol is also required for barrier recovery.
To examine the effect of exogenous application of cholesterol, AD patients were treated
with 10%(w/w) cholesterol ointment. Unexpectedly, cholesterol treatment is efficacious to
eliminate of clinical manifestations of AD. This phenomenon made us to hypothesize that
cholesterol possesses anti-inflammatory effect.
Dendritic cells are known to contribute to maintain the late phase inflammatory reaction in
AD by the interaction of allergen-specific IgE and its high-affinity receptor, Fc epsilon receptor
1 (FceR1). FceR1 utilizes lipid raft to initiate the downstream signal transduction, and
exogenous cholesterol administration leads to instability of lipid raft. Taken together, there is
possibility that external application of cholesterol might induce dysfunction of the FceR1-
mediated signaling in dendritic cells.
To verify above hypothesis, monocyte derived dendritic cells (MoDC) from healthy
volunteers and patients with AD were treated with cholesterol in vitro. As expected,
cholesterol loaded MoDC has demonstrated abnormal localization of FceR1alpha, and lost
the induction of TARC following mite antigen and IgE stimulation.
These results indicated that cholesterol might have potential to be a novel therapeutic
intervention for AD.
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The Role of the Raft-Associated Proteins src-Kinase and Caveolin-1 (Cav-1) in Ultraviolet
A Radiation (UVAR)-Induced Signaling in Human Keratinocytes (KC)
Grether-Beck S, Salahshour-Fard M, Brammertz D, Brenden H, Felsner I, Fu¨llekrug J,
Krutmann J
Inst fu¨r Umweltmed Forschung, Du¨sseldorf, Germany
Rafts are cell membrane microdomains which serve as relay stations for signaling. This
function depends on their cholesterol content and on raft-associated proteins such as src-
kinases and caveolin-1. We have previously provided preliminary evidence that raft signaling
is involved in UVA-induced gene expression in human keratinocytes by demonstrating that
the cholesterol content of rafts is critical for their capacity to mount a UVA response. We had
also observed that UVAR decreased the caveolin-1 content in the raft, but not in the non-raft
fraction of keratinocyte membranes. We now demonstrate that caveolin-1 is critically involved
in UVAR-induced signaling. Accordingly, caveolin-1 knockdown by means of retrovirus-
mediated RNA interference substantially prevented UVAR-induced gene expression in
keratinocytes. We next addressed the mechanisms of UVAR-induced caveolin-1 activation.
We have found that UVAR leads to a transient phosphorylation of caveolin-1 at Y14 mediated
by src family kinases Yes and Fyn which were phosphorylated at Y418. Inhibition of their
phosphorylation by means of the src inhibitor Su6656 prevented UVAR-induced caveolin-1 (i)
phosphorylation and (ii) translocation from the raft into the non-raft fraction of the
cytoplasmic membrane. Most importantly, caveolin-1 phosphorylation and translocation
were of functional relevance for UVAR-induced gene expression, because their inhibition
resulted in complete prevention of UVAR-induced ICAM-1 expression. We have previously
shown that UVA-induced signaling in keratinocytes is initiated by the formation of second
messenger ceramide from cell membrane sphingomyelin. Preincubation with Su6656 did not
prevent UVA-induced ceramide formation and stimulation of unirradiated keratinocytes with
cell-permeable ceramide induced src kinase phosphorylation, indicating that ceramide
formation occurred upstream of src kinase activation. Our studies clearly demonstrate that
raft-signaling plays a pivotal role in UVA-induced gene expression in human KC.
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5-HT2 Blockage Prevents PsoralenþUVA (PUVA)-Induced Suppression of Delayed Type
Hypersensitivity
Wolf P1, Nghiem DX2, Walterscheid JP2, Ananthaswamy HN2, Ullrich SE2
1Medical University Graz (MUG), Austria; 2The Univ. Texas MD Anderson Cancer Center,
USA
PUVA has been used for many years as a very effective treatment modality for various skin
diseases, including psoriasis and cutaneous T cell lymphoma. PUVA-induced immune
suppression may be the mechanism by which PUVA exhibits therapeutic effects and leads to
clearance of skin lesions. However, the molecular events by which PUVA leads to immune
suppression are not well understood. Activation of serotonin (5-hydroxytryptamine, 5-HT)
receptors may be one event involved in PUVA-induced immune suppression. In this study we
used the 5-HT2 receptor antagonists ketanserin and cyproheptadine to study the possible
role of 5-HT signaling in PUVA-induced systemic immune suppression in the model of
delayed-type hypersensitivity (DTH) to Candida albicans. Six to 8 wk old C3H/HeNCr mice
were painted on the their shaved backs with 8-methoxypsoralen (100 ug/100 ul ethanol) 30
min before exposure to 50 kJ/m2 UVA (i.e. minimal inflammatory PUVA dose, as determined
by skin swelling measurements 48 h after exposure). At day 5, the mice were immunized by
injecting 2 108 formalin-fixed C. albicans into each flank, and at day 14 they were
challenged by injecting 50 ul of Candida antigen into each hind footpad. PUVA suppressed
the immune response in the mice by approximately 80%. The intraperitoneal injection of
either ketanserin or cyproheptadine (100 ul of 5mM solution in 50% DMSO each) immediately
before UVA exposure nearly totally abrogated PUVA-induced immune suppression. These
results suggest that 5-HT signaling is involved in PUVA-induced immune suppression. A
better understanding of the molecular events after PUVA exposure may offer the opportunity
to dissect the beneficial (i.e. therapeutic) from the detrimental (i.e. tumorigenic) effects of this
treatment modality.
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Overexpression of PHGPx in Fibroblasts Abrogates UVA-Induced Expression of
Interstitial Collagenase by Suppression of Phosphatidylcholine Hydroperoxide-Mediated
NFjB Activation and IL-6 Release
Sulyok S1, Wenk J2, Schu¨ller J1, Hinrichs C1, Syrovets T1, Azoitei N1, Podda M3, Wirth T1,
Simmet T1, Scharffetterkochanek K1
1University of Ulm, Germany; 2University of Cologne, Germany; 3University of Frankfurt,
Germany
Phospholipid hydroperoxide glutathione peroxidase (PHGPx) exhibits high specific activity in
reducing phosphatidylcholine hydroperoxides (PCOOHs) and thus may play a central role in
protecting the skin against UV irradiation-triggered detrimental long-term effects like cancer
formation and premature skin aging. We here addressed the role of PHGPx in the protection
against UV irradiation-induced expression of matrix-metalloproteinase-1 (MMP-1). Therefore
we created human dermal fibroblast cell lines overexpressing human PHGPx. In contrast to a
maximal 4.5-fold induction of specific MMP-1 mRNA levels in vector-transfected cells at 24 h
after UVA irradiation, no MMP-1 induction occurred after UVA treatment of PHGPx
overexpressing fibroblasts. As interleukin-6 (IL-6) was shown to mediate the UVA induction
of MMP-1, we studied whether PHGPx overexpression might interfere with the NFkB-
mediated IL-6 induction and downstream signaling. Using transient transfections of IL-6
promoter constructs containing NFkB binding sites, we observed a high induction of the
reporter gene luciferase in vector-transfected control cells and a significantly lower induction
in PHGPx-overexpressing fibroblasts following UVA irradiation. Consistently both UVA
irradiation and treatment of fibroblasts with PCOOHs led to phosphorylation and nuclear
translocation of the p65 subunit, whereas cells overexpressing PHGPx exhibited impaired
NFkB activation, p65 phosphorylation and nuclear translocation. In line with this, the PHGPx-
overexpressing fibroblasts showed a reduced constitutive and UVA irradiation-induced IL-6
release. After incubating PHGPx-overexpressing cells with PCOOHs a reduced induction of
IL-6 was observed. This together with the suppression of UVA irradiation-induced IL-6 release
in the presence of Trolox, a chain breaker of PCOOH-initiated lipid peroxidation, indicates
that UVA irradiation-induced PCOOHs and subsequent lipid peroxides initiate the NFkB-
mediated induction of IL-6, which mediates the induction of MMP-1.
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Overexpression of a Putative Ubiquitin C-Hydrolase Isolated from PUVA-Senesced
Fibroblasts Results in a Senescence-Like Phenotype
Chen Y, Wlaschek M, Hinrichs C, Ma W, Gall N, Scharffetter Kochanek K
University of Ulm, Germany
Premature ageing of the skin is a prominent side effect of psoralen plus UVA (PUVA)
photochemotherapy, used for various skin disorders. Following PUVA-treatment fibroblasts
undergo long time growth arrest reminiscent of replicative senescence. Since the molecular
basis of the functional and morphological changes is unknown, we applied subtractive
hybridization to isolate genes that might be involved in this cell cycle arrest. Out of several
differentially expressed cDNAs, one cDNA of an unknown gene showed the highest change
with a 6-fold induction post PUVA-treatment. Using RT-PCR and RACE, we isolated a full
length cDNA revealing a 53bp 50-untranslated region, a 3222bp open reading frame and a
2269bp 30-untranslated region. In addition, three transcripts with high homology were
detected. Northern blot analysis revealed strong expression in postmitotic human tissues like
brain and heart, but no expression in proliferating cells. From the translated cDNA sequence,
the first 400 amino acids show high homology with a putative murine ubiquitin c-terminal
hydrolase releasing ubiquitin from ubiquitinated proteins. Overexpression in fibroblasts
resulted in a senescent phenotype with enlarged cell size, cessation of proliferation,
expression of senescence-associated b-galactosidase and of matrix metalloproteinase-1,
and high levels of reactive oxygen species. The de-ubiquitination enzymes are involved in
biologically important processes including growth and differentiation, cell cycle progression,
and signal transduction. Analysis of this unknown gene might be useful in understanding the
role of de-ubiquitination in stress-induced and physiological senescence.
318
Induction of regulatory T cells by UV-radiation is an Active Process Driven by UV-
Damaged Langerhans Cells
Schwarz A, Maeda A, Schwarz T
University of Kiel, Germany
Application of haptens onto UV-exposed skin does not induce contact hypersensitivity but
causes hapten-specific tolerance which is mediated via regulatory T cells (Tr). Since UV-
radiation depletes Langerhans cells (LC) from the epidermis inhibition of sensitization is
supposed to be due to the absence of LC. However, the mechanisms by which Tr are induced
are still unclear. It is still debated whether induction of Tr is a consequence of killing of LC by
UV or whether hapten presentation by damaged LC is necessary. FACS-analysis identified LC
harbouring UV-damaged DNA in the lymph nodes (LN) upon UV-exposure. The number of
DNA-damaged LC was reduced when UV-exposed mice received IL-12 which induces DNA
repair. Likewise, IL-12 injection prevented the generation of Tr, implying that damaged LC in
the LN are required to induce Tr. To address whether induction of Tr is a consequence of
killing of LC or of their appearance in the LN we utilized topical corticosteroids (CS). Upon
application of CS LC were killed and thus not detected in the LN. Accordingly, CS-treated
mice could not be sensitized upon hapten application onto CS-treated skin. However, in
contrast to UV, Tr were not induced upon CS treatment as adoptive transfer experiments
demonstrated. This suggests that induction of Tr requires damaged LC in the LN. If as in the
case of CS LC are killed and do not reach the LN Tr are not induced. Therefore, prevention of
sensitization upon UV or CS can be explained by the absence of LC in the epidermis
representing a kind of null event. In contrast, induction of Tr is an active process which
requires damaged LC in the LN and thus is only observed upon UV but not upon CS which
entirely kill LC.
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Enhanced Photocarcinogenesis in Interleukin-12 Deﬁcient Mice
Maeda A1, Kernebeck K2, Schneider S2, Beissert S2, Schwarz T1, Schwarz A1
1University of Kiel, Germany; 2University of Mu¨nster, Germany
DNA damage induced by ultraviolet (UV) B radiation is the basis for the development of UV-
induced skin cancer since reduction of DNA damage via the application of the DNA repair
enzyme T4N5 endonuclease reduces the risk to develop UV-induced skin tumors in mice. The
immunomodulatory cytokine interleukin (IL)-12 was recently demonstrated to exhibit the
capacity to reduce UV-induced DNA damage, presumably via the induction of nucleotide
excision repair. Since IL-12 is also produced in the skin we wondered whether endogenous
IL-12 production protects from photocarcinogenesis. Thus we utilized knock out mice which
lack the IL-12-p40 chain and thus do not secrete biologically active IL-12 (IL-12/ mice). If
endogenous IL-12 production should protect, IL-12/ mice should have an increased risk
for skin cancer. IL-12/ and wild type (wt) mice were exposed 3 times/week to UVB starting
with 5J/m2 which were subsequently increased up to 20kJ/m2. After around 200 days first
skin tumors developed. Kaplan-Meier analysis indicated a significantly increased probability
of tumor development in the IL-12/mice. In addition, the numbers of tumors developing in
the individual mice was significantly higher in the IL-12/ than in wt mice. Tumors in IL-12/
 mice revealed a more malignant phenotype growing much faster than those obtained from
wt mice upon inoculation into nu/nu mice. This was also confirmed in an electrophysiological
assay evaluating the intrinsic invasive potency of tumor cells. In this assay breakdown of the
transepithelial electrical resistance across a renal cell monolayer indicates opening of tight
junctions induced by tumor cell invasion. Transepithelial electrical resistance was stronger
reduced upon seeding in tumor cells obtained from IL-12/ than from wt mice. Together,
these data indicate that IL-12 deficiency is associated with an increased risk to develop UV-
induced skin cancer, implying that endogenous IL-12 may protect from photocarcinogenesis.
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Interleukin-18 Reduces UV-Induced DNA Damage Presumably Via Induction of DNA
Repair
Schwarz A, Maeda A, Schwarz T
University of Kiel, Germany
It was recently demonstrated that the cytokine interleukin (IL)-12 exhibits the capacity to
reduce DNA damage most likely via induction of nucleotide excision repair (NER). This was
the first demonstration of a cytokine being able to affect NER. Thus, we studied whether this
effect is restricted to IL-12 or applies also for other cytokines. IL-18 is a proinflammatory
cytokine sharing some biological activities with IL-12 including the induction of interferon-g.
Since the amount of UV-induced DNA damage determines the apoptotic fate of a cell, normal
human keratinocytes and KB cells were exposed to UV with or without IL-18. Apoptosis was
significantly reduced in cells which were treated with IL-18. IL-18 also supported the long
term survival of cells upon UV exposure as indicated in a colony formation assay.
Southwesterndotblot analysis using an antibody against cyclobutane pyrimidine dimers
(CPD) revealed lower amounts of CPD in UV-exposed cells which were treated with IL-18.
Injection of IL-18 into mice which were exposed to UV significantly reduced the number of
sunburn cells. Accordingly, immunohistochemistry revealed reduced nuclear CPD-staining in
the skin of UV-exposed mice which had received IL-18. When both in vitro and in vivo
analyses were performed immediately after UV exposure no differences in the amounts of
DNA damage were observed in untreated and IL-18 treated samples, suggesting that IL-18
might reduce DNA damage more effectively. To prove the link between IL-18 and NER, Xpa
knock-out mice were used which lack NER. Injection of IL-18 into UV-exposed wild type mice
reduced the number of apoptotic keratinocytes, while it had no effect on sunburn cell
formation in Xpa knock-out mice, implying that IL-18 requires functional NER to exert this
effect. Thus, IL-18 is an additional cytokine which exhibits the capacity to affect NER.
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Photo-Oxidation of the Membrane Phospholipid PAPC Induces Heme Oxygenase 1
Expression in Skin Cells
Gruber F1, Oskolkova O1, Mildner M1, Mlitz V1, Kadl A2, Botchkov VN1, Lengauer B1, Binder
BR1, Leitinger N2, Tschachler E3
1Medical University Vienna, Austria; 2CVRC, UVA Charlottesville, USA; 3Medical University
Vienna; CERIES, Neuilly, France
Cells of the skin respond to long wave UVA irradiation by expression of stress response genes
which degrade noxious substances that arise through UV- induced photooxidation. A
prominent member of this class of genes is Heme Oxygenase-1, which degrades heme-
containing proteins that accumulate after tissue damage and oxidative stress.
The mechanism of UVA mediated HO-1 induction is not clearly defined, but there is strong
evidence that singlet oxygen mediated lipid peroxidation mechanisms are involved. UVA light
and singlet oxygen are known to be effective mediators of lipid peroxidation and especially
polyunsaturated fatty acids are targets of this peroxidation.
We and others have shown before, that oxidation of the cell membrane phospholipid 1-
palmitoyl-2-arachidonoyl-3glycerophosphocholine (PAPC) by atmospheric oxygen leads to
formation of lipid oxidation products that are capable of inducing HO-1 synthesis in various
cell types of the vasculature and immune system.These phospholipid oxidation products
have recently been attributed cell protective and anti-inflammatory properties.
Here we show for the first time that oxidized PAPC (OxPAPC) induces HO-1 expression in
dermal fibroblasts and keratinocytes and that oxidation of PAPC with UVA I (340-390) but not
UVB leads to formation of lipid oxidation products that induce HO-1 expression in dermal
fibroblasts, keratinocytes and a three dimensional epidermal equivalent model. Using mass
spectrometry and EO6 antibodies that recognize and bind to epitopes of oxidized
phospholipids we could identify oxidation products that are formed upon UVA I irradiation
and have biological activity.
In addition our data suggest that the oxidation of PAPC by UVA is a singlet oxygen
dependent mechanism.
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Ultraviolet B Radiation-Induced Signaling is Initiated in the Cytoplasm
Fritsche E, Scha¨fer C, Hu¨benthal U, Abel J, Krutmann J
Institut f. Umweltmedizinische Forschung, Du¨sseldorf, Germany
UVB radiation-induced signaling in mammalian cells has previously been shown to involve
two major pathways: one that is initiated through the generation of DNA photoproducts in the
nucleus and a second one that is triggered at the level of the cell membrane and
characterized by cell surface receptor clustering such as the epidermal growth factor
receptor (EGFR). The chromophore for the latter one is unknown. In the present study we
provide evidence for a hitherto unknown, 3rd pathway that is initiated in the cytoplasm and
involves tryptophan (trp) as a chromophore. In this regard it is of interest that UVB radiation is
known to induce the formation of trp dimers which can act as ligands for the arylhydrocarbon
receptor (AhR). The AhR is an intracellular transcription factor which is localized in the
cytoplasm of cells and upon ligand binding translocates into the nucleus where it initiates
transcriptional expression of genes including CYP1A1. In earlier transfection studies in
HaCaT cells using a green fluorescent protein coupled AhR we found that UVB radiation
shuttled the AhR into the nucleus. We now report that UVB-induced AhR shuttling is of
functional relevance for UVB-induced signaling. Accordingly, inhibition of the AhR either
through treatment of cells with the AhR-antagonist methoxynitroflavone or through trp-
depletion inhibited not only UVB-induced AhR translocation, but also UVB-induced gene
expression (CYP1A1, COX-2, etc.). Interestingly, both strategies also prevented UVB-induced
EGFR clustering and internalization indicating that the UVB events are initiated in the
cytoplasm rather than at the cell membrane. Taken together these studies indicate the
existence of a 3rd molecular pathway involved in UVB radiation-induced signaling, which is
initiated in the cytoplasm, involves trp as a chromophore, is mediated through the AhR and is
partly responsible for the previously observed membrane effects.
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Melanin does not Protect Against Ultraviolet B-Induced Photodamage in Caucasian Skin
Robinson S1, Dixon S1, Gough C1, Wakamatsu K2, Healy E1
1University of Southampton, United Kingdom; 2Fujita Health University, Japan
It is generally accepted that the function of cutaneous melanin is to protect against damage from
incident ultraviolet radiation (UV). This view has been based predominantly on differences in
susceptibility to UV-induced erythema and skin cancer between Africans, Asians and
Caucasians and between Caucasians with skin type I/II and skin type III/IV. However, this
interpretation could be confounded by other non-pigmentary genetic differences and
photoadaptive mechanisms within and between racial groups. There has been little research
to date which has examined the relationship between the extent of UV-induced photodamage
and the specific amount and types of melanin in Caucasian human skin.
To investigate the protective effect of melanin in Caucasian skin, 46 subjects due to receive
UVB therapy for psoriasis were irradiated on untanned skin with incremental doses (
p
3) of UV
(TL12 lamp). Erythema was measured at 24 hours with an erythema index meter and biopsies
taken from unirradiated and 200mJ/cm2 irradiated skin for quantification of pyrimidine dimers
(n¼ 40) and p53 (n¼ 40) by image analysis. Epidermal eumelanin and phaeomelanin were
quantified (n¼ 46) by HPLC for pyrrole-2,3,5-tricarboxylic acid (PTCA) and 4-amino-3-
hydroxyphenylalanine (4AHP). Following UVB therapy for psoriasis, these investigations were
repeated on tanned skin in 16 subjects. Analysis of the data showed no relationship between
total melanin and (i) erythema (D0.025 [p¼ 0.6148], D0.05 [p¼ 0.8454] and at 200mJ/cm2
[p¼ 0.9812], (ii) pyrimidine dimers [p¼0.8104] and (iii) p53 levels [p¼ 0.4845] in skin. Similarly
there was no evidence that protection against UVB-induced photodamage was related to
eumelanin in skin, nor that phaeomelanin augments this type of photodamage. The results
suggest that differences in the amount and type of cutaneous melanin do not account for the
variation in UVB-induced erythema and DNA damage in Caucasian skin, and raise questions
about the protective effects of melanin in Caucasian skin.
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Ultraviolet-A Radiation Causes DNA Damage and Tumorigenic Conversion in Human
Skin Keratinocytes
Wischermann K1, Popp S1, Schmezer P1, Greinert R2, Volkmer B2, Scharfetter-Kochanek
K3, De Gruijl F4, Boukamp P1
1German Cancer Research Center, Heidelberg, Germany; 2Dermatologisches Zentrum
Buxtehude, Germany; 3Dept of Dermatology, University of Ulm, Germany; 4Leiden University
Medical Center, The Netherlands
Ultraviolet radiation is the most prominent physical carcinogen in our natural environment that
causes skin cancer, the most common type of cancer in the industrial world. Because UVB is
able to modify DNA bases directly (e.g. cyclobutane pyrimidine dimers, DNA double-strand
breaks) it was thought to be the major source of tumor malignancy. Recently, also UVA (320–
400 nm) gains considerable interest. The amount of UVA radiation reaching earth’s surface is
approximately 20 times larger than that of UVB and UVA can penetrate the skin to the actively
dividing basal layer as well as to the dermis leading to damage at different sites than UVB.
UVA most probably acts indirectly through reactive oxygen species metabolisms thereby
inducing DNA lesions such as single strand breaks, alkali-labile sites, photo-modification of
bases and DNA-to-protein cross-links.
Here we demonstrate that different treatment regimes of the HaCaTcells with UVA radiation
(steadily increasing levels, split doses of 5 J/cm2 4  per week or 20 J/cm2 once a week)
cause tumorigenic conversion of the HaCaT cells following s.c. injection of the cells treated
for 5 and 15 weeks, respectively. Furthermore, since tumor growth correlated with
chromosomal aberrations as measured by multi-colour fluorescence in situ hybridisation
(M-FISH) it was suggested that UVA radiation may cause genomic instability. To test this
normal human skin keratinocytes as well as the spontaneously immortalized HaCaT skin
keratinocytes were exposed to 40 J/cm2 UVA radiation and analyzed for single (ss) and
double strand (ds) breaks by comet assay highlighting ss-, ds breaks, and alkali-labile-sites
as well as by immocytochemistry using an antibody against g-H2AX, a phosphorylated
histone - generally accepted as a marker for DNA ds breaks. In the comet assay HaCaT cells
showed maximal damage directly after UVA radiation with 62% of DNA in the tail (median
from 153 cells). After 2h 18% and after 4 h 12% of the DNA were still in the tail demonstrating
a continuous but incomplete repair during this time span. g-H2AX foci were detected in both
normal keratinocytes and HaCaTcells as early as 10 min after UVA treatment with a maximum
number and intensity (100% of the cells showing g-H2AX foci) after 20 to 30 min. Although the
number significantly decreased already after 1 h, g-H2AX foci were still seen after 6 h in 40%
of the cells indicating the ds repair is even slower than ss repair.
Taken together, these findings demonstrate that UVA is able to contribute to tumor growth
by inducing ss as well as ds breaks. Since these are only slowly repaired it is tempting to
speculate that the remaining ds breaks may develop into chromosomal breaks that are causal
for the chromosomal rearrangements seen in the UVA-induced tumorigenic HaCaT cells.
Thus, UVA radiation has to be considered an important biologically damaging agent that can
contribute to tumor development and progression by causing chromosomal damage.
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Induction or Inhibition of Apoptosis: IL-1-Mediated NFjB-Activation Differentially Affects
Apoptosis Induced by DNA Modiﬁers
Strozyk E1, Pu¨ppelmann B1, Schwarz T2, Kulms D3
1University of Mu¨nster, Germany; 2University of Kiel, Germany; 3University of Stuttgart,
Germany
Recently much effort is made to induce or enhance apoptosis in a tumor selective fashion,
e.g. by combining death ligands (TRAIL, CD95L) with chemotherapeutic drugs. Another way
to kill tumors is the selective knock-down of signal transduction pathways that activate the
transcription factor nuclear factor-kB (NFkB), which is generally associated with the induction
of antiapoptotic pathways. In this context, interleukin-1 (IL-1)- mediated NFkB activation was
shown to suppress death ligand-induced apoptosis). In contrast, UVB-mediated cell death
was significantly enhanced upon NFkB-dependent repression of antiapoptotic genes (c-IAP,
FLIP, TRAF-1, TRAF-2, TRAF-6), coinciding with a strong release of the cytokine tumor
necrosis factor (TNFa), which as an additional apoptotic trigger enhanced UVB-induced
apoptosis. Time course studies revealed that the temporal sequence of the application of IL-1
and UVB determines whether TNFa is released or not, thereby influencing the UVB-induced
apoptosis rate differentially. Only when given in a short time frame up to 1.5 h before or after
UVB (when DNA damage is predominant) IL-1 results in an enhanced apoptosis rate and
corresponds with accelerated TNFa release. These findings imply UVB-induced DNA damage
to be critically involved in changing the properties of NFkB from an anti- into a proapoptotic
factor. Consequently a combination of IL-1 plus radiation or DNA-damaging cytostatic drugs
may serve as a novel treatment of cancer. It was the aim of this study to analyse the rate of
apoptosis induced by several DNA-damaging agents including cytostatic drugs (cis-platinum,
doxorubicin, etoposide), g-radiation, UVB and UVA radiation with concomitant activation of
NFkB. Whereas UVB, UVA and cis-platinum induce base modifications (pyrimidine dimers,
bulky purine adducts), the topoisomerase inhibitors doxorubicine and etoposide as well as g-
radiation mainly induce DNA strand breaks. We observed an enhancement of apoptosis upon
UVB-radiation and cis-platinum treatment and to a lesser extend upon UVA radiation,
coinciding with TNFa release. Apoptosis induced by doxorubicin, etoposide and g-radiation
remained unaffected by IL-1-mediated NFkB activation and did not result in TNFa production.
The effect on TNFa expression seems to be highly specific because expression of another
NFkB-inducible gene, encoding the proinflammatory cytokine IL-6, remained unaffected by
any of these proapoptotic costimuli. Together, the present study indicates on the one hand
that NFkB may be converted from an anti- into a proapoptotic mediator in a DNA damage-
dependent manner. On the other hand, it demonstrates that this phenomenon cannot be
generalized but is restricted to certain types of DNA lesions, an observation that should be
carefully taken into account when developing new anticancer strategies. Nevertheless, this
study presents new promising aspects to treat skin cancer in a combination therapy of IL-1
plus UVB.
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Modulation of UVA Light-Induced Alteration of Gap Junction Intercellular Communica-
tion by Carotenoids
Camera E1, Daubrawa F2, De Spirt S2, Stahl W2, Picardo M1
1Istituto Dermatologico San Gallicano (IRCCS), Italy; 2Heinrich-Heine University, Du¨sseldorf,
Germany
Skin photocarcinogenesis and photoaging are consequences of chronic exposure to UVA
light. Among other targets, in skin cells the intercellular communication via gap junctions (GJ)
is sensitive to UVA that leads to an impaired transfer of small molecules to adjacent cells and
an altered expression of connexins, the structural elements of the GJ. Several endogenous
chromophores account for the photosensitization mechanism of UVA leading to the formation
of singlet oxygen (1O2), a mediator of some UVA-related detrimental effects. There is
evidence that carotenoids (CARs), which are 1O2 quenchers, protect against UVA-induced
photodamage. In human primary fibroblasts, we investigated the efficacy of CARs to interfere
with the UVA-induced alterations of GJIC, assessed by the dye transfer assay as well as the
protein levels and localization of Cx43, a widely expressed connexins family member up-
regulated by CARs. Additionally, parameters of oxidative damage, including the formation of
carbonylated proteins (CP), were detected. We tested b-carotene (bC), possessing pro-
vitamin A activity, astaxanthin (Ast) and cantaxanthin(Cant) that, conversely, lack this
property. Exposure to 10 J/cm2 UVA led to a significant decrease of GJIC and to an altered
expression of Cx43 at 24h. Additionally, a slight increment of CP was observed. Upon 24–72
h pretreatment with 10 mM bC and Cant up-regulated, whereas 10 mM Ast down-regulated,
the GJIC. Interestingly, the CARs enhanced the GJIC over the control levels when the
pretreated cells were exposed to low doses UVA. This effect was paralleled by a modest
protection towards UVA-induced CP formation. Nevertheless, bC caused visible alterations of
cell morphology 24h after UVA exposure, consistent with the activation of the apoptotic
cascade. In conclusion, we found that CARs differ in the modulation of the GJIC alteration
induced by physiological doses of UVA.
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Photodegradation of Folic Acid During Extracorporeal Photochemotherapy
Der-Petrossian M1, Foedinger M2, Knobler R1, Trautinger F1
1Dept of Dermatology, Medical University of Vienna, Austria; 2Dept of Medical and Chemical
Laboratory Diagnostics, Medical University of Vienna, Austria
Photodegradation of folic acid by UV radiation is a well documented photochemical reaction
and decreased serum levels of folic acid have been found in patients receiving
photochemotherapy (PUVA). During extracorporeal photochemotherapy (ECP) leukocytes
and plasma are subjected to 8-MOP/UVA and in the current study we investigated whether
ECP leads to the photodegradation of folic acid in the extracorporeal system.
Thirty patients undergoing ECP on two consecutive days were enrolled into the study.
Heparinized plasma was obtained from the extracorporeal system before and immediately
after UVA exposure on both treatment days. Healthy donor plasma was exposed to 8-MOP
and increasing doses of UVA in vitro. Folic acid (5-methyltetrahydrofolate) was determined by
a radioassay (Simultrac-SNB, Becton-Dickinson). Vitamin B12 and homocysteine, not
undergoing photodegradation, were used as control parameters.
On the first day of ECP folic acid levels decreased from 7.11  5.8 nmol/l (mean  SD,
po0,005) to 3.9  2.6 nmol/l (mean  SD, po0,005) after UVA exposure. On the second
day the reduction was from 5.9  4.9 nmol/l (mean  SD, po0,005) to 3.4  3.0 nmol/l
(mean  SD, po0,005). This correlates to a decrease after UVA of 45.1% and 42.4%,
respectively. This effect could be reproduced in vitro demonstrating that folic acid reduction
depends on the UVA dose but not on the presence of 8-MOP. Only minor changes were
observed for vitamin B12 and homocysteine.
From these results we conclude that extracorporeal exposure of plasma to UVA during ECP
leads to photodegradation of folic acid. Further investigations are required to determine the
biological effects of folate photoproducts and whether clinically relevant loss of folic acid
might be a consequence of ECP.
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New Vision on Photoaging of Human Skin
Bruijnzeel P, Rijken F, Van Weelden H, Kiekens R
UMCU, The Netherlands
The pathophysiology of photoaging of human skin remains a topic of discussion. A frequently
cited hypothesis states that matrix metalloproteinases produced by keratinocytes and
fibroblasts are the main contributors to the photoaging process. Other cells that infiltrate the
skin after UV exposure, like macrophages and neutrophils, and may be involved in the
process of photoaging are considered of less importance. The purpose of our studies was to
investigate whether neutrophils and macrophages can contribute to the process of
photoaging and whether comparison of the reaction of black and white skin to UV can
provide further clues to its pathophysiology.
Volunteers with skin phototype I-III (white) and VI (black) were recruited and exposed to
12.000-18.000 mJ per cm2 of solar simulating radiation (SSR) corresponding to 2 times the
individual MED. Dose-response and time course studies were performed and skin biopsies
collected. The presence and distribution of skin pigment, DNA photodamage, migration of
cells (influx and efflux), photoaging associated proteolytic enzymes and keratinocyte
activation were studied using immunohistochemistry and in situ enzymography. In all white
skinned subjects SSR induced DNA damage in epidermal and dermal cells, a strong influx of
neutrophils, active proteolytic enzymes and diffuse keratinocyte activation. Proteolytic
enzyme activity appeared to be neutrophil-derived and not keratinocyte-, fibroblast-, or
macrophage-derived. Except for DNA damage in the supra basal epidermis, none of these
changes were found in black skinned subjects.
Our results suggest that neutrophils could play a major role in the pathophysiology of
photoaging of human skin by the local secretion of proteolytic enzymes. Increased resistance
to photoaging of black skin could be explained by increased skin pigmentation resulting in
prevention of neutrophil influx and release of proteolytic enzymes.
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The UV(B) Fingerprint Dominates the PTCH Mutation Spectrum of Psoralen Plus UVA-
Associated Basal Cell Carcinomas
Heitzer E, Lassacher A, Kerl H, Wolf P
Photodermatology, Medical University of Graz, Austria
Basal cell carcinoma (BCC) represents the most frequent human skin cancer. Epidemiologic
studies have clearly revealed that in the general population BCCs are most often linked to
chronic sun exposure. In psoralen and UVA (PUVA)-treated psoriasis patients BCCs also
occur at an increased incidence but the exact etiology and pathogenesis in those subjects is
unclear at present. Photochemical reactions of psoralen with DNA are well characterized and
particularly the TpA sequence is the common cross-linking binding site of psoralen at the
DNA level; consecutively, as shown in vitro and in animal studies mutations at TpA sites are
considered to be of PUVA origin. Interestingly however, in a previous study of the p53 tumor
suppressor gene we had found that PUVA-associated BCCs most frequently carried the
UV(B) fingerprint, i.e. C-to-T or tandem CC-to-TT transitions at dipyrimidine sites. In this
study, we performed a molecular mutation analysis of the patched (PTCH) tumor suppressor
gene in PUVA-associated BCCs. We analyzed 8 BCCs from 4 psoriasis patients treated with
long-term PUVA and high cumulative UVA doses. DNA was extracted from archived paraffin-
embedded sections. Polymerase chain reaction (PCR) was used to amplify DNA of exon 2 to
23 of the PTCH gene and the adjacent intron region. To detect mutations direct automated
multicolor fluorescent labeling capillary electrophoresis sequencing was performed. Four of 8
BCCs showed a total of 9 missense and 1 nonsense exon mutations as well as 3 additional
intron mutations. The majority of mis/nonsense mutations (8/10; 80%) was of UV(B)
fingerprint (C-to-T transitions at dipyrimidine sites). There were no mutations at TpA sites. We
conclude that environmental and/or therapeutic exposure to UV(B) radiation seems to be the
main factor in PUVA-associated BCC mutagenesis whereas PUVA treatment itself does not
play a major direct role.
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Intense Pulse Light Induces the Peroxidation of Lipids, but does not Generate Thymine
Dimers in Human Skin
Sorg O, Janer V, Tran C, Antille C, Carraux P, Leemans E, Masgrau E, Saurat JH, Salomon D
Geneva University Hospital, Switzerland
Intense pulse light (IPL) generates high intensity short flashes of visible light (550–950 nm),
and has been used for about 10 years to improve dermatological conditions such as
telangiectasia, pigmented lesions and skin ageing. In these systems, a moderate dose (10–30
J/cm2) of visible light is delivered in a very short time (2–5 ms) using a very high fluence rate
(  4000 W/cm2). For this reason, the Bunsen-Roscoe law of reciprocity, which states that
the strength of a radiative stimulus only depends on the dose, i.e. the product of the time and
the fluence rate, is no longer valid. As a consequence, the flashes produced by these systems
can induce biological effects which cannot be observed when the same doses are delivered
by common light sources that produce much lower fluence rates (0.1-50 mW/cm2). In this
pilot study, we analysed the concentrations of lipid peroxides and thymine dimers - markers
of oxidative stress and DNA photodamage, respectively - in skin biopsies of 9 volunteers
following a single exposure to IPL (9 J/cm2), UVA (40 J/cm2) or UVB (80 mJ/cm2). Lipid
peroxides were assayed using ferrous oxidation followed by xylenol orange complexometry,
and thymine dimers were analysed by slot blots followed by densitometric quantitation. Only
UVB irradiation, as expected, produced measurable amounts of thymine dimers, whereas
UVA and IPL irradiation induced 3-fold and 6-fold increases of lipid peroxides, respectively.
These preliminary results indicate that IPL, although filtered for wavelengths shorter than 500
nm, can generate an oxidative stress, a typical hallmark of UVA.
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Topical Calcineurin Inhibitors Decrease the Production of UVB-Induced Thymine Dimers
from Hairless Mouse Epidermis
Tran C, Lu¨bbe J, Sorg O, Doelker L, Carraux P, Antille C, Grand D, Leemans E, Kaya G,
Saurat JH
Geneva University Hospital, Switzerland
An increased incidence of ultraviolet-light-related skin tumours is a well-known problem in
patients undergoing post-transplantation immunosuppression with systemic calcineurin
inhibitors such as cyclosporine A or tacrolimus. UV-related carcinogenesis as a consequence
of long-term treatment of sun-exposed sites with topical calcineurin inhibitors is therefore of
theoretical concern. In this study, we show that tacrolimus acts as a UVB filter when
incorporated into liposome membranes. In hairless mice pretreated with 1% pimecrolimus
cream, 0.1% tacrolimus ointment or vehicle, the amount of epidermal thymine dimers,
measured one hour after 1 J/cm2 of UVB irradiation, was decreased by 89%, 84% and 47%,
respectively, as compared to untreated mice. Forty-eight hours after UVB irradiation, 97%,
89% and 93% of epidermal thymine dimer levels were removed in pimecrolimus-, tacrolimus-
or vehicle-treated mice, respectively. In contrast, 69% of thymine dimers, originally present in
much higher amount than in treated mice, were removed from untreated controls. UVB-
induced apoptosis was less pronounced in treated mice. Taken together, these results
suggest that topical calcineurin inhibitors prevent DNA photodamage due to a filter effect of
both vehicle and active components, whereas they do not affect the clearance of DNA
photoproducts.
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Hairless Mice Exposed to Long Term UVB Produce More Epidermal Retinoic Acid from
Topical Retinaldehyde than Unirradiated Mice
Sorg O, Tran C, Grand D, Saurat JH
Geneva University Hospital, Switzerland
It is well known that acute UVB irradiation induces the depletion of cutaneous vitamin A in
hairless mice. In this study of photocarcinogenesis in hairless mice, the animals were
exposed to 70 mJ/cm2 UVB thrice a week during 1 to 20 weeks. Mice were either treated with
topical RAL or its vehicle thrice a week during the whole protocol. The first cutaneous
tumours appeared in the vehicle-treated group after 14 weeks and all mice had at least one
tumour after 18 weeks. Epidermal vitamin A and retinoic acid were analysed after 1, 5, 10 and
20 weeks for the vehicle-treated group, and after 1, 5, 10 and 13 weeks for the group treated
with retinal, since the mice of this group had to be sacrificed after 13 weeks due to bad
general condition (highly squamous skin and ascites). Retinoid asnalysis in the epidermis
revealed unexpected and interesting findings : (i) in vehicle-treated mice, epidermal vitamin A
was depleted after one week, whereas its concentration reached 200% of that of unirradiated
mice after 20 weeks; (ii) in RAL-treated mice, the epidermal concentration of retinoic acid,
due to retinal oxidation, was much higher in irradiated animals except for those treated and
exposed to UVB during one week. In summary, the epidermis of hairless mice contains more
vitamin A and produces more retinoic acid from exogenous retinal during long term UVB
irradiation, in spite of the photosensitivity of retinoids, which are destroyed by a single UVB
exposure. This adaptive response of the epidermis, which precedes the development of
cutaneous tumours, indicates a probable interaction between cutaneous retinoids and
photocarcinogenesis, a question that remains a matter of debate.
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Aquaporin-3 Expression Decreases with Ageing and Sun-Exposure in the Human
Epidermis
Juan M, Bonnet-Duquennoy M, Noblesse E, Lachmann-Weber N, Langle S, Pelle De Queral
D, Bernois A, Schnebert S, Kurfurst R, Bonte´ F, Dumas M
LVMH Recherche, St Jean de Braye, France
Aquaporins (AQPs) are a family of transmembrane channels for water and small solutes.
Eleven aquaporins, named aquaporin-0 (AQP0) through aquaporin-10 (AQP10), have been
identified in mammals. In human skin, the AQP3 protein is abundant in keratinocytes,
expressed in all the layers of the human living epidermis and functional in terms of water flux
[citation removed]. The mechanisms for providing water to cells is a crucial point regarding
hydration of the epidermis because it is the most external part of the skin, the most exposed
to dehydration due to environment, and is not vascularized. The present study focuses on the
expression of aquaporin-3 in the epidermis of 41 asian women as a function of the age (from
20 to 80 yo) and the sun exposure. Immunostaining was performed using an affinity-purified
rabbit polyclonal antibody raised against the C-terminal peptide sequence of this aquaporin
isoform and characterized by [citation removed]. Immunostained skin sections showed that
AQP3 is expressed at the plasmic membrane of the keratinocytes from the basal to the
granular cell layers where it disappears to water clamp water just below the stratum corneum
as we previously showed. We observed that AQP3 expression linearly decreased with the age
in the epidermis. Investigating the relation between AQP3 expression and sun-exposure, we
demonstrated a significant lower level of epidermal AQP-3 in the sun-exposed skin areas
compared to the sun-protected ones suggesting that the protein expression is modified by
chronic UV radiations. In addition, this sun-related decrease was only observed for people
over 40 years old indicating that the response to chronic photo-exposure is age-dependent.
More over, for the sun-exposed skin areas, outside activities leading to a more important
chronic insulation induced a lower expression of AQP3. These results suggest that the
expression of AQP3 channels are strongly affected by ageing and chronic sun-exposure and
that a defective osmotic equilibrium could occur in the epidermis and account for the skin
dryness observed for older people and skin areas the most exposed to sunlight.
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Protection by Food-derived Antioxidants from UVA1-induced Photodamage, Measured
Using Living Skin Equivalents
Dekker P, Parish W, Green M
Unilever R & D, Sharnbrook, United Kingdom
In a study of biomarkers of UVA1-induced skin damage, living skin equivalent cultures (LSEs)
were treated with the antioxidants hesperetin and quercetin-3-glucoside and irradiated with
25 or 50 J/cm2 UVA1. Changes in the following biomarkers were measured; Interleukin 1-
alpha (IL-1a), Heme Oxygenase-1 (HO-1), TdT-mediated dUTP nick end labeling (TUNEL) and
8-hydroxy-20-deoxyguanosine (8-OHdG). IL-1a and HO-1 were analysed by Real Time PCR,
Western blot, ELISA and immunohistochemistry. TUNEL and 8-OHdG were determined by
(immuno)histochemical techniques. Sections were stained with haematoxylin and eosin
(H&E). UVA1 induced keratinocyte and fibroblast vacuolation and nuclear pyknosis, intense
TUNEL staining of fibroblasts, and increased staining of cells and nuclei for 8-OHdG. Lesser
or marginal increases in intensity followed staining for HO-1 and IL-1a. The IL-1a increase
was confirmed by ELISA assays of the medium supernatants. Hesperetin and quercetin-3-
glucoside reduced changes in H&E, 8-OHdG, TUNEL and IL-1a. Quercetin-3-glucoside
reduced the amount of IL-1a in LSE media. These observations support the use of the
selected biomarkers to monitor UVA1 damage and provide evidence that dietary ingredients
could reduce UVA-induced damage.
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The Intermediary Metabolism of Chronically Photodamaged Skin
Heath A, Green M
Unilever R&D, Sharnbrook, United Kingdom
The purpose of this study was to investigate the effects of chronic oxidative, UV induced
tissue damage on cellular glucose and amino acid metabolism.
Paired protected and photodamaged 4mm punch biopsies from the inner upper arm and
outer volar forearm of the same individual were incubated for 16hrs in culture medium.
Glucose utilisation, oxidation via the pentose phosphate pathway and Kreb’s cycle, lactate
production, glutaminolysis and free amino acid changes in the medium were determined.
At the protected skin site 0.8% of glucose utilised was oxidised via the Kreb’s cycle, 1.5%
was oxidised via the pentose phosphate pathway and the remaining 97.7% glucose was
utilised for aerobic glycolysis.
At the photodamaged site overall amino acid metabolism was significantly reduced by 63%
(po0.0001, n¼ 5) and glutamine oxidation to carbon dioxide tended to be reduced by 20%
(n¼ 6, p¼ 0.11). In contrast Kreb’s cycle activity was significantly increased by 30% (p¼ 0.02,
n¼13); whilst glucose utilisation and lactate production tended to be increased by 20%
(p¼ 0.053, n¼ 11) and 25% (p¼0.066, n¼ 19) respectively. No significant change was in the
pentose phosphate pathway.
An increase in general glucose metabolism and a reduction in amino acid metabolism in
photoaged skin, to our knowledge, have not been previously reported. The data are
consistent with other reports of increased mitochondrial mass and oxygen consumption with
replicative senescence and oxidative stress. One explanation for these data is an increase in
energy requirement for repair, damage to amino acid transport as a result of membrane lipid
oxidation.
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Induction of Mitochondrial DNA Mutations by Treatment of Melanocytes with Intense
Pulsed Light
Kamenisch Y, Blaheta B, Wenz J, Ro¨cken M, Berneburg M
Eberhard Karls University, Tu¨bingen, Germany
Mutations of mitochondrial (mt) DNA have been shown to play a role in photoaging and
carcinogenesis. In addition to this, the effective removal of pigmented skin lesions by lasers
or intense pulsed light (IPL) technology is increasingly applied in clinical practice. Lasers and
IPL employed for the removal of pigmented skin lesions emit radiation within the interaction
spectrum of melanin, thus inducing selective photothermolysis. While progress has been
made in the identification of the mechanism of action by which melanin is removed by lasers
or IPL, little is known about long term effects of IPL interaction with melanin. Since melanin
and DNA absorb the same wavelengths, we investigated whether treatment of melanocytes
by IPL technology leads to the induction of mtDNA mutations. Dose response experiments
did not reveal decreased viability or induction of apoptosis in melanocytes following exposure
to IPL at doses regularly applied for treatment of pigmented skin lesions (0–14 J/cm2). In
addition to this, viability of melanocytes was normal for up to 7 days. Real time PCR did not
reveal mutations of mtDNA after 24 h. However, timepoints later than 24 h did show increased
levels of mtDNA deletions reaching a maximum at four days. Follow-up of mtDNA deletions
revealed a subsequent decrease of induced mutations leading to levels undetectable by real
time PCR seven days after IPL exposure. These data indicate that exposure of melanocytes
to IPL at doses regularly applied for removal of pigmented skin lesions do transiently induce
mutations of mtDNA while viability of cells is unaffected.
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Spectroscopic Properties of Human Melanin In Vivo
Zonios G, Galaris D, Bassukas I
University of Ioannina, Greece
Melanin is an important chromophore of the skin but several aspects regarding its biological
role as well as its detailed structure remain quite controversial and not well established.
Characterization of melanin is difficult due to the highly heterogeneous nature of the melanin
polymer and even more difficult is its characterization in vivo. We have used diffuse
reflectance spectroscopy, which is a non-invasive technique, to study the optical properties
of human melanin in vivo. Skin lesions studied included melanocytic nevi and melanoma as
well as normal skin. The data were analyzed using an analytical model based on diffusion of
light in skin and analysis provided parameters regarding the hemoglobin concentration (both
oxy and deoxy hemoglobin forms) melanin concentration, average scatterer size and average
scatterer density. In addition, the spectral absorption properties of melanin were obtained in
the 400–800 nm region. The in vivo absorption spectra of melanin exhibited a monotonically
decreasing behavior as a function of wavelength. The shape of the absorption spectrum was
described very well by an exponential dependence on the wavelength i.e. Amel  ekl/l0 with
l0¼ 400 nm. The value of the parameter k was in the range k¼ 5.5-6.5 for normal skin,
k¼ 5.4-5.8 for melanocytic nevi and k¼ 2.2-3.0 for melanomas. Furthermore, the absorption
spectrum of synthetic melanin studied in vitro was described with k¼ 6.0. These results
indicate a possible difference in the optical properties of melanin between melanomas and
melanocytic nevi or normal skin. In addition, they show that, in the visible range, the optical
properties of melanin in vivo and in vitro can be described by a single parameter.
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Impact of Ultraviolet Radiation of Different Wavelengths on Barrier Properties in Patients
with Atopic Dermatitis
Brandt O1, Schreiner V1, Vietzke JP1, Abeck D2
1Paul-Gersson-Unna Research-Center, Beiersdorf AG, Hamburg, Germany; 2Department of
Dermatology, Technische Universita¨t Mu¨nchen, Germany
Seasonal variations of atopic dermatitis (AD) are well known. Improvement during the
summer period is believed to be mainly due to effects of ultraviolet radiation (UVR). Hence
phototherapy has become a standard in the treatment for this common inflammatory
dermatosis. We were interested whether UVR has direct positive impacts on the disrupted
barrier function of atopic skin.
The non-lesional skin of the volar aspects of the forearms of patients with AD were
irradiated for 10 consecutive days with medium-dose UVA-1 and simulated UV-solar light,
respectively. Treatment session consisted of 50 J/cm2 UVA-1 and of 1.5 J/cm2 simulated UV-
solar light resulting in a total dosage of 500 J/cm2 and 15 J/cm2, respectively. Subsequently,
the stratum corneum (SC) lipid profile, surface area of corneocytes, TEWL, and corneometric
values were measured at definite times.
Results: Both UVA-1 and simulated UV-solar light showed to have marked impacts on the
composition and total amount of SC ceramides and the surface areas of corneocytes.
However, exposure to UVA-1 induced much more pronounced alterations including
significant reductions of the total amount of SC ceramides and SC lipids as a whole.
Furthermore, UVA-1 further reduced the surface area of the already abnormally small
corneocytes, which are typically found in patients with atopic dermatitis.
Conclusion: According to our results, UVR does not strengthen the perturbed barrier of
non-lesional skin of atopic dermatitis directly. Therefore, positive effects of ultraviolet
radiation on this inflammatory dermatosis might mainly be mediated by immunological
modulations in the skin.
339
Quantitative Determination of Photoaging by Use of Multiphoton Fluorescence and
Second Harmonic Generation Microscopy
Lin S1, Wu T2, Young T1, Lo W2, Jee S3, Dong C2
1Institute of Biomedical Engineering, National Taiwan University, Taiwan; 2Dept of Physics,
National Taiwan University, Taiwan; 3Dept of Dermatology, National Taiwan University,
Taiwan
Photoaging is caused by cumulative damage from sun light exposure. It is a field of great
interest to develop skin rejuvenation therapies. However, clinical response can not be
objectively determined due to lack of a reliable non-invasive method to quantify photoaging.
Recently, mutliphoton fluorescence microscopy has gained much popularity in biomedical
imaging due to its ability to acquire enhanced axial depth discrimination images with reduced
photodamage and enhanced imaging depths. In addition to multiphoton autofluorescence,
non-centrosymmetric molecules including collagen can contribute to a second harmonic
generation signals. In this work, the photoaging process is investigated by use of multiphoton
fluorescence and second harmonic generation microscopy. We obtain the autofluorescence
and second harmonic generation images of superficial dermis from facial skin of patients of
different ages. The results show that areas of autofluorescence increase with age while areas
of second harmonic generation decrease with age. The results are consistent with the
histological findings in which collagen is progressively replaced by elastic fibers. In severe
photoaging, masses of autofluorescent materials representative of solar elastosis can be
clearly demonstrated. We propose a second harmonic generation to autofluorescence aging
index of dermis (SAAID) to quantify photoaging. This index is demonstrated to be a good
indicator of photoaging. Our results suggest that multiphoton fluorescence and second
harmonic generation microscopy can be further developed into a non-invasive imaging tool
for the clinical evaluation of photoaging.
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Invasive Human Melanocytic Neoplasia in a 3-Dimensional Model using Deﬁned Genetic
Elements
Adams A, Chudnovsky Y, Khavari P
Stanford University, CA, USA
The Ras, Rb, and p53 pathways have been linked genetically to sporadic and heritable
human melanoma. The Ras-Raf-MEK-ERK cascade may be activated via mutation of either
RAS or RAF isoform genes, while the Rb (p16INK4a/CDK4/Rb) and p53 (p14ARF/HDM2/p53)
tumor suppressor pathways are often inactivated in human melanoma via mutations or
deletions at the genetic locus which encodes both p16INK4a and p14ARF. We have engineered
primary human melanocytes to express one or more genes of interest in order to assess the
contributions of specific genes to human melanoma development. Specifically, we
introduced different combinations of oncogenic Ras, CDK4R24C (a constitutively active
CDK4 mutant found in a subset of melanoma-prone families), p53R248W (a dominant-negative
mutant), and hTERT (the catalytic subunit of human telomerase) into melanocytes. The
melanocytes were then combined with normal human keratinocytes, and placed on
devitalized human dermis to regenerate human skin on immune-deficient mice. Expression
of oncogenic Ras and hTERT, together with inactivation of either Rb or p53 pathways or both
led to invasive melanocytic neoplasia displaying the key histopathologic features of malignant
melanoma.
These data are the first to describe a three-dimensional model of human melanocytic
neoplasia using introduction of defined genetic elements.
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Identiﬁcation and Characterisation of Novel Telomere-Associated Proteins Modulating
DNA Double-Strand Break Repair
Herrmann G1, Hoffbauer J1, Kais S2, Scha¨r P2
1University of Cologne, Germany; 2University of Basel, Switzerland
Telomeres the free ends of chromosomes are important for the regulation of cellular
senescence and immortality and thus centrally involved in processes as aging and
carcinogenesis. Structurally, telomeres represent DNA double-strand breaks (DSB) that have
to be protected from degradation or deleterious end-to-end ligations which result in genetic
instability. End-to-end ligations at telomeres are mediated by DNA ligase IV and XRCC4,
proteins that act in the final steps of the highly conserved DSB repair pathway of non-
homologous end-joining (NHEJ). Using yeast two-hybrid screens, we searched for proteins
that interact with Lif1p, the yeast orthologue of human XRCC4, and identified a novel protein
which we called Nej2p (non-homologous end-joining associated 2). Database searches
revealed that Nej2p belongs to a vaguely characterized family of G-patch proteins that have
dual functions in DNA repair and RNA splicing. We identified a closely related human
homologue, hNEJ2, and established that this ubiquitously expressed protein engages in a
conserved protein-protein interaction with XRCC4.
NEJ2 interfere with the complex formation of DNA ligase IV and XRCC4(Lif1p) and have
inhibitory effects on NHEJ. Searching for in vivo functions, we identify PinX1 as a novel NEJ2-
interacting protein. PinX1 is a potent telomerase inhibitor and interacts with a main stabilizer
of human telomeres, telomeric repeat factor 1 (TRF1). Using yeast three-hybrid analysis, we
find that PinX1 acts as a bridging factor between TRF1 and NEJ2 which structurally links
NEJ2 to telomere metabolism. Indeed, using confocal microscopy, we show that NEJ2
colocalizes with telomeres in human and yeast cells.
Taken together, NEJ2 proteins represent novel factors associated with telomere structures
that may modulate undesired NHEJ events. Further studies are currently under way to
elucidate the underlying mechanistic details and relevance for phenotypes as cellular
senescence and immortality.
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Evidence for a PPARgamma Agonist-Induced Proteasomal Degradation of cyclin D1 in
Melanoma Cell Lines
Mo¨ssner R, Wussow M, Schmidt D, Kru¨ger U, Reich K
Georg-August-University Go¨ttingen, Germany
Peroxisome proliferator-activated receptor (PPAR) g is a member of the nuclear receptor
superfamily. We have recently shown that agonists of PPARg inhibit melanoma cell
proliferation through induction of cell cycle arrest. This study focused on potential
mechanisms involved in the growth inhibitory effects of PPARg agonists.
Western analysis revealed a time- and dose-dependent decrease of the cell cycle regulator
cyclin D1 after treatment of melanoma cell lines with the PPARg agonist troglitazone. There
was evidence that the troglitazone-induced reduction of cyclin D1 is independent of PPARg. i)
Stimulation of melanoma cells with troglitazone did not increase the DNA binding activity of
PPARg as assessed by electrophoretic mobility shift assay and an ELISA-based assay. ii)
Transcription of cyclin D1 as determined by quantitative real-time RT-PCR remained
unchanged after treatment with troglitazone. iii) The specific PPARg inhibitor GW9662 did
not affect the troglitazone-dependent decrease of cyclin D1.
Pre-treatment of melanoma cell lines with the proteasome inhibitor MG132 largely reversed
the troglitazone-induced decrease of cyclin D1, while protease inhibitors had no effect,
indicating that proteasome-dependent degradation of cyclin D1 is involved in the growth
control mediated by PPARg agonists. Proteasome-dependent degradation of cyclin D1 can
be enhanced by a GSK3b dependent pathway, in which GSK3b-mediated phosphorylation of
cyclin D1 increases the cytoplasmatic translocation and subsequent proteasomal degrada-
tion of cyclin D1. However, the troglitazone-dependent degradation of cyclin D1 could not be
prevented by pre-treatment of melanoma cells with the GSK3b inhibitor SB216763.
In summary, we provide evidence that the PPARg agonist troglitazone induces growth
arrest in melanoma cells through a PPARg-independent proteasomal degradation of cyclin
D1. Furthermore, the proteasome-mediated degradation of cyclin D1 induced by troglitazone
appears to be independent of GSK3b.
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CP-31398, a Mutant p53-Rescuing Chemical Agent, Suppresses Ultraviolet B (UVB)-
Induced Skin Photocarcinogenesis in SKH-1 Hairless Mice (SKH)
Tang X1, Kim AL1, Zhu Y1, Kopelovich L2, Bickers DR1, Athar M1
1Dept of Dermatology, Columbia University, USA; 2Division of Cancer Prevention, NCI, USA
More than 80% of human skin squamous cell carcinomas have detectable p53 mutations.
CP-31398, a small molecular weight styrylquinazoline, is known to act by inducing wild-type
p53, enhancing its half-life and/or converting mutant p53 to wild-type, thereby restoring its
tumor suppressor functions. In addition, p53-independent effects of CP-31398 are also
known (for example, it has been shown that CP-31398 induces apoptosis in human glioma
cells both in p53-dependent and p53-independent manner). In this study, we show that CP-
31398 suppresses the growth of UVB-induced skin tumors in a complete photocarcinogen-
esis protocol in SKH. At week 35, mice receiving topical treatment with CP-31398, 30 minutes
prior to UVB irradiation, showed a 50% decrease in the number of tumors and a 58%
decrease in tumor size, as compared to UVB-irradiated vehicle-treated controls. CP-31398
inhibition of tumor growth was associated with the increased levels of SMAC/Diablo, active
poly(ADP-ribose) polymerase (PARP), and induction of apoptotic cells, in addition to
decreases in cyclin D1 and Bcl-2 protein levels. To investigate the anticarcinogenic
properties of p53 in skin, the effect of CP-31398 was further evaluated using p53//SKH.
The CP-31398-mediated alterations in cell cycle regulators and apoptotic proteins observed
in p53þ /þ /SKH were not observed in p53//SKH. To determine whether results obtained
from the experiments in murine skin can be replicated in human skin cells, we studied the
effects of CP-31398 in A431 human epidermoid carcinoma cells carrying mutant p53. CP-
31398 resulted in a rapid induction of apoptosis in A431 cells in a dose-dependent manner.
Our results indicate that CP-31398 acts to abrogate UVB-induced photocarcinogenesis by
mechanisms involving p53-dependent cell cycle and apoptosis regulation.
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Melanocortin 1 Receptor (MC1R) Gene Polymorphisms and the Risk of Cutaneous
Melanoma in a Case-Control Study
Dimisianos R1, Poulou M2, Stefanaki I3, Nikolaou V3, Goga H4, Papadopoulos O3,
Sofokleous C2, Katsambas A3, Kanavakis E2, Stratigos A3
1Medical Genetics, Agia Sophia Hospital, University of Athens, Greece; 2Medical Genetics,
Agia Sophia Hospital, Athens, Greece; 3Dermatology, Andreas Sygros Hospital, University of
Athens, Greece; 4Internal Medicine, Laikon Hospital, University of Athens, Greece
Individuals with particular MC1R gene variants have been shown to carry an increased risk for
the development of cutaneous melanoma (CM). These variants have also been associated
with other phenotypic changes that predispose to CM, such as red hair and fair skin. In the
present study, we investigated the relationship of MC1R gene polymorphisms and the
development of melanoma in 120 CM patients and 100 control subjects (matched for age and
sex) from Greece. Following the extraction of DNA from peripheral blood samples, we
analyzed the entire MC1R gene for polymorphisms using sequencing analysis. The results
were correlated with phenotypic and clinical information that was obtained from all
participants through a specially designed questionnaire and clinical examination. A logistic
regression model was used to assess possible relation between CM and the polymorphisms
under study. Our preliminary data showed that, after adjustment for skin phototype, the cd60
variant imposed the highest risk for CM with an odds ratios of 2.32 (95% CI: 1.17–4.6,
p¼0.015) in heterozygotes. In addition, the cd151 polymorphism (cgc4tgc) was weakly
associated with the risk of CM in heterozygotes (odds ratio of 2.7%, 95% CI: 0.68–10.65,
p¼0.15). Interestingly we have not yet observed, in either patients or controls, any
polymorphisms of cd260 (gac4cac) or cd294 (cat4cct), which have been linked to CM in
other european studies. In conclusion, in this hospital-based, case-control study, we have
identified at least two MC1R polymorphisms that may predispose to cutaneous melanoma,
with cd60 being the most prevalent in CM patients and cd151 showing a weaker association
with the disease. Further analysis is underway to determine the contribution of other MC1R
polymorphisms in melanoma risk.
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Suppression of P-selectin Function as Distinctive Feature of Antithrombotic Agents to
Indicate their Inhibitory Capacity on Experimental Blood-Borne Metastasis
Ludwig R1, Alban S2, Bistrian R3, Henschler R3, Boehncke WH1, Kaufmann R1, Gille J1
1Klinikum der J.W. Goethe Universita¨t, Frankfurt/Main, Germany; 2Pharmaceutical Institute,
Christian-Albrechts University of Kiel, Germany; 3Institute of Transfusion Medicine and
Immune Hematology, Johann Wolfgang Goethe University, Frankfurt/Main, Germany
Ample evidence suggests that many of the in vivo anti-metastatic effects by heparins reflect
their actions on P-selectin-mediated binding. We hypothesized that the ability of widely used
heparins and derivatives to interfere with P-selectin-dependent tumor cell interactions under
flow in vitro could be used as distinctive feature to identify anticoagulants with advanced
inhibitory functions on experimental blood-borne metastasis in vivo. Therefore, we
determined the impact of UFH, the LMWHs nadroparin and enoxaparin, and the synthetic
fondaparinux with regard to their capacity to interfere with P-selectin-dependent tumor cell
binding under flow conditions and correlated it with their capacity to block experimental
melanoma metastasis in the B16.F10 model. Our data revealed that commonly used
anticoagulants widely differ in their potential to interfere with P-selectin-mediated cell
binding. The superior inhibitory capacity on P-selectin function of unfractionated heparin and
low-molecular-weight heparin (LMWH) nadroparin as opposed to LMWH enoxaparin and
synthetic heparin pentasaccharide fondaparinux (observed rolling interactions at 0.dyn/cm2
were 46  4, 16  2, 19  4, 36  7 and 40  2 cells/mm2min1 for buffer, UFH,
nadroparin, enoxaparin and fondaparinux each at 10 U/ml, respectively) strongly correlated
with the individual 50% inhibitory drug concentrations (IC50) in experimental lung metastasis
assay in vivo (IC50 expressed as units per mouse for UFH: 5.2, nadroparin: 6.4, enoxaparin:
35.4 and fondaparinux 297). Hence, P-selectin inhibition may constitute a valuable feature to
identify anticoagulants particularly suitable for anticancer therapy.
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Transgenic overexpression of VEGF-C does not enhance skin carcinogenesis but
potently promotes tumor and lymph node lymphangiogenesis and metastasis to sentinel
lymph nodes and beyond
Hirakawa S1, Brown LF2, Kodama S1, Min M1, Alitalo K3, Detmar M4
1Massachusetts General Hospital and Harvard University, USA; 2Beth Israel Deaconess
Medical Center, Harvard University, USA; 3Molecular/Cancer Biology Laboratory, University
of Helsinki, Finland; 4Swiss Federal Institute of Technology Zurich, Switzerland
The extent of lymph node metastasis is a major determinant for the staging and the prognosis
of most human malignancies. Vascular endothelial growth factor (VEGF)-C is a lymphatic-
specific growth factor that has been previously shown to induce tumor-associated
lymphangiogenesis and sentinel lymph node (SLN) metastasis in xenotransplant tumor
models. To directly investigate the biological importance of VEGF-C in skin cancer growth
and metastasis, we generated transgenic mice with epidermis-targeted overexpression of
both VEGF-C and of green fluorescent protein under control of the keratin 14 promoter, and
subjected them to a standard DMBA/TPA chemically-induced skin carcinogenesis regimen. A
comparable number and time of onset of papillomas and squamous cell carcinomas was
observed in VEGF-C transgenic and wild-type mice. However, targeted overexpression of
VEGF-C potently enhanced tumor lymphangiogenesis and SLN metastasis. Importantly, we
found a significant increase of distant lymph node metastasis in SLN-positive VEGF-C
transgenic mice, as compared with SLN-positive wild-type mice. Immunofluorescence
analyses revealed that VEGF-C-overexpressing tumors continued to induce lymphatic vessel
growth within the metastatic lymph nodes. Surprisingly, VEGF-C overexpressing primary
tumors induced SLN lymphangiogenesis already prior to metastasis. These findings indicate
that primary tumors might begin preparing their future metastatic site by producing
lymphangiogenic factors that facilitate their efficient transport to SLN and beyond. This
newly identified mechanism of inducing intra-nodal lymphangiogenesis likely contributes to
tumor metastasis and might represent a new therapeutic target for advanced cancer and for
the treatment and/or prevention of metastasis.
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Sequence-Speciﬁc Alterations Characterize Skin SCC Development and Progression
Jelinek B1, Popp S1, Wischermann K1, Boukamp P1
1DKFZ, Heidelberg, Germany
Non melanoma skin cancer is the most common malignancy in man. Furthermore,
immunosuppression in organ transplant recipients strongly contributes to an increase in
squamous cell carcinomas (SCCs), occurring 65-250 times more frequently than in the
general population. Nevertheless, little is known about the genetic changes contributing to
SCC development and progression. In addition, it is still a matter of debate whether
keratoacanthoma (KA) that during their rapid growth phase strongly resembles SCCs but
spontaneously regress, are a ‘‘pre-stage’’ or an own tumor entity.
By using comparative genomic hybridisation to broadly characterize KAs and SCCs, we now
demonstrate that with a few exceptions similar chromosomal aberrations (gains (þ ) and
losses()) are involved in KAs and SCCs, including 3p, 3qþ , 4q, 9p plus 11qþ ,7qþ ,8qþ ,
or 17qþ . However, while KAs only contain one or a few of these aberrations simultaneously, they
are generally present as a group in SCCs, thus making their aberration pattern highly complex
and suggesting that KAs are genetic precursor lesions of SCCs.
Correlating with these genetic aberrations, we can further show by immunofluorescence and -
histochemistry that p53 expression (17p), correlating with mutational stabilisation, is frequently
detected in both tumor types, Similarly, the two growth promoting factors, cyclinD1 (11q13þ )
and hTERT (possibly c-myc-induced, 8qþ ) are up-regulated in both, KAs and SCCs, thereby
substantiating their early role in skin cancer development. The cell cycle inhibitor p16 is highly
expressed in KAs but absent in SCCs where it frequently correlates with 9p loss. Accordingly, the
anti-angiogenic matrix glycoprotein TSP-1 is expressed in most KA while absent in many SCC
and conversely, the matrix degrading protein, the matrix metalloproteinase MMP13 (11q22) is
absent in most KAs but expressed in many SCCs. Thus, differential regulation of these three
proteins is likely to be involved in the transition from benign to malignant growth. Finally, we
provide evidence for nuclear translocation of -catenin. Since this correlates with either 7qþ ,
8qþ , or 17qþ , all carrying members of the Wnt pathway, it is tempting to speculate that
dysregulation of the Wnt-pathway is one of the underlying mechanisms of SCC development.
Taken together, this comprehensive classification of genetic aberrations not only allows to
identify KAs as benign ‘‘precursor’’ stages of SCCs but establishes a step-wise progression
profile that includes already known but also newly identified aberrations and suggests a role for a
dysregulated Wnt pathway as an underlying mechanism.
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Chemokine Receptors in Head and Neck Cancer: Determination of Metastatic Spread and
Regulation During Chemotherapy
Mu¨ller A1, Sonkoly E2, Eulert C3, Gerber PA4, Kubitza R4, Schirlau K5, Franken-Kunkel P4,
Poremba C6, Snyderman C7, Klotz LO8
1Dept of Radiation Oncology, Heinrich-Heine-University Du¨sseldorf, Germany; 2Depts of
Dermatology and Radiation Oncology, Heinrich Heine, Germany; 3Depts of Otorhinolar-
yngology and Radiation Oncology, Heinrich-Heine-University Du¨sseldorf, Germany; 4Dept of
Dermatology, Heinrich Heine University Du¨sseldorf, Germany; 5Dept of Otorhinolaryngology,
Heinrich-Heine-University Du¨sseldorf, Germany; 6Dept of Pathology, Heinrich-Heine-
University Du¨sseldorf, Germany; 7Dept of Otorhinolaryngology, University of Pittsburgh,
PA, USA; 8Inst Molecular Biology and Biochemistry, Heinrich-Heine-University Du¨sseldorf,
Germany
Head and neck carcinomas are histologically and clinically heterogeneous. While squamous
cell carcinomas (SCC) are characterized by lymphogenous spread, adenoid cystic carcinomas
(ACC) disseminate preferentially hematogenously. To study cellular and molecular mechanisms
of organ-specific metastasis, we used SCC and ACC cell lines and tumor tissues obtained from
patients with primary or metastatic disease. Comprehensive analysis at the mRNA and protein
level of human chemokine receptors showed that SCC and ACC cells exhibited distinct and
non-random expression profiles for these receptors. SCC predominantly expressed receptors
for chemokines homeostatically expressed in lymph nodes, including CC chemokine receptor
(CCR) 7. No difference in expression of chemokine receptors was seen in primary SCC and
corresponding lymph node metastases. In contrast to SCC, ACC cells primarily expressed CXC
chemokine receptor (CXCR) 4. In chemotaxis assays, ACC cells were responsive to CXCL12,
the ligand for CXCR4. Exposure of ACC cells to cisplatin resulted in upregulation of CXCR4 on
the cell surface, which was repressed by the transcriptional inhibitor a-amanitin. Treatment of
ACC cells with CXCL12 resulted in the activation of Akt and ERK1/2 pathways. Furthermore,
CXCL12 suppressed the rate of apoptosis induced by cisplatin in ACC cells, suggesting that
signaling via CXCR4 may be part of a tumor cell survival program. Discrimination of the
chemokine receptor profile in SCC and ACC in vitro and in tissues provided insights into their
distinct biologic and clinical characteristics as well as indications that chemokine receptors
might serve as future therapeutic targets in these malignancies.
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CCR10 and CXCR4 Regulate Tumor Progression and Metastasis of Malignant Melanoma
Mu¨ller A1, Wagner SN2, Soto H3, Mcclanahan T3, Sathe M3, Murphy E3, Yuan W3, Hevezi P4,
Ruzicka T5, Zlotnik A4
1Dept of Radiation Oncology, Heinrich Heine University Du¨sseldorf, Germany; 2Medical
University of Vienna and CeMM - Center of Molecular Medicine, Austria; 3Department of
Immunology, DNAX Research Inc, Palo Alto, CA, USA; 4Neurocrine Inc, San Diego, CA,
USA; 5Dept of Dermatology, Heinrich Heine University Du¨sseldorf, Germany
Malignant melanoma is an aggressive malignant tumor and its high tendency to metastasize
represents the major survival-limiting factor. To investigate the role of chemokine receptors in
melanoma progression and metastasis, cells lines as well as tissue samples of primary
melanoma tumors and metastases were analyzed using quantitative RT-PCR, DNA microarrays,
and immunohistochemistry. The regulation of chemokine receptors by factors of the local
microenvironment was assessed and their in-vivo-functional role was determined in two
melanoma xenograft models. Here, we show that melanoma cells preferentially express two
chemokine receptors, CXCR4 and CCR10. CXCR4 expression directly correlates with the
invasive stage of the primary tumor, is induced by TGF-b1 and shows enhancement at
the invasive tumor front. Notably, growth factors such as bFGF, EGF, and TGF-b1, or the
proinflammatory cytokines TNF-a and IL-1b induce chemokine receptor expression by
melanoma cells. In vivo, neutralization of CXCL12/CXCR4 interactions results in significant
suppression of the development of lung metastases. Clinically, melanoma is characterized by a
high frequency of skin metastases which correlates with the abundant expression of CCR10, a
receptor binding to the skin-specific chemokine CCL27. Cutaneous and subcutaneous
melanoma metastases exhibit significantly increased levels of CCR10 suggesting the selection
of CCR10-high expressing melanoma cells. In addition to the induction of migration and
invasion, CCL27 also enhances melanoma cell proliferation in vitro and in vivo. Taken together,
our findings strongly suggest that specific chemokine receptors are regulated by the tumor
microenvironment and play critical roles in melanoma progression and metastasis.
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Reduced Tumour Interstitial Fluid Pressure Enhances the Uptake of Therapeutics in a
Xenograft Tumour Model
Hofmann M1, Guschel M1, Salvesen GS2, Raa A2, Bernd A1, Bereiter-Hahn J3, Kaufmann R1,
Wiig H2, Kippenberger S1
1University Hospital Frankfurt/Main, Germany; 2University of Bergen, Norway; 3JW-Goethe
University Frankfurt/Main, Germany
It is a common observation that in both human and experimental solid tumours the interstitial
fluid pressure is elevated compared to normal tissue. Clinically a high tumour interstitial fluid
pressure (TIFP) may result in reduced delivery and uptake of anticancer drugs and thus lack
of therapeutic effects. In the present study the impact of TIFP on the delivery of potential
therapeutics was investigated by i.v. injection of fluorescent-coupled dextrans in a xenograft
tumour model. Furthermore the effect of increased plasma colloid osmotic pressure (COP) on
the TIFP was examined. A431 squamous epidermoid vulva tumours or G361 melanomas
were s.c. transplanted into the back of anaesthetised NMRI nude mice or Rowett nude rats.
During tumour growth TIFP was measured three times per week using the wick-in-needle
technique to measure TIFP directly in the central region of solid tumours. Nude rats were
injected with hyperosmotic human serum albumin (HSA) solutions i.v. to increase the COP.
During HSA injection the micropuncture method was used to measure the TIFP in peripheral
parts of the tumours. In our experimental set-up we could demonstrate that the reduction of
TIFP by drainage enhanced the delivery of fluorescent-coupled dextrans. Fluorescence
microscopy of cryosectioned tumour tissue showed an enrichment of dextrans in tumours
with reduced TIFP in contrast to untreated control tumours. Additionally, we could show for
the first time that HSA-induced COP increase lowered TIFP in nude rats without affecting the
blood pressure. These data demonstrate that that an increased COP can reduce TIFP and
lowered TIFP can augment the delivery of dextrans to tumours. Therefore, the reduction of
TIFP could enhance the efficacy of anti-tumour therapies using chemotherapeutics.
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Melanoma Epithelial Cell Interaction Stimulates Localized MMP2 Secretion
Schna¨ker EM, Ossig R, Rattenholl A, Go¨rge T, Steinhoff M, Oberleithner H, Luger T,
Schneider SW
WWU Mu¨nster, Germany
Matrix-metalloproteases (MMPs) are known to play an important role in invasion and
metastasis. Therefore, in a recently published study we investigated storage, intracellular
transport and exocytosis of MMP2 and MMP9 in human melanoma cells . We found small
cytoplasmatic MMP containing vesicles that are conveyed along microtubules by kinesin.
Disruption of the microtubular organisation by paclitaxel is followed by decreased MMP
secretion and subsequently reduced invasive activity.
We now investigated local extracellular MMP activity bound to the cell surface during
melanoma epithelial cell interaction. For this purpose we cocultivated melanoma cells and
MDCK-C7 cells and stained surface-bound MMP2 on the plasma membrane of the non-
permeabilized cells by immunofluorescence technique. Melanoma cells showed secreted
MMP2 polarised in those areas of their membrane that were in close proximity to epithelial
cells. Beyond this membrane-typ 1 MMP (Mt1-MMP), a membrane bound MMP known to
activate MMP2, was found colocalized to MMP2 on the membrane indicating high local
MMP2 activity bound to the surface of the cells. Moreover atomic force microscopy revealed
fusion events of exocytotic vesicles polarised in similar areas of the lamellipodium of
melanoma cells that were close to epithelial cells. Disruption of the microtubular organisation
of the cells by paclitaxel resulted in weaker staining of MMP2 on the cell surface and
abrogated polarisation. We therefore conclude that interaction between melanoma cells and
epithelial cells stimulates localized MMP2 release, a process that can be disturbed by
paclitaxel.
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Is the Adhesion Molecule L1 a Promising Target for Therapeutic Intervention in Malignant
Melanoma?
Meier F1, Busch S1, Gast D2, Altevogt P2, Garbe C1, Schittek B1
1University of Tuebingen, Germany; 2German Cancer Research Center Heidelberg, Germany
The adhesion molecule L1 is expressed in primary melanomas and cutaneous metastases in
contrast to melanocytes and melanocytic nevi, and is significantly associated with metastatic
spread. Recent studies have demonstrated an association of L1 with sustained activation of
the extracellular signal-regulated kinase (ERK) pathway and upregulation of ERK-dependent,
motility- and invasion-associated gene prodcucts including avb3 integrin in carcinomas. The
objective of this study was to further investigate the potential role of the adhesion molecule
L1 in melanoma development and progression. Using a three-dimensional organotypic
human skin culture model mimicking the pathophysiological environment of malignant
melanoma, we found that (1) L1 expression correlates with melanoma progression and avb3
integrin expression with up-regulation of L1 and avb3 integrin in advanced vertical growth
phase primary melanomas and metastatic melanomas, (2) de novo expression of L1 in
melanocytes by adenovirus-mediated gene transfer does not alter their biological behavior,
and (3) de novo expression of L1 in early radial growth phase melanoma cells induces
invasive tumor growth. Our own studies together with those of others suggest a role of L1 in
melanoma invasion and progression implicating that L1 may be a suitable target for
therapeutic intervention in malignant melanoma. However, further studies will be required to
elucidate the molecular mechanisms underlying L1-dependent promotion of invasive
melanoma growth and to test whether targeting the L1 adhesion molecule would have
therapeutic effects against invasive and metastatic melanoma growth.
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TNFR1- and IFN-c-Signaling Determine whether T Cells Arrest or Promote Multistage
Carcinogenesis
Braumuller H1, Pichler BJ1, Muller-Hermelink N1, Kneilling M1, Ghoreschi K1, Schwaiger M2,
Weber WA2, Rocken M1
1Eberhard Karls University, Tu¨bingen, Germany; 2Technical University Munich, Germany
The effects of adaptive immunity on early events of multistage carcinogenesis are poorly
characterized. Using a model of multistage carcinogenesis induced by oncogenic T antigen
(Tag) in pancreatic islets, here we show that Tag-specific CD4þ T cells home selectively into
the pancreas where they either promote or arrest transition of dysplastic islets into islet-
carcinomas. Arrest of tumor growth was independent of CD8þ T cells and did not involve
detectable signs of tumor cell or vessel cell apoptosis. As only IFN-g-producing CD4þ T cells
(Th1 cells) arrested multistage carcinogenesis, while interleukin 4 (IL-4) producing Th2 cells
were inefficient, we next analyzed the role of cytokines in Th1 cell-mediated arrest of tumor
growth. TNFR1- and IFN-g-signaling were strictly needed for the arrest of multistage
carcinogenesis by Tag-specific Th1 cells. Importantly, tumor arrest by Th1 cells was
associated with the induction of anti-angiogenic chemokines and led to prevention of avb3
integrin-expressing tumor vessels. In the absence of either TNFR1- or IFN-g-signaling the
same T cells rather accelerated cancer development and progression. Thus, tumor-specific T
cells directly survey multistage carcinogenesis through cytokine-signaling.
Previous studies revealed that Th1 cells reject transplanted tumors better than cytotoxic
CD8þ T cells, at least in part by inhibiting angiogenesis, but the effects of T cells on
multistage carcinogenesis remain enigmatic. Here, we found that Th1 cells can either arrest
or promote multistage carcinogenesis through cytokine-signaling. As in the absence of IFN-g-
and TNFR1-signaling Th1 cells were not only ineffective but rather promoted multistage
carcinogenesis, the data suggest that tumor vaccination might unexpectedly also promote
tumor progression if the wrong type of immune response is induced. .
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Trafﬁcking of Adoptively Transferred Th1 Cells in a Mouse Model of Pancreatic
Carcinoma
Pichler BJ1, Braumuller H1, Kneilling M1, Sutcliff-Goulden J2, Borowsky AD2, Bodenstein
CH2, Hanahan D2, Cardiff RD2, Cherry SR2, Rocken M1
1Eberhard Karls University, Tu¨bingen, Germany; 2University of California Davis, San
Francisco, USA
In RIP1-Tag2 mouse Tantigen (Tag) is expressed in all insulin-producing b cells. In these mice
30% of islets develop into adenomas and 2% into carcinomas. At 15 weeks mice die of
hypoglycemia. Previously we found that intra peritoneal (i.p.) injection of Tag-specific
Interferon-g (IFN-g) producing CD4þ Th1 (Tag-Th1) cells delayed tumor development about
two-fold. Th1 cells caused neither a major T cell infiltrate in tumors and nor major sings of
tumor cell or vessel cell destruction. To understand how Th1 cells delay tumor development,
we visualized Th1 cell trafficking, homing, and accumulation with in vivo non-invasive high-
resolution positron emission tomography (PET) and invasive methods such as autoradio-
graphy combined with histology. We incubated Tag-Th1 cells in vitro with [64Cu]PTSM. After 3
hours non-absorbed [64Cu]PTSM was removed by washings. Viability was always490%. We
injected 10  106 labeled Th1 cells i.p. into RIP1-Tag2 (n¼ 5) and naı¨ve C3H (n¼3) mice. At
30 minutes, and 3, 8, and 24 hours after injection PET scans showed that Tag-Th1 cells
homed in the pancreatic lymph node and the pancreas. Surprisingly, autoradiography
combined with micrographic analysis of the pancreas and the lymph nodes revealed
accumulation of tumor-specific Th1 cells either in the tumor draining lymph node or in
lymphoid-like structures around the islet tumors. In sharp contrast, almost no tumor-specific
Th1 cells infiltrated directly the islet tumors. Together, the findings strongly suggest that the
arrest of tumor development by Th1 cells is largely independent on Th1 cell-infiltration into the
tumor. Arrest of tumor development by Th1 cells seems to depend strictly on secondary
messengers, which might either be soluble such as cytokines or cells, such as tissue
infiltrating macrophages.
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TNF Receptor 1-Signaling Accelerates Multistage Carcinogenesis in an Endogenously
Developing Cancer
Bru¨ck J1, Braumu¨ller H1, Pichler BJ1, Kneilling M1, Sakrauski A2, Ro¨cken M1
1Eberhard Karls University, Tu¨bingen, Germany; 2Ludwig Maximilians University, Germany
Tumor-necrosis-factor (TNF), was originally discovered because if its potent anti-tumor
effects. Yet recent studies with chemically induced cancer suggest that, under certain
conditions, TNF may rather promote than inhibit tumor development. The data published tell
neither whether TNF-signaling may also promote growth of endogenously growing tmors nor
what TNF-signaling pathway may be involved. To address these questions, we analyzed
RIP1-Tag2 mice that develop islet carcinomas due to selective expression of Tantigen (Tag) in
all islet cells. RIP1-Tag2 mice develop adenomas at 6 weeks and die at 14 weeks from
hypoglycemeia due to rapid growth of 2-3 insulin-producing carcinomas. RIP1-Tag2 C3H
mice were backcrossed to TNF receptor 1 (TNFR1)-deficient C3H mice. Blood glucose and
survival were monitored in RIP1-Tag2 and double transgenic RIP1-Tag2xTNFR1/ C3H
mice, starting at 6-7 weeks. Double transgenic RIP1-Tag2  TNFR1/ mice developed
carcinomas later and lived significantly longer than single transgenic RIP1-Tag2 animals.
Single transgenic RIP1-Tag2 animals lived for 14–15 weeks; in double transgenic RIP1-
Tag2TNFR1/ mice life was prolonged by 30% to 19–20 weeks (po0.05). To determine
whether lack of TNFR1-signalling altered tumor growth or whether it merely delayed it, we
compared tumor growth and integrin avb3 expression on endothelial cells, as an objective
marker to quantify tumor angiogenesis. At the same age double transgenic RIP1-
Tag2  TNFR1/ mice had lower avb3-expressing tumor vessels than single transgenic
RIP1-Tag2 mice. At time of death, tumors of both groups of mice did not differ one from each
other. Thus, 1) TNF can promote multi-step carcinogenesis of endogenous tumors, especially
when continuously present at low doses. 2) TNF promotes multi-step carcinogenesis through
TNFR1-signalling. As continuously supplied low doses of TNF can promote angiogenesis, we
speculate that the angiogenic switch from vascular quiescence to tumor angiogenesis is
facilitated by TNFR1 signal transduction.
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Stable Overexpression of Smad7 Inhibits the Tumorigenicity of in Human Melanoma
Cells In Vitro and In Vivo
Javelaud D1, Delmas V2, Sextius P1, Moller M1, Menashi S1, Larue L2, Mauviel A1
1INSERM U697, Hoˆpital Saint Louis, Paris, France; 2Developmental Genetics of Melano-
cytes, UMR146 CNRS-Institut Curie, Orsay, France
We previously identified constitutive Smad signaling in human melanoma cells despite
resistance to TGF-b control of cell proliferation. This led us to investigate the effect of
inhibitory Smad7 overexpression on melanoma cell behavior. Using the highly metastatic cell
line, 1205-Lu, we thus generated melanoma cell clones expressing constitutively Smad7, and
their mock-transfected counterparts. Stable expression of Smad7 resulted in an inhibition of
constitutive Smad2/3 phosphorylation, and in a reduced TGF-b response of Smad3/Smad4-
driven gene transactivation, as measured using transfected Smad3/4-specific reporter gene
constructs. Smad7 overexpression, however, did not alter their proliferative capacity and
resistance to TGF-b-driven growth inhibition. On the other hand, expression of Smad7
efficiently reduced the capacity of human melanoma cells to invade Matrigel in Boyden
migration chambers, while not affecting their motility and adhesion to collagen and laminin.
Gelatin zymography identified reduced MMP-2 and MMP-9 secretion by Smad7-expressing
melanoma cells as compared with their control counterparts. Smad7-expressing melanoma
cells exhibited a dramatically reduced capacity to form colonies under anchorage-
independent culture conditions, and, when injected subcutaneously into nude mice, were
largely delayed in their ability to form tumors. These results suggest that TGF-b production by
melanoma cells not only affects the tumor environment but also directly contributes to tumor
cell aggressiveness through autocrine activation of Smad signaling.
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A Novel Mouse Model for Spontaneous and Ultraviolet B (UVB)-Induced Basal Cell
Carcinomas (BCCs): Ptch1 Heterozygosity Bred into a Tumor-Susceptible SKH-1 Hairless
Genetic Background
Kim AL1, Tang X1, Russo J1, Kopelovich L2, Athar M1, Bickers DR1
1Columbia University Medical Center, USA; 2National Cancer Institute, USA
BCCs constitute more than 70% of all skin malignancies. Individuals with the nevoid BCC
syndrome (Gorlin’s), an autosomal dominant disorder, develop numerous BCCs often in the
first two decades of life. BCCs are locally aggressive non-metastasizing tumors in this
population that closely resemble the behavior of sporadic BCCs in the general population.
Mutations in sonic hedgehog (shh) signaling genes, including Patched (Ptch1) and
Smoothened (SMO), are linked to tumorigenesis in sporadic BCCs and in Gorlin’s syndrome.
Ptch1 heterozygous knockout mice bred on a C57BL/6 and DBA/2J hybrid genetic
background (B6D2) develop BCCs following exposure to UVB or gamma radiation. This
model is limited by the slow rate of tumor growth and the lack of tumor multiplicity and the
failure to develop spontaneous BCCs. SKH-1 hairless mice are widely used for skin
carcinogenesis studies and are highly susceptible to developing squamous cell carcinomas
(SCCs) but not BCCs. In this study we introduced Ptch1 heterozygosity into the tumor-
susceptible SKH-1 hairless genetic background to accelerate development of spontaneous
and UVB-induced BCCs. The Ptch1þ //SKH-1 cross developed BCCs indistinguishable from
human BCCs that were detectable microscopically by 7 weeks of age. Irradiation of Ptch1þ /
/SKH-1 with UVB accelerated the growth of BCCs, papillomas, and SCCs, compared to
Ptch1þ //B6D2. Cell cycle regulatory proteins, including cyclins A1, B1, D1, and E, as well as
the shh components Gli1, Gli2, and Ptch1, were increased in UVB-induced BCCs in Ptch1þ /
/SKH-1 mice just as in humans. We have conducted cancer chemoprevention studies in this
model indicating that inhibition of ornithine decarboxylase (ODC), the rate-limiting enzyme for
polyamine synthesis, reduces both UVB-induced BCCs and SCCs. This new mouse provides
a highly sensitive model for studying UVB-induced BCCs.
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Melanoma-Associated Chondroitin Sulfate Proteoglycan (MCSP): A new Hope for Cancer
Immunotherapy?
Erfurt C1, Heirman C2, Thielemans K2, Zhaojun S3, Schuler G1, Van Der Bruggen P3, Schultz
ES1
1Universita¨tsklinikum Erlangen, Germany; 2Free University of Brussels, Belgium; 3Ludwig
Institute for Cancer Research, Belgium
The identification of tumor antigens recognized by cytolytic CD8þ T cells (CTLs) on human
tumor cells has opened new avenues in cancer immunotherapy. There is consensus, that the
induction of both, tumor-specific CTLs and CD4þ T helper cells is necessary for an optimal
antitumor immunity. Unfortunately, only a few tumor-specific helper T cell epitopes have been
described so far and most of them do not seem to play a functional role for the tumor itself,
favoring the possibility of antigen loss. We describe here the identification of a new T helper cell
epitope from the human melanoma-associated chondroitin sulfate proteoglycan (MCSP), which
is involved in adhesion, migration, proliferation and invasion of melanoma cells. CD4þ T cells
were isolated from the peripheral blood of a healthy human donor and stimulated with a long
MCSP-derived candidate peptide incorporating several HLA-DR binding motifs. CD4þ T cell
clones could be obtained which recognized a 16-mer peptide presented by HLA-DR11
molecules. The Tcells directly recognized HLA-matched MCSP-expressing melanoma cells and
produced high amounts of IFN-gamma. MCSP, also known as High-Molecular Weight-
Melanoma-associated Antigen, has already been studied as a target antigen for antibody-
based therapies as it is expressed by 490% of melanoma tissues. Targeting MCSP in
melanoma patients with unlabelled or radiolabelled antibodies has not been associated with
significant normal-organ-related accumulation or toxicity, although MCSP is known to have a
limited expression in normal tissues. We could show by quantitative real time PCR that MCSP
expression in normal tissues is much lower than in tumor cells which could explain the lack of
toxicity in the above mentioned studies. In addition, serial ELISPOT analysis of the blood of
patients with metastatic melanoma showed spontaneous T cell reactivity against the identified
epitope in approximately 20% of patients without any signs of toxicity. In summary, MCSP might
be an excellent candidate antigen for cancer vaccination as it is expressed in the majority of
melanoma tissues, plays a functional role for the tumor and can elicit cellular and humoral
immune responses in patients without significant toxicity.
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Abnormal Splicing of FAS mRNA with FAS-Mediated Apoptosis Impairment in a Patient
with CD30þ Sezary Syndrome
Dereure O, Dupont M, Portales P, Rittore C, Guillot B
University Hospital of Montpellier, France
The membrane protein Fas is a key mediator of post-activation lymphocytes apoptosis. It has
been found mutated with subsequent loss of function in congenital lympho-accumulation
with auto-immunity and in some lymphoid hematological malignancies, both B and T,
including cutaneous T cell lymphoma of the Mycosis Fungoides type.
A 77-year-old woman was diagnosed with atypical Se´zary Syndrome leading to a lethal
generalized infection 6 years after first referral. Hematological and immunological analysis
steadily displayed a marked lymphocytosis with 98% of blood lymphocytes featuring as
large-size Se´zary cells expressing CD3, CD4 and CD30 but completely lacking Fas/CD95
membrane expression on repeated investigations. Multiple skin papules and nodules
disclosed a heavy infiltrate with large-size Se´zary cells expressing CD3, CD4 and CD30 as
well. Further in vitro analysis of blood lymphocytes revealed that they do not enter apoptosis
when incubated with anti-Fas antibodies although dexamethasone-induced cell death was
still operative. Fas genomic and cDNA analysis of blood lymphocytes revealed a significant
abnormal splicing of Fas mRNA with deletion of exon 4, 6 and 7 at cDNA level whereas Fas
gene was not modified.
Fas gene somatic changes have been reported in several lymphoid malignancies, involving
key-points such as Fas-ligand binding regions, membrane-anchoring sequence or intracel-
lular death-domain. These changes are presumably significant in early lymphoid carcinogen-
esis with apoptosis impairement proning to subsequent molecular events. Variant splicing of
Fas mRNA has been described as well. In our patient, it is likely that abnormal Fas mRNA
splicing in neoplastic cells led to the lack of membrane-anchoring domain, encoded by exon
7, in the resulting protein with subsequent lack of Fas expression and lack of Fas-induced
apoptosis of tumoral cells. These changes, of unkown mechanisms, are probably of
importance in lymphoid carcinogenesis.
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Comparison of Gene Expression Proﬁles in Blood and Skin Cells of Sezary Syndrome
and Mycosis Fungoides
Hahtola S1, Tuomela S2, Ha¨kkinen T2, Karenko L, Elo L3, Nedoszytko B4, Roszkiewicz J4,
Aittokallio T3, Lahesmaa R2, Ranki A
1Helsinki University Hospital, Finland; 2Turku Center for Biotechnology, Finland; 3University
of Turku, Finland; 4Medical University of Gdansk, Poland
Molecular mechanisms behind cutaneous T-cell lymphomas (CTCL) are largely unknown. To
reveal gene expression patterns, microarray studies have been performed. However, probably
due to the wide range of varying study designs, the gene expression signatures reported differ
considerably. In this study, we analyzed the similarity of expression profiles in different cell
populations and tissues of CTCL subtypes SzS and mycosis fungoides (MF). Affymetrix
oligonucleotide microarray hybridizations with HGU133A chips were performed on altogether 17
fresh CTCL samples, including peripheral blood mononuclear cells (PBMC), enriched CD4þ T-
cells and lesional skin samples. Comparison was performed using matched healthy controls and
skin samples with inflammatory lymphocyte infiltrates. Special emphasis was put on the data
quality and analysis criteria. Algorithms embedded in the Bioconductor R software packages
Affy and Limma were used. The significance of genes expressed differentially among patients
and controls was assessed with moderated t-statistics. Genes showing at least two-fold change
in expression levels were included in the final data. We identified 150 genes differentially
regulated in SzS PBMC samples, while less differences were found in MF blood samples.
Instead, gene expression varied substantially between control and MF skin samples. The key
findings were confirmed with quantitative RT-PCR. Interestingly, three Th1-specific genes and
IL-2Raˆ were found downregulated in SzS samples. Genes upregulated both in MF and SzS
included e.g. S100P and MMP9. Some previous findings on differentially expressed genes in
SzS could not be confirmed with this data set. Finally, we combined the obtained gene
expression profiles with DNA copy number changes detected by comparative genomic
hybridization. By so doing, we found seven common chromosomal areas where both DNA copy
number and gene expression level was changed.
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CTCL-Associated NAV3 Gene Deletion Functionally Affects IL-2 Expression
Ranki A1, Zhou Y2, Pa¨ivinen S3, Blazevic V4, Hahtola S3, Krohn K2, Visakorpi T2, Poustka A5,
Karenko L3, Saksela K2
1Helsinki University Hospital, Finland; 2University of Tampere, Finland; 3University of
Helsinki, Finland; 4FIT Biotech Ltd, Finland; 5German Cancer Research Center, Helsinki,
Germany
We recently identified that a deletion/translocation of the NAV3 (POMFIL1) gene, a human
homologue of unc-53, associates with cutaneous T-cell lymphoma (CTCL). The deletion is
detectable, with locus-specific FISH, in the skin lesions from half of the early MF cases
compared with 85% of cases with later stages of CTCL (e.g. Sezary syndrome). The function
of the NAV3 gene in lymphoid tissue has not been known, nor the molecular pathways
involved. To understand the functional consequences of NAV3 deficiency, we infected human
lymphoid cell cultures with a NAV3 expression-inhibiting lentiviral siRNA construct (vector
pLL3.7). The lentiviral infection efficacy in Jurkat cells was 70% as indicated by the GFP
reporter gene. The NAV3–silenced cells showed a slight growth advantage; however, the
overall rate of apoptotic cell death was somewhat increased in these cultures. Interestingly,
NAV3 silencing increased IL-2 expression both in Jurkat cells and in primary lymphocytes: the
proportion of IL-2þ /GFPþ Jurkat cells increased from 12% (empty vector/vector control) to
35% (siRNA; FACS analysis). In double immunofluorescence (IL-2/GFP), intracellular IL-2 was
similarly increased, and IL-2- ELISA of culture supernatants showed about 40% higher
concentration of IL-2 in NAV3-silenced primary lymphocytes compared with those infected
with empty vector. No upregulation of CD25 (IL-2Ra) was found. Since IL-2 is critical for the
polarization of naı¨ve CD4 Tcells towards the Th2 phenotype, an enhanced expression of IL-2
in early MF might explain the Th2 skewing in Sezary syndrome. We hypothesize that the IL-2
proliferative signalling in CTCL cells is aberrantly regulated by some NAV3 interactome-
associated, as yet undefined mechanism. NAV3, a novel putative haploinsufficient tumor
suppressor gene, may thus contribute to the growth, differentiation and apoptosis of CTCL
cells as well as to the skewing from Th1 type to Th2 type phenotype during disease
progression.
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Effects of Vitamin D Analogs on the Growth of Melanoma Cell Lines
Reichrath J1, Rech M1, Moeini M1, Meineke V2, Tilgen W1, Seifert M1
1Saarland University Hospital, Germany; 2Federal Armed Forces Medical Academy,
Germany
Vitamin D analogs inhibit proliferation and induce differentiation in different cell types,
including human melanocytes and new vitamin D analogs are interesting candidates for the
treatment of malignancies, including malignant melanoma. We studied effects of 25(OH)D3,
1,25(OH)2D3, vitamin D analog seocalcitol (EB 1089), and A-ring diastereomers of 2-methyl-
1,25(OH)2D3 that differ in their binding affinities for VDR, on the growth of seven melanoma
cell lines (IGR, MelJuso, MeWo, SK-Mel-5, SK-Mel-25, SK-Mel-28, SM). We have analyzed
expression of vitamin D receptor (VDR), vitamin D-25-hydroxylase (25OHase), 25-hydro-
xyvitamin D-1a-hydroxylase (1aOHase), and 1,25-dihydroxyvitamin D-24-hydroxylase
(24OHase) using real time PCR. Incubation of melanoma cell lines with calcitriol resulted in
a dose-dependent suppression of cell proliferation (up to appr. 30%), as measured by a WST-
1 based colorimetric assay and CV. Three melanoma cell lines (MeWo, SK-Mel-28, SM)
responded to antiproliferative effects of active vitamin D analogs, while the others were
resistant. Antiproliferative effects of vitamin D analogs were correlated with binding affinity of
these compounds to VDR. A strong induction (up to 7000-fold) of 24OHase mRNA was
detected in responsive cell lines along with 1,25(OH)2D3-treatment, indicating functional
integrity of vitamin D receptor (VDR)-mediated transcription. In contrast, induction of
24OHase was much lower in resistant melanoma cells (up to 70-fold). VDR mRNA was
induced up to 3–fold both in responsive and resistant cell lines along with 1,25(OH)2D3-
treatment. RNA levels for 25-OHase and 1a-OHase were detected both in sensitive and
resistant cell lines. Our findings indicate that (i) melanoma cells express the enzymatic
machinery for the local synthesis of 1,25(OH)2D3 that may be of importance for growth control
in normal and malignant melanocytes, (ii) melanoma cells show a differential response to
antiproliferative effects of vitamin D analogs, and (iii) vitamin D-mediated growth control is
disrupted in a proportion of cases with malignant melanoma.
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Functional DNA Repair System Analysis in Primary Hematopoietic Cells using Host Cell
Reactivation
Baesecke J1, Thoms K2, Roedling T2, Emmert B3, Viereck V4, Griesinger F1, Haase D1,
Neumann C2, Truemper L1, Emmert S2
1Depts of Hematology and Oncology, 2Dermatology and Venerology, 3Occupational and
Social Medicine and 4Gynecology and Obstetrics, Georg-August University, Go¨ttingen,
Germany
Host cell reactivation (HCR) is used to investigate skin cancer-prone nucleotide excision
repair (NER) defective syndromes. We developed a modified HCR assay for DNA repair
analysis of primary hematopoietic cells of clinical samples. Therapy related acute
myelogenous leukemia (t-AML) is frequently observed among patients after high dose
chemotherapy. Its incidence varies between 5–15% in non-myeloablative and myeloablative
treatment protocols. Deficiencies in individual DNA repair systems seem to be involved in t-
AML leukemogenesis since indirect genetic markers, e.g. microsatellite instability (mismatch
repair) or polymorphisms of XRCC genes (base/nucleotide excision repair), are frequent in
these patients. We performed HCR using 75–250 ng luciferase reporter gene plasmid.
Primary lymphocytes and cord blood CD34þ -progenitor cells from healthy donors were
collected according to the convention of Helsinki. 2  105–2  106 cells were cryopre-
served, thawed, and transfected using DEAE-dextran at a concentration of 0,1 mg/ml in a
transfection volume of 250 ml. We obtained luciferase activities of 350-fold above background
in CD34þ -progenitor cells (1000-fold in primary blood lymphocytes) rendering these cells
applicable for DNA repair analysis. In addition, we evaluated the normalized NER capacity
(1000 J/m2 UVC irradiated vs. unirradiated plasmid) of normal lymphocytes (GM03715) and
two AML cell lineages, Kasumi-1 and HL60, as well as CD34þ -progenitor cells. Kasumi-1
and HL60 cells exhibited a reduced NER capacity compared to normal lymphocytes and
CD34þ -progenitor cells (6.15%  1.6% and 6.5%  1.6% vs. 12.3%  3.2% and
13.52%  3.4%, respectively). Our modified HCR can be used for functional DNA repair
analysis in fresh and cryopreserved patient samples of pre- and post-leukemic conditions as
well as in leukemic blasts to elucidate the role of defective DNA repair during t-AML
leukemogenesis and to determine the individual susceptibility for therapy related myeloid
leukemia prior to chemotherapy.
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Absence of BRAF Mutations in Melanocytic Nevi which Develop In Utero Implicates UV-
Light as a Causative Agent for BRAF Mutations
Bauer J, Curtin JA, Bastian BC
UCSF Comprehensive Cancer Center, San Francisco, USA
Most melanomas and melanocytic nevi develop on sun-exposed skin and commonly harbor
BRAF mutations. Because mutations lack a UV-signature, it has been difficult to establish a
causative link between UV-light and mutations in BRAF. Occasionally, nevi are present at
birth, and therefore must have developed independently of UV-light. We hypothesized that if
BRAF mutations were induced by UV-light, they would be expected to be absent in nevi that
develop in utero.
To test this hypothesis, we sequenced BRAF exon 15 from DNAs extracted from micro-
dissected tumor bearing tissue of 34 melanocytic nevi that were present at birth. Additionally
we analyzed nine cases of atypical nodular proliferations developing within nevi presenting at
birth. These lesions present as rapidly growing nodules in the neonatal period and are often
suspicious for melanoma clinically and microscopically. DNAs from archival tissue of
melanomas from intermittently sun-exposed skin, known to harbor frequent BRAF mutations,
were used as positive controls.
All 34 melanocytic nevi present at birth (100%), as well as the nine atypical nodular
proliferations showed wild-type sequences for BRAF exon 15.
BRAF mutations frequently found in acquired melanocytic nevi and cutaneous melanomas
are absent in melanocytic neoplasms developing in utero. These results are in striking
contrast with previous studies, reporting high frequencies of BRAF mutations in ‘‘congenital’’
melanocytic nevi. The diagnosis of ‘‘congenital’’ melanocytic nevus is frequently made based
on histopathological features such as periadnexal and perivascular distribution of
melanocytes rather than definite history. Our findings suggest that these features are
inadequate predictors of a congenital origin of melanocytic nevi. Together with reports that
BRAF mutations are absent in melanomas from mucosa-lined body cavities these data
strongly suggest that UV-exposure is required for BRAF mutations. Future studies are
required to delineate the exact mechanism how UV-light causes these mutations.
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Inhibition of uPA Decreases Invasiveness of Metastatic Melanoma Cells
Schuh T1, Besch R1, Magdolen V2, Degitz K1
1Ludwig-Maximilians-University Munich, Germany; 2Technical University Munich, Germany
The process of tumor invasion requires several factors including cell adhesion and de-
adhesion processes. Proteolysis allows tumor cells to degrade the extracellular matrix (ECM)
for migration. A key proteolytic tumor cells activity is the plasminogen activator system,
including the serine protease urokinase-type plasminogen activator (uPA), its receptor
(uPAR), and the cellular inhibitors, PAI-1 and PAI-2. In melanoma, the expression of uPA and
uPAR is increased in advanced stages and positively correlates with the invasive potential of
melanoma cells. Furthermore, interference with uPA/uPAR expression or function reduced
invasion and/or metastasis in animal models of human tumors, including melanoma. For
further characterization of the role of the plasminogen activator system in melanoma, we
tested the serine protease inhibitor, WX-UK1, that inhibits uPA. A metastatic melanoma cell
line, 1205Lu, was used as a model. Cell surface activity of uPA was assessed by its ability to
activate plasminogen. When cells had been treated for 24h with WX-UK1, plasminogen
activation was reduced by 50%, compared to the inactive D-enantiomer as a control. As a
next step, activity of WX-UK1 on cell invasiveness was examined in a synthetic ECM-
simulating barrier (MatrigelTM). When cells had been treated with WX-UK1, the amount of
invading cells was found to be 10fold decreased. Taken together, WX-UK1 inhibits uPA
function in a melanoma line. Inhibition of the plasminogen activator system may interfere with
melanoma invasion and might lead to the development of a new molecular therapeutic
strategy.
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A Microsatellite Polymorphism in the Heme Oxygenase-1 Gene Promoter Is Associated
with Risk for Melanoma
Okamoto I, Kroegler J, Endler G, Kaufmann S, Mustafa S, Mannhalter C, Wagner O,
Pehamberger H
Medical University Vienna, Austria
Recently, heme oxygenase-1 (HO-1) has been demonstrated to play an important role in the
regulation of signaling systems which are involved in the control of cell cycle progression and
apoptosis. A (GT)n dinucleotide repeat polymorphism in the HO-1 promoter was suggested to
modulate HO-1 gene expression. Malignant melanoma (MM) is the most serious cutaneous
malignancy with high tendency to aggressive growth and resistance to apoptosis. Therefore,
we sought to study the influence of this polymorphism on the progression of MM. We
determined the HO-1 promoter genotype in 152 patients with MM and 398 healthy controls
and studied their association in regard to susceptibility to MM, Breslow thickness and
disease free survival. In our study, the homozygous short allele with o25 (GT)n repeats (S/S)
was found more frequently in the melanoma group compared to the healthy control
population (21% and 12%, respectively). Moreover, the S/S genotype was significantly
associated with primary tumors with deeper Breslow thickness compared to L allele (425
repeats) carriers (Mean Breslow thickness: 4.0 mm  2.9 mm versus 3.1 mm  1.7 mm,
p¼0.03). However, no significant differences were observed in disease free survival (67
months (  49) in L-allele carriers versus 56 (  42) in S/S individuals, p¼ 0.3). These data
suggest that HO-1 might render a higher risk for MM in S/S genotype individuals and could
represent an important candidate gene in the pathogenesis and growth of malignant
melanoma.
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The Regulation of NF-jB by CYLD and TRIP (Traf-Interacting Protein)
Huber M, Regamey A, Contzler R, Hohl D
CHUV, Lausanne, Switzerland
Familial cylindromatosis and Spiegler-Brooke syndrome are autosomal dominant predis-
position to multiple neoplasms (cylindroma and trichoepithelioma) of skin appendages.
Affected individuals carry germline mutations in one allele of CYLD, a tumor-suppressor gene
localized on chromosome 16q12-13. In most tumors, the second normal allele has been lost
during tumor formation. CYLD protein interacts with TRIP (TRAF-Interacting Protein), TRAF2
and NEMO and harbors at the C-terminal end a functional deubiquitinase domain acting on
K63-linked ubiquitin moieties. CYLD and TRIP function as negative regulator of the NF-kB
signaling pathway. The mechanism of how TRIP and CYLD act together to inhibit NF-kB
activation is presently not known. TRIP contains a N-terminal C3H2C3-RING domain (amino
acids 1-55) commonly found in proteins functioning as E3 ligase in protein ubiquitination.
Overexpression of TRIP in 293T cells leads to its ubiquitination. However, this was not due to
autoubiquitination by the N-terminal RING domain since TRIP mutants with a deletion at the
N-terminal end (aa 1-76) or with a mutation (C25A) at an amino acid essential for E3 ligase
activity were ubiquitinated to the same extent as the wild type protein. Furthermore, inhibition
of NF-kB activation by these mutants was not different from that by the normal protein.
Immunoprecipitation with an antibody directed against TRIP revealed that the endogenous
protein is ubiquitinated upon overexpression of TRAF2 and TRAF6. These results indicate
that the level of TRIP is regulated through ubiquitination by TRAF2 and/or TRAF6. It remains
to be seen whether CYLD can deubiquitinate TRIP and prevent it from degradation.
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Melanoma Cells Induce Endothelial Cell Activation that Promotes Tumor Cell Adhesion
Goerge T, Barg A, Gorzolanny C, Schnaeker EM, Kleineru¨schkamp F, Luger TA, Steinhoff M,
Schneider SW
University of Mu¨nster, Germany
As a hallmark of malignant tumors, cancer cells leave their original site and migrate via the
vascular system to settle up metastases. A crucial step of this process is extravasation, the
ability of circulating tumor cells to adhere to and pass the endothelium as the physiological
barrier between blood and tissue. Successful adhesion of tumor cells to endothelium in blood
flow requires effective binding partners on both sides, tumor cells and endothelium.
Therefore, we assessed A7-melanoma cells’ ability to promote endothelial cell activation
which subsequently supports tumor cell adhesion. We incubated melanoma cells on an
endothelial cell layer and found an immediate endothelial cell activation displayed by a
marked raise of intracellular calcium concentrations and von-Willebrand factor (vWF) release.
This response could be even enhanced by stimulating endothelium with melanoma-cell
derived supernatant. Incubating melanoma cells on confluent histamin-activated endothelium
resulted in firm adhesion of A7-cells. These findings display that melanoma cells rapidly
induce endothelial cell activation that promotes tumor cell adhesion. In the context of the
recent observation that MMPs activate proteinase-activated receptor-1 (PAR-1), it is a thrilling
conception that melanoma-derived MMP’s might pave the metastatic way via PAR-activation.
369
Targeting Melanoma by Proapoptotic Strategies and Genes
Eberle J, Fecker LF, Oppermann M, Kurbanov B, Franke J, Schwarz C, Geilen CC
Charite´ Universita¨tsmedizin Berlin, Germany
Apoptosis resistance is a critical feature of tumor cells and often results in therapy resistance.
Death ligands as CD95/Fas ligand (CD95L) or TRAIL are of general importance for the
regulation of apoptosis as are pro- and antiapoptotic Bcl-2-related proteins which control the
release of proapoptotic mitochondrial factors.
Highly varying response of melanoma cells to exogeneous apoptotic triggers as CD95L and
TRAIL was seen in vitro. Varying sensitivity was linked to death receptor expression (TRAIL)
respectively to the Bax/Bcl-2 ratio (CD95L). Melanoma cell lines were found to express CD95
but not CD95L, and overexpression of CD95L but not of CD95 triggered apoptosis in
melanoma cells and resulted in sensitization to chemotherapeutics. Activation of downstream
signalling cascades as cleavage of caspase-8, Bid and caspase-3 as well as release of
cytochrome c were confirmed. In a nude mouse melanoma model, CD95L-transfected
melanoma cells lost tumorigenicity when CD95L expression was induced.
In addition, melanoma cells turned out as critically sensitive to overexpression of
proapoptotic Bcl-2 proteins as shown by transient and stable transfection of Bcl-XS, Bax
and NBK/Bik. Combination with proapoptotic agents as etoposide, pamidronate, and
ceramide resulted in additive proapoptotic effects. Adenoviral expression of NBK/Bik
triggered apoptosis in all melanoma cell lines, investigated. In the nude mouse melanoma
model, induced expression of these proteins was able to reduce size of xenotransplanted
melanomas. On the other hand, stable overexpression of Bcl-2 and of Bcl-XL converted
melanoma cells from apoptosis-sensitive to resistant for proapoptotic signals (agonistic
CD95 activation, ceramide). With regard to the signalling pathway, clear indications for
apoptosis as DNA fragmentation and nuclear condensation were found, however no
indication for caspase activation nor cytochrome c release.
Thus, melanoma cells and melanomas can be targeted by proapoptotic strategies as
overexpression of death ligands and proapoptotic Bcl-2-related proteins. Selective
expression and selective induction of apoptosis can be mediated by applying tyrosinase-
derived promoters as we demonstrated by a tyrosinase promoter CD95L construct.
Combined use of selective promoters and proapoptotic strategies may appear as suitable
for future melanoma therapies.
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Real time RT-PCR in Malignant Melanoma Patients for Quantitative Detection of
Circulating Melanoma Cells
Arenberger P, Arenbergerova M, Lippert J, Gkalpakiotos S, Kremen M
Charles University, Prague, Czech Republic
Malignant melanoma seems to be the most malignant tumor of the skin and mucous
membranes, particularly because of its aggressive biological behavior and tendency to
generate early metastases. It is essential to be able to detect the therapeutic response of
adjuvant immunotherapy and to investigate if the disease is showing regression or
progression in clinically tumor-free patients. The best candidate for such an examination
seems to be the detection of circulating melanoma cells. The majority of the previous studies
have been carried out with a single marker which was tyrosinase, detected by conventional or
semiquantitative RT-PCR.
We introduced a quantitative multimarker real-time RT-PCR. This method detects the
expression of tyrosinase, MART-1, MIA, MAGE-3, gp 100 and telomerase genes which exhibit
high specificity for melanoma cells.
Study inclusion criterion was a histologically documented diagnosis of melanoma, stage II
or III, treated by surgery. Blood samples of 50 patients were examined.
The overall evaluation in 5 out of 6 tested markers revealed correlation between the tumor
stage and concomitant tumor cell blood load. We could observe down-regulation of
tyrosinase in many patients even in higher stages. In addition, MIA and MAGE-3 had some
background expression in control persons, however, significant difference between patients
and controls could be shown.
We described a method of multimarker real-time RT-PCR for quantitative detection of
circulating tumor cells in patients with malignant melanoma. The results provide us with
information on the frequency of melanoma-associated gene transcripts and help us to
determine which patients are in a risk of developing distant metastases. The time-course of
the circulating malignant cell load is necessary to obtain important data on the possible
prognosis of the disease. Therefore, more blood sample collections over a longer time period
in every patient is needed. Judgment of routine application of this method for rapid screening
of risk patients and monitoring of therapy effect should be the final aim of the study which is in
progress in our laboratory.
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Angiogenesis in Cutaneous Cancers and the Mechanism of Antiangiogenic Activity of
Retinoids and Calcitriol
Majewski S, Pagounis CE, Malejczyk M, Jablonska S
Department of Dermatology and Venerology, Warsaw School of Medicine, Poland
Recently it was suggested that newly described proteins belonging to the family of p53
proteins (i.e. p63 and p73) could be involved in regulation of tumor angiogenesis. The aim of
the study was to investigate correlations between intensity of tumor angiogenesis and various
histological types of skin tumors and to investigate expression of DNp63 and Ki-67 proteins in
skin tumors at various differentiation stages. We also studied the effects of all-trans retinoic
acid, 9-cis retinoic acid and calcitriol on the expression of DNp63 mRNA in tumor cell lines
in vitro.The study was performed in 23 cases of various histological types of basal cell
carcinomas, in 19 cases of squamous cell carcinomas showing various degree of
differentiation (10 cases of well differentiated tumos and 9 cancers poorly differentiated)
and in 12 samples of healthy skin. In vitro studies were performed with the use of two human
keratinocyte lines (Skv and HaCat). The results of the study showed that the intensity of
angiogenesis inversely correlated with the degree of tumor differentiation, highest expression
of DNp63 protein was seen in poorly differentiated squamous cell carcinomas and in
basaliomas. Strong DNp63 expression could be detected also in cells without proliferative
potential (negative for Ki-67 protein). Retinoids in a dose-dependent manner, decreased
expression of DNp63 mRNA and protein in both Skv and HaCat cells and this effect was
synergized by calcitriol. It seems that inhibition of DNp63 expression by retinoids and
calcitriol may be an important mechanism elucidating pleiotropic effects of these
compounds, i.e. their anti-angiogenic, anti-proliferative, and pro-apoptotic properties.
372
Proteomic Study of Classic Kaposi Sarcoma
Cuccuru MA1, Masala MV1, Carta F2, Turrini F3, Cottoni F1, Cerimele D1
1University of Sassari, Italy; 2Porto Conte Ricerche-Alghero, Italy; 3University of Torino, Italy
A proteomic investigation has been done on skin biopsies obtained from 8 patients affected
by classic Kaposi’s sarcoma (K.S.). Proteins extracted from the samples were separated by
two-dimensional electrophoresis, and the proteins corrisponding to the 95 most intense
spots have been identified with mass spectrometry (MALDI-TOF). 18 out of 95 proteins
identified belong to the family of stress proteins: among these are heat shock protein 27
(HSP27), HSP60, HSP70, protein disulfide isomerase (ER60), 58 kDa glucose-regulated
protein (GRP58), chaperonin containing TCP1, chaperone HSPA5 precursor, BIP protein,
peroxiredoxin 3, manganese superoxide dismutase. It is thought that HSPs may contribute to
tumours development through a block of apoptotic processes: high expression of these
proteins has been observed in several tumors. The abundant presence of stress proteins in
the lesional tissues of the patients affected by cKS suggests a possible involvement of these
proteins in the pathogenesis of the disease. In addition an overexpression of GRP58 and a
downexpression of prohibitin has been correlated with the aggressiveness of the disease. In
this scenario proteomic analysis may give a strong support not only to the investigation of
mechanisms involved in the pathogenesis of cKS, but also to the detection of specific
markers of the disease and possibly of targets for new drugs.
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High Amount of Aneuploid Cells in Low-Grade Keratinocytic Intraepidermal Neoplasias
Kleinpenning M
Radboud University Medical Centre, Nijmegen, The Netherlands
Epithelial neoplasias of the skin are commonly classified according to the KIN (keratinocytic
intraepidermal neoplasia) grade, in which the amount of atypical keratinocytes in the
epidermis are semi-quantitatively scored in three categories (I–III). Aneuploidy can be seen as
the result of chromosomal aberrations leading to altered DNA content and has been
associated with malignancy. Aim of the study was to analyze the presence and the amount of
aneuploidy in various KIN-lesions and to correlate this to KIN-grade.
For this purpose, nuclei were isolated from 55 formalin-fixed KIN-lesions from 32 patients in
which DNA content was measured by flow cytometry after staining with propidium iodide.
The resulting DNA histograms were analysed using Modfit software.
No aneuploidy was found in the 12 KIN I-lesions that were studied (0%). These lesions all
appeared to be diploid. In KIN II-lesions however, 7 out of the 16 lesions (44%) showed
aneuploidy (16.43þ /2.34%; MEANþ /SEM). The remaining 9 lesions were all diploid. In
the 27 KIN III-lesions, 12 (44%) were found aneuploid (23.36þ /4.94; MEANþ /SEM). The
remaining 15 lesions were all diploid.
In conclusion, in the present study relatively high amounts of aneuploidy were found in KIN
II- and III-lesions whereas KIN I-lesions were all diploid. These results show that KIN II-
lesions, which are regarded to be low-grade KIN lesions, show a substantial amount of
aneuploidy, whereas KIN I-lesions lack aneuploidy. Regarding aneuploidy rates, KIN II-lesions
have more in common with KIN III lesions. This emphasizes the current opinion that KIN II-
lesions are not just pre-stages in the progression to squamous cell carcinoma but are in fact
squamous carcinomas in situ and should be treated accordingly.
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Antiproliferative Effect of Semaphorins 3A and 3F on Melanoma Cell Lines
Buffard V1, Chabbert De Ponnat I2, Marie-Cardine A2, Bagot M1, Bensussan A2,
Wolkenstein P1
1Hopital Henri Mondor, Cre´teil, France; 2Unite´ INSERM 659, Cre´teil, France
Introduction: Semaphorins are proteins implicated in axonal development, morphogenesis,
immunomodulation, apoptosis and carcinogenesis. Sema3A and Sema3F, members of the
class 3 secreted semaphorins, have anti-angiogenic and anti-tumoral properties. They
compete with VEGF for his binding to neuropilin 1 (NRP1) for Sema3A and to neuropilin 2
(NRP2) for Sema 3F. Sema3F, initially described as a tumor suppressor in lung cancer, inhibits
tumorigenicity of different cancer cell lines, including melanoma, on nude mice. Sema 3A also
has an anti-mitotic effect on mesothelioma cells. We investigated Sema 3A and Sema 3F
effect on cell proliferation of A375 and MM170 melanoma cell lines.
Methods: Soluble forms of Sema3A and sema3F fused to alkaline phosphatase (AP) were
prepared from transiently transfected Cos cells. Expression of Sema 3A and Sema 3F and
their receptors was tested by RT-PCR and flow cytometry. We measured melanoma cell lines
proliferation after incubation with Sema3A-AP or Sema3F-AP for 2 days and after
electroporation with Sema3A-AP or Sema3F-AP cDNA (negative contols: AP and vector
alone).
Results: Sema3A and 3F bind to A375 and MM170 melanoma cell lines. These 2 cell lines
express NRP1, NRP2, plexin A1 and A2 by RT-PCR and flow cytometry. Sema 3A and 3F
inhibit cell proliferation of the two melanoma cell lines. For Sema3F, this inhibition can be
prevented by a blocking anti-Sema3F antibody. Preliminary results on tumor samples of
cutaneous metastasis show an expression of Sema3A and 3F mRNAs.
Conclusion: Sema3A and 3F are expressed on melanoma cell lines and have an anti-
proliferative effect on cell cultures. The mecanism of this antiproliferative effect could be a
competition with VEGF for his binding to NRPs. As in lung cancer, loss of expression of Sema
3F on cell surface could be correlated with a more agressive phenotype.
375
Genomic Instability in Patients with Cutaneous T-Cell Lymphoma Characterized by
Microsatellite Instability and Chromosomal Aberrations: Pathogenetical and Prognostic
Implication
Aguilar Sanchez JA1, Assaf C2, Lukowsky A2, Walden P2, Feliciani C1, Amerio PL1, Sterry
W2
1Catholic University Rome, Italy; 2Charite´ University Hospital Berlin, Germany
The aim of this study was to determine the frequency and prognostic value of microsatellite
instability (MSI) in tumour cells of cutaneous T-cell lymphoma (CTCL) patients presenting
different clinical stages. In order to study its possible role in the initial developed and
progression of mycosis fungoides (MF) one hundred samples of 25 patients (twice skin and
blood from different stages of each patient during the clinical course) were analyzed by using
eight microsatellite loci and Genescan-analyses. Moreover, cases with MSI where
additionally analyzed for chromosomal instability by comparative genomic hybridisation.
MSI was detected by amplifying microsatellite markers using a PCR-based methodology and
an automated sequencer and comparing the size of microsatellite repeats in tumor and
normal DNA. MSI was defined as the presence of novel peaks in the tumour DNA compared
to the normal control. PCR was performed at microsatellite primers DXS418 (Xpter-Xp21),
DXS453 (Xq12-Xq12), DXS556 (Xp21.1-Xp11.4), DXS1060 (Xp22.3-Xp22.3), D1S201 (1p32),
D6S260 (6p23), D9S162 (9p21), D10S215 (10q22-23). All samples from healthy donors and
inflammatory skin diseases did not display any MSI. The sensitivity of the MSI-PCR technique
was determined by serial dilution of T-cell lines (MyLa and SeAx) in peripheral blood of healthy
donors. Overall 6/25 cases have MSI (25%). 4/6 patients had a progressive disease,
interestingly at least in 3-4/8 primers. 2/6 had complete remission, and they presented
interestingly just one MSI. Of 7 cases analyzed also for chromosomal aberrations only one
had MSI. In conclusion, the mutational phenotype is frequent in MF; MSI is a feature of
progressed rather than early MF; microsatellite and chromosomal instability seem to be
mutually exclusive in carcinogenesis; MSI is associated with reduced response to therapy
and poorer outcome.
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Activating c-Kit Exon 11 Mutation is Absent in Merkel Cell Carcinoma
Lassacher A, Heitzer E, Kerl H, Wolf P
Photodermatology, Medical University of Graz, Austria
Merkel cell carcinoma (MCC) is a rare but very aggressive skin tumor of putative
neuroendocrine origin, primarily affecting elderly persons at sun-exposed body sites. The
exact causes and molecular mechanisms of MCC formation are not known at present. A
candidate gene is the proto-oncogene c-Kit, which encodes for a transmembrane receptor
tyrosin kinase (ckit/CD117) related to the platelet-derived growth factor (PDGF)/colony
stimulating factor 1 (CSF-1) receptor subfamily. The fact that strong c-Kit expression has
been reported in primary and metastatic MCC makes the c-Kit gene a suspect candidate in
this type of tumor. C-Kit is involved in activation of cell proliferation and is thought to play an
important role in melanogenesis, hematopoesis, and carcinogenesis. In other cancers, most
c-Kit mutations were found in the hot-spot region of exon 11, involving codons 550 - 560.
Previous studies give evidence that a point mutation at codon 560 is capable of inducing
constitutive activation of c-Kit product, and raise the possibility that this activating mutation
may be involved in oncogenesis of some cell types, including hematopoetic stem cells and
mast cells. In this study, we analyzed MCC from 14 patients (12 females and 2 males; age
range, 70 to 88 years). Direct sequence analysis of c-Kit exon11 revealed no mutations.
Although the results of the present study do not exclude the possibility of c-Kit mutations in
exons other than 11, the data do not support the hypothesis that activating mutations in c-Kit
exon 11 play a role in the pathogenesis of MCC.
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Epigenetic Regulation of E-Cadherin in Squamous Cell Carcinoma of the Skin
Fujiwara H1, Ito M2
1Niigata University School of Medicine, Japan; 2Graduate School of Pharmaceutical
Sciences, Nagoya City University, Japan
E-cadherin is a transmembrane protein, which serves as a adhesive molecule to the adjacent
keratinocytes in the skin. The reduced expression of E-cadherin in cancers were well
documented, as in squamous cell carcinoma of the skin. It’s importance in carcinogenesis
and metastasis is reported, however, the mechanism of suppression on E-cadherin
expression in the skin has not disclosed, so far. In this study we report epigenetic
mechanism in suppression of E-cadherin expression by DNA methylation.
Snap-frozen tissues of twelve squamous cell carcinoma of the skin were microdissected.
Genomic DNA was prepared and subjected for methylation-specific polymerase chain
reaction. E-cadherin gene mutation was detected with non-isotopic ribonuclease cleavage
assay and direct sequence by PCR amplification of all the exons and exon-intron boundaries.
Loss of heterozygosity was analyzed with microsatellite markers, D16S3095, D16S421, and
D16S752 at 16q22.1.Localization of E-cadherin mRNA expression was determined by in situ
hybridization, and the protein expression was visualized by immunohistochemistry with anti-
E-cadherin monoclonal antibody.
All the cases revealed genomic DNA methylation in E-cadherin promoter. None of the
tumors showed E-cadherin gene mutation; loss of heterozygosity was not detected in any of
the cases. E-cadherin mRNA and protein were expressed ubiquitously in adjacent normal
tissue, but in the cancer cells, their expression varied in cell by cell manner. The high-
expression cells and low-expression cells intermingled and formed mosaic pattern.
The E-cadherin gene inactivation by DNA methylation was observed in all the squamus cell
carcinoma samples, regardless of its invasiveness or metastasis. The reduction of E-cadherin
varied cell by cell, not in large low-expression foci as seen in other epigenetically-regulated
cancer-related gene, such as p16. We speculate E-cadherin suppression in squamous cell
carcinoma of the skin may be not directly related to carcinogenesis.
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Role of CCL27 and CCR10 Interaction in Melanoma Progression and Immune Escape
Simonetti O1, Goteri G2, Lucarini G3, Biagini G3, Offidani A1
1Clinica Dermatologica, Ancona, Italy; 2Istituto di Patologia, Ancona, Italy; 3Istituto di
Morfologia-Istologia Umana Normale, Ancona, Italy
In animal models it has been showed that ligation of tumor-associated CCR10 with CCL27
may be a mechanism to promote neoplastic cell survival and reduce immune response. Aim
of this study was to investigate the interrelation between T immunoreactive cells and the
expression of CCR10 and its ligand CCL27 in 59 human cutaneous melanocytic lesions (40
malignant melanomas, 10 Spitz nevi, and 9 benign melanocytic nevi), by immunohistochem-
istry. In malignant melanomas T lymphocyte density was significantly different in the three
groups of cases selected by different thickness, showing tendency to decrease from thin
melanomas to intermediate and thick ones. In malignant melanomas CCR10 exhibited a
tendency to be directly correlated with the Breslow depth and inversely with T lymphocyte
density. Moreover, there was a correlation between high CCR10 expression and metastasis in
sentinel lymph node. Melanomas, positive for both CCR10 and CCL27, displayed a
decreased mean density of CD3þ and CD8þ lymphocytes.
Our results confirm that also in human melanomas CCR10 and CCL27 may act to increase
the ability of neoplastic cells to grow, invade tissue, disseminate to lymph nodes and to
escape the host immune response.
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Efﬁcacy of RGD-Porphyrins on Murine Tumoral Melanocytes: Preliminary Results
Sparsa A, Faucher K, Sol V, Krausz P, Guilloton M, Sturtz F, Be´dane C
University Hospital, Limoges, France
Background: Photodynamic therapy (PDT) is mediated by reactive oxygen species after
activation of a photosensitizer by light. PDT remains controversial for melanoma treatment.
This is due the poor light penetration of the activating 630nm light into melanin-rich tissue
with sodic porphymer PDT. To increase their specificity RGD function has been grafted on
porphyrins. RGD binds specifically on cell surface integrin a´5aˆ3 which is expressed by
tumour melanocytes and endothelial cells. We report herein some preliminary results
concerning the efficacy of newly synthetized porphyrins on murine melanocytes (B16F10) and
bovine endothelial cells (EJG).
Materiel and Methods: Para-Triglycosyl-RGD porphyrin and Ortho-TG-RGD synthesis have
been previously published. B16F10 and EJG cells have been cultured in wells. Porphyrins
were added after 3 days. Irradiation was performed with 10J/cm2, blue light, (450 nm
Wawelenght) after 3 hours incubation. Colorimetric MTT test was performed after irradiation,
at day 1, 2, 3, and 4 to determine cytotoxic and phototoxic porphyrin concentrations.
Results: oTG-RGD porphyrin is phototoxic and not cytotoxic at 105M concentration on
B16F10, inducing 60% of cell death at day 2. pTG-RGD porphyrin is phototoxic and not
cytotoxic on B16F10 at 104M concentration, inducing 90% cell death At these
concentrations porphyrins are cytotoxic on EJG. pTG-RGD porphyrin is phototoxic and not
cytotoxic on EJG (109M). Percentage of cell mortality is comparable to rate of cell mortality
with Photofrin (15mg/ml).
Conclusion: These results suggest that PDT using new RGD-porphyrins is active on tumour
melanocytes. Various types of porphyrins are being synthetised and evaluated to further
precise their activity and specificity.
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Expression of PAR2 in Skin Tumors
Bocheva G1, D’Andrea M2, Rattenholl A3, Steinhoff M3
1Dept of Pharmacology and Toxicology, Medical University Sofia, Bulgaria; 2John-
son&Johnson, USA; 3University of Mu¨nster, Germany
Recent studies show that the proteinase-activated receptor PAR2 plays a regulatory role in
cutaneous neurogenic inflammation and the immune response. However, its role in skin
tumorigenesis is still unknown. The aim of our study was to determine the expression of PAR2
in benign and malign skin tumors by immunohistochemistry. Sections from skin biopsies of
normal skin, neurofibromas, actinic keratosis, basal cell carcinomas, squamous cell
carcinomas, B cell lymphomas, and melanomas, were incubated with polyclonal antibodies
against PAR2. PAR2 expression in actinic keratosis, as well as in normal human skin, was
found to be higher in keratinocytes of upper spinous and differentiated granular layers than
basal and suprabasal layers, unlike the staining of the whole epidermis in other skin tumors.
Marked staining intensity for PAR2 was seen in the epidermis of actinic keratosis and
melanoma patients. In benign tumors, such as neurofibroma, strong staining appeared in
spindle neuronal cells presented in pale stroma. In malign tumors, PAR2 expression in tumor
cells revealed differences – from negative staining in B cells, weak staining in basal malign
keratinocytes, to moderate in atypical spinous keratinocytes, and strong immunostaining in
malign melanomas. Overexpression and/or overactivation of PAR2 in sun exposed areas of
healthy skin, in IV-VI skin types, actinic keratosis, and melanoma suggested a strong link
between PAR2 activation and melanogenesis. Our results support the idea that PAR2 may
play a role in skin tumor progression and prognosis. Extensive research in this field may lead
to a beneficial therapy of malign skin tumors.
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NGF and its Precursor proNGF Differentially Regulate Human Hair Growth
Peters E1, Liezman C1, Hansen M2, Overall R1, Arck P1, Klapp B1, Paus R2
1University-Medicine Charite´ Berlin, Germany; 2University-Hospital Eppendorf, Germany
NGF and its low-affinity receptor p75 (member of the tumor necrosis-receptor family) have
been implicated in the hair cycle- and stress-associated termination of hair growth in a
mouse-model for hair cycle associated tissue-remodelling. Whether this model holds any
implications for human epithelial growth control and if proNGF, the newly discovered high-
affinity ligand of p75, participates has yet to be determined. We therefore applied
immunohistomorphometry and semiquantitative PCR-analysis to human scalp skin and
cultured human anagen scalp skin hair follicles to detect and quantify NGF, its precursor and
its receptors under various growth conditions and to probe the functional relevance of their
distribution patterns. We found expression of all four in human scalp skin anagen hair follicles
with strongest expression of NGF and its precursor in terminally differentiating inner root
sheath keratinocytes. TrkA was highly expressed together with p75 in the proliferative zone of
the outer root sheath but not the hair bulb. During spontaneous catagen-like hair follicle
involution in organ culture, p75 and pro-NGF expression increased dramatically in
compartments largely devoid of TrkA expression. In these same compartments, namely the
regressing epithelial strand, p75 colocalized with TUNEL demonstrating its presence on
apoptotic cells. By quantitative rtPCR, p75 mRNA increased significantly during the later
stages of catagen-like development in culture. ProNGF/NGF administered to cultured hair
follicles inhibited hair shaft elongation and induced premature entry into catagen-like
involution which was associated with increased mRNA levels of the known catagen-promotor
tumor growth factor b2 (TGFb2) as early as 48 hrs after onset of culture. During spontaneous
catagen-like development, this marker was increased early on during the development.
ProNGF/NGF effects on hair shaft elongation could be antagonized by co-administration of
NGF with anti-p75 neutralizing antibodies. These antibodies were also able to neutralise
endogenous receptor activation in hair follicle cultures with low growth quality of control hair
follicles (early catagen-like development, high p75 expression), while they inhibited hair
growth of hair follicle cultures with optimal hair follicle growth (late entry into a catagen-like
stage, co-expression of TrkA with p75). Our findings demonstrate a key role for pro-NGF/
NGF/p75 interaction in termination of epithelial appendage growth and holds major
implications for future skin and stress research.
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EGFR and b1-Integrin Cooperate During Skin Tumor Development
Frank C, Lingl A, Lichtenberger B, Holcmann M, Sibilia M
Medical University of Vienna, Austria
The epidermal growth factor receptor (EGFR) plays a key role in skin development and is
implicated in epithelial tumor formation. Transgeniic mice expressing an activated form of the
Ras activator Son of Sevenless (SOS) in the epidermis from the K5 promoter develop skin
papillomas in an EGFR-dependent manner [citation removed]. In these tumors the EGFR
provides an essential survival signal via activation of Akt and we could show that genetic as
well as pharmacological inhibition of EGFR leads to apoptosis of tumor cells.
In this study we investigated additional mechanisms leading to EGFR-dependent tumor
formation. We found that in SOS-expressing tumors the protein levels of Src and b1-integrin
are significantly increased suggesting that they might contribute to the tumorigenic
phenotype. Indeed, SOS expressing keratinocytes display impaired adhesion properties
which are accompanied by increased cell migration and reduced focal contacts. These
phenotypes can be reverted by pharmacological inhibition of EGFR and Src implying
molecular cross-talk between these signaling systems. In addition, constitutive (K5-cre) as
well as tamoxifen-inducible (K5-creER) genetic deletion of a floxed b1-integrin allele
completely abolishes K5-SOS-dependent tumor formation in mice. Our results suggest that
EGFR and b1-integrin cooperate during tumor formation most likely via the Src kinase.
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Brain-Derived Neurotrophic Factor (BDNF) and Pro-Nerve Growth Factor (NGF) Induce
Apoptosis in Human Keratinocytes through the p75 Neurotrophin Receptor
Panza MC, Atzei P, Truzzi F, Lotti R, Marconi A, Pincelli C
Dept of Dermatology, University of Modena and Reggio Emilia, Italy
The p75 neurotrophin receptor (p75NTR) belongs to the TNF-receptor superfamily and
signals apoptosis in many cell settings. In the nervous system, while pro-NGF induces
apoptosis by binding p75NTR and its co-receptor sortilin, mature neurotrophins (NT) bind to
p75NTR alone and trigger cell death in the absence of the NT high-affinity receptor trk. The
aim of the present study was to evaluate the expression and function of p75NTR in human
keratinocytes. p75NTR was detected in a subpopulation of non proliferating basal
keratinocytes, as shown by double staining with MIB-1 and keratin 10. p75NTR was more
expressed in transit amplifying cells that are more susceptible to apoptosis, than in stem
keratinocytes which are completely protected from cell death. Sortilin was detected in human
keratinocytes and was shown to co-localize with p75NTR in a subpopulation of basal
keratinocytes, by immunofluorescence. HaCaT cells overexpressing p75NTR expressed
higher levels of sortilin, as compared to parental HaCaT cells. BDNF, which can signal only
through p75NTR, due to the lack of its high-affinity receptor trkB, induced apoptosis in
keratinocytes, as shown by TUNEL. This effect was partially blocked by anti-p75NTR
antibody. Furthermore, BDNF induced JNK phosphorylation through p75NTR, indicating that
p75NTR possesses its own signal in human keratinocytes. Finally, caspase assay showed
that pro-NGF induced a significant apoptosis in HaCaT keratinocytes transfected with
p75NTR and sortilin, but not in unstimulated HaCaT cells (po0.05) or in cells transfected with
p75NTR alone (po0.05). These results indicate that p75NTR acts as a proapoptotic receptor
in human keratinocytes. Depending on the ligand, p75NTR can induce apoptosis in human
keratinocytes either alone or by interacting with the co-receptor sortilin, even in the presence
of trk.
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Apoptosis of Endothelial Cells Involves Truncation of LTBPs and Activation of TGF-b
Solovyan VT, Keski-Oja J
University of Helsinki, Finland
TGF-bs modulate cell growth, differentiation and apoptosis. Exogenous TGF-b can induce
apoptosis in target cells, but the role of TGF-b targeting and activation under physiological
conditions is poorly understood. The current work was carried out to understand the
interrelationship between endothelial cell apoptosis and activation of latent TGF-b. We
analysed TGF-b activation in human umbilical vein endothelial cells (HUVECs) undergoing
apoptosis induced spontaneously, by staurosporine or by the prevention of cell adhesion
(anoikis). We found that apoptosis of induced by these treatments was accompanied by the
release of truncated large latent (LL-) TGF-b complexes from the pericellular matrix, followed
by activation of TGF-b, as monitored by SMAD phosphorylation. We observed two distinct
sources of activatable TGF-b1, namely direct release of LTBP-1 containing TGF-b1
complexes from the extracellular matrix, and secretion from the cells of soluble LTBP-4
containing TGF-b1 complexes. To analyse the relevance of the solubilization of truncated LL-
TGF-b and phosphorylation of Smad2 for staurosporine-induced apoptosis, caspase
inhibition assays were carried out. Both of these events were partially suppressed by the
pan-caspase inhibitor, BOC-D-fmk. Apoptosis was accompanied by the activation of TGF-b1
in parallel with proteolytic truncation of both LTBPs-1 and -4. Truncation of LL-LTBP-1 into
the conditioned medium was prevented by the serine protease inhibitor AEBSF. Activation of
TGF-b during apoptosis was accompanied by enhanced synthesis of b1-LAP protein.
Activated TGF-b modulated the apoptotic response of HUVECs leading to attenuation of cell
death. Current results suggest distinct roles for LTBP-1 and -4 in providing activatable TGF-
b1. The apoptosis favouring conditions lead to the activation of endogenous TGF-b.
Regulatory signals appear to operate between apoptosizing cells and their non-apoptotic
neighbors. Current results indicate that activation of TGF-b may play a protective feed-back
role against apoptotic cell death.
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Involvement of BMP Signaling in Modulating the Expression of Cell Cycle-Associated
Genes and Controlling Hair Follicle Size
Sharov A1, Sharova T1, Atoyan R1, Weiner L2, Brissette J2, Botchkarev V1
1Boston University, USA; 2Harvard University, USA
BMP signaling is involved in regulation of cell proliferation, differentiation and organ size
during development. To assess the effects of BMP antagonist noggin on cell proliferation and
size of the hair follicles, K5-Noggin transgenic mice were generated using C3H/HeJ mice as a
background. Together with phenotypes described previously (delay in the eyelid opening and
progressive hair darkening; [citation removed]), K5-Noggin mice showed progressive
increase of size of the anagen hair follicles through several hair cycles associated with
significant increase of the cellularity in the hair shaft, inner and outer root sheaths, compared
to the age-matched wild-type controls. In contrast to wild-type mice, proliferative cells in
anagen hair follicles of K5-Noggin mice were ectopically seen among the differentiating cells
of the inner root sheath and hair shaft. Microarray and RT-PCR analyses of the late anagen
skin showed strong increase in expression of the selected cyclins (cyclins A1, A2, B2, D3, E2,
F) and cyclin-dependent kinases (CDK4) in K5-Noggin mice versus wild-type mice. However,
the expression of cyclin-dependent kinase inhibitor p27 was decreased in K5-Noggin mice,
compared to wild-type controls. Furthermore, p27 knockout mice showed increased size of
anagen hair follicles associated with increased cell proliferation in the hair bulb. Also, p27
mRNA expression was markedly increased in primary epidermal keratinocytes cultured with
BMP-4. These data suggest that BMP signaling plays important role in the control of cell
proliferation and size of anagen hair follicles via modulating the expression of cell-cycle
associated genes.
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Smad3 and ERK1/2 Coordinately Mediate Transforming Growth Factor-b-induced
Expression of Connective Tissue Growth Factor in Human Fibroblasts
Leivonen SK1, Ha¨kkinen L2, Liu D3, Ka¨ha¨ri VM1
1University of Turku, Finland; 2University of British Columbia, Canada; 3Fibrogen Inc., USA
Connective tissue growth factor (CTGF) is secreted by fibroblasts stimulated with
transforming growth factor-b (TGF-b). CTGF is a potent enhancer of fibroblast proliferation,
chemotaxis, and extracellular matrix deposition, and it appears to mediate some of the
fibrogenic effects of TGF-b. Here, we have characterized the cellular signaling pathways
involved in regulating the TGF-b-induced production of CTGF in human primary fibroblasts.
TGF-b induced the expression of CTGF mRNA and protein in human gingival fibroblasts after
2 h of treatment. Adenoviral overexpression of Smad3 enhanced the TGF-b-elicited
expression of CTGF, whereas adenovirally delivered Smad7 and dominant-negative Smad3
suppressed the effects of TGF-b on CTGF expression. Pre-treatment of cells with PD98059
(30 mM), an inhibitor for ERK1/2-activator MEK1, potently inhibited the TGF-b-induced
expression of CTGF, whereas SB203580 (10 mM), an inhibitor for p38 mitogen-activated
protein kinase, had no significant effect. Furthermore, co-expression of Smad3 with
constitutively active MEK1 resulted in potent induction of CTGF production without
exogenous TGF-b stimulation, suggesting that ERK1/2 can induce Smad3 activation.
Together, these results demonstrate that Smad3 and ERK1/2 coordinately mediate TGF-b-
induced release of soluble of CTGF in fibroblasts. It is conceivable that the crosstalk between
Smad3 and ERK1/2 signaling cascades plays an important role in regulating CTGF
expression, e.g., in wound repair and tissue fibrosis and could be exploited in therapeutic
targeting of CTGF expression in fibrotic conditions.
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Transforming Growth Factor Beta Signalling in Melanoma
Schlegel N, Dummer R, Hoek K
University Hospital Zu¨rich, Switzerland
A series of large-scale DNA microarray experiments were performed on a subset of
established cell lines of human cutaneous metastases of stage IV melanoma. Hierarchical
clustering of fold-change-restricted data distributed the melanomas among three distinct
cohorts (A, B and C) showing expression profiles which are increasingly different from the
signature profile of control melanocyte cultures. Comparisons with previous studies of gene
expression in different melanoma cell lines suggest that cohort A is representative of a weakly
metastatic subtype of melanomas and that cohort C members have the signature of
aggressively metastatic subtypes. Self-organizing map (SOM) and principal component
analyses of ANOVA-selected data show that genes with the most profoundly altered
expression levels fall within two main expression pattern groupings. Close examination of the
largest and most coherent grouping (motif 1), where genes are strongly up-regulated in cohort
A, shows that a significant fraction of its members are known to positively respond to
changes in Transforming Growth Factor-b (TGF-b)-like signalling.
Further analyses of TGF-b and activin transcriptional profiles showed a strong correlation
between the inhibin bA (subunit of the homodimer activin A) profile and the profile of motif 1.
To support this, a correlation was found between the expression data and activin A protein
production through analyses of activin A secretion by western blotting and ELISA. Smad-
dependent TGF-b signalling was further investigated by analysing the phosphorylation state
of receptor-activated smad proteins, Smad2 and Smad3, by western blotting. We found a
significant, although imperfect, correlation between Smad3 phosphorylation and motif 1. The
lack of an unambiguous correlation between the latter and motif 1, and the known complex
pathway crosstalks involved in TGF-b signalling, highlight the need to investigate crosstalk
pathways such as the Map kinase pathway.
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Phosphoinositide 3-kinase is an Important Regulator of Keratinocyte Differentiation and
Proliferation
Pankow S1, Bamberger C1, Klippel A2, Werner S1
1ETH Zurich, Switzerland; 2Atugen AG, Berlin, Germany
Growth factor-mediated phosphoinositide 3-kinase (PI3K) signaling is regarded as a crucial
stimulator of cell proliferation, and mutations leading to an aberrant activation of this pathway
are frequently found in epithelial cancers. In this study we determined a possible role of PI3K
in wound repair, where transient hyperproliferation of different cell types, including
keratinocytes, occurs. For this purpose we first studied the expression of PI3K and
downstream targets in wounded mouse skin. High levels of the class I PI3K subunits p110a
and p110b were found in suprabasal hyperproliferative keratinocytes at the injured site. In
addition, the downstream effector Akt was phosphorylated in suprabasal keratinocytes,
indicating sustained PI3K activity. To gain insight into the function of PI3K signaling in
keratinocytes, we generated stable HaCaT keratinocyte cell lines, expressing a constitutively
active PI3K mutant in a tamoxifen-inducible manner. Activation of PI3K in keratinocytes
resulted in enhanced proliferation and delayed terminal differentiation, indicating that PI3K
activation is necessary and sufficient to induce hyperproliferation. RTP801/REDD1 was
identified as a novel target gene of the activated PI3K-pathway in keratinocytes. The latter is
implicated in the preservation of the undifferentiated state of a keratinocyte by as yet
unknown mechanisms. Therefore, we suggest that growth factors in the wound activate the
PI3K -pathway, which alters epidermal homeostasis in favor of keratinocyte proliferation and
concommittant inhibition of terminal differentiation.
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Microarray Analysis Suggests the Fas-ligand, TNF and Bcl-2 Related Genes as Early
Response Markers Activated in the Hair Follicle after Chemotherapy
Sharova T1, Sharov A1, Tommasi Di Vignano A2, Dotto GP2, Botchkarev VA1
1Boston University, USA; 2Harvard Univeristy, USA
Chemotherapy induces DNA damage in rapidly proliferating hair follicle keratinocytes
followed by activation of the p53 pathway to induce apoptosis. To determine whether p53-
independent apoptotic pathways are also activated in the hair follicle by chemotherapy, late
anagen skin of the C57BL/6 mice was harvested three hours after cyclophosphamide
treatment. Hair matrix keratinocytes were isolated from the control and cyclophosphamide-
treated hair follicles using laser capture microdissection system (Arcturus), and microarray
analysis was performed using Mouse Apoptosis Gene Array kit (SuperArray). Microarray data
validated by the real-time PCR revealed that cyclophosphamide treatment resulted in
upregulation of the genes encoding the selected TNF-related molecules (Fas-ligand, Tnfsf9,
Tnfsf14) and pro-apoptotic members of the Bcl-2 family (Bnip1, Bnip2 and Bim). However, the
expression of the other members of the TNF-related signaling pathways (TNF-alpha, TNF-
alpha induced proteins 1/6) and anti-apoptotic Bcl-2 gene were strongly reduced, compared
to the control. While p53 transcripts were increased three hours after cyclophosphamide
treatment, the expression levels of its target genes (Fas, Bax, p21) remained unchanged,
compared to the control. These data suggest that in addition to p53, selected members of the
TNF pathway and Bcl-2 family may also be considered as the early response markers
activated in the hair follicle keratinocytes by chemotherapy and that pharmacological
modulation of these pathways may be important for prevention of chemotherapy-induced
hair loss.
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Ligation of b4 Integrins Activates PKB/Akt and ERK1/2 by Distinct Pathways
Kippenberger S, Mu¨ller J, Guschel M, Hofmann M, Kaufmann R, Bernd A
JW Goethe University Clinic, Frankfurt/Main, Germany
In normal skin keratinocytes, expression of the a6b4 integrin is restricted to the proliferative
basal layer and mediates stable adhesion to the underlying basement membrane. Recent
findings demontrated that ligation of the b4 integin facilitated cell adhesion in carcinoma and
pre-carcinoma cells but not in normal human keratinocytes. This finding together with the
observation of a functional and spatial dissociation of a6b4 integins from the hemidesmo-
somal complex in carcinoma cells stimulated the hypothesis that b4 integrins trigger essential
signalling cascades determing cell fate. In the present study we evaluated the activation of
PKB/Akt and ERK1/2 upon b4 ligation. We found rapid phosphorylation of the anti-apototic
kinase PKB/Akt at both phosphorylation sites in the presence a b4 antibody (clone 3E1). This
signal was sensitive towards LY294002 and wortmannin indicating the relevance of PI3K.
Further upstream, dominant-negative expression of ras and EGF-R had only marginal effects
on PKB/Akt phosphorylation. Likewise to PKB/Akt, phosphorylation of the proliferation-
associated MAPK ERK1/2 was detected in response to b4 ligation. In contrast to PKB/Akt,
this activation was not sensitive towards pharmacological PI3K inhibitors, but to ectopic
expression of dominant negative ras and EGFR. Taken together these findings demonstrate
the b4 integrin as a modulator of kinases relvant in the conversion processes during
carcinogenesis.
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Expression and Activation of Keratinocyte Growth Factor Receptor Modulate the
Intracellular Production of Reactive Oxygen Species
Kovacs D, Raffa S, Flori E, Cardinali G, Torrisi MR, Picardo M
San Gallicano Dermatological Institute, Rome, Italy
Keratinocyte growth factor (KGF/FGF7) is a paracrine mediator involved in migration,
proliferation, differentiation and survival of human keratinocytes. KGF is known to exert a
protective function both in vitro and in vivo reducing the oxidative damage through the
expression of transcription factors which regulates genes involved in the detoxification of
reactive oxygen species (ROS). We analyzed the possible modulation of ROS production in
response to UV irradiation and pro-oxidant stimuli dependent on the receptor for KGF
(KGFR). The intracellular production of ROS, measured with the oxidation-sensitive
fluorescent probe 20,70-dichlorofluorescein diacetate (DCFH-DA) and confocal microscopy,
as well as the generation of an intracellular oxidative stress, based on the decrease of
catalase activity by spectrophotometric assay, were evaluated in NIH3T3 untransfected
control cells and NIH3T3 cells transfected with KGFR after exposure to UVB or pro-oxidant
agents (cumene hydroperoxide CUH, hydrogen peroxide H2O2). We observed a reduced
production of ROS in response to UVB exposure or pro-oxidant stimuli in NIH3T3/KGFR
compared to NIH3T3 control cells. Similar results were obtained performing KGF
pretreatment before the oxidative stimuli suggesting that KGFR phosphorylation and
activation play a role on ROS modulation. Moreover, we analyzed the protective role of
KGFR on a human keratinocyte cell line (HaCaT) expressing endogenous KGFR: in confluent
HaCaT cells, which express higher levels of KGFR compared to preconfluent HaCaT cells, we
observed both a significant reduction of ROS and a minor decrease of catalase activity,
confirming that the ligand induced phosphorylation and activation of the receptor are involved
in the control of intracellular ROS production.
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Nerve Growth Factor has Mitogenic and Antiapoptotic Effects on Malignant Triton Tumor
Cells
Takahashi T, Fujisawa Y, Nakamura Y, Kawachi Y, Otsuka F
Dept of Dermatology, University of Tsukuba, Japan
Malignant triton tumor (MTT) is a rare variant of malignant peripheral nerve sheath tumor
(MPNST) with rhabdomyoblastic change. Although this rare tumor shows an extremely poor
prognosis, the malignant behavior of MTTcells has not yet been evaluated in vitro presumably
deu to its rarity. In this study, we focused a role of nerve growth factor, an effector for nerve-
derived lineage cells, in MTT cells. Following the confirmation of the expression of NGF
receptor (NGF-R) on MTT cell surface, NGF effect on a mitogenic activity of MTT cells was
determined by [3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl tetrazolium bromide] colorimetric
bioassay. Proliferation of MTTcells was significantly accelerated by NGF whereas some other
growth factors did not serve as a mitogen. Cell cycle analysis also supported the mitogenic
effect of NGF which induced an increased proportion of S phase and a concomitant decrease
of G0/G1 phase. The NGF effect was efficiently attenuated by an anti-NGF-R neutralizing
antibody. Regarding other function, NGF did not elicit an invasion activity of MTT cells into
extracellular matrix, which was assessed by invasion assay using modified Boyden chamber.
NGF also failed to augment an adhesion activity of MTT cells to type I collagen, type IV
collagen and fibronectin. The results imply a participation of NGF in MTT progression via
enhancing a mitogenic activity but not an invasion activity. We previously showed an insulin-
like growth factor enhanced invasive and metastatic potential of MTT cells. NGF might
differently contribute to poor prognosis of MTT patients.
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Fibroblast Growth Factor-6 Enhances Mitogenic and Antiapoptotic Effects of Insulin-Like
Growth Factor-I on Melanoma Cells
Maki K, Takahashi T, Banno T, Kawachi Y, Otsuka F
Dept of Dermatology, University of Tsukuba, Japan
Fibroblast growth factors (FGFs) are multifunctional growth factors implicated in a variety of
developmental events. Whereas FGF-2 (basic FGF) is widely expressed in many tissues and
has been proven to play an important role in tumor progression, the relevance of other FGF
members has still been unclear. FGF-6, a protooncogene product, is expressed in both
epithelial and mesenchymal derivatives and has autocrine and/or paracrine roles. The mode
of action on mesenchymal lineages has recently been noted. We herein show that FGF-6
augmented the receptor of insulin-like growth factor-I (IGF-I), which is well known to enhance
a mitogenic activity of melanoma cells and suppress an apoptosis of them, and the related
intracellular signaling in human melanoma cells. Flow cytometry analysis showed the dose-
and time-dependent FGF-6 effect on IGF-R induction. In accordance to the finding, FGF-6
and IGF-I synergistically accelerated a mitogenic activity of melanoma cells. Furthermore,
FGF-6 enhanced the antiapoptotic effect of IGF-I on melanoma cells while FGF-6 had no
significant antiapoptotic effect. The FGF-6 effects were attenuated by anti-FGF-R neutralizing
monoclonal antibody, notably anti-FGF-R IV monoclonal antibody. The findings suggest FGF-
6 could contribute to melanoma progression via synergy with IGF-I.
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The Nicotinic Receptor Alpha-Subunits 3, 5, 7 and 9 are Differentially Regulated in Atopic
Dermatitis Skin
Kindt F1, Wiegand S1, Niemeier V1, Lo¨ser C1, Kurzen H2, Kummer W1, Gieler U1,
Haberberger R1
1Justus-Liebig-University Giessen, Germany; 2University Medical Centre, Mannheim,
Germany
The cholinergic system, which includes all acetylcholine (ACh) producing and ACh-sensitive
cells plays an important role for the integrity and function of human skin. Keratinocytes are
capable of synthesizing and releasing ACh and express various ACh-receptors. In patients
suffering from atopic dermatitis (AD) the ACh-synthesis is increased and the reaction to ACh
is changed. One reason for these changes could be differences in quantity and composition
of ACh-receptors. Nicotinic ACh-receptors (nAChR) are pentameric ligand-gated ion
channels that are involved in the regulation of skin homeostasis.
We investigated the presence of nAChR alpha-subunits at the transcriptional (quantitative
RT-PCR) and translational (immunohistochemistry) level in the skin of AD-patients and healthy
controls. The mRNAs of all investigated subunits (a3, 5, 7, 9) were found to be present and
differentially regulated in lesional, non-lesional AD and healthy skin. The expression of the a3,
7, 9, 10 subunits was reduced in AD skin. The a7-subunit expression was reduced in the
lesional area compared to the non-lesional area in 12/16 patients whereas the a3-subunit was
increased in most lesional areas. The a3, 5, 7, 9-proteins were found in neuronal as well as
non-neuronal cells of the epidermis and dermis. Comparing lesional and non-lesional skin,
changes were seen for subunits a3, 7 and 9. In healthy control skin and in non-lesional areas
of AD patients the a3-subunit was restricted to the basal layer of the epidermis whereas it
could be detected in lesional skin throughout the whole epidermis. The a7-IR was reduced in
the epidermis and dermis of lesional skin. Immunoreactivity to the a9-subunit, however, was
stronger in epidermis and dermis of lesional skin. Our results suggest that ACh and changes
in the nAChR content of the skin might be involved in the pathogenesis of AD.
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Synergistic Effect of Retinaldehyde and Hyaluronate Fragments in Skin Hyperplasia
Kaya G, Tran C, Sorg O, Hotz R, Grand D, Carraux P, Didierjean L, Stamenkovic I, Saurat JH
Geneva University Hospital, Switzerland
Retinoids are known to modulate keratinocyte differentiation and to stimulate epidermal
hyperplasia. In this study we first analyzed the effect of an association of retinaldehyde (RAL)
and intermediate hyaluronate (HA) fragments (HAFi : 50-400 kDa) on in vitro proliferation of
keratinocytes from SKH1, DBA/1 and (CD44/) mice. The combined treatment (RALþHAFi)
was more potent than RAL or HAFi alone for keratinocyte proliferation and HA production,
except for (CD44/) keratinocytes, which did not proliferate. Antibodies against HB-EGF,
erbB1 or TIMP-3 abrogated the RAL- and HAFi-induced keratinocyte proliferation. Topical
application of (RALþHAFi) for 3 days resulted in a significant epidermal hyperplasia and
keratinocyte proliferation in SKH1 and DBA/1 mice, whereas no epidermal hyperplasia and
keratinocyte proliferation was observed in (CD44/) mice. Finally we applied topical
(RALþHAFi) twice a day to the forearm skin of elderly patients showing important skin
atrophy. After 1 month of treatment, we observed a significant epidermal hyperplasia and an
increase in epidermal and dermal HA content as well as in CD44 and erbB1 amounts,
accompanied by a significant clinical improvement. Our results indicate that RAL and HAFi
show a synergy in vitro and in vivo in the proliferative response of keratinocytes, in the
increase in CD44 expression and in the production of HA and pro-HB-EGF in mouse skin, and
that the combination of RAL and HAFi seems to have a therapeutic effect in age-related
human skin atrophy.
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Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Triggers Apoptosis
and NF-kappa B Activation in Melanoma Cells through TRAIL Receptor 1 /DR4.
Kurbanov B, Geilen C, Fecker L, Orfanos C, Eberle J
Charite´ Universita¨tsmedizin Berlin, Germany
Resistance to conventional therapeutic options is crucial for high mortality of malignant
melanoma. TRAIL bears high potential as a new anticancer agent. It triggers apoptosis in
most cancer cells upon binding to its death receptors TRAIL-R1/DR4 or TRAIL-R2/DR5,
whereas normal cells were largely unaffected. For melanoma, however, only weak
responsiveness of primary cultures was reported, and in particular the role of DR4 was
neglected. For evaluating melanoma susceptibilitywe studied the functionality of DR4 and
DR5 in melanoma cells as well as their expression in vivo.
DR5 was consistently expressed in melanoma cell lines, whereas, significant
expression of DR4 was found in only 2/7 cell lines. High sensitivity to TRAIL-induced
apoptosis was characteristic for DR4-positive melanoma cells, whereas DR4-
negative cells showed less and delayed response or were resistant. Caspase
cascades were activated in sensitive cells, and significance of the mitochondrial
pathway was evident due to suppression of TRAIL sensitivity by Bcl-2 and Bcl-XL
overexpression. DR4-positive melanoma cell lines showed in addition strong
activation of nuclear factor (NF)-kappaB, whereas NF-kappaB activation remains
only weak in DR4-negative melanoma cells and normal melanocytes. Employment of
selective DR4/DR5 blocking antibodies unequivocally proved the prevalent role of
DR4 in melanoma cells. The significance of these data for the in vivo situation was
finally evaluated by immunohistochemistry, which proved for the first time significant
expression of DR4 as well as of DR5 in melanoma primary tumors.
Thus, DR4 expression in vivo and high efficiency of DR4-mediated apoptosis may
suggest reassessment of TRAIL and especially of DR4-based strategies for
melanoma treatment.
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Kinin-Induced Filaggrin Expression is Enhanced after Blocking EGF Receptor Transacti-
vation in Human Keratinocytes
Matus CE, Pavicic F, Sarmiento JM, Concha M, Vidal MA, Gonzalez CB, Figueroa CD
Universidad Austral de Chile, Chile
The expression of kinin receptors and the enzyme tissue kallikrein, that releases the
vasoactive kinin peptides from kininogens, have been reported to occur in normal human
skin. To investigate the effect of kinins on keratinocyte differentiation, cells were grown to
subconfluence on a low calcium medium and the synthesis of filaggrin was examined.
Expression of B1 and B2 receptors was investigated by RT-PCR and protein phosphorylation
was evaluated by Western blotting using antibodies to phosphotyrosine or directed to
specific tyrosine phosphorylated residues of the of EGF receptor (EGFR). Filaggrin expression
was assessed by Western blotting after 24 h stimulation with the kinin B1 (Lys-Des[Arg9]-
bradykinin) or B2 (bradykinin) receptor agonists, in the presence or absence of the EGFR
tyrosine kinase inhibitor, AG1478.
The kinin B1 receptor displayed a lower level of expression than the B2 type, but it was up-
regulated by IL-1beta, TNF alpha and IL-8. Both, kinin B1 and B2 agonists induced tyrosine
phosphorylation of proteins ranging 140 to 90 kDa. Phosphorylation was greatly reduced by
herbimycin A and the inhibitor GF109203X indicating the participation of a tyrosine kinase
and PKC in the signalling pathway. Kinin B1 and B2 agonists also triggered EGFR
transactivation. Transactivation, induced by the kinin B1 agonist, was detected by
phosphorylation on specific tyrosine residues of the EGFR, namely Tyr845, Tyr992 and
Tyr1068, but not on Tyr1045. Kinin peptides (100 nM) induced a moderated synthesis of
filaggrin that increased dramatically after blocking EGFR phosphorylation by pre-treatment of
keratinocytes with 1 mM AG1478.
Our results suggest that kinins generated in the skin may contribute to differentiation of
human keratinocytes during epidermogenesis and wound healing counterbalancing the
proliferative effects of EGF.
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Galanin Receptor Expression in Cultured Human Keratinocytes and in Normal Human
Skin
Kiss M, Dallos A, Polya´nka H, Dobozy A, Keme´ny L, Husz S
University of Szeged, Hungary
Galanin (GAL) is a biologically active neuropeptide, that is widely distributed in the central and
peripheral nervous systems. GAL exerts diverse action via the GAL receptors (GALR1,
GALR2 and GALR3), which belong in the superfamily of G-protein coupled transmembrane
receptors, that have different molecular structures and intracellular signalling mechanisms. In
human skin, GAL-like immunoreactivity has been reported in free nerve endings and fibres of
the dermis, and extra-neuronal expression of GAL has also been demonstrated. Although the
GAL receptors are essential for the biological function, their expression in cultured human
keratinocytes and in normal skin has not yet been investigated. The aim of our study was to
investigate the mRNA and protein expression of different GAL receptors in HaCaTcells and in
cultured human keratinocytes. When quantitative Real-Time PCR was used with different
GAL receptor-specific primers, only GALR2 mRNA was identified in cultured HaCaT cells and
keratinocytes. Human small intestine mRNA served as positive control. Sequencing of the
PCR products proved the presence of GALR2 mRNA in the keratinocytes. The presence of
GALR2 protein was next investigated, using a polyclonal antibody against human GALR2.
Both HaCaT cells and the cultured keratinocytes displayed specific immunohistochemical
staining, with more intensity along the cell surface of the keratinocytes. Immunohistochemical
investigations of normal human skin specimens revealed that GALR2 was expressed with
great intensity in the basal layer of the epidermis and also around the hair follicles in the
dermis. We have provided the direct biological relevance of GALR2, since an increased level
of cytosolic Ca2þ was demonstrated in GAL-treated (108 M) keratinocytes. Further studies
are necessary to clarify the biological effects of GAL in the skin.
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Enhanced Proliferation of Keratinocytes by Adenoviral Expression of Keratinocyte
Growth Factor
Toriseva M1, Metta¨la¨ T1, Peltonen J2, Ka¨ha¨ri VM1
1University of Turku, Finland; 2University of Oulu, Finland
The purpose of this study is to develop a tool to stimulate the proliferation of epidermal cells,
which is a critical event in efficient preparation of skin grafts in vitro for serious skin injury or
chronic wounds. We have constructed a replication deficient recombinant adenovirus
(RAdKGF) for the expression of keratinocyte growth factor (KGF, FGF-7), which is normally
expressed only by cells of mesenchymal origin, and specifically stimulates the proliferation of
keratinocytes. The conditioned media of fibroblasts infected with RAdKGF were examined for
production of KGF and used to treat HaCaT keratinocytes. Primary human epidermal
keratinocytes were infected with RAdKGF. Proliferation of keratinocytes was determined by
quantifying the DNA synthesis by BrdU incorporation.
Infection of primary human skin fibroblasts with RAdKGF potently stimulated the secretion
of native KGF protein (28 kDa) into the culture media. In addition, proteolytically processed
form of KGF (16 kDa) was detected, and it was in part associated with the cell layer.
Treatment with the conditioned medium of the RAdKGF-infected skin fibroblasts stimulated
the DNA synthesis of HaCaT cells by 400% in a concentration dependent manner (0.15–7.5
ng/ml) and more potently than human recombinant KGF (5–20 ng/ml). Infection of human
epidermal keratinocytes with RAdKGF (MOI 5-40) also resulted in potent production of KGF
and in stimulation of keratinocyte proliferation in an autocrine manner by up to 100% 72 h
after adenoviral infection.
These results show that adenoviral expression of KGF by dermal fibroblasts and epidermal
keratinocytes potently stimulates proliferation of keratinocytes in a paracrine and autocrine
manner, respectively. These results provide evidence, that adenoviral delivery of KGF can be
used for large scale production of epidermal keratinocytes in vitro and in organotypic cultures
for skin grafting.
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Loss of Foxp3þ Cells in Skin and Peripheral Blood Separates Se´zary Syndrome from
other Cutaneous T-cell Lymphomas
Klemke CD1, Fritzsching B1, Franz B1, Kleinmann E1, Oberle N1, Poenitz N2, Sykora J3,
Goerdt S2, Krammer PH1, Suri-Payer E1
1Deutsches Krebsforschungszentrum, Germany; 2Universita¨tsklinikum Mannheim, Germany;
3Ruprecht-Karls-Universita¨t Heidelberg, Germany
Cutaneous T-cell lymphomas (CTCL) are mainly comprised of two variants: mycosis
fungoides (MF) with CD4þ tumour cells confined to the skin and the leukemic Se´zary
syndrome with tumour cell spread to the blood. A recent study suggested that CTCL is a
malignant proliferation of regulatory T cells (Treg) because CTCL tumour cells could under
certain circumstances in vitro become FOXP3þ , the currently best identified marker of Treg.
However, it remains unclear if FOXP3þ CTCL cells exist in vivo and if FOXP3 might serve as a
CTCL tumour cell marker. Therefore, we investigated FOXP3 expression in 29 CTCL patients
and 16 control patients with chronic inflammatory skin diseases (eczema and psoriasis).
Immunohistochemical analysis revealed significantly lower numbers of CD4þFOXP3þ cells
within the dermal lymphomononuclear infiltrate of Se´zary patients (calculated 12% FOXP3þ
cells of CD4þ cells) in contrast to other CTCL (including MF [43% FOXP3þ cells of CD4þ
cells, po0.05]) and inflammatory skin diseases (38%). Furthermore, CD4þCD25þFOXP3þ
T cells were also markedly reduced in peripheral blood of Se´zary patients compared to
controls as determined by FACS, quantitative PCR, and functional analysis of Treg
characteristics. Our data collectively indicate that CTCL tumour cells are not of Treg origin
suggesting that in indolent CTCL forms (MF) the increase of FOXP3þ cells denotes an
accumulation of Treg. This conclusion is also supported by the fact that inflammatory skin
diseases accumulate similar numbers of Treg in the skin. In contrast, Se´zary syndrome is the
first reported disease with a clear reduction in Treg cell numbers. Therapeutically, this loss of
Treg could possibly be counteracted by extracorporeal photopheresis which was recently
shown to induce antigen-specific Treg.
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Severe and Long-Standing Psoriasis is Associated with an Increased Prevalence and
Severity of Coronary Artery Calciﬁcation
Ludwig R1, Herzog C1, Rostock A1, Fichtlscherer S1, Scha¨chinger V1, Ochsendorf F1,
Zollner T2, Kaufmann R1, Vogl T3, Boehncke WH1
1Klinikum der JW Goethe University, Frankfurt/Main, Germany; 2RBA Dermatology, Berlex
Biosciences, USA; 3JW Goethe University, Dept of Radiology, Germany
Background: Psoriasis is a chronic-inflammatory skin disease affecting approximately 1.5%
of the western population. As inflammatory processes have been recognized to significantly
contribute to cardiovascular disease, we thought out to determine the prevalence and degree
of coronary artery calcification (CAC) in patients with psoriasis opposed to a matched control
population.
Methods: Between 2000 and 2004, 32 patients with severe and long-standing psoriasis
patients were enrolled. Patient population was matched for age, sex and known risk factors
of coronary artery disease to an equally sized control population. All participants underwent
multi-slice computer tomography (CT) for evaluation of CAC, and were free of any past or
present cardiovascular disease.
Findings: Patients were successfully matched for age, sex, smoking, diabetes, body-mass
index (BMI) total cholesterol and triglycerides, but not for family history of cardiovascular
disease, which had a greater prevalence in the control population. Despite this bias,
prevalence and severity of CAC were higher in patients with psoriasis (prevalence: 59.4% vs.
28.1% - unadjusted odds ratio of 2.11 and p¼ 0.015 considering the assessed risk factors in
a multiple linear regression; median CAC score according to Agatston 3.7 vs. 0.0, p¼ 0.009
McNemars test).
Interpretation: These findings substantiate data from retrospective analyses, showing an
increased risk for cardiovascular mortality in patients with severe psoriasis. While many
attractive hypothesis, e.g. the chronic inflammatory response or the activated state of
platelets, offer explanations for the observed increase in CAC, our findings may help to
understand psoriasis as a general, rather than a local (skin) disease.
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Array CGH Analysis Reveals Recurrent Chromosomal Alterations and Prognostic
Parameters in Primary Cutaneous Large B-Cell Lymphoma
Dijkman R, Szuhai K, Knijnenburg J, Jordanova E, Willemze R, Vermeer M, Tensen C
Leiden University Medical Center, The Netherlands
Purpose: To evaluate the clinical relevance of genomic aberrations in primary cutaneous
large B-cell lymphomas (PCLBCL).
Patients and Methods: Skin biopsy samples of 31 patients with a PCLBCL classified as either
primary cutaneous follicle center lymphoma (PCFCL; n¼ 19) or PCLBCL, leg type (n¼ 12)
according to the WHO-EORTC classification, were analyzed using array-based comparative
genomic hybridization, fluorescence in situ hybridization (FISH) and methylation status of
promoter regions.
Results: The most recurrent alterations in PCFCL were high-level DNA amplifications at
2p16.1 (63%) and deletion of chromosome 14q32.33 (68%). FISH analysis confirmed REL
amplification in patients with gains at 2p16.1. In PCLBCL, leg, most prominent aberrations
were a high-level amplification of 18q21.31-q21.33 (67%), including the BCL-2 and MALT1
genes as confirmed by FISH, and deletions of a small region within 9p21.3 containing the
CDKN2A, CDKN2B and NSG-x genes.
Homozygous deletion of 9p21.3 was detected in 5/12 PCLBCL, leg, but in 0/19 PCFCL.
Complete methylation of the promoter region of the CDKN2A gene was demonstrated in one
PCLBCL, leg patient with hemizygous deletion, one patient without deletion, but in 0/19
PCFCL. Seven of eight PCLBCL, leg patients with deletion of 9p21.3 and/or complete
methylation of CDKN2A died of lymphoma.
Conclusion: Our results demonstrate prominent differences in chromosomal alterations
between PCFCL and PCLBCL, leg (type), which supports their classification as separate
entities within the WHO-EORTC scheme. Inactivation of CDKN2A either by deletion or
methylation of its promoter is an important prognostic parameter for the group of PCLBCL, leg.
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Sentinel Lymph Node Biopsy is a Major Prognostic Factor in the Staging of Malignant
Melanoma even Long Period after Primary Excision
Gerber PA1, Homey B1, Braunstein S2, Ruzicka T1, Schulte KW1
1Dept of Dermatology, Heinrich-Heine-University Du¨sseldorf, Germany; 2Dept of Pathology,
Heinrich-Heine-University Du¨sseldorf, Germany
Malignant melanoma is a highly aggressive tumor with a strong tendency to metastize to local
draining lymph nodes (LN). In the late 1980s Morton et al. developed the concept of sentinel
lymph node biopsy (SLNB) to detect patients in the stadium of micrometastatic lymphatic
disease. Since then SLN status has been found to be among the strongest prognostic factors,
and has become a standard procedure in the staging of primary melanoma. SLNB is
recommended to be performed within the first 4 weeks after excision of the primary tumor.
Since the concept of SLNB is relatively new, significant numbers of patients present at
operative centers who have undergone melanoma excision, but not SLNB within the
recommended time period.
The aim of the present study was to investigate whether SLNB is reliable, even if performed
months (o4 month) after excision of the primary tumor. Between 2001 and 2003, SLNB was
performed in 10 melanoma patients who had not undergone SLND within the first 4 weeks
after excision of the primary tumor. Time periods between melanoma excision and SLND
ranged from 4 up to 64 months. SLNs could be identified in all patients, histopathological
analysis showed evidence for melanoma micrometastases in 9 out of 10 patients. Of these,
positive SLNs could be identified in 9 cases (90%).
Our study for the first time shows that SLNB can be performed successfully even long
period (4 up to 64 month) after excision of the primary tumor, providing this main prognostic
option for patients who have not undergone SLND in the first place.
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The Psoriasis-Associated S100A15 is Regulated by Cytokines, UVB Radiation, and
Bacterial Microbes
Bu¨chau AS1, Lewrenz V1, Wolf R2, Ruzicka T1, Walz M1
1Heinrich-Heine-Universita¨t Du¨sseldorf, Germany; 2Center for Cancer Research, NCI, USA
Members of the S100 family are low molecular proteins characterized by Ca2þ -binding EF-
hands motifs. S100 proteins were found to be overexpressed in psoriasis, wound healing, and
skin cancer. It is assumed that these proteins play a role in Ca2þ -dependent differentiation
and proliferation, chemotaxis, signal transduction and innate immunity. Recently, we
identified and characterized a new member of the human S100 family. We detected two
transcripts, a short (S100A15S; 0.5 kb) and a long isoform (S100A15L; 4.4 kb) both
overexpressed in psoriatic skin in comparison to normal skin. The aim of this study was to
investigate the effect of different stimuli on the mRNA-expression of S100A15. We performed
RT-PCR analysis specific for both S100A15 transcripts to study i), Th1- and Th2-type
cytokines, ii) ultraviolet (UV)B radiation, and iii) bacterial stimulation in primary keratinocytes.
We found the S100A15L-mRNA upregulated by TNF-a, IFN-g, and IL-1b 6and 24 hours after
stimulation. Incubation with IL-4 resulted in a downregulation of S100AS15L-mRNA after 24
hours. S100A15S was downregulated by TNF-a after 1 hour and by IL-1b and IL-13 after 6
hours. UVB radiation of primary keratinocytes was performed with 50, 200, and 400 J/m2. An
upregulation of mRNA-expression of S100A15 was observed 4 and 24 hours after UVB-
treatment of the keratinocytes with 200 and 400 J/m2. After stimulation of keratinocytes with
Escherichia coli, Staphylococcus aureus, Streptococcus epidermidis, and Pseudomonas
aerigunosa for 3 and 24 hours an upregulation of S100A15-mRNA wae observed. These data
are the first to demonstrate that S100A15 is upregulated by Th-1-type cytokines and IL-1b,
UVB radiation, and bacterial microbes indicating that S100A15 is involved in innate immunity
responses. Further experiments will elucidate the function oh this novel protein and its
specific role in psoriasis.
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Dimethyl Fumarate (BG00012) as an Oral Therapy for Moderate to Severe Psoriasis:
Results of a Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
Mrowietz U1, Spellman M2
1University of Kiel, Germany; 2Biogen Idec, Inc., USA
The efficacy and safety of oral dimethyl fumarate in a microtablet formulation (BG00012) was
evaluated in a multicenter, randomized, double-blind, placebo-controlled trial in patients with
moderate to severe psoriasis vulgaris (mean PASI: 18.2) in 5 European countriesy. BG00012
was administered orally as 240 mg (2  120 mg) three times daily (daily dose: 720 mg) for 16
weeks. A total of 105 patients received BG00012 and 70 received placebo. The primary
efficacy endpoint was PASI at Week 16, and the percentage PASI reduction was calculated.
Safety assessments included laboratory monitoring and adverse events.
At Week 16, BG00012-treated patients showed a median PASI reduction of 67.8%
compared to 10.2% in the placebo group. At Week 12, the median PASI reduction was 59.1%
in the BG00012 group (placebo: 13.3%). At Week 16%, 65% of the BG00012-treated patients
achieved PASI 50% and 39% achieved PASI 75 (14% and 1%, respectively, for placebo).
Gastrointestinal (GI) side effects were reported in 58% of the BG00012-treated patients
compared to 23% in placebo patients. Eighty- two percent of these GI complaints were
classified as mild to moderate in severity. Flushing was reported by 42% of patients in the
BG00012 group (placebo: 9%). There were no clinically relevant trends to abnormal values in
hematology, chemistry, renal, or hepatic function studies.
Dimethyl fumarate seems to mediate its anti-psoriatic effect by modulation of nuclear
factor kappa B (NFkB)-activity through an interaction with the glutathione-system. This
modulation can be regarded as a safe measure to balance the disturbed immune and
inflammatory response in psoriasis skin. The results of this multicenter study indicate that
BG00012 is a highly efficacious oral treatment for moderate to severe psoriasis vulgaris with a
favourable tolerability profile.
yParticipating centres: Sweden: Stockholm; Denmark: Aarhus; The Netherlands: Nijmegen;
France: Nice; Germany: Berlin, Dresden, Frankfurt, Go¨ttingen, Kiel, Tu¨bingen.
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Phase II Study of a Human anti-Interleukin (IL)-12/IL-23 Monoclonal Antibody in the
Treatment of Psoriasis
Langely RG1, Lebwohl M2, Leonardi C3, Yeilding N4, Guzzo C4, Wang Y4, Dooley L4, Krueger
GG5
1Dalhousie University, Canada; 2Mount Sinai School of Medicine, USA; 3St. Louis University,
USA; 4Centocor, Inc., USA; 5University of Utah Health Sciences Cente, USA
Purpose: We report the results of a Phase II study of CNTO 1275 (human monoclonal
antibody against the p40 subunit of IL-12 and IL-23) in the treatment of psoriasis.
Methods: Safety and efficacy of CNTO 1275 were studied in 321 patients (Pts) with moderate
to severe psoriasis in a double-blinded, placebo-controlled study. Pts were randomized to
placebo (PBO) or subcutaneous CNTO 1275: a single 50 mg dose (50 mg), a single 100 mg
dose (100 mg), 50 mg weekly  4 (200 mg), or 100 mg weekly  4 (400 mg). Pts in the CNTO
1275 groups received a dose at week 16 if they had a PGA score  3. Pts in the PBO group
received 100 mg of CNTO 1275 at week 20.
Results: The proportions (number) of Pts who achieved PASI-75 at week 12 in the 50 mg, 100
mg, 200 mg, and 400 mg arms were 51.6%(33/64), 59.4% (38/64), 67.2% (43/64), and 81.3%
(52/64), respectively, vs 1.6% (1/64) in PBO (po0.001 vs PBO) 23.4% (15/64), 29.7% (19/64),
43.8% (28/64), and 51.6% (33/64) of Pts in these respective groups achieved PASI-90 vs
1.6% (1/64) in PBO. CNTO 1275-treated Pts had significant improvements in quality of life
compared to PBO. 79.4% of CNTO 1275-treated Pts experienced at least one adverse event
(AE) compared to 71.6% in PBO through the PBO-controlled portion of the trial. The
proportion of Pts experiencing AEs did not increase with dose, and AE frequency in the 400
mg group was similar to PBO. Serious AEs were reported in 3.6% of CNTO 1275-treated Pts
and 1.5% in PBO.
Conclusions: CNTO 1275 appears highly effective and well-tolerated in the short-term
treatment of psoriasis. Additional studies to evaluate long-term safety and efficacy are
warranted.
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Higher Transcriptional Expression of Steroidogenic Acute Regulatory Protein and Type I
5a-Reductase in Scalp of Men with Androgenetic Alopecia
Chen W1, Liao CY1, Tsai RY2, Tsai SJ3
1Chang Gung Memorial Hospital, Kaohsiung, Taiwan; 2Wan Fang Hospital, Taipei Medical
University, Taipei, Taiwan; 3College of Medicine, National Cheng Kung University, Taiwan
Androgenetic alopecia can be defined as an androgen-dependent process with continuous
miniaturization of androgen sensitive hair follicles. Higher levels of androgen receptors and
5a-reductase type I and II have been demonstrated in frontal hair follices than in occipital
follicles. Factors controlling de novo synthesis of androgens from cholesterol, however,
remain largely undefined.
Objective: To determine the transcriptional levels of genes encoding steroidogenic acute
regulatory protein, P450 side chain cleavage enzyme, P450 17a-hydroxylase and 3b-
hydroxysteroid dehydrogenase in the frontal versus occipital scalps of patients with
androgenetic alopecia. Expression of aromatase, the type I and type II 5a-reductase was
also evaluated.
Methods: 50 male patients aged between 22–58 years (mean¼ 36) with androgenetic
alopecia at stage II-V according to the modified Norwood/Hamilton classification were
examined. Pair specimens were taken from the bald frontal-parietal and hairy occipital scalp
of each subject and the mRNA levels of the aforementioned seven enzymes were analyzed by
quantitative, competitive RT-PCR with standard-curve methodology.
Results: A higher level of steroidgenic acute regulatory protein was found in the bald versus
occipital scalp (po0.05). There was no difference in the expression of P450 side chain
cleavage enzyme, p450 17a-hydroxylase and the type II 3b-hydroxysteroid dehydrogenase.
Expression of the type I 5a-reductase was higher in bald scalp than in occipital scalp, while
the type II 5a-reductase showed reverse pattern. The amount of aromatase mRNA was
beyond the detection limit.
Conclusion: Regulation of the cutaneous de novo synthesis of androgen from cholesterol
seems to play some role in the pathogenesis of androgenetic alopecia in men.
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Inhibition of Fatty Acid Oxidation Prevents the Development of Psoriasis in the
Humanized Transplant Model of Psoriasis
Caspary F1, Elliott GR2, Nave B1, Verzaal P1, Rohrbach M3, Nieland JD3
1Medigene AG, Martinsried, Germany; 2Derphartox, Delft, The Netherlands; 3TNO Pharma;
Leiden, The Netherlands
Fatty acid metabolites and intermediates of fatty acid oxidation are able to stimulate the
immune system and keratinocyte proliferation. Actively proliferating keratinocytes also have a
high demand for energy and depend on fatty acid oxidation to provide this. Carnitine
palmitoyl transferase (CPT-1) activity, an enzyme crucial for fatty acid oxidation, is up-
regulated in psoriasis lesions compared to both healthy and non-involved psoriasis skin. We
hypothesized that blocking fatty acid metabolism and specifically CPT-1 activity, could be
beneficial in treating psoriasis. To test this hypothesis we investigated the effect of Etomoxir,
a dermal CPT-1 inhibiter, in a humanized psoriasis model (see Elliott et al, A humanized
mouse model of psoriasis for the routine testing of new drugs). A psoriasis lesion was induced
in non-lesional psoriasis skin transplanted onto BNX mice by injecting super-antigen
activated autologous PBMCs intra-dermally into the transplants. The transplants were then
treated topically for 3 weeks with Etomoxir or betamethasone propionate (BMP) as a positive
control. Placebo treated transplants had an average epidermal ridge thickness of 138  24
mm. and a proliferation rate (Ki-67 expression) of 55  37 positive cells/unit-length.
Treatment with BMP significantly reduced average epidermal ridge thickness to 81  9 mm
and the number of Ki67 positive cells to 10  6 positive cells/unit-length. The epidermal
ridges of transplants treated with 30% and 1% Etomoxir were 69  4 mm and 88  10 mm,
respectively. There were similar reductions in Ki67 expression.
Our data indicate that blocking fatty acid oxidation with Etomoxir is at least as efficacious
as a general immune/inflammatory blockade. The finding that inhibition of fatty acid oxidation
limits the development of psoriatic changes in the transplant model of psoriasis opens up
new therapeutic options for the treatment of this disease.
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Glycosaminoglycans Inhibit the Antibacterial Action of LL-37 in Biological Fluids
Baranska-Rybak W1, Sonesson A2, Nowicki R1, Schmidtchen A2
1Medical University, Gdansk, Poland; 2Medical University Lund Sweden
The antibacterial activity of antimicrobial peptides is influenced by various factors such as
salt content, pH, and presence of proteins. In this study, we explored the antibacterial action
of the human cathelicidin LL-37 in physiologically relevant conditions, i.e. various human
wound fluids, human plasma fractions and serum. Radial diffusion assays using Staphylo-
coccus aureus and Escherichia coli were employed for the study of antibacterial effects of LL-
37 in presence of 12 different wound fluids, citrate-, heparin-, or EDTA-plasma, or human
serum. Glycosaminoglycan content of wound fluids was determined by an Alcian blue-
binding assay. Protein content of wound fluids was measured by the Bradford method. A slot-
binding assay was used to study effects of inhibitors of the interaction between LL-37 and
glycosaminoglycans. Five of twelve wound fluids derived from acute wounds showed marked
inhibitory effects on the antibacterial action of LL-37. The inhibition was significantly
correlated to high wound fluid glycosaminoglycan content. Analogous to these findings,
heparin-plasma strongly inhibited the antibacterial effect of LL-37. The interaction between
LL-37 and glycosaminoglycans was abrogated by the cationic polymers DEAE-dextran and
chitosan, yielding increased activity of LL-37. Thus, glycosaminoglycan-rich biological fluids
inhibit the antibacterial effects of LL-37. Furthermore, polycations that bind to glycosami-
noglycans increase the antibacterial activities of endogenous antimicrobial peptides in
glycosaminoglycan-containing biological fluids.
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Prevention of Corticosteroid-Induced Skin Atrophy by Retinaldehyde in Mouse
Kaya G, Tran C, Sorg O, Grand D, Hotz R, Carraux P, Didierjean L, Saurat JH
Geneva University Hospital, Switzerland
Topical application of retinaldehyde (RAL) increases the expression of CD44 in mouse skin.
The increased expression of CD44 accompanying epidermal hyperplasia induced by topically
applied RAL is associated with an increase in epidermal and dermal hyaluronate (HA) and
with increased expression of hyaluronate synthases. It was previously shown that tretinoin
could prevent corticosteroid-induced skin atrophy in hairless mice. In this study, we
examined the preventive effect of topical RAL on corticosteroid-induced skin atrophy in
hairless mice. Mice were treated dorsally for 3 weeks in the morning and afternoon (AM:PM)
as follows: 1) vehicle : vehicle, 2) steroid (0.05% clobetasol propionate) : vehicle, 3) steroid:
0.05% RAL. Topical application of the steroid caused an epidermal and dermal atrophy as
determined by epidermal and dermal thickness measurements and by quantitation of Ki67 in
the back skin of SKH1 hairless mice. Topical application of RAL not only prevented the
steroid-induced skin atrophy but also resulted in an epidermal hyperplasia, induced the CD44
RNA and protein expression in the follicular and interfollicular epidermis and increased the
epidermal HA, as determined by Northern blot analysis, immunohistochemistry and ELISA,
respectively. We conclude that RAL has the ability to prevent steroid-induced skin atrophy
and to induce an epidermal hyperplasia, CD44 expression and HA production in the presence
of the steroid in hairless mouse.
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A Topical Retinoid X Receptor (RXR) Antagonist Exerts Anti-inﬂammatory Activity in
Inﬂammation-induced Human Models in vivo: a Proof of Concept Study
Tran C, Milingou M, Sorg O, Saurat JH
Geneva University Hospital, Switzerland
BAL10092, a new retinoid X receptor antagonist, was shown to penetrate into the mouse skin
easily and to decrease the inflammation induced by topical 9-cis retinoic acid (9cRA) or 12-O-
tetradecanoylphorbol-13-acetate (TPA). In this clinical trial, we asssessed the antiinflamma-
tory potential of topical BAL10092 using 4 non-invasive inflammation models. The
antiinflammatory effect was monitored using quantitative criteria (area of inflammation,
cutaneous thickness by ultra-sonography and erythema intensity by colorimetry). BAL10092
1% was compared to vehicle treated controls, and to the topical steroids betamethasone
dipropionate 0.05% (BM) and/or clobetasone butyrate 0.05% (CB).
A cutaneous inflammation was induced on 7 volunteers (mean age: 32  13 yrs) by an
intradermal injection of candidin. Compared to vehicle, topical BAL10092 and CB decreased
the area of inflammation by 15% and 18%, and the cutaneous thickness by 30% and 3%,
respectively. An erythema was induced in 5 volunteers (mean age: 28  7 yrs; skin phototype
II-III; mean MED: 89  9 mJ/cm2) by exposing a defined area of skin to a single dose of 2
MED UVB. The inflammation-induced cutaneous thickness was reduced by 12% by topical
BAL10092%, 6% by CB and 18% by BM. An immediate non-immunological contact
dermatitis was induced in 14 volunteers (mean age: 24  4 yrs) by topical methyl nicotinate
(MN). The inhibition of this inflammation was monitored for up to 60 minutes after
inflammation elicitation. Topical BAL10092 decreased the inflammation-induced cutaneous
thickness to the same extent as did BM (32%), and inhibited the erythema induced by MN. In
the atopy patch test we applied topical BAL10092 under occlusion for 3 days on 10 atopic
volunteers (mean age: 30  11 yrs). BAL10092 decreased skin infiltration by 58%,
compared to pimecrolimus 1% (35%) and CB (39%), but none decreased the erythema.
This pilot study demonstrates that RXR antagonists could represent a new class of topical
anti-inflammatory drugs.
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Home UVB Phototherapy for Psoriasis: As Equally Effective as Outpatient UVB
Phototherapy. Results of a Single-Blind Randomised Trial
Koek M, Buskens E, Bruijnzeel-Koomen C, Sigurdsson V
University Medical Center Utrecht, The Netherlands
Home ultraviolet B (UVB) phototherapy for psoriasis is a much debated treatment, especially
with regard to alleged suboptimality and side-effects. Despite all discussions no randomised
research has been performed yet, and only two studies compare two groups of patients.
However, the scarce literature and guidelines on the subject suggest being reluctant with this
treatment, while home UVB phototherapy is increasingly being prescribed.
To solve the issue we conducted a single-blind randomised trial in 16 hospitals. 196
patients with psoriasis who were clinically eligible for narrowband (TL-01) UVB phototherapy
were included. Participants were randomised into two groups: either home UVB
phototherapy or UVB phototherapy in an outpatient setting. Effectiveness of both treatments
was measured using differences in the Psoriasis Area and Severity Index (PASI) and the Self-
Administered PASI (SAPASI). Short term side-effects were reported using a diary.
Treatment effect (decline in (SA)PASI) was significant for both groups (all p-valueso0.001).
Between both treatment-groups no difference in treatment effect was found (p-values
between 0.30 and 0.48). At inclusion both groups had comparable psoriasis severity (PASI
7.05 vs. 8.40, p¼0.276 and SAPASI 7.33 vs. 7.18, p¼0.766). At the end of the therapy also
no difference was detected (PASI 2.10 vs. 2.20, p¼ 0.620, and SAPASI 1.45 vs. 1.18,
p¼ 0.136). Side-effects were reported for less than 6% of all irradiations. Both treatment-
groups reported side-effects in the same frequencies (p-values between 0.241 and 0.807).
In conclusion: home UVB photoherapy for patients with psoriasis is as equally effective as
UVB phototherapy in the hospital, and the frequency of side-effects does not differ between
both treatments.
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Peptide Epitopes Derived from Tumor Stroma-Associated Antigens CD105 and FAPa for
Cancer Immunotherapy
Hofmeister V, Ullrich R, Becker JC
Julius-Maximilians-University Wu¨rzburg, Germany
The development and progression of tumors is dependent on the active contribution of
stromal cells, i. e. fibroblasts, endothelial cells, and macrophages, e. g. in secreting growth
factors, proteolytic enzymes or angiogenic factors. Therefore, harnessing the immune system
against tumor stroma-associated antigens (TSAAs) selectively induced or upregulated in the
tumor microenvironment may help to control tumor growth. In contrast to cancer cells, stroma
cells are genetically more stable, hence focusing on the stroma for anti-tumor therapy avoids
treatment resistance. In addition, induction or upregulation of TSAAs is a universal
phenomenom in carcinogenesis; thus, therapies designed to target TSAAs should be widely
applicable.
Our goal was to identify TSAAs that can be used to induce an immunological anti-tumor
response. As a first step we analysed expression of CD105 (endoglin) and fibroblast
activation protein (FAPa, seprase) in normal skin, nevi, and melanoma by immunohistochem-
istry. As described by other groups CD105 was mainly expressed on tumor endothelial cells
and FAPa in cancer-associated fibroblasts (CAFs), but CD105 was also found on some CAFs
and, more important, FAPa was also expressed by nevus and melanoma cells. Subsequently,
we applied reverse immunology and tested peptide epitopes derived from these TSAAs for
their capacity to bind to MHC class I molecules. This analysis revealed seven FAPa and nine
CD105 peptides with intermediate binding affinity. Exchange of anchor amino acids in some
low affinity peptides significantly enhanced their binding affinity. Preliminary functional tests
(ELISPOT) with selected peptides allowed the in vitro induction of FAPa-peptide specific T
cells in PBMC of melanoma patients. These results encourage further efforts to establish the
immunogenicity of TSAAs for future clinical trials.
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Expression Pattern of the Lymphatic and Vascular Markers VEGFR-3 and CD31 does not
predict Regional Lymph Node Metastasis in Cutaneous Melanoma
Wobser M, Siedel C, Schrama D, Broecker EB, Becker JC, Vetter CS
Julius-Maximilians-University Wu¨rzburg, Germany
Malignant melanoma of the skin preferentially metastasises via the lymphatic system.
Established prognostic factors for the risk for lymph node metastases include tumor
thickness and ulceration. However, these morphological criteria often do not accurately
assess metastatic potential. Novel molecular biomarkers, which are involved in malignant
transformation, proliferation, angiogenesis and lymphangiogenesis, are currently under
investigation to elucidate the risk for lymph node metastasis. To this end, the vascular
endothelial growth factors VEGF-C and VEGF-D have been identified to promote
lymphangiogenesis through activation of its receptor VEGFR-3, leading to an increased
lymphatic spread to regional lymph nodes and a reduced survival rate.
Prompted by this observation, we analysed expression of VEGFR-3 together with the
panvascular marker CD31 in cutaneous malignant melanoma (n¼ 26) and correlated these
findings with sentinel lymph node (SLN)-status. In contrast to other studies, we observed an
inverse correlation between the expression of these markers and the lymph node status.
Additionally, no difference between intratumoral versus peritumoral CD31-expression or
VEGFR-3 expression on blood vessels versus lymphatic capillaries could be detected.
Hence, in our series VEGFR-3/CD31 immunohistochemical staining of primary melanoma
does not serve as a valid marker to predict lymph node involvement. As lymphatic spread is a
complex, multi-step process, several different biomarkers should be combined to define new
prognostic subgroups in cutaneous melanoma which may then presuppose further diagnostic
procedures, i.e. SLN-biopsy, or an intensified treatment regimen.
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Skin Perfusion Follows Non-Linear Laws
Ha¨fner H1, Bra¨uer K2, Eichner M3, Stroelin A1, Ro¨cken M1
1University Hospital Tu¨bingen, Germany; 2Institute of Theoretical Physics Tu¨bingen,
Germany; 3Department of Medical Biometry, Tu¨bingen, Germany
Complex systems regulate interactions inside systems responsible for neuronal networks,
growth and blood flow. Various mathematical models have been developed for decoding non-
linear systems, such as akin blood flow, yet with little success. Based on recent studies in
decoding Gene arrays using Wavelet analysis we extended this approach to more complex
in vivo systems in decoding the rules determining tissue perfusion. There we investigated
rhythmic changes of dermal perfusion in healthy volunteers, using Wavelet transformation. We
examined the influence of heart beat, respiration or skin temperature represented in Laser
Doppler Flux signals, and measured their contribution to different rhythmic changes. We found
that tissue perfusion is governed by six closely connected, overlying waves with different
degrees of freedom. The major determinant is skin temperature responsible for 68.5% of the
influence. Surprisingly, though indispensable for blood flow, respiration and heart beat
contributed to less then 2.5% of the vasomotion. The missing undefined 29% are contributed
to the scaling levels between 0.056 to 0.16 Hz that might be derived from the neurovegetative
system. Yet further analysis is needed to identify this second major wave. The application of this
novel analysis method allows identifying mechanisms regulating skin perfusion which will greatly
facilitate the diagnosis of a variety of vascular diseases. These insights have major relevance for
heart transplantation and disturbances in microsvasculation.
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Occult Melanoma Cells in Sentinel Lymph Nodes
Ulmer A, Fischer J, Schanz S, Breuninger H, Sotlar K, Fierlbeck G, Klein Ch
University Hospital Tu¨bingen, Germany
We investigated whether a novel immuncytochemical approach could improve detection of
disseminated tumor cells in sentinel lymph nodes from melanoma patients in comparison to
routine histopathology. In a prospective study we examined 494 sentinel lymph nodes from
358 consecutive melanoma patients who underwent sentinel lymph node biopsy and 59
lymph nodes from nonmelanoma patients. One part of the lymphatic tissue was diaggregated
mechanically into a single cell suspension and examined after immunocytochemical staining
with the antibodies HMB45 and Melan A, one half was examined by standard histopathology
including immunohistochemistry. Additionally 30 immunocytochemically positive cells were
examined by single cell comparative genomic hybridisation.
159 of 358 patients (44%) were positive by HMB45 immunocytochemistry while
histopathology detected metastatic disease in 43 patients (12%). None of the 59 control
lymph nodes were positive by HMB45 immunocytochemistry. Chromosomal aberrations were
detected in 24 of 30 cells examined (80%). Interestingly 15 of these cells were isolated from
histopathologically negative nodes and in some cases contained the full range of
chromosomal aberrations typical for fully metastatic cells. Both the number of immunocy-
tochemically positive samples and the number of positive cells in the sentinel node correlated
with the thickness of the primary tumor (p¼ 0.001 and Po0.001 respectively) strongly arguing
for the clinical relevance of the method.
We conclude that immunocytochemical detection of melanoma cells in the sentinel lymph
node is superior to standard histopathology. Immunocytochemistry in combination with a
single cell comparative hybridisation may provide the basis for studying the clinical
significance of low volume metastastic disease in the sentinel node and may help to define
genomic changes associated with early progression of melanoma.
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Circulating Tumor Cells in Melanoma Patients
Fierlbeck G, Ulmer A, Fischer J, Klein Ch
University Hospital Tu¨bingen, Germany
The aim of our study was to quantitatively detect circulating melanoma cells, to assess their
prognostic significance and to describe their genomic characteristics.
In a prospective study blood samples were taken from 164 patients with cutaneous or uveal
melanoma and from 50 controls. Circulating melanoma cells were detected using the murine
monoclonal antibody 9.2.27 combined with immunomagnetic enrichment. We carried out a
genetic characterisation of antigen positive cells using single-cell comparative genomic
hybridisation on the DNA of 15 individually isolated antigen positive cells from 7 patients.
Detection of circulating melanoma cells was associated with the clinical stage of the patient
and with the tumor load. All controls were negative. The finding of two or more cells
correlated significantly with a reduced survival of patients with metastatic melanoma. All cells
that were analyzed by comparative genomic hybridization displayed multiple chromosomal
changes. Chromosomal changes associated with a poor prognosis in primary tumors such as
gains of 6p in cutaneous melanoma and monosomy three in uveal melanoma were among the
most frequent chromosomal changes detected in individually isolated circulating melanoma
cells.
We conclude that circulating melanoma cells displaying multiple genomic changes may be
detected in peripheral blood of melanoma patients. The prognostic impact on survival of
metastatic patients apparently reflects the aggressiveness of an ongoing hematogenous
tumour spread. Direct genomic analysis of the isolated cells will help to further clarify the
molecular-genetic basis of the establishment of generalized melanoma.
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Cell Cycle Regulation in Psoriasis
Belso˜ N1, Sze´ll M2, Pivarcsi A2, Polya´nka H2, Dobozy A2, Keme´ny L2, Bata Zs2
1University of Szeged 1, Hungary; 2University of Szeged 2, Hungary
Psoriasis is a chronic inflammatory skin disease characterized by the hyperproliferation of the
normally quiescent basal keratinocyte population which contains the keratinocyte stem cells.
Abnormal expression of several cell proliferation related genes as well as their protein
products have been described in psoriasis, such as a5 integrin and KGF. Previously we have
shown that the G0-G1/S phase of the keratinocyte cell cycle is characterized by the
appearance of D1-type cyclin, while during the repeated rapid turnover of highly proliferating
cells the expression of cyclin D2 and D3 dominate. We have also demonstrated that blocking
a5 integrin in HaCaT keratinocytes down-regulates the expression of D1 cyclin. Here we
compared the expression of D-type cyclins in lesional psoriatic, non-lesional and normal
epidermis, and examined whether KGF could regulate the activity of the a5 integrin promoter
in highly proliferating HaCaT keratinocytes. In chronic plaques of lesional psoriatic epidermis
a significant increase was measured in D2 and D3 cyclin mRNA expression compared to non-
lesional and normal epidermis, while the expression of D1 cyclin mRNA showed no
difference. At the protein level however we found no difference in the D type cyclins
expression between the psoriatic lesional, non-lesional and normal epidermis. In all samples
the D1 and D2 cyclins expressing cells were low, but D3 was expressed by a larger
percentage of the cells. In HaCaT keratinocytes transfected with a5 integrin promoter fused
to the luciferase reporter gene, a higher a5 integrin promoter activity was detected in the
presence of KGF. These data suggest that keratinocytes in chronic plaque-type lesions
rapidly undergo repeated cell cycles without entering the G0 state and using the D3-type of
G1-S cyclin and that KGF can regulate a5 integrin expression in keratinocytes.
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Protection Against Solar Ultraviolet (UV) Radiation Causes Vitamin-D Deﬁciency in
Transplant Recipients
Querings K, Tilgen W, Reichrath J
Dept of Dermatology, University of Homburg/Saar, Germany
Immunosuppressive therapy markedly increases the risk to develop solar ultraviolet (UV)
radiation induced skin cancer. Therefore, transplant recipients including renal transplant
recipients need to protect themselves against solar UV radiation. However, it has been
suggested that lack of UV-exposition may induce vitamin D deficiency. This represents a
serious dilemma, for a connection between vitamin D deficiency and other severe health
problems including various types of cancer has now been demonstrated. We aimed to test
the hypothesis whether transplant recipients are at risk to develop vitamin D deficiency. Basal
serum 25-hydroxyvitamin D (25(OH)D) levels were analyzed in renal transplant patients
(n¼ 31), other transplant recipients and in an age- and gender-matched control group at the
end of winter (February/March). All transplant patients had been advised after transplantation
to avoid solar UV radiation by mechanical protection and by the use of sunscreens. Basal
25(OH)D levels were compared using a non parametrical test (Wilcoxon rank sum test).
Po0,05 was considered significant. Basal serum 25(OH)D levels were significantly lower in
renal transplant recipients as compared to controls (p¼ 0.007). Geometric mean (with 95%
confidence interval) in renal transplant patients was 10.9 ng/ml (8.2–14.3) compared to 25.1
ng/ml (15.7–25.5) in the control group. Other transplant recipients revealed vitamin D
deficiency as well. Our findings demonstrate that transplant recipients are at high risk to
develop vitamin D deficiency, that has to be substituted (e.g. via oral treatment) to protect
against serious vitamin D deficiency-related health problems without increasing the risk to
develop solar UV-induced skin cancer. These connections, that show the need for re-defining
dermatological recommendations for solar UV protection in skin cancer prevention programs,
should as well be considered in other groups at high risk to develop vitamin D deficiency due
to lack of sun exposure (e.g. in patients with xeroderma pigmentosum).
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Modiﬁed Protocol for Treatment of Pemphigus with Protein A Immunoadsorption
Shimanovich I1, Herzog S2, Goebeler M2, Klinker E2, Bro¨cker EB2, Zillikens D1
1University of Lu¨beck, Germany;2University of Wu¨rzburg, Germany
Pemphigus is a life-threatening autoimmune blistering skin disease mediated by IgG
autoantibodies to desmogleins 1 and 3. Protein A immunoadsorption (PAIA) selectively
removes IgG antibodies from pemphigus patients’ circulation. We have previously reported
PAIA to be an effective and safe adjuvant therapy in 5 patients with pemphigus. In these
patients, 19 cycles of PAIA had been administered in combination with a single high-dose i.v.
dexamethasone/cyclophosphamide pulse followed by an oral low-dose immunosuppressive
regimen starting with 0.5 mg/kg prednisolone plus 2.5 mg/kg azathioprine. While excellent
short-term clinical response was achieved in all cases, 3 out of 5 patients developed a
recurrence once PAIA and immunosuppressive medication were tapered. Here, we report 9
further pemphigus patients treated with a modified PAIA protocol aimed at maintaining a
longer remission period. In this protocol, again 19 PAIA cycles were administered, but were
now combined with an oral high-dose immunosuppressive regimen starting with 2 mg/kg
prednisolone plus 2.5 mg/kg azathioprine. In all patients, formation of new blisters was
stopped or greatly reduced and most skin lesions healed within the first 2 weeks of treatment.
A single PAIA cycle reduced antibody levels by 75%. Within 4 weeks of treatment, levels of
anti-desmoglein antibodies were reduced by an average factor of 38. Within 6 months,
complete clinical remission was achieved in all patients. Within a 1.5 to 3.5 years follow-up,
one patient demonstrated a complete clinical and serological remission. Six patients were
free of skin lesions yet showed elevated levels of autoantibodies. Two patients developed a
clinical relapse. Our data confirm that PAIA is effective in severe pemphigus and suggest that
the modified protocol reported here leads to a longer-lasting disease remission than the
regimen used so far.
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Autoimmune Phenomena in Psoriasis Vulgaris
Reichelt A, Wetzig T, Mothes T, Sticherling M
Universita¨tsklinikum Leipzig, Germany
Current pathogenic concepts regard psoriasis as immunologically mediated and more
specifically to be an autoimmune disease with a still hypothetical autoantigen. In other
classical such diseases, diverse autoimmune phenomena are known apart from the specific
cell or organ directed autoreactions. Interestingly, bullous pemphigoid has been described
coincident with psoriasis as well as antibodies to endomysium and to the nutritional antigen
gliadin indicating correlations to celiac disease. However, such correlations have only
anecdotically be described or in small numbers of patients. Therefore, in this study the
incidence of autoantibodies to basement membrane zone (BMZ) antigens as well as
endomysium and tissue transglutaminase have been examined in immunofluorescence
(monkey esophagus, human salt split skin) and ELISA assays (anti-BP180, anti-gliadin, anti-
transglutaminase). Serum from 137 patients with psoriasis vulgaris and 50 healthy controls
were studied and results correlated to clinical data like past therapy regimens. Only low
titered anti-BMZ-antibodies were found in 4% of patients with no correlation to past therapy,
especially UV-therapy which has been speculated to modulate basement membrane and
dermal antigens to result in autoimmune phenomena and/or overt autoimmune disease. In
addition, anti-gliadin IgG and IgA antibodies could be detected in 2% patients. Anti-
transglutaminase antibodies of IgA and IgG isotype which are characteristic for celiac disease
or might indicate dietary, gut mediated pathogenic mechanisms could only be detected in 2%
and 6% of patients respectively. None of the patients suffered from either bullous pemphigoid
or celiac disease or other relevant gastrointestinal manifestations. Thus, routine serological
testing or even invasive diagnostic tests for these diseases are not indicated. Any such
examination might only be performed on clear-cut indications in the individual case history.
Moreover, associations of either of the autoimmune diseases to psoriasis seems rather
coincident than pathogenetically related.
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Adalimumab for Psoriatic Skin Lesions
Schopf R, Flores-Wendt ER
Department of Dermatology, Johannes Gutenberg University, Mainz, Germany
Psoriasis has shown improvement during anti-tumor necrosis factor (TNF)-alpha treatment.
We studied the effects of the recombinant human IgG1 monoclonal antibody specific for TNF-
alpha, Adalimumab. We treated 13 patients with psoriasis (4 female, 9 male, aged 25–68
years) with a psoriasis area and severity index (PASI) of 21.1þ /2.67 (meanþ /SE). Anti-
psoriatic systemic or UV-treatment was not permitted 4 weeks, topical treatment 2 weeks
before or during the study. At week 0, patients received a loading dose of 80 mg, then 40 mg
every other week starting at week 1 until week 11 by subcutaneous injection. Week 12 was
the end of observation. Skin biopsies for staining with H&E, anti-CD4, anti-CD8, HLA-DR, the
proliferation marker MIB-1, and the differentiation markers cytokeratin 16, filaggrin and
involucrin were taken at weeks 0 and 12. Epidermal thickness was measured with a
microscopic micrometer grid. The patients were also photographed. We found a diminution of
the PASI as follows: weeks 0, 1, 3, 5, 7, 9, 11, 12, respectively: 100% (week 0), 88.6þ /2.2,
55.7þ /5.7, 32.1þ /6.4, 18.3þ /4.4, 14.1þ /3.4, 9.4þ /2.2 and 5.2þ /1.9 (%) (week
12). The epidermal thickness of non-lesional skin was 0.1150þ / 0.0054, of lesional skin at
week 0: 0.4431þ /0.0412, at week 12: 0.1803þ /0.0178 mm. At week 12, skin staining
with the different immunologic and proliferation/differentiation markers also tended to
normalize. Treatment was well tolerated; some patients experienced fatigue at the day of
injection. Our results demonstrate that subcutaneous Adalimumab mono-treatment for 12
weeks clears psoriatic skin lesions almost completely.
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Anti-Cyclic Citrullinated Peptide Antibodies Occuring in Psoriasis Patients without
Arthritis
Bo¨ckelmann R, Gollnick H, Bonnekoh B
Otto-von-Guericke-University Magdeburg, Germany
Very recently a detection rate of 7.8% was shown for anti-cyclic citrullinated peptide (CCP)
antibodies in patients suffering from psoriatic arthritis. Moreover, these antibodies may be
directed to citrullinated filaggrin as it physiologically occurs in the epidermal cornification
process being highly disturbed in the psoriatic skin lesion. So, we addressed the question of
the existence of anti-CCP-antibodies in psoriasis patients with positive skin but negative joint
involvement.
Sera of n¼ 62 psoriasis patients without arthritis and of n¼ 117 control patients with
random dermatologic diagnoses but without psoriasis were tested with a commercially
available anti-CCP enzyme immunoassay. The cut-off level was set to 25 units/mL. The
psoriasis patients were stratified for type 1 (n¼ 33) and type 2 (n¼29) with a first disease
manifestation before or after the age of 40 years.
The detection rate of positive anti-CCP antibody titres was 17.7% in the psoriasis and
4.2% in the control patients (po0.004). Stratification analysis revealed a significantly higher
anti-CPP antibody prevalence in psoriasis type 2 (24.1%) as compared to type 1 (12.1%,
po0.03).
Non-arthritic psoriasis has to be added to the list of exceptional diseases which beside
rheumatoid arthritis may show a higher rate of a positive anti-CCP antibody titre. In psoriasis
such titres might be an irrelevant epiphenomenon or of direct pathogenetic relevance in a
subgroup of patients with regard to a possibly existing hitherto unknown citrullinated
autoantigen.
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In Vivo Confocal Microscopy of Melanocytic Lesions Improves Diagnostic Accuracy for
Melanoma
Pellacani G, Cesinaro AM, Longo C, Bassoli S, Grana C, Seidenari S
University of Modena and Reggio Emilia, Italy
In vivo reflectance-mode confocal laser microscopy enables the visualization of the skin at
quasi- histopathologic resolution. The aim of our study was to describe confocal features in
melanocytic lesions, to evaluate their diagnostic significance for melanoma identification, to
develop a simple algorithm useful for diagnostic purposes. A total of 102 consecutive
melanocytic lesions (37 melanomas, 49 acquired nevi and 16 Spitz nevi), corresponding to
lesions with equivocal aspects at clinical and dermoscopic inspection and excised in order to
rule out a melanoma, were investigated by means of confocal microscopy (Vivascope 1000).
In superficial layers the general pattern and the presence and aspects of pagetoid cells were
evaluated. At basal cell layer dermal papilla features and cytological aspects, suggesting the
presence of cellular atypia, were described. In dermal papilla, the presence and morphology
of melanocytic nests and the presence and aspect of solitary cells were evaluated. Some
features were more frequently observed in melanomas. In multivariate analysis 6 features
appeared independently correlated with melanoma diagnosis. The presence of non edged
dermal papillae, atypical cells in basal layers and isolated nucleated cells within dermal
papilla were strongly correlated with melanoma diagnosis and were considered as major
criteria (scored 2 points), whereas the presence of pagetoid cells, a widespread pagetoid
infiltration in superficial layers and cerebriform nests in upper dermis were considered
‘‘minor’’ criteria (scored 1 point). A total score, ranging between 0 to 9, was obtained for each
lesion and a ROC curve with an area under the curve of 0.951 was obtained on our dataset. In
conclusion, characterization of confocal microscopy features of melanomas and nevi seems
to improve diagnostic accuracy for difficult to diagnose melanocytic lesions.
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A Humanized Mouse Model of Psoriasis for the Routine Testing of New Drugs
Elliott GR1, Butter L2, Van Oosterom NA3, Meinardi M4, Das PK2
1Derphartox, Leiden, The Netherlands; 2Dept Pathology, University of Amsterdam, The
Netherlands; 3Delft, The Netherlands; 4Dept Dermatology, University of Amsterdam, The
Netherlands
Humanized mouse models of psoriasis have been used successfully to test novel approaches
to treating psoriasis and to elucidate the basic mechanisms involved. Published methods use
large split skin samples which limit the use of the model for routine testing. For this reason we
investigated the potential of transplanting small, 0.5 cm diameter, full thickness punch
biopsies from non-lesional psoriasis skin onto BNX mice. Volunteers had, typically, a PASI
scoreo6 and were not taking systemic drugs. Each volunteer gave three biopsies and 20 ml
blood. Typically 80% of all transplanted biopsies could be used in experiments Three weeks
after transplantation, autologous super antigen- activated PBMCs were injected intra-
dermally into the transplants. Three weeks later the biopsies were harvested. Different
markers of keratinocyte proliferation (epidermal ridge length, expression of Ki67) and
epidermal differentiation (ULEX) were assessed for their value in determining the effect of test
chemicals. Healthy non-transplanted breast skin had an epidermal ridge thickness of 81
mm  4 (average  sem, n¼ 12), few Ki67 positive cells (4% basal keratinocytes) and ULEX
expression limited to the upper 30% of the epidermis, similar to values obtained using non-
lesional psoriasis skin. There were no statistically significant differences in these parameters
after transplantation. Three weeks after injecting cells into non-lesional psoriasis transplants
epidermal ridge length was 212 mm  4 (n¼12), about 21% of basal keratinocytes were Ki67
positive and ULEX was expressed in about 95% of the epidermis. Topical treatment with
betamethasone propionate (BMP) (100 mg daily) reduced epidermal thickness to 98 mm  20
(n¼ 34). The was also a reduction in Ki67 expression (12% of basal keratinocytes ) and ULEX
(50% epidermis) expression. We suggest that small biopsies from non-lesional skin can be
used routinely to test anti-psoriatic drugs.
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Pulse Oximetry as a Rapid Screening Test in the Assessment of Peripheral Vascular
Disease
Zamiri M, Bianchi J, Macintosh H, Scott R, Guse J, Douglas WS
Dept of Dermatology Monklands Hospital, United Kingdom
An accurate non-invasive assessment of peripheral limb perfusion is an important part of
decision making in both vascular surgery and dermatology. Pulse oximetry has emerged in
pilot studies as an alternative non-invasive, simple and rapid test of peripheral arterial
perfusion, with angiography regarded as the standard investigation. The purpose of the study
was to compare pulse oximetry to arteriography in the assessment of peripheral vascular
disease.
38 legs were studied in 20 patients with clinical evidence of peripheral vascular disease.
Arterial pressures of both lower limbs were assessed by pulse palpation, Lanarkshire
Oximetry Index (LOI) by pulse oximeter and conventional intra-arterial angiography. LOI was
measured using a pulse oximeter with transmission sensor, and consisted of (1) measurement
of finger oximetry pressure, (2) measurement of toe oximetry pressure, (3) calculation of toe/
finger oximetry index (ratio). Aorto-femoral arteriography was then performed and scored
using a standard arteriography scoring system. LOI and arteriography scores were compared
statistically.
LOI scores ranged from 0–1.8 (mean 0.757), with no oximetry signal present in severely
diseased limbs and an abnormally elevated score in the presence of significant arteriosclerosis
in diabetic patients. Arteriography scores ranged from 0–6 (mean 3.56), with 0 for all occluded
vessels and a maximum of 6 for three widely patent vessels to the ankle. LOI and arteriography
scores showed a fair correlation. 4 patients progressed to investigation with MR angiography
due to technical difficulties in catheterising the femoral artery or in advancing the guide wire. LOI
and MR angiography scores in these patients also compared fairly.
Pulse oximetry is a simple, non-invasive aid in the assessment of peripheral vascular disease
and shows a fair comparison to arteriography.
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A New Fibronectin-Like Peptide that Displays a Remarkable Anti-Aging Effect on the Lips
and Skin. In Vivo Studies
Oberto G, Bauza E, Berghi A, Dal Farra C, Domloge N
Vincience, Sophia Antipolis, France
New active ingredients that help the skin and lips fight against the signs of aging have
become increasingly important in recent years.
Therefore, in these two double-blind studies, we investigated the effects of a synthetic
fibronectin-like peptide at 0.5% together with a booster molecule at 1%. Evaluation of clinical
effects was performed through a detailed questionnaire, and from a clinical exam of the
areas.
The first study included 12 volunteers who applied the cream formula containing the active
ingredient twice a day on the back of one hand and the placebo on the other hand.
Evaluations were performed after 1h, 3h, and after 7 days. This study revealed that volunteers
noticed an increased smoothness of skin surface and a lightening effect on the skin at all time
points. A 40% improvement on the peptide-treated side was estimated by volunteers one
hour after application.
The second study was on the lips and included two groups of 12 volunteers each. One
group applied the cream formula with the active ingredient, and the other group applied the
placebo. Evaluations were made at 1h and 3h. The Student’s test was used for statistical
analysis. For the repulping effect of the lips, the questionnaire revealed in the active-treated
group a statistically significant increase of 154.35% at 1h. At 3h, the increase was 158.06%
and was also statistically significant. A significant improvement of skin hydration of 155.56%
at 3h was observed. A significant improvement in smoothness of 425.01% in the active-
treated group was seen at 1h and a significant increase of 533.33% at 3h. These results
demonstrate that the fibronectin-like peptide can be of great use in anti-aging skin care
products.
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A Remarkable Anti-Aging Collagen-Like Peptide. In Vitro and In Vivo Studies
Perrin A, Bauza E, Oberto G, Berghi A, Dal Farra C, Domloge N
Vincience, Sophia Antipolis, France
Collagen plays a central role in skin appearance, aging, and photoaging. We developed a
synthetic oligo collagen-like peptide and evaluated, in vitro, its effect on the skin. Histological
studies were also performed on ex vivo skin as well as in vivo evaluation through a clinical
double-blind study on wrinkles. Ex vivo studies showed that application of 1% of collagen-
like peptide to the skin rapidly enhanced the synthesis of many ECM molecules. Moreover,
comparative studies with vitamin C at 20 mg/ml, showed that the synthesis response of some
ECM molecules, such as laminin 5, collagen III, IV, and pan keratin, was greater and more
rapid when prompted by collagen-like peptide than by vitamin C. Furthermore, a clinical
double-blind study that included 20 healthy women volunteers, age 40 to 62, was performed.
Volunteers applied either a gel formula containing 3% of the collagen-peptide and 1% of a
booster, or a placebo gel, on the eye zone area twice a day for 4 weeks. Control visits were
performed at the beginning and end of the study. Skin wrinkles were evaluated clinically and
by silicon replica analysis followed by statistical treatment using the matched paired
Student’s test. The results showed that application of the collagen-peptide on the skin
significantly reduced the total surface of wrinkles in 75% of the replicas. Similarly, the
decrease in number and average depth of wrinkles was significant, and observed in 65% and
70% of the replicas, respectively. Moreover, the effect on reducing the total length of wrinkles
was highly significant and was observed in 75% of the replicas. These studies reveal the
rapid anti-aging effect of collagen-like peptide and demonstrate that the peptide can be of
great use in the field of anti-aging skin care products.
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Pimecrolimus Cream in the Treatment of Facial Seborrheic Dermatitis: A Randomized,
Controlled Clinical Trial
Firooz A, Solhpour A, Gorouhi F, Daneshpazhouh M, Balighi K, Rashighi-Firouzabadi M,
Farsinejad K
Tehran University of Medical Sciences, Islamic Republic of Iran
Background: Seborrheic dermatitis is a chronic inflammatory disease that mainly affects
seborrheic areas of face, scalp and chest. According to side effects of chronic use of
corticosteroids and also resistance to different treatments, any new modality could be
favorable.
Objective: To compare the efficacy and safety of pimecrolimus 1% and hydrocortisone
acetate 1% creams in patients with facial seborrheic dermatitis.
Methods: Forty patients (28 males and 12 females) with facial seborrheic dermatitis were
randomized to be treated with either pimecrolimus 1% cream or hydrocortisone acetate 1%
cream twice daily (20 patients in each group) in an investigator-blinded study. They were
treated for two weeks and followed up for 4 more weeks. The severity of erythema, scaling,
and pruritus were recorded in each visit on a 0–2 scale.
Results: Complete disappearance of all signs and symptoms were observed in 15 patients
treated with pimecrolimus and 17 patients treated with hydrocortisone acetate after 2 weeks
(p¼ 0.4). However, 10 patients in pimecrolimus group and 13 in hydrocortisone group
relapsed at the end of study (p¼ 0.3). Recurrence of scaling was significantly less in patients
treated with pimecrolimus (6 vs. 14, respectively, po0.05). Burning sensation was
experienced more frequently in patients treated with pimecrolimus, but they were mild and
transient (7 vs. 1, respectively, po0.05).
Conclusion: Pimecrolimus cream has the same efficacy as hydrocortisone cream in the short
term treatment of facial seborrheic dermatitis and may be a good therapeutic alternative for
corticosteroids in treating this disease.
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Peroxynitrite Oxidation in Scleroderma
Shimizu K, Ogawa F, Sato S
Dept of Dermatology, Nagasaki University, Japan
Nitric oxide (NO) has been reported to be involved in the pathogenesis of various human
diseases. Furthermore, serum NO has been reported to increase in scleroderma and we have
confirmed an increase of serum nitrite, which is thought to reflect NO, in scleroderma
patients. Meanwhile, superoxide (O2-) is produced in some inflammatory processes and O2-
induces the expression of NO synthase through NFkB activation. NO can react easily with
O2- and give rise to peroxynitrite, which can cause severe cytotoxicity against various cells. It
is assumed that the strong cytotoxicity by the oxidative stress by peroxynitrite may occur in
scleroderma patients.
Nitrotyrosine (NT) has been identified as a marker of inflammation and NO production. NT is
formed in presence of the active metabolite NO. Various pathways including the formation of
peroxynitrite lead to NT production. Since NT is a stable endproduct of peroxynitrite
oxidation, assessment of its concentration may be useful as a marker of NO-dependent
damage in vivo.
The presence of NT has been detected in various inflammatory precesses including
atherosclerotic plaques, rheumatoid arthritis, chronic renal failure and so on.
Therefore, we conducted to measure the serum NT in scleroderma patients.
After receiving the informed consents, 60 scleroderma patients were examined and 40
persons were used as healthy controls. Blood samples were collected and the concentration
of serum NT was measured by ELISA (Nitrotyrosine Elisa test kit, HyCult biotechnology).
Other parameters in blood of scleroderma patients were also examined and statistical
analysis was performed using Mann-Whitney’s U test.
The mean value of serum NT in the scleroderma patients (0.033  0.002mM)was
significantly increased compared with that in the controls (0.030  0.004mM, Po0.001).
Peroxynitrite oxidation may be involved in the pathogenesis of scleroderma.
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Chemokine Receptors in Primary Cutaneous Melanoma: Do They Have Clinical
Signiﬁcance?
Longo-Imedio I, La´zaro P, Sa´nchez-Mateos P
Hospital GU Gregorio Maran˜o´n, Spain
Expression of chemokine receptors by tumour cells has been correlated with an increased
rate of metastases. With the hypothesis that chemokine receptor expression might correlate
with prognosis we analyzed the expression of chemokine receptors CXCR3 and CXCR4 in
primary melanomas and correlated it with clinical outcome.
We obtained punch biopsies from primary melanomas and nevi. The specimens were
frozen for immunohistochemical study. Serial sections were stained with monoclonal anti-
human CXCR3, CXCR4, HMB-45, polyclonal rabbit anti -S-100 serum, and isotype matched
control antibodies.
The expression of chemokine receptors was correlated with the development of
metastases and the occurrence of death.
Forty primary melanomas and seven nevi were available for analysis. More than 50% of the
primary tumours expressed CXCR3, whereas roughly one third (35%) expressed CXCR4.
None of the cases of melanoma in situ or nevi expressed either chemokine receptor. Patient
population included 20 women and 20 men with a mean age of 61 years. The mean Breslow
thickness was 1.45 mm (0–6.50). The median follow-up time was 32 months. The expression
of CXCR4, but not of CXCR3, was significantly associated with the development of regional
lymph node metastases (p¼0.04), distant metastases (p¼ 0.04), and an increased mortality
rate (p¼0.009). Also expression of CXCR4, but not of CXCR3, was significantly associated
with the presence of ulceration and increased tumour thickness.
Chemokine receptors not only drive the migration of tumour cells but also enhance their
invasiveness, growth and survival. The expression of certain chemokine receptors in primary
melanomas, particularly CXCR4, might predict a highly aggressive biologic behaviour and
thus correlate with prognosis. Likewise chemokine receptors might prove to be a useful target
for biologic therapy in the management of patients at risk for disseminated disease.
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Expression of the 27 and 72 kD Heat Shock Proteins and the Heat Shock Response in
Aging Human Skin
Klosner G1, Matsui M2, Muizzuddin N2, Kokesch C1, Hofsta¨tter E1, Binder M1, Trautinger F1
1Medical University of Vienna, Austria; 2Estee Lauder Research, USA
Experimental evidence supports the hypothesis that the ability to respond to environmental
stress with the induction of heat shock proteins (hsp) deteriorates with age in various tissues
and that the lack of an appropriate heat shock response further contributes to the aging
process. In human skin the influence of age on hsp and on the heat shock response has not
been systematically studied to date. Thus, in the present study baseline expression of hsp27
and hsp72 as well as heat-related induction of hsp72 were investigated in the skin of healthy
volunteers of different ages. Healthy female volunteers (phototypes II and III) were included in
the study. Ages were either between 19 and 28 (group I, n¼ 22) or between 55 and 65 (group
II, n¼ 22). Punch biopsies from the upper inner arms were either immediately snap frozen or
exposed to heat shock (421 C, 4 h) prior to cryopreservation. Baseline expressions of hsp27
and hsp72 mRNA was quantified by real-time RT-PCR. Immunohistochemistry was used to
investigate hsp72 before and after heat stress. Baseline expressions of hsp27 and hsp72
mRNA showed considerable interindividual variation (cv¼ 49.8 %) with no significant
difference between age groups. Heat shock induced a strong increase in the intensity of
hsp72 immunostaining without statistically significant differences between the two groups
(group I: from 2.9  1.2 to 4.7  1.1, group II: from 2.8  1.3 to 4.6  1.1; mean  SD,
arbitrary units). These results demonstrate that in healthy human skin the expression of hsp72
and the ability to respond to heat shock remain remarkably stable between 19 and 65 years.
This stability suggests that hsp and the heat shock response are essential for the physiology
of human skin.
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Inﬂiximab Phase III Results: Every 8 Week Versus As Needed Maintenance Therapy
Gottlieb A1, Feldman S2, Weinstein G3, Guzzo C4, Evans R4, Li S4, Menter A5
1UMDNJ-Robert Wood Johnson Medical School, USA; 2Wake Forest University School of
Medicine, USA; 3University of California, USA; 4Centocor, Inc., USA; 5Baylor University
Medical Center, USA
Purpose: Infliximab, a tumor necrosis factor alpha (TNF-a) antagonist, is an effective
psoriasis treatment. In this placebo-controlled pivotal Phase III trial we evaluated the safety
and efficacy of several infliximab induction and maintenance regimens.
Methods: Patients with moderate to severe psoriasis were randomised to induction doses of
infliximab 3 mg/kg or 5 mg/kg, or placebo, at weeks 0, 2 and 6. Patients in the active
induction treatment groups were randomized at week 14 to receive either scheduled or ‘‘as-
needed’’ maintenance treatment at the same dose administered during the induction phase.
Patients in the placebo group crossed over at week 14 to receive infliximab 5 mg/kg at weeks
16, 18 and 22, then every 8 weeks through week 46.
Results: More patients treated with infliximab 3 mg/kg (70%) and 5 mg/kg (76%) achieved at
least 75% improvement in the PASI score at week 10 compared to patients receiving placebo
(2%) (po0.001), and a more sustained improvement was observed for each dose with
regularly scheduled treatment compared to ‘‘as-needed’’ maintenance therapy regimens
within each dose. Patients’ quality of life was significantly enhanced by treatment and
paralleled PASI responses. Infliximab was generally well-tolerated.
Conclusions: These results confirm the safety and efficacy of infliximab treatment of
psoriasis. Scheduled maintenance treatment provides better long term control.
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Patients Remember the Pain Caused by Dermatological Surgery as Being much less than
Anticipated
Naysmith L
Royal Infirmary of Edinburgh, United Kingdom
Pain caused by dermatological surgery attracts little research interest, and it remains unclear
whether there is anything specific about its neurobiology.
In a dental setting, patients recall the pain associated with dental treatment as being
greater than that experienced at the time and closer to anticipated pain. I was interested to
see if this is true of pain associated with dermatological surgery.
50 consecutive patients of whom 27 were female were studied. Patients were asked to rank
their perception of pain immediately before, immediately after, and 1 month post surgical
procedure using a 10 cm visual analogue scale. All procedures were performed by the same
operator using 1% Lignocaine with Adrenaline and a 30 G needle. 50 patients undergoing
venesection were used as a control group. Because data was negatively skewed non
parametric analyses were conducted using ‘R’ software. Medians are quoted as measures of
central tendency and interquartile ranges as a measure of dispersion.
There was a striking and highly significant difference in median pain score perception
immediately before and after the surgical procedure, 4.1 (2.5–5.2) and 0.6(0.3–1.95),
po0.001. There was no difference between immediate recall and that of one month later.
Although there was no apparent difference in pain perception by procedure type or body site,
as I expected, men found the procedure more painful than women, although this did not quite
reach statistical significance (p¼0.06).
Patients remember pain of cutaneous surgery as being much less than expected, and
similar to that actually experienced. This is in marked contrast to dental pain. These findings
have clear implications for clinical practice and suggest these aspects of cutaneous
neurobiology deserve more attention.
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Immunocytometric Analysis of Peripheral Blood Lymphocytes in Mycosis Fungoides
Pawlaczyk M, Kostrzewa A, Kramer L, Wiktorowicz K
University of Medical Sciences, Poznan, Poland
Characteristic feature of mycosis fungoides (MF), the most common form of cutaneous T-cell
lymphoma, is duration measured in many years and clinical progression of skin lesions from
patch, through plaque to tumour stage. The aim of this study was to determine the
immunophenotype of peripheral blood lymphocytes in patients with MF at various stages of
development and to compare it with chronic inflammatory skin disorders. The study group
consisted of 48 patients, aged between 30 and 82 years, at various stages of advancement of
the neoplastic process as assessed using the TNM classification. There were 2 patients at
stage IA, 9 patients at stage IB, 12 patients at stage IIA, 10 patients at stage IIB, 9 patients at
stage III and 6 patients at stage IVA. The patients at the initial stages IA and IB were combined
into one group, as were patients with stages III and IVA. The obtained results were analyzed
statistically with Kruskal-Wallis test and ROC curves. Immunocytometric analysis of the
subpopulations of lymphocytes in peripheral blood showed an increase in the total number as
well as percentage of CD4þ lymphocytes, together with the simultaneous decrease in total
number and percentage of CD8þ lymphocytes, accompanying the progression of MF. Hence
an elevated CD4/CD8 ratio was seen in the advanced stages of MF. Patients presenting at the
early stages of MF had a lower total number and percentage of NK lymphocytes. Progression
of the neoplastic process resulted in an expansion of the CD4þCD7- lymphocyte
subpopulation. No statistically significant differences were observed in absolute number
and percentage of CD4þCD26- lymphocytes between early and advanced stages of MF.
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Human Melanocytes Express EGF Receptor
Kormos B, Kenderessy Szabo´ A, Szabad G, Sonkoly E, Kis K, Sze´ll M, Keme´ny L, Bata Zs
University of Szeged, Hungary
The expression of EGF receptor in normal human melanocytes is controversial. In previous
work we found that EGF enhanced the growth of normal human adult melanocytes cultured
without chemical mitogens in AIM-V and keratinocyte-SFM (v:v) supplemented with BPE and
FBS (all from Gibco). In dose response studies EGF in the range of 2,5–10 ng/ml
concentration showed enhanced growth on the cultured normal human melanocytes. Using
real-time RT-PCR we detected the presence of EGF receptor (EGFR) mRNA in the cells.
Compared to cultured keratinocytes derived from normal adult skin, the expression of
cultured normal human melanocyte EGFR was lower.
To substantiate the translation of the EGF receptor mRNA in human melanocytes, cell
cultures from normal human adult skin and child foreskin were used for immunhistochemical
detection and flow cytometric analysis of the EGFR protein. We used the sc-120 monoclonal
anti-EGFR antibody and detected the expression of EGFR protein with both methods. The
cultured cells were also stained with the melanocyte specific Mel-5 monoclonal antibody to
exclude the presence of contaminating keratinocytes.
Since chemical mitogens can render cultured cells refractory to certain physiologic growth
factors their exclusion from melanocyte cultures is essential to study normal cell responses to
regulatory factors. Because EGFR expressions have been reported to be markers for
potential malignancy in melanocytic lesions and the EGFR activation has been implicated in
the autocrine regulation of melanoma it is important to clarify its expression and function in
normal melanocytes.
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Treatment of Scalp Psoriasis with Xenon-Chloride Excimer Laser
Kinyo A, Koreck I, Gyulai R, Czako S, Kemeny L
University of Szeged, Hungary
The scalp is a very frequent localisation of psoriasis and its therapy causes many problems
for the dermatologists and patients equally. Xenon-chloride (XeCl) excimer laser is a new
therapeutic modality for the treatment of psoriatic lesions. Our aim was to examine the
effectiveness of XeCl excimer laser on scalp psoriasis. 13 patients with scalp symptoms have
been enrolled to our study. After the measurement of standard minimal erythema dose (MED)
the therapy was started with the two times of MED value. The dose of irradiation was
increased in each treatment with max. 200 mJ/cm2, and the maximum doses were between
1400–1500 mJ/cm2. Patients were treated twice a week until they reached 475% clearance
or complete remission. During the therapy erythema, thickness, scaling and the size of the
affected area were evaluated and modified PASI score was calculated. Each of the enrolled
patients completed the study, 13 treatments were needed in average. There was a significant
difference in the mean of modified PASI score measured before and after the treatments (3.08
and 0.33 respectively po0.0001). Besides the development of the transient UV-erythema,
mild blistering occurred on 3 individuals. We conclude that the treatment of scalp psoriasis
with XeCl excimer laser is an effective therapeutic modality and the scalp tolerates well the
relatively high dose UV-light.
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Urticaria Factitia: Clinical Features and Response to Psychosocial Stress
Wallengren J
Dept of Dermatology, University Hospital Lund, Sweden
The aim of the study was to investigate how dermographism affects the life stile of patients
with urticaria factitia and to find out if a standardized psychosocial stress test influences the
dermographic reaction.
Twenty one adult patients with urticaria factitia (14 female, mean age 49 y) completed a
questionnaire. Twelve patients (7 female, mean age 50 y) were enrolled in a provocation of
prick test and dermographism prior and after the Trier Social Stress Test. Eleven age-
matched controls underwent corresponding tests except provocation of dermographism. The
flare and volume of test reactions were evaluated.
Areas most commonly affected were extremities (19 patients), trunk (16), buttocks (10) and
face (9). The precipitating factors were: scratching (9), pressure (7), stress (7), tight clothes (6),
shower (5), heath (5) and cold (3). As associated symptoms the patients mentioned frustration
(2), exhaustion (1), swelling of fingers and face (1) and heating of the whole body (2).
Restrictions in life stile was clothing (2), taking a shower (3), sports (3) and deteriorated
concentration (1). Eleven patients reported having chronic urticaria, two atopy, nine heredity
for atopy.
The dermographic reaction in patietnts was intensified after the stress test (flare 564 mm2
vs 648mm2, weal 66 mm3 vs 94 mm3 respectively). The prick test reaction was unchanged
(flare 1338 mm2 vs 1412 mm2, weal 241 mm3 vs 249mm3 respectively). In contrast, the
control subjects displayed reduced pricktest reactions to histamine following the stress test
(flare 750 mm2 vs 706 mm2, weal 181 mm3 vs 81 mm3).
While the control subjects display reduced prick test reactions following stress
provocation, the dermographic reaction in patients with urticaria factitia is enlarged. This
finding supports the clinical observation, that patients with urticaria factitia often make, of its
being enhanced by psychological stress.
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Anti-B- Cell-Directed Immunotherapy (Rituximab) in the Treatment of Refractory
Pemphigus
Arin M, Engert A, Krieg T, Hunzelmann N
University of Cologne, Germany
To investigate whether depletion of B lymphocytes that are thought to produce disease
causing autoantibodies shows a longterm benefit in pemphigus, we treated five patients with
recalcitrant disease with the monoclonal anti-CD20 antibody rituximab. Rituximab was
administered intravenously at a dosage of 375 mg/m2 once weekly for four weeks. The
significant clinical improvement in all patients after rituximab was accompanied by a marked
reduction of the immunosuppressive co-medication. The mucocutaneous lesions gradually
improved in all patients and complete healing was observed in two patients. Treatment was
well tolerated, adverse effects such as nausea, vomiting, facial edema, chills or cough
occurred mostly during the first intravenous administration and were controlled by
paracetamol and antihistamines. Depletion of CD20 lymphocytes occurred rapidly after the
last infusion of rituximab and the values returned to normal after 6–15 months. Interestingly,
the CD20 count in one patient is still below normal 3 years after the last application of
rituximab. The variability of the persistence of B cell depletion is not clear, recent work in
patients with systemic lupus erythematodes suggests a correlation between polymorphisms
of Fc receptors on effector cells and the degree of B cell depletion and response to rituximab.
Our observation that despite clinical improvement the antibody titre to desmoglein 1 and 3
remained constant in two patients is in line with the assumption that plasma cells with longer
life spans exist. In conclusion, this study documents the favorable effect of a single course of
rituximab in pemphigus. The therapy was effective in cases refractory to standard
immunosuppressive agents such as azathioprine, methotrexate and mycophenolate mofetil
and was long-lasting.
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A Dermatology Tele-Education Collaboration Between Internal Medicine and Dermatol-
ogy Residents
Williams CM1, Kedar I1, Smith L2, Lugn N3, Brandley-Bennett H1, Kvedar JC1
1Harvard Medical School; Partners Telemed, USA; 2Saint Michael’s Medical Center, USA;
3Partners Telemedicine, USA
The educational curriculum of internal medicine training programs has increasing emphasis
on dermatology training. Primary care physicians frequently acknowledge insufficient
training. Moreover, the Accreditation Council for Graduate Medical Education commonly
cites internal medicine (IM) residency programs for the lack of dermatology training.
Dermatologist shortages and a geographically mal-distributed workforce further complicate
the problem. To address this issue, we designed a 12-month educational curriculum to
provide dermatology education via interactive videoconferencing from dermatology residents
at Harvard Medical School Department of Dermatology to internal medicine residents at Saint
Michael’s Medical Center in Newark, NJ. During the trial, we experienced few technical
difficulties. Difficulties occurring were a result of obsolete technology at one site. We
evaluated knowledge improvement of the IM residents using a 25-question standardized
examination derived from Medical Knowledge Self-Assessment Program (MKSAP), made
available by the American College of Physicians, administered both before and after the
educational program. Seventeen IM residents completed both the pre- and post-educational
assessment. We restricted subsequent analyses to this subset population. Statistical analysis
was performed using a paired Wilcoxon signed rank test. In addition, program evaluations as
well as resident attitudes and perceptions were elicited at 6 months and 12 months during the
educational series. Average scores improved from 29% to 39% (2.3 points; p¼ 0.0056).
Overall satisfaction with the dermatology education via interactive videoconferencing was
high. The IM residents were accepting of this program and a high percentage believed it
improved their ability to provide effective patient care. We proved in this study that
dermatology education via interactive videoconferencing is a feasible, effective, and
acceptable means to provide dermatologic education to internal medicine residents.
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Intralesional Chloroquine is Useful in Cutaneous Leishmaniasis : A Case Report
Bhat R, Khanna N
All India Institute of Medical Sciences, India
Cutaneous leishmaniasis continues to be a significant problem in many parts of the tropics
and sub-tropics, and is commonly treated with intralesional antimonials. However these are
relatively expensive and often unavailable; alternatives need to be explored. We used
intralesional chloroquine (ILC) in a case, this being the first such report to the best of our
knowledge.
A 40-year-old man presented with lesions of cutaneous leishmaniasis on his lower lip, left
cheek, left little finger and left arm, probably acquired in Kabul, Afghanistan. Histopathology
showed Leishmania organisms. Oral rifampicin (600 mg/day) produced no response over a
month and the lesions continued to spread. We then initiated therapy with twice-weekly
intralesional injections of sodium stibogluconate (ILSSG) into the lip lesion and ILC into the
cheek lesion (0.5–0.6 ml per lesion per sitting). The daily rifampicin was continued. The
response was assessed with the aid of clinical photographs, and the 2 lesions on the left
upper limb that were not injected served as internal controls.
ILC had an efficacy comparable to that of ILSSG in our patient. Improvement began in both
the lesions after 2 injections each. The ILC-treated lesion subsided with hyperpigmentation
and mild atrophic scarring with 15 injections, while the one treated with ILSSG which was
larger, required 22 injections for clearance. His 2 other lesions did not improve during the
initial 5 weeks of this period. They were also then treated with ILC and responded
satisfactorily. Apart from the pain of injection, no significant side effects occurred.
Our observations suggest that ILC may be a viable alternative to ILSSG in the treatment of
cutaneous leishmaniasis, especially where the latter is not available or is too costly.
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Itraconazol in treatment of the Inﬂammatory Skin Diseases
Valles Kazlouskaya V
Vitebsk State Medical University, Belarus
Introduction. Many of the inflammatory skin diseases (such as seborrhoeic dermatitis,
rosacea, seborrhoeic psoriasis, atopic dermatitis of the face and neck, Malassezia-folliculitis,
palmar-plantar pustulosis) are difficult to cure. In treatment of these dermatoses are usually
used topical agents that cause discomfort of the patients. These diseases also may repeat
many times. Systemic therapy has given the new approach in the treatment of them.
Aim of Study. To reveal the effect of the therapy of seborrhoeic dermatitis, rosacea,
seborrhoeic psoriasis, atopic dermatitis of the face and neck, Malassezia-folliculitis, palmar-
plantar pustulosis with Itraconazol.
Material and methods. During 2002–2005 79 patients with inflammatory diseases were
studied (40 with seborrhoeic dermatitis, 7 with rosacea, 8 with seborrhoeic psoriasis, and 3
with atopic dermatitis of the face and neck, 2 with Malassezia-folliculitis, 19 with palmar-
plantar pustulosis. Clinical evaluation was performed to all patients. Itraconazol in the dose of
200 mg every day during 14 days was administrated for the all patients. Results were
evaluated during the treatment, 3 and 6 months after the treatment.
Results. In the patients with seborrhoeic psoriasis 50% of patients had remission after the
treatment, after the third and sixth months the result was 62,5%. 50% of the patients with the
seborrhoeic dermatitis had remission, after the sixth month the result was 70%. Remission in
the group of the patients with rosacea for the sixth month was 42,86%, in the group of the
patients with palmar-plantar pustulosis - 42,1%. The patients with atopic dermatitis of the
face and neck and Malassezia-folliculitis had shown the great improvement.
Conclusion. Itraconazol is a safe and effective method for the treatment of the inflammatory
diseases of the skin that provides the long-term remission in these diseases.
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Exposure To Polycyclic Aromatic Hydrocarbons During Coal Tar Treatment in the Clinic
Van Houtum J, Scheepers P, Anzion R, Roelofzen J, Van Der Valk P
Radboud University Nijmegen Medical Centre, The Netherlands
Coal tar (pix lithantracis) is used in the dermatological clinic for topical treatment of psoriasis
and eczema patients. Tar contains numerous components of which a part is considered as
mutagenic. Although no reports on an increased cancer risk are available, concern has been
raised for nursing personnel potentially exposed to tar by applying topical tar preparations.
Previous work showed skin absorption of mutagens from coal tar in patients therapeutically
exposed to tar. However, it is not known whether and to what extent nurses are exposed to
tar components if working with tar.
Our objectives were to determine urinary excretion rates of 1-hydroxypyrene as a marker of
PAH (polycyclic aromatic hydrocarbons) exposure in nurses occupationally exposed to coal
tar preparations. Putative routes of absorption were also studied by measurements of PAH in
the ambient air and on the skin.
Pyrene (PYR) or benzo(a)pyrene (BaP) was not detected in the breathing-zone of the
nurses. In 11 of the 18 nurses there was a statistical significant increase in 1-hydroxypyrene
(1-OHP) excretion in comparison to the background values, after exposure to coal tar
ointments during the treatment of the patient(s). The maximum value of 1-OHP appeared at
14 hours (mean) after start of the treatment procedure, which is characteristic for cutaneous
absorption of PAH. With appropiate cutaneous protection, exposure can be avoided.
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Mechanism of Action of Vitamin D3 Analogues in the Treatment of Psoriasis
Tiberio R1, Bozzo C2, Guenzi C2, Pertusi G1, Leigheb G1
1Dermatologic Clinic, University of Piemonte Orientale, Italy; 2Laboratory of Cellular Biology,
University of Piemonte Orientale, Italy
In recent years vitamin D3 analogues have become one of the most widely prescribed topical
treatment for mild or moderate chronic plaque psoriasis. These molecules are effective and
safe, however their exact mechanism of action is unknown.
In vitro studies demonstrated that D3 analogues decrease keratinocytes proliferation,
induce their differentiation, and have strong immunomodulating effects, but there are not
certain data about apoptosis.
This study aimed to evaluate differences of apoptosis response between lesional and
perilesional keratinocytes of psoriasic patients after treatment with calcipotriol, a syntetic
vitamin D3 analogue, and to determine if activation of caspase 9 is involved in the induction of
apoptosis.
We culture keratinocyte isolated from psoriasic plaques including lesional and perilesional
skin. Cells have been treated with calcipotriol for 20 hours and examined by confocal
microscope after staining with propidium iodide. To identify caspase 9 we used
immunohistochemical technique.
The number of apoptotic cells after treatment with calcipotriol is significantly higher in
lesional keratinocytes than in perilesional ones (po0,05).
We do not observe any immunohistochemical positive reaction to caspase 9 both in
psoriasic and non psoriasic cells.
In conclusion Calcipotriol seems to induce apoptosis in psoriasic keratinocytes but the
apoptotic pathway, instead of we thought, does not involve caspase 9 activation.
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Rapid Decline of Skin Elasticity Between 50 and 60 Years of Age
Williams S1, Reuther T1, Kru¨ger N1, Bayrhammer J1, Keschawarzi M2, Sievers E2, Kerscher M1
1University of Hamburg, Germany; 2Vichy Laboratories, Germany
Cutaneous elasticity decreases with age. However, is this a gradual, constant process or is
there a ‘‘critical’’ age period, during which skin elasticity declines particularly striking? We
analysed the data of 2023 probands (69% female, 31% male).
Overall, clinical examination by specialist dermatologists, proband self-assessment and
bioengineering in vivo skin elasticity measurements using the ‘‘Cutometer 580 MPA’’ (Courage
& Khazaka, Cologne, Germany) corresponded well. All three revealed an impaired cutaneous
elasticity in approximately one third of probands. After dividing the group into different age
groups, our data confirmed an overall decrease of cutaneous elasticity with increasing
chronological age with a particularly strong decline between 50 and 60 years. In contrast to
the deterioration of facial skin elasticity, the prevalence of mimic wrinkles peaked much
earlier. Our data indicated a maximum ‘‘myo-ageing’’ caused by repeated facial expressions
between 30 and 40 years of age.
In summary, our study indicated that skin elasticity seems to decline particularly strongly
between 50 and 60 years of age, whereas mimic wrinkles occur at a much younger age, when
cutaneous elasticity is still high.
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Treatment of Mycosis Fungoides with Photochemotherapy, Interferon and Traditional
Chinese Medicine
Chen M, Xiao LM, Hu Y, Qiu BS
Huashan Hospital, Fudan University, China
Objective: To compare the therapeutic responses of Mycosis fungoides (MF) with PUVA,
interferon and traditional Chinese medicine.
Patients and methods: 138 MF patients were treated with PUVA, Interferon (IFN)-a traditional
Chinese medicine (TCM) and/or combined with each other in our hospital from 1994 to 2004.
The diagnosis and classification of MF were in compliance with the established criteria. 15
patients (11%) were in stage IA, 68 (49%) in stage IB, 24 (17%) in stage IIA, 20 (15%) in stage
IIB and 11 (8%) in stage IIIA.
78 patients (IB54, IIA14, IIB9, IIIA1) were treated with PUVA (including 38 in combination with
interferon). 79 patients (IA6, IB28, IIA24, IIB20, IIIA1) were treated with INF (in addition to 38
patients combined with PUVA, 9 patients were combined with TCM regimen). 28 patients (IA9,
IIA5, IIB4, IIIA10) were treated by TCM regimen (including 9 cases combined with INF,10 with
chemotherapy). According to the yin-yang theory of the TCM, MF is due to deficiency of both qi
and yin.and flaring-up of fire of deficiency type. We have adopted the TCM principle of heat-
removing, detoxifying, supplementing qi and nourishing yin.
Results: Complete response (CR) was noted in 32 patients (23%), partial response (PR) in 74
(54%), no response (NR) in 14 (10%), and disease progress (DP) in 7 (5%). 11 patients (8%) died.
Conclusions: The TCM can be used to treat MF patients of very early stage or combined with
INF or chemotherapy for stage II and III cases, which is beneficial in reducing the dosage of INF
and the side effects of chemotherapy. PUVA in combination with low dosage of IFN-a may
increase the remission rate as well as the total dosage of UVA. It is an effective and
comparatively safe therapy.
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Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Results on Drug Risks
Based on the EuroSCAR-study
Mockenhaupt M1, Viboud C2, Dunant A3, Naldi L4, Halevy S5, Bouwes Bavinck JN6, Sidoroff
A7, Schlingmann J1, Roujeau JC8, Flahault A2
1Department of Dermatology, University of Freiburg, Germany; 2Inserm U444 Paris, France;
3Biostatistics and Epidemiology Unit, Institut Gustave-Roussy, France; 4GISED Study
Center, Department of Dermatology, Azienda Osped, Italy; 5Department of Dermatology,
Soroka University Medical Center, Israel; 6Department of Dermatology, Leiden University
Medical Center, The Netherlands; 7Department of Dermatology, University of Innsbruck,
Austria; 8Department of Dermatology, Hopital Henri Mondor, Cre´teil, France
Background: Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are
rare but life-threatening severe cutaneous adverse reactions (SCAR) that may occur after the
use of a variety of drugs. Although SCAR are rare disorders with an overall incidence of 1–2
cases/mio. inhabitants/year, the public health impact is significant because of a high mortality
(440% for TEN).
Objectives: The main objective of the European Ongoing Case Control Surveillance of SCAR
(EuroSCAR-study) was to estimate the risk for certain drugs to induce SCAR by calculating
relative risks (RR). Special attention was devoted to newly released drugs, for which there
were alerts on potential risks of SCAR.
Methods: The EuroSCAR-study is a case-control study conducted in Austria, France,
Germany, Israel, Italy and The Netherlands between 1997 and 2001. Cases were actively
detected by regular contact with a network of about 1800 hospitals covering 120 mio.
inhabitants. Three control matched with cases on age, gender and date of interview were
enrolled for each case. All cases and controls were validated by an expert committee blinded
for information on exposures; an index-day, i.e. the day of onset of the adverse event was
defined for each case as well as for the controls.
Drug exposure was restricted to a 7 day window prior to the index-day for most drugs and
extended to 14 days (oxicams, allopurinol) or 21 days (phenobarbital) for drugs with a long
half-life. Drug exposures were analyzed according to the start of treatment (o8 or 48 weeks
before the index-day). RR were estimated with a multivariate unconditional logistic regression
when 43 cases and 43 controls were exposed. Adjustment was done on matching factors
(country, gender), drug exposure and non-drug factors, e.g. HIV-infection, recent cancer,
rheumatic disease.
Results: 379 community cases of SCAR (174 in Germany, 130 in France, 75 in the other
countries) and 1505 controls were finally enrolled in the EuroSCAR-study. Multivariate RR were
72 (23–225 confidence interval (CI) 95%) for carbamazepine, 18 (11–32) for allopurinol with 3%
and 11% of comedication with other ‘‘highly suspected’’ drugs in cases that started the drug
o8 weeks before SCAR. In the previous SCAR-study the multivariate RR was 12 (3.5–38) for
carbamazepine and 5.5 (2.1–15) for allopurinol. RR varied between country and e.g. the
increased rate of exposure to allopurinol among cases and controls was most prominent in
Germany (23.6% of cases and 3% of controls). The RR for oxicam-NSAIDS was 16 (4.9–52).
Concerning drugs marketed in recent years lamotrigine and nevirapine showed an infinite risk
with CI 14 to infinite for lamotrigine, and CI 22 to infinite for nevirapine, as no controls reported
the use of either one of the drugs. Sertraline revealed a multivariate RR of 11 (2.7–47), whereas
no increased risk could be found for terbinafine.
Conclusions: Antibacterial sulfonamides, allopurinol, and antiepileptics were associated with a
highly increased risk to induce SJS and TEN. New drugs with a high risk to induce SCAR are
lamotrigine and nevirapine, both requiring careful monitoring in the future to estimate their risk
more accurately. In general, risks were restricted to the first eight weeks of use for all drugs with
an increased risk for SCAR. However, for a number of drugs widely used no detectible risk could
be found.
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Improving Protection In Sunscreen Users: A Randomized Study Showing The Major
Effect Of Labeling and Cost
Nicol I1, Gouvernet J2, Richard MA1, Grob JJ1
1Hoˆpital Sainte-Marguerite, Marseille, France; 2Hoˆpital de la Timone, France
Background: Although sunscreens (SCs) are not an ideal protection, they are widely used. A
misleading labeling for the layman (Sun Protection Factor, SPF), and a high cost may account
for an insufficient amount per application, and an incorrect choice of SCs which compromise
protection.
Methods: 3-arm prospective randomized survey in 364 individuals in vacation in 3 beach
resorts to assess whether an explicit labeling and a low cost could influence favorably the use
of SCs and the skin protection: 1/Free SCs (FS)¼ 4 types of SCs with their usual SPF B and A
label (60B-60A, 20B-20A, 12B-12A, 6B-3A) at free disposal; 2/Same free SCs with new
explicit labeling (FNL), summarizing their properties in terms of sunburn protection, likely
protection against long-term effects of UV, and possibility to get a tan; and 3/No intervention
(NI). Main outcome measures were the quantity and type of SCs applied, sunburns, and sun
exposure.
Results: As compared to FS, FNL significantly increased the quantity of SCs applied (þ 85%,
and much more in individuals who did not consider tanning as a major objective than in ‘‘tan-
seekers’’), reduced sunburns particularly in sun-sensitive individuals (25.6% vs 58.3%,
p¼ 0.005), and induced a shift in the level of SCs chosen. As compared to paying SCs (NI),
free-SCs delivery was associated with a more systematic application of SCs, and a
decreased sunburn occurrence, without increase of sun exposure.
Conclusion: An explicit labeling of SC bottles dramatically improves the use of SCs and the
skin protection in those who search for safety, and gives a better perception of the risks in
‘‘tan-seekers’’. Measures as to SCs labeling and cost could improve the protection in SCs-
users, without inducing a more risky behavior.
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Should Furry Pets be Banned for Atopic Eczema?
Langan S, Flohr C, Williams HC
Queens Medical Centre, Nottingham, United Kingdom
Domestic animals are frequently blamed for either promoting the onset or precipitating flares
of atopic eczema (AE).
We sought to systematically search, summarise and critically appraise the evidence to
support the roles of pets in atopic eczema.
We searched Medline and Embase from 1966 until May 2005 to identify relevant articles for
inclusion in our review. There were no language restrictions. Meta-analysis was not possible
due to differences in study methodology and populations. A descriptive summary of studies
is therefore presented.
Preliminary data from 13 relevant studies identified six papers showing a possible
protective effect between pet keeping and the development of AE. Of these, two showed a
protective effect for any pet, two for cat or dog, one for dog only and one for cat- an
association that was no longer significant when adjusted for avoidance behaviour. Six papers
failed to show a significant association. One retrospective questionnaire study of 6 to 12 year
olds suggested increased AE in those keeping furry pets. No studies on pets and AE flares
were identified.
Contrary to public opinion, pet keeping in early life may have a protective effect on the
development of AE. Such an effect may be related to increased endotoxin exposure
promoting a Th1 response. Reverse causation may be another explanation, i.e. families at risk
of atopic disease avoiding pet ownership, although this has not been shown in the two papers
that have adjusted for such an effect.
Currently, there is no good evidence to support advising atopic parents to avoid purchasing
a pet or to remove domestic animals from the household following the development of AE in a
child in the absence of clinically obvious flares.
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Is Eczema Really on the Increase Worldwide?
Williams H, Stewart A, Von Mutius E, Cookson W, Anderson R
Queens Medical Centre, Nottingham, United Kingdom
We wanted to see if atopic eczema symptoms have increased worldwide. We did this by
studying children (n¼ 298,080) aged 13–14 years in 104 centres from 55 countries around the
world, and children aged 6–7 years (n¼185,891) from 64 centres in 36 countries who
participated in successive cross sectional prevalence surveys 7 years apart in the same study
centres using validated and translated questionnaires (Phase 1 and III of the International
Study of Asthma and Allergies in Childhood). Children with a positive response to an itchy
relapsing skin rash in the last 12 months that had affected the skin creases were considered
to have eczema, and those with symptoms resulting in sleep disturbance for 1 or more nights
per week were considered to have severe eczema. Changes in prevalence per year (weighted
by the standard error) over the 7 year period were generally small. Many of the centres
previously showing the highest prevalences now show a levelling off or decrease in
prevalence. Similar patterns are seen for those with severe eczema, arguing against
differential reporting of mild disease. The picture elsewhere is mixed, with many formally low
prevalence countries experiencing substantial increases in eczema symptoms. Our results
suggest that the epidemic of eczema may be levelling off or falling in some countries with
previously high prevalence rates, and has highlighted other areas of the world where an
increase in eczema might be targeted by primary and secondary prevention programmes.
The changing prevalence of eczema symptoms needs to be confirmed in studies with
objective skin examination. The observation of changes over such a short time suggest that
environmental factors are important in determining eczema expression, and that a threshold
effect may be operating whereby a number of susceptibles develop disease until a saturation
point occurs.
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Epidemiology of Tick Bites and Borreliosis in Children Attending Kindergarten or So-
Called ‘Forest Kindergarten’ in South-Western Germany
Weisshaar E, Schaefer A, Scheidt R, Diepgen TL
University Hospital of Heidelberg, Germany
So-called ‘forest kindergartens’ have been increasingly popular in Germany since the
beginning of the 90s. These are nurseries located in forested areas where children spend all
day outdoors (mostly 6 hours per day), even during winter time. 53 kindergartens in the state
of Baden-Wu¨rttemberg participated in this study. In a retrospective part, the child’s personal
data, personal history and protective habits of the parents concerning tick bites were
documented. In a prospective clinical study, tick bites and borreliosis were documented
monthly by using a standardised questionnaire between March and October 2004.
Altogether, 1707 children of 25 ‘forest kindergartens’ (506 children) and 28 conventional
kindergartens (1201 children) were included. The average monthly return of questionnaires
was 75% in ‘forest kindergartens’ and 65% in the other kindergartens. In the ‘forest
kindergartens’, 1503 tick bites especially on the trunk and on the head were found whereas
502 tick bites were registered in conventional kindergartens. Altogether, 16 cases of
borrelioses were diagnosed (10 in ‘forest kindergartens’, 6 in kindergarten), most frequently
manifestating as erythema migrans. In conclusion, children attending ‘forest kindergarten’
have a 7.5 times increased risk of experiencing tick bites and a 4.0 times increased risk of
suffering from borreliosis compared to conventional kindergarten in Germany, though
protective behaviour of the parents of ‘forest kindergarten’ children was significantly better
compared to the parents of conventional kindergartens.
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Immunoglobulin E Responsiveness and Atopy-Related Diseases in Relation to Risk of
Cancer of the Lung, Breast, Colorectum and Prostate
Wang H1, Rothenbacher D2, Stegmaier C2, Lo¨w M2, Brenner H2, Diepgen TL1
1University of Heidelberg, Germany; 2German Centre for Research on Aging, Germany
Background: There is increasing epidemiological evidence for a role of allergic/atopic
disorders in cancer development. Inconsistent findings may be due to differences in defining
allergy and the associated atopic disorders. Use of a biological marker for atopy may
enhance the specificity in the exploration of the association with cancer risks.
Methods: To examine the association of atopy with common malignancy, we conducted a
population-based case-control study enrolling 318 patients with prostate cancer, 381
patients with breast cancer, 196 patients with lung cancer, 477 patients with colorectal cancer
and 4271 controls in Saarland, Germany. Data on physician-diagnosed atopy-related
diseases (asthma, hay fever, atopic dermatitis) was obtained by self-administered
questionnaire. Allergen-specific immunoglobulin E (IgE) was assessed among cases and
controls to define atopy.
Results: We observed a significantly increased risk of prostate cancer with specific IgE
positivity (odds ratio (OR) 1.35, 95% confidence interval (CI) 1.00–1.83). A history of asthma
conferred a nonsignificant increase in risk of lung cancer (OR 1.40, 95% CI 0.71–2.77). The
prevalence of atopy and atopy-related diseases was slightly higher among breast cancer
cases than controls, but the difference was not statistically significant. There was no clear
evidence that atopy or atopy-related diseases were significantly associated with risk of
colorectal cancer, although a nonsignificant inverse association was observed between
atopic dermatitis and risk of colorectal cancer.
Conclusion: Our findings are consistent with other epidemiological evidence suggesting an
increased risk of prostate cancer with atopy and increased risk of lung cancer with asthma.
The results indicate a complex association between atopy/atopy-related diseases and
cancer risk that varies on by type of atopy-related disorders and the particular type of cancer
under consideration. The effect on cancer risk by atopy, defined by IgE reactivity, may differ
from the effect by atopy-related clinically defined diseases such as asthma, hay fever and
atopic dermatitis.
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Psoriasis has a Signiﬁcant Negative Impact on Patients’ Work and Productivity
Wu Y1, Mills D2, Bala M3
1Centocor, Inc., USA; 2Consumer Health Sciences, USA; 3Centocor, Inc, USA
Purpose: Psoriasis negatively impacts patient quality of life. To evaluate the impact of
psoriasis on work and productivity.
Methods: The National Health and Wellness Survey (NHWS) is an annual comprehensive
nationwide study of healthcare related attitudes and behaviors in the US. Data in this analysis
came from a 2004 survey, conducted in May-June 2004 via the internet. A broad range of
health-related questions were asked, including employment and work productivity assessed
by the Work Productivity and Activity Impairment Instrument (WPAI). Patients with a diagnosis
of psoriasis were extracted. A matched cohort of patients without psoriasis was used to
assess whether psoriasis has a negative impact on work and productivity as measured by
WPAI.
Results: Of 1127 psoriasis cases (72% mild, 20% moderate, 6% severe, 1% missing on
severity) included in the analysis, each case was matched to non-psoriasis patients by age
(within 4 years), gender, region, and race. A matched patient was then randomly chosen as
the control. Among 629 employed psoriasis patients and their matched controls, psoriasis
patients were more likely to have missed hours due to health in the last week (OR 1.37,
po0.05). Psoriasis patients were also likely to have missed more than one day due to health
in the last week. Compared to matched controls, psoriasis patients reported significantly
more productivity impairment at work due to health (OR 1.66, po0.001), more overall work
impairment, which reflects both time lost from work and productivity while working (OR 1.62;
po0.001), and more impairment for activity other than work (OR 1.59; po0.001).
Conclusions: This large-scale national survey suggests psoriasis has a significant negative
impact on work and productivity. Further research is needed to further investigate the
economic burden of psoriasis.
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Life Time Prevalence and Characteristics of Photodermatoses in Europe
Bock M1, Anastasopoulou L2, Antoniou C2, Aubin F3, Bruckner T1, Faivre B3, Gibbs NK4, de
Gruijl FR5, Jansen C6, Janssens AS5, Ling TC4, Niemela¨ S6, Pavel S5, Rhodes LE4, Stratigos
CA2, Diepgen TL1
1Dep of Clinical Social Medicine, Univ of Heidelberg, Germany; 2A Sygros Hosp, Univ of
Athens, Greece; 3Dep of Dermatology, Univ Hospital, Besanc¸on, France; 4Univ of
Manchester, United Kingdom; 5Leiden Univ Medical Centre, The Netherlands; 6Univ of
Turku, Finland
Objectives/Methods: Although photodermatoses appear to be common skin diseases,
epidemiological data are lacking. In the framework of the European project SUNALL (http://
www.sunall.net) we performed a survey in indoor workers (mainly hospital staff) on
prevalence, signs, symptoms and treatment of photodermatoses (‘‘sun allergies’’) using a
standardised questionnaire within Europe.
Results: In 6 centres distributed from the Mediterranean to Scandinavia, the data of 6866
participants were analysed. 18% of them answered that they do get an itching rash/abnormal
skin after sun exposure (a so-called ‘‘sun allergy’’), which does not fit the criteria of a sunburn.
In 29% the photodermatoses have been confirmed by a physician (55% dermatologists).
Women are nearly three times more often affected than men (23% vs. 9%). Comparing the
different centres we found the following lifetime prevalence rates for photodermatoses:
Athens (Greece) men 15%/women 26%, Besanc¸on (France) 5%/21%, Heidelberg (Germany)
9 %/29%, Leiden (The Netherlands) 7%/26%, Manchester (United Kingdom) 9%/26% and
Turku (Finland) 2%/14%. Increasing pigmentation correlates with a decrease of photo-
dermatoses (overall prevalence skin type I 32%, II 26%, III 14%,  IV 9%). About half of the
photodermatoses have been treated mostly with sun block cream (65% of those treated).
Other treatments were steroid cream (42%), phototherapy (9%) or steroid tablets/injections
(7%). Only 54% get their rash during springtime but over 90% during sunny holidays. 93%
experience itching during the rash. 25% of people with photodermatoses report a reduction
of their quality of life.
Conclusions: Our data document the high prevalence of photodermatoses in Europeans. We
found no evidence of increasing prevalence at higher latitudes, i.e. in association with more
striking seasonal changes in ambient UVR. In contrast, prevalence was highest in Greece, the
most southerly country, where there was also a reduced sex ratio. This may reflect that they
live in a climate that aggravates their disease.
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Does Peritoneal Dialysis Protect Against Skin Cancer in Transplant Recipients?
Bouwes Bavinck J1, EC Group2
1Leiden University Medical Center, The Netherlands; 2EPI-HPV-UV-CA study group,
Renal-transplant recipients have an increased risk of skin cancer. The influence of
haemodialysis and peritoneal dialyses before renal transplantation on the risk of skin cancer
up to 30 years after the transplantation was studied in 76 renal-transplant recipient with and
114 recipients without a history of skin cancer.
Recipients with haemodialysis before the transplantation had a 2-fold increased risk of skin
cancer compared to recipients who were not dialyzed: OR (odds ratio and 95% confidence
interval) 2.3 (0.77;7.2). By contrast, peritoneal dialysis was not associated with an increased
risk of skin cancer compared to recipients who were not dialyzed: OR 0.68 (0.17;2.7). The risk
in recipients who had peritoneal dialysis in addition to haemodialysis was reduced to base-
line level: OR 0.52 (0.15;1.9). The risk of skin cancer was 4-fold lower in recipients who had
peritoneal dialysis in addition to haemodialysis compared to recipients who received only
haemodialysis: OR 0.23 (0.10;0.50). Major factors that may confound this association are time
period after transplantation (peritoneal dialysis was introduced in 1982, transplantations
started in 1967); age of the patients (peritoneal dialysis patients are younger) and number of
transplantations (peritoneal dialysis is more likely to be given after failure of a graft).
Adjustment for these factors as well as sex and time period on dialysis resulted in an adjusted
OR of 0.34 (0.14;0.80).
Peritoneal dialysis before the transplantation appears to have a protective effect on the
development of later skin cancers compared to recipients who received only haemodialysis.
We hypothesize that peritonitis caused by infections, which is a frequent complication of
peritoneal dialysis, may lead to cross-reactive anti-tumor activity or cross-reactive ‘‘cancer
vaccination’’, providing - to some extent - protection against the later development of skin
cancer.
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Effect of Authors’ Suggestions Concerning Reviewers on Manuscript Acceptance
Goldsmith LA1, Blalock EN2, Bobkova HN2, Hall RP3
1University of North Carolina at Chapel Hill, USA; 2Journal of Investigative Dermatology,
USA; 3Duke University, USA
Purpose: Determine the effects of authors’ suggested/excluded reviewers on manuscript
acceptance.
Design: The Journal of Investigative Dermatology is ranked first in impact factor in its clinical
and basic science specialty. 228 consecutive submissions of original articles, representing
one-third of 2003 annual submissions, were analyzed for the effect of authors’ suggestions
concerning reviewers on peer review outcome.
Results: 40% of submitters neither suggested nor excluded reviewers; 39% suggested only,
16% both suggested and excluded, and 5% excluded only. 55% of submitters suggested
between one and fourteen reviewers (mode¼ 4). 19% of suggested reviewers were invited; of
those 92% agreed to review; of that number, 90% completed reviews. 21% of submitters
asked to exclude one or more reviewers. Of those requesting exclusion of reviewers, 54%
named one; 25% named two; 21% named three or more. The most common reason was
‘‘close competitors’’, but usually no reason was given. Authors’ requests for exclusion were
followed 93% of the time. Odds ratios were calculated with STATA7 and are presented with
the 95% confidence intervals in parentheses. Odds ratios for acceptance were 1.64 (.97–
2.79) for authors suggesting reviewers compared with those not suggesting reviewers, and
2.38 (1.19–4.72 ) for those excluding reviewers. Multivariate analysis of acceptance rate had
an odds ratio of 2.17 (1.08–4.38) for excluding reviewers after correcting for the authors
suggesting reviewers. No significant difference (t-test) was found in the time to first decision
for either group.
Conclusions: Authors excluding reviewers had higher acceptance rates by univariate
analysis and multivariate analysis. Suggesting reviewers had less of an influence on
acceptance than excluding reviewers. The advantage for authors of excluding reviewers
requires processes to eliminate bias during peer review.
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Prevalence and Severity of Acne in 20 to 60 Year Olds
Radulescu M, Radulescu G, Bruckner T, Diepgen TL
University of Heidelberg, Germany
As few population-based data is found on the prevalence of acne in Germany, we
investigated the point prevalence and lifetime prevalence of acne as well as its severity in
the population of Heidelberg.
2500 randomly selected inhabitants of Heidelberg between 20 and 60 years of age were
asked to fill in a questionnaire requiring information about the presence of acne at the time
and the quantity, localisation and nature of existing lesions. With 143 persons having already
moved out of the study area and a remaining sample size of 2357, the response rate was 72%
after 2 additional reminders. For yet another 5% of the study population, reasons for non-
response could be assessed. 13% of the participating 20 to 60 year olds reported the
presence of acne at the time, 18% of participants 20 to 40 years compared to almost 8% of
participants over 40 years of age. One third of study participants stated they had had acne in
the past. More than 75% of participants reported comedones, papules and pustules,
whereas nodules, cysts and abscesses occurred only in 11% of participants. 89% of affected
participants reported lesions on their face. The back, chest and upper arms were affected in
48%, 29% and 12% of participants reporting acne, respectively. Almost half of the affected
study participants had less than 5 concurrent lesions, whereas 8% reported more than 20
lesions occurring at the same time. Only 16% of affected study participants received medical
treatment because of their acne, 74% of these being treated by a dermatologist.
Our results confirm that acne is not uncommon in adults 20 to 60 years old, particularly in
those up to 40 years of age. Mild forms are much more common than severe ones, and
medical treatment is rarely required.
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Prospective Study on the Long-Term Effect of In-Patient Treatment on Quality of Life and
Clinical Severity in Atopic Dermatitis and Psoriasis Vulgaris
Schmitt J, Pfeiffer C, Heese E, Wozel G, Meurer M
University Hospital Dresden, Germany
Financial constraints challenge evidence of the effectiveness of dermatological in-patient
management. From the patient’s perspective, quality of life (QoL) is the primary outcome. It is
unclear whether clinical improvement translates into QoL benefit. A prospective study on
adults with psoriasis vulgaris (Pso) and atopic dermatitis (AD) was conducted to assess the
long-term effect of hospitalization in severe Pso and AD on both QoL and clinical severity.
Adults with Pso and AD hospitalized between 07/2003 and 05/2004 at the Department of
Dermatology, University Hospital Dresden, Germany were eligible (n¼ 62). 36 patients were
enrolled, 29 (81%) followed-up. At admission, discharge, and 3-month follow-up Dermatol-
ogy Life Quality Index (DLQI), visual analogue scales of severity and itching, Investigator/
Patient Global Assessment (IGA/PGA), Psoriasis/Eczema Area Severity Index (PASI/EASI),
SCORAD-Index, and Psoriasis Life Stress Inventory (PLSI) were assessed. Primary endpoint
was the change in mean DLQI between admission and 3-month follow-up. Linear regression
models were fitted to explore the association of DLQI-change, change in clinical severity
measurements, and sociodemographic factors. DLQI decreased by 9.46 (95%-CI 5.11–
13.81, p¼ 0.0011) in AD and 8.81 (95%-CI 4.64–12.98, p¼ 0.0009) in Pso. Absolute scores
and changes in scores of subjective and objective measurements of disease severity were
highly interrelated in AD, and weakly respectively moderately interrelated in Pso. Best
predictors for DLQI-change were SCORAD-change in AD (R2¼ 66.51%) respectively PLSI-
changeþPASI-change in Pso (R2¼ 66.52%). Thus, the SCORAD seems appropriate to
measure subjective disease severity in AD. In Pso the PASI alone does not adequately reflect
subjective disease severity. We conclude that hospitalization had a long-term beneficial effect
on QoL in Pso and AD. To assess the relative importance of dermatological in-patient
management, future studies should compare in-patient and outpatient treatment.
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Assessment of Severity of Hand Eczema, and Discrepancies Between Patient- and
Physician-Related Scores
Van Coevorden AM, Van Sonderen E, Bouma J, Coenraads PJ
University Medical Centre Groningen, The Netherlands
Unvalidated methods are used to measure severity of chronic hand eczema. This scoring can
be done on clinical severity, by either physician or patient, and on burden of disease by the
patient.
We will demonstrate the relationships and discrepancies between physician and patient
rated severity scores of hand eczema (including both clinical severity and burden of disease),
and their changes over time.
In 158 patients three domains of hand eczema were measured: the dermatologist’s
assessment of severity, the patient’s assessment of severity, and the patient’s burden of
disease. The first is measured by a scoring system based upon erythema, desquamation,
infiltration, and fissures, the second with a self-rating scale, and the third by the DLQI.
Correlations before and after a 10 weeks intervention were calculated to assess the relations
between the physician’s and the patient’s assessments.
Patient-rated severity showed only correlations with DLQI items embarrassment and
occupational impairment. Only desquamation and infiltration were correlated with the patient-
rated severity. After 10 weeks all these correlations were lost.
We conclude that the DLQI items embarrassment and occupational impairment are most
influential on the patient’s perception of his hand eczema. Surprisingly, patient-rated severity
did not correlate with fissures or vesicles.
Each of the three domains for hand eczema may be relevant as outcome variable in clinical
research or epidemiological studies. However, relations among them are limited. Importantly,
disease severity as assessed by a physician, does not necessarily reflect the patient’s
opinion. Nor can we make assumptions about burden of disease based upon the patient’s
assessment of clinical severity.
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Allergic Sensitization to Common Inhalant Allergens and its Association to Atopic
Diseases in the Elderly: Results of the Population Based ESTHER study
Wolkewitz M1, Rothenbacher D1, Loew M1, Stegmaier C2, Ziegler Helber, Radulescu M1,
Brenner H1, Diepgen T1
1Universita¨t Heidelberg, Germany; 2Saarland Ministry for Public Health, Germany
Background/Aim: We aimed to determine the prevalence of allergic sensitization to
common inhalant allergens and describe the main socio-demographic determinants of
allergic sensitization in a large population based sample of elderly. In addition we investigated
the association of allergic sensitization with the prevalence of various self-reported atopic
diseases.
Methods: 4696 participants aged 50 to 74 years were recruited by their general practitioner
between June 2000 and December 2002 in the State of Saarland, Germany. All subjects filled
out a standardized questionnaire and reported whether a physician had diagnosed an atopic
disease (hay fever, asthma or atopic dermatitis). The presence or absence of specific IgE to
common inhalants, like mite, oak, ragweed, grass, dog, cat and alternaria, was determined in
the serum samples of all participants.
Results: Overall, we found a prevalence of 21.2% for allergic sensitization in the study
population (mean age 61.9 years (SD¼ 6.6)). The prevalence was 24.4% in males and 18.7%
in females, decreased with increasing age (p trend o.0001). Urban living in adolescence, a
longer duration of school education and having a family history of atopy were associated with
an increased risk for allergic sensitization. The prevalence of self-reported hay fever, asthma
and atopic dermatitis was 28.7%, 10.8% and 4.1% among those with positive IgE response
and 2.7%, 4.0% and 3.7% in those without an IgE response.
Conclusion: The prevalence of allergic sensitization to inhalants appeared lower in the elderly
compared to studies among younger adults. Even in our age group the prevalence decreased
with increasing age. Sensitization to inhalants was associated with a high prevalence of
respiratory symptoms such as hay fever and asthma.
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Atopic Dermatitis and Cancer Risk
Wang H, Diepgen TL
University of Heidelberg, Germany
Background: Epidemiological studies have provided growing evidence of a link between
atopy and cancer risk.
Objective: The aim of this paper is to review the evidence from case-control studies and
cohort studies on a possible association between atopic dermatitis (AD) and cancer risk, with
particular attention to the case-definition of AD.
Methods: Studies with quantitative data on the association between AD (eczematous
disease) and cancer risk were obtained from MEDLINE in combination with a review of cited
references.
Results In 23 publications, AD has been implicated in the risk of haematologic (childhood
leukaemia (n¼ 3), adult leukaemia (n¼ 3), non-Hodgkin lymphoma (NHL) (n¼ 4) and different
haematological cancers (n¼1), pancreatic (n¼ 5), skin (n¼ 2) and brain malignancies (n¼ 5).
The overall picture of the results of these studies shows that a history of AD may be
associated with a decreased risk of pancreatic cancer, brain tumour and childhood
leukaemia, although in most instances the findings were not statistically significant. No
consistent associations were observed for skin cancer or Non-Hodgkin’s Lymphoma. The
definition of AD had varying quality, and was imprecise in many publications.
Conclusions: The findings of the epidemiological studies tend to support a lower risk of
cancer among persons with a history of AD. Although a more careful definition of AD is
needed, these epidemiological studies could provide an estimate of the background cancer
risk in patients with AD when the long-term effects of treatments for AD are assessed.
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Cost-Effectiveness of Salicylic Acid and Cryotherapy for Cutaneous Warts
Thomas KS1, Keogh-Brown M2, Chalmers JR1, Fordham RF2, Holland RH2, Armstrong SJ1,
Rodgers S1, Avery AJ1, Harvey I2, Williams HW1
1University of Nottingham, United Kingdom; 2University of East Anglia, United Kingdom
Purpose: In 2002, a Cochrane systematic review found little convincing evidence that
cryotherapy was any better than salicylic acid for the treatment of cutaneous warts. Rather
than proceeding directly to a randomised controlled trial, the NHS Health Technology
Assessment Board (UK), commissioned an economic decision model to compare the cost-
effectiveness of these two commonly used treatments.
Methods: An economic decision model was developed using Monte Carlo simulation
techniques. The model was informed by a combination of published evidence and primary
data collection; including a postal questionnaire of 720 patients who had attended their
general practitioner for the treatment of warts, focus group discussions, and structured
observation of practice.
Results: The three most cost-effective options for the treatment of warts (compared to
spontaneous resolution) were duct tape, over-the-counter cryotherapy and over-the-counter
salicylic acid. However, efficacy data are limited for the first two options. The model
estimated incremental cost-effectiveness ratios for these treatments of 0.22, 0.76 and 1.12
respectively. Of treatments prescribed by a general practitioner, the incremental cost-
effectiveness ratios were 2.20 for salicylic acid, or from 1.95 to 7.06 for cryotherapy;
depending on the frequency of applications and the mode of delivery. Cryotherapy delivered
by a nurse could be of comparable cost-effectiveness to salicylic acid prescribed by a GP
under certain circumstances. This may be a useful way of delivering cryotherapy in the future.
Conclusions: Cryotherapy delivered by a doctor is an expensive option for the treatment of
warts in primary care in the UK. Alternative options such as prescribed salicylic acid and
nurse-led cryotherapy clinics provide more cost-effective alternatives, but are still expensive
compared to self-treatment. Given the minor nature of most cutaneous warts, coupled with
the fact that the majority spontaneously resolve in time, we conclude that a shift towards self-
treatment is warranted.
Disclaimer: The views and opinions expressed therein are those of the authors and do not
necessarily reflect those of the Department of Health.
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What Constitutes a Flare of Atopic Eczema?
Langan S, Thomas KS, Williams HC
Queen’s Medical Centre, Nottingham, United Kingdom
Atopic eczema (AE) is a chronic relapsing disease characterised by flares and remissions.
Although some trials over the last 3 years have evaluated long-term control of AE and
prevention of flares, they have run into difficulties in defining what constitutes a ‘‘flare’’ in AE.
Our aim was to critically assess how flares have been defined in published scientific studies
of AE.
An optimally sensitive electronic Medline search combining terms for atopic eczema and
synonyms for ‘‘flare’’, restricted to prospective studies was performed and supplemented by
hand searching of references.
As anticipated, the definition of flares used is widely varied. Preliminary data from 36
studies has revealed that the majority have defined disease exacerbations on the basis of an
arbitrary cut off point on a clinical scoring system only. Scoring systems included the
Investigator global assessment (IGA), three item score (TIS), scratch scores, Costa scores,
total body disease activity score and SCORAD scores. Some have defined exacerbations on
the basis of behaviour only, for example the use of topical corticosteroids to treat a flare. One
study group has used a composite score combining a clinical score, behaviour and duration
of symptoms.
There is no consistent definition for AE flares. This is a critical deficit in a disease with a
fluctuating clinical course as it limits comparison of study results. Investigators in diseases
such as asthma and rheumatoid arthritis have experienced similar problems.
There is a need to develop a consensus definition for a disease flare in AE incorporating a
standard disease severity score, a quality of life score, treatment use and duration. Pending
this, we propose that authors planning trials in AE combine the TIS, dermatology life quality
index (DLQI) score, corticosteroid use and symptoms greater than three days to define
disease flares.
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An Audit of the Management of Tinea Capitis using the British Association of
Dermatology Guidelines
Madan V, Wittering KL, Walker SL
Hope Hospital, Manchester, United Kingdom
Tinea capitis is a dermatophyte infection of scalp hair follicles and the surrounding skin. There
has been a large increase in the number of cases reported from large urban areas in the UK,
the USA and Europe. It has also been observed that the commonest causative organism is
now the anthropophilic organism Trichophyton tonsurans.
The British Association of Dermatologists published guidelines for the management of tinea
capitis in 2000. We decided to audit the management of tinea capitis at our Dermatology
Centre based in a large teaching hospital, which receives dermatology referrals from the
whole of Greater Manchester.
Case notes of all individuals with a positive mycology result regardless of site between
January 2001 and December 2002 were reviewed retrospectively. Those identified as having
tinea capitis were then analysed against the guidelines. Recommendations to improve
adherence to the guidelines were proposed. This process was then repeated for the period
January 2003 to the end of October 2004 to see if any of the recommendations had altered
management.
57 cases were identified over the 46-month period of which 58% were due to T. tonsurans.
In the initial audit it was found that treatment with griseofulvin was suboptimal in 35% either
due to incorrect dose or duration of therapy. The rate of documented mycological cure was
also very low at 13% and a similar result of 15% was identified for the recommendation or
actual screening of siblings of affected children. There were also high rates of premature
follow up (78%) at six weeks or earlier, rather than at eight weeks.
The reaudit performed by the same investigator using an identical methodology
demonstrated an improvement in the appropriate dosing of griseofulvin to 80% of those
treated. The documented mycological cure rate had risen to 42% of cases. The screening of
siblings had also risen to 47%. The follow up before eight weeks had also fallen to 42%.
Our auditing of the management of tinea capitis at our centre has improved the treatment
and follow up of cases. It has also increased the chances of identifying latent disease in
siblings and potentially reduced the number of clinic attendances.
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Increased Urinary Concentration of Nitric Oxide in Yusho Victims over 35 Years after the
Accidental Poisoning of Polychlorinated Biphenyls in Japan
Ogawa F, Shimizu K, Sato S
Dept of Dermatology, Nagasaki University, Japan
The accidental poisoning of polychlorinated biphenyls (PCB), which is one kind of dioxin,
occurred in a large area of western Japan in 1968. The victims were called Yusho patients. At
the early stage, Yusho patients suffered with severe acne-like eruption, pigmentation, and
hyperkeratosis as skin lesion. These lesions are still recognized in Yusho patients, although
their severity is reduced. It has been hypothesized that the strong cytotoxicity generated by
the oxidative stresses may contribute to the persistent development of these eruptions in
Yusho patients. To assess this hypothesis, the urinary nitrite, which reflects nitric oxide, was
assessed in Yusho patients. After receiving informed consents, 48 Yusho patients (mean age,
67  12 years) were examined at Nagasaki Prefecture and age-matched 66 healthy
individuals (68  13 years) were used as normal controls. Blood samples were collected
and urine samples were snap-frozen and kept at 801C until analyses. The concentration of
urinary nitrite was measured using the Griess method and other parameters, including PCB,
were also assessed in Yusho patients. The mean value of urine nitrite in Yusho patients
(7.10  2.75 mM) was significantly higher than that found in normal controls (1.12  2.75 mM,
po0.01). This result suggests that there is an imbalance of reduction and oxidation regulation
(redox) in Yusho patients, and also suggests that the continuous redox instability may result in
carcinogenesis and organ failures of not only skin lesions in the near future.
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Cutaneous Malignant Melanoma at a Speciﬁc Anatomical Site and Number of Nevi at the
Same Site: A Case-Control Study in Italy
Randi G1, Naldi L2, Gallus S1, La Vecchia C1
1Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy; 2Centro Studi GISED, Italy
Cutaneous malignant melanoma (CMM) is strongly associated with total number of nevi, but
scanty information is available on the association between CMM at a specific anatomical site
and number of nevi at the same site. We analysed data from a case-control study conducted
in Italy between 1992 and 1994, on 541 CMM cases and 538 hospital controls. Cases and
controls were examined by trained dermatologists who counted the number of melanocytic
nevi. We analysed the correlation between total number of nevi and number of nevi at specific
site and derived odds ratio (OR) of site specific risk of CMM for the highest versus the lowest
tertile of number of nevi at the corresponding site after allowance for sex, age, education,
pigmentary phenotypes, propensity to sunburns, sunburn episodes and tobacco smoking.
Separate case-case analyses of CMM at specific site versus CMM at all other sites were also
performed. We found the highest correlation between total number of nevi and number of nevi
at upper limbs (r2 over 0.8 among cases and among controls for both genders). The OR of
CMM was 1.4 at face and neck, 2.3 at anterior trunk, 4.9 at posterior trunk, 2.9 at upper limbs
and 5.0 at lower limbs. In the case-case analysis, the only excess risk was found for the
posterior trunk (OR¼ 2.1). Our data do not support the hypothesis of a specific effect of nevi
at each single anatomical site, with the possible exception of posterior trunk. A tentative
interpretation is that total count of melanocytic nevi is a general risk indicator and that
melanocytic nevi by themselves are not an important precursor to CMM with the possible
exception of nevi on the trunk.
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Anthropometric Measures and Risk of Cutaneous Malignant Melanoma: A Case-Control
Study From Italy
Gallus S1, Naldi L2, Martin L2, Martinelli M2, La Vecchia C3
1Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy; 2Centro Studi GISED, Italy;
3Istituto Mario Negri; Istituto di Statistica Medica e Biomet, Italy
Several studies investigated the role of various anthropometric factors on the risk of
cutaneous malignant melanoma (CMM). Since results are controversial, we analysed the
issue in a case-control study conducted in Italy.
We analysed the role of several body size measures in a hospital-based case-control study
of CMM conducted in Italy. Cases were 542 patients with incident, histologically confirmed
CMM and controls were 538 patients admitted to the same hospitals of cases for non-
dermatologic and non-neoplastic diseases. Odds ratios (OR) of CMM were estimated by
unconditional multiple logistic regression models after allowance for age, sex, education,
history of sunburns, propensity to sunburns, number of nevi, number of freckles, skin, hair
and eyes colour, and tobacco smoking.
The OR for the highest vs the lowest quartile were 2.06 for weight, 1.16 for height, 1.90 for
BMI and 1.87 for BSA. When allowing in the same model for all these four anthropometric
measures, BMI was the strongest independent anthropometric risk factor for CMM.
The present results provide further evidence on the association between obesity and risk of
CMM, indicating that BMI has an independent role in the risk of melanoma. In terms of
population attributable risk, overweight and obesity would account for 31% of cases of CMM
in this Italian population.
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The Prevalence of Tinea Capitis Among School Children is Different Between Urban and
Rural Schools in the Greater Accra Region, Ghana
Lavrijsen AP1, Hogewoning AA2, Boakye D3
1Leiden University Medical Center, The Netherlands; 2University of Ghana Medical School,
Ghana; 3Noguchi Memorial Institute for Medical Research, Ghana
Infections with tinea capitis are endemic among school children in Africa. The objectives of
this study were to determine the prevalence and causative species of tinea capitis among
school children in different rural and urban schools in Ghana. The spectrum of causative
species was compared with other African countries.
A cross-sectional study was performed with 475 children aged between 5–17 years, and
residing in two rural and two urban schools in the greater Accra region (Ghana). All children
were clinically examined for tinea capitis. Skin and hair samples of symptomatic children
were tested by microscopic examination using 20% potassium hydroxide solution (KOH) and
cultivation on Sabouraud’s dextrose agar with chloramphenicol.
Based on clinical examination, 39 (8,4%) out of 463 children had tinea capitis. A total of 31
(6.7%) children were positive by direct examination (KOH) and/or fungal culture. The
prevalence of tinea capitis largely depended on the schools studied, ranging from 0.9% in an
urban school to more than 10% in the two rural schools. Similarly, the spectrum of causative
species varied importantly between the different schools. Taken all schools together, T.
violaceum (25.9%) was the most prominent species, followed by T. tonsurans (22.2%) and M.
audouinii (14.9%). These causative species were different compared to studies conducted in
other African countries.
Tinea capitis is endemic among school children in the greater Accra region (Ghana). The
prevalence of tinea capitis and the causative species largely depended on the type of school
that was investigated. More research should be done to study the different patterns of tinea
capitis in Africa into more detail.
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Psychometric Properties of Beer Sheva Psoriasis Severity Score
Cohen A
Faculty of Life Sciences, Bar-Ilan Universiy, Ramat-Gan, Israel
Background: The ‘‘golden standard’’ to assess psoriasis severity in research settings is
Psoriasis Area and Severity Index (PASI). However, its drawbacks prevent extensive use of
PASI in clinical settings. Beer Sheva Psoriasis Severity Score (BPSS) is a novel instrument
designed for use during routine working conditions. The first version of BPSS is being used
routinely since 2002 in patients with psoriasis vulgaris who receive climatotherapy at the
Dead Sea, in parallel to PASI, within the southern district of Clalit Health Service in Israel. In a
previous study, we have demonstrated the responsiveness and criterion validity of BPSS.
Objective: To review psychometric properties of BPSS.
Methods: The sample used to study BPSS included 70 patients with psoriasis vulgaris who
were treated by climatotherapy at the Dead Sea. In all patients, psoriasis severity was
assessed using BPSS and PASI. Factor analysis was used for data reduction in order to
identify the factors that explain the variance in BPSS. Internal consistency analysis (using
Cronbach’s alpha statistic) was performed for the identified factors of BPSS. Correlation
matrices were generated to compare BPSS factors, using a pre-defined correlation statistic
of 0.5 or greater as a minimum standard.
Results: The study included 70 patients (40 men, 30 women). The mean age was 50.8 years
(SD 13.8 years, range 19–78 years). Factor analysis demonstrated that BPSS included 6
factors. The factors were labeled as follows: ‘‘patients’ assessment’’ (3 items), ‘‘trunk, limbs
and total involvement’’ (4 items), ‘‘palms and soles involvement’’ (3 items), ‘‘genitals, nails and
pruritus’’ (3 items), ‘‘face involvement’’ (2 items) and ‘‘scalp involvement’’ (1 item). The total
explained variance of BPSS was 74.0%. The explained variance for each factor was as
follows: ‘‘patients’ assessment’’; 26.0%, ‘‘trunk, limbs and total involvement’’; 13.2%, ‘‘palms
and soles involvement’’; 11.9%, ‘‘genitals, nails and pruritus’’; 9.0%, ‘‘face involvement’’;
7.3% and ‘‘scalp involvement’’; 6.6%. Total scale Cronbach’s alpha was 0.76. Alpha for each
factor was as follows: ‘‘patients’ assessment’’; 0.81, ‘‘trunk, limbs and total involvement’’;
0.67, palms and soles involvement; 0.46, ‘‘genitals, nails and pruritus’’; 0.62 and ‘‘face
involvement’’; 0.39.
Conclusion: BPSS is constructed of 6 factors that explain most of the scale total variance,
which include particularly ‘‘patients’ assessment’’, ‘‘trunk, limbs and total involvement’’,
‘‘palms and soles involvement’’ and ‘‘face involvement’’.
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Incidence and Recovery Rate of Self-Reported Eczema in an Adult Population
Montnemery P1, Nihle´n U2, Lo¨fdahl CG2, Nyberg P1, Svensson A
1Dept of Health Sciences, Lund University, Sweden; 2Department of Respiratory Medicine,
Lund University, Sweden; 3Department of Dermatology, Lund and Malmo¨ University
Hospital, Sweden
Objective: Several studies have demonstrated an increasing prevalence of eczema, but few
have studied the incidence of eczema in the same population. Moreover the recovery rate
from it is even less studied. The objective of this study was to investigate the incidence and
recovery rate of self reported eczema in a large population of adult people. Furthermore,
factors of potential importance both for incidence and recovery rate were assessed.
Method: Postal surveys focusing on respiratory symptoms and airway diseases were mailed
out in 1992 and in 2000 to the same subjects. Of 4,933 subjects aged 28–67, 4,280 (86.8%)
answered the same questionnaire on both occasions. Odds ratios (OR) and confidence
intervals (CI) for different determinants of incidence and recovery were calculated by multiple
logistic regression with adjustment for age and gender.
Results: The 8 year cumulative incidence of eczema was 4.7% which was highest in the
youngest age group (28–37 years), and the incidence decreased with age. The 8 year
recovery rate of eczema was 3.4%. The age pattern for the recovery rate was reverse
compared with the incidence. The highest recovery rate was seen in the oldest age group
(58–67 years). Self-reported allergic rhinitis (OR¼ 0.6, 95% CI 0.42–0.86) and asthma
symptoms during the last year in 1992 (OR¼ 0.29, 95% CI 0.16–0.52) were associated with a
reduced chance of recovery. Use of asthma medication in 1992 was also associated with less
chance of recovery. Male sex was associated with an increased rate of recovery.
Conclusion: The study shows that the incidence of eczema and recovery rate of eczema are
low in an adult population during an eight-year period.
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Disease-Free Survival and Survival after Metastases of 202 Patients with Metastatic
Malignant Melanoma
Roller E, Ruzicka T, Schulte KW
Universita¨tsklinikum Du¨sseldorf, Germany
The aim of the study was the examination of the epidemiologic developments and prognostic
factors of metastasing malignant melanomas in the area of Du¨sseldorf. 202 patients suffering
from metastatic malignant melanoma were registered at the department of dermatology of
the Heinrich-Heine-University of Du¨sseldorf from 1990 until 1998. 103 (51%) of them were
male and 99 (49%) were female. Comparable to other results most melanomas in males were
diagnosed on the upper trunk (46.9%), whereas in females most melanomas were found on
the lower extremities (50%). Disease-free survival was significantly dependent on the
localisation of the primary tumor. Localisation of the malignant melanoma on the upper
extremity was associated with the longest disease-free survival (43.6 months). Shortest
disease-free survival periods have been seen for localisations on the head and special
localisations such as mucosa and eye for 21.3 months and 8.6 months respectively.
Localisation of the primary tumor was even proved to be a significant prognostic parameter
concerning the 5-years-survival rate among patients with progressive disease. 5-years-
survival rate after metastases was higher in patients with malignant melanomas of the lower
(38.7%) and upper extremities (35.9%) than any other localisation. Primary tumors on the
head and neck area (20%) and the trunk (7.9%) were associated with much lower 5-years-
survival rates.
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Analysis of HIV-1 Replication in Dendritic Cells Identiﬁes Restrictions Early in the Viral
Life Cycle
Pion M1, Arrighi JF1, Jiang J2, Lundquist C2, Hartley O1, Aiken C2, Piguet V1
1University Hospital of Geneva, Switzerland; 2Vanderbilt University School of Medicine, USA
During HIV mucosal transmission, Dendritic Cells (DC) are likely to be the first targets of HIV
infection. Viral replication in specific DC subsets is well demonstrated in vitro, at least with
large viral inoculum. Nevertheless, HIV/SIV-infected DC are rarely detected in vivo. We
analyzed whether the relatively inefficient viral replication in immature DC (iDC) could be
attributed to specific restrictions during the viral life cycle. In our experimental system, iDC
expressed CD4 and CCR5 and could be infected productively with HIV-1 using CCR5 (HIV-1-
R5). Although iDC also expressed CXCR4 coreceptor at their surface, infection with CXCR4-
tropic HIV-1 (HIV-1-X4) was non-productive. Viral capture by iDC was similar for HIV-1-R5 and
HIV-1-X4. However, using a specific and quantitative assay of HIV-1 particle fusion with the
cellular membranes, we observed markedly less efficient fusion of HIV-1-X4 with iDC relative
to HIV-1-R5. By real time PCR of genomic DNA extracted from infected iDC, we showed that
fusion restriction is accompanied by a 15-fold decrease in late reverse transcription products
for HIV-1-X4 compared to HIV-1-R5. Integrated provirus levels in iDC of HIV-1-X4 were
reduced by the same magnitude relative to HIV-1-R5. In conclusion, blocks early in the viral
cycle control viral replication in iDC. This restriction appears to be at least partly env-specific
during fusion steps.
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Trafﬁcking of HIV-1 to the Dendritic Cell-T Cell Infectious Synapse Uses DC-SIGN and the
Pathway of Tetraspanin Sorting to the Immunological Synapse
Garcia E1, Pion M1, Pelchen-Matthews A2, Collinson L2, Arrighi JF1, Marsh M2, Piguet V1
1University Hospital of Geneva, Switzerland; 2University College London, United Kingdom
DCs capture and internalize HIV at mucosal surfaces and efficiently transfer the virus to
CD4þT cells in trans via an infectious synapse. In this study, we characterized the DCs
trafficking pathways that HIV-1 follows during its capture and internalization, and subsequent
presentation to T cells. Using ratio imaging of pH-reporting fluorescent virions, we show that
HIV-1 is captured by live immature and mature DCs and accumulates in an intracellular
endocytic compartment with a pH of 6.2. Significantly, we demonstrate that the infectivity of
cell-free virus is more stable at mildly acidic pH than at neutral pH. Our immunofluorescence
microscopy and electron microscopy demonstrates that HIV-1 accumulates in intracellular
vacuoles that contain CD81 positive internal membranes (MVB), but overlaps only partially
with CD63, indicating that HIV-1 is localized in a non-conventional endocytic compartment.
When allowed to contact T cells, HIV-1-loaded DCs redistribute the tetraspanins CD81 and
CD9, as well as internalized HIV-1, to the infectious synapse. Furthermore, we recently
demonstrated that DC-SIGN was required downstream from viral capture for the formation of
the infectious synapse between DCs and T cells [citation removed]. Since CD81 and DC-
SIGN are components of the immunological synapse and modulate T cell activation, our
results suggest that HIV-1 is able to subvert the intracellular trafficking machinery required for
formation of the DC-T cell immunological synapse to facilitate efficient cell-to-cell transfer
and propagation. These findings offer potential novel opportunities to interfere with the early
events of HIV infection during or early after mucosal transmission of the virus.
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Candida Albicans Secreted Aspartic Proteinases (Saps) Modify the Epithelial Cytokine
Response in an In Vitro Model of Vaginal Candidiasis
Schaller M, Korting HC, Hube B
University of Tu¨bingen, Germany
Secreted aspartyl proteinases (Saps) are important virulence factors of Candida albicans
during mucosal and disseminated infections and may also contribute to the induction of an
inflammatory host immune response. We used a model of vaginal candidiasis based on
reconstituted human vaginal epithelium (RHVE) to study the epithelial cytokine response
induced by C. albicans. In order to study the impact of the overall proteolytic activity and of
distinct Sap isoenzymes, we studied the effect of the proteinase inhibitor pepstatin A on the
immune response and compared the cytokine expression pattern induced by the wild type
strain SC5314 with the pattern induced by Sap-deficient mutants. Infection of RHVE with the
C. albicans wild type strain induced a strong IL-1a, IL-1b, IL-6, IL-8, IL-10, GM-CSF, IFN-g
and TNF-a response in comparison with non-infected tissue. Addition of the aspartyl
proteinase inhibitors pepstatin A strongly reduced the cytokine response of RHVE.
Furthermore, SAP null mutants lacking either SAP1 or SAP2 caused reduced tissue damage
and had a significantly reduced potential to stimulate cytokine expression. In contrast, the
vaginopathic and cytokine inducing potential of mutants lacking SAP4 to SAP6 was similar to
the wild type infection. These data show that the potential of specific Saps to cause tissue
damage correlates with an epithelial-induced proinflammatory cytokine response, which may
be crucial in controlling and managing C. albicans infections at the vaginal mucosa in vivo.
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BOB.1/OBF.1 is a Critical Regulator of Th1-Mediated Immunity in Experimental
Leishmaniasis
Sindrilaru A1, Brunner C2, Girkontaite I2, Fischer KD2, Wirth T2, Sunderko¨tter C1
1University of Ulm, Department of Dermatology and Allergology, Germany; 2University of
Ulm, Department of Physiological Chemistry, Germany
In experimental leishmaniasis healing in genetically resistant strains is associated with Th1-
mediated, IFN-g-dependent containment of intracellular parasites. BOB.1/OBF.1 is a
transcriptional coactivator critical for the activity of octamer transcription factors Oct1 and
Oct2 which had been shown to be essential for B-cell function. In T-cells, this coactivator is
also expressed, e.g. after TCR engagement or treatment with PMA/ionomycin. However, it
has not been analysed yet if its expression has a relevant role for T-cell function.
We therefore investigated if BOB.1/OBF.1 influences the T-cell-mediated immunity in
experimental leishmaniasis.
BOB.1/OBF.1-deficient mice, generated on C57Bl/6 background, showed susceptibility to
L. major infection in contrast to the resistant wildtype (WT). This was reflected by significant
increase in footpad swelling and in parasite load of infected footpads and draining
lymphnodes. There were no differences in functions of macrophages or dendritic cells (DC)
with regard to NO or IL-12 release. However, when restimulated with L. major antigen, T-cells
from draining lymphnodes from infected BOB.1/OBF.1-deficient mice produced significantly
lower amounts of IFNg than those from WT mice.
To exclude an effect of BOB.1/OBF.1-defficient B-cells on the observed susceptibility,
Rag2-/- mice were reconstituted with WT B-cells and with either WT or BOB.1/OBF.1-
deficient CD4þcells prior to infection with L. major. Rag2-/- mice reconstituted with BOB.1/
OBF.1-deficient CD4þ cells showed higher parasite loads than mice with WT T cells,
independent from the presence of B-cells. This confirmed that the unfavourable course of the
infection was indeed caused by lack of BOB.1/OBF.1 in CD4þT-cells with subsequent
reduction in IFNg release, and not by defects in B-cells, macrophages or DC. To elucidate the
mechanism responsible for impaired IFNg production, we further showed that BOB.1/OBF.1
directly binds (electro mobility shift assays) and transactivates the IFNg promoter in vitro
(transient transfection) and in vivo (chromatin immunoprecipitation).
Thus, using the model of experimental leishmaniasis we revealed that BOB.1/OBF.1 is
important for Th1-mediated immunity in vivo. At molecular level, absence of BOB.1/OBF.1
causes inefficient IFNg promoter activation, reduced mRNA synthesis and consequently
reduced IFNgproduction.
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The MyD88-Dependent Signaling Pathway of the Sporothrix Schenckii Antigen-Induced
TLR2 Natural Immune Response in HDMEC
Yahata Y1, Shirakata Y1, Hanakawa Y1, Hirakawa S1, Mochizuki T2, Hashimoto K1
1Ehime University School of Medicine, Japan; 2Kanazawa Medical University School of
Medicine, Japan
Sporotrichosis is a granulomatous mycotic infection, mainly of the skin, caused by Sporothrix
schenckii. The immunological mechanisms involved in the prevention and control of
sporotrichosis have not been fully understood. Toll like receptors (TLRs) are components of
the innate immune system. Activation of TLRs results in secretion of proinflammatory
cytokines and induction of direct antimicrobial mechanisms. Human dermal microvascular
endothelial cells (HDMEC) are damaged in sporotrichosis and might play a role in the
formation of granuloma. In this study, we investigated TLR functions of HDMEC in
sporotrichosis using specific antigen. TLR2-9 were detected in HDMEC by RT-PCR. Among
them, TLR2 mRNA was increased by stimulation with sporotrichin antigen. TLR2 stimulation
results in the activation of MyD88 followed by IkBa activation. Sporotrichin antigen induced
the phosphorylation of IkBa with a maximum at 1 h. NFkB target molecules such as IL-6, IL-8,
GM-CSF and MCP-1 production were increased in HDMEC by Sporotrichin antigen.
Next, the role of MyD88 in the sporotrichin antigen-induced HDMEC reaction was studied
using an adenovirus vector expressing a dominant-negative form of MyD88 (DN-MyD88). DN-
MyD88 abolished the sporotrichin antigen-induced phosphorylation of IkBa. Transfection of
DN-MyD88 reduced Sporotrichin antigen-induced IL-6 and GM-CSF production in HDMEC
markedly. Combined, these data demonstrate that the inflammatory cytokine production
including IL-6 and GM-CSF in Sporotrichosis is mediated in part by the activation of TLR2 in
HDMEC.
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Vaccination with TAT-LACK Fusion Proteins Protects Mice Against Progressive Infection
with Leishmania major
Moelle K1, Butsch F1, Tada Y2, Lopez S1, Shibagaki N2, Knop J1, Udey MC2, Von Stebut E1
1Department of Dermatology, University of Mainz, Germany; 2Dermatology Branch, NIH,
Bethesda, MD, USA
In cutaneous leishmaniasis, healing is associated with IFNg-producing Th1/Tc1 cells. Fusion
proteins comprised of the protein transduction domain (PTD) of HIV-1 TAT protein and the
Leishmania-antigen LACK accumluate in the cytosol of dendritic cells (DC) and therefore
facilitate MHC-class-I-dependent antigen presentation. Leishmania-susceptible BALB/c as well
as resistant C57BL/6 mice were vaccinated with TAT-LACK-transduced DC i.d. in ears on d-7.
On d0, infections were initiated into contralateral ears using physiological low dose inocula with
1,000 promastigotes. In all experiments, TAT-LACK-vaccinated mice showed significantly
decreased lesion volumes as compared to non-vaccinated mice, and administration of TAT-
LACK was superior to injection of LACK alone (47  7, 98  8, and 98  10 mm3 for TAT-
LACK, LACK and PBS respectively in BALB/c mice (p  0.002, wk7)). Reduced lesion sizes
correlated with significantly lower lesional parasite burdens. We also utilized TAT-LACK as a
direct protein vaccine. BALB/c mice were vaccinated with 10 mg protein on d-7 and d-6. Co-
injection of CpG (10 mg) as adjuvant on d-5 was necessary to obtain protective immunity. In TAT-
LACK-vaccinated mice, lesion volumes were reduced by 4-fold compared to PBS-injected mice
and TAT-LACK was superior to LACK. By increasing the interval between vaccination and
infection from 7d to 14d we obtained an additional 73% reduction in lesion volume, suggesting
that longer priming intervals are beneficial for induction of Leishmania-specific Tcells. To assess
activation of DC by TAT-LACK in vivo, MHC-class-II positive cells in epidermal sheets were
visualized via immunofluorescence 3d after vaccination. Both, TAT-LACKþCpG as well as TAT-
LACK alone induced 10-fold higher activation and migration of DC as compared to PBS. Thus,
CpG does not play an obvious role in DC activation in this instance. These data suggest that TAT
PTD-containing fusion proteins may serve as promising tools for the induction of protective
immunity against infectious diseases.
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Human Dendritic Cell Subtypes Phagocytose Leishmania major and Release IL-12
Kirschsiefen P, Zahn S, Knop J, Von Stebut E
Johannes Gutenberg-University, Mainz, Germany
In murine experimental leishmaniasis, infected skin dendritic cells (DC) prime naı¨ve T cells,
release IL-12 and thus efficiently vaccinate against disease. In contrast, the role that infected
DC play for the induction of protective Th1-immunity in humans remains controversial. We
now studied the interaction of several life forms of L. major with monocyte-derived human DC
subtypes generated with GM-CSF/IL-4 in vitro (immature DC¼ imDC, matured with
cytokines¼mDC, Langerhans cell-like DC generated with TGF-b1¼TGF-DC) or with DCs
isolated ex vivo (myeloid DC¼ mDC, plasmacytoid DC¼pDC). First, the various DCs were co-
incubated with infectious stage metacyclic promastigotes or obligate intracellular amasti-
gotes of L. major. The majority of DCs phagocytosed both parasite life forms in a time- and
dose-dependent fashion. However, no parasite uptake was observed by pDC. Most efficient
promastigote phagocytosis was observed by DCs with an immature phenotype (imDC
41  7%, followed by TGF-DC 30  8%, mDC 14  3%, and mDC 10  4% infected cells/
18 hrs, parasite/cell ratio 3:1, n  3). Amastigotes isolated freshly from infected tissue were
taken up by imDC, mDC, TGF-DC and mDC with almost same efficiency (53  10%,
38  6%, 24  6%, and 42  8% infected cells/18 hrs, respectively). In parallel,
phagocytosis of L. major was associated with cell activation as determined by upregulation
of CD40, CD80 and CD83. IL-12p40/p70 release was detected by L. major-infected mDC and
mDC, but not imDC and TGF-DC (parasite/cell ratio 10:1, n  3). Production of IL-4, IL-6, IL-
10 or TNF-a was not found. In summary, in contrast to prior studies indicating that human DC
do not contribute to primary immunity against L. major, our results show that human DC
phagocytose the parasite and release IL-12. Thus, depending on the type of DC that interact
with L. major in vivo, human DC may contribute to the induction of Th1-dependent protective
immunity against this important human pathogen.
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Serological Relationship of HPV92, a New Type Isolated from a Basal Cell Carcinoma, to
High-Risk HPV EV-Types 5 and 8
Handisurya A1, Shafti-Keramat S1, Forslund O2, Favre M3, Kirnbauer R1
1Medical University of Vienna, Austria; 2Medical Microbiology, Lund University, Sweden;
3Genetics, Papillomavirus, and Human Cancer Unit, Institut Pasteur, Paris, France
Human papillomaviruses (HPV) may act as a cofactor to UV light in the development of non-
melanoma skin cancer (NMSC). Recently, DNA of a novel type HPV92 was isolated from a
basal cell carcinoma of an immunocompetent male. For most HPV types, infectious virions
and neutralization assays are not available. Thus we generated virus like particles (VLP) to
characterize the serological relationship of HPV92 to high-risk HPV types 5 and 8 associated
with the development of skin-cancer in patients with the rare genodermatosis epidermodys-
plasia verruciformis (EV).
Recombinant baculoviruses were generated and the L1 major capsid proteins of HPV92, 5
and 8 were expressed and purified by density gradients. By electron microscopy, negative
staining visualized spherical structures indicating efficient self-assembly of the L1s of HPV92,
5 and 8 into full-size VLP. Immunization of a NZW rabbit (4  50 mg HPV92 VLP in Freund’s
adjuvant) elicited high titer antibodies (4600.000). By Western blotting and VLP-ELISA,
HPV92 immune sera cross-reacted significantly with L1 of HPV5 and 8. We next examined
sera by hemagglutination inhibition (HAI) assays, a stringent surrogate for viral neutralization.
In contrast to pre-immune serum, HPV92 immune sera scored positive using homologous
HPV92, but not HPV5 or 8 VLP. In contrast, the HPV8 immune serum had HAI activity to all
three VLP types indicating that HPV8 VLP display immunogenic cross-reacting epitopes. The
HPV5 antiserum scored positive in the homologous HAI, and results for HPV92 and HPV5 HAI
are undetermined.
These results demonstrate a serological relationship between HPV92, 5 and 8. VLP of high-
risk HPV skin types may also have potential as a vaccine to reduce the incidence of NMSC.
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Pronounced Upregulation of Human Beta-Defensin 2 Expression, Impaired Epidermal
Differentiation and Skin Barrier Function in Dermatophytosis
Jensen JM, Neumann C, Schunck M, Harder J, Schro¨der JM, Brasch J, Proksch E
Dept of Dermatology, University of Kiel, Germany
The antimicrobial peptide human beta-defensin 2 (hBD-2) has been described originally in
psoriasis, a disease characterised by impaired barrier function, impaired epidermal
differentiation, and inflammation. It is thought that hBD-2 protects the skin from bacterial
infection, which is uncommon in psoriasis. Dermatophytosis may clinically and histological
resemble psoriasis including neutrophilic inflammation, a hallmark of fully developed
psoriasis lesions. We examined skin barrier function, epidermal proliferation, differentiation,
and hBD-2 expression in this disease by immunohistochemistry and biophysical methods. In
ten patients with dermatophytosis confirmed by KOH preparation and culture methods a
threefold increase in transepidermal water loss (TEWL) and a 30% reduction in stratum
corneum hydration compared to uninvolved skin was measured. Also, we found a five fold
increase in epidermal proliferation and an induction of proliferation and inflammation
associated keratins K6, K16, and K17. Expression of differentiation associated keratins K5
and K14 was reduced. Involucrin expression was increased and showed a broadening of the
stained layers, while loricrin and filaggrin expression was significantly reduced and even
focally absent. Similar changes have been found previously during epithelial wound healing.
Surprisingly, we found a pronounced expression of hBD-2; staining was already visible in the
lower to middle spinous layers and increased towards the outer epidermis. Staining intensity
was even significantly higher compared to psoriasis. We suggest that there are several
defence mechanisms against fungal infections: enhanced epidermal proliferation, which
targets the removal of the invading fungus, enhanced proliferation, which is followed by
changes in differentiation as part of skin repair mechanisms, and finally, enhanced expression
of hBD-2, which may be directed against the invading pathogens, including the fungus.
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E. coli-killing Psoriasin (S100A7) is Secreted In Vivo in Newborn and Adult Human Skin
Gla¨ser R, Harder J, Lange H, Weichenthal M, Janssen H, Schro¨der JM
University Hospital Schleswig-Holstein, Germany
Human healthy skin is continuously exposed to bacteria, but is surprisingly resistant to the
common gut bacterium E. coli. Recently we identified the S100 protein psoriasin as E. coli
killing compound from healthy human stratum corneum extracts. We could demonstrate that
psoriasin-mRNA and -protein is inducible in primary keratinocytes by proinflammatory
cytokines and contact with bacteria. In vivo treatment of human skin with neutralizing anti-
psoriasin antibodies inhibited its E. coli killing properties suggesting that psoriasin functions
as the major E. coli-cidal factor.
Using a newly developed sandwich-ELISA with monoclonal antibodies directed against
natural psoriasin we could identify psoriasin in vivo in aqueous skin washing fluids derived
from different body sites of various adult healthy volunteers and interestingly also in a
newborn baby. Significant bactericidal levels of psoriasin were found on the skin surface in all
donors depending on the location. To determine whether psoriasin can also be recovered
from lipid extracts of the skin additional experiments were performed using acetone for
washing. In agreement with psoriasin immunoreactivity and the hydrophobic properties of the
protein we found high amounts of psoriasin in lipid-rich skin regions (e.g. scalp and nose skin)
as compared to forearm acetone extracts
In summary, detection of significant bactericidal amounts of psoriasin in aqueous and lipid
extracts of the skin surface could explain the unexpected resistance of human skin towards
E. coli.
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E6 Activity Of Cutaneous HPV Types In Non-Melanoma Skin Cancer
Nindl I1, Dang C1, Koehler A1, Schmook T1, Pawlita M2, Sehr P2, Waterboer T2, Stockfleth E1
1Charite Berlin, Germany; 2German Cancer Research Center (DKFZ), Heidelberg, Germany
Objective: HPV E6 and E7 is constitutively expressed in cervical carcinomas and possibly in
HPV-infected non-melanoma skin cancer (NMSC). We examined HPV E6 and E7 RNA
expression of cutaneous types in normal skin, benign and malignant NMSC of immunosup-
pressed patients. In addition, we examined antibodies against L1, E6 and E7 of HPV 8, 9, 15,
and 16.
Patients and Methods: Thirty-one biopsies of 6 immunosuppressed organ-transplanted
patients representing 7 invasive squamous cell carcinoma (SCC), 1 basal cell carcinoma
(BCC), 4 actinic keratoses (AK), 7 normal skin samples and 12 warts were typed by a novel
HPV L1 PCR-based method to detect DNA of 24 cutaneous HPV. Total RNA of snap frozen
tissues was extracted, reverse transcribed (RT) and the expression of E6 and E7 of HPV types
5, 8, 9, 15, and 20 was investigated by real-time RT-PCR. Antibody response was measured
by a bead-based immunosorbent assay (Luminex XMAPTM technology) using affinity-purified,
bacterially expressed complete viral proteins fused to Glutathione S-transferase as antigens.
Results: HPV DNA was detected in 25 of 31 tissue samples indicating 8 single and 17
multiple HPV infections. HPV E6 RNA expression was found in 4 of 31 biopsies, i.e. in one
SCC, and three AK but not in normal skin. In contrast all biopsies showed no E7 RNA
expression. All four patients examined showed antibodies against some of the HPV antigens
but the antibody response was not correlated with E6 expression or HPV DNA type present in
the tumor.
Conclusion: The expression of the viral E6 oncogene only in AK and SCC suggest an active
role of HPV during skin carcinogenesis. The presence of antibodies against E6 and/or E7 of
cutaneous types may indicate that both proteins were expressed at a yet unknown time point
after HPV infection and skin cancer.
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Community-Acquired Staphylococcus aureus Carrying Panton-Valentine Leukocidin
Genes: Their Characteristics and Signiﬁcance in Dermatology Outpatients
Jappe U1, Heuck D2, Werner G2, Witte W2
1University of Heidelberg, Germany; 2Robert Koch Institute, Wernigerode Branch, Germany
Methicillin-resistant Staphylococcus aureus (MRSA) is a well known pathogen inducing
hospital-acquired infections. However, during the past two years, MRSA strains emerged as a
community based pathogen (C-MRSA). Amongst these are strains associated with deep skin
infections, carrying the genes for the toxin Panton-Valentine leukocidin. The aim of this
prospective study was to isolate S. aureus strains from dermatology outpatients and
investigate them for antibiotic resistance, the presence of the lukS-lukF determinant of
Panton-Valentine leukocidin and to further characterize strains found to contain the genes.
220 outpatients in the Dermatology Department of Heidelberg University with inflammatory
skin diseases, leg ulcers and deep skin infections were included. A standardized
questionnaire documented potential risk factors for MRSA colonization/infection. The
isolates collected from the anterior nose and lesional skin were investigated for lukS-lukF
by polymerase chain reaction (PCR). If the presence of lukS-lukF was demonstrated, strains
were further characterized by molecular typing (determination of SmaI pattern, spa sequence,
and multilocus sequence type), PCR demonstration of resistance genes, and characterization
of the SCCmec element. 115/220 carried S. aureus. 15/115 were MRSA, 10 of them
belonging to the Rhine-Hesse epidemic strain. 1/15 MRSA could not be identified, 3/15 were
C-MRSA (fusidic acid (FUS) resistant) and 1/15 isolates corresponded to the C-MRSA of
multilocus sequence type 1 from the USA being sensitive for FUS and carrying the lukS/lukF-
gene. Only 3/31patients with topical use of FUS carried FUS-resistant S. aureus. The results
demonstrate that C-MRSA may be detected in dermatology outpatients and that the risk
factors for the acquisition of MRSA do not necessarily apply for C-MRSA. From these data,
topical use of FUS does not select for FUS-resistant MRSA. For the first time the endemic
North-American PVL-gene positive C-MRSA was detected in Germany.
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Herpes simplex Virus Typ I Modulates Immune Responses in a Subgroup of Patients with
Atopic Eczema
Peng WM, Juana Hart A, Eis-Hu¨binger AM, Bieber T, Novak N
Dept of Dermatology, University of Bonn, Germany
Atopic Eczema (AE) is a chronic inflammatory skin disease which is predominated by Th2
cytokines. The course of AE is often complicated by viral infections such as Herpes simplex
virus (HSV). Spreading of clustered umbilicated vesicles and dissiminated cutaneous
eruptions of HSV have been designated as Eczema herpeticatum (EH). At the present, the
cellular mechanisms predisposing AE patients for EH are unclear. It is known that soluble
factors such as type I and type II interferons, in combination with specific T-cell responses are
crucial for the defense against viral infections. Here, we evaluated the capacity patients with
AE to respond to inactivated HSV in vitro. We found that peripheral blood mononuclear cells
(PBMC) of patients with AE which underwent one or more episodes of EH produce less type I
and type II interferons after stimulation with viral stimuli or inactivated HSV. Further on,
patients with AE with EH in their history displayed a significantly suppressed proliferation of T-
cells after stimulation with viral stimuli or HSV in vitro. Taken together, modified T-cell
responses and a lower interferon-producing capacity to viral stimuli in patients AE might
contribute to the higher susceptibility of these patients to HSV infections.
486
Gene Expression Proﬁling of Human Primary Endothelial Cells after Infection with
Candida albicans
Mu¨ller V1, Viemann D2, Schmidt M1, Roth J2, Goebeler M1
1University of Heidelberg, University Hospital Mannheim, Germany; 2University of Mu¨nster,
Institute of Experimental Dermatology, Germany
Endothelial cells are actively involved in the innate host response to microbial pathogens
such as Candida. We here studied the gene expression program of primary human endothelial
cells elicited by exposure to C. albicans (strain SC5314). After co-culture of C. albicans
blastospores with human umbilical vein endothelial cells (HUVEC) at a MOI of 1 for 5 h RNA
was extracted and processed for oligonucleotide microarray analysis using Affymetrix Human
Genome 133A Gene Chips which cover more than 13,000 genes. Data sets underwent a
sophisticated statistical analysis using the Gene Data Expressionist Suite software. Real-time
RT-PCR was employed to confirm reliability of data by an independent method. More than 30
genes were found to be differentially regulated upon exposure to Candida. Genes up-
regulated or switched-on by the fungus included granulocyte-attracting chemokines such as
CXCL2, CXCL3, CXCL8, cytokines such as VEGF and bone morphogenetic protein-2,
adhesion molecules such as ICAM-1, inflammation-associated molecules such as cycloox-
ygenase 2, apoptosis-related molecules and others. A considerable number of these genes
turned out to be regulated in a NF-kB-dependent manner. In conclusion, our data
demonstrate that infection of primary endothelial cells with C. albicans results in the
simultaneous expression of multiple genes reflecting the initial host response towards
Candida.
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KSHV (Kaposi Sarcoma Associated Virus) Viremia in Kaposi Sarcoma (KS)
Lebbe´ C, Pellet C, Kerob D, Dupuy A, Mourah S, Morel P, Rabian C, Calvo F
Hoˆpital Saint Louis, Paris, France
In order to gain further in classic and endemic KS pathogenesis, we aimed to determine -i/
whether KSHV is detectable in PBMC from classic and endemic KS-ii/which PBMC
subpopulation harbour the virus -iii/what clinical, histological and immunological parameters
are associated with positive KSHV viremia in a population of classic and endemic KS. KSHV
viremia was assessed on 81 consecutive patients suffering from non HIV related KS attending
our institution from January 1994 to January 2002. KSHV viral load was assessed using real-
time PCR (orf26). Majority (B and T lymphocytes, monocytes) and minority (S-endo-1 and
CD34 cells) PBMC subpopulations were isolated using immuno-magnetic Dynabeads (Dynal).
KSHV viremia was positive in 47 (58%) patients. 37.5% of patients with positive PBMC viral
load, 37.5% had KSHV infected B cells(28.5%) had infected monocytes and only (12.5%) had
infected T cells. None had non CEC CD34þ cells infected by KSHV but 50% of the patients
tested had CEC infected by KSHV. We observed a significant increase of IL-2 and IFN-g
production by CD4 T cells as well as an increase of IFN-g production by CD8 T cells
compared to control patients matched for age. Using univariate analysis, the prevalence of
positive KSHV was significantly associated to endemic versus classic KS (p¼ 0,02), KS
progression (p¼ 0,001), decision of systemic therapy (p¼ 0,03), KS staging (p¼ 0,003),
lymphedema (p¼0,01) while it did not depend on the histologic type, length of KS evolution,
the presence painful KS lesions . In a multivariate analysis, only KS progression (p¼ 0.001)
and KS staging (p¼ 0,03) remained signicantly and independently associated with positive
KSHV viremia. There was no specific immunosupression in classic or endemic KS but rather a
physiological T cell response to a herpesvirus infection. The pathogenic role of g interferon in
KSHV reactivation and KS progression can be hypothesized. KSHV viremia is associated with
tumor burden and KS progression. KSHV can be detected within CEC and we think that
KSHV viremia could be an indicator of circulating mature or precursor spindle cell
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Search for Mycobacterial DNA in Cutaneous Lesions of Sarcoidosis by Polymerase Chain
Reaction
Pourakbari B1, Mahtipour F1, Valikhani M1, Mirsalehian A1, Mortazavi H1, Mansori D2
1Tehran University of Medical Sciences, Islamic Republic of Iran; 2Shahid Beheshti
University of Medical Sciences, Islamic Republic of Iran
Sarcoidosis is a granulomatous multisystem disease with unknown etiology, but mycobac-
teria have been considered as a possible etiologic agent. We have used the polymerase chain
reaction-restriction fragment length polymorphism (PCR-RFLP) to search for mycobacterial
DNA in 20 cases of paraffin-embedded granulomatous tissues from patients with cutaneous
sarcoidosis. The target sequence used for PCR amplification is 205 to 318 base pair segment
of the16S-23S RNA gene. This assay can detect Mycobacterium tuberculosis and atypical
mycobacteria in specimens. Twenty sarcoidosis blocks and 10 normal controls were negative
with mycobacterial PCR but positive with beta-globin PCR, indicating the presence of
amplifiable DNA. Mycobacterial PCR gave positive results for four blocks from patients with
tuberculosis. These results do not support the role of mycobacteria species in the
pathogenesis of sarcoidosis and indicate that mycobacterial PCR is helpful in differentiating
tuberculosis and sarcoidosis.
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Relationship between Acrosin Activity of Human Spermatozoa and Oxidative Stress
Ahmed A1, Zalata A1, Allamaneni S2, Comhaire F3, Agarwal A2
1Mansoura Faculty of Medicine, Egypt; 2Center for Advanced Research in Human
Reproduction, The Cleveland Clinic Foundation, OH, USA; 3University Hospital Ghent,
Belgium
Aim: To study the association between oxidative stress as measured by induced
peroxidation of semen samples and sperm function evaluated by acrosin activity.
Patients and Methods: It is a prospective study consisting of 30 infertile men and 12 fertile
normozoospermic volunteers. A full history, clinical examination and scrotal ultrasound were
done to exclude other related factors such as smoking and varicocele. Presence of white
blood cells (WBCs) in semen samples was evaluated by peroxidase staining. Lipid
peroxidation in spermatozoa was induced after incubation with ferrous sulphate (4 mmol/L)
and sodium ascorbate (20 mmol/L). Induced peroxidation of spermatozoa was assessed by
determining the production of thiobarbituric acid reactive substance (TBARS). Acrosin activity
was measured using the gelatinolysis technique. The halo diameters around the sperm heads
and the percentages of spermatozoa showing halo formations were evaluated. An acrosin
activity index was calculated by multiplying the halo diameter by the halo formation rate.
Results: A significant difference was observed in acrosin activity parameters and TBARS
levels between samples with (41 million/mL of ejaculate) and without WBCs. This difference
was also noted between normozoospermic and oligoasthenoteratozoospermic semen
samples. TBARS production by spermatozoa had significant negative correlation with
acrosin activity index (r¼0.89, Po0.001).
Conclusion: Our data suggest that presence of oxidative stress in an individual with
leukocytospermia and abnormal semen parameters is associated with impaired sperm
function as measured by acrosin activity.
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Characterisation of Cytochrome P450 Expression in Organotypic Skin Models
Neis MM, Marquard Y, Joussen S, Heise R, Baron JM, Merk HF
Dept of Dermatology, University Hospital RWTH Aachen, Germany
Our long term goal is the development and optimization of an in vitro model for the study of
drug metabolism in human skin. Cytochrome P450 (CYP) enzymes are crucial for phase one
drug metabolism. Little is known about expression or inducibility of CYPs in organotypic skin
models. The only data that exists was obtained from human skin samples or mono layer cell
culture experiments with keratinocytes and fibroblasts. We constructed an organotypic skin
model by embedding fibroblasts from neonatal foreskins in a collagen matrix from calf skin
and by seeding keratinocytes on top. For comparison we bought commercialized skin models
from different companies. To induce enzyme activity, models were treated with benzan-
thracene, liquor carbonis detergens, pix lithanthracis or DMSO as a solvent control. RNA was
isolated by phenol chloroform extraction and purified. Gene expression patterns were studied
by cDNA microarray analysis. Microarray data was confirmed by real time PCR. For quality
control of the models and to detect and localize enzyme expression immunofluorescence
staining was performed with antibodies against CYPs and structural proteins. The
immunofluorescence staining demonstrated the regular structure of our models. We could
proof that CYP 1A1, 1B1, 2E1, 2C and 3A5 are expressed in organotypic skin models. The
expression of CYP 1A1 and 1B1 was highly inducible by treatment with liquor carbonis
detergens. The proof of CYP expression in organotypic skin models is an essential step in the
development of an in vitro model for the study of drug metabolism in human skin, because
these enzymes are indispensable for drug metabolism.
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Tacrolimus Reduces Dendritic Cells Arrest on Endothelial Cells under Shear Flow
Conditions and Modiﬁes Dendritic Cells Adhesion Molecules Proﬁle
Kwiek B1, Jockers J1, Allam JP1, Baltus T2, Bieber T1, Novak N1
1University of Bonn, Germany; 2University Hospital Aachen, Germany
Introduction: Tacrolimus (FK-506) is calcineurin inhibitor known to have strong influence on
T cells activation. Recently it was successfully introduced into the treatment of atopic
dermatitis (AD) and other cells appeared to be also affected by this drug. Tacrolimus has
shown to influence dendritic cells (DC), restoring physiological Langerhans cells (LC)
population and diminishing the number of inflammatory epidermal dendritic cells (IDEC),
claimed to be characteristic for lesional skin in AD. There are several hypothetic events
leading to this shift in DC balance in the epidermis and one of them is modulation of their
traffic. Migration of cells from blood stream through endothelium to the skin is multi-step
process in which several adhesion molecules are involved.
THE AIM: The aim of the study was to answer whether tacrolimus can influence arresting of
two types of monocyte derived DC: Langerhans cells and IDEC on activated human dermal
microvacsular endothelial cells (HDMEC) under shear flow conditions and if DC arresting
capacity can be related to phenotypical modulation of their adhesion molecules profile?
Methods and Results: The arrest of LC and IDEC under the shear flow conditions was
analyzed with video microscopy. Tacrolimus strongly inhibited arresting of LC and IDEC (by
62.3% and 56.9% respectively) generated from monocytes of patients with AD. Cells treated
with tacrolimus had started to roll but did not arrest.
Flow cytometry was used to analyse a- and b-integrines, selectines, ICAM-1 and cutaneous
lymphocyte antigen (CLA) expression on LC and IDEC with and without tacrolimus.
Flow cytometric evaluation of both cell types showed modulation of distinct integrines. In LC
tacrolimus significantly increased CD29 b-integrine and decreased CD11a a-integrine (po0.05).
In IDEC tacrolimus significantly decreased CD11b and CD49a a-integrine (po0.05). As integrines
are of a major role in arresting process, this changes can be at least in part responsible for
reduction of arrested DC shown in videomicroscopy.
Selectines are responsible for rolling which directly precedes cells arrest. Expression of all
selectines was unaffected by tacrolimus in both cells types. This findings are in accordance with
videomicroscopy experiments were rolling of DC was not disturbed.
CLA was strongly reduced by tacrolimus in IDEC-DC. This phenomenon can be partially
responsible for loss of IDEC in epidermis during AD treatment with tacrolimus.
Conclusions: In view of these data a picture emerges that tacrolimus modifies migratory
capacities of LC and IDEC which could be at least in part responsible for the immunomodulatory
effect of this drug in the treatment of AD.
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Therapeutic Efﬁcacy and Immunological Response of a RANTES Antagonist in
Inﬂammatory Skin Disease Models
Canavese M1, Ferrandi C1, Proudfoot AE2, Altruda F3, Cirillo R1, Wells TN2, Ladel CH1
1LCG-RBM, Italy; 2Serono-Pharmaceutical Research Institute, Switzerland; 3University of
Turin, Italy
Irritant Contact Dermatitis (ICD) is a pathological non-specific inflammatory skin condition
arising from the release of pro-inflammatory cytokines by keratinocytes in response to
haptens, usually chemicals. Contact Hypersensitivity (CHS) is a T-cell dependent model
modeling in part the T-cell-mediated skin diseases such as psoriasis. In this study we have
evaluated the therapeutic efficacy and the immunological response in ICD and CHS mouse
models of a RANTES antagonist. This antagonist is a RANTES variant with abrogated
glycosaminoglycan (GAG) binding which acts as a dominant negative inhibitor of wild type
RANTES. ICD model: mice were irritated by topical application of 2% croton oil solution to
both surfaces of the right ear. CHS model: mice were sensitized with DNFB 0.5% and after 5
days they were challenged with DNFB 0.2%. In both models ear swelling was assessed by
measuring the ear thickness. Immunological and histopathological parameters were
determined at the end of the experiments. The results demonstrated, for both models,
therapeutic efficacy of RANTES antagonist starting from 0.5 mg/kg, as shown by reduced
swelling (ICD: max. percentage of reduction: 16.6%, 10.7%, 31.3% with 0.5, 1 and 5 mg/Kg
respectively; CHS: max. percentage of reduction: 8%, 13%, 39% with 0.05, 0.5 and 5 mg/Kg
respectively), modulation of cytokines and chemokines (mainly reduced IL-10, IL-12p70 and
MCP-1) as well as reduction of MPO-activity (ICD: max. percentage of reduction: 51.3%,
72.4%, 71.7% with 0.5, 1 and 5 mg/Kg respectively) in homogenates derived from challenged
ears. In conclusion modulation of RANTES showed therapeutic efficacy in inflammatory skin
disease models.
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Pravastatin as a Modulator of Vascular Dysfunction in the Cutaneous Radiation
Syndrome
Vereycken-Holler V, Buard V, Baudelin C, Isoir M, Gaugler MH, Benderitter M
IRSN, Fontenay aux Roses, France
Skin response to ionising radiation is defined as a pathological tissue repair process. The
hypothesis developed in this study is based on the deleterious effects of the endothelium
activation after radiation exposure. An experimental model of cutaneous radiation syndrome
(CRS) was developed and pharmacological modulation of the CRS by pravastatin was
investigated.
Mice were subjected to a local dorsal skin irradiation (42 Gy) and treated with pravastatin
(40 mg/kg/day) during 28 days. Functional activation of the skin endothelium was quantified
by intravital microscopy from day 1 to day 28. Leukocyte-endothelium interactions were
visualized in the dorsal skin post capillary venules and quantified according to: the number of
rolling leukocytes and their mean rolling velocity. Histological assessment, daily clinical
scoring of the lesion and determination of cytokine in the plasma and tissue were also carried
out.
We demonstrated that interactions between leukocytes and endothelium were increased
after local radiation exposure at day 1 and day 28. In fact, a 7-fold increase in the number of
rolling leukocytes and a 1.2-fold decrease in the rolling velocity was observed 28 days after
irradiation. Treatment with pravastatin was characterized, by a 3-fold decreased in the
number of rolling leukocytes and a 2-fold increased in the rolling velocity 28 days after
irradiation.
Our results indicate that the functional activation of the endothelium induced by irradiation
persisted at least 28 days after exposure and suggest that pravastatin, used as a modulator
of radio-induced vascular dysfunction, exerts its anti-inflammatory effect on irradiated
endothelium through the limitation of its interactions with leukocytes.
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The Effects of Arsenic Trioxide on CTCL cells In Vitro and on Artiﬁcial Mycosis fungoides
Tumors In Vivo in a Mouse Model
Do¨bbeling U1, Qin JZ2, Navarini A1, Oberholzer P1, Dummer R1, Burg G1, Tun-Kyi A1
1University Hospital Zurich, Switzerland; 2Loyola University Illinois, USA
Mycosis fungoides (MF) and its leukemic variant Se´zary syndrome (SS) are the most frequent
types of cutaneous T cell lymphomas (CTCL). They progress from a patch/plaque stage to a
tumor stage that often kills the patients. Until now there is no cure for these diseases. Se´zary
syndrome patients have been treated systematically with arsenic trioxide with little success,
since too little arsenic trioxide may have reached the skin.
MF and SS cell lines undergo apoptosis, when they are treated with arsenic trioxide. Using
Western blotting and EMSA (electrophoretic mobility shift assay) we found that arsenic
trioxide suppresses the expression of the apoptosis preventing bcl-2, bcl-xL, and Mcl-1
genes and the DNA binding activities of NFkB, a transcription factor that increases the
expression of apoptosis preventing genes including bcl-2.
When we injected artificial MF tumors that had been derived from MyLa 2059 cells injected
into nude mice, we found that arsenic trioxide concentrations of 0,25 and 1 mM injected into
the tumors caused partial remission in 7 of 8 mice and one complete remission.
Therefore we conclude that arsenic trioxide induces apoptosis of MF and SS cells by the
inhibition of the expression of apoptosis preventing genes. This may occur by the inhibition of
transcription factors that stimulate the expression of apoptosis preventing genes. Arsenic
trioxide in higher concentrations may be also suitable for the local treatment of MF tumors.
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A Topical RXR Ligand with Anti-Inﬂammatory Activity in Mouse Models
Tran C, Sorg O, Grand D, Hotz R, Carraux P, Saurat JH
Geneva University Hospital, Switzerland
Retinoids exert various biological actions such as inhibition of cell proliferation or
angiogenesis and induction of cell differentiation or apoptosis, by binding to the nuclear
receptors RARs and RXRs. Based on in vitro receptor profiling assays the compound
BAL10092 was identified as a putative RXR antagonist. BAL10092 penetrates easily into the
mouse skin following topical application and does not induce irritation even at high
concentrations, indicating a therapeutical potential.
The RXR agonist 9-cis retinoic acid (9c RA) is very irritant when applied to the skin. Treating
ears of C57BL/6 mice for 4 days with 9c RA increased the ear thickness and the dermal
polymorphonuclear infiltration as measured by myeloperoxidase (MPO) activity. BAL10092
reduced 9cRA-induced irritation, suggesting that RXR pathway may be involved in the
inflammation process. To confirm this, we utilized a semi-chronic in vivo model to test the
topical anti-inflammatory potential of BAL10092. Inflammation was induced by topical
application of 12-O-tetradecanoylphorbol-13-acetate (TPA) to the ears of C57BL/6 mice for
11 days. BAL10092 was compared to the topical corticosteroids clobetasol (CB) and
betamethasone (B). Epidermal and dermal thickness induced by TPA was significantly
decreased by CB and B but only slightly by BAL10092. TPA-induced MPO activity was
decreased by BAL10092, B and CB by 39.7%, 58.2 % and 67%, respectively. BAL10092, B
and CB also decreased the TPA-induced c-jun mRNA expression by 46.1%, 73.6 % and
85.3% respectively. Western blot analysis also showed an increase of NF-kB protein levels
after TPA treatment, which was diminished by 41% after topical application of BAL10092.
Taken together, these results show that RXR may be involved in the inflammation process,
and that some RXR antagonists may have a significant topical anti-inflammatory effect.
Although the mechanism of action remains elusive, our data indicate a possible repression of
the AP-1 and NF-kB signalling pathways.
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Cladribine Treatment Inﬂuence on CD117 Expression in Skin and Bone Marrow in
Mastocytosis Patients
Zalewska A, Najder M, Urbanska-Rys H, Sysa-Jedrzejowska A, Narbutt J, Robak T
Medical University of Lodz, Poland
The aim of the study was to examine c-kit gene product (CD117) expression in skin and bone
marrow in mastocytosis patients before and after cladribine (2-chlorodeoxyadenosine) treatment.
The study included 6 patients with long-lasting systemic mastocytosis, one of which presented
also chronic lymphatic leukaemia. The patient with coexisting chronic lymphatic leukaemia
received numerous cladribine courses during 4 years, whereas 5 others received three courses
of cladribine. The skin and bone marrow specimens obtained before treatment implementation
and 8 weeks after the last cladribine course were analysed by immunohistochemistry using a
polyclonal CD117 antibody.
Before treatment implementation, pronounced CD117 expression was observed in the basal
layer of the epidermis confined to melanocytes, in patients presenting urticaria pigmentosa
lesions with strong brownish pigmentation. Patients with slightly pigmented macular lesions had
less pronounced CD117 expression in the basal layer of the epidermis. Mast cells in the dermis
showed strong membrane immunoreactivity. Localization of those cells was rather scattered in 3
cases and in 2 others clusters of CD117 positive mast cells were observed. As regards bone
marrow, CD117 was also expressed in either scattered or clustered manner. After cladribine
treatment, in the patient with coexisting chronic lymphatic leukaemia, skin specimens did not
demonstrate increased expression of CD117 and pigmented macular lesions disappeared, bone
marrow also did not demonstrate increased CD117 expression. In other patients however, either
no change in CD117 expression or slightly decreased CD117 expression was noted. Skin lesions
also demonstrated some improvement as regards colour and expanse.
In conclusion, it seems that CD117 expression could, to some extend, respond to cladribine
therapy however many more courses of the drug, also leading to severe side-effects, are
required to obtain a favourable effect.
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Thymidylate Synthase Induces Apoptosis with a p53 Independent Pathway in Melanoma
Cell Lines and in Normal Human Melanocytes
Benassi L1, Magnoni C1, Bertazzoni G1, Giudice S1, Costi PM2, Rossi T2, Bernardi C1,
Gualdi G1, Giannetti A1
1Department of Dermatology, University of Modena and Reggio, Italy; 2Department of
Pharmaceutical Sciences, University of Modena, Italy
Melanoma patients have a very poor prognosis and this type of tumor is particular resistant to
conventional chemotherapy and radiotherapy. For this reason in the last years has been
developed a variety of new therapeutic agents. We investigated four experimental antifolate
substances (MR7, MR36, MR21 and NMR707) with a critical target for thymidylate synthase
(TS), an essential enzyme for DNA synthesis and repair. All the compounds were tested for
their inhibitory properties against TS enzymes from different species: Lactobacillus casei,
Pneumocystis carinii, Cryptococcus neoformans and human. These compounds behave as
antifolates but show new structure with respect to all known antifolate agents. We studied
how these substances may influence apoptosis in melanoma cell lines SKmel 2 (derived from
malignant melanoma metastasis) and SKmel 28 (derived from primary malignant melanoma)
and normal human melanocytes. The antifolate agents induced apoptosis in Skmel 2 and
Skmel 28 cells. These results were confirmed by Comet Assay. Western blot analysis showed
down regulation of the level of Bcl2 and PARP clivage especially for MR36, MR7 and MR21.
Moreover a different apoptotic behaviour for the two cell lines was observed, in fact in
primary melanoma cells apoptosis occurred also at low concentrations especially for MR7.
After chemotherapeutic treatment with all the tested compounds p53 was not modulated
indicating a p53 independent pathway for apoptosis. Caspases 8 and 9 clearly mediate
antifolate agents apoptosis independent of the status of p53. Our results show that TS
inhibitors inducing apoptosis may play a future potential role as new therapeutic agents for
melanoma, but further studies are necessary to understand their molecular mechanism.
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Noxious Heat Stimuli and Scratching Inhibit Itch Response in Humans-Evidence of
Central Inhibition
Yosipovitch G, Duque M, Fast K, Coghill R
Wake Forest University School of Medicine, Winston-Salem, USA
Patients who suffer from chronic itch employ creative techniques to alleviate their itch, often
using painful thermal stimuli such as hot and very cold showers in addition to mechanical
stimuli such as scratching. It has long been thought that such stimuli inhibit itch by direct local
action on primary afferents. The present study examined whether the sensory perception of
itch is attenuated by central interactions between both thermal and mechanical stimuli and
afferent information related to itch. Itch was induced with histamine iontophoresis in 21
healthy young subjects. Repetitive thermal stimuli including innocuous warmth, innocuous
cool, noxious cold and noxious heat as well as scratching were applied 3 cm distal to the area
of histamine iontophoresis. Subjects rated their perceived intensity of itch with a
computerized visual analogue scale. Itch intensity ratings were significantly reduced during
each period of scratching and repeated noxious heat and cold. Innocuous cooling and
warming did not significantly alter itch intensity ratings. Inter-individual differences in itch
sensitivity were not related to inter-individual differences in pain sensitivity. The present study
demonstrates that both thermal and mechanical stimuli do not require a direct physical
interaction with the skin where the itch emanates. Thus, painful thermal stimuli as well as
scratching appear to modulate itch via the central nervous system.
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In Vivo Anti-Irritative Efﬁcacy of Licochalcone A-Containing Formulations on Razor and
UV-Induced Skin Irritation
Kolbe L, Batzer J, Eggers K, Weber T, Wolber R, Sta¨b F
Beiersdorf AG, Hambrug, Germany
The skin, has to cope with all kinds of environmental stress and physical insults, like
mechanical stress or solar radiation. Especially in sensitive skin this often results in irritation
with associated tingling, itching, redness or even pain. Botanical ingredients are frequently
used in cosmetic products to soothe the early signs of skin irritation. We investigated the
in vivo efficacy of a soothing lotion (o/w) with Licochalcone A, a compound extracted from
Glycyrrhiza inflata. Vehicle controlled studies with two different stress models were
performed to demonstrate in vivo efficacy. Anti-inflammatory efficacy in razor shaving-
induced skin irritation, and UV-induced sunburn was evaluated. In the shaving study, 45
subjects were shaved without lubricant at test sites on the volar forearm with a disposable
razor to induce erythema. Test products were applied twice a day for three days directly after
shaving and at night. Skin redness was determined on day 4 by clinical grading and by
measuring the redness (a-values) with a Spectrophotometer. In the UV-erythema study, 12
volunteers were irradiated with 1.4 MED on two test sites on the back. Immediately
afterwards the test areas were treated either with a Licochalcone A-containing lotion or its
vehicle. After five hours the developing erythema was evaluated by clinical grading and
reflectance spectroscopy, and the lotions were applied once again. A final measurement of
redness, clinical and instrumental, was performed 24 hours after irradiation. Statistical
analysis revealed highly significant anti-inflammatory efficacy of the lotion containing 0.025%
Licochalcone A in razor shaving-induced skin irritation when compared to its vehicle. A lotion
with 0.05% Licochalcone also significantly reduced erythema at 5 hours as well as 24 hours
after solar simulated irradiation. In conclusion our data suggest a very potent anti-
inflammatory activity of cosmetic formulations containing Licochalcone A from Glycyrrhiza
inflata.
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Adverse Cutaneous Reactions to Drugs in Hospitalized Children in a Department of
Infectious Disease
Fattahi F1, Pourpak Z1, Moin M1, Khotaei GT2, Mamishi S2, Tabatabaei P2
1Immunology, Asthma & Allergy Research Institute, Tehran, Islamic Republic of Iran;
2Infectious Diseases, Children’s Medical Center, Tehran, Islamic Republic of Iran
Various adverse cutaneous drug reactions have been found in 2–3 percent of hospitalized
patients. Most of the times these reactions are mild or moderate and in a few cases are
severe. A few prospective studies have been reported to frequency of these reactions in
hospitalized patients. No study has specially focused on the frequency of these reactions in
Iran. We have carried out a prospective study to assess the frequency of these reactions in
hospitalized children.
All 404 children admitted to Department of Pediatric Infectious Disease were evaluated for
presence of suspected cutaneous reactions to systemic drugs with determination of the
allergic type during above 5 months period (between 14th February and 20th July). All of the
reactions were approved by a pharmacologist or dermatologist.
In 25 patients (6.2%), cutaneous drug reactions were detected. Among them 48% (12
cases) were female and 52% (13 cases) were male in the age range of 1 month to 5.5 years
old. Eighty percent of these reactions (20 cases) were allergic reaction. The most commonly
involved pharmacological group was anti-infective medicines (84%) and most related to
Cephalosporins. The reactions were mild or moderate in more 95% of cases. In 5 cases
(20%), culprit drug was discontinued.
This study shows a more frequency than other studies that reported a rate of 2% of
cutaneous drug reactions in hospitalized patients. Despite most of them were mild or
moderate but in a few cases could be life threatening. As high frequency of these reactions,
attention to appropriate prescription of medicine especially antibiotics seems necessary.
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Circulating CLAþT Cells from Psoriasis Patients Manifest a Different Frequency and
Activation State Between Acute and Chronic Stages
Ferran M1, Gime´nez-Arnau AM1, Pont M2, Pujol RM1, Santamaria-Babi LF2
1Department of Dermatology, Hospital del Mar, Spain; 2Almirall Prodesfarma. Research
Center. Barcelona, Spain
The cutaneous lymphocyte-associated antigen (CLA) distinguishes circulating human
memory T cells with skin tropism. In this study we analysed by flow cytometry the percentage
and activation state of several circulating CLAþ T cell subpopulations in guttate psoriasis
(n¼ 7), acute plaque psoriasis (n¼ 8), chronic psoriasis (n¼16) and control subjects (n¼ 11).
Guttate psoriasis patients showed significantly the lowest percentage of circulating CLAþ
CD4þ cells compared with acute plaque psoriasis and controls (8,8  4,9 vs 16,0  5,4
(p¼ 0,009) and 16,7  8,0 (p¼0,03), respectively. Both CLAþ T cells (CD3 or CD4) from
patients with guttate and acute plaque psoriasis presented significantly higher frequency of
HLA-DR positive cells when compared with chronic stage psoriasis and controls. We also
related those results with PASI and BSA. A direct correlation between the percentage of
circulating CLAþCD3þHLA-DRþ and PASI and BSA in acute plaque psoriasis (0,60
(p¼ 0,02), and 0,61 (p¼ 0,03), but not for CLACD3þHLA-DRþ cells was found. Conversely,
a inverse correlation between the percentage of circulating CLAþCD3þHLA-DRþ and PASI
and BSA in chronic psoriasis (0,58 (p¼ 1,9  105), and 0,63 (p¼1,6  105) was
detected. These results suggest that in acute psoriasis a sequestration of circulating CLAþ T
cells to skin might occur. These results would support other studies showing early infiltration
of CLAþ T cells in advance of active edge of lesions. On the other hand, the increased
frequency of HLA-DRþCLAþ T cells found in acute and guttate psoriasis suggests that those
cells could be memory effector T cells activated in the skin that are present in the periphery
during the acute phase of psoriasis. Those results support an early role of CLAþ T cells in the
development of psoriatic lesions.
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Type I Interferon-Associated Recruitment of CXCR3þCytotoxic Lymphocytes: A
Common Mechanism in Regressive Melanocytic Lesions
Wenzel J1, Bekisch B1, Uerlich M1, Haller O2, Bieber T1, Tu¨ting T1
1University of Bonn, Germany; 2University of Freiburg, Germany
Introduction: Melanocytic lesions of the skin can occasionally show clinical signs of
spontaneous regression. The destruction of melanocytes is thought to be mediated by
cytotoxic T cells. Recent studies provided direct evidence for potentially autoreactive
melanocyte-specific cytotoxic T cells within the inflammatory infiltrate of regressive
melanoma. Thus, spontaneous regression of melanoma can be regarded as a special form
of cellular skin autoimmunity. In analogy to our observations in cutaneous lupus
erythematosus (LE), a prototype autoimmune disease of the skin, we hypothesized that a
type I interferon (IFN) induced lymphocytic inflammation with recruitment of CXCR3þand
granzyme Bþcytotoxic cells is involved in specific destruction of melanocytic cells.
Methods: 253 primary melanomas of the skin were investigated for histological signs of
regression. Detailed immunohistological analyses, including the expression of MxA, an
antiviral protein specifically induced by type I interferons, of the chemokine IP10/CXCL10, the
chemokine receptor CXCR3, and the cytotoxic molecule granzyme B, were performed for 14
typical regressive tumors and 20 control samples (congenital nevi, halo nevi, unaffected skin).
Results: We found a high expression of the antiviral MxA protein, indicating local type I
interferon production, in inflamed regressive melanocytic lesions, along with large numbers of
natural interferon producing plasmacytoid dendritic cells (pDC), CXCR3 positive lymphocytes
and cytotoxic, granzyme B expressing lymphocytes. Additionally, we detected a high
expression of the interferon induced chemokine IP10/CXCL10, linking type I IFN production
and recruitment of CXCR3 positive lymphocytes.
Conclusion: Our results provide evidence that endogenous activation of type I IFNs,
infiltration of pDCs and recruitment of CXCR3þ cytotoxic lymphocytes is involved in
spontaneous regression of melanoma and other melanocytic lesions. We believe that this
cytotoxic immune response represents an evolutionarily conserved pathway against
intracellular pathogens.
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MAGE-A4 Cancer/Testis-Antigen Staining Pattern Differs in Epithelial Skin Tumors of
Immunosuppressed and Immunocompetent Patients
Mu¨hleisen B, Scha¨rer L., Dummer R, Burg G, Hofbauer GF
Universita¨tsspital Zu¨rich, Switzerland
The human MAGE gene family encodes proteins (Cancer/Testis antigens ) which are
expressed in normal testis and in a variety of tumors. MAGE-derived peptides are recognized
by CD8þT cells and represent targets for immunotherapy. Monoclonal antibody 57B
predominantly detects MAGE-A4 protein.
Studied mainly in melanoma, recent data suggest MAGE-A4 expression in epithelial
cutaneous neoplasms. Frequency of intraepithelial and invasive epithelial skin tumors is
greatly increased in immunosuppressed patients. We were interested in expression and
pattern of MAGE-A4 in epithelial skin tumors in organ transplant recipients and
immunocompetent patients. We examined mAb 57B immunoreactivity in 119 formalin-fixed,
paraffin-embedded specimens of epithelial skin tumors of actinic keratosis, bowenoid actinic
keratosis, Bowen’s disease and squamous cell carcinoma (n¼ 17, 25, 61, 16, respectively) in
immunocompetent patients (n¼ 84) and organ transplant recipients (n¼ 35) using the alkaline
phosphatase anti-alkaline phosphatase method after antigen retrieval. 57B immunoreactivity
was rated positive if there were at 5% or more positive tumor cells. In all positive samples,
staining pattern and polarity of 57B immunoreactivity in the epidermis was assessed. Normal
skin was immunonegative. All four epithelial skin tumors showed comparable immunor-
eactivity (p¼0.361) ranging from 25% to 71% of samples. Absolute 57B immunoreactivity
was equal between immunosuppressed and immunocompetent patients. However, scattered
staining pattern was more frequent in immunocompetent patients (p¼ 0.025). In squamous
cell carcinoma there was a polarity of immunoreactivity within the basal layer (p¼ 0.002)
compared to intraepithelial tumors. In conclusion, MAGE-A4 expression may help diagnosis
and delineation of epithelial skin tumors. Invasiveness of tumors seems accompanied by
increased MAGE-A4 expression on the leading cell front, possibly reflecting pronounced
anaplasia. Cancer antigen expression as judged by MAGE-A4 expression displays subtle
differences for organ transplant recipients only, suggesting other mechanisms underlying the
increased cutaneous carcinogenesis in these high-risk immunosuppressed patients such as
TGF-beta and VEGF induction by calcineurine inhibitors.
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Accuracy of Clinical Assessment of Melanocytic Lesions: Correlation to Histological
Outcome
Ga¨chter T, Mu¨hleisen B, Scha¨rer L, Dummer R, Burg G, Hofbauer GF
Universita¨tsspital Zu¨rich, Switzerland
Melanocytic lesions cause a large number of diagnostic skin biopsies. Few studies on
accuracy of clinical assessment are available. We thus studied 3822 biopsy samples which
were clinically assessed as melanocytic lesions. 10% turned out to be nonmelanocytic
lesions such as seborrhoic keratosis, dermatofibroma, squamous cell carcinoma, while41%
were inflammatory in nature. The main confounder was seborrhoic keratosis in 5%. In 8%,
clinicians mistook melanocytic lesions for fibroma, seborrhoic keratosis, basal cell carcinoma
clinically. Accuracy of clinical judgment was best for benign nevi [64 to 78%], worst for
atypical nevi [6 to 12%], intermediate for melanoma [58 to 43%]. At least in benign nevi,
dermatologists scored significantly better than non-dermatologists. With a lower degree of
accuracy, benign nevi [72 to 86%], atypical nevi [88 to 93%], melanoma [66 to 78%] were
recognized as melanocytic lesion irrespective of dignity. Finally, 97 to 99% of benign nevi,
99% of atypical nevi and 91 to 99% of melanoma were correctly diagnosed as tumor.
Clinically completely excised melanocytic lesions were not completely removed histologically
in 10 to 18%, but with increasing clinical suspicion of malignancy, excision totality improved.
In summary, dermatologists fared slightly better than non-dermatologists in our database in
correctly identifying melanocytic lesions clinically, but all showed substantial errors in
assessing type and dignity of lesions as well as excision margins.
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The Anti-Psoriatic Agent Dimethylfumarat is a Potent Inhibitor of Endothelial Cell
Function
Ziegler A1, Heidenreich R1, Bieber K2, Ro¨cken M1, Ghoreschi K1
1Eberhard Karls University, Tu¨bingen, Germany; 2University of Heidelberg, Germany
Psoriasis is a chronic inflammatory autoimmune disease of skin and small joints, resulting in a
severe impairment of quality of life. One hallmark of the disease is the formation of
erythematous plaques, infiltrated by interferon g producing Tcells, mast cells and neutrophils.
Keratinocytes of psoriatic lesions show an increase in Vascular Endothelial Growth Factor
(VEGF) expression, whereas its high affinity receptors, VEGFR-1 (Flt-1) and VEGFR-2 (Flk-1/
KDR) are upregulated on the microvascular endothelial cells. Furthermore, an increase in
proliferation and avb3 expression of endothelial cells is observed. This profound angiogenic
activity of the superficial microvasculature of lesional skin suggests a crucial role for
angiogenesis in the pathogenesis of psoriasis. However, the mechanism, by which
dimethylfumarat (DMF) mediates its anti-psoratic effect, is not fully understood. Here, we
investigated the influence of DMF on angiogenesis. In the chorioallantoic membrane (CAM)
assay, DMF inhibited angiogenesis, changed blood vessel morphology, and caused
embryonic lethality. To analyze the influence of DMF on endothelial functioning in more
detail, we performed two different in vitro assays of sprouting angiogenesis, using human
lung microvasular endothelial cells (HLMECs) and human umbilical vene endothelial cells
(HUVECs), respectively. In both assays, DMF strongly inhibited sprout formation in a dose-
dependent manner. In addition DMF suppressed endothelial cell migration. Annexin V/
propidium iodide staining revealed only a slight increase of apoptosis in DMF-treated cells,
excluding apoptotic cell death as cause for the inhibition. First data show that growth
inhibition might be regulated through MAPK signaling as DMF reduced p38MAPK
phosphorylation in endothelial cells. The data suggest that the anti-angiogenic potential of
DMF might contribute to its anti-psoriatic activity.
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The Role of CD26 on Skin Homing T Cells in Diagnosis and Prognosis of Sezary
Syndrome
Sokolowska-Wojdylo M1, Wenzel J2, Steitz J2, Gaffal E2, Roszkiewicz J1, Bieber T2, Tueting
T2
1Medical University of Gdansk, Poland; 2Medical University of Bonn, Germany
Patients with Se´zary syndrome (SS) show clonal expansion of skin homing CD4þT helper
cells expressing the cutaneous lymphocyte antigen (CLA) in the peripheral blood. Increase of
CLAþCD4þT cells can also be observed in other type of Cutaneoous T Cell Lymphomas
(like the most common Mycosis fungoides (MF)). To facilitate early diagnosis and therapeutic
monitoring of SS using flow cytometry, the expression of CD7 and CD26 on the
CLAþCD4þ lymphocyte subset was evaluated.
Material and methods:
1. Three coloured flow cytometry analysis for the expression of CD4, CD7, CD26, CLA and
CCR4 on peripheral lymphocytes from 23 patients with CTCL (7 with SS, 16 with Mycosis
fungoides) and 11 healthy donors.
2. Sixteen (16) months lasting analysis in 2 patients with SS.
Results: The absence of CD7 and CD26 on CLAþCD4þT cells was highly specific for SS.
The absence of CD26 on CLAþCD4þTcells was very sensitive for SS and indicated 100% in
group of our patients. The number of CD26- CLAþCD4þT cells closely correlated with
therapeutic interventions in the longitudinal analysis of 2 patients over more than one year.
Conclusion: The absence of CD26 expression on skin homing CLAþCD4þT helper cells is a
very sensitive and highly specific parameter for early diagnosis and therapeutic monitoring of
patients with SS.
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Functional Involvement of Vanilloid Receptor-1 Signaling in Murine Hair Follicle Cycling
Telek A1, Biro T1, Bodo E2, Liotiri S2, Tychsen B2, Paus R2
1University of Debrecen, Hungary; 2University-Hospital Hamburg-Eppendorf, Germany
The vanilloid receptor-1 (VR1 or transient receptor potential vanilloid-1 receptor, TRPV1) is a
central integrator of noxious stimuli and was originally described on sensory neurons. We
previously reported that, beyond the neuronal system, TRPV1 is widely expressed on several
cell types of human skin in situ and on isolated, organ-cultured human hair follicles (HF). We
furthermore presented that the receptor plays pivotal role in the regulation of human hair
follicle cycling and growth via induction of apoptosis and catagen and suppression of
proliferation. Here we studied the possible role of TRPV1 in murine hair biology. By
immunhistology, keratinocytes of the developing hair peg of C57BL/6 mice showed strong
TRPV1 immunreactivity (TRPV1-ir) while the developing dermal papilla (DP), as well as
interfollicular dermal fibroblasts were TRPV1-negative. In mature hair follicles, TRPV1-ir was
most prominent in the proliferating keratinocyte populations of matrix keratinocytes while
TRPV1 was absent in the differentiated inner root sheath keratinocytes, in dermal fibroblasts,
and in the DP. In order to investigate the functional role of the receptor in HF biology, skin
samples of TRPV1 knockout and wild type mice were analyzed. In the skin of TRPV1/mice,
no obvious macroscopic or microscopic abnormalities were found compared to age-matched
wild type control, and HF morphogenesis proceeded normally. In contrast, by quantitative
histomorphometry, we were able to detect a significant delay in HF cycling of TRPV1
knockout skin compared to wild type control (catagen retardation). This suggests that TRPV1
promotes catagen development in perfect agreement with the catagen-inducing effect of
TRPV1 activation in human HF. In summary, the HF of C57BL/6 mice express functional
TRPV1 which appears to be involved in hair cycle control.
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Functional Cannabinoid Receptor-1 Expression in Human Skin and Hair Follicle–A Novel
Player in Skin and Hair Biology
Biro T1, Telek A1, Dajnoki A1, Bodo E2, Funk W3, Kovacs L1, Paus R2
1University of Debrecen, Hungary; 2University Hospital Hamburg-Eppendorf, Germany;
3Klinik Dr Koslowski, Germany
Among cannabinoid receptors (CB), CB1 was originally described on neurons of the central
nervous system whereas CB2 was mostly shown on different immune cells. In this study, we
investigated the expression and functional characteristics of these receptors in normal
human skin in situ and HaCaT keratinocytes in vitro. By immunohistochemistry, we provide
the first evidence that CB1 immunoreactivity (CB1-ir) was confined to basal epidermal
keratinocytes, sebocytes, and the outer and inner root sheath (IRS, ORS) and matrix
keratinocytes of the hair follicle (HF) in situ. A similar CB1-ir pattern was observed on organ
cultured human scalp HF. In contrast, CB2-ir was not found on human skin. Functionally, the
activation of CB1 by the specific endocannabinoid agonist anandamide (AEA) resulted in a
dose-dependent inhibition of hair shaft elongation of organ-cultured human scalp HF. This
effect was largely abrogated by the CB1-specific antagonist AM-251. In addition, AEA
decreased proliferation (number of Ki-67þcells) and up-regulated apoptosis (number of
TUNELþ cells) of human bulb keratinocytes in situ, and induced catagen transformation of
organ cultured human anagen VI HF. CB1, but not CB2, was also identified on cultured human
epidermal HaCaT keratinocytes both at protein and mRNA levels. Similar to the organ culture
experiments, activation of CB1 by AEA inhibited HaCaT cell proliferation and induced
apoptosis in a dose-dependent and CB1-specific fashion. These findings strongly suggest
the existence of a novel, endogenously active CB1 signaling pathway in human skin and HF
with potential pathological and therapeutic significance.
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Expression of Prohormone Convertase (PC)-1, PC2 and 7B2 Immunoreactivity in Human
Fetal Skin, Normal Adult Skin
Schiller M, Fisbeck T, Sta¨nder S, Scholzen TE, Luger TA, Bo¨hm M, Brzoska T
University Hospital Mu¨nster (UKM), Germany
Human skin is a source for proopiomelanocortin (POMC)-derived peptides whose expression
is regulated by stress-like stimuli in analogy to the hypothalamic-pituitary adrenal axis. The
biosynthesis of POMC peptides is dependent on the expression of distinct members of the
subtilisin/kexin family of serine proteases. We studied the in situ expression of prohormone
convertase (PC)-1, PC2 and the regulatory factor 7B2 by immunohistochemistry in human
fetal skin, normal adult skin, compound (n¼ 6) and junctional nevi (n¼ 6) as well as in in situ
(n¼ 6) and invasive (n¼ 6) primary cutaneous malignant melanomas. In fetal skin, PC1
immunoreactivity was detectable in the upper layers of the periderm at a gestational age of 4–
6 weeks and became undetectable at a gestational age of 12-14 weeks. In contrast, PC2
immunoreactivity was persistently expressed throughout the early and later periderm as well
as in primary hair bulbs. In healthy adult skin epidermal keratinocytes and melanocytes,
dermal fibroblasts, endothelial cells as well as macrophages displayed PC1, PC2 and 7B2
immunoreactivity. Undifferentiated cells of the sebaceous glands as well as secretory and
ductal epithelia of apocrine and eccrine sweat glands also displayed prominent immunos-
taining. In contrast to melanocytes of junctional and compound nevi, transformed
melanocytes of in situ and invasive melanomas strikingly lacked PC1, PC2 and 7B2
immunoreactivity. In summary, our data suggest that human periderm via expressing PC1,
PC2 and 7B2 contributes to the POMC system of the fetal-maternal interface. In adult human
skin, PC1, PC2 and 7B2 appear to be widely expressed in various cell types including the
adnexal structures. On the other hand, lack of PC1, PC2 and 7B2 expression in transformed
melanocytes suggest a loss of the differentiated neuroendocrine phenotype of pigment cells
which appear to loose regular POMC processing during cellular transformation.
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No Correlation Between Immunophenotype and T-cell Receptor c Clonality in Mycosis
fungoides
Yazdi AS1, Thaller E2, Puchta U2, Sander CA3
1Eberhard Karls University Tu¨bingen, Germany; 2LMU Munich, Germany; 3AK St Georg
Hamburg, Germany
Mycosis fungoides is the most common form of cutaneous T-cell lymphoma. Clonality
analysis is besides clinical course, histology and immunophenotype an important diagnostic
tool.
To find a correlation between immunphenotype and the presence of clonality, we used
laser-capture microdissection (LCM) to evalute T-cell receptorgchain gene rearrangement in
separately microdissected T-cells expressing CD2, CD3, CD4 and CD8. As each
immunophenotype correlates with a specific stage of maturity, a pattern might lead towards
a hint at what stage of development the clonal expansion of malignant cells occurs.
15 biopsies diagnosed mycosis fungoides due to clinical presentation, morphology and
immunophenotype were included in the study.
After immunohistochemistry, the labelled cells (CD3, CD4, CD5, CD7, CD8) were separately
microdissected and subjected to T-cell receptorggene analysis.
Using clonality analysis of certain subgroups of lymphocytes, we could detect more than
one single clone in 11 of 15 biopsies. A correlation between immunophenotype and clonality
could not be drawn, as all stages of lymphocytic development expressed clonality.
Finding a clonal dominance in both CD4 and CD8 positive T-lymphocytes describes very
early occurence of clonality, as only thymocytes express both CD4 and CD8 simultaneously.
The combination of immunohistochemistry and microdissection showing clonal hetero-
genity in one single biopsy in early stages of mycosis fungoides can hint towards the
evolution of monoclonality from the stage of polyclonality and oligoclonality.
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Plasmacytoid Dendritic Cells in Cutaneous B-Cell Lymphoma
Asagoe K1, Cozzio A2, Kempf W2, Burg G2, Dummer R2
1Okayama University Graduate School of Medicine and Dentistry, Japan; 2University
Hospital Zurich, Switzerland
Imiquimod is a potent inducer of Th1-type immune response through synthesis, induction and
release of cytokines upon binding to Toll-like receptor (TLR)-7. Innate and acquired immunity
are both potentiated by imiquimod, through the induction of IFN-a, TNF-a and IL-6, and,
indirectly, via enhanced IL-12 response and production of IFN-g. The substance has been
shown to have potent antiviral and antiumoral action in animals and humans (i.e. Bowen’s
disease, actinic keratosis, early MF).
The biologic response to imiquimod depends on the presence of TLR-7þplasmacytoid
dendritic cells (pDC) in the target tissue.
We examined pDC infiltration in the lesion of cutaneous B-cell lymphoma (CBCL), and
pseudolymphoma. Morphometric immunohistochemical analyses of CD123 and BDCA-2
were performed in follicle center cell lymphoma (FCL), marginal zone B-cell lymphoma (MZL),
diffuse large B-cell lymphoma, and pseudolymphoma. CD123þBDCA2þpDC appear to be
less frequent in DLBCL lymphoma than in other CBCL entities with better prognosis, possibly
indicating an immunologically less favourable setting in DLBCL. Preliminary studies with
imiquimod in cutaneous T-cell lymphoma (CTCL) have shown this drug to be efficient in
subtypes of CTCL. Here, we show that the target cells for imiquimod can be found in CBCL,
underlining a rational for the treatment of these lymphoma with immunomodulators such as
imiquimod.
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Confocal Examination of Untreated Fresh Specimens from Basal Cell Carcinoma:
Implications for Microscopically Guided Surgery
Gerger A, Horn M, Koller S, Weger W, Massone C, Leinweber B, Kerl H, Smolle J
Department of Dermatology, Medical University of Graz, Austria
Fast confocal laser scanning microscopy offers the opportunity to examine fresh and
untreated skin excisions from basal cell carcinoma during microscopy guided surgery without
histotechnical processing. Since vertical sections are prepared, morphologic features
according to standard criteria used in conventional histopathology can be assessed. In this
study we validate the diagnostic confocal examination of basal cell carcinoma in microscopy
guided surgery. 4 independent observers without previous experience in confocal laser
scanning microscopy received a standardized instruction about diagnostic confocal
microscopy features. Subsequently, 120 confocal images of fresh excisions from basal cell
carcinoma or normal skin, imaged using a commercially available, near-infrared, reflectance
confocal laser scanning microscope, were evaluated by each observer. Logistic regression
analysis was performed on combination of all morphologic features using the forward-
stepwise (Wald) method. Reliability (interobserver agreement) data were evaluated by kappa
statistic.
Approximately 5 minutes are required to prepare confocal examination of surgical
excisions. Overall, high diagnostic performance was achieved by the 4 observers. All images
were classified correctly by two observers, respectively, followed by the remaining two
observers with two misclassified images each. Logistic regression analysis revealed that
mainly tumour cell nuclei and tumour nests should be taken into account for diagnostic
decisions, whereas disintegration of tumour cells, peripheral palisading and retraction of
stroma were rarely useful. However, most of the features were highly reliable, indicating good
definitions of the morphologic features. This first diagnostic validation study of confocal
microscopy in microscopy guided surgery has yielded promising results and implications for
further studies. In the future, confocal laser scanning microscopy may guide microsurgery of
any skin cancer.
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Development and Characterization of an In Vitro Assay for the Study of Human
Chemotherapy-Induced Alopecia
Bodo E1, Liotiri S1, Funk W2, Paus R1
1University-Hospital Hamburg-Eppendorf, Germany; 2Klinik Dr. Koslowski, Germany
Chemotherapy-induced alopecia (CIA) is a common side effect and one of the major
unresolved problems of clinical oncology. Although the molecular mechanisms of CIA are
becoming increasingly defined in the murine system, for which a well-established and
instructive CIA model (¼CIA induction by cyclophosphamide in C57BL/6 mice) exists, they
are virtually unknown in the human system. Largely, this is due to the lack of adequate
research models for human CIA. Therefore, we have explored whether microdissected,
organ-cultured bulbi of human scalp hair follicles in anagen VI (hHF) can be exploited as such
a model. Here, we show that hHF respond by the typical morphological changes of
chemotherapy-induced follicle dystrophy when the cyclophosphamide metabolite, 4-
hydroperoxycyclophosphamide (4-HC), which spontaneously converts to highly toxic
metabolites were administrated: melanin clumping and incontinence, shrinkage of the hair
matrix, premature catagen entry, downregulation of proliferation, ectopic and massively
upregulated apoptosis. These effects are dose-dependent. We are currently investigating,
how major regulators of intrafollicular apoptosis (p53, Bcl-2, Fas/FasL) are affected by 4-HC
application on fibroblasts, melanocytes and epithelial cells which cell types besides hair
matrix keratinocytes respond with increased apoptosis to 4-HC administration. This novel,
pragmatic and clinically highly relevant in vitro-assay for the study of human CIA can now be
employed a) to dissect the underlying molecular controls and b) to explore the efficacy of
agents that we and others have already reported to modulate rodent CIA (e.g. estrogens,
calcitriols, glucocortidosteroids, cyclosporine A, CDK inhibitors).
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Schwann Cells of the Subepidermal Nerve Plexus Constitute a Signifcant and Discrete
Entity
Reinisch CM, Ghannadan M, Tschachler E
Medical University of Vienna, Austria
Dermal nerve fibers are composed of one or several axons ensheated by individual Schwann
cells. Apart from their function as axonal supply and scaffold, the Schwann cells in the dermis
are largely unnoticed cells assumed to correspond to Schwann cells of peripheral nerves. In
this study, we analysed Schwann cells in the hairy skin of various body regions from 10
individuals in comparison to Schwann cells of larger peripheral nerves. To depict the entire
subepidermal nerve plexus, we used immunostainings of dermal sheet preparations for
neural cell adhesion molecule (NCAM), L1cell adhesion molecule (L1CAM), nerve growth
factor receptor (NGFr), CD146, S100, Vimentin, myelin basic protein and peripheral myelin
protein 22. In parallel, stainings of skin sections (100 mm thick) and peripheral nerves (4 mm
thick) as well as double stainings were done. In chest- and abdominal skin, the highest
number of Schwann cells per mm2 superficial dermis was found with 458  109
(mean  standard deviation) respectively 414  103. Intermediate Schwann cell numbers
were present in skin from lower arm inside (272  70), thigh (245  70), upper arm
(241  92) and shoulder (239  65). The lowest values were seen in skin from the lower arm
outside (186  58) and the lower leg (178  54). In the subepidermal nerve plexus, both non-
myelinating as well as myelinating Schwann cells stained positive for NCAM, L1CAM, NGFr
and CD146. In contrast, myelinating Schwann cells in peripheral nerves were negative for
these markers, suggesting differences in their functional properties. In summary, we show for
the first time, that myelinating Schwann cells of the subepidermal nerve plexus exhibit a
phenotype different from their equivalents in peripheral nerves probably reflecting different
axon signals or the influence of the respective microenvironment. The high number and
regular distribution of Schwann cells within the papillary dermis suggest that they may not
only play a role in the maintenance of the peripheral nerve fibers but also may participate in
tissue homeostasis of this region.
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Down Regulation of TAp63 mRNA Levels in Psoriasis and Eczema
GuX1, Nylander Lundqvist E2, Coates PJ3, Thurfjell N1, Wettersand E1, Nylander K1
1Dept of Pathology, Umea University, Sweden; 2Dept of Dermatology, Umea University
Sweden; 3Dept of Molecular and Cellular Pathology, University of Dundee, United Kingdom
The p63 gene encodes 6 different proteins with homology to the tumour suppressor protein
p53. The p63 proteins are crucial for normal development of ectodermally derived structures
such as skin and oral mucosa. p63 knockout mice lacking all p63 proteins lack normal
epidermal structures such as skin, hair follicles, oral mucosa, teeth and salivary glands.
Psoriasis and eczema are common diagnoses among patients referred to a Dermatological
Clinic. They are both chronic relapsing diseases affecting huge parts of the skin, and rarely
occur within the same patient.
In the present study we have analysed 15 patients diagnosed with psoriasis and six
patients with atopic eczema concerning p63 status. Levels of the different p63 isoforms were
analysed by using quantitative RT/PCR.
Results show a clear down regulation of the TAp63 isoforms in both psoriasis and eczema.
Furthermore lower levels of TAp63 are seen also in clinically normal skin from the patients
compared with an aged and sex matched control group.
The relevance of this finding and similarities/dissimilarities between psoriasis and eczema
from a p63 point of view are further discussed.
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Immunhistochemical Analysis of the Eczematous Reaction to Native Pollen Grains
Eyerich K1, Huss-Marp J1, Darsow U1, Wollenberg A2, Ring J1, Behrendt H1, Traidl-
Hoffmann C1
1Center for Allergy and Environment GSF/TUM, Germany; 2Department of Dermatology and
Allergy, Ludwig Maximilians University, Germany
Eczematous reactions to epicutaneous application of aeroallergens (Atopy patch test, APT)
are well documented in a subgroup of patients with atopic eczema (AE). The role of IgE-
mediated hypersensitivity in the elicitation and maintenance of eczematous skin lesions in AE
is still controversial. The aim of this study was to delineate the mechanisms underlying the
cutaneous reaction to pollen grains in comparison to a classical delayed type hypersensitivity
(DTH) response tested by epicutaneous test to nickel (ECT).
Patients with history of AE, sensitisation to grass and birch pollen and positive APT
reactions were chosen for the study (n¼ 4). Biopsies of healthy control (n¼ 2), negative patch
test reactions in AE patients (n¼ 2) and positive nickel patch test biopsies (n¼ 2) served as
references. Pollen grains (grass and birch) were applied in large Finn chambers with
petrolatum as carrier. Biopsies were taken from positive and negative APT and ECT reactions
6, 24, 48, 72 and 96 hours after application and investigated by alkaline anti-alkaline
phosphatase (APAAP)-immunohistochemistry. Quantification was performed automatically in
a blinded manner with the KS 300 Zeiss programm.
Histology of both positive pollen and nickel patch tests showed a strong influx of
lymphocytes with a clear feature of epidermotropism. By immunohistochemistry, the majority
of these T lymphocytes were characterised as CD3þ , CD4þ , CD45ROþand just a small
amount were CD8þ . A quotient of CD25/CD4 positivity revealed a biphasic course of
occurrence of CD25 positive cells: in ATP-lesions a rapid influx of CD25þT-cells (6 h) was
observed with a second late peak (96 h) whereas in ECT-lesion a maximum after 24 and 96 h
was observed. High amounts of IgE were found only in APT biopsies. In ECT lesion the
cytokine pattern of the cellular infiltrate was clearly IFN-g dominated as shown by a quotient
of IFN-g and IL-5. In contrast, the APT reaction showed a biphasic pattern with a dominating
IL-5 production in the early phase of the reaction and a more IFN-g driven response 96 hours
after pollen application. Concerning FceRI there was an increase in positive cells from 6 to 96
hours in the positive APT compared to the negative controls. CD1a positive cells (IDEC) were
more prominent in ATP compared to ECT-lesions. CD64 and CD68 were maximally expressed
after 72 hours in both the APT- and ECT-reactions. Negative pollen patch test reactions
showed only a scarce cellular infiltrate which was dominated by CD25þT-cells and IFN-g.
In this study we demonstrate that pollen induce acute eczematous reactions which show
immunohistochemical similarities to DTH reactions, but follow a faster kinetic and a biphasic
cytokine expression pattern–Th2 in the early phase and Th1 and the late (96h) phase.
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Assessment of Epidermal Subpopulations and Proliferation in Healthy, Symptomless and
Lesional Skin of Spreading Psoriasis
Korver J, Van Duijnhoven M, Pasch M, Van Erp P, Van De Kerkhof P
University Medical Centre Nijmegen, The Netherlands
The aim of this study was to quantify in a dynamic model of the margin zone in psoriasis the
characteristics of epidermal subpopulations: basal cells, transit amplifying cells and
differentiated cells with respect to epidermal proliferation and differentiation. From seven
patients with active psoriasis, biopsies were taken from the distant uninvolved skin, outer
margin, inner margin and the center of a spreading sporiatic plaque. Frozen sections were
immunofluorescent labelled using direct immunofluorescence for Ki-67 and b-1 integrin and
the Zenon labelling technique for keratin 6, 10, and 15. The immunofluorescent photographs
were quantitatively analysed. In the distant uninvolved skin the amount of Ki-67 positive
nuclei was increased and keratin 15 expression was lost. The outer margin showed a
suprabasal expression of b-1 integrin and Ki-67. From the outer to the inner margin of the
psoriasis plaque, which coincided with the appearance of the clinical lesion, there was a
significant change in the various markers, The patchy expression of keratin 6 in the inner
margin became homogeneous in the center of the psoriasis plaque and there was also co-
expression of both keratin 6 and keratin 10. The present study provides additional evidence
that the distant uninvolved skin has already psoriasis associated changes in the basal
compartment of the epidermis. The cascade between symptomless and lesional skin
comprizes first an abnormality in inflammation with involvement of b-1 integrin dim cells
(transit amplifying cells) subsequently eliciting an enlarged germanitive compartment with
increased recruitment of cycling epidermal cells and focal expression of proliferation
associated keratins, ultimately culminating in a more or less homogeneous epidermis with
massive recruitment of cycling epidermal cells and proliferation associated keratinization.
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The Palmar Sweat Gland and Duct is a Neuroendocrine Organ with Strong Expression of
Chromogranins and Somatostatin Receptor 2
Hagforsen E1, Lindbom I1, Stridsberg M2, Michae¨lsson G1
1Dep of Medical Sciences/Dermatology and 2Clinical Chemistry, Uppsala University,
Sweden
Chromogranins are water-soluble proteins present in the neuroendocrine system and are co-
secreted with peptide hormones. They are widely used as markers for neuroendocrine tissue
and tumours. Chromogranin A, which is the most studied is up-regulated by nicotine and
corticosteroids. Somatostatin is a neuropeptide with antiproliferative effects. Somatostatin
recpetors (sst) are present in most tissues.
The target for the inflammation in pustulosis palmoplantaris (PPP) is the palmo-plantar
sweat duct (acrosyringium). PPP is most common in smoking women and there is an
increased prevalence of autoimmune thyroid and coeliac disease and abnormal calcium
homeostasis as well as increased risk for diabetes type 2.
The purpose was to study with immunohistochemistry the expression of chromogranin A, B
and C (secretogranin II) and somatostatin receptor 2 (sst2) in palmar sweat glands and duct in
healthy controls and PPP patients.
Polyclonal rabbit antibodies against the chromogranins and sst2were used. Control
staining, including preincubation of primary antiserum with relevant antigen was performed.
We found a strong expression of chromogranins and SSTR2 in the sweat glands and all
parts of the sweat duct both in 14 controls and 24 patients with PPP. The epidermis was also
stained but usually with less intensity than the sweat gland and duct. In involved PPP skin the
epidermal staining displayed an irregular pattern and below the pustule there was no staining.
The palmar sweat gland and duct is a neuroendocrine organ. To which extent the intense
inflammation in the duct in PPP has an influence on the properties of chromogranins and
somatostatin receptors is unknown.
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Nerves in the Skin: From Anatomy to Function
Peters E
University-Medicine Charite´ Berlin, Germany
The skin is one of the most densely innervated organs of the mammalian body together with
other epithelial organs facing environmental insults such as the lung or the gut. Ever since the
first anatomical analysis of cutaneous innervation a functional role for these nerve fibers other
than the classical afferent (touch, itch, pain, temperature) and efferent (glandular secretion,
muscle contraction, blood flow control) functions was suggested. This notion was supported
from early on by the observation, that small diameter nerve fibers in the skin were devoid of their
schwan cell sheathing over long stretches along their path and they displayed a bead like
structure suggesting release of neuronal signalling molecules not only from synapse-like
structures at nerve endings, but also when passing by mast cells, fibroblasts and keratinocytes in
the skin. Since these early days, modern analysis techniques such as fluorescenceimmunohis-
tochemistry, electronmicroscopy and animal experiments have demonstrated, that the skin is
richly innervated by a wide variety of different nerve fiber subsets containing classical
neurotransmitters and an abundance of neuropeptides that can act as trophins in epithelial,
endothelial and mesenchymal growth control, modulate inert and specific immune responses
and act as stress-mediators in the skin. This set-up enables the skin to mount a rapid
inflammatory and trophic response to environmental challenges. For example the sensory
neuropeptide substance P (SP) and the neurotrophin nerve growth factor (NGF) can act as
growth factors during the early stages of hair growth, promoting hair growth. However, their
prime function appears to be the conduction of neurogenic inflammation. Upon exposure to
noise (sonic stress) or in inflamed skin, nerve fiber numbers and nerve fiber-mast cell contacts
increase, mast cells degranulate and endothelial cells form gaps. SP and NGF can thereby cause
apoptosis in the hair follicle epithelium and the interfollicular dermis, terminate and inhibit hair
growth of growing and resting hair follicles and aggravate cutaneous inflammatory diseases such
as allergic dermatitis. These observations strongly suggest, that inert immune responses in the
skin and possibly other epithelial organs are key players determining disease severity and stress-
sensitivity and deserve to be included in the analysis of peripheral inflammatory diseases.
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Feasibility of Immunohistochemical Detection of Gangliosides in Routinely Processed
Samples of Melanoma
Debarbieux S1, Duhieu S1, Portoukalian J1, Zabawski B1, Popa I1, Thomas L2, Haftek M1
1Universite´ Claude Bernard Lyon 1, EA3732, France; 2Dept. of Dermatology, Hotel-Dieu
Hospital, Lyon, France
Gangliosides are ubiquitous glycolipids synthesised by various cell types. Interestingly, their
profile of expression in melanoma diverges from that observed in normal melanocytes. GD3
appears to be the principal type of gangliosides present in melanoma cells, however, the
laboratory and clinical data bring conflicting results as to the possible correlation between
GD3 expression level and tumour aggressivity. Since definition of such relationship may have
a prognostic value, we have decided to evaluate the feasibility of an immunohistochemical
study of ganglioside expression in paraffin-embedded melanoma tumours, which would allow
for retrospective comparisons based on the observed clinical evolution.
Eighteen tumours (mostly SSM) have been obtained and fragments of each were frozen or
fixed in a fixative (Bouin’s or formol) and embedded in paraffin. Immunostainings were
performed on frozen or de-waxed tissue sections (with and without antigen retrieval) using 2
different anti-GD3 monoclonal antibodies, revealed with biotin-streptavidin-peroxidase Dako
kit. Antibodies to CD1a and PS100 served as the negative and positive controls, respectively.
GD3 detection on Bouin’s–fixed tissues was very poor and irregular whereas formol fixation
allowed for a partial visualisation of the antigen on GD3-rich tumours, as compared with the
frozen tissue counterparts. Biochemical analysis of the ganglioside fate during routine
procedures of histological preparation revealed that a significant fraction of these glycolipids
is eluted from tissues during dehydration and rehydration steps. Additionally, acid-containing
Bouin’s fixative contributed to the time-dependent CD3 degradation. Our results indicate that
retrospective studies of formol-fixed, paraffin-embedded melanomas can be proposed in
order to establish clinical correlations of high GD3 expression in the initial tumours.
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Study of E-Cadherin Expression: Application in Human Solar Lentigo
Marteau C1, Noblesse E1, Talbourdet S1, Duquesne C1, Nizard C1, Cario-Andre M2, Taieb
A2, Kurfurst R1, Schnebert S1
1LVMH Recherche, France; 2INSERM E 217, France
Solar Lentigo is a regular and widespread component of photoaged skin. This study was
carried out to increase our knowledge about solar lentigo formation and the prevention in
human skin. Using biopsies from volunteers, we performed a systematic comparison
between lesional and perilesional skin using histology, immunochemistry and transmission
electron microscopy.
These studies showed important modifications in the structure and ultrastructure of
lesional skin in comparison to perilesional skin. We observed a hyperpigmented basal layer
and an elongation of the rete ridges of the epidermis which drove deeply into the dermis. We
also observed a disruption and disorganization in the dermal-epidermal junction. The
epidermis contained clusters of keratinocytes which accumulated melanin. The pigment
agglomerated in polymelanosomes and formed a massive cap on the nuclei. Considering our
observations and the role of E-cadherin in adherens junctions and signal transduction, an
immunostaining of this molecule on lesional and perilesional skin was performed. In the
lesional skin, we observed an important decrease of the E-cadherin expression in the
epidermis. Using cells in culture and a reconstructed epidermis model, we tested several
active ingredients on E-cadherin expression. We showed that a Citrus unshiu extract (5%)
could increase the E-cadherin expression (þ45%). These results open a new strategy to
reduce and prevent solar lentigo in human skin.
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Histocompatibility Antigens in Saudi Patients with Vitiligo
Abanmi A, Al-Harthi F, Arfin M, Tariq M
Armed forces Hospital, Saudi Arabia
Vitiligo, a dermatological disorder is characterized by the presence of depigmented patches
on the skin. It is an autoimmune disease and there is an association between vitiligo and HLA
complex. In present study a group of Saudi patients with vitiligo and a group of matched
controls were tested for HLA class I (HLA-A, B, C) and class II (HLA-DR, DQ) antigens and
genes, using two stage microcytotoxicity assay. The frequencies of 89 antigens and genes of
various HLA loci were tested for each patient and control. HLA-B7, Bw6, Cw6, Cw7 were
significantly increased in patients compared to controls (P¼0.02, 0.03, 0.01 and P¼ 0.01
respectively and RR43, EF40.4) while HLA-A9, A19, B5, DR52 and DQ1 were found to be
significantly decreased in vitiligo patients compared to healthy Saudis (P¼ 0.008, 0.078,
0.004, 0.015 and P¼ 0.015 respectively and RRo1 and PFo0.5). Among the patients, the
highest gene frequency was noted for Bw6 (55.3%) while in controls it was for B5 (43.6%).
These results for antigens and gene frequency of various HLA Loci in vitiligo patients and
control subjects suggested that HLA-B7, Bw6, Cw6, and Cw7 could be susceptible to vitiligo,
while HLA-A9, A19, B5, DR52 and DQ1 might be negatively associated with the development
of vitiligo in Saudis. The positive association of HLA-Cw6 with vitiligo in our study is similar to
one reported for North Italian and Kuwaiti vitiligo patients, of Cw7 for Dutch Vitiligo patients
and HLA-Bw6 and DR7 for Omani vitiligo patients.
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